id.exposure	id.outcome	outcome	exposure	method	nsnp	b	se	pval	lo_ci	up_ci	or	or_lci95	or_uci95	OR_CI	effect_direction	exposure_name	exposure_cat
ieu-a-974	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Body mass index	Inverse variance weighted	36	-0.30663494811409336	0.06790155967062857	6.305588677447898e-6	-0.4397220050685253	-0.17354789115966138	0.7359192005699067	0.6442154848321416	0.8406768892066684	0.736 [0.644:0.841]	negative	Body mass index (F) Locke AE/2015 [171K]	Antrophometric
ieu-a-974	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Body mass index	MR Egger	36	-0.7255543107961432	0.16871075846270675	1.3573506821155148e-4	-1.0562273973830485	-0.39488122420923794	0.48405617701110143	0.3477653190015524	0.6737600608804722	0.484 [0.348:0.674]	negative	Body mass index (F) Locke AE/2015 [171K]	Antrophometric
ieu-a-974	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Body mass index	Weighted median	36	-0.31219469972212627	0.0607451236855161	2.755878835195412e-7	-0.4312551421457378	-0.19313425729851472	0.7318390255012359	0.6496931255281287	0.8243712888469066	0.732 [0.65:0.824]	negative	Body mass index (F) Locke AE/2015 [171K]	Antrophometric
ieu-a-95	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Body mass index	Inverse variance weighted	11	-0.40228425272130774	0.13138160033215343	0.0021989815941250773	-0.6597921893723284	-0.14477631607028701	0.6687906131170127	0.5169587528528848	0.8652158063386464	0.669 [0.517:0.865]	negative	Body mass index (F) Randall JC/2013 [ 73K]	Antrophometric
ieu-a-95	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Body mass index	MR Egger	11	-1.0330702559800493	0.5110501272154658	0.07394679793439754	-2.034728505322362	-0.031412006637736356	0.35591253875081813	0.13071596637611932	0.9690762249774781	0.356 [0.131:0.969]	negative	Body mass index (F) Randall JC/2013 [ 73K]	Antrophometric
ieu-a-95	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Body mass index	Weighted median	11	-0.4116774839901633	0.08097322572539473	3.6933709123711817e-7	-0.5703850064119369	-0.25296996156838963	0.6625379206849079	0.565307749688046	0.7764912060514135	0.663 [0.565:0.776]	negative	Body mass index (F) Randall JC/2013 [ 73K]	Antrophometric
ukb-b-19953	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Body mass index (BMI)	Inverse variance weighted	415	-0.11792686410853603	0.03326887981304222	3.931199798274453e-4	-0.1831338685420988	-0.05271985967497329	0.8887610505694785	0.8326566817397734	0.9486457291844878	0.889 [0.833:0.949]	negative	Body mass index (BMI) (M/F) MRC-IEU/2018 [461K]	Antrophometric
ukb-b-19953	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Body mass index (BMI)	MR Egger	415	-0.38906514503097767	0.08872170271293388	1.4721211723027848e-5	-0.562959682348328	-0.21517060771362725	0.677690120432035	0.5695209658145856	0.8064038497236027	0.678 [0.57:0.806]	negative	Body mass index (BMI) (M/F) MRC-IEU/2018 [461K]	Antrophometric
ukb-b-19953	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Body mass index (BMI)	Weighted median	415	-0.11188546499324148	0.03509359749017309	0.0014316066761517802	-0.18066891607398072	-0.043102013912502235	0.8941466627298124	0.8347116725693728	0.9578136747625445	0.894 [0.835:0.958]	negative	Body mass index (BMI) (M/F) MRC-IEU/2018 [461K]	Antrophometric
ukb-a-248	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Body mass index (BMI)	Inverse variance weighted	289	-0.13228868817338674	0.03368917431650286	8.610433576641742e-5	-0.19831946983373233	-0.06625790651304113	0.8760880423122328	0.8201078115766657	0.9358894611757153	0.876 [0.82:0.936]	negative	Body mass index (BMI) (M/F) Neale Lab/2017 [336K]	Antrophometric
ukb-a-248	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Body mass index (BMI)	MR Egger	289	-0.4307452024095927	0.096128696649473655	1.0746884994417661e-5	-0.619157447842561	-0.24233295697662433	0.6500245143561204	0.5383978748365911	0.784794831131443	0.65 [0.538:0.785]	negative	Body mass index (BMI) (M/F) Neale Lab/2017 [336K]	Antrophometric
ukb-a-248	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Body mass index (BMI)	Weighted median	289	-0.11699608607402309	0.03647028782997105	0.0013366911007027795	-0.18847785022076635	-0.04551432192727985	0.8895886749408213	0.8282188481001188	0.9555059177876885	0.89 [0.828:0.956]	negative	Body mass index (BMI) (M/F) Neale Lab/2017 [336K]	Antrophometric
ukb-a-34	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Comparative body size at age 10	Inverse variance weighted	144	-0.4460667371007739	0.06546450334203906	9.500633756662019e-12	-0.5743771636511704	-0.31775631055037734	0.6401410494783438	0.5630554510192513	0.7277801191435844	0.64 [0.563:0.728]	negative	body size at age 10 (M/F) Neale Lab/2017 [331K]	Antrophometric
ukb-a-34	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Comparative body size at age 10	MR Egger	144	-0.9829406601922877	0.13578613442937756	2.6102603304658952e-11	-1.2490814836738677	-0.7167998367107076	0.37420905760185663	0.28676807708870533	0.4883124377472243	0.374 [0.287:0.488]	negative	body size at age 10 (M/F) Neale Lab/2017 [331K]	Antrophometric
ukb-a-34	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Comparative body size at age 10	Weighted median	144	-0.5327432373719204	0.07387053212650656	5.519653869154729e-13	-0.6775294803398733	-0.3879569944039676	0.5869924992340279	0.5078701469395068	0.6784415194186464	0.587 [0.508:0.678]	negative	body size at age 10 (M/F) Neale Lab/2017 [331K]	Antrophometric
ukb-b-4650	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Comparative body size at age 10	Inverse variance weighted	204	-0.5050803700353863	0.0682362894524943	1.3421729690215806e-13	-0.6388234973622751	-0.3713372427084975	0.60345707361166	0.5279131500420766	0.6898112685068057	0.603 [0.528:0.69]	negative	body size at age 10 (M/F) MRC-IEU/2018 [454K]	Antrophometric
ukb-b-4650	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Comparative body size at age 10	MR Egger	204	-0.8048778744515632	0.14304151490130002	6.070372131121443e-8	-1.0852392436581113	-0.5245165052450151	0.4471425307518026	0.33782095470493356	0.5918414474370285	0.447 [0.338:0.592]	negative	body size at age 10 (M/F) MRC-IEU/2018 [454K]	Antrophometric
ukb-b-4650	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Comparative body size at age 10	Weighted median	204	-0.564627541490154	0.06787050105004833	8.856705144838743e-17	-0.6976537235482487	-0.43160135943205935	0.5685718767587303	0.4977517981199376	0.6494682294709644	0.569 [0.498:0.649]	negative	body size at age 10 (M/F) MRC-IEU/2018 [454K]	Antrophometric
ukb-a-35	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Comparative height size at age 10	Inverse variance weighted	342	0.12758726290578332	0.04630342650195948	0.0058609580239502215	0.03683254696194273	0.21834197884962392	1.1360840019069733	1.0375192705371608	1.2440124208206074	1.136 [1.038:1.244]	positive	height size at age 10 (M/F) Neale Lab/2017 [332K]	Antrophometric
ukb-a-35	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Comparative height size at age 10	MR Egger	342	0.24432888999709784	0.11515195121603926	0.034577760098249144	0.018631065613660902	0.4700267143805348	1.2767641764103825	1.0188057068145007	1.6000369366420208	1.277 [1.019:1.6]	positive	height size at age 10 (M/F) Neale Lab/2017 [332K]	Antrophometric
ukb-a-35	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Comparative height size at age 10	Weighted median	342	0.059990434594133696	0.041923900138258904	0.1524484446310648	-0.022180409676853752	0.14216127886512114	1.0618263896964055	0.978063766965273	1.152762549781414	1.062 [0.978:1.153]	overlaps null	height size at age 10 (M/F) Neale Lab/2017 [332K]	Antrophometric
ieu-a-85	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Extreme body mass index	Inverse variance weighted	7	-0.13461173467284762	0.02401872196580636	2.0891686694294903e-8	-0.18168842972582808	-0.08753503961986717	0.8740552111471696	0.833861106279478	0.9161867682523486	0.874 [0.834:0.916]	negative	Extreme body mass index (M/F) Berndt SI/2013 [ 16K]	Antrophometric
ieu-a-85	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Extreme body mass index	MR Egger	7	-0.1875258530021132	0.11971100700271742	0.1780142507323495	-0.42215942672743934	0.047107720723212954	0.829007685565906	0.655629506194385	1.0482349196217826	0.829 [0.656:1.048]	overlaps null	Extreme body mass index (M/F) Berndt SI/2013 [ 16K]	Antrophometric
ieu-a-85	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Extreme body mass index	Weighted median	7	-0.14551017728043025	0.020139603957461946	5.008201956549427e-13	-0.18498380103705567	-0.10603655352380484	0.8645810909449607	0.8311177469886668	0.8993917715365203	0.865 [0.831:0.899]	negative	Extreme body mass index (M/F) Berndt SI/2013 [ 16K]	Antrophometric
ieu-a-1034	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Height	Inverse variance weighted	4	0.22512377938622752	0.14787722359675434	0.12791651511101387	-0.064715578863411	0.5149631376358661	1.252477737523058	0.9373340230762071	1.673576808662732	1.252 [0.937:1.674]	overlaps null	Height (M/F) Cousminer/2013 [ 13K]	Antrophometric
ieu-a-1034	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Height	MR Egger	4	-3.3197267666425283	3.3254906110570697	0.4233174302087913	-9.837688364314385	3.1982348310293283	0.036162711263292964	5.340061130981075e-5	24.489264333047768	0.036 [0:24.489]	overlaps null	Height (M/F) Cousminer/2013 [ 13K]	Antrophometric
ieu-a-1034	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Height	Weighted median	4	0.06932574065209245	0.06494526259179603	0.2857692357440619	-0.057966974027827786	0.19661845533201266	1.0717852763273883	0.943681112908335	1.2172795055862882	1.072 [0.944:1.217]	overlaps null	Height (M/F) Cousminer/2013 [ 13K]	Antrophometric
ieu-a-51	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Hip circumference	Inverse variance weighted	16	-0.31412131012400163	0.1088746872004735	0.00391210013722335	-0.5275156970369297	-0.10072692321107357	0.7304304141805283	0.5900690606183336	0.9041799097225218	0.73 [0.59:0.904]	negative	Hip circumference (F) Shungin D/2015 [127K]	Antrophometric
ieu-a-51	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Hip circumference	MR Egger	16	-1.0640211217917754	0.31998539410178584	0.005004758058235328	-1.6911924942312757	-0.43684974935227516	0.3450654665654775	0.1842996166702366	0.6460684963284564	0.345 [0.184:0.646]	negative	Hip circumference (F) Shungin D/2015 [127K]	Antrophometric
ieu-a-51	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Hip circumference	Weighted median	16	-0.4544526905452829	0.08785314125996521	2.305280515441326e-7	-0.6266448474148147	-0.2822605336757511	0.634795302360646	0.5343817288262608	0.7540771964345299	0.635 [0.534:0.754]	negative	Hip circumference (F) Shungin D/2015 [127K]	Antrophometric
ukb-a-388	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Hip circumference	Inverse variance weighted	261	-0.11176795914952614	0.042477321815942645	0.008507434167542873	-0.1950235099087737	-0.028512408390278562	0.8942517363610836	0.8228153135156667	0.9718902344779788	0.894 [0.823:0.972]	negative	Hip circumference (M/F) Neale Lab/2017 [336K]	Antrophometric
ukb-a-388	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Hip circumference	MR Egger	261	-0.37673722133257964	0.12360012489823495	0.002541876423951964	-0.6189934661331201	-0.13448097653203914	0.686096341692109	0.5384861694796215	0.874169508454032	0.686 [0.538:0.874]	negative	Hip circumference (M/F) Neale Lab/2017 [336K]	Antrophometric
ukb-a-388	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Hip circumference	Weighted median	261	-0.12769331101263182	0.03944774087508365	0.0012078296299306264	-0.20501088312779578	-0.05037573889746785	0.8801232618694406	0.8146384505488058	0.9508720777442554	0.88 [0.815:0.951]	negative	Hip circumference (M/F) Neale Lab/2017 [336K]	Antrophometric
ieu-a-101	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Hip circumference	Inverse variance weighted	5	0.3043390954904184	0.1912519386418483	0.11154221145863016	-0.07051470424760431	0.6791928952284411	1.3557286996420188	0.9319140363303168	1.9722852488312133	1.356 [0.932:1.972]	overlaps null	Hip circumference (F) Randall JC/2013 [ 73K] AdjBMI	Antrophometric
ieu-a-101	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Hip circumference	MR Egger	5	2.2987763309454166	1.6980440520740578	0.2687664770865245	-1.029390011119737	5.62694267301057	9.96198482085563	0.35722479727750145	277.81145745563913	9.962 [0.357:277.811]	overlaps null	Hip circumference (F) Randall JC/2013 [ 73K] AdjBMI	Antrophometric
ieu-a-101	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Hip circumference	Weighted median	5	0.1336031229985019	0.10977373020031812	0.22357477940076803	-0.08155338819412161	0.34875963419112543	1.142939123367616	0.921683501522629	1.417308476897221	1.143 [0.922:1.417]	overlaps null	Hip circumference (F) Randall JC/2013 [ 73K] AdjBMI	Antrophometric
ukb-a-269	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Impedance of whole body	Inverse variance weighted	333	0.16803665122590014	0.04911356193905559	6.230191456359353e-4	0.07177406982535119	0.2642992326264491	1.1829799675192896	1.0744125744197688	1.3025178938432485	1.183 [1.074:1.303]	positive	Impedance of whole body (M/F) Neale Lab/2017 [331K]	Antrophometric
ukb-a-269	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Impedance of whole body	MR Egger	333	0.36622709772650386	0.13623861420962996	0.007548723343787153	0.09919941387562914	0.6332547815773786	1.4422827445979092	1.1042864876521794	1.883731747716611	1.442 [1.104:1.884]	positive	Impedance of whole body (M/F) Neale Lab/2017 [331K]	Antrophometric
ukb-a-269	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Impedance of whole body	Weighted median	333	0.14185247768161158	0.045378922119023606	0.0017722854710137015	0.05290979032832531	0.23079516503489783	1.1524066302987432	1.0543345296574975	1.2596012026542664	1.152 [1.054:1.26]	positive	Impedance of whole body (M/F) Neale Lab/2017 [331K]	Antrophometric
ieu-a-90	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Obesity class 1	Inverse variance weighted	16	-0.15494843565611505	0.040340960601644146	1.2254889181228235e-4	-0.23401671843533756	-0.07588015287689252	0.8564593391089064	0.7913485856748308	0.9269272894717385	0.856 [0.791:0.927]	negative	Obesity class 1 (M/F) Berndt SI/2013 [ 98K]	Antrophometric
ieu-a-90	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Obesity class 1	MR Egger	16	-0.2884206971731296	0.11106669621321084	0.021107374890758	-0.5061114217510229	-0.07072997259523636	0.7494462359960563	0.6028351988082324	0.9317134463266948	0.749 [0.603:0.932]	negative	Obesity class 1 (M/F) Berndt SI/2013 [ 98K]	Antrophometric
ieu-a-90	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Obesity class 1	Weighted median	16	-0.17922214445035808	0.030234023522256463	3.069644824158025e-9	-0.23848083055398075	-0.11996345834673541	0.8359201837401878	0.7878237902580122	0.8869528468483856	0.836 [0.788:0.887]	negative	Obesity class 1 (M/F) Berndt SI/2013 [ 98K]	Antrophometric
ieu-a-91	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Obesity class 2	Inverse variance weighted	10	-0.13482251464776354	0.027711513788552973	1.1433157471643394e-6	-0.18913708167332738	-0.08050794762219972	0.8738709972266736	0.8276730401125103	0.9226475707003017	0.874 [0.828:0.923]	negative	Obesity class 2 (M/F) Berndt SI/2013 [ 72K]	Antrophometric
ieu-a-91	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Obesity class 2	MR Egger	10	-0.2570568004598127	0.07498356727846674	0.00897897887044538	-0.4040245923256075	-0.1100890085940179	0.773324287342835	0.6676277025491968	0.8957544019082033	0.773 [0.668:0.896]	negative	Obesity class 2 (M/F) Berndt SI/2013 [ 72K]	Antrophometric
ieu-a-91	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Obesity class 2	Weighted median	10	-0.1514374567119896	0.023080169836164673	5.33168417049407e-11	-0.19667458959087236	-0.10620032383310685	0.8594716347739708	0.8214579007760648	0.8992444899284185	0.859 [0.821:0.899]	negative	Obesity class 2 (M/F) Berndt SI/2013 [ 72K]	Antrophometric
ieu-a-93	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Overweight	Inverse variance weighted	14	-0.2575390593260097	0.05727356136664328	6.903305268689329e-6	-0.3697952396046305	-0.14528287904738885	0.7729514347617763	0.6908757801531265	0.8647776310350149	0.773 [0.691:0.865]	negative	Overweight (M/F) Berndt SI/2013 [158K]	Antrophometric
ieu-a-93	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Overweight	MR Egger	14	-0.5410242205768455	0.18332443929893105	0.012117526646062693	-0.9003401216027505	-0.18170831955094063	0.5821516951780156	0.4064314001301714	0.8338445210928447	0.582 [0.406:0.834]	negative	Overweight (M/F) Berndt SI/2013 [158K]	Antrophometric
ieu-a-93	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Overweight	Weighted median	14	-0.22510266924477607	0.04492625272984212	5.429080825643782e-7	-0.3131581245952666	-0.13704721389428554	0.7984342399106809	0.731134293113799	0.8719290579938944	0.798 [0.731:0.872]	negative	Overweight (M/F) Berndt SI/2013 [158K]	Antrophometric
ukb-b-16881	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Sitting height	Inverse variance weighted	550	0.04922309292115386	0.032856028321203296	0.13409559454360664	-0.015174722588404604	0.11362090843071232	1.0504546736028442	0.9849398333309715	1.120327337724051	1.05 [0.985:1.12]	overlaps null	Sitting height (M/F) MRC-IEU/2018 [461K]	Antrophometric
ukb-b-16881	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Sitting height	MR Egger	550	0.0982167798309089	0.07573783606158302	0.19524597489719805	-0.05022937884979381	0.2466629385116116	1.1032019111124733	0.9510112576118236	1.279747686413804	1.103 [0.951:1.28]	overlaps null	Sitting height (M/F) MRC-IEU/2018 [461K]	Antrophometric
ukb-b-16881	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Sitting height	Weighted median	550	0.03686144560910344	0.033303270686883046	0.26836241629203456	-0.028412964937187327	0.10213585615539421	1.0375492538737192	0.9719868874045917	1.1075339268088424	1.038 [0.972:1.108]	overlaps null	Sitting height (M/F) MRC-IEU/2018 [461K]	Antrophometric
ukb-a-195	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Sitting height	Inverse variance weighted	406	0.03866238258942864	0.034532637943096973	0.262888685882865	-0.02902158777904143	0.10634635295789871	1.0394194982845983	0.9713954939689667	1.1122070259970978	1.039 [0.971:1.112]	overlaps null	Sitting height (M/F) Neale Lab/2017 [336K]	Antrophometric
ukb-a-195	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Sitting height	MR Egger	406	0.049279118719404574	0.08748598205638485	0.5735566043776789	-0.12219340611110971	0.22075164354991886	1.0505135278131206	0.8849771919527489	1.2470136882095948	1.051 [0.885:1.247]	overlaps null	Sitting height (M/F) Neale Lab/2017 [336K]	Antrophometric
ukb-a-195	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Sitting height	Weighted median	406	0.004151502243822736	0.03192365482033948	0.896531058239976	-0.05841886120404264	0.06672186569168811	1.00416013166682	0.9432547718512587	1.0689981117722134	1.004 [0.943:1.069]	overlaps null	Sitting height (M/F) Neale Lab/2017 [336K]	Antrophometric
ukb-b-10787	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Standing height	Inverse variance weighted	710	0.07273858403543723	0.027582865426517156	0.008361987884445978	0.018676167799463607	0.12680100027141086	1.0754493605323852	1.0188516582150329	1.1351910925833846	1.075 [1.019:1.135]	positive	Standing height (M/F) MRC-IEU/2018 [461K]	Antrophometric
ukb-b-10787	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Standing height	MR Egger	710	0.1290535604067398	0.055722008977491834	0.02084166525140391	0.019838422810855794	0.2382686980026238	1.1377510609434105	1.02003651207845	1.26905013825456	1.138 [1.02:1.269]	positive	Standing height (M/F) MRC-IEU/2018 [461K]	Antrophometric
ukb-b-10787	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Standing height	Weighted median	710	0.04464012830751758	0.02907268636024828	0.12466934449437723	-0.012342336958569046	0.1016225935736042	1.0456514918185604	0.9877335172886261	1.1069656169447188	1.046 [0.988:1.107]	overlaps null	Standing height (M/F) MRC-IEU/2018 [461K]	Antrophometric
ieu-a-68	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist circumference	Inverse variance weighted	24	-0.17808133140410418	0.0876755838469317	0.04224085722167082	-0.34992547574409033	-0.006237187064118022	0.8368743565543386	0.7047406080311679	0.9937822238097341	0.837 [0.705:0.994]	negative	Waist circumference (F) Shungin D/2015 [134K] AdjBMI	Antrophometric
ieu-a-68	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist circumference	MR Egger	24	-0.660149798869266	0.3204685129466863	0.051426755967738935	-1.2882680842447711	-0.032031513493760766	0.516773916544919	0.27574794197616515	0.968476061533973	0.517 [0.276:0.968]	negative	Waist circumference (F) Shungin D/2015 [134K] AdjBMI	Antrophometric
ieu-a-68	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist circumference	Weighted median	24	-0.2930645561301383	0.07227741274499394	5.0194731976395255e-5	-0.43472828511032646	-0.1514008271499502	0.7459739819493084	0.647440562421249	0.8595031174201321	0.746 [0.647:0.86]	negative	Waist circumference (F) Shungin D/2015 [134K] AdjBMI	Antrophometric
ukb-b-9405	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist circumference	Inverse variance weighted	344	-0.15138044720482863	0.04316154597355315	4.5268018717857067e-4	-0.2359770773129928	-0.06678381709666445	0.8595206342249921	0.7897987780354921	0.935397396405358	0.86 [0.79:0.935]	negative	Waist circumference (M/F) MRC-IEU/2018 [462K]	Antrophometric
ukb-b-9405	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist circumference	MR Egger	344	-0.5328479196644683	0.12048357633200175	1.3122091083672303e-5	-0.7689957292751918	-0.29670011005374486	0.5869310547296315	0.4634782923472761	0.7432668772066652	0.587 [0.463:0.743]	negative	Waist circumference (M/F) MRC-IEU/2018 [462K]	Antrophometric
ukb-b-9405	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist circumference	Weighted median	344	-0.1461077172437436	0.046171852427607844	0.0015538562140593743	-0.236604548001855	-0.05561088648563223	0.8640646235119288	0.7893033578992376	0.9459071295375424	0.864 [0.789:0.946]	negative	Waist circumference (M/F) MRC-IEU/2018 [462K]	Antrophometric
ieu-a-62	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist circumference	Inverse variance weighted	17	-0.33041741338461045	0.10014647132588922	9.691192208175157e-4	-0.5267044971833533	-0.13413032958586757	0.7186237076648192	0.5905479187524721	0.8744760870698941	0.719 [0.591:0.874]	negative	Waist circumference (F) Shungin D/2015 [134K]	Antrophometric
ieu-a-62	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist circumference	MR Egger	17	-0.9652693671407117	0.3082234414989163	0.006857976742309835	-1.5693873124785875	-0.36115142180283577	0.3808805892047379	0.208172688100741	0.6968734686403462	0.381 [0.208:0.697]	negative	Waist circumference (F) Shungin D/2015 [134K]	Antrophometric
ieu-a-62	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist circumference	Weighted median	17	-0.4461844205835369	0.08314275821936552	8.028557579268029e-8	-0.6091442266934933	-0.2832246144735805	0.6400657198827931	0.5438160532620364	0.7533505554159743	0.64 [0.544:0.753]	negative	Waist circumference (F) Shungin D/2015 [134K]	Antrophometric
ieu-a-105	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist circumference	Inverse variance weighted	5	-0.21964119765805346	0.1750418502929675	0.20955410272943886	-0.5627232242322697	0.12344082891616287	0.8028067952506046	0.5696556495921264	1.1313830573996895	0.803 [0.57:1.131]	overlaps null	Waist circumference (F) Randall JC/2013 [ 73K] AdjBMI	Antrophometric
ieu-a-105	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist circumference	MR Egger	5	-0.5880158624391812	0.9187149215344491	0.5676739789039685	-2.3886971086467015	1.2126653837683388	0.5554282381814926	0.09174914520600125	3.362434898731002	0.555 [0.092:3.362]	overlaps null	Waist circumference (F) Randall JC/2013 [ 73K] AdjBMI	Antrophometric
ieu-a-105	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist circumference	Weighted median	5	-0.28274393679132476	0.16102711808594194	0.07910928171514622	-0.598357088239771	0.03286921465712145	0.7537127612600365	0.5497140262558459	1.033415374818604	0.754 [0.55:1.033]	overlaps null	Waist circumference (F) Randall JC/2013 [ 73K] AdjBMI	Antrophometric
ieu-a-75	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist-to-hip ratio	Inverse variance weighted	20	-0.25124846962241504	0.11437929827716882	0.02804721203543407	-0.4754318942456659	-0.02706504499916415	0.7778290806485199	0.6216165258802485	0.9732979313022244	0.778 [0.622:0.973]	negative	Waist-to-hip ratio (F) Shungin D/2015 [118K]	Antrophometric
ieu-a-75	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist-to-hip ratio	MR Egger	20	-0.39612362305855064	0.6116961406451781	0.5254293105674135	-1.5950480587230995	0.8028008126059983	0.6729235019336641	0.20289877721207739	2.2317829889204086	0.673 [0.203:2.232]	overlaps null	Waist-to-hip ratio (F) Shungin D/2015 [118K]	Antrophometric
ieu-a-75	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist-to-hip ratio	Weighted median	20	-0.14135628420690935	0.09495172276151419	0.1365617945298825	-0.32746166081947714	0.04474909240565844	0.8681799377878321	0.7207509237456119	1.045765436498163	0.868 [0.721:1.046]	overlaps null	Waist-to-hip ratio (F) Shungin D/2015 [118K]	Antrophometric
ieu-a-109	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist-to-hip ratio	Inverse variance weighted	4	-0.2613973199121031	0.15427827958249524	0.09020382090214993	-0.5637827478937938	0.04098810806958758	0.7699749324592233	0.5690524055845455	1.0418397159864083	0.77 [0.569:1.042]	overlaps null	Waist-to-hip ratio (F) Randall JC/2013 [ 73K]	Antrophometric
ieu-a-109	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist-to-hip ratio	MR Egger	4	-4.261600974440798	2.2912628865406908	0.2039744514167291	-8.752476232060552	0.22927428317895604	0.014099711053877428	1.580694235220403e-4	1.2576869540813727	0.014 [0:1.258]	overlaps null	Waist-to-hip ratio (F) Randall JC/2013 [ 73K]	Antrophometric
ieu-a-109	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist-to-hip ratio	Weighted median	4	-0.38009802687499505	0.0948683991699878	6.160372684491283e-5	-0.5660400892481712	-0.194155964501819	0.6837943757010776	0.5677693087951783	0.8235294528910563	0.684 [0.568:0.824]	negative	Waist-to-hip ratio (F) Randall JC/2013 [ 73K]	Antrophometric
ukb-a-266	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Whole body fat-free mass	Inverse variance weighted	375	-0.0187716011878874	0.047510386105476254	0.6927652423305062	-0.11189195795462085	0.07434875557884606	0.98140348803767	0.8941408570889117	1.0771824133708399	0.981 [0.894:1.077]	overlaps null	Whole body fat-free mass (M/F) Neale Lab/2017 [331K]	Antrophometric
ukb-a-266	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Whole body fat-free mass	MR Egger	375	-0.15772299677590615	0.12082180598076739	0.19255508087957926	-0.3945337364982102	0.07908774294639792	0.8540863338722863	0.6739942249040135	1.0822992820321102	0.854 [0.674:1.082]	overlaps null	Whole body fat-free mass (M/F) Neale Lab/2017 [331K]	Antrophometric
ukb-a-266	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Whole body fat-free mass	Weighted median	375	0.010251151785365759	0.05192167124123682	0.8434871934610529	-0.0915153238474584	0.11201762741818992	1.0103038748451851	0.9125473323087495	1.118532577312767	1.01 [0.913:1.119]	overlaps null	Whole body fat-free mass (M/F) Neale Lab/2017 [331K]	Antrophometric
ukb-b-2346	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Duration of moderate activity	Inverse variance weighted	6	0.4296344836201164	0.3836280317441635	0.2627458791386956	-0.32227645859844406	1.1815454258386768	1.5366957334213267	0.7244978689754656	3.2594074851520043	1.537 [0.724:3.259]	overlaps null	Duration of moderate activity (M/F) MRC-IEU/2018 [343K]	Physical activity
ukb-b-2346	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Duration of moderate activity	MR Egger	6	-0.48571414983092803	1.7405338660684937	0.7940322609254957	-3.8971605273251755	2.9257322276633198	0.6152576536838023	0.02029946947879962	18.64787554235542	0.615 [0.02:18.648]	overlaps null	Duration of moderate activity (M/F) MRC-IEU/2018 [343K]	Physical activity
ukb-b-2346	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Duration of moderate activity	Weighted median	6	0.6987114645455625	0.3052175957276748	0.022066337180665484	0.1004849769193199	1.2969379521718052	2.01115958673322	1.1057070304533747	3.6580782900968414	2.011 [1.106:3.658]	positive	Duration of moderate activity (M/F) MRC-IEU/2018 [343K]	Physical activity
ukb-a-508	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Number of days/week of moderate physical activity 10+ minutes	Inverse variance weighted	7	0.07670081373117847	0.1480165109823618	0.6043250611862585	-0.21341154779425064	0.3668131752566076	1.0797189909673657	0.8078236107707628	1.4431282818575661	1.08 [0.808:1.443]	overlaps null	Days/week of moderate physical activity 10+ minutes (M/F) Neale Lab/2017 [321K]	Physical activity
ukb-a-508	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Number of days/week of moderate physical activity 10+ minutes	MR Egger	7	0.8598686347883199	1.0797135926056687	0.4619288041774995	-1.2563700067187908	2.9761072762954304	2.362850276990457	0.28468555980694316	19.61132638852487	2.363 [0.285:19.611]	overlaps null	Days/week of moderate physical activity 10+ minutes (M/F) Neale Lab/2017 [321K]	Physical activity
ukb-a-508	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Number of days/week of moderate physical activity 10+ minutes	Weighted median	7	0.0379058117751464	0.10833768394794394	0.7264244419639794	-0.1744360487628237	0.2502476723131165	1.0386334012349396	0.8399305671105984	1.284343473618115	1.039 [0.84:1.284]	overlaps null	Days/week of moderate physical activity 10+ minutes (M/F) Neale Lab/2017 [321K]	Physical activity
ukb-b-969	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Time spend outdoors in summer	Inverse variance weighted	44	0.10934095787569728	0.12172120406952079	0.36903088591114946	-0.12923260210056348	0.34791451785195804	1.1155426385549243	0.8787695381309014	1.4161111923393865	1.116 [0.879:1.416]	overlaps null	Time spend outdoors in summer (M/F) MRC-IEU/2018 [419K]	Physical activity
ukb-b-969	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Time spend outdoors in summer	MR Egger	44	1.3732924597922223	0.6571608444255059	0.04273601815780597	0.08525720471823073	2.661327714866214	3.9483290330067793	1.0889971258794993	14.315283100764814	3.948 [1.089:14.315]	positive	Time spend outdoors in summer (M/F) MRC-IEU/2018 [419K]	Physical activity
ukb-b-969	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Time spend outdoors in summer	Weighted median	44	0.08555026628241591	0.12719081325101558	0.5011931697705361	-0.16374372768957463	0.33484426025440645	1.089316315849474	0.8489595588322671	1.3977226872950674	1.089 [0.849:1.398]	overlaps null	Time spend outdoors in summer (M/F) MRC-IEU/2018 [419K]	Physical activity
ukb-b-8865	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Time spent doing light physical activity	Inverse variance weighted	3	-1.0878333448506481e-4	0.0016105002417532857	0.9461468031010204	-0.003265363808321505	0.003047797139351375	0.9998912225822073	0.9967399616939344	1.0030524463951824	1 [0.997:1.003]	overlaps null	Time spent doing light physical activity (M/F) MRC-IEU/2018 [ 64K]	Physical activity
ukb-b-8865	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Time spent doing light physical activity	MR Egger	3	5.744027359737665e-4	0.0046877157242676175	0.922379613768768	-0.008613520083590764	0.009762325555538296	1.000574567736816	0.9914234699993941	1.0098101324980013	1.001 [0.991:1.01]	overlaps null	Time spent doing light physical activity (M/F) MRC-IEU/2018 [ 64K]	Physical activity
ukb-b-8865	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Time spent doing light physical activity	Weighted median	3	-1.8226833149982778e-4	0.0018813255960281677	0.9228193668272459	-0.003869666499715036	0.0035051298367153806	0.9998177482783633	0.9961378110114268	1.003511279987895	1 [0.996:1.004]	overlaps null	Time spent doing light physical activity (M/F) MRC-IEU/2018 [ 64K]	Physical activity
ukb-a-487	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of physical activity in last 4 weeks: Heavy DIY (eg: weeding  lawn mowing  carpentry  digging)	Inverse variance weighted	3	-1.1014827757934817	0.5588847107003417	0.048740044043748265	-2.1968968087661516	-0.006068742820811934	0.33237787626121107	0.11114753581022832	0.9939496348037481	0.332 [0.111:0.994]	negative	Physical activity: Heavy DIY  (M/F) Neale Lab/2017 [335K]	Physical activity
ukb-a-487	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of physical activity in last 4 weeks: Heavy DIY (eg: weeding  lawn mowing  carpentry  digging)	MR Egger	3	-2.804229935187251	12.195615574990724	0.8561181557722032	-26.70763646216907	21.099176591794567	0.06055338325285148	2.5177978583840398e-12	1456317158.7253873	0.061 [0:1456317158.725]	overlaps null	Physical activity: Heavy DIY  (M/F) Neale Lab/2017 [335K]	Physical activity
ukb-a-487	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of physical activity in last 4 weeks: Heavy DIY (eg: weeding  lawn mowing  carpentry  digging)	Weighted median	3	-1.2049980124534838	0.6395363115906547	0.059541375111064554	-2.4584891831711673	0.04849315826419942	0.29969259516562785	0.08556412508365684	1.0496881901064878	0.3 [0.086:1.05]	overlaps null	Physical activity: Heavy DIY  (M/F) Neale Lab/2017 [335K]	Physical activity
ukb-b-7663	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of physical activity in last 4 weeks: Strenuous sports	Inverse variance weighted	6	-1.3267378782598853	1.0438136399562186	0.20371135517719072	-3.372612612574074	0.7191368560543032	0.2653414270643094	0.03429990780982449	2.0526607041304605	0.265 [0.034:2.053]	overlaps null	Physical activity: Strenuous sports (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-7663	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of physical activity in last 4 weeks: Strenuous sports	MR Egger	6	-6.034998784075805	4.918649789488562	0.2871148363043399	-15.675552371473387	3.605554803321777	0.0023934994376613753	1.5566612128513355e-7	36.80209611950058	0.002 [0:36.802]	overlaps null	Physical activity: Strenuous sports (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-7663	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of physical activity in last 4 weeks: Strenuous sports	Weighted median	6	-2.348015509307753	0.9144512887118693	0.010238251598075041	-4.140340035183017	-0.5556909834324892	0.09555860934615401	0.01591743809521318	0.5736757237910639	0.096 [0.016:0.574]	negative	Physical activity: Strenuous sports (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-a-482	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of physical activity in last 4 weeks: Walking for pleasure (not as a means of transport)	Inverse variance weighted	6	-0.760995065106629	0.8033438337172569	0.34349388827949295	-2.3355489791924526	0.8135588489791946	0.46720129992109694	0.09675735017155493	2.2559222039560627	0.467 [0.097:2.256]	overlaps null	Physical activity: Walking for pleasure  (M/F) Neale Lab/2017 [335K]	Physical activity
ukb-a-482	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of physical activity in last 4 weeks: Walking for pleasure (not as a means of transport)	MR Egger	6	-35.14807426633343	20.635501505429097	0.16372413339856948	-75.59365721697446	5.297508684307601	5.43732505210293e-16	1.4794210840522189e-33	199.83832893098472	0 [0:199.838]	overlaps null	Physical activity: Walking for pleasure  (M/F) Neale Lab/2017 [335K]	Physical activity
ukb-a-482	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of physical activity in last 4 weeks: Walking for pleasure (not as a means of transport)	Weighted median	6	-1.2931119223128553	0.6092980956177411	0.033812749903591975	-2.487336189723628	-0.09888765490208296	0.27441549328571385	0.08313111741732053	0.9058444694928631	0.274 [0.083:0.906]	negative	Physical activity: Walking for pleasure  (M/F) Neale Lab/2017 [335K]	Physical activity
ukb-b-16886	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of transport used (excluding work): Car/motor vehicle	Inverse variance weighted	5	0.5186443043853698	1.2061075759773054	0.6671847568970946	-1.8453265445301485	2.8826151533008884	1.6797488772004592	0.1579737270097944	17.860921204202945	1.68 [0.158:17.861]	overlaps null	Types of transport used : Car/motor vehicle (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-16886	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of transport used (excluding work): Car/motor vehicle	MR Egger	5	-8.623883708067133	9.578872426161618	0.43431313931321175	-27.398473663343903	10.150706247209637	1.7976075895192943e-4	1.2618103210994371e-12	25609.18223494796	0 [0:25609.182]	overlaps null	Types of transport used : Car/motor vehicle (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-16886	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of transport used (excluding work): Car/motor vehicle	Weighted median	5	-0.43481930806792896	0.8340657647216606	0.6021404105974479	-2.0695882069223837	1.1999495907865259	0.6473816331483846	0.126237754836792	3.3199495624721154	0.647 [0.126:3.32]	overlaps null	Types of transport used : Car/motor vehicle (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-17557	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of transport used (excluding work): Cycle	Inverse variance weighted	8	-2.081030551038946	0.8903636263574094	0.019424544898364524	-3.8261432586994686	-0.3359178433784238	0.12480153155597899	0.021793505668169774	0.714681819247947	0.125 [0.022:0.715]	negative	Types of transport used : Cycle (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-17557	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of transport used (excluding work): Cycle	MR Egger	8	-6.617792518624079	5.223646979543684	0.2521481912748335	-16.8561405985297	3.6205555612815408	0.0013363777208709974	4.7804761065437196e-8	37.35831689223882	0.001 [0:37.358]	overlaps null	Types of transport used : Cycle (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-17557	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of transport used (excluding work): Cycle	Weighted median	8	-2.1798792228298884	0.9414694912284951	0.020591007226430556	-4.025159425637739	-0.3345990200220381	0.11305518430113434	0.017860576492527303	0.7156249801181448	0.113 [0.018:0.716]	negative	Types of transport used : Cycle (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-15957	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of transport used (excluding work): Public transport	Inverse variance weighted	9	1.1133161204068722	0.6337047139091239	0.0789455340554944	-0.1287451188550106	2.355377359668755	3.0444373945819887	0.8791980279897704	10.54210627692287	3.044 [0.879:10.542]	overlaps null	Types of transport used : Public transport (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-15957	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of transport used (excluding work): Public transport	MR Egger	9	1.7514984649850778	2.574166599127566	0.5181067687741999	-3.293868069304952	6.796864999275107	5.763232210531695	0.03711002726118965	895.0369472578301	5.763 [0.037:895.037]	overlaps null	Types of transport used : Public transport (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-15957	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of transport used (excluding work): Public transport	Weighted median	9	0.8400239496070527	0.6003636935363865	0.16175547858697892	-0.3366888897242648	2.0167367889383705	2.316422453524296	0.714130978831812	7.513765880831849	2.316 [0.714:7.514]	overlaps null	Types of transport used : Public transport (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-14926	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of transport used (excluding work): Walk	Inverse variance weighted	7	-1.1178407815850107	0.7560852273456263	0.13928504392982016	-2.599767827182438	0.36408626401241695	0.3269850651065255	0.0742908245222428	1.4391983598285	0.327 [0.074:1.439]	overlaps null	Types of transport used : Walk (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-14926	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of transport used (excluding work): Walk	MR Egger	7	-14.812035608262837	8.78925565336574	0.15275533319227222	-32.03897668885969	2.4149054723340146	3.6916002742349387e-7	1.2180054125229644e-14	11.188712664669302	0 [0:11.189]	overlaps null	Types of transport used : Walk (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-14926	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of transport used (excluding work): Walk	Weighted median	7	-1.2272414241366545	0.6204524169260919	0.04793115340711303	-2.4433281613117943	-0.011154686961514448	0.2931000020894032	0.08687124827861736	0.9889072958786251	0.293 [0.087:0.989]	negative	Types of transport used : Walk (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-4711	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Usual walking pace	Inverse variance weighted	53	-0.3136244242863002	0.2361499324884795	0.18415388716557954	-0.7764782919637201	0.1492294433911196	0.7307934448937018	0.4600232294527372	1.1609393285094383	0.731 [0.46:1.161]	overlaps null	Usual walking pace (M/F) MRC-IEU/2018 [459K]	Physical activity
ukb-b-4711	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Usual walking pace	MR Egger	53	-0.2631766774948964	0.965874999905265	0.7863570855547529	-2.156291677309216	1.629938322319423	0.7686060899159299	0.11575357773807772	5.103559933089849	0.769 [0.116:5.104]	overlaps null	Usual walking pace (M/F) MRC-IEU/2018 [459K]	Physical activity
ukb-b-4711	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Usual walking pace	Weighted median	53	-0.6147281373270314	0.1783266421032051	5.66422785356526e-4	-0.9642483558493133	-0.26520791880474937	0.5407878953692408	0.38126967118173594	0.7670464500138354	0.541 [0.381:0.767]	negative	Usual walking pace (M/F) MRC-IEU/2018 [459K]	Physical activity
ukb-b-1004	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Added milk to espresso	Inverse variance weighted	3	-0.2229843179098426	1.186505776200011	0.8509286924600289	-2.5485356392618645	2.102567003442179	0.8001273968661429	0.07819608948539535	8.187159427395159	0.8 [0.078:8.187]	overlaps null	Added milk to espresso (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-1004	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Added milk to espresso	MR Egger	3	3.9198561762127273	2.426089159526548	0.352825755393298	-0.8352785764593067	8.67499092888476	50.39319651646599	0.4337536310499872	5854.64667811507	50.393 [0.434:5854.647]	overlaps null	Added milk to espresso (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-1004	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Added milk to espresso	Weighted median	3	0.6804588228120916	1.1733440888677356	0.5619610277058243	-1.6192955913686702	2.9802132369928533	1.9747836001628187	0.1980381497447366	19.692015263214053	1.975 [0.198:19.692]	overlaps null	Added milk to espresso (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-d-1468_5	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cereal type: Other (e.g. Cornflakes, Frosties)	Inverse variance weighted	10	2.696367147050106	1.1537437844857812	0.019436123167332443	0.4350293294579748	4.957704964642237	14.82577391731555	1.5450083725449568	142.2669133405995	14.826 [1.545:142.267]	positive	Cereal type: Other (e.g. Cornflakes, Frosties) (M/F) Neale lab/2018 [299K]	Diet and supplements
ukb-d-1468_5	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cereal type: Other (e.g. Cornflakes, Frosties)	MR Egger	10	-3.8942647097108094	5.698382593848658	0.5136574079410228	-15.063094593654178	7.27456517423256	0.020358338235531688	2.8719781904541775e-7	1443.123548395639	0.02 [0:1443.124]	overlaps null	Cereal type: Other (e.g. Cornflakes, Frosties) (M/F) Neale lab/2018 [299K]	Diet and supplements
ukb-d-1468_5	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cereal type: Other (e.g. Cornflakes, Frosties)	Weighted median	10	1.6627514823982903	0.6220428953805911	0.007516514684017121	0.4435474074523318	2.8819555573442486	5.273801672149124	1.5582250849433763	17.849144097287827	5.274 [1.558:17.849]	positive	Cereal type: Other (e.g. Cornflakes, Frosties) (M/F) Neale lab/2018 [299K]	Diet and supplements
ukb-b-2221	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cherry intake	Inverse variance weighted	3	-0.9053862144836607	0.5352395490714366	0.09073118099723654	-1.9544557306636765	0.1436833016963549	0.40438567533492376	0.1416415468694754	1.1545184165969002	0.404 [0.142:1.155]	overlaps null	Cherry intake (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-2221	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cherry intake	MR Egger	3	1.7794732467793037	2.4084199692265518	0.5948996775294699	-2.941029892904737	6.499976386463345	5.92673367015549	0.052811310726591086	665.125926883469	5.927 [0.053:665.126]	overlaps null	Cherry intake (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-2221	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cherry intake	Weighted median	3	-1.0490468250057536	0.554278333695975	0.05840636567195325	-2.1354323590498647	0.037338709038357454	0.3502714600403416	0.1181934773082836	1.0380445563741263	0.35 [0.118:1.038]	overlaps null	Cherry intake (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-4955	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Dairy smoothie intake	Inverse variance weighted	3	-0.21730777329774667	0.2259828769695516	0.33624470366452275	-0.6602342121580678	0.22561866556257446	0.8046822714732379	0.5167302958001676	1.2530977248404633	0.805 [0.517:1.253]	overlaps null	Dairy smoothie intake (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-4955	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Dairy smoothie intake	MR Egger	3	-0.03915675133696744	1.0337713757120217	0.9758979098380274	-2.06534864773253	1.987035145058595	0.9615999652518408	0.1267740833653635	7.293876387237801	0.962 [0.127:7.294]	overlaps null	Dairy smoothie intake (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-4955	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Dairy smoothie intake	Weighted median	3	-0.18062203769464558	0.2544082882894387	0.47772326344093613	-0.6792622827419454	0.31801820735265424	0.8347508034169833	0.5069908703552479	1.3744012852086385	0.835 [0.507:1.374]	overlaps null	Dairy smoothie intake (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-16576	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Dried fruit intake	Inverse variance weighted	40	-0.6161217734645628	0.1539264063575247	6.262274930517682e-5	-0.9178175299253111	-0.3144260170038144	0.540034758736625	0.3993897467648101	0.7302078809135336	0.54 [0.399:0.73]	negative	Dried fruit intake (M/F) MRC-IEU/2018 [421K]	Diet and supplements
ukb-b-16576	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Dried fruit intake	MR Egger	40	-0.7019560015344759	0.6992790823412965	0.32181111185619155	-2.072543002923417	0.6686309998544653	0.49561493150941394	0.12586529856076561	1.951563799902267	0.496 [0.126:1.952]	overlaps null	Dried fruit intake (M/F) MRC-IEU/2018 [421K]	Diet and supplements
ukb-b-16576	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Dried fruit intake	Weighted median	40	-0.5300525920270551	0.15029839782677618	4.208236462269954e-4	-0.8246374517675364	-0.2354677322865738	0.5885740145638684	0.4383939025914232	0.7902011605820315	0.589 [0.438:0.79]	negative	Dried fruit intake (M/F) MRC-IEU/2018 [421K]	Diet and supplements
ukb-b-3881	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Fresh fruit intake	Inverse variance weighted	53	-0.4395753311871921	0.17020161621786872	0.009803784125301583	-0.7731704989742147	-0.10598016340016941	0.644309981347633	0.46154741051411075	0.8994424897797045	0.644 [0.462:0.899]	negative	Fresh fruit intake (M/F) MRC-IEU/2018 [446K]	Diet and supplements
ukb-b-3881	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Fresh fruit intake	MR Egger	53	-0.9931866905109142	0.5817465182645031	0.09385760882240668	-2.13340986630934	0.1470364852875118	0.3703944757841781	0.11843276465501118	1.1583962266782328	0.37 [0.118:1.158]	overlaps null	Fresh fruit intake (M/F) MRC-IEU/2018 [446K]	Diet and supplements
ukb-b-3881	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Fresh fruit intake	Weighted median	53	-0.4134669889589263	0.1904653077785248	0.029944348925251375	-0.7867789922048349	-0.04015498571301773	0.6613533659832216	0.45530898973071665	0.9606405420547958	0.661 [0.455:0.961]	negative	Fresh fruit intake (M/F) MRC-IEU/2018 [446K]	Diet and supplements
ukb-d-1418_1	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Milk type used: Full cream	Inverse variance weighted	3	5.700334502393601	4.554975661959021	0.21076952755452266	-3.2274177950460787	14.62808679983328	298.96738955033095	0.039659776351719835	2253706.6074671214	298.967 [0.04:2253706.607]	overlaps null	Milk type used: Full cream (M/F) Neale lab/2018 [360K]	Diet and supplements
ukb-d-1418_1	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Milk type used: Full cream	MR Egger	3	1.7791596713500848	40.79197937313033	0.9722511423408047	-78.17311989998537	81.73143924268554	5.924875483457076	1.1216190948574408e-34	3129774595976599e20	5.925 [0:3.1297745959766e+35]	overlaps null	Milk type used: Full cream (M/F) Neale lab/2018 [360K]	Diet and supplements
ukb-d-1418_1	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Milk type used: Full cream	Weighted median	3	0.9552542638353353	1.5836334314583433	0.5463728847784166	-2.1486672618230176	4.059175789493688	2.5993314148779816	0.11663950415260665	57.926547728903174	2.599 [0.117:57.927]	overlaps null	Milk type used: Full cream (M/F) Neale lab/2018 [360K]	Diet and supplements
ukb-d-1418_3	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Milk type used: Skimmed	Inverse variance weighted	3	-4.930812451082527	1.977709859785235	0.01265999977067561	-8.807123776261587	-1.054501125903467	0.007220634485340286	1.4966310204252197e-4	0.3483661748242542	0.007 [0:0.348]	negative	Milk type used: Skimmed (M/F) Neale lab/2018 [360K]	Diet and supplements
ukb-d-1418_3	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Milk type used: Skimmed	MR Egger	3	-16.5541512309497	5.5252519291146776	0.20508198482735315	-27.38364501201447	-5.724657449884932	6.465817879265325e-8	1.2806606837079875e-12	0.00326447132950009	0 [0:0.003]	negative	Milk type used: Skimmed (M/F) Neale lab/2018 [360K]	Diet and supplements
ukb-d-1418_3	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Milk type used: Skimmed	Weighted median	3	-3.529918975215426	1.2993495040162673	0.006593999623268541	-6.07664400308731	-0.9831939473435423	0.02930729038773205	0.0022958686666728536	0.3741142872582448	0.029 [0.002:0.374]	negative	Milk type used: Skimmed (M/F) Neale lab/2018 [360K]	Diet and supplements
ukb-b-14238	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Mineral and other dietary supplements: None of the above	Inverse variance weighted	7	0.331569800221031	0.5321170778255314	0.5332093641459917	-0.7113796723170105	1.3745192727590725	1.3931533852988653	0.49096635727809934	3.953175866733193	1.393 [0.491:3.953]	overlaps null	Supplements None of the above (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-14238	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Mineral and other dietary supplements: None of the above	MR Egger	7	-3.6562721891362036	4.159915518270352	0.41966692642339576	-11.809706604946092	4.4971622266736855	0.02582861768611646	7.4320665278951476e-6	89.76204519586081	0.026 [0:89.762]	overlaps null	Supplements None of the above (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-14238	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Mineral and other dietary supplements: None of the above	Weighted median	7	0.7719904104782772	0.5583560828007332	0.16678354334936846	-0.32238751181116	1.8663683327677143	2.164069356216517	0.7244174156268942	6.46477580120384	2.164 [0.724:6.465]	overlaps null	Supplements None of the above (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-5495	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Never eat eggs, dairy, wheat, sugar: Sugar or foods/drinks containing sugar	Inverse variance weighted	20	0.5523027621938497	0.49017671666127083	0.25985152049798027	-0.4084436024622411	1.5130491268499404	1.7372488863910547	0.6646839579730617	4.540554435028616	1.737 [0.665:4.541]	overlaps null	Never eat: Sugar or foods/drinks containing sugar (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-5495	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Never eat eggs, dairy, wheat, sugar: Sugar or foods/drinks containing sugar	MR Egger	20	6.6579412310718	2.56395570982529	0.018223601172737903	1.6325880398142312	11.683294422329368	778.9456161700394	5.117100857019303	118574.2258955505	778.946 [5.117:118574.226]	positive	Never eat: Sugar or foods/drinks containing sugar (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-5495	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Never eat eggs, dairy, wheat, sugar: Sugar or foods/drinks containing sugar	Weighted median	20	0.14575367834397002	0.4230902645718212	0.7304719271475398	-0.6835032402167995	0.9750105969047396	1.1569111806725898	0.5048452964934921	2.651195305297846	1.157 [0.505:2.651]	overlaps null	Never eat: Sugar or foods/drinks containing sugar (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-3599	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Never eat eggs, dairy, wheat, sugar: Wheat products	Inverse variance weighted	5	0.01655136719691478	1.1687463035696677	0.9887010218542285	-2.274191387799634	2.3072941221934635	1.0166890999139626	0.10288006488573626	10.04720134101679	1.017 [0.103:10.047]	overlaps null	Never eat: Wheat products (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-3599	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Never eat eggs, dairy, wheat, sugar: Wheat products	MR Egger	5	-3.675684809026151	4.190855367709892	0.4450139631718456	-11.889761329737539	4.538391711685236	0.02533205196363055	6.860286661303383e-6	93.54023940541272	0.025 [0:93.54]	overlaps null	Never eat: Wheat products (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-3599	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Never eat eggs, dairy, wheat, sugar: Wheat products	Weighted median	5	-0.36179187277743186	0.8044436377801667	0.6528966784999173	-1.9385014028265586	1.2149176572716949	0.6964272982385704	0.1439194655559866	3.370016556538691	0.696 [0.144:3.37]	overlaps null	Never eat: Wheat products (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-6500	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Pancake intake	Inverse variance weighted	4	-0.0017415743894442055	0.49180293829396726	0.9971745341387915	-0.9656753334456201	0.9621921846667316	0.9982599412712265	0.38072599590128636	2.6174280744549114	0.998 [0.381:2.617]	overlaps null	Pancake intake (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-6500	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Pancake intake	MR Egger	4	0.3433508407801115	2.575442008375535	0.9061465732305307	-4.704515495635937	5.39121717719616	1.4096632425311024	0.009054300003216022	219.47035735920824	1.41 [0.009:219.47]	overlaps null	Pancake intake (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-6500	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Pancake intake	Weighted median	4	-0.44169139800248935	0.596330945251312	0.4588864783607355	-1.610500050695061	0.7271172546900823	0.6429480198862734	0.19978768512164574	2.06910729269415	0.643 [0.2:2.069]	overlaps null	Pancake intake (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-8006	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Poultry intake	Inverse variance weighted	7	1.0648389800111526	0.6276582640486652	0.08978618518527019	-0.16537121752423123	2.2950491775465363	2.900371928602414	0.8475790094999598	9.92492408370017	2.9 [0.848:9.925]	overlaps null	Poultry intake (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-8006	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Poultry intake	MR Egger	7	-7.960739974998304	19.81766667844116	0.7044998767847238	-46.80336666474298	30.881886714746372	3.4889484845041614e-4	4.7158080884394256e-21	25812673669577.004	0 [0:25812673669577]	overlaps null	Poultry intake (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-8006	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Poultry intake	Weighted median	7	0.6604297613926369	0.3580561247984556	0.06511224180157035	-0.04136024321233611	1.3622197659976099	1.9356240121488202	0.9594834202922499	3.904851545288717	1.936 [0.959:3.905]	overlaps null	Poultry intake (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-4643	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Age at hysterectomy	Inverse variance weighted	4	0.1836037492968582	0.13727871773590986	0.18107501276286567	-0.08546253746552512	0.4526700360592415	1.2015396178357776	0.9180875362959053	1.5725052308777163	1.202 [0.918:1.573]	overlaps null	Age at hysterectomy (M/F) MRC-IEU/2018 [ 46K]	Reproductive
ukb-b-4643	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Age at hysterectomy	MR Egger	4	0.09296205935288543	1.2455426380582122	0.9472978697268479	-2.3483015112412104	2.534225629946981	1.0974200976495465	0.0955312833069588	12.606664843550915	1.097 [0.096:12.607]	overlaps null	Age at hysterectomy (M/F) MRC-IEU/2018 [ 46K]	Reproductive
ukb-b-4643	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Age at hysterectomy	Weighted median	4	0.09482943915320607	0.11944545022907213	0.4272453819649076	-0.1392836432957753	0.32894252160218745	1.0994713123747681	0.8699812291153278	1.389497987174212	1.099 [0.87:1.389]	overlaps null	Age at hysterectomy (M/F) MRC-IEU/2018 [ 46K]	Reproductive
ukb-a-320	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Age at last live birth	Inverse variance weighted	4	-0.3402761422100582	0.13475743538190954	0.011566502397337862	-0.6044007155586009	-0.07615156886151553	0.7115738000679827	0.5464017786261196	0.9266757407275119	0.712 [0.546:0.927]	negative	Age at last live birth (M/F) Neale Lab/2017 [123K]	Reproductive
ukb-a-320	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Age at last live birth	MR Egger	4	-2.0470141771783874	1.0501697347293235	0.19059235421772494	-4.105346857247861	0.011318502891086712	0.12911985761714467	0.016484300147652585	1.0113827994963958	0.129 [0.016:1.011]	overlaps null	Age at last live birth (M/F) Neale Lab/2017 [123K]	Reproductive
ukb-a-320	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Age at last live birth	Weighted median	4	-0.404067378420872	0.16392030886436126	0.013700434745448199	-0.7253511837950201	-0.0827835730467239	0.6675991379778019	0.484154511877608	0.9205503575713289	0.668 [0.484:0.921]	negative	Age at last live birth (M/F) Neale Lab/2017 [123K]	Reproductive
ukb-b-17422	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Age at menopause (last menstrual period)	Inverse variance weighted	102	0.15386452302765596	0.0365291036207769	2.5299872273094584e-5	0.08226747993093324	0.22546156612437868	1.1663328648292413	1.0857461863078022	1.252900879354449	1.166 [1.086:1.253]	positive	Age at menopause (last menstrual period) (M/F) MRC-IEU/2018 [143K]	Reproductive
ukb-b-17422	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Age at menopause (last menstrual period)	MR Egger	102	0.1852080056660523	0.07847347530471721	0.020209365882212043	0.031399994068806586	0.339016017263298	1.2034687424119848	1.0318981744975335	1.4035658263160788	1.203 [1.032:1.404]	positive	Age at menopause (last menstrual period) (M/F) MRC-IEU/2018 [143K]	Reproductive
ukb-b-17422	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Age at menopause (last menstrual period)	Weighted median	102	0.2059392307043085	0.03420639925076805	1.7389154318322164e-9	0.13889468817280312	0.2729837732358139	1.2286785357973165	1.149003090016961	1.3138789246482816	1.229 [1.149:1.314]	positive	Age at menopause (last menstrual period) (M/F) MRC-IEU/2018 [143K]	Reproductive
ukb-b-4564	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Age last used hormone-replacement therapy (HRT)	Inverse variance weighted	4	0.39248856057080644	0.2787208163704828	0.15907832774185343	-0.15380423951533978	0.9387813606569526	1.4806609272683218	0.8574398574251091	2.556863624374462	1.481 [0.857:2.557]	overlaps null	Age last used hormone-replacement therapy (HRT) (M/F) MRC-IEU/2018 [ 72K]	Reproductive
ukb-b-4564	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Age last used hormone-replacement therapy (HRT)	MR Egger	4	1.085343506832355	0.6581530267630704	0.2409074037005185	-0.20463642562326312	2.375323439287973	2.960456581159593	0.8149435551508835	10.754491048534607	2.96 [0.815:10.754]	overlaps null	Age last used hormone-replacement therapy (HRT) (M/F) MRC-IEU/2018 [ 72K]	Reproductive
ukb-b-4564	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Age last used hormone-replacement therapy (HRT)	Weighted median	4	0.2327379576417885	0.13705115856987163	0.08947321426725507	-0.035882313155159884	0.5013582284387369	1.2620507252451383	0.9647538256361581	1.6509621322740098	1.262 [0.965:1.651]	overlaps null	Age last used hormone-replacement therapy (HRT) (M/F) MRC-IEU/2018 [ 72K]	Reproductive
ukb-b-9487	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Age started hormone-replacement therapy (HRT)	Inverse variance weighted	22	0.1785270967653427	0.09578656796429513	0.06234966172344423	-0.009214576444675743	0.3662687699753612	1.1954552758056964	0.9908277476655059	1.442342849015699	1.195 [0.991:1.442]	overlaps null	Age started hormone-replacement therapy (HRT) (M/F) MRC-IEU/2018 [ 87K]	Reproductive
ukb-b-9487	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Age started hormone-replacement therapy (HRT)	MR Egger	22	1.017339844063615	0.2675326750575909	0.0011155390924844097	0.4929758009507369	1.5417038871764932	2.765827436914111	1.637180902688488	4.672544981574608	2.766 [1.637:4.673]	positive	Age started hormone-replacement therapy (HRT) (M/F) MRC-IEU/2018 [ 87K]	Reproductive
ukb-b-9487	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Age started hormone-replacement therapy (HRT)	Weighted median	22	0.23092377159348978	0.07370044183724339	0.0017286723966945397	0.08647090559249274	0.3753766375944868	1.259763206047264	1.0903196450522392	1.4555395222971015	1.26 [1.09:1.456]	positive	Age started hormone-replacement therapy (HRT) (M/F) MRC-IEU/2018 [ 87K]	Reproductive
ukb-b-18541	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ever used hormone-replacement therapy (HRT)	Inverse variance weighted	6	-1.2309040783069614	0.669740867395392	0.06607992851742964	-2.5435961784019296	0.08178802178800693	0.29202844171987963	0.07858329150616691	1.0852257412334103	0.292 [0.079:1.085]	overlaps null	Ever used hormone-replacement therapy (HRT) (M/F) MRC-IEU/2018 [250K]	Reproductive
ukb-b-18541	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ever used hormone-replacement therapy (HRT)	MR Egger	6	-0.5835151384857314	1.5671225044649564	0.728522027152706	-3.655075247237046	2.488044970265583	0.5579337013271675	0.025859551550148106	12.037719001931029	0.558 [0.026:12.038]	overlaps null	Ever used hormone-replacement therapy (HRT) (M/F) MRC-IEU/2018 [250K]	Reproductive
ukb-b-18541	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ever used hormone-replacement therapy (HRT)	Weighted median	6	-0.7690114158312309	0.5169309454334579	0.1368436820536691	-1.7821960688808083	0.2441732372183465	0.4634710220260936	0.16826821263090888	1.2765654599842973	0.463 [0.168:1.277]	overlaps null	Ever used hormone-replacement therapy (HRT) (M/F) MRC-IEU/2018 [250K]	Reproductive
ukb-b-18105	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Had menopause	Inverse variance weighted	9	-1.1034415858482705	0.5422048724350661	0.04184072851658317	-2.166163135821	-0.04072003587554085	0.3317274483755134	0.11461654242953423	0.9600978852889666	0.332 [0.115:0.96]	negative	Had menopause (M/F) MRC-IEU/2018 [211K]	Reproductive
ukb-b-18105	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Had menopause	MR Egger	9	-2.927277597194574	1.2472046490932533	0.05130819029877018	-5.37179870941735	-0.4827564849717976	0.05354260444679384	0.0046457674048386455	0.6170800733502063	0.054 [0.005:0.617]	negative	Had menopause (M/F) MRC-IEU/2018 [211K]	Reproductive
ukb-b-18105	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Had menopause	Weighted median	9	-1.8996106762598055	0.2872722141574097	3.7767730299340835e-11	-2.4626642160083287	-1.3365571365112825	0.14962686117363797	0.08520763674483578	0.2627487211236617	0.15 [0.085:0.263]	negative	Had menopause (M/F) MRC-IEU/2018 [211K]	Reproductive
ukb-a-316	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Had menopause	Inverse variance weighted	7	-1.1839665772152799	0.5993808092386563	0.0482322845063474	-2.358752963323046	-0.009180191107513558	0.30606230788595157	0.09453804212466839	0.990861818197439	0.306 [0.095:0.991]	negative	Had menopause (M/F) Neale Lab/2017 [152K]	Reproductive
ukb-a-316	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Had menopause	MR Egger	7	-2.93042343913979	1.4465135803992382	0.09863132921300194	-5.765590056722297	-0.09525682155728354	0.05337443253568524	0.0031335458483827206	0.90913941788238	0.053 [0.003:0.909]	negative	Had menopause (M/F) Neale Lab/2017 [152K]	Reproductive
ukb-a-316	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Had menopause	Weighted median	7	-2.0896327487691555	0.3551923981120765	4.02650065759703e-9	-2.7858098490688255	-1.3934556484694856	0.12373256841240098	0.06167911802290595	0.24821607339203297	0.124 [0.062:0.248]	negative	Had menopause (M/F) Neale Lab/2017 [152K]	Reproductive
ukb-b-1209	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Number of live births	Inverse variance weighted	10	-0.35893211262082286	0.23414432992033865	0.12528758341677074	-0.8178549992646866	0.09999077402304091	0.6984217637653054	0.4413773946728318	1.1051607218412567	0.698 [0.441:1.105]	overlaps null	Number of live births (M/F) MRC-IEU/2018 [250K]	Reproductive
ukb-b-1209	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Number of live births	MR Egger	10	-2.0420236836730803	2.1688514149618867	0.3739943382623757	-6.2929724569983785	2.208925089652218	0.12976583997268076	0.00184925493842487	9.105923079571932	0.13 [0.002:9.106]	overlaps null	Number of live births (M/F) MRC-IEU/2018 [250K]	Reproductive
ukb-b-1209	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Number of live births	Weighted median	10	-0.2697553220127581	0.1638289387713421	0.09964708084267149	-0.5908600420045886	0.05134939797907245	0.7635662993476343	0.5538507449368408	1.0526906370161662	0.764 [0.554:1.053]	overlaps null	Number of live births (M/F) MRC-IEU/2018 [250K]	Reproductive
ukb-a-317	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Number of live births	Inverse variance weighted	3	-0.0775637236434576	0.15528116519489948	0.617423641558368	-0.3819148074254606	0.2267873601385454	0.9253680546937904	0.6825531991928511	1.2545630694580128	0.925 [0.683:1.255]	overlaps null	Number of live births (M/F) Neale Lab/2017 [180K]	Reproductive
ukb-a-317	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Number of live births	MR Egger	3	0.07951240033139428	1.132061823901202	0.9553591753094793	-2.1393287745149614	2.2983535751777504	1.082758986016439	0.11773384246110606	9.957774224404888	1.083 [0.118:9.958]	overlaps null	Number of live births (M/F) Neale Lab/2017 [180K]	Reproductive
ukb-a-317	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Number of live births	Weighted median	3	-0.14484691854750276	0.1909164784422308	0.4480364673119629	-0.5190432162942751	0.22934937919926962	0.8651547221157668	0.5950896477524957	1.2577814049128209	0.865 [0.595:1.258]	overlaps null	Number of live births (M/F) Neale Lab/2017 [180K]	Reproductive
ukb-a-26	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Average weekly red wine intake	Inverse variance weighted	13	-0.5604416650021483	0.3265033918766196	0.08607135610025157	-1.2003883130803228	0.07950498307602605	0.5709568365004992	0.3010772769651532	1.0827509549463217	0.571 [0.301:1.083]	overlaps null	Average weekly red wine intake (M/F) Neale Lab/2017 [241K]	Alcohol
ukb-a-26	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Average weekly red wine intake	MR Egger	13	0.31346559792351714	0.9337661270998487	0.7434124803020754	-1.5167160111921865	2.1436472070392205	1.368158394462458	0.2194313149913551	8.530493436690366	1.368 [0.219:8.53]	overlaps null	Average weekly red wine intake (M/F) Neale Lab/2017 [241K]	Alcohol
ukb-a-26	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Average weekly red wine intake	Weighted median	13	-0.21258401528429705	0.16026492054457445	0.18468942348369907	-0.526703259551663	0.10153522898306888	0.8084923877501645	0.5905486496337433	1.106868911571232	0.808 [0.591:1.107]	overlaps null	Average weekly red wine intake (M/F) Neale Lab/2017 [241K]	Alcohol
ukb-b-1707	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Average weekly spirits intake	Inverse variance weighted	3	-1.3219403743304081	1.374096509795957	0.33602784157722276	-4.015169533530484	1.3712887848696673	0.26661746204728715	0.01803989592424206	3.940425785550821	0.267 [0.018:3.94]	overlaps null	Average weekly spirits intake (M/F) MRC-IEU/2018 [326K]	Alcohol
ukb-b-1707	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Average weekly spirits intake	MR Egger	3	4.866721928558183	6.8826071069699335	0.608174448726639	-8.623188001102886	18.356631858219252	129.89441505418722	1.7988586327675977e-4	93795914.55894744	129.894 [0:93795914.559]	overlaps null	Average weekly spirits intake (M/F) MRC-IEU/2018 [326K]	Alcohol
ukb-b-1707	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Average weekly spirits intake	Weighted median	3	-0.06560340592411346	0.39602885043920416	0.8684299584436007	-0.8418199527849537	0.7106131409367267	0.9365022018769275	0.430925545188008	2.0352387643617	0.937 [0.431:2.035]	overlaps null	Average weekly spirits intake (M/F) MRC-IEU/2018 [326K]	Alcohol
ukb-d-20406	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ever addicted to alcohol	Inverse variance weighted	2	-0.05482189213837001	0.07046298625273241	0.4365548837363357	-0.1929293451937255	0.08328556091698551	0.9466537394125368	0.8245402298112652	1.0868521267286935	0.947 [0.825:1.087]	overlaps null	Ever addicted to alcohol (M/F) Neale lab/2018 [  6K]	Alcohol
ukb-b-223	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Current tobacco smoking	Inverse variance weighted	34	0.31573659724680064	0.1700840712919318	0.06340282272233487	-0.01762818248538567	0.649101376978987	1.3712690120187083	0.9825262849317473	1.9138202531175925	1.371 [0.983:1.914]	overlaps null	Current tobacco smoking (M/F) MRC-IEU/2018 [462K]	Smoking
ukb-b-223	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Current tobacco smoking	MR Egger	34	0.5250761655371554	0.6435833451563119	0.42060995856677985	-0.7363471909692159	1.7864995220435267	1.6905876079887774	0.4788599084884016	5.968523172689955	1.691 [0.479:5.969]	overlaps null	Current tobacco smoking (M/F) MRC-IEU/2018 [462K]	Smoking
ukb-b-223	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Current tobacco smoking	Weighted median	34	0.3144196148466839	0.218268876545087	0.14972171804407797	-0.11338738318168662	0.7422266128750544	1.3694642635359011	0.8928047355785742	2.1006075509742574	1.369 [0.893:2.101]	overlaps null	Current tobacco smoking (M/F) MRC-IEU/2018 [462K]	Smoking
ukb-b-17685	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Maternal smoking around birth	Inverse variance weighted	16	0.3307303417459247	0.342854620082567	0.33472652938551545	-0.34126471361590666	1.002725397107756	1.3919843816161266	0.7108707061426192	2.7257003304824505	1.392 [0.711:2.726]	overlaps null	Maternal smoking around birth (M/F) MRC-IEU/2018 [397K]	Smoking
ukb-b-17685	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Maternal smoking around birth	MR Egger	16	-1.1930706761876455	1.870500624085414	0.5338751764524462	-4.859251899395057	2.473110547019766	0.303288531867534	0.007756284202161837	11.859278381873423	0.303 [0.008:11.859]	overlaps null	Maternal smoking around birth (M/F) MRC-IEU/2018 [397K]	Smoking
ukb-b-17685	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Maternal smoking around birth	Weighted median	16	0.2738202961608415	0.37523017773993167	0.4655494090197921	-0.4616308522094245	1.0092714445311075	1.314978474324597	0.6302549542285986	2.7436014208780994	1.315 [0.63:2.744]	overlaps null	Maternal smoking around birth (M/F) MRC-IEU/2018 [397K]	Smoking
ukb-b-4801	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Number of unsuccessful stop-smoking attempts	Inverse variance weighted	3	0.5035501003278914	0.6996239588577872	0.4716826706973034	-0.8677128590333715	1.8748130596891541	1.6545847985215905	0.4199108471054957	6.519600230310178	1.655 [0.42:6.52]	overlaps null	Number of unsuccessful stop-smoking attempts (M/F) MRC-IEU/2018 [104K]	Smoking
ukb-b-4801	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Number of unsuccessful stop-smoking attempts	MR Egger	3	4.569285740783956	2.9099420924389183	0.36101061313514815	-1.1342007603963244	10.272772241964237	96.4751768735945	0.3216791173102598	28933.988101609655	96.475 [0.322:28933.988]	overlaps null	Number of unsuccessful stop-smoking attempts (M/F) MRC-IEU/2018 [104K]	Smoking
ukb-b-4801	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Number of unsuccessful stop-smoking attempts	Weighted median	3	0.08165262376445498	0.2700078710837117	0.7623408212789243	-0.44756280355962	0.61086805108853	1.0850788137600087	0.6391840719547696	1.8420296808556014	1.085 [0.639:1.842]	overlaps null	Number of unsuccessful stop-smoking attempts (M/F) MRC-IEU/2018 [104K]	Smoking
ukb-a-225	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Smoking status: Current	Inverse variance weighted	15	0.7049211865824246	0.5128247643159577	0.16926016704520006	-0.3002153514768525	1.7100577246417017	2.0236871849339124	0.7406587015607704	5.5292806441560804	2.024 [0.741:5.529]	overlaps null	Smoking status: Current (M/F) Neale Lab/2017 [336K]	Smoking
ukb-a-225	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Smoking status: Current	MR Egger	15	3.584269999380086	2.2022496183348133	0.12760268680646863	-0.7321392525561476	7.90067925131632	36.02704834947083	0.48087916696993294	2699.115083220612	36.027 [0.481:2699.115]	overlaps null	Smoking status: Current (M/F) Neale Lab/2017 [336K]	Smoking
ukb-a-225	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Smoking status: Current	Weighted median	15	0.9120355374173961	0.5204260090348984	0.07969151553834992	-0.10799944029100494	1.932070515125797	2.4893846151389543	0.8976280988408154	6.903789854721889	2.489 [0.898:6.904]	overlaps null	Smoking status: Current (M/F) Neale Lab/2017 [336K]	Smoking
ukb-d-22506_114	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Tobacco smoking: Never smoked	Inverse variance weighted	3	-1.0554891663447559	0.3490762111387766	0.002497336459311548	-1.739678540176758	-0.3712997925127537	0.3480221449408571	0.17557683244375114	0.6898371025575798	0.348 [0.176:0.69]	negative	Tobacco smoking: Never smoked (M/F) Neale lab/2018 [ 91K]	Smoking
ukb-d-22506_114	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Tobacco smoking: Never smoked	MR Egger	3	-9.63718911949385	4.911867709233281	0.30007732791199143	-19.26444982959108	-0.009928409396620097	6.525622464234891e-5	4.300864320874712e-9	0.9901207145513118	0 [0:0.99]	negative	Tobacco smoking: Never smoked (M/F) Neale lab/2018 [ 91K]	Smoking
ukb-d-22506_114	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Tobacco smoking: Never smoked	Weighted median	3	-0.809542133989498	0.37412132583932955	0.030475924272578378	-1.542819932634584	-0.07626433534441213	0.4450617982483879	0.213777412743581	0.9265712486551569	0.445 [0.214:0.927]	negative	Tobacco smoking: Never smoked (M/F) Neale lab/2018 [ 91K]	Smoking
met-a-558	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	1-arachidonoylglycerophosphocholine*	Inverse variance weighted	3	0.09704482215970475	0.10795909795759064	0.3687040085393456	-0.1145550098371729	0.3086446541565824	1.101909762489499	0.8917628813379274	1.361578453285666	1.102 [0.892:1.362]	overlaps null	1-arachidonoylglycerophosphocholine* (M/F) Shin/2014 [  7K]	Metabolites
met-a-558	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	1-arachidonoylglycerophosphocholine*	MR Egger	3	0.1301739595665211	0.2114468241304938	0.6486901588014722	-0.2842618157292467	0.5446097348622889	1.139026510649099	0.7525695843560352	1.7239354591663651	1.139 [0.753:1.724]	overlaps null	1-arachidonoylglycerophosphocholine* (M/F) Shin/2014 [  7K]	Metabolites
met-a-558	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	1-arachidonoylglycerophosphocholine*	Weighted median	3	0.10922446026809263	0.11040531977608076	0.3225142690251647	-0.10716996649302565	0.32561888702921093	1.1154126880759587	0.8983729667106168	1.3848874697067761	1.115 [0.898:1.385]	overlaps null	1-arachidonoylglycerophosphocholine* (M/F) Shin/2014 [  7K]	Metabolites
met-a-682	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	1-arachidonoylglycerophosphoethanolamine*	Inverse variance weighted	2	0.2317166449728465	0.17008074439783444	0.17307420812123692	-0.10164161404690897	0.565074903992602	1.2607624348362385	0.9033532427751293	1.759579577321425	1.261 [0.903:1.76]	overlaps null	1-arachidonoylglycerophosphoethanolamine* (M/F) Shin/2014 [  7K]	Metabolites
met-a-634	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	1-arachidonoylglycerophosphoinositol*	Inverse variance weighted	3	0.3801734638620931	0.3179738766866344	0.2318479067026257	-0.24305533444371036	1.0034022621678966	1.4625382649677199	0.7842281177442826	2.72754588632624	1.463 [0.784:2.728]	overlaps null	1-arachidonoylglycerophosphoinositol* (M/F) Shin/2014 [  7K]	Metabolites
met-a-634	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	1-arachidonoylglycerophosphoinositol*	MR Egger	3	1.1933581098073691	3.5978709951665486	0.796112403257025	-5.858469040719066	8.245185260333804	3.298138141832596	0.002855612163787934	3809.241093924257	3.298 [0.003:3809.241]	overlaps null	1-arachidonoylglycerophosphoinositol* (M/F) Shin/2014 [  7K]	Metabolites
met-a-634	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	1-arachidonoylglycerophosphoinositol*	Weighted median	3	0.3982655299235257	0.2163975501900379	0.06570446358992386	-0.02587366844894856	0.822404728296	1.4892394150396495	0.9744581866472196	2.2759663428335006	1.489 [0.974:2.276]	overlaps null	1-arachidonoylglycerophosphoinositol* (M/F) Shin/2014 [  7K]	Metabolites
met-a-427	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	2-hydroxyisobutyrate	Inverse variance weighted	2	0.06443021797129446	0.3321058559095684	0.8461719164087234	-0.5864972596114597	0.7153576955540486	1.0665511495448528	0.5562723538505907	2.044918009534906	1.067 [0.556:2.045]	overlaps null	2-hydroxyisobutyrate (M/F) Shin/2014 [  6K]	Metabolites
met-a-500	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	3-dehydrocarnitine*	Inverse variance weighted	3	-0.7428937622412526	0.19018084184793807	9.373983835177348e-5	-1.1156482122632112	-0.37013931221929397	0.4757352570045604	0.32770278907120814	0.6906381096073493	0.476 [0.328:0.691]	negative	3-dehydrocarnitine* (M/F) Shin/2014 [  7K]	Metabolites
met-a-500	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	3-dehydrocarnitine*	MR Egger	3	-0.8750993230942534	1.0257531647122697	0.550350645534428	-2.885575525930302	1.1353768797417951	0.4168206177089571	0.05582265290539412	3.1123463021673796	0.417 [0.056:3.112]	overlaps null	3-dehydrocarnitine* (M/F) Shin/2014 [  7K]	Metabolites
met-a-500	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	3-dehydrocarnitine*	Weighted median	3	-0.8102164106718763	0.22521272527634945	3.212157612566155e-4	-1.2516333522135212	-0.36879946913023143	0.44476180460633646	0.2860372155824642	0.6915640764921925	0.445 [0.286:0.692]	negative	3-dehydrocarnitine* (M/F) Shin/2014 [  7K]	Metabolites
met-c-841	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Albumin	Inverse variance weighted	3	0.10467347764651196	0.062163252679300264	0.09221102017370651	-0.017166497604916564	0.22651345289794048	1.1103479977169555	0.9829800071924583	1.254219482607104	1.11 [0.983:1.254]	overlaps null	Albumin (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-841	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Albumin	MR Egger	3	-0.09545723915392662	0.1719290834493491	0.6773377992876772	-0.43243824271465087	0.24152376440679763	0.908957228602813	0.6489249277389239	1.2731877111087118	0.909 [0.649:1.273]	overlaps null	Albumin (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-841	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Albumin	Weighted median	3	0.1287183036205046	0.07173323858178189	0.07274894601903832	-0.01187884399978792	0.26931545124079714	1.1373696861120053	0.9881914309307184	1.3090680230531322	1.137 [0.988:1.309]	overlaps null	Albumin (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-851	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Average number of double bonds in a fatty acid chain	Inverse variance weighted	5	0.027788585538120907	0.025390049543187028	0.27374996801538787	-0.021975911566525667	0.07755308264276747	1.02817828968221	0.9782637996098495	1.0806395941416278	1.028 [0.978:1.081]	overlaps null	Average number of double bonds in a fatty acid chain (M/F) Kettunen/2016 [ 15K]	Metabolites
met-c-851	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Average number of double bonds in a fatty acid chain	MR Egger	5	0.028922903139525266	0.05681051318848699	0.6457567285606542	-0.08242570270990923	0.14027150898895976	1.0293452321301344	0.9208798541928646	1.1505861509346615	1.029 [0.921:1.151]	overlaps null	Average number of double bonds in a fatty acid chain (M/F) Kettunen/2016 [ 15K]	Metabolites
met-c-851	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Average number of double bonds in a fatty acid chain	Weighted median	5	0.02609463271285652	0.02172336898408975	0.2296643126070485	-0.016483170495959393	0.06867243592167244	1.0264380784974783	0.9836519336255637	1.0710853026093359	1.026 [0.984:1.071]	overlaps null	Average number of double bonds in a fatty acid chain (M/F) Kettunen/2016 [ 15K]	Metabolites
met-a-362	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Betaine	Inverse variance weighted	3	-0.3982393317521023	0.35081359383875665	0.25629661627262784	-1.0858339756760653	0.2893553121718608	0.6715012968468699	0.33762010149967103	1.3355661871556763	0.672 [0.338:1.336]	overlaps null	Betaine (M/F) Shin/2014 [  7K]	Metabolites
met-a-362	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Betaine	MR Egger	3	0.8666416193374499	0.6076460594391758	0.3892914516971008	-0.3243446571633347	2.0576278958382344	2.378908143864946	0.7230010119549154	7.827380409392646	2.379 [0.723:7.827]	overlaps null	Betaine (M/F) Shin/2014 [  7K]	Metabolites
met-a-362	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Betaine	Weighted median	3	-0.3480727508315649	0.25900264597822054	0.1789818562223218	-0.8557179369488772	0.15957243528574733	0.7060475088025063	0.4249779741420291	1.1730092264019873	0.706 [0.425:1.173]	overlaps null	Betaine (M/F) Shin/2014 [  7K]	Metabolites
met-c-875	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cholesterol esters in large HDL	Inverse variance weighted	13	0.05908853991322906	0.02106882020876313	0.0050387018817466605	0.017793652304053324	0.10038342752240478	1.0608691658459286	1.0179529024803966	1.1055947522722547	1.061 [1.018:1.106]	positive	Cholesterol esters in large HDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-875	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cholesterol esters in large HDL	MR Egger	13	0.036234288780204224	0.05600380729678253	0.5309032728303089	-0.07353317352148954	0.146001751081898	1.0368987517785704	0.9291053235848635	1.1571982143978676	1.037 [0.929:1.157]	overlaps null	Cholesterol esters in large HDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-875	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cholesterol esters in large HDL	Weighted median	13	0.05039642606173446	0.024328219138329082	0.03831009864939003	0.0027131165506094554	0.09807973557285946	1.0516879302530229	1.0027168003821194	1.1030507339843014	1.052 [1.003:1.103]	positive	Cholesterol esters in large HDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-887	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cholesterol esters in large VLDL	Inverse variance weighted	12	-0.1108036839253861	0.021033107321318446	1.3787259865239992e-7	-0.15202857427517025	-0.06957879357560195	0.8951144570378394	0.8589637361242956	0.9327866328948313	0.895 [0.859:0.933]	negative	Cholesterol esters in large VLDL (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-887	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cholesterol esters in large VLDL	MR Egger	12	-0.09713283372848162	0.05219653293391849	0.09237753320042107	-0.19943803827896187	0.0051723708219986175	0.9074354600916394	0.8191909777232537	1.0051857706249139	0.907 [0.819:1.005]	overlaps null	Cholesterol esters in large VLDL (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-887	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cholesterol esters in large VLDL	Weighted median	12	-0.10175410886741111	0.029150084727511988	4.817625641435117e-4	-0.1588882749333346	-0.044619942801487615	0.9032516259300248	0.8530916653681604	0.9563608846103767	0.903 [0.853:0.956]	negative	Cholesterol esters in large VLDL (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-910	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cholesterol esters in medium VLDL	Inverse variance weighted	14	-0.07520807794200302	0.024049069243453763	0.0017643418818661459	-0.1223442536591724	-0.02807190222483364	0.9275504634558084	0.8848437053815655	0.9723184524278011	0.928 [0.885:0.972]	negative	Cholesterol esters in medium VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-910	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cholesterol esters in medium VLDL	MR Egger	14	-0.08445318580074772	0.06785088930991634	0.23700725785903734	-0.21744092884818372	0.0485345572466883	0.9190146773060245	0.8045751306958058	1.0497316470290188	0.919 [0.805:1.05]	overlaps null	Cholesterol esters in medium VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-910	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cholesterol esters in medium VLDL	Weighted median	14	-0.07008504728254514	0.026775934518491265	0.008858580669615155	-0.12256587893878801	-0.01760421562630226	0.9323145257172287	0.8846476233771113	0.9825498332829529	0.932 [0.885:0.983]	negative	Cholesterol esters in medium VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-958	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of chylomicrons and largest VLDL particles	Inverse variance weighted	7	-0.1173298474612577	0.029688352018024434	7.748459019411887e-5	-0.1755190174165856	-0.05914067750592981	0.889291814133698	0.839021441001474	0.9425741608477134	0.889 [0.839:0.943]	negative	Concentration of chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-958	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of chylomicrons and largest VLDL particles	MR Egger	7	-0.12678297643778433	0.11184740208281864	0.3083970037001909	-0.3460038845201089	0.0924379316445402	0.8809248332985852	0.7075097387653563	1.0968450600783997	0.881 [0.708:1.097]	overlaps null	Concentration of chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-958	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of chylomicrons and largest VLDL particles	Weighted median	7	-0.10968668221722554	0.03573310142691064	0.0021433852415509514	-0.1797235610139704	-0.039649803420480675	0.89611486003726315	0.83550114457957	0.9611259632489072	0.896 [0.836:0.961]	negative	Concentration of chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-878	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of large HDL particles	Inverse variance weighted	11	0.045480337182158194	0.018350370730935695	0.01319574091827553	0.00951361054952423	0.08144706381479216	1.0465304266744937	1.009559008795235	1.084855787937046	1.047 [1.01:1.085]	positive	Concentration of large HDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-878	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of large HDL particles	MR Egger	11	-0.030381224412755613	0.04907829640449596	0.5512381259853196	-0.12657468536556768	0.06581223654005647	0.9700756465293304	0.8811083411875192	1.0680261620506246	0.97 [0.881:1.068]	overlaps null	Concentration of large HDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-878	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of large HDL particles	Weighted median	11	0.03403449441620526	0.020689642096267863	0.09996948048201137	-0.006517204092479745	0.07458619292489027	1.0346202947356569	0.9935039868219495	1.077438207070563	1.035 [0.994:1.077]	overlaps null	Concentration of large HDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-890	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of large VLDL particles	Inverse variance weighted	10	-0.10506752701630674	0.022519724994482637	3.0775115566202265e-6	-0.1492061880054927	-0.060928866027120776	0.9002637284101953	0.861391487994461	0.9408901666511912	0.9 [0.861:0.941]	negative	Concentration of large VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-890	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of large VLDL particles	MR Egger	10	-0.08889590505674475	0.06154303069974924	0.18661144201256422	-0.20952024522825324	0.03172843511476377	0.9149408093292148	0.81097322092892965	1.0322371478766252	0.915 [0.811:1.032]	overlaps null	Concentration of large VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-890	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of large VLDL particles	Weighted median	10	-0.09079180435187297	0.02996594386571566	0.002446890293373982	-0.14952505432867566	-0.03205855437507027	0.9132078170022829	0.8611168630445141	0.9684498734418181	0.913 [0.861:0.968]	negative	Concentration of large VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-913	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of medium VLDL particles	Inverse variance weighted	14	-0.09827323038703331	0.020986977030868794	2.8328449745955155e-6	-0.13940770536753616	-0.057138755406530475	0.9064012135628292	0.8698733041364873	0.944463010925166	0.906 [0.87:0.944]	negative	Concentration of medium VLDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-913	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of medium VLDL particles	MR Egger	14	-0.07065679515574919	0.05270266785738129	0.20485661945676173	-0.17395402415621652	0.03264043384471814	0.9317816292257274	0.8403355319054442	1.033178976252362	0.932 [0.84:1.033]	overlaps null	Concentration of medium VLDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-913	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of medium VLDL particles	Weighted median	14	-0.08477900757510148	0.029070126515637885	0.003541395318033647	-0.14175645554575173	-0.02780155960445123	0.9187152910891302	0.8678325865644089	0.9725813470802901	0.919 [0.868:0.973]	negative	Concentration of medium VLDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-922	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of small HDL particles	Inverse variance weighted	5	-0.07952675497137811	0.027850770752397225	0.004297456924024433	-0.13411426564607667	-0.02493924429667955	0.9235533099956754	0.8744901347139353	0.9753691694680888	0.924 [0.874:0.975]	negative	Concentration of small HDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-922	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of small HDL particles	MR Egger	5	-0.07335815267383851	0.07595978526176472	0.4054084125609314	-0.22223933178689737	0.07552302643922033	0.9292679506172998	0.8007237027656272	1.0784480602508595	0.929 [0.801:1.078]	overlaps null	Concentration of small HDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-922	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of small HDL particles	Weighted median	5	-0.08830924912920296	0.030902907728151106	0.004268102331052243	-0.14887894827637912	-0.027739549982026795	0.9154777222545338	0.8616734156381001	0.9726416583523199	0.915 [0.862:0.973]	negative	Concentration of small HDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-930	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of small VLDL particles	Inverse variance weighted	15	-0.0762370289706359	0.02388815778697131	0.001415776824406393	-0.12305781823309966	-0.029416239708172136	0.9265965503014496	0.8842125374762526	0.9710122065008672	0.927 [0.884:0.971]	negative	Concentration of small VLDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-930	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of small VLDL particles	MR Egger	15	-0.09947396714778271	0.06807476314957513	0.1676948261689345	-0.23290050292094994	0.033952568625384524	0.9053135174547511	0.7922323944121977	1.0345355361218171	0.905 [0.792:1.035]	overlaps null	Concentration of small VLDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-930	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of small VLDL particles	Weighted median	15	-0.07755765174942056	0.026987957650091283	0.004055819203169923	-0.13045404874359948	-0.024661254755241648	0.9253736734476219	0.8776968232938855	0.9756403495871141	0.925 [0.878:0.976]	negative	Concentration of small VLDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-950	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of very large VLDL particles	Inverse variance weighted	8	-0.11547561924641662	0.02690260567379411	1.7678547368332804e-5	-0.16820472636705308	-0.06274651212578017	0.8909422938168053	0.8451807861796097	0.9391815146432644	0.891 [0.845:0.939]	negative	Concentration of very large VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-950	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of very large VLDL particles	MR Egger	8	-0.07126551986928509	0.0874889050968957	0.44643823186859566	-0.24274377385920068	0.1002127341206305	0.9312146033192492	0.7844724903815	1.1054060506485246	0.931 [0.784:1.105]	overlaps null	Concentration of very large VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-950	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of very large VLDL particles	Weighted median	8	-0.09762614610930995	0.033031560641889245	0.003121207700344256	-0.16236800496741288	-0.032884287251207026	0.9069879213416526	0.8501282955320356	0.9676505226129749	0.907 [0.85:0.968]	negative	Concentration of very large VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-876	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in large HDL	Inverse variance weighted	15	0.06690170702858503	0.024662214797410452	0.006673327410545462	0.018563766025660546	0.11523964803150952	1.069190379110064	1.018737143917333	1.122142324550686	1.069 [1.019:1.122]	positive	Free cholesterol in large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-876	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in large HDL	MR Egger	15	0.0017748635748615572	0.05810193418171366	0.9760944864616198	-0.11210492742129721	0.11565465457102034	1.0017764395774749	0.8939504526633281	1.122608117600532	1.002 [0.894:1.123]	overlaps null	Free cholesterol in large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-876	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in large HDL	Weighted median	15	0.0379337121674414	0.023622750617765143	0.10831507665897155	-0.008366879043378274	0.08423430337826107	1.0386623799185413	0.9916680258728436	1.087883758789637	1.039 [0.992:1.088]	overlaps null	Free cholesterol in large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-888	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in large VLDL	Inverse variance weighted	11	-0.10074435608603108	0.022193523356686604	5.642566460804468e-6	-0.14424366186513682	-0.05724505030692534	0.9041641474046083	0.8656767899377822	0.9443626246588618	0.904 [0.866:0.944]	negative	Free cholesterol in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-888	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in large VLDL	MR Egger	11	-0.09372617170219669	0.062254852804288253	0.16645106654985498	-0.21574568319860166	0.028293339794208283	0.9105320575505684	0.8059402399567202	1.0286973980500014	0.911 [0.806:1.029]	overlaps null	Free cholesterol in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-888	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in large VLDL	Weighted median	11	-0.09160630965498243	0.030789242030552687	0.0029273072588196277	-0.1519532240348657	-0.03125939527509916	0.9124643072299247	0.8590284616867382	0.9692241283062485	0.912 [0.859:0.969]	negative	Free cholesterol in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-900	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in medium HDL	Inverse variance weighted	5	0.08552042097993577	0.03333939433577446	0.010313233686066863	0.02017520808181783	0.1508656338780537	1.0892838053596763	1.0203801032065294	1.162840401229086	1.089 [1.02:1.163]	positive	Free cholesterol in medium HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-900	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in medium HDL	MR Egger	5	0.06796648991579439	0.09296588329070538	0.5176503294641225	-0.11424664133398814	0.2501796211655769	1.0703294410481201	0.8920379153265715	1.2842560755447034	1.07 [0.892:1.284]	overlaps null	Free cholesterol in medium HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-900	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in medium HDL	Weighted median	5	0.07410503026939352	0.038603287341044054	0.054901371677007704	-0.001557412919052828	0.14976747345783986	1.0769199087446142	0.9984437992190992	1.1615641168361952	1.077 [0.998:1.162]	overlaps null	Free cholesterol in medium HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-911	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in medium VLDL	Inverse variance weighted	12	-0.0820990882075491	0.025983377489747713	0.0015794396481323076	-0.13302650808745461	-0.031171668327643585	0.9211806760318887	0.8754418855111287	0.969309159110117	0.921 [0.875:0.969]	negative	Free cholesterol in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-911	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in medium VLDL	MR Egger	12	-0.10006025941536209	0.06808187461591146	0.17238826992884584	-0.23350073366254856	0.03338021483182438	0.9047828947049396	0.791757014857565	1.033943585201982	0.905 [0.792:1.034]	overlaps null	Free cholesterol in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-911	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in medium VLDL	Weighted median	12	-0.07699853011675968	0.026833654775501394	0.004111524489839001	-0.1295924934767424	-0.02440456675677695	0.9258912145574738	0.8784533334555602	0.9758908169002724	0.926 [0.878:0.976]	negative	Free cholesterol in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-928	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in small VLDL	Inverse variance weighted	14	-0.07444633717986136	0.024918918703700672	0.0028122987637550756	-0.12328741783911468	-0.02560525652060805	0.9282572856262178	0.8840095459302958	0.9747197779537278	0.928 [0.884:0.975]	negative	Free cholesterol in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-928	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in small VLDL	MR Egger	14	-0.08329561636178515	0.07558578939147151	0.29207318928146053	-0.2314437635690693	0.064852530845499	0.9200791165727549	0.7933873115193353	1.0670016629484127	0.92 [0.793:1.067]	overlaps null	Free cholesterol in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-928	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in small VLDL	Weighted median	14	-0.07895336478120142	0.026801472565972304	0.0032205895543579296	-0.13148425101050715	-0.02642247855189571	0.9240830182539788	0.8767930836341231	0.9739235408724087	0.924 [0.877:0.974]	negative	Free cholesterol in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-944	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in very large HDL	Inverse variance weighted	13	0.04917967237417767	0.018140008589746848	0.00670571082458925	0.013625255538273845	0.08473408921008149	1.0504090632765624	1.0137185023551194	1.0884276035705853	1.05 [1.014:1.088]	positive	Free cholesterol in very large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-944	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in very large HDL	MR Egger	13	0.05248547699916873	0.05457566232026707	0.356863737308173	-0.05448282114855472	0.15945377514689218	1.0538872563618948	0.9469747766571042	1.1728700452220964	1.054 [0.947:1.173]	overlaps null	Free cholesterol in very large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-944	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in very large HDL	Weighted median	13	0.0503089695657314	0.025631903978786612	0.049675456825229836	7.043776730964596e-5	0.10054750136415316	1.0515959573336275	1.0000704402481073	1.1057761663329206	1.052 [1:1.106]	positive	Free cholesterol in very large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-a-573	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Isobutyrylcarnitine	Inverse variance weighted	3	0.04640453692431918	0.09079907413025395	0.6093031668645137	-0.13156164837097858	0.22437072221961693	1.0474980769071616	0.8767252247898518	1.2515349052346583	1.047 [0.877:1.252]	overlaps null	Isobutyrylcarnitine (M/F) Shin/2014 [  7K]	Metabolites
met-a-573	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Isobutyrylcarnitine	MR Egger	3	-0.08699298947878042	0.19200661767333507	0.7291778825349704	-0.4633259601185172	0.28933998116095633	0.9166835220399089	0.6291875090439272	1.3355457117328522	0.917 [0.629:1.336]	overlaps null	Isobutyrylcarnitine (M/F) Shin/2014 [  7K]	Metabolites
met-a-573	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Isobutyrylcarnitine	Weighted median	3	0.020416945728577184	0.09548386083218076	0.8306826368545394	-0.1667314215024971	0.20756531295965147	1.020626797307903	0.8464269128801758	1.2306780934439079	1.021 [0.846:1.231]	overlaps null	Isobutyrylcarnitine (M/F) Shin/2014 [  7K]	Metabolites
met-a-652	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Isovalerylcarnitine	Inverse variance weighted	3	-0.45244763405537697	0.2608999758808009	0.08288607301593741	-0.9638115867817467	0.05891631867099273	0.6360693796730553	0.3814362343526819	1.060686477372206	0.636 [0.381:1.061]	overlaps null	Isovalerylcarnitine (M/F) Shin/2014 [  7K]	Metabolites
met-a-652	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Isovalerylcarnitine	MR Egger	3	-4.472332759131605	3.1921798643212056	0.3946421388898338	-10.729005293201169	1.7843397749379575	0.011420643142520179	2.190040795569991e-5	5.955646582138048	0.011 [0:5.956]	overlaps null	Isovalerylcarnitine (M/F) Shin/2014 [  7K]	Metabolites
met-a-652	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Isovalerylcarnitine	Weighted median	3	-0.3956883338154181	0.17716032982255778	0.02551571623833199	-0.7429225802676314	-0.04845408736320489	0.6732164820564288	0.47572154745091677	0.9527010793203466	0.673 [0.476:0.953]	negative	Isovalerylcarnitine (M/F) Shin/2014 [  7K]	Metabolites
met-c-896	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Mean diameter for LDL particles	Inverse variance weighted	8	0.046865076540724394	0.039546315086585904	0.2359905219151277	-0.030645701028983972	0.12437585411043275	1.0479806023722034	0.9698191181292277	1.1324414237852376	1.048 [0.97:1.132]	overlaps null	Mean diameter for LDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-896	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Mean diameter for LDL particles	MR Egger	8	0.03852760835512038	0.10944281626161022	0.7368471520812363	-0.17598031151763566	0.2530355282278764	1.039279420757225	0.8386344946149898	1.287929033857996	1.039 [0.839:1.288]	overlaps null	Mean diameter for LDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-896	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Mean diameter for LDL particles	Weighted median	8	0.04388626406098412	0.032064645974981106	0.1710990866722591	-0.01896044204997884	0.10673297017194708	1.044863509597674	0.9812181764546797	1.1126371075120352	1.045 [0.981:1.113]	overlaps null	Mean diameter for LDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-941	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Mean diameter for VLDL particles	Inverse variance weighted	14	-0.08693020453541608	0.019094304123193125	5.296749368847162e-6	-0.12435504061687461	-0.04950536845395756	0.9167410777697209	0.8830662608292311	0.9517000489648537	0.917 [0.883:0.952]	negative	Mean diameter for VLDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-941	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Mean diameter for VLDL particles	MR Egger	14	-0.1393782548300861	0.06825775942858078	0.0637722616153902	-0.27316346331010444	-0.005593046350067771	0.8698989227500468	0.760968387050314	0.9944225656139621	0.87 [0.761:0.994]	negative	Mean diameter for VLDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-941	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Mean diameter for VLDL particles	Weighted median	14	-0.08042039051914959	0.02620798033124076	0.002151032836155327	-0.13178803196838149	-0.029052749069917706	0.9227283585854534	0.876526771043714	0.9713652245030435	0.923 [0.877:0.971]	negative	Mean diameter for VLDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-959	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Phospholipids in chylomicrons and largest VLDL particles	Inverse variance weighted	8	-0.13758082633153593	0.02845122798772247	1.3269611158581952e-6	-0.19334523318747196	-0.0818164194755999	0.8714639099195849	0.8241973847268446	0.921441101810857	0.871 [0.824:0.921]	negative	Phospholipids in chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-959	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Phospholipids in chylomicrons and largest VLDL particles	MR Egger	8	-0.06476083350998765	0.09206827207176951	0.5081685288169314	-0.2452146467706559	0.1156929797506806	0.9372916053160761	0.7825365512699323	1.1226511425827919	0.937 [0.783:1.123]	overlaps null	Phospholipids in chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-959	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Phospholipids in chylomicrons and largest VLDL particles	Weighted median	8	-0.1252001221204612	0.03707017568138594	7.317950137052187e-4	-0.19785766645597763	-0.052542577784944755	0.8823203131034698	0.8204866275967014	0.948813921800637	0.882 [0.82:0.949]	negative	Phospholipids in chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-891	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Phospholipids in large VLDL	Inverse variance weighted	9	-0.12415275160411163	0.023877650134735938	1.997843744575474e-7	-0.17095294586819407	-0.07735255734002919	0.8832449135004655	0.8428612326420836	0.9255634818783026	0.883 [0.843:0.926]	negative	Phospholipids in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-891	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Phospholipids in large VLDL	MR Egger	9	-0.05583097761971159	0.06640974383870521	0.4282928317531902	-0.1859940755435738	0.07433212030415062	0.9456989666729094	0.830278513916239	1.077164494294541	0.946 [0.83:1.077]	overlaps null	Phospholipids in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-891	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Phospholipids in large VLDL	Weighted median	9	-0.09935292276108859	0.03108567421743259	0.0013929883327925374	-0.16028084422725647	-0.03842500129492071	0.9054231072067156	0.851904502904915	0.9623038735779101	0.905 [0.852:0.962]	negative	Phospholipids in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-914	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Phospholipids in medium VLDL	Inverse variance weighted	15	-0.08913727494344893	0.02294977480057779	1.027454657393478e-4	-0.13411883355258142	-0.04415571633431646	0.9147199968195432	0.874486140133884	0.9568049557119844	0.915 [0.874:0.957]	negative	Phospholipids in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-914	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Phospholipids in medium VLDL	MR Egger	15	-0.08966038466267467	0.05945071229112838	0.15543011221085523	-0.2061837807532863	0.026863011427936956	0.9142416230307346	0.8136835231700249	1.0272270747544898	0.914 [0.814:1.027]	overlaps null	Phospholipids in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-914	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Phospholipids in medium VLDL	Weighted median	15	-0.07761111979487245	0.026761331923404328	0.0037301778486361586	-0.13006333036474493	-0.02515890922499997	0.9253241968487104	0.8780398225775071	0.9751549385997573	0.925 [0.878:0.975]	negative	Phospholipids in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-931	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Phospholipids in small VLDL	Inverse variance weighted	14	-0.07344839475651942	0.024977372372025273	0.003275800585765644	-0.12240404460568896	-0.02449274490734988	0.9291840953257625	0.8847908013205092	0.9758047684467295	0.929 [0.885:0.976]	negative	Phospholipids in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-931	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Phospholipids in small VLDL	MR Egger	14	-0.10750177015022905	0.07495580901531544	0.17705670720742187	-0.2544151558202473	0.03941161551978922	0.8980749327218477	0.7753698359178188	1.0401985574131052	0.898 [0.775:1.04]	overlaps null	Phospholipids in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-931	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Phospholipids in small VLDL	Weighted median	14	-0.07836802191166702	0.02655418023260709	0.0031649073357052026	-0.1304142151675769	-0.02632182865575712	0.9246240819980253	0.8777317857933571	0.9740215711089283	0.925 [0.878:0.974]	negative	Phospholipids in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-951	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Phospholipids in very large VLDL	Inverse variance weighted	9	-0.10888820782933252	0.02710866386447681	5.901104289817297e-5	-0.16202118900370707	-0.05575522665495797	0.8968306705417594	0.8504231847293089	0.945770606995379	0.897 [0.85:0.946]	negative	Phospholipids in very large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-951	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Phospholipids in very large VLDL	MR Egger	9	-0.14871119024231103	0.09124588461935522	0.14716941835297717	-0.32755312409624726	0.03013074361162521	0.8618179804019275	0.7206850045190312	1.0305892681085247	0.862 [0.721:1.031]	overlaps null	Phospholipids in very large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-951	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Phospholipids in very large VLDL	Weighted median	9	-0.10443367988896805	0.0324782688670706	0.0013022019999656025	-0.16809108686842644	-0.04077627290950968	0.9008345388724704	0.8452768375579118	0.9600438937497544	0.901 [0.845:0.96]	negative	Phospholipids in very large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-a-355	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Proline	Inverse variance weighted	3	-0.2441919687526157	0.1572198504167823	0.12037825204645373	-0.552342875569509	0.06395893806427758	0.7833372435546434	0.5755996709867974	1.0660486238427007	0.783 [0.576:1.066]	overlaps null	Proline (M/F) Shin/2014 [  7K]	Metabolites
met-a-355	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Proline	MR Egger	3	-0.34882657710441634	0.23038588341341718	0.37159058616049	-0.8003829085947141	0.10272975438588133	0.7055154721972696	0.44915694513088306	1.108191884608826	0.706 [0.449:1.108]	overlaps null	Proline (M/F) Shin/2014 [  7K]	Metabolites
met-a-355	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Proline	Weighted median	3	-0.24723572568642121	0.17133396638062678	0.1490191358560006	-0.5830502997924497	0.08857884841960728	0.780956580306163	0.5581931107869363	1.0926204006059366	0.781 [0.558:1.093]	overlaps null	Proline (M/F) Shin/2014 [  7K]	Metabolites
met-a-501	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Pyroglutamine*	Inverse variance weighted	3	-0.21926887285123906	0.12156595758080813	0.07127789130940332	-0.457538149709623	0.019000404007144867	0.8031057557873139	0.6328396859163024	1.019182060374159	0.803 [0.633:1.019]	overlaps null	Pyroglutamine* (M/F) Shin/2014 [  7K]	Metabolites
met-a-501	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Pyroglutamine*	MR Egger	3	-0.12312048319040911	0.33374925384996995	0.7750102703571538	-0.7772690207363502	0.5310280543555319	0.8841571300714086	0.4596596196264522	1.7006798014830953	0.884 [0.46:1.701]	overlaps null	Pyroglutamine* (M/F) Shin/2014 [  7K]	Metabolites
met-a-501	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Pyroglutamine*	Weighted median	3	-0.17704785459027733	0.1371243941240095	0.19665244493133757	-0.44581166707333597	0.09171595789278131	0.8377396938739313	0.6403043510991874	1.096053452529598	0.838 [0.64:1.096]	overlaps null	Pyroglutamine* (M/F) Shin/2014 [  7K]	Metabolites
met-c-844	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ratio of bisallylic groups to double bonds	Inverse variance weighted	4	0.014374000775209016	0.01958484652423478	0.4629884651731361	-0.02401229841229115	0.05276029996270919	1.0144778034814284	0.9762737030675686	1.0541769285833917	1.014 [0.976:1.054]	overlaps null	Ratio of bisallylic groups to double bonds (M/F) Kettunen/2016 [ 13K]	Metabolites
met-c-844	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ratio of bisallylic groups to double bonds	MR Egger	4	0.024936161938342964	0.04568640712858224	0.6399389958869136	-0.06460919603367823	0.11448151991036415	1.0252496684837349	0.9374337446262231	1.1212919192973165	1.025 [0.937:1.121]	overlaps null	Ratio of bisallylic groups to double bonds (M/F) Kettunen/2016 [ 13K]	Metabolites
met-c-844	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ratio of bisallylic groups to double bonds	Weighted median	4	0.015596271098383432	0.016587710904750346	0.34709935937043285	-0.016915642274927246	0.04810818447169411	1.0157185276898681	0.9832266238977997	1.0492841654374387	1.016 [0.983:1.049]	overlaps null	Ratio of bisallylic groups to double bonds (M/F) Kettunen/2016 [ 13K]	Metabolites
met-c-845	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ratio of bisallylic groups to total fatty acids	Inverse variance weighted	6	0.02717861430647364	0.021776448679759683	0.21200404458018363	-0.015503225105855337	0.06986045371880262	1.0275513217401429	0.9846163312547171	1.0723585271680471	1.028 [0.985:1.072]	overlaps null	Ratio of bisallylic groups to total fatty acids (M/F) Kettunen/2016 [ 13K]	Metabolites
met-c-845	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ratio of bisallylic groups to total fatty acids	MR Egger	6	0.006752862732816945	0.040748010657566745	0.8764141811153023	-0.07311323815601388	0.08661896362164777	1.0067757147201795	0.9294955697018266	1.090481087581171	1.007 [0.929:1.09]	overlaps null	Ratio of bisallylic groups to total fatty acids (M/F) Kettunen/2016 [ 13K]	Metabolites
met-c-845	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ratio of bisallylic groups to total fatty acids	Weighted median	6	0.021751762935160728	0.018134138184492592	0.23033649526151603	-0.013791147906444756	0.05729467377676621	1.0219900571673945	0.9863035143073197	1.0589678144688965	1.022 [0.986:1.059]	overlaps null	Ratio of bisallylic groups to total fatty acids (M/F) Kettunen/2016 [ 13K]	Metabolites
met-a-464	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Serine	Inverse variance weighted	3	0.47803993831255903	0.23908926698976246	0.04556289534003464	0.009424975012624626	0.9466549016124934	1.6129098989969648	1.0094695299560197	2.577074656622612	1.613 [1.009:2.577]	positive	Serine (M/F) Shin/2014 [  7K]	Metabolites
met-a-464	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Serine	MR Egger	3	1.6684642066364823	3.63942713353048	0.7263479642557467	-5.464812975083258	8.801741388356223	5.30401566672863	0.0042331326742894235	6645.806866335731	5.304 [0.004:6645.807]	overlaps null	Serine (M/F) Shin/2014 [  7K]	Metabolites
met-a-464	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Serine	Weighted median	3	0.577636708897098	0.24750434086426404	0.01960385213113365	0.09252820080314045	1.0627452169910554	1.781822485732138	1.0969440758280549	2.8943055900675807	1.782 [1.097:2.894]	positive	Serine (M/F) Shin/2014 [  7K]	Metabolites
met-c-864	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in HDL	Inverse variance weighted	12	0.05780447870742047	0.022640336096577094	0.010674938666587487	0.013429419958129366	0.10217953745671157	1.0595078191189378	1.0135199996416888	1.1075823063886523	1.06 [1.014:1.108]	positive	Total cholesterol in HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-864	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in HDL	MR Egger	12	0.0018029968847707788	0.05610161555334736	0.9749943605489948	-0.10815616959979005	0.11176216336933162	1.0018046232609576	0.8974874252334646	1.1182468689474485	1.002 [0.897:1.118]	overlaps null	Total cholesterol in HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-864	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in HDL	Weighted median	12	0.049182246115955564	0.026051170273899145	0.05903813050167219	-0.0018780476208867594	0.10024253985279788	1.0504117667617314	0.9981237148070659	1.1054389985762225	1.05 [0.998:1.105]	overlaps null	Total cholesterol in HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-874	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in large HDL	Inverse variance weighted	14	0.060469498881106705	0.021409716076011925	0.0047369939766158725	0.01850645537212333	0.10243254239009009	1.062335194664088	1.018678761098827	1.1078625656282817	1.062 [1.019:1.108]	positive	Total cholesterol in large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-874	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in large HDL	MR Egger	14	0.028822376731576813	0.05299709141993509	0.5965056083286826	-0.07505192245149596	0.1326966759146496	1.0292417609522897	0.9276953168629325	1.1419035789362382	1.029 [0.928:1.142]	overlaps null	Total cholesterol in large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-874	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in large HDL	Weighted median	14	0.03906735470631561	0.022792806827185264	0.08652482761472166	-0.005606546674967509	0.08374125608759872	1.0398405194443134	0.9944091406768595	1.0873475128579753	1.04 [0.994:1.087]	overlaps null	Total cholesterol in large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-886	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in large VLDL	Inverse variance weighted	10	-0.1065202010146209	0.022716713546588635	2.7445298199989204e-6	-0.1510449595659346	-0.061995442463307175	0.8989568881365658	0.8598090411489229	0.9398871703515936	0.899 [0.86:0.94]	negative	Total cholesterol in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-886	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in large VLDL	MR Egger	10	-0.10850960137215647	0.06962336406412721	0.15772658486904867	-0.2449713949378458	0.027952192193532857	0.8971702807098646	0.7827269278740598	1.0283465202547974	0.897 [0.783:1.028]	overlaps null	Total cholesterol in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-886	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in large VLDL	Weighted median	10	-0.08856298310460459	0.030778343773761516	0.004009101333449269	-0.14888853690117715	-0.028237429308032018	0.915245463919836	0.8616651534146308	0.9721575207100772	0.915 [0.862:0.972]	negative	Total cholesterol in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-898	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in medium HDL	Inverse variance weighted	6	0.10430993328929294	0.04074483317855958	0.010464880376139333	0.024450060259316175	0.1841698063192697	1.1099444103332392	1.0247514140094427	1.2022199503094804	1.11 [1.025:1.202]	positive	Total cholesterol in medium HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-898	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in medium HDL	MR Egger	6	0.029014458552613486	0.1013544147667225	0.7888878572884361	-0.16964019439016262	0.22766911149538957	1.0294394785723926	0.8439684265472238	1.2556697699923993	1.029 [0.844:1.256]	overlaps null	Total cholesterol in medium HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-898	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in medium HDL	Weighted median	6	0.07552771337678277	0.0380741589067778	0.04728928082156073	9.023619194982735e-4	0.15015306483406726	1.0784531148814276	1.000902769170502	1.1620120923047708	1.078 [1.001:1.162]	positive	Total cholesterol in medium HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-909	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in medium VLDL	Inverse variance weighted	15	-0.07499743410633265	0.026003753647244016	0.003925336888315574	-0.12596479125493093	-0.024030076957734382	0.9277458668227434	0.8816458878822614	0.9762563464954612	0.928 [0.882:0.976]	negative	Total cholesterol in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-909	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in medium VLDL	MR Egger	15	-0.08691703832228659	0.07245051877690378	0.2516739507806798	-0.228920055125018	0.05508597848044483	0.9167531478575939	0.7953921184868875	1.0566314583373164	0.917 [0.795:1.057]	overlaps null	Total cholesterol in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-909	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in medium VLDL	Weighted median	15	-0.07600134125053522	0.026954594193596793	0.0048082615411688895	-0.12883234586998493	-0.023170336631085503	0.9268149634674828	0.8791213415148323	0.9770960343507242	0.927 [0.879:0.977]	negative	Total cholesterol in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-927	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in small VLDL	Inverse variance weighted	16	-0.04623469501874547	0.02586437917654252	0.07384349438141039	-0.09692887820476881	0.00445948816727787	0.9548178449001301	0.9076205554411059	1.0044694464821278	0.955 [0.908:1.004]	overlaps null	Total cholesterol in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-927	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in small VLDL	MR Egger	16	-0.07375103961878632	0.07015590455922417	0.31095401034331516	-0.2112566125548657	0.06375453331729306	0.928902925082723	0.809566295348642	1.0658307407124026	0.929 [0.81:1.066]	overlaps null	Total cholesterol in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-927	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in small VLDL	Weighted median	16	-0.062324916841438205	0.03166049007302576	0.04900602659766501	-0.1243794773845687	-2.703562983077182e-4	0.9395775526189846	0.8830446818078186	0.999729680244663	0.94 [0.883:1]	negative	Total cholesterol in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-942	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in very large HDL	Inverse variance weighted	13	0.0729931000815528	0.020573696395286917	3.8833836487528364e-4	0.03266865514679044	0.11331754501631516	1.0757231144873347	1.0332081343197828	1.1199875229439287	1.076 [1.033:1.12]	positive	Total cholesterol in very large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-942	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in very large HDL	MR Egger	13	0.07982755844191318	0.056351491198886584	0.18429140277313105	-0.03062136430790452	0.19027648119173088	1.0831002800705891	0.9698427206338057	1.2095839786500096	1.083 [0.97:1.21]	overlaps null	Total cholesterol in very large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-942	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in very large HDL	Weighted median	13	0.07041883462098135	0.027389805480820015	0.010140912504207017	0.016734815878574123	0.12410285336338858	1.072957478895947	1.0168756272975774	1.132132308626815	1.073 [1.017:1.132]	positive	Total cholesterol in very large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-957	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in chylomicrons and largest VLDL particles	Inverse variance weighted	9	-0.13031470809835144	0.027323964133008014	1.8491668760894176e-6	-0.18386967779904714	-0.07675973839765574	0.877819130656571	0.832044230596732	0.9261123361122486	0.878 [0.832:0.926]	negative	Total lipids in chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-957	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in chylomicrons and largest VLDL particles	MR Egger	9	-0.07138705108876983	0.08653484091362329	0.43660508280793187	-0.24099533927947148	0.09822123710193181	0.9311014385495714	0.785845288985081	1.103206828393343	0.931 [0.786:1.103]	overlaps null	Total lipids in chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-957	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in chylomicrons and largest VLDL particles	Weighted median	9	-0.11181296988303785	0.03541432641181532	0.0015924796026307777	-0.18122504965019587	-0.042400890115879816	0.8942114863403342	0.8342475904395866	0.9584854561961063	0.894 [0.834:0.958]	negative	Total lipids in chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-877	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in large HDL	Inverse variance weighted	11	0.04627823363302916	0.0182341704841277	0.01114895752662267	0.010539259484138863	0.08201720778191945	1.047365782807194	1.0105949931043205	1.0854744882771146	1.047 [1.011:1.085]	positive	Total lipids in large HDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-877	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in large HDL	MR Egger	11	-0.026383140489531467	0.05021072531849251	0.6119698770850153	-0.12479616211377678	0.07202988113471384	0.9739618538909726	0.8826768072228844	1.0746874564646955	0.974 [0.883:1.075]	overlaps null	Total lipids in large HDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-877	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in large HDL	Weighted median	11	0.0358293569017067	0.021655840753475302	0.09802813473034959	-0.006616090975104891	0.0782748047785183	1.0364789634177818	0.9934057471672036	1.0814197971685198	1.036 [0.993:1.081]	overlaps null	Total lipids in large HDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-889	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in large VLDL	Inverse variance weighted	9	-0.11456529130760221	0.024727829295032276	3.6031593587336756e-6	-0.16303183672586546	-0.06609874588933895	0.8917537127513663	0.8495641406433855	0.9360384297807258	0.892 [0.85:0.936]	negative	Total lipids in large VLDL (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-889	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in large VLDL	MR Egger	9	-0.05525189863377179	0.07616668153355789	0.4917349758667052	-0.20453859443954525	0.09403479717200168	0.9462467596639319	0.8150232859435624	1.098597973354706	0.946 [0.815:1.099]	overlaps null	Total lipids in large VLDL (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-889	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in large VLDL	Weighted median	9	-0.09249114836769495	0.03416663660652861	0.006788190943035394	-0.15945775611649105	-0.025524540618898875	0.9116572805837829	0.8526059840235449	0.9747984565147819	0.912 [0.853:0.975]	negative	Total lipids in large VLDL (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-912	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in medium VLDL	Inverse variance weighted	12	-0.09786909966718466	0.02110021865026024	3.5129022323621696e-6	-0.1392255282216947	-0.05651267111267459	0.9067675921651758	0.8700317896080557	0.945054509527105	0.907 [0.87:0.945]	negative	Total lipids in medium VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-912	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in medium VLDL	MR Egger	12	-0.05121655408490308	0.050122450514124145	0.3309457781441679	-0.1494565570925864	0.04702344892278024	0.9500729060848968	0.8611758491897533	1.0481465866998692	0.95 [0.861:1.048]	overlaps null	Total lipids in medium VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-912	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in medium VLDL	Weighted median	12	-0.07977345123366718	0.029622047550938894	0.007080311217521374	-0.13783266443350742	-0.021714238033826945	0.9233255009470506	0.8712444697354337	0.9785198188494733	0.923 [0.871:0.979]	negative	Total lipids in medium VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-929	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in small VLDL	Inverse variance weighted	14	-0.07284267874899028	0.02538922304111164	0.004117206357827552	-0.12260555590956909	-0.023079801588411462	0.9297470874957144	0.8846125239355315	0.9771844997864414	0.93 [0.885:0.977]	negative	Total lipids in small VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-929	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in small VLDL	MR Egger	14	-0.1116548558065799	0.07346456919759665	0.1544506747813965	-0.2556454114338693	0.03233569982070954	0.894352884941915	0.7744165193563127	1.0328641794324944	0.894 [0.774:1.033]	overlaps null	Total lipids in small VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-929	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in small VLDL	Weighted median	14	-0.07730459849427468	0.02643846221325307	0.003456262674921438	-0.1291239844322507	-0.02548521255629866	0.9256078718990046	0.8788649932130779	0.9748367942033709	0.926 [0.879:0.975]	negative	Total lipids in small VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-945	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in very large HDL	Inverse variance weighted	13	0.04598951191807146	0.016406163389104632	0.005060062717883253	0.013833431675426382	0.07814559216071654	1.0470634292123187	1.0139295563245374	1.081280073112835	1.047 [1.014:1.081]	positive	Total lipids in very large HDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-945	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in very large HDL	MR Egger	13	0.02899476939950346	0.04768498671418104	0.5555018152142098	-0.06446780456029137	0.1224573433592983	1.0294192099804178	0.9375662991353961	1.1302709054857714	1.029 [0.938:1.13]	overlaps null	Total lipids in very large HDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-945	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in very large HDL	Weighted median	13	0.037950267348703715	0.023367420438837775	0.10436141009161476	-0.007849876711418326	0.08375041140882575	1.0386795753048472	0.9921808531097659	1.0873574679193116	1.039 [0.992:1.087]	overlaps null	Total lipids in very large HDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-949	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in very large VLDL	Inverse variance weighted	8	-0.11367438286093474	0.026830941572946514	2.2683893871486452e-5	-0.1662630283439099	-0.06108573737795958	0.892548537671949	0.8468234663196219	0.9407425795161569	0.893 [0.847:0.941]	negative	Total lipids in very large VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-949	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in very large VLDL	MR Egger	8	-0.0764139515143926	0.08839831147049104	0.4205634726022132	-0.24967464199655504	0.09684673896776984	0.9264326289838498	0.7790542133648178	1.1016915143028831	0.926 [0.779:1.102]	overlaps null	Total lipids in very large VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-949	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in very large VLDL	Weighted median	8	-0.09655539489457296	0.034043746966191196	0.004565166432142462	-0.1632811389483077	-0.029829650840838218	0.9079595998803324	0.8493523688137066	0.9706108622105599	0.908 [0.849:0.971]	negative	Total lipids in very large VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-960	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in chylomicrons and largest VLDL particles	Inverse variance weighted	9	-0.12478146308423699	0.026326851439846557	2.1403145563248587e-6	-0.17638209190633625	-0.07318083426213773	0.8826897818107046	0.8382976154020281	0.9294327415441487	0.883 [0.838:0.929]	negative	Triglycerides in chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-960	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in chylomicrons and largest VLDL particles	MR Egger	9	-0.06664326765881953	0.08542355652349173	0.46086271359773856	-0.23407343844486334	0.10078690312722427	0.9355288752230049	0.7913037016484363	1.1060409227870194	0.936 [0.791:1.106]	overlaps null	Triglycerides in chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-960	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in chylomicrons and largest VLDL particles	Weighted median	9	-0.11327414383630106	0.03308633971614207	6.179922001761356e-4	-0.17812336967993952	-0.04842491799266262	0.8929058419268885	0.836839176538757	0.9527288694164532	0.893 [0.837:0.953]	negative	Triglycerides in chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-892	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in large VLDL	Inverse variance weighted	9	-0.115214284808613	0.02402957961475504	1.6292997242052141e-6	-0.16231226085353287	-0.06811630876369312	0.8911751581466846	0.8501756865014259	0.9341518172155304	0.891 [0.85:0.934]	negative	Triglycerides in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-892	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in large VLDL	MR Egger	9	-0.06262941920679675	0.06969409685667136	0.3987031818697637	-0.1992298490458726	0.07397101063227911	0.9392914925869628	0.8193615422188892	1.076775590000232	0.939 [0.819:1.077]	overlaps null	Triglycerides in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-892	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in large VLDL	Weighted median	9	-0.09030431575895884	0.030653522262142636	0.0032194502298532887	-0.1503852193927584	-0.03022341212515927	0.9136531039233605	0.8603764788747789	0.9702287484666164	0.914 [0.86:0.97]	negative	Triglycerides in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-915	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in medium VLDL	Inverse variance weighted	13	-0.11131490880619703	0.02101072811014099	1.1707579205281917e-7	-0.15249593590207336	-0.0701338817103207	0.8946569692057731	0.8585623832309058	0.9322689977825329	0.895 [0.859:0.932]	negative	Triglycerides in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-915	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in medium VLDL	MR Egger	13	-0.0815302066081145	0.051930816251331786	0.14472002757851327	-0.18331460646072478	0.020254193244495802	0.9217048678556427	0.8325062027032293	1.0204607012779585	0.922 [0.833:1.02]	overlaps null	Triglycerides in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-915	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in medium VLDL	Weighted median	13	-0.08100531054269654	0.029948981582793546	0.006835029818989136	-0.1397053144449719	-0.022305306640421192	0.922188794108639	0.8696144604639812	0.9779416173988174	0.922 [0.87:0.978]	negative	Triglycerides in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-923	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in small HDL	Inverse variance weighted	11	-0.10918217038586582	0.023960922933925898	5.196941283997699e-6	-0.15614557933636058	-0.06221876143537106	0.8965670746506287	0.8554346476975069	0.9396772991498374	0.897 [0.855:0.94]	negative	Triglycerides in small HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-923	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in small HDL	MR Egger	11	-0.05166857639472079	0.06932320229279798	0.47508658986769225	-0.18754205288860482	0.08420490009916325	0.9496435489821984	0.8289942558442794	1.087851771910113	0.95 [0.829:1.088]	overlaps null	Triglycerides in small HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-923	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in small HDL	Weighted median	11	-0.08740100710373486	0.02888316387198926	0.0024779660500960942	-0.1440120082928338	-0.03079000591463591	0.9163095753000295	0.865877350287995	0.9696791785895055	0.916 [0.866:0.97]	negative	Triglycerides in small HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-932	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in small VLDL	Inverse variance weighted	14	-0.0951052863179525	0.018657829530490767	3.444607455287376e-7	-0.13167463219771441	-0.05853594043819059	0.9092771949804331	0.8766261746145985	0.9431443427695663	0.909 [0.877:0.943]	negative	Triglycerides in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-932	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in small VLDL	MR Egger	14	-0.04131062262627668	0.04979638366336413	0.4229664875792494	-0.13891153460647038	0.05629028935391701	0.9595310316031199	0.8703050169286071	1.0579047376500121	0.96 [0.87:1.058]	overlaps null	Triglycerides in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-932	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in small VLDL	Weighted median	14	-0.08081545313329228	0.025782674695365403	0.0017215500743843874	-0.13134949553620845	-0.030281410730376088	0.9223638951056549	0.876911244263187	0.9701724781842788	0.922 [0.877:0.97]	negative	Triglycerides in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-952	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in very large VLDL	Inverse variance weighted	9	-0.10794282627614425	0.027025309474620486	6.492993105779094e-5	-0.1609124328464004	-0.0549732197058881	0.8976789186098846	0.8513666195946517	0.9465104954435237	0.898 [0.851:0.947]	negative	Triglycerides in very large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-952	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in very large VLDL	MR Egger	9	-0.12948448335661136	0.08352205279760956	0.16500351986621398	-0.2931877068399261	0.03421874012670337	0.8785482204299208	0.745882120380473	1.0348109366488942	0.879 [0.746:1.035]	overlaps null	Triglycerides in very large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-952	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in very large VLDL	Weighted median	9	-0.10119107787764378	0.0335524188871179	0.002562092389245542	-0.16695381889639488	-0.0354283368588927	0.903760327780996	0.8462386906714665	0.9651919004349936	0.904 [0.846:0.965]	negative	Triglycerides in very large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-956	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in very small VLDL	Inverse variance weighted	19	-0.0472799191461365	0.023854762921376265	0.0474802773788261	-0.09403525447203398	-5.245838202390246e-4	0.9538203676358401	0.910250671268261	0.9994755537497965	0.954 [0.91:0.999]	negative	Triglycerides in very small VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-956	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in very small VLDL	MR Egger	19	-0.13475520676711775	0.06945668019182069	0.06913710714748104	-0.27089029994308633	0.0013798864088508112	0.8739298176109702	0.7627001600669947	1.0013808388901564	0.874 [0.763:1.001]	overlaps null	Triglycerides in very small VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-956	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in very small VLDL	Weighted median	19	-0.06299818538145033	0.02565318594848862	0.014058522215077364	-0.11327842984048803	-0.012717940922412636	0.9389451775149236	0.8929020149369127	0.9873625903294903	0.939 [0.893:0.987]	negative	Triglycerides in very small VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-a-316	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Uridine	Inverse variance weighted	3	-0.4823218241868344	0.3672601698491588	0.1890827561452273	-1.2021517570911857	0.23750810871751687	0.6173483521601891	0.3005468119044663	1.2680852792943473	0.617 [0.301:1.268]	overlaps null	Uridine (M/F) Shin/2014 [  7K]	Metabolites
met-a-316	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Uridine	MR Egger	3	-0.41606486291026545	1.763823747755558	0.8525249135403604	-3.8731594085111594	3.0410296826906285	0.6596374830898732	0.020792573308460065	20.926780088354953	0.66 [0.021:20.927]	overlaps null	Uridine (M/F) Shin/2014 [  7K]	Metabolites
met-a-316	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Uridine	Weighted median	3	-0.48160889482692665	0.43299876157816236	0.2660246970194057	-1.330286467520125	0.36706867786627156	0.6177886348523153	0.2644015080055972	1.4434970520085224	0.618 [0.264:1.443]	overlaps null	Uridine (M/F) Shin/2014 [  7K]	Metabolites
met-a-485	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-02269	Inverse variance weighted	2	0.18401009625737041	0.09820647213441729	0.06097090207329701	-0.00847458912608745	0.3764947816408283	1.2020279590186784	0.9915612189799498	1.457167935378709	1.202 [0.992:1.457]	overlaps null	X-02269 (M/F) Shin/2014 [  7K]	Metabolites
met-a-373	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-03094	Inverse variance weighted	5	-0.3498069900467854	0.20262889023107217	0.0842857026570235	-0.7469596148996869	0.04734563480611603	0.7048241146606025	0.4738049144485963	1.0484843391403829	0.705 [0.474:1.048]	overlaps null	X-03094 (M/F) Shin/2014 [  7K]	Metabolites
met-a-373	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-03094	MR Egger	5	-0.3193164643188665	0.9130190587361442	0.749647867195515	-2.108833819441709	1.470200890803976	0.7266455555250585	0.12137943426524785	4.350108950174079	0.727 [0.121:4.35]	overlaps null	X-03094 (M/F) Shin/2014 [  7K]	Metabolites
met-a-373	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-03094	Weighted median	5	-0.47057645185933217	0.26397257088081333	0.07463974825461117	-0.9879626907857263	0.04680978706706196	0.6246420883862218	0.3723344793008876	1.0479226616780597	0.625 [0.372:1.048]	overlaps null	X-03094 (M/F) Shin/2014 [  7K]	Metabolites
met-a-444	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-10510	Inverse variance weighted	3	0.33647165976786253	0.16608469104451587	0.04277461102500826	0.01094566532061142	0.6619976542151136	1.3999991924055424	1.0110057882769519	1.938661243548939	1.4 [1.011:1.939]	positive	X-10510 (M/F) Shin/2014 [  7K]	Metabolites
met-a-444	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-10510	MR Egger	3	0.7235552013013743	0.3720843514688007	0.3023805372830422	-0.0057301275774750415	1.4528405301802236	2.0617501331272976	0.9942862582909073	4.2752412356147955	2.062 [0.994:4.275]	overlaps null	X-10510 (M/F) Shin/2014 [  7K]	Metabolites
met-a-444	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-10510	Weighted median	3	0.3615584901595058	0.18431045714510677	0.04979952889073553	3.0999415509652684e-4	0.722806986163915	1.435564985953775	1.0003100422082498	2.0602080774346794	1.436 [1:2.06]	positive	X-10510 (M/F) Shin/2014 [  7K]	Metabolites
met-a-495	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-11315	Inverse variance weighted	3	-0.6435316909374705	0.3537709839523251	0.06890182619516422	-1.3369228194840277	0.04985943760908662	0.5254334747171006	0.2626526559560048	1.0511233375821272	0.525 [0.263:1.051]	overlaps null	X-11315 (M/F) Shin/2014 [  7K]	Metabolites
met-a-495	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-11315	MR Egger	3	-1.2246260728616303	1.5210204913659375	0.568458436454323	-4.205826235938868	1.756574090215607	0.2938675648391707	0.01490846307093443	5.792558579218553	0.294 [0.015:5.793]	overlaps null	X-11315 (M/F) Shin/2014 [  7K]	Metabolites
met-a-495	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-11315	Weighted median	3	-0.9593143435651724	0.2545519786864309	1.6414051426409063e-4	-1.458236221790577	-0.4603924653397678	0.38315550897051515	0.23264624945652648	0.6310359371681504	0.383 [0.233:0.631]	negative	X-11315 (M/F) Shin/2014 [  7K]	Metabolites
met-a-513	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-11440	Inverse variance weighted	3	-0.11386956204778914	0.048703447629984575	0.019386287966550862	-0.20932831940255892	-0.01841080469301938	0.8923743477738124	0.8111288825712392	0.9817576388605512	0.892 [0.811:0.982]	negative	X-11440 (M/F) Shin/2014 [  7K]	Metabolites
met-a-513	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-11440	MR Egger	3	-0.13362859378310557	0.07682212207363728	0.3321587498160088	-0.2841999530474346	0.016942765481223504	0.8749149531196345	0.7526161417688421	1.0170871081681372	0.875 [0.753:1.017]	overlaps null	X-11440 (M/F) Shin/2014 [  7K]	Metabolites
met-a-513	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-11440	Weighted median	3	-0.11354401406698238	0.05211867837301301	0.029363876613189673	-0.2156966236780879	-0.011391404455876872	0.8926649057335664	0.8059797799683543	0.9886732319259972	0.893 [0.806:0.989]	negative	X-11440 (M/F) Shin/2014 [  7K]	Metabolites
met-a-517	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-11445--5-alpha-pregnan-3beta,20alpha-disulfate	Inverse variance weighted	2	-0.2000510193649377	0.08319451083278927	0.016189378081595016	-0.36311226059720464	-0.036989778132670736	0.8186889830204548	0.6955083509335427	0.9636859859690031	0.819 [0.696:0.964]	negative	X-11445--5-alpha-pregnan-3beta,20alpha-disulfate (M/F) Shin/2014 [  2K]	Metabolites
met-a-519	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-11469	Inverse variance weighted	2	0.1794704608855369	0.0989533115215094	0.06972573121579813	-0.014478029696621514	0.3734189514676953	1.19658355752676	0.9856262730027417	1.4526928201511267	1.197 [0.986:1.453]	overlaps null	X-11469 (M/F) Shin/2014 [  7K]	Metabolites
met-a-629	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-12510--2-aminooctanoic acid	Inverse variance weighted	3	0.11323191871850236	0.09039043555951419	0.21031563059976144	-0.06393333497814546	0.2903971724151502	1.1198916266644225	0.9380675337389219	1.3369583855805174	1.12 [0.938:1.337]	overlaps null	X-12510--2-aminooctanoic acid (M/F) Shin/2014 [  7K]	Metabolites
met-a-629	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-12510--2-aminooctanoic acid	MR Egger	3	0.027586314760508303	0.18277891944555646	0.9046364947693055	-0.3306603673527823	0.38583299687379896	1.027970340291783	0.7184491363906703	1.470839015588977	1.028 [0.718:1.471]	overlaps null	X-12510--2-aminooctanoic acid (M/F) Shin/2014 [  7K]	Metabolites
met-a-629	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-12510--2-aminooctanoic acid	Weighted median	3	0.09265779688145595	0.06457464120095982	0.15131716595624867	-0.03390849987242531	0.2192240936353372	1.097086244690478	0.9666599500998149	1.2451102667124825	1.097 [0.967:1.245]	overlaps null	X-12510--2-aminooctanoic acid (M/F) Shin/2014 [  7K]	Metabolites
prot-a-54	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Advanced glycosylation end product-specific receptor, soluble	Inverse variance weighted	5	-0.008012743062983425	0.02295364163809666	0.7270264434820141	-0.05300188067365288	0.036976394547686024	0.9920192733924338	0.948378228890673	1.0376685259141452	0.992 [0.948:1.038]	overlaps null	Advanced glycosylation end product-specific receptor, soluble (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-54	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Advanced glycosylation end product-specific receptor, soluble	MR Egger	5	-0.03242101865148909	0.07123785227502494	0.6799475311388643	-0.17204720911053795	0.10720517180755978	0.9680989085691499	0.841939425018888	1.11316262063836	0.968 [0.842:1.113]	overlaps null	Advanced glycosylation end product-specific receptor, soluble (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-54	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Advanced glycosylation end product-specific receptor, soluble	Weighted median	5	-0.010779146042127222	0.018643040227111125	0.5631385067882839	-0.047319504887265024	0.02576121280301058	0.9892787407757218	0.9537826106970069	1.026095900653506	0.989 [0.954:1.026]	overlaps null	Advanced glycosylation end product-specific receptor, soluble (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-67	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Alcohol dehydrogenase [NADP(+)]	Inverse variance weighted	3	-0.030597465210002225	0.008400978939825563	2.703904829333724e-4	-0.04706338393206033	-0.014131546487944121	0.9698658992769092	0.9540269256960762	0.9859678351257216	0.97 [0.954:0.986]	negative	Alcohol dehydrogenase [NADP(+)] (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-67	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Alcohol dehydrogenase [NADP(+)]	MR Egger	3	-0.02128040142489568	0.017325593523449756	0.43501120748762595	-0.0552385647308572	0.012677761881065841	0.9789444286684371	0.9462593769104768	1.0127584653902333	0.979 [0.946:1.013]	overlaps null	Alcohol dehydrogenase [NADP(+)] (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-67	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Alcohol dehydrogenase [NADP(+)]	Weighted median	3	-0.028971363273137353	0.008725707561248618	8.994304599491254e-4	-0.046073750093184644	-0.011868976453090062	0.9714442830528823	0.954971530354217	0.9882011820039189	0.971 [0.955:0.988]	negative	Alcohol dehydrogenase [NADP(+)] (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1411	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Alpha-L-iduronidase	Inverse variance weighted	2	0.02268932594310247	0.010701397514683351	0.033987426395093556	0.0017145868143231026	0.043664065071881836	1.0229486865569843	1.0017160575587478	1.0446313677738859	1.023 [1.002:1.045]	positive	Alpha-L-iduronidase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-99	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Angiopoietin-related protein 4	Inverse variance weighted	3	0.04630849954506258	0.024303183622553456	0.05672161005134487	-0.0013257403551421923	0.09394273944526735	1.0473974827675552	0.9986751380503803	1.098496843577644	1.047 [0.999:1.098]	overlaps null	Angiopoietin-related protein 4 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-99	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Angiopoietin-related protein 4	MR Egger	3	-0.08461229287595075	0.15432268930037016	0.6807205712009664	-0.3870847639046762	0.21786017815277475	0.9188684672004892	0.6790335349533385	1.2434131991336717	0.919 [0.679:1.243]	overlaps null	Angiopoietin-related protein 4 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-99	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Angiopoietin-related protein 4	Weighted median	3	0.05773054018852775	0.029775238833288673	0.05251625810939166	-6.289279247180465e-4	0.11609000830177355	1.0594294835760796	0.9993712698089936	1.123096955633713	1.059 [0.999:1.123]	overlaps null	Angiopoietin-related protein 4 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-216	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Beta-1,4-galactosyltransferase 1	Inverse variance weighted	5	0.03235304671308949	0.034575279287519294	0.34941340267635823	-0.035414500690448325	0.1001205941166273	1.032882096571661	0.9652052550850976	1.105304203222776	1.033 [0.965:1.105]	overlaps null	Beta-1,4-galactosyltransferase 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-216	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Beta-1,4-galactosyltransferase 1	MR Egger	5	-0.08820575887802579	0.10287400340790842	0.45425168164889795	-0.2898388055575263	0.11342728780147471	0.9155724701766157	0.7483841932289955	1.1201104402385602	0.916 [0.748:1.12]	overlaps null	Beta-1,4-galactosyltransferase 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-216	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Beta-1,4-galactosyltransferase 1	Weighted median	5	-4.552245406166597e-4	0.020014215439826392	0.9818536320564505	-0.03968308680267639	0.03877263772144307	0.9995448790583537	0.961093974258488	1.0395341059365248	1 [0.961:1.04]	overlaps null	Beta-1,4-galactosyltransferase 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-212	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Beta-1,4-glucuronyltransferase 1	Inverse variance weighted	3	0.02365092422100774	0.015893199675999288	0.13672031305894244	-0.007499747143950863	0.05480159558596634	1.0239328253496134	0.9925283057858928	1.0563310131475585	1.024 [0.993:1.056]	overlaps null	Beta-1,4-glucuronyltransferase 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-212	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Beta-1,4-glucuronyltransferase 1	MR Egger	3	0.03481955795694397	0.048746675693161975	0.6051325559621974	-0.0607239264016535	0.13036304231554144	1.0354328563220667	0.9410830120897115	1.1392419012756236	1.035 [0.941:1.139]	overlaps null	Beta-1,4-glucuronyltransferase 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-212	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Beta-1,4-glucuronyltransferase 1	Weighted median	3	0.028799344619682143	0.0150387876168817	0.0554919411014992	-6.766791094059872e-4	0.05827536834877027	1.0292180556138777	0.99932354978627	1.0600068478604014	1.029 [0.999:1.06]	overlaps null	Beta-1,4-glucuronyltransferase 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-674	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Beta-crystallin B2	Inverse variance weighted	3	0.049876291188754196	0.07309877877412467	0.49504067277299113	-0.09339731520853015	0.19314989758603854	1.0511410529223206	0.9108315411712532	1.213064615349002	1.051 [0.911:1.213]	overlaps null	Beta-crystallin B2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-674	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Beta-crystallin B2	MR Egger	3	0.8242271856882244	0.2892763102119278	0.214881950365082	0.2572456176728459	1.3912087537036029	2.2801179764580604	1.2933627605009064	4.019705952066922	2.28 [1.293:4.02]	positive	Beta-crystallin B2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-674	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Beta-crystallin B2	Weighted median	3	0.01765065915660491	0.037556620515778086	0.6383731370911341	-0.05596031705432014	0.09126163536752996	1.0178073525974825	0.9455766584130612	1.0955556038577303	1.018 [0.946:1.096]	overlaps null	Beta-crystallin B2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-390	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	C-C motif chemokine 14	Inverse variance weighted	3	-0.02643320642708768	0.011941724905582037	0.026862049401969897	-0.04983898724202847	-0.0030274256121468855	0.9739130927982587	0.9513825969048413	0.9969771524197227	0.974 [0.951:0.997]	negative	C-C motif chemokine 14 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-390	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	C-C motif chemokine 14	MR Egger	3	-0.014355617339908372	0.020041841100372524	0.6042960288886214	-0.05363762589663852	0.024926391216821775	0.9857469332226586	0.9477754935754216	1.025239651103673	0.986 [0.948:1.025]	overlaps null	C-C motif chemokine 14 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-390	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	C-C motif chemokine 14	Weighted median	3	-0.026538126342246462	0.01250989902889511	0.03389066545274157	-0.05105752843888088	-0.0020187242456120476	0.9738109152795122	0.950224004056463	0.997983312007736	0.974 [0.95:0.998]	negative	C-C motif chemokine 14 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-394	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	C-C motif chemokine 17	Inverse variance weighted	6	9.659289379204811e-4	0.013289419266414753	0.9420575338357363	-0.025081332824252435	0.0270131907000934	1.0009663955975183	0.9752305905444298	1.0273813545534398	1.001 [0.975:1.027]	overlaps null	C-C motif chemokine 17 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-394	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	C-C motif chemokine 17	MR Egger	6	-0.026795936373404317	0.02879462586397162	0.40474432032029045	-0.0832334030667887	0.02964153031998006	0.9735598894169852	0.9201363595068716	1.0300852134455125	0.974 [0.92:1.03]	overlaps null	C-C motif chemokine 17 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-394	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	C-C motif chemokine 17	Weighted median	6	-0.001965621522042713	0.016899174717904027	0.9074031787075008	-0.035088003969134605	0.031156760925049178	0.9980363090468115	0.9655204428873697	1.0316472131828052	0.998 [0.966:1.032]	overlaps null	C-C motif chemokine 17 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-399	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	C-C motif chemokine 23	Inverse variance weighted	3	0.01457201706507691	0.013879491709849503	0.29376612177480765	-0.012631786686228113	0.04177582081638193	1.0146787065026062	0.9874476594637778	1.0426607097219711	1.015 [0.987:1.043]	overlaps null	C-C motif chemokine 23 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-399	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	C-C motif chemokine 23	MR Egger	3	0.057450874153430996	0.034950670328135876	0.34793948903514843	-0.011052439689715317	0.12595418799657732	1.0591332385597088	0.989008414121135	1.1342302057347127	1.059 [0.989:1.134]	overlaps null	C-C motif chemokine 23 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-399	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	C-C motif chemokine 23	Weighted median	3	0.018474315536333344	0.013188711558233089	0.16128367788239373	-0.00737555911780351	0.044324190190470195	1.0186460214568487	0.9926515735711168	1.0453211828364941	1.019 [0.993:1.045]	overlaps null	C-C motif chemokine 23 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-408	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	C-C motif chemokine 3-like 1	Inverse variance weighted	3	0.02334866669825083	0.016754988259526277	0.16345799421728008	-0.00949111029042067	0.05618844368692233	1.0236233807186934	0.99055378813925965	1.0577970001227825	1.024 [0.991:1.058]	overlaps null	C-C motif chemokine 3-like 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-408	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	C-C motif chemokine 3-like 1	MR Egger	3	-0.009601855283330182	0.04106610096621317	0.853775866223283	-0.090091413177108	0.07088770261044763	0.9904440953410919	0.9138476437363812	1.073460672268274	0.99 [0.914:1.073]	overlaps null	C-C motif chemokine 3-like 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-408	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	C-C motif chemokine 3-like 1	Weighted median	3	0.017276119392177457	0.017942103838595864	0.33560700759731976	-0.017890404131470437	0.05244264291582535	1.0174262146515218	0.9822686790483864	1.053842115034122	1.017 [0.982:1.054]	overlaps null	C-C motif chemokine 3-like 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-670	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	C-reactive protein	Inverse variance weighted	3	0.042437759093834765	0.030230170452996016	0.16037205076782807	-0.016813374994037428	0.10168889318170696	1.0433511152338408	0.9833271809528848	1.1070390107642694	1.043 [0.983:1.107]	overlaps null	C-reactive protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-670	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	C-reactive protein	MR Egger	3	0.6717557055784036	0.3167877456667058	0.28053011641196945	0.050851724071660165	1.292659687085147	1.9576713997350903	1.052166870696772	3.642461491685994	1.958 [1.052:3.642]	positive	C-reactive protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-670	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	C-reactive protein	Weighted median	3	0.017325077123562127	0.026558947186275203	0.5141912467424454	-0.03473045936153727	0.06938061360866152	1.0174760267501763	0.9658657212377769	1.071844089967932	1.017 [0.966:1.072]	overlaps null	C-reactive protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-486	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cadherin-7	Inverse variance weighted	4	-0.0489434736912616	0.0259813001140697	0.05959255159839647	-0.0998668219148382	0.001979874532315011	0.9522349545042615	0.9049579305753128	1.0019818357780235	0.952 [0.905:1.002]	overlaps null	Cadherin-7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-486	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cadherin-7	MR Egger	4	0.0034757368356914662	0.07603238014711199	0.9676922637899287	-0.14554772825264803	0.15249920192403096	1.0034817842133015	0.8645486256939894	1.164741532542016	1.003 [0.865:1.165]	overlaps null	Cadherin-7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-486	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cadherin-7	Weighted median	4	-0.03857277746327626	0.018751719585635516	0.03968371095206106	-0.07532614785112188	-0.0018194070754306499	0.9621616785054593	0.9274409541218909	0.9981822470422992	0.962 [0.927:0.998]	negative	Cadherin-7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-488	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cadherin-related family member 3	Inverse variance weighted	2	-0.0885465569685957	0.0345278843592743	0.01033263253003814	-0.15622121031277333	-0.02087190362441807	0.9152604979897834	0.8553699527863448	0.9793444070039111	0.915 [0.855:0.979]	negative	Cadherin-related family member 3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-346	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Calcium/calmodulin-dependent protein kinase type 1	Inverse variance weighted	3	-0.02280632624864035	0.006453624272531605	4.095087558687523e-4	-0.035455429822802295	-0.010157222674478404	0.9774517721940801	0.9651657508799054	0.9898941877023036	0.977 [0.965:0.99]	negative	Calcium/calmodulin-dependent protein kinase type 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-346	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Calcium/calmodulin-dependent protein kinase type 1	MR Egger	3	9.79523348766708e-4	0.039608072358124864	0.9842593488042484	-0.07665229847315802	0.07861134517069143	1.000980003238437	0.9262118428971219	1.0817837998585311	1.001 [0.926:1.082]	overlaps null	Calcium/calmodulin-dependent protein kinase type 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-346	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Calcium/calmodulin-dependent protein kinase type 1	Weighted median	3	-0.02287695059581617	0.006595385070818452	5.231193426128819e-4	-0.035803905334620335	-0.009949995857012004	0.9773827427383819	0.9648294728466111	0.9900993415804081	0.977 [0.965:0.99]	negative	Calcium/calmodulin-dependent protein kinase type 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-366	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Calpastatin	Inverse variance weighted	4	0.054910973832457736	0.017114176782664883	0.0013342557790093704	0.021367187338434568	0.0884547603264809	1.0564465591004828	1.0215971002969657	1.0924848278355717	1.056 [1.022:1.092]	positive	Calpastatin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-366	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Calpastatin	MR Egger	4	0.03420294191801184	0.029778253970220592	0.3695596806802828	-0.02416243586362052	0.0925683196996442	1.034794588618896	0.9761271388246563	1.096988084896695	1.035 [0.976:1.097]	overlaps null	Calpastatin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-366	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Calpastatin	Weighted median	4	0.05151114028710407	0.020036003235799037	0.010142614003055864	0.012240573944937959	0.09078170662927018	1.0528609153996786	1.0123157963787797	1.0950299413894298	1.053 [1.012:1.095]	positive	Calpastatin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-550	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Carbohydrate sulfotransferase 11	Inverse variance weighted	2	0.06055361774263282	0.027434269359077453	0.027298312058422317	0.006782449798841017	0.11432478568642462	1.0624245608498606	1.0068055027003895	1.1211161882504304	1.062 [1.007:1.121]	positive	Carbohydrate sulfotransferase 11 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-643	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Carboxypeptidase A4	Inverse variance weighted	2	0.0039385273471726125	0.005789105319650111	0.4962927637217168	-0.007408119079341606	0.01528517377368683	1.0039462935384431	0.9926192534002352	1.0154025895195669	1.004 [0.993:1.015]	overlaps null	Carboxypeptidase A4 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-710	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cardiotrophin-1	Inverse variance weighted	3	-0.029474922433307547	0.011495944844551222	0.010349118402026491	-0.05200697432862794	-0.006942870537987152	0.9709552265303363	0.9493222459344844	0.9930811755059608	0.971 [0.949:0.993]	negative	Cardiotrophin-1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-710	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cardiotrophin-1	MR Egger	3	-0.2154983537290665	0.11611447241465078	0.31462892302469014	-0.44308271966178203	0.012086012203649021	0.8061395973812124	0.6420540943935594	1.012159343177708	0.806 [0.642:1.012]	overlaps null	Cardiotrophin-1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-710	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cardiotrophin-1	Weighted median	3	-0.031082561903593882	0.011024350600657243	0.004810661498824876	-0.05269028908088208	-0.009474834726305687	0.9693955346313337	0.9486737816170433	0.9905699100921445	0.969 [0.949:0.991]	negative	Cardiotrophin-1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-722	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cathepsin F	Inverse variance weighted	2	0.06051195086973448	0.09425475607731468	0.5208704449698478	-0.12422737104180229	0.24525127278127126	1.0623802938629594	0.8831790087205964	1.2779423850022795	1.062 [0.883:1.278]	overlaps null	Cathepsin F (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-532	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cell growth regulator with EF hand domain protein 1	Inverse variance weighted	4	0.019369715553808623	0.017539531425372533	0.2694429723107431	-0.01500776603992154	0.05374719714753878	1.0195585255894044	0.9851042892141192	1.0552178063617161	1.02 [0.985:1.055]	overlaps null	Cell growth regulator with EF hand domain protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-532	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cell growth regulator with EF hand domain protein 1	MR Egger	4	0.0539213600445796	0.04140742906930978	0.3226228889686612	-0.027237200931267573	0.13507992102042676	1.0554016021566206	0.9731303867119581	1.144628260554423	1.055 [0.973:1.145]	overlaps null	Cell growth regulator with EF hand domain protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-532	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cell growth regulator with EF hand domain protein 1	Weighted median	4	0.011375468673056003	0.0214106916900596	0.5952119351741023	-0.03058948703946081	0.05334042438557282	1.0114404153494898	0.9698736370633226	1.0547886597886325	1.011 [0.97:1.055]	overlaps null	Cell growth regulator with EF hand domain protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-412	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cerebral cavernous malformations 2 protein	Inverse variance weighted	4	-0.049574497148316125	0.047840187106133546	0.30008451916388484	-0.14334126387633786	0.044192269579705616	0.9516342614569763	0.8664583275079024	1.0451832925230962	0.952 [0.866:1.045]	overlaps null	Cerebral cavernous malformations 2 protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-412	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cerebral cavernous malformations 2 protein	MR Egger	4	0.09135392405741177	0.14882249329387748	0.6018361687705002	-0.20033816279858807	0.3830460109134116	1.095656715914781	0.818453935602555	1.4667455148167483	1.096 [0.818:1.467]	overlaps null	Cerebral cavernous malformations 2 protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-412	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cerebral cavernous malformations 2 protein	Weighted median	4	-0.014898240307893475	0.0275861763885993	0.5891544078292095	-0.0689671460295481	0.03917066541376115	0.9852121893913344	0.9333573440690854	1.039947951653361	0.985 [0.933:1.04]	overlaps null	Cerebral cavernous malformations 2 protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-381	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Coiled-coil domain-containing protein 134	Inverse variance weighted	3	0.03748619399404606	0.04691434524126241	0.4242702394580146	-0.054465922678828264	0.12943831066692038	1.038197663619756	0.9469907792169082	1.138188895183147	1.038 [0.947:1.138]	overlaps null	Coiled-coil domain-containing protein 134 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-381	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Coiled-coil domain-containing protein 134	MR Egger	3	-0.3493258484015403	0.16675640732453176	0.283535994789543	-0.6761684067576226	-0.02248329004545807	0.7051633164902582	0.5085618662133495	0.9777675755085691	0.705 [0.509:0.978]	negative	Coiled-coil domain-containing protein 134 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-381	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Coiled-coil domain-containing protein 134	Weighted median	3	0.06363253706527713	0.037630386650517156	0.09083907017790668	-0.010123020769736493	0.13738809490029075	1.0657007212878549	0.989928044547997	1.147273313053804	1.066 [0.99:1.147]	overlaps null	Coiled-coil domain-containing protein 134 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-303	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Complement C1q tumor necrosis factor-related protein 1	Inverse variance weighted	6	0.02407351676825374	0.010508645599417088	0.02197326890332144	0.003476571393396251	0.04467046214311123	1.024365623172613	1.0034826216771056	1.0456832109200802	1.024 [1.003:1.046]	positive	Complement C1q tumor necrosis factor-related protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-303	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Complement C1q tumor necrosis factor-related protein 1	MR Egger	6	0.005531595122233583	0.020491297792843356	0.8005546624422085	-0.03463134855173939	0.04569453879620656	1.0055469226433795	0.9659614537155481	1.0467546191913804	1.006 [0.966:1.047]	overlaps null	Complement C1q tumor necrosis factor-related protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-303	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Complement C1q tumor necrosis factor-related protein 1	Weighted median	6	0.017590028966380716	0.010752269964378463	0.10185291543265869	-0.003484420163801072	0.0386644780965625	1.0177456446147852	0.9965216433834446	1.0394216763978543	1.018 [0.997:1.039]	overlaps null	Complement C1q tumor necrosis factor-related protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-305	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Complement C1q tumor necrosis factor-related protein 5	Inverse variance weighted	4	-0.08076986263830506	0.02529375749625265	0.0014067008514250876	-0.13034562733096025	-0.031194097945649868	0.9224059470907693	0.8777919895822744	0.96928741811977015	0.922 [0.878:0.969]	negative	Complement C1q tumor necrosis factor-related protein 5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-305	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Complement C1q tumor necrosis factor-related protein 5	MR Egger	4	0.09070010777759316	0.09844773838797394	0.4541525753142458	-0.10225745946283576	0.2836576750180221	1.09494059184912	0.9027970880918372	1.3279782528019668	1.095 [0.903:1.328]	overlaps null	Complement C1q tumor necrosis factor-related protein 5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-305	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Complement C1q tumor necrosis factor-related protein 5	Weighted median	4	-0.07677683264760646	0.02198557267688935	4.7915602125340464e-4	-0.11986855509430958	-0.03368511020090333	0.9260965050518031	0.8870370255526531	0.9668759160699266	0.926 [0.887:0.967]	negative	Complement C1q tumor necrosis factor-related protein 5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-322	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Complement component C8	Inverse variance weighted	3	-0.003960329584569455	0.032161262088888476	0.9019964394908867	-0.06699640327879088	0.05907574410965196	0.996047502178441	0.9351985649792409	1.0608555912593105	0.996 [0.935:1.061]	overlaps null	Complement component C8 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-322	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Complement component C8	MR Egger	3	0.06175834755559427	0.04495606096460307	0.40057980957805855	-0.02635553193502775	0.14987222704621628	1.0637052666896938	0.9739887439410962	1.1616858012188898	1.064 [0.974:1.162]	overlaps null	Complement component C8 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-322	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Complement component C8	Weighted median	3	0.0013419357104665908	0.028327865826005705	0.962217080912655	-0.05418068130850459	0.05686455272943777	1.001342836509085	0.9472609386929538	1.058512428066109	1.001 [0.947:1.059]	overlaps null	Complement component C8 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-518	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Complement factor B	Inverse variance weighted	4	0.029564267531139166	0.015027221693133566	0.049139325429729624	1.1091301259737521e-4	0.05901762204968096	1.0300056292636655	1.000110919163673	1.0607939339388575	1.03 [1:1.061]	positive	Complement factor B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-518	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Complement factor B	MR Egger	4	0.06178641269046742	0.021177487913730628	0.10014268600298404	0.020278536379555387	0.10329428900137945	1.0637351201403873	1.0204855427929918	1.1088176739115436	1.064 [1.02:1.109]	positive	Complement factor B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-518	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Complement factor B	Weighted median	4	0.0280967329181933	0.014235109436146483	0.04840869294201331	1.9591842334619122e-4	0.0559975474130404	1.0284951689486732	1.0001959376166139	1.0575950898895043	1.028 [1:1.058]	positive	Complement factor B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-521	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Complement factor H-related protein 5	Inverse variance weighted	3	0.004692440158780057	0.015201461678445171	0.7575623082485171	-0.02510242473097248	0.03448730504853259	1.0047034668967916	0.9752100212887068	1.0350888878895095	1.005 [0.975:1.035]	overlaps null	Complement factor H-related protein 5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-521	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Complement factor H-related protein 5	MR Egger	3	0.02297877350993461	0.018466001054312016	0.43095278532677955	-0.013214588556516943	0.05917213557638616	1.0232448194207033	0.9868723407857151	1.0609578536142752	1.023 [0.987:1.061]	overlaps null	Complement factor H-related protein 5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-521	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Complement factor H-related protein 5	Weighted median	3	0.008149949738798536	0.014900884797952551	0.5844171962790905	-0.02105578446518846	0.03735568394278553	1.0081832509855244	0.9791643408868093	1.0380621772308185	1.008 [0.979:1.038]	overlaps null	Complement factor H-related protein 5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-608	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Contactin-4	Inverse variance weighted	3	0.01556180125403671	0.01965051645159371	0.4284024499584759	-0.022953210991086964	0.05407681349916038	1.0156835166337348	0.9773082099860745	1.0555656807346063	1.016 [0.977:1.056]	overlaps null	Contactin-4 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-608	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Contactin-4	MR Egger	3	0.11139801866563823	0.08166593322494689	0.40272398165024476	-0.04866721045525768	0.27146324778653413	1.1178397394042319	0.9524980583555163	1.3118826563790489	1.118 [0.952:1.312]	overlaps null	Contactin-4 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-608	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Contactin-4	Weighted median	3	0.010405977277786894	0.02199181251263426	0.6360882870525082	-0.032697975246976256	0.053509929802550045	1.0104603077496914	0.9678308243169023	1.0549674673342284	1.01 [0.968:1.055]	overlaps null	Contactin-4 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-609	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Contactin-5	Inverse variance weighted	3	-0.01863115327260363	0.0145391539157138	0.20003675037620375	-0.04712789494740268	0.009865588402195417	0.9815413337914649	0.953965382435566	1.009914413750963	0.982 [0.954:1.01]	overlaps null	Contactin-5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-609	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Contactin-5	MR Egger	3	-0.03214148078722732	0.0749367171973444	0.7420531309024767	-0.17901744649402235	0.11473448491956773	0.9683695666982807	0.836091312407706	1.1215756027974884	0.968 [0.836:1.122]	overlaps null	Contactin-5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-609	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Contactin-5	Weighted median	3	-0.02145811922235102	0.015332347990644016	0.16165336126161134	-0.05150952128401329	0.00859328283931125	0.9787704682791295	0.9497946066549434	1.008630311083016	0.979 [0.95:1.009]	overlaps null	Contactin-5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-500	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Corneodesmosin	Inverse variance weighted	4	0.019147356172954568	0.021372326644264316	0.37030895496001304	-0.022742404049803492	0.06103711639571263	1.0193318423904119	0.9775142550576155	1.062938365896045	1.019 [0.978:1.063]	overlaps null	Corneodesmosin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-500	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Corneodesmosin	MR Egger	4	-0.04032861576081385	0.08133682637453821	0.6691457589078003	-0.19974879545490873	0.11909156393328105	0.9604737604711301	0.8189364477990038	1.1264730578702618	0.96 [0.819:1.126]	overlaps null	Corneodesmosin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-500	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Corneodesmosin	Weighted median	4	0.0063236999793699865	0.018524707395801598	0.7328282823379051	-0.029984726516401144	0.04263212647514111	1.0063437367833972	0.9704603557456414	1.0435539283673823	1.006 [0.97:1.044]	overlaps null	Corneodesmosin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-655	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	CREB-binding protein	Inverse variance weighted	4	-0.009137409605634878	0.024944305067882817	0.7141319374482835	-0.0580282475386852	0.03975342832741545	0.9909042096609545	0.9436232920248797	1.0405541713757445	0.991 [0.944:1.041]	overlaps null	CREB-binding protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-655	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	CREB-binding protein	MR Egger	4	0.06319388603656692	0.04471933984662536	0.29316625023701115	-0.024456020062818773	0.15084379213595261	1.0652333530834306	0.9758406053831924	1.162815003046309	1.065 [0.976:1.163]	overlaps null	CREB-binding protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-655	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	CREB-binding protein	Weighted median	4	-0.01768924691620948	0.02586921955138799	0.4941045283240639	-0.06839291723692993	0.03301442340451098	0.982466289355205	0.9338934586413318	1.033565446666323	0.982 [0.934:1.034]	overlaps null	CREB-binding protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-735	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	CUB and zona pellucida-like domain-containing protein 1	Inverse variance weighted	2	0.021479347369104822	0.009123246378156293	0.018554954311317984	0.0035977844679184884	0.039360910270291156	1.0217116890850886	1.0036042642630958	1.0401458152228884	1.022 [1.004:1.04]	positive	CUB and zona pellucida-like domain-containing protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-706	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cystatin-8	Inverse variance weighted	2	0.015041088740563986	0.009890044660297255	0.12830219629136624	-0.004343398793618634	0.03442557627474661	1.0151547751899856	0.995666020121286	1.0350249950937327	1.015 [0.996:1.035]	overlaps null	Cystatin-8 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-831	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Delta-like protein 1	Inverse variance weighted	3	0.05390027266738221	0.028843606717887348	0.061663479138731825	-0.0026331964996769916	0.1104337418344414	1.0553793467395962	0.9973702673212519	1.1167623519758831	1.055 [0.997:1.117]	overlaps null	Delta-like protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-831	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Delta-like protein 1	MR Egger	3	0.03718251205089128	0.06444643092910414	0.6668567490565289	-0.08913249257015284	0.1634975166719354	1.0378824296037512	0.9147243713624897	1.177622430760959	1.038 [0.915:1.178]	overlaps null	Delta-like protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-831	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Delta-like protein 1	Weighted median	3	0.05772201207131006	0.0341602996341424	0.0910777778852782	-0.009232175211609045	0.12467619935422916	1.0594204486757852	0.9908103104723406	1.1327815982630856	1.059 [0.991:1.133]	overlaps null	Delta-like protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-867	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Desmocollin-3	Inverse variance weighted	3	0.04717141138674928	0.02781735583213177	0.08993234811118156	-0.007350606044228991	0.10169342881772755	1.0483016845254831	0.9926763435879087	1.1070440319016697	1.048 [0.993:1.107]	overlaps null	Desmocollin-3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-867	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Desmocollin-3	MR Egger	3	0.049637590394549624	1.8670690829356456	0.983078917727961	-3.6098178121593154	3.709092992948415	1.0508901746617783	0.027056775832902776	40.816768635739606	1.051 [0.027:40.817]	overlaps null	Desmocollin-3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-867	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Desmocollin-3	Weighted median	3	0.04829224972856818	0.03500564024713493	0.16772331629741088	-0.02031880515581628	0.11690330461295265	1.0494773199728582	0.9798862307227805	1.1240107377822832	1.049 [0.98:1.124]	overlaps null	Desmocollin-3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2629	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Diamine acetyltransferase 2	Inverse variance weighted	3	-0.07510937233205453	0.02508906173694069	0.0027560786590543227	-0.12428393333645828	-0.025934811327650784	0.9276420224086787	0.8831290555020188	0.9743986072899583	0.928 [0.883:0.974]	negative	Diamine acetyltransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2629	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Diamine acetyltransferase 2	MR Egger	3	-0.1817115872358046	0.07918709697772575	0.2616314097446731	-0.33691829731214706	-0.026504877159462148	0.8338417963561761	0.7139671705566752	0.9738432942349157	0.834 [0.714:0.974]	negative	Diamine acetyltransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2629	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Diamine acetyltransferase 2	Weighted median	3	-0.05565324886611004	0.031128336260678683	0.07379786367666064	-0.11666478793704026	0.005358290204820176	0.9458670595085611	0.8898834428368414	1.0053726715167202	0.946 [0.89:1.005]	overlaps null	Diamine acetyltransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2464	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Dihydropteridine reductase	Inverse variance weighted	4	-0.019343191916997245	0.011848428434564812	0.10256296253028446	-0.04256611164874428	0.003879727814749788	0.9808426871919423	0.958327106841527	1.003887263701286	0.981 [0.958:1.004]	overlaps null	Dihydropteridine reductase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2464	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Dihydropteridine reductase	MR Egger	4	-0.006817465724875956	0.023690882292079378	0.8006037952560088	-0.053251595017351536	0.03961666356759963	0.9932057204742853	0.9481414348103371	1.0404118699655518	0.993 [0.948:1.04]	overlaps null	Dihydropteridine reductase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2464	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Dihydropteridine reductase	Weighted median	4	-0.018660078690383858	0.012788979476000488	0.14454449934103888	-0.04372647846334481	0.0064063210825770975	0.9815129427089304	0.9572157407900584	1.0064268854480056	0.982 [0.957:1.006]	overlaps null	Dihydropteridine reductase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-766	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Discoidin, CUB and LCCL domain-containing protein 2	Inverse variance weighted	3	-0.06166197972090952	0.017929036786731856	5.833835735100867e-4	-0.09680289182290396	-0.02652106761891508	0.9402006399672775	0.9077349104744292	0.9738275273921834	0.94 [0.908:0.974]	negative	Discoidin, CUB and LCCL domain-containing protein 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-766	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Discoidin, CUB and LCCL domain-containing protein 2	MR Egger	3	-0.00479587362654439	0.08960447090425466	0.9659588688384291	-0.18042063659888352	0.17082888934579477	0.9952156082128928	0.8349189400743648	1.1862877451819933	0.995 [0.835:1.186]	overlaps null	Discoidin, CUB and LCCL domain-containing protein 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-766	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Discoidin, CUB and LCCL domain-containing protein 2	Weighted median	3	-0.05363196302888565	0.020226586529294273	0.00801214010853855	-0.09327607262630241	-0.013987853431468876	0.9477808607178978	0.9109419794340541	0.986109522037006	0.948 [0.911:0.986]	negative	Discoidin, CUB and LCCL domain-containing protein 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-836	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	DnaJ homolog subfamily B member 11	Inverse variance weighted	3	0.020047071534164407	0.029773019361232698	0.5007372769202392	-0.03830804641385168	0.0784021894821805	1.0202493635992502	0.9624164262946632	1.0815575622833145	1.02 [0.962:1.082]	overlaps null	DnaJ homolog subfamily B member 11 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-836	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	DnaJ homolog subfamily B member 11	MR Egger	3	-0.029256300884574944	0.06999228174485927	0.7479489108594539	-0.16644117310449913	0.10792857133534924	0.9711675214709892	0.8466726225923619	1.1139681732855558	0.971 [0.847:1.114]	overlaps null	DnaJ homolog subfamily B member 11 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-836	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	DnaJ homolog subfamily B member 11	Weighted median	3	0.01345430191285302	0.02587252569262642	0.6030477200518541	-0.03725584844469476	0.0641644522704008	1.013545218314175	0.963429611846307	1.066267734493723	1.014 [0.963:1.066]	overlaps null	DnaJ homolog subfamily B member 11 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-842	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	DnaJ homolog subfamily B member 9	Inverse variance weighted	4	-0.0241081029941398	0.01809363676306361	0.18272621602320055	-0.05957163104974447	0.011355425061464874	0.9761801760539061	0.9421680426881034	1.011420142633827	0.976 [0.942:1.011]	overlaps null	DnaJ homolog subfamily B member 9 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-842	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	DnaJ homolog subfamily B member 9	MR Egger	4	-0.028472379220061916	0.0716204953843962	0.7293821251766197	-0.16884855017347847	0.11190379173335464	0.9719291392162637	0.8446368137987085	1.1184052556378306	0.972 [0.845:1.118]	overlaps null	DnaJ homolog subfamily B member 9 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-842	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	DnaJ homolog subfamily B member 9	Weighted median	4	-0.023369771207280628	0.017794580810840406	0.18907907275557048	-0.058247149596527825	0.01150760718196657	0.9769011870475021	0.9434167535511004	1.0115740744083859	0.977 [0.943:1.012]	overlaps null	DnaJ homolog subfamily B member 9 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-586	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Dual specificity protein kinase CLK2	Inverse variance weighted	3	-0.021777953482281016	0.013533790759763322	0.1075826728460676	-0.04830418337141713	0.004748276406855094	0.97845747400658	0.9528439037198236	1.0047595673350154	0.978 [0.953:1.005]	overlaps null	Dual specificity protein kinase CLK2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-586	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Dual specificity protein kinase CLK2	MR Egger	3	0.014191149724103574	0.03817099008230971	0.7733994770429399	-0.06062399083722345	0.0890062902854306	1.0142923221069875	0.9411770644512099	1.0930875321372826	1.014 [0.941:1.093]	overlaps null	Dual specificity protein kinase CLK2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-586	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Dual specificity protein kinase CLK2	Weighted median	3	-0.022046835706407128	0.014120806857303521	0.11845265024929717	-0.04972361714672203	0.005629945733907772	0.9781944195516745	0.9514923643375369	1.0056458236616967	0.978 [0.951:1.006]	overlaps null	Dual specificity protein kinase CLK2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2573	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	E3 ubiquitin-protein ligase RNF8	Inverse variance weighted	3	-0.02680239826026931	0.01615097953402166	0.09701697896101645	-0.058458318146951765	0.004853521626413143	0.9735535984034495	0.9432175546358207	1.0048653190411159	0.974 [0.943:1.005]	overlaps null	E3 ubiquitin-protein ligase RNF8 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2573	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	E3 ubiquitin-protein ligase RNF8	MR Egger	3	0.04754282967434292	0.0655941943087259	0.6007256632459256	-0.08102179117075983	0.17610745051944568	1.0486911152584022	0.9221735959833568	1.1925661936234397	1.049 [0.922:1.193]	overlaps null	E3 ubiquitin-protein ligase RNF8 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2573	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	E3 ubiquitin-protein ligase RNF8	Weighted median	3	-0.02869058303040809	0.018196176113156857	0.11485606703353118	-0.06435508821219553	0.006973922151379347	0.9717170837112011	0.9376719841408344	1.0069982965752995	0.972 [0.938:1.007]	overlaps null	E3 ubiquitin-protein ligase RNF8 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-892	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Endothelin-2	Inverse variance weighted	3	0.018659777512166745	0.015359696742606475	0.2244220668407206	-0.011445228103341944	0.04876478312767543	1.018834959080494	0.9886200193585639	1.0499733502443562	1.019 [0.989:1.05]	overlaps null	Endothelin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-892	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Endothelin-2	MR Egger	3	0.04526835999856859	0.050132285178912564	0.5324294676977062	-0.05299091895210003	0.1435276389492372	1.046308609613015	0.9483886248057233	1.154338715075354	1.046 [0.948:1.154]	overlaps null	Endothelin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-892	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Endothelin-2	Weighted median	3	0.02307521181018735	0.016602002031347096	0.16455761411934752	-0.00946471217125296	0.05561513579162766	1.023343504170249	0.990579937241343	1.0571907305571633	1.023 [0.991:1.057]	overlaps null	Endothelin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-387	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Eotaxin	Inverse variance weighted	3	-0.002397472808036148	0.016769869062504522	0.8863193076900435	-0.03526641617054501	0.03047147055447271	0.997605398834543	0.9653481976254324	1.0309404774690267	0.998 [0.965:1.031]	overlaps null	Eotaxin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-387	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Eotaxin	MR Egger	3	-0.002444794987527519	0.04387824786073779	0.9645656493184559	-0.08844616079457358	0.08355657081951855	0.9975581910897934	0.915352391254804	1.0871467143339022	0.998 [0.915:1.087]	overlaps null	Eotaxin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-387	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Eotaxin	Weighted median	3	-0.0027812167784655797	0.01779237098961213	0.8757846311766448	-0.037654263918105356	0.032091830361174196	0.9972226472218813	0.9630458430361981	1.0326123261141973	0.997 [0.963:1.033]	overlaps null	Eotaxin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2071	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Epididymal secretory protein E1	Inverse variance weighted	3	-0.009088636694255256	0.015702027927720276	0.5627111121541091	-0.039864611432586995	0.021687338044076486	0.990952540122757	0.960919527864139	1.0219242176901457	0.991 [0.961:1.022]	overlaps null	Epididymal secretory protein E1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2071	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Epididymal secretory protein E1	MR Egger	3	0.010663823362320163	0.014278951893971607	0.5916316255623945	-0.017322922349864187	0.03865056907450451	1.0107208845765345	0.9828262568210394	1.0394072191593728	1.011 [0.983:1.039]	overlaps null	Epididymal secretory protein E1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2071	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Epididymal secretory protein E1	Weighted median	3	-0.007574919867655017	0.007495668336982394	0.31222085482372813	-0.02226642980814051	0.007116590072830475	0.9924536975340813	0.9779796374101013	1.0071419731779543	0.992 [0.978:1.007]	overlaps null	Epididymal secretory protein E1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1707	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Epididymal-specific lipocalin-10	Inverse variance weighted	3	-0.03877980499871457	0.028806462200876917	0.17823191875610808	-0.09524047091243332	0.017680860915004183	0.9619625051623597	0.909154283019648	1.0178380926334418	0.962 [0.909:1.018]	overlaps null	Epididymal-specific lipocalin-10 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1707	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Epididymal-specific lipocalin-10	MR Egger	3	0.011019380590842155	0.0633353035959872	0.8903355783780437	-0.11311781445729274	0.13515657563897707	1.01108031758878	0.8930454402540454	1.1447160049600815	1.011 [0.893:1.145]	overlaps null	Epididymal-specific lipocalin-10 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1707	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Epididymal-specific lipocalin-10	Weighted median	3	-0.06334289550409512	0.02580795990587964	0.014112236155264473	-0.11392649691961922	-0.01275929408857103	0.9386215693863289	0.8923235420010213	0.9873217606044588	0.939 [0.892:0.987]	negative	Epididymal-specific lipocalin-10 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1835	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Epididymis-specific alpha-mannosidase	Inverse variance weighted	3	-0.03245228572200286	0.03335437410900135	0.33057595597992906	-0.0978268589756455	0.03292228753163978	0.9680686394255276	0.9068058954643073	1.0334702225985688	0.968 [0.907:1.033]	overlaps null	Epididymis-specific alpha-mannosidase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1835	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Epididymis-specific alpha-mannosidase	MR Egger	3	0.1837282199706508	0.0866328406339289	0.28050165958682566	0.013927852328150164	0.3535285876131514	1.2016891835896801	1.0140252967349266	1.4240836975232962	1.202 [1.014:1.424]	positive	Epididymis-specific alpha-mannosidase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1835	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Epididymis-specific alpha-mannosidase	Weighted median	3	-0.036324102341828465	0.0196031878820746	0.06388678088591573	-0.07474635059069468	0.002098145907037746	0.9643277019635411	0.9279788377629613	1.0021003485553845	0.964 [0.928:1.002]	overlaps null	Epididymis-specific alpha-mannosidase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2892	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Estrogen sulfotransferase	Inverse variance weighted	3	0.01933978980696375	0.02597362558842935	0.45651756789259595	-0.03156851634635778	0.07024809596028528	1.0195280149956025	0.9689245670081569	1.0727742992113887	1.02 [0.969:1.073]	overlaps null	Estrogen sulfotransferase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2892	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Estrogen sulfotransferase	MR Egger	3	0.0782060416228726	0.057370309762209915	0.40292210991865474	-0.034239765511058826	0.19065184875680402	1.0813454378873075	0.9663397819073919	1.2100381024691707	1.081 [0.966:1.21]	overlaps null	Estrogen sulfotransferase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2892	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Estrogen sulfotransferase	Weighted median	3	0.021870159420543846	0.017467740925143527	0.21055843719038694	-0.012366612792737468	0.05610693163382516	1.0221110643615314	0.9877095395245992	1.0577107804315624	1.022 [0.988:1.058]	overlaps null	Estrogen sulfotransferase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2891	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Extracellular sulfatase Sulf-2	Inverse variance weighted	3	-0.045566330620373435	0.02127567604623335	0.03221681615382667	-0.0872666556709908	-0.0038660055697560675	0.9554562244659147	0.9164326910745133	0.9961414578088578	0.955 [0.916:0.996]	negative	Extracellular sulfatase Sulf-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2891	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Extracellular sulfatase Sulf-2	MR Egger	3	0.13870485810409589	0.12763603503297394	0.4735580259443083	-0.11146177056053302	0.3888714867687248	1.1487849953825529	0.8945255879614227	1.4753149416593387	1.149 [0.895:1.475]	overlaps null	Extracellular sulfatase Sulf-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2891	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Extracellular sulfatase Sulf-2	Weighted median	3	-0.04637365278580671	0.022962386250291247	0.04343024135549721	-0.09137992983637755	-0.0013673757352358692	0.9546851747624392	0.9126708941169476	0.9986335586970096	0.955 [0.913:0.999]	negative	Extracellular sulfatase Sulf-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-b-71	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	fatty acid binding protein 4	Inverse variance weighted	3	0.019134734582821823	0.011041256301625635	0.08309184705927712	-0.002506127768364421	0.04077559693400806	1.0193189768828796	0.9974970099481112	1.0416183369688585	1.019 [0.997:1.042]	overlaps null	fatty acid binding protein 4 (M/F) Folkersen L/2018 [  3K]	Proteins
prot-b-71	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	fatty acid binding protein 4	MR Egger	3	0.014799519152988532	0.030978811647698928	0.7162753011122902	-0.04591895167650137	0.07551798998247843	1.0149095742873506	0.9551193698774603	1.0784426287075337	1.015 [0.955:1.078]	overlaps null	fatty acid binding protein 4 (M/F) Folkersen L/2018 [  3K]	Proteins
prot-b-71	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	fatty acid binding protein 4	Weighted median	3	0.018760056199192417	0.01237330728309202	0.12947598569443716	-0.005491626075667944	0.04301173847405278	1.0189371316352656	0.9945234253379601	1.0439501491604273	1.019 [0.995:1.044]	overlaps null	fatty acid binding protein 4 (M/F) Folkersen L/2018 [  3K]	Proteins
prot-a-1148	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ferritin	Inverse variance weighted	3	0.02073995266407095	0.01958331514875995	0.2895713641537231	-0.01764334502749855	0.05912325035564045	1.0209565200904904	0.9825113874485172	1.0609059897230986	1.021 [0.983:1.061]	overlaps null	Ferritin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1148	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ferritin	MR Egger	3	0.02804407500049063	0.054717071683590114	0.6984839289360385	-0.079201385499346	0.13528953550032724	1.0284410119606189	0.9238538549399657	1.1448682163601656	1.028 [0.924:1.145]	overlaps null	Ferritin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1148	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ferritin	Weighted median	3	0.02106140549803713	0.01360968276113291	0.12173526363621308	-0.005613572713783373	0.04773638370985764	1.0212847622115833	0.9944021539441827	1.0488941133006804	1.021 [0.994:1.049]	overlaps null	Ferritin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1097	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Fibroblast growth factor 7	Inverse variance weighted	3	0.02643777621114167	0.024895538928248945	0.28825913867522385	-0.02235748008822626	0.0752330325105096	1.0267903544876582	0.9778905961438746	1.078135362203416	1.027 [0.978:1.078]	overlaps null	Fibroblast growth factor 7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1097	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Fibroblast growth factor 7	MR Egger	3	-0.022390260697418028	0.08557955963146438	0.8370921062619641	-0.19012619757508822	0.14534567618025215	0.9778585408198095	0.826854780290689	1.1564392546876041	0.978 [0.827:1.156]	overlaps null	Fibroblast growth factor 7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1097	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Fibroblast growth factor 7	Weighted median	3	0.03212341544350174	0.02813371778963939	0.2535321900169644	-0.02301867142419147	0.08726550231119495	1.0326449417746113	0.9772442370612427	1.0911863537608801	1.033 [0.977:1.091]	overlaps null	Fibroblast growth factor 7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1117	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Filamin-A	Inverse variance weighted	2	-0.05494224891773153	0.029150212566643723	0.05945717731304519	-0.11207666554835322	0.0021921677128901654	0.9465398100735123	0.8939757177344569	1.0021945722692736	0.947 [0.894:1.002]	overlaps null	Filamin-A (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1166	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Galanin peptides	Inverse variance weighted	3	-0.057301293829811396	0.043306142992890616	0.1857795825473797	-0.142181334095877	0.027578746436254208	0.9443095118716082	0.867463941433528	1.0279625603083649	0.944 [0.867:1.028]	overlaps null	Galanin peptides (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1166	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Galanin peptides	MR Egger	3	-0.04483985271021084	0.2720239064762944	0.895996177449834	-0.5780067094037478	0.48832700398332607	0.9561505944988227	0.5610155197499124	1.6295876445057915	0.956 [0.561:1.63]	overlaps null	Galanin peptides (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1166	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Galanin peptides	Weighted median	3	-0.05321483096102571	0.03400864037341022	0.11764284370135206	-0.11987176609290974	0.013442104170858324	0.9481762929762112	0.8870341772825786	1.013532855426502	0.948 [0.887:1.014]	overlaps null	Galanin peptides (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1414	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Gamma-interferon-inducible protein 16	Inverse variance weighted	3	-0.009508968030405272	0.010344798262935485	0.3579894815098113	-0.02978477262575882	0.010766836564948278	0.9905360992452126	0.9706544224710387	1.0108250075347454	0.991 [0.971:1.011]	overlaps null	Gamma-interferon-inducible protein 16 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1414	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Gamma-interferon-inducible protein 16	MR Egger	3	-0.02199338606420761	0.035590230582387763	0.6476170919821844	-0.09175023800568763	0.0477634658772724	0.9782467050907104	0.9123329871976722	1.048922520011313	0.978 [0.912:1.049]	overlaps null	Gamma-interferon-inducible protein 16 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1414	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Gamma-interferon-inducible protein 16	Weighted median	3	-0.010263017714791928	0.010847929047331013	0.34410736067685477	-0.03152495864756071	0.010998923217976858	0.9897894673463543	0.9689667720517743	1.0110596337532956	0.99 [0.969:1.011]	overlaps null	Gamma-interferon-inducible protein 16 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1305	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	GDH/6PGL endoplasmic bifunctional protein	Inverse variance weighted	4	0.012070913520648017	0.01800323738515382	0.5025482086931553	-0.02321543175425347	0.0473572587955495	1.0121440610200094	0.97705197307819	1.0484965267820965	1.012 [0.977:1.048]	overlaps null	GDH/6PGL endoplasmic bifunctional protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1305	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	GDH/6PGL endoplasmic bifunctional protein	MR Egger	4	-0.02119449721840901	0.03306661290660498	0.5871904686191136	-0.08600505851535477	0.043616064078536756	0.9790285277249561	0.9175895895673829	1.0445812256339992	0.979 [0.918:1.045]	overlaps null	GDH/6PGL endoplasmic bifunctional protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1305	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	GDH/6PGL endoplasmic bifunctional protein	Weighted median	4	0.00533709231222129	0.011785597203538408	0.6506576967159676	-0.01776267820671399	0.028436862831156567	1.0053513599606885	0.9823941482364407	1.0288450504201752	1.005 [0.982:1.029]	overlaps null	GDH/6PGL endoplasmic bifunctional protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1223	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Glycolipid transfer protein domain-containing protein 2	Inverse variance weighted	3	-0.03177866101972274	0.02088830205146315	0.12816911500878975	-0.07271973304059051	0.009162411001145038	0.9687209740642432	0.9298614029371717	1.009204514380067	0.969 [0.93:1.009]	overlaps null	Glycolipid transfer protein domain-containing protein 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1223	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Glycolipid transfer protein domain-containing protein 2	MR Egger	3	0.055855422536764975	0.08783355299910395	0.6394084396112149	-0.11629834134147876	0.22800918641500872	1.0574447899991342	0.8902095973503713	1.2560968644064308	1.057 [0.89:1.256]	overlaps null	Glycolipid transfer protein domain-containing protein 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1223	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Glycolipid transfer protein domain-containing protein 2	Weighted median	3	-0.029384061796996944	0.022570300120199796	0.19295378277493164	-0.07362185003258855	0.014853726438594658	0.9710434521481051	0.9290229374192374	1.0149645912716556	0.971 [0.929:1.015]	overlaps null	Glycolipid transfer protein domain-containing protein 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1046	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Glycosaminoglycan xylosylkinase	Inverse variance weighted	3	0.09122850227122038	0.06217534377379278	0.1423004974576826	-0.030635171525413465	0.21309217606785424	1.0955193053097403	0.9698293298968571	1.2374987137520115	1.096 [0.97:1.237]	overlaps null	Glycosaminoglycan xylosylkinase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1046	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Glycosaminoglycan xylosylkinase	MR Egger	3	0.4140513400080871	0.09668994119898912	0.14604725654233514	0.22453905525806842	0.6035636247581058	1.5129347989753492	1.2517455976407335	1.8286237317429286	1.513 [1.252:1.829]	positive	Glycosaminoglycan xylosylkinase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1046	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Glycosaminoglycan xylosylkinase	Weighted median	3	0.09224128881590166	0.03733089304661293	0.013476961168352732	0.019072738444540313	0.16540983918726299	1.0966293945684407	1.0192557850014825	1.1798765792924055	1.097 [1.019:1.18]	positive	Glycosaminoglycan xylosylkinase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1277	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Granulins	Inverse variance weighted	4	0.014984303416346828	0.007994136186132839	0.06087368457947308	-6.842035084735371e-4	0.030652810341167194	1.0150971309336354	0.9993160305053729	1.0311274449471146	1.015 [0.999:1.031]	overlaps null	Granulins (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1277	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Granulins	MR Egger	4	-0.0035569566434196717	0.015364707948709146	0.8384536803831386	-0.0336717842228896	0.026557870936050255	0.9964493618331262	0.9668888007229762	1.0269136739976823	0.996 [0.967:1.027]	overlaps null	Granulins (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1277	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Granulins	Weighted median	4	0.012225125232295322	0.008407677727468785	0.1459343755356168	-0.004253923113543497	0.02870417357813414	1.0123001575237383	0.9957551120012829	1.0291201085204824	1.012 [0.996:1.029]	overlaps null	Granulins (M/F) Sun BB/2018 [  3K]	Proteins
prot-b-55	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	growth differentiation factor 15	Inverse variance weighted	3	-0.008378462274524082	0.012160960237324122	0.49084600194513867	-0.03221394433967936	0.015457019790631197	0.9916565392194064	0.968299397741768	1.0155770974039837	0.992 [0.968:1.016]	overlaps null	growth differentiation factor 15 (M/F) Folkersen L/2018 [  3K]	Proteins
prot-b-55	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	growth differentiation factor 15	MR Egger	3	-0.001217214443852832	0.017728485160115482	0.9563590135756073	-0.03596504535767917	0.03353061646997351	0.9987835260611667	0.9646740127288687	1.0340991037057758	0.999 [0.965:1.034]	overlaps null	growth differentiation factor 15 (M/F) Folkersen L/2018 [  3K]	Proteins
prot-b-55	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	growth differentiation factor 15	Weighted median	3	-0.007804284372998303	0.013967076665648516	0.576323539914335	-0.03517975463766939	0.019571185891672786	0.9922260899862144	0.9654318598050914	1.0197639570835086	0.992 [0.965:1.02]	overlaps null	growth differentiation factor 15 (M/F) Folkersen L/2018 [  3K]	Proteins
prot-a-1317	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Hemoglobin subunit zeta	Inverse variance weighted	3	0.010879129463606281	0.0076818970909594535	0.1567159346273025	-0.004177388834674247	0.02593564776188681	1.0109385223782137	0.9958313243171004	1.026274903261442	1.011 [0.996:1.026]	overlaps null	Hemoglobin subunit zeta (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1317	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Hemoglobin subunit zeta	MR Egger	3	0.011679855868906772	0.014212162370828991	0.5620656730329915	-0.01617598237791805	0.039535694115731594	1.0117483317218114	0.9839541462275456	1.0403276317971288	1.012 [0.984:1.04]	overlaps null	Hemoglobin subunit zeta (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1317	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Hemoglobin subunit zeta	Weighted median	3	0.011058297484030602	0.008491067483989248	0.19279854740422167	-0.005584194784588322	0.027700789752649526	1.0111196664591675	0.9944313678493727	1.0280880239241972	1.011 [0.994:1.028]	overlaps null	Hemoglobin subunit zeta (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1313	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Heparin-binding EGF-like growth factor	Inverse variance weighted	2	-0.01936928988545963	0.07572250112060494	0.7981106369458627	-0.1677853920818453	0.12904681231092605	0.9808170895244505	0.8455352737796613	1.1377433833161437	0.981 [0.846:1.138]	overlaps null	Heparin-binding EGF-like growth factor (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1360	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Hepatocyte nuclear factor 4-alpha	Inverse variance weighted	5	-0.007588416225384626	0.020061254268955716	0.7052357470122311	-0.04690847459253783	0.03173164214176857	0.9924403031143374	0.9541747248244595	1.032240458294342	0.992 [0.954:1.032]	overlaps null	Hepatocyte nuclear factor 4-alpha (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1360	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Hepatocyte nuclear factor 4-alpha	MR Egger	5	-0.05125997661856954	0.03712097811121666	0.2612023223901721	-0.1240170937165542	0.021497140479415117	0.9500316524078228	0.8833647407672001	1.021729868675613	0.95 [0.883:1.022]	overlaps null	Hepatocyte nuclear factor 4-alpha (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1360	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Hepatocyte nuclear factor 4-alpha	Weighted median	5	-0.02319485031563894	0.024735726445395675	0.34839528650544066	-0.07167687414861446	0.02528717351733658	0.977072082420336	0.9308316229829003	1.0256096061561817	0.977 [0.931:1.026]	overlaps null	Hepatocyte nuclear factor 4-alpha (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-10	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Histo-blood group ABO system transferase	Inverse variance weighted	3	0.015260996711020009	0.008096849839685895	0.05945594200202395	-6.088289747643444e-4	0.031130822396804363	1.0153780403642925	0.9993913563239889	1.031620454119474	1.015 [0.999:1.032]	overlaps null	Histo-blood group ABO system transferase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-10	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Histo-blood group ABO system transferase	MR Egger	3	-0.0035695365954499696	0.009510129894275784	0.7714094931864295	-0.022209391188230506	0.015070317997330569	0.9964368266268	0.978035421609831	1.0151844478432202	0.996 [0.978:1.015]	overlaps null	Histo-blood group ABO system transferase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-10	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Histo-blood group ABO system transferase	Weighted median	3	0.013085860333403556	0.0050639501328931975	0.009762751177322952	0.003160518072932888	0.023011202593874222	1.0131718548986228	1.0031655177760073	1.0232780028508943	1.013 [1.003:1.023]	positive	Histo-blood group ABO system transferase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2904	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Histone-lysine N-methyltransferase SUV420H2	Inverse variance weighted	3	-0.04560781032208634	0.027144538082293692	0.09292158050905536	-0.09881110496338197	0.0075954843192092905	0.9554165932486753	0.905913814485619	1.007624403181452	0.955 [0.906:1.008]	overlaps null	Histone-lysine N-methyltransferase SUV420H2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2904	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Histone-lysine N-methyltransferase SUV420H2	MR Egger	3	0.016035190933582282	0.07475661840377505	0.8654842309351476	-0.13048778113781684	0.16255816300498138	1.0161644445523692	0.8776672169779877	1.1765167462080595	1.016 [0.878:1.177]	overlaps null	Histone-lysine N-methyltransferase SUV420H2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2904	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Histone-lysine N-methyltransferase SUV420H2	Weighted median	3	-0.05902851065968976	0.034306996283573414	0.08532400059506304	-0.12627022337549365	0.008213202056114123	0.9426798923483567	0.8813766460287884	1.0082470229292682	0.943 [0.881:1.008]	overlaps null	Histone-lysine N-methyltransferase SUV420H2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1347	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	HLA class II histocompatibility antigen, DQ alpha 2 chain	Inverse variance weighted	4	-0.001543779447754623	0.01597426664462726	0.9230109812673474	-0.03285334207122405	0.029765783175714804	0.9984574115667703	0.9676804671958757	1.030213212426888	0.998 [0.968:1.03]	overlaps null	HLA class II histocompatibility antigen, DQ alpha 2 chain (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1347	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	HLA class II histocompatibility antigen, DQ alpha 2 chain	MR Egger	4	-0.03681077925138618	0.0316989747015943	0.36539585515631823	-0.098940769666511	0.02531921116373865	0.9638585001218608	0.9057963570550093	1.0256424648004443	0.964 [0.906:1.026]	overlaps null	HLA class II histocompatibility antigen, DQ alpha 2 chain (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1347	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	HLA class II histocompatibility antigen, DQ alpha 2 chain	Weighted median	4	-0.00982871976156843	0.013300417059136427	0.4599201663603451	-0.03589753719747582	0.016240097674338965	0.9902194242440874	0.9647391382948928	1.016372684830965	0.99 [0.965:1.016]	overlaps null	HLA class II histocompatibility antigen, DQ alpha 2 chain (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1576	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Immunoglobulin superfamily containing leucine-rich repeat protein 2	Inverse variance weighted	4	-0.07950397657723703	0.03187791970608607	0.012630757883933589	-0.14198469920116571	-0.01702325395330833	0.923574347296578	0.8676345318857858	0.9831208229233853	0.924 [0.868:0.983]	negative	Immunoglobulin superfamily containing leucine-rich repeat protein 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1576	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Immunoglobulin superfamily containing leucine-rich repeat protein 2	MR Egger	4	-0.08809710302575062	0.10782815114836701	0.49976244237148004	-0.29944027927655	0.12324607322504873	0.9156719578885456	0.7412329880582624	1.1311627355655927	0.916 [0.741:1.131]	overlaps null	Immunoglobulin superfamily containing leucine-rich repeat protein 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1576	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Immunoglobulin superfamily containing leucine-rich repeat protein 2	Weighted median	4	-0.09272089648752847	0.016285137569414694	1.2439559256326372e-8	-0.12463976612358127	-0.06080202685147567	0.9114478530963432	0.882814865131743	0.9410095159532254	0.911 [0.883:0.941]	negative	Immunoglobulin superfamily containing leucine-rich repeat protein 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1115	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inactive peptidyl-prolyl cis-trans isomerase FKBP6	Inverse variance weighted	3	-0.008605749803361522	0.008938503865287823	0.3356614744379326	-0.026125217379325653	0.008913717772602608	0.9914311736675117	0.9742130935604156	1.008953563257342	0.991 [0.974:1.009]	overlaps null	Inactive peptidyl-prolyl cis-trans isomerase FKBP6 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1115	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inactive peptidyl-prolyl cis-trans isomerase FKBP6	MR Egger	3	-0.013078607470569981	0.02292850301566643	0.6699911960460254	-0.05801847338127618	0.03186125844013622	0.9870065458827768	0.943632515192545	1.0323742621529648	0.987 [0.944:1.032]	overlaps null	Inactive peptidyl-prolyl cis-trans isomerase FKBP6 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1115	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inactive peptidyl-prolyl cis-trans isomerase FKBP6	Weighted median	3	-0.007524498382617043	0.005799690709874648	0.1944947988643524	-0.01889189217397135	0.003842895408737267	0.992503739784934	0.9812854411444787	1.00385028879894	0.993 [0.981:1.004]	overlaps null	Inactive peptidyl-prolyl cis-trans isomerase FKBP6 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1403	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inducible T-cell costimulator	Inverse variance weighted	3	0.018824718101453888	0.014075588068095729	0.18109148748344112	-0.008763434512013741	0.04641287071492152	1.0190030201786984	0.9912748524567994	1.0475068065731663	1.019 [0.991:1.048]	overlaps null	Inducible T-cell costimulator (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1403	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inducible T-cell costimulator	MR Egger	3	-0.01767521312389666	0.041883823594211375	0.745777522416472	-0.09976750736855095	0.06441708112075764	0.9824800771798117	0.9050478105247163	1.066537138513842	0.982 [0.905:1.067]	overlaps null	Inducible T-cell costimulator (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1403	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inducible T-cell costimulator	Weighted median	3	0.019119750737018906	0.015368099131361964	0.2134556108557046	-0.011001723560450545	0.049241225034488356	1.019303703678932	0.9890585740716581	1.0504737207387205	1.019 [0.989:1.05]	overlaps null	Inducible T-cell costimulator (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1397	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Intercellular adhesion molecule 1	Inverse variance weighted	3	9.820863847733066e-4	0.019353785260904477	0.9595296010988843	-0.03695133272659947	0.03891550549614608	1.000982568789515	0.9637230359802557	1.039682632470543	1.001 [0.964:1.04]	overlaps null	Intercellular adhesion molecule 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1397	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Intercellular adhesion molecule 1	MR Egger	3	0.039355351191054606	0.029412025215700185	0.40858240869640783	-0.018292218231717755	0.09700292061382697	1.040140032985956	0.981874068928178	1.1018635917343527	1.04 [0.982:1.102]	overlaps null	Intercellular adhesion molecule 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1397	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Intercellular adhesion molecule 1	Weighted median	3	0.004358832145351349	0.005337737440174182	0.4141532261709985	-0.006103133237390049	0.014820797528092747	1.0043683456717862	0.9939154530495152	1.0149311701437307	1.004 [0.994:1.015]	overlaps null	Intercellular adhesion molecule 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-b-38	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	interleukin 1 receptor like 1	Inverse variance weighted	3	-0.014836787780719906	0.01054506302532681	0.15943064779546395	-0.03550511131036045	0.005831535748920643	0.985272735030497	0.9651178012007771	1.0058485722537456	0.985 [0.965:1.006]	overlaps null	interleukin 1 receptor like 1 (M/F) Folkersen L/2018 [  3K]	Proteins
prot-b-38	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	interleukin 1 receptor like 1	MR Egger	3	0.003412492208905591	0.03260354706853113	0.9336091062124985	-0.06049046004541542	0.0673154444632266	1.003418321389235	0.9413027489610469	1.0696328347185733	1.003 [0.941:1.07]	overlaps null	interleukin 1 receptor like 1 (M/F) Folkersen L/2018 [  3K]	Proteins
prot-b-38	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	interleukin 1 receptor like 1	Weighted median	3	-0.015681956140116426	0.011206167459406622	0.16169185275848133	-0.0376460443605534	0.006282132080320552	0.9844403654852221	0.9630537588794624	1.0063019060579512	0.984 [0.963:1.006]	overlaps null	interleukin 1 receptor like 1 (M/F) Folkersen L/2018 [  3K]	Proteins
prot-a-1486	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Interleukin-17 receptor A	Inverse variance weighted	3	-0.0026495206972189903	0.006612765066268254	0.6886648694247093	-0.015610540227104768	0.010311498832666788	0.9973539861848743	0.9845106727032259	1.0103648455405911	0.997 [0.985:1.01]	overlaps null	Interleukin-17 receptor A (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1486	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Interleukin-17 receptor A	MR Egger	3	-0.007693194279340752	0.011647836515578165	0.6283992110884948	-0.030522953849873954	0.01513656529119245	0.9923363225982427	0.9699381679965933	1.0152517032933817	0.992 [0.97:1.015]	overlaps null	Interleukin-17 receptor A (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1486	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Interleukin-17 receptor A	Weighted median	3	-0.003346752299333117	0.006797289783839116	0.6224608469219889	-0.016669440275657782	0.00997593567699155	0.9966588418336775	0.9834687260601336	1.010025861203146	0.997 [0.983:1.01]	overlaps null	Interleukin-17 receptor A (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1506	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Interleukin-21	Inverse variance weighted	3	0.04760186165450126	0.01797276403983085	0.008083659351581767	0.012375244136432796	0.08282847917256972	1.0487530233987725	1.0124521343210535	1.0863554599799854	1.049 [1.012:1.086]	positive	Interleukin-21 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1506	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Interleukin-21	MR Egger	3	0.0781673501084226	0.05882445910358008	0.41070124480683223	-0.03712858973459435	0.19346328995143955	1.0813035998040665	0.963552224457579	1.2134448401148479	1.081 [0.964:1.213]	overlaps null	Interleukin-21 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1506	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Interleukin-21	Weighted median	3	0.050330390567910326	0.020815794732267266	0.015610612484163561	0.009531432892666482	0.09112934824315416	1.05161848381419	1.0095770016626493	1.095410685542927	1.052 [1.01:1.095]	positive	Interleukin-21 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1530	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Interleukin-3 receptor subunit alpha	Inverse variance weighted	3	-0.05306336727228435	0.0166945140230866	0.0014804367033475734	-0.08578461475753407	-0.020342119787034617	0.9483199181318458	0.9177918887616223	0.9798633853029926	0.948 [0.918:0.98]	negative	Interleukin-3 receptor subunit alpha (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1530	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Interleukin-3 receptor subunit alpha	MR Egger	3	-0.07321280106037702	0.03189396696138579	0.26155073966326636	-0.13572497630469316	-0.010700625816060863	0.9294030310301004	0.8730827179080041	0.9893564222158323	0.929 [0.873:0.989]	negative	Interleukin-3 receptor subunit alpha (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1530	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Interleukin-3 receptor subunit alpha	Weighted median	3	-0.053247468660459166	0.008788527482217255	1.3718556525909087e-9	-0.07047298252560498	-0.03602195479531335	0.9481453471883535	0.9319529181997716	0.9646191152354114	0.948 [0.932:0.965]	negative	Interleukin-3 receptor subunit alpha (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1540	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Interleukin-6 receptor subunit alpha	Inverse variance weighted	2	-0.005255557745326347	0.0055990110512618525	0.34790625096559247	-0.016229619405799575	0.005718503915146883	0.9947582285361742	0.9839013712669289	1.0057348857703419	0.995 [0.984:1.006]	overlaps null	Interleukin-6 receptor subunit alpha (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1541	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Interleukin-6 receptor subunit alpha	Inverse variance weighted	2	-0.005230013827550114	0.005629404379427757	0.3528617305593735	-0.016263646411228516	0.005803618756128288	0.9947836388831097	0.9838678926192196	1.0058204923783585	0.995 [0.984:1.006]	overlaps null	Interleukin-6 receptor subunit alpha (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1542	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Interleukin-6 receptor subunit beta	Inverse variance weighted	4	-0.047181241839003026	0.04718278531319179	0.3173263391316254	-0.13965950105285893	0.04529701737485289	0.9539144927051353	0.8696543013648619	1.0463385945021921	0.954 [0.87:1.046]	overlaps null	Interleukin-6 receptor subunit beta (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1542	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Interleukin-6 receptor subunit beta	MR Egger	4	-0.04248047344129174	0.18076367834325377	0.8360738595188487	-0.3967772829940691	0.3118163361114856	0.9584091797713492	0.6724837825299165	1.3659038027866899	0.958 [0.672:1.366]	overlaps null	Interleukin-6 receptor subunit beta (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1542	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Interleukin-6 receptor subunit beta	Weighted median	4	-0.025173496250847582	0.022899481770908756	0.27163540553175514	-0.07005648052182875	0.01970948802013358	0.9751407140932093	0.9323411593036132	1.0199050023625071	0.975 [0.932:1.02]	overlaps null	Interleukin-6 receptor subunit beta (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1657	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Kallikrein-12	Inverse variance weighted	3	-0.002119077634727601	0.019099760878400526	0.9116576914448217	-0.03955460895639263	0.03531645368693743	0.9978831660251737	0.961217461474893	1.0359474863352074	0.998 [0.961:1.036]	overlaps null	Kallikrein-12 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1657	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Kallikrein-12	MR Egger	3	0.05808622087771789	0.042141120835373296	0.3995622863577049	-0.024510375959613764	0.14068281771504954	1.0598063692064434	0.9757875641335232	1.151059494397134	1.06 [0.976:1.151]	overlaps null	Kallikrein-12 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1657	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Kallikrein-12	Weighted median	3	0.007749421218175354	0.018602357539650366	0.676983630548677	-0.028711199559539366	0.04421004199589007	1.0077795256966335	0.971697050484146	1.045201868120626	1.008 [0.972:1.045]	overlaps null	Kallikrein-12 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1659	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Kallikrein-14	Inverse variance weighted	2	0.012958033671966932	0.010835918063340557	0.2317586639355611	-0.008280365732180559	0.034196433076114426	1.0130423528000365	0.9917538220685738	1.0347878533264419	1.013 [0.992:1.035]	overlaps null	Kallikrein-14 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1666	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Kallikrein-7	Inverse variance weighted	3	0.02455592613930289	0.01406364676876172	0.08080108164183637	-0.00300882152747008	0.052120673806075865	1.024859905962351	0.9969957004396212	1.0535028650434672	1.025 [0.997:1.054]	overlaps null	Kallikrein-7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1666	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Kallikrein-7	MR Egger	3	0.03415042475893491	0.022250758778707403	0.3676256992182399	-0.009461062447331602	0.07776191196520141	1.0347402455738572	0.9905835525912334	1.0808652869406845	1.035 [0.991:1.081]	overlaps null	Kallikrein-7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1666	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Kallikrein-7	Weighted median	3	0.02769930762366189	0.014417853743183351	0.05470888432906203	-5.596857129774799e-4	0.05595830096030126	1.0280865001662642	0.9994404708818552	1.0575535838482797	1.028 [0.999:1.058]	overlaps null	Kallikrein-7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1655	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Kelch-like protein 13	Inverse variance weighted	3	-0.014279590674066589	0.014778651130091672	0.333928610354735	-0.04324574688904627	0.014686565540913087	0.9858218791242628	0.9576760152454393	1.0147949430591325	0.986 [0.958:1.015]	overlaps null	Kelch-like protein 13 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1655	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Kelch-like protein 13	MR Egger	3	-0.01809367338238911	0.09537390899649935	0.880643366257236	-0.2050265350155278	0.16883918825074962	0.9820690343212999	0.8146257000190208	1.183929733803207	0.982 [0.815:1.184]	overlaps null	Kelch-like protein 13 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1655	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Kelch-like protein 13	Weighted median	3	-0.014556927706844636	0.015225584710863275	0.3390301369202586	-0.04439907374013666	0.015285218326447383	0.98554851211860806	0.9565721384701354	1.0154026347585563	0.986 [0.957:1.015]	overlaps null	Kelch-like protein 13 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1644	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Killer cell immunoglobulin-like receptor 2DL5A	Inverse variance weighted	2	0.015421573088086558	0.007627606028860099	0.04319594441696227	4.71465271520765e-4	0.03037168090465235	1.0155410991827138	1.0004715764287402	1.0308376054126631	1.016 [1:1.031]	positive	Killer cell immunoglobulin-like receptor 2DL5A (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2824	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Kunitz-type protease inhibitor 2	Inverse variance weighted	3	0.0029288703651066056	0.0069191598751840045	0.6720774496883964	-0.010632682990254043	0.016490423720467256	1.002933163696428	0.9894236441704867	1.0166271412337553	1.003 [0.989:1.017]	overlaps null	Kunitz-type protease inhibitor 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2824	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Kunitz-type protease inhibitor 2	MR Egger	3	-0.007114644310657005	0.014946802557707192	0.7171739682149818	-0.0364103773237631	0.022181088702449087	0.9929106048560781	0.964244508197297	1.022428918033247	0.993 [0.964:1.022]	overlaps null	Kunitz-type protease inhibitor 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2824	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Kunitz-type protease inhibitor 2	Weighted median	3	0.0023948906138505275	0.006773007001432624	0.7236436168404659	-0.010880203108957416	0.01566998433665847	1.0023977606550643	0.9891787722192511	1.015793402351313	1.002 [0.989:1.016]	overlaps null	Kunitz-type protease inhibitor 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2666	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	L-Selectin	Inverse variance weighted	2	-0.026747278288126945	0.03662155620200461	0.46516417960367884	-0.09852552844405599	0.04503097186780209	0.9736072621296306	0.9061725591435101	1.046060257847021	0.974 [0.906:1.046]	overlaps null	L-Selectin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1792	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Leucine-rich repeat neuronal protein 1	Inverse variance weighted	2	-0.01673146271320705	0.012745937973073742	0.18928749750882481	-0.04171350114043158	0.008250575714017484	0.983407730824046	0.9591445350276329	1.0082847055127488	0.983 [0.959:1.008]	overlaps null	Leucine-rich repeat neuronal protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1744	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Leukocyte immunoglobulin-like receptor subfamily B member 2	Inverse variance weighted	3	-0.016630542924819358	0.011013075896338981	0.1310249285967908	-0.03821617168164376	0.004955085832005046	0.9835069811322154	0.9625048521080883	1.0049673825718841	0.984 [0.963:1.005]	overlaps null	Leukocyte immunoglobulin-like receptor subfamily B member 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1744	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Leukocyte immunoglobulin-like receptor subfamily B member 2	MR Egger	3	-0.05612929619019381	0.08769835596497555	0.6375518723060987	-0.22801807388154588	0.11575948150115828	0.9454168891856334	0.7961098709099179	1.122725803331457	0.945 [0.796:1.123]	overlaps null	Leukocyte immunoglobulin-like receptor subfamily B member 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1744	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Leukocyte immunoglobulin-like receptor subfamily B member 2	Weighted median	3	-0.016794095033359505	0.011085093643139412	0.1297683339365561	-0.03852087857391275	0.004932688507193743	0.9833461396450279	0.962211614923773	1.004944874243056	0.983 [0.962:1.005]	overlaps null	Leukocyte immunoglobulin-like receptor subfamily B member 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1746	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Leukocyte immunoglobulin-like receptor subfamily B member 4	Inverse variance weighted	2	0.05838547363968849	0.03237054515913046	0.07128454553108383	-0.005060794872207203	0.12183174215158418	1.0601235666483206	0.9949519893749192	1.129564027777084	1.06 [0.995:1.13]	overlaps null	Leukocyte immunoglobulin-like receptor subfamily B member 4 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1074	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Low affinity immunoglobulin gamma Fc region receptor II-a	Inverse variance weighted	4	0.008793062247946492	0.007430849199577049	0.23668289457979125	-0.005771402183224524	0.02335752667911751	1.008831834779568	0.9942452203645121	1.0236324500424383	1.009 [0.994:1.024]	overlaps null	Low affinity immunoglobulin gamma Fc region receptor II-a (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1074	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Low affinity immunoglobulin gamma Fc region receptor II-a	MR Egger	4	0.0023634534876434987	0.01627966593557262	0.8978801494175315	-0.02954469174607884	0.034271598721365835	1.002366248645479	0.9708874860145816	1.0348656367464193	1.002 [0.971:1.035]	overlaps null	Low affinity immunoglobulin gamma Fc region receptor II-a (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1074	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Low affinity immunoglobulin gamma Fc region receptor II-a	Weighted median	4	0.009086066521727974	0.005110599209104401	0.07542245992158268	-9.307079281166523e-4	0.0191028409715726	1.0091274701277804	0.9990697250461724	1.0192864676381135	1.009 [0.999:1.019]	overlaps null	Low affinity immunoglobulin gamma Fc region receptor II-a (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1779	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Low-density lipoprotein receptor-related protein 1B	Inverse variance weighted	3	-0.026982239114351377	0.02630623352158046	0.3050341723984077	-0.07854245681664908	0.024577978587946327	0.9733785294355661	0.9244628093503362	1.024882506881996	0.973 [0.924:1.025]	overlaps null	Low-density lipoprotein receptor-related protein 1B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1779	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Low-density lipoprotein receptor-related protein 1B	MR Egger	3	0.01671564385724842	0.08805614107329622	0.8805718628155274	-0.15587439264641217	0.189305680360909	1.0168561319232488	0.8556666616462086	1.208410283322966	1.017 [0.856:1.208]	overlaps null	Low-density lipoprotein receptor-related protein 1B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1779	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Low-density lipoprotein receptor-related protein 1B	Weighted median	3	-0.015231746819440428	0.02545844443784654	0.5496408375769352	-0.06513029791761965	0.03466680427873879	0.9848836694957241	0.9369453733924643	1.0352747022243467	0.985 [0.937:1.035]	overlaps null	Low-density lipoprotein receptor-related protein 1B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2356	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Lysosomal Pro-X carboxypeptidase	Inverse variance weighted	2	-0.008829213106472798	0.023354486156650592	0.7053918726490241	-0.05460400597350796	0.03694557976056236	0.9912096499347708	0.946860024637802	1.0376365508720689	0.991 [0.947:1.038]	overlaps null	Lysosomal Pro-X carboxypeptidase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1931	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MAGUK p55 subfamily member 6	Inverse variance weighted	3	-0.02202959816591678	0.027859378010176572	0.42909418715874453	-0.07663397906586286	0.03257478273402929	0.9782112813629167	0.9262288107045331	1.033111149131518	0.978 [0.926:1.033]	overlaps null	MAGUK p55 subfamily member 6 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1931	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MAGUK p55 subfamily member 6	MR Egger	3	0.05602788830238546	0.07398372557691663	0.5873705192817322	-0.08898021382837111	0.20103599043314202	1.0576271787518985	0.9148636750450635	1.2226687754102845	1.058 [0.915:1.223]	overlaps null	MAGUK p55 subfamily member 6 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1931	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MAGUK p55 subfamily member 6	Weighted median	3	-0.026752010708259215	0.019906081114865005	0.17897701691854662	-0.06576792969339462	0.012263908276876193	0.9736026546219246	0.9363481376786934	1.0123394183671992	0.974 [0.936:1.012]	overlaps null	MAGUK p55 subfamily member 6 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1833	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB	Inverse variance weighted	3	0.09597953992321277	0.041039662367588436	0.01935086226062504	0.015541801682739442	0.1764172781636861	1.1007365426094007	1.015663203601955	1.192935740842827	1.101 [1.016:1.193]	positive	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1833	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB	MR Egger	3	0.005027918409149838	0.17386469468403196	0.9815949957680199	-0.33574688317155277	0.34580271998985246	1.0050405796018351	0.7148040118443508	1.41312380723787	1.005 [0.715:1.413]	overlaps null	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1833	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB	Weighted median	3	0.05843931280233141	0.027254168749649216	0.03201414935230456	0.00502114205301895	0.11185748355164388	1.060180644349941	1.0050337691120168	1.1183534655231886	1.06 [1.005:1.118]	positive	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1854	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MAP kinase-activated protein kinase 5	Inverse variance weighted	4	-0.0034788114953802616	0.009352429236862525	0.7099161099023438	-0.021809572799630812	0.014851949808870288	0.9965272325585904	0.9784265363383127	1.0149627880569954	0.997 [0.978:1.015]	overlaps null	MAP kinase-activated protein kinase 5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1854	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MAP kinase-activated protein kinase 5	MR Egger	4	-0.001360935276831131	0.026957874672159158	0.9643253034247412	-0.054198369634263076	0.05147649908060082	0.9986399903756175	0.9472441833810791	1.0528244436590053	0.999 [0.947:1.053]	overlaps null	MAP kinase-activated protein kinase 5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1854	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MAP kinase-activated protein kinase 5	Weighted median	4	-0.002061363054429867	0.006941607123069211	0.7664988730704085	-0.01566691301564552	0.011544186906785787	0.9979407600952799	0.984455174655562	1.0116110781864518	0.998 [0.984:1.012]	overlaps null	MAP kinase-activated protein kinase 5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2815	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Maspardin	Inverse variance weighted	3	-0.016164309617213025	0.01292968025857996	0.21123713551449794	-0.041506482924029746	0.009177863689603695	0.983965631755873	0.9593431159727732	1.0092201094235111	0.984 [0.959:1.009]	overlaps null	Maspardin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2815	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Maspardin	MR Egger	3	-0.0202828307153272	0.022188954050984804	0.5285521804486648	-0.06377318065525742	0.023207519224603016	0.9799214822157463	0.9382177813406914	1.0234789090606828	0.98 [0.938:1.023]	overlaps null	Maspardin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2815	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Maspardin	Weighted median	3	-0.016252891227289276	0.012779835022125034	0.2034581759446277	-0.041301367870654346	0.00879558541607579	0.9838784743562807	0.9595399118694217	1.0088343802351125	0.984 [0.96:1.009]	overlaps null	Maspardin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1898	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MHC class I polypeptide-related sequence B	Inverse variance weighted	4	0.030121121693196935	0.013437146534733033	0.024985242901608022	0.003784314485120191	0.05645792890127368	1.0305793519103603	1.003791484044284	1.0580820991873667	1.031 [1.004:1.058]	positive	MHC class I polypeptide-related sequence B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1898	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MHC class I polypeptide-related sequence B	MR Egger	4	0.0025219020501984018	0.017927007981469747	0.9010154715541054	-0.03261503359348231	0.03765883769387911	1.002525084720072	0.9679111011348736	1.0383769173786321	1.003 [0.968:1.038]	overlaps null	MHC class I polypeptide-related sequence B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1898	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MHC class I polypeptide-related sequence B	Weighted median	4	0.02642963294273397	0.012178690263063955	0.029995184291992917	0.0025594000271286187	0.050299865858339315	1.0267819930922477	1.002562678087404	1.051586383955314	1.027 [1.003:1.052]	positive	MHC class I polypeptide-related sequence B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1922	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Multimerin-2	Inverse variance weighted	4	0.02051840135683629	0.01746210486125186	0.2399849067006862	-0.01370732417121736	0.054744126884889936	1.0207303508938004	0.9863861934171443	1.0562703089206396	1.021 [0.986:1.056]	overlaps null	Multimerin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1922	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Multimerin-2	MR Egger	4	0.005927998820603909	0.02540807311426193	0.8372240465200448	-0.043871824483349475	0.05572782212455729	1.0059456041765968	0.957076623402173	1.0573098682162638	1.006 [0.957:1.057]	overlaps null	Multimerin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1922	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Multimerin-2	Weighted median	4	0.01828935691043491	0.013079600489494112	0.16201952003306738	-0.007346660048973549	0.04392537386984337	1.018457631511153	0.9926802606917791	1.0449043748089284	1.018 [0.993:1.045]	overlaps null	Multimerin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2395	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Myeloblastin	Inverse variance weighted	3	0.012513716498049764	0.013527889199039904	0.3549497969192952	-0.014000946332068448	0.039028379328167974	1.012592340666245	0.9860966110875747	1.0397999920566452	1.013 [0.986:1.04]	overlaps null	Myeloblastin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2395	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Myeloblastin	MR Egger	3	0.0015429227012588927	0.028292411673605196	0.9653163864146757	-0.05391020417900729	0.05699604958152508	1.0015441136189092	0.9475171857654605	1.0586516282702887	1.002 [0.948:1.059]	overlaps null	Myeloblastin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2395	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Myeloblastin	Weighted median	3	0.011953163842767817	0.014101682879090797	0.39663796252724964	-0.015686134600250146	0.03959246228578578	1.0120248883992626	0.9844362520489948	1.0403866909693675	1.012 [0.984:1.04]	overlaps null	Myeloblastin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2396	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Myeloblastin	Inverse variance weighted	3	0.023702856066273027	0.025248901499302395	0.3478499673700189	-0.025784990872359668	0.07319070300490572	1.0239860014514162	0.9745446030692415	1.0759357015226938	1.024 [0.975:1.076]	overlaps null	Myeloblastin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2396	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Myeloblastin	MR Egger	3	-0.020092039670238496	0.05640355380376005	0.782145721368845	-0.13064300512560817	0.09045892578513119	0.9801084602957475	0.8775309925455379	1.094676543738655	0.98 [0.878:1.095]	overlaps null	Myeloblastin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2396	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Myeloblastin	Weighted median	3	0.02084543324515315	0.01330021231682153	0.11704440128166195	-0.0052229828958170466	0.04691384938612335	1.021064216857348	0.994790633163552	1.0480317166145874	1.021 [0.995:1.048]	overlaps null	Myeloblastin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1930	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Myeloperoxidase	Inverse variance weighted	4	-0.022722192914155077	0.01849253719519067	0.21917594067458757	-0.05896756581672878	0.013523179988418631	0.9775340119304764	0.9427373455770796	1.0136150317625916	0.978 [0.943:1.014]	overlaps null	Myeloperoxidase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1930	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Myeloperoxidase	MR Egger	4	-0.031887680245261035	0.037790965509706995	0.4876208792765331	-0.10595797264428675	0.042182612153764676	0.968615370610396	0.8994624493098834	1.0430849413475405	0.969 [0.899:1.043]	overlaps null	Myeloperoxidase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1930	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Myeloperoxidase	Weighted median	4	-0.02351781636651217	0.02117108530411597	0.2666346233046958	-0.06501314356257948	0.017977510829555128	0.9767565722607359	0.9370551470534977	1.0181400790065496	0.977 [0.937:1.018]	overlaps null	Myeloperoxidase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-213	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2	Inverse variance weighted	3	0.04788608102325931	0.03640112727550266	0.18833824431978705	-0.023460128436725902	0.11923229048324452	1.0490511416845547	0.9768129209505987	1.1266315936921605	1.049 [0.977:1.127]	overlaps null	N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-213	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2	MR Egger	3	-0.00816152113570124	0.1283342633580901	0.9595681006577801	-0.2596966773175578	0.24337363504615533	0.9918716936554263	0.7712854987126256	1.2755451234555657	0.992 [0.771:1.276]	overlaps null	N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-213	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2	Weighted median	3	0.029931485515169796	0.015240783784593216	0.04954085087965205	5.9549297367095244e-5	0.0598034217329725	1.0303839353105246	1.0000595510704617	1.0616278330721118	1.03 [1:1.062]	positive	N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2736	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	NAD-dependent protein deacetylase sirtuin-2	Inverse variance weighted	3	-0.014682310129243214	0.023242019729991688	0.527573753502451	-0.06023666880002693	0.030872048541540496	0.9854249494052253	0.9415416736752112	1.031353532255082	0.985 [0.942:1.031]	overlaps null	NAD-dependent protein deacetylase sirtuin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2736	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	NAD-dependent protein deacetylase sirtuin-2	MR Egger	3	-0.0746186039247312	0.03198579249170171	0.2578081788941529	-0.13731075720846656	-0.011926450640995845	0.9280973915378337	0.8716992971975107	0.9881443875756182	0.928 [0.872:0.988]	negative	NAD-dependent protein deacetylase sirtuin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2736	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	NAD-dependent protein deacetylase sirtuin-2	Weighted median	3	-0.02973196594685509	0.016865258778992052	0.07791534419470052	-0.06278787315367951	0.003323941259969331	0.9707056808608333	0.9391426699337687	1.0033294716786172	0.971 [0.939:1.003]	overlaps null	NAD-dependent protein deacetylase sirtuin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2025	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial	Inverse variance weighted	2	0.010155264880753117	0.007291676676427667	0.16370443924791092	-0.00413642140504511	0.024446951166551344	1.0102070045782774	0.9958721218024802	1.0247482279671885	1.01 [0.996:1.025]	overlaps null	NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2007	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Neural cell adhesion molecule 1	Inverse variance weighted	3	0.004071298873793398	0.03743243479975452	0.9133897304408315	-0.06929627333372546	0.07743887108131225	1.0040795978697954	0.9330502012299177	1.0805161796540252	1.004 [0.933:1.081]	overlaps null	Neural cell adhesion molecule 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2007	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Neural cell adhesion molecule 1	MR Egger	3	0.36014171175422893	0.2007768135910351	0.32377112014107584	-0.033380842884199846	0.7536642663926577	1.4335325485789647	0.9671701495710433	2.1247714983208863	1.434 [0.967:2.125]	overlaps null	Neural cell adhesion molecule 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2007	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Neural cell adhesion molecule 1	Weighted median	3	0.026376174610100292	0.037465580184180704	0.48142602239428994	-0.04705636255089389	0.09980871177109447	1.026727104506058	0.9540336243062812	1.1049595321065595	1.027 [0.954:1.105]	overlaps null	Neural cell adhesion molecule 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2101	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Neurensin-1	Inverse variance weighted	3	-0.013214561337814183	0.01986980403002137	0.5060137440172523	-0.05215937723665606	0.0257302545610277	0.9868723676471003	0.9491775774877742	1.0260641350200226	0.987 [0.949:1.026]	overlaps null	Neurensin-1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2101	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Neurensin-1	MR Egger	3	-0.24332506641309473	0.18812966355316285	0.4189980919001422	-0.6120592069772939	0.12540907415110444	0.7840166148754618	0.5422331483778705	1.1336120896327417	0.784 [0.542:1.134]	overlaps null	Neurensin-1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2101	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Neurensin-1	Weighted median	3	-0.0128956413883335	0.02233398762537698	0.5636693669393917	-0.05667025713407238	0.030878974357405376	0.98718715112543165	0.9449055938807649	1.0313606752444735	0.987 [0.945:1.031]	overlaps null	Neurensin-1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2082	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Neuropeptide W	Inverse variance weighted	3	0.00609367107037518	0.014113933021623079	0.6659241279533206	-0.021569637652006052	0.03375697979275641	1.0061122752539933	0.9786613234194591	1.0343332123107787	1.006 [0.979:1.034]	overlaps null	Neuropeptide W (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2082	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Neuropeptide W	MR Egger	3	-0.009057145791141821	0.03983670679446939	0.8576794903148841	-0.08713709110830183	0.06902279952601818	0.9909837466045457	0.9165514359677652	1.0714606376645517	0.991 [0.917:1.071]	overlaps null	Neuropeptide W (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2082	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Neuropeptide W	Weighted median	3	0.003055385110291972	0.015262863597528134	0.8413364738784925	-0.026859827540863173	0.03297059776144712	1.003060057556874	0.9734976895260923	1.0335201509885377	1.003 [0.973:1.034]	overlaps null	Neuropeptide W (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2337	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Neutrophil-activating peptide 2	Inverse variance weighted	3	0.04448505039342863	0.022597798251525008	0.04900400252311088	1.9336582043961298e-4	0.08877673496641764	1.045489346939215	1.000193384516815	1.092836636878406	1.045 [1:1.093]	positive	Neutrophil-activating peptide 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2337	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Neutrophil-activating peptide 2	MR Egger	3	-0.13196412368154276	0.21156903532361598	0.6449616620420977	-0.5466394329158301	0.28271118555274455	0.8763724355319704	0.5788919504406671	1.3267219300175013	0.876 [0.579:1.327]	overlaps null	Neutrophil-activating peptide 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2337	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Neutrophil-activating peptide 2	Weighted median	3	0.038965375017667045	0.026466061980026625	0.14094608463252742	-0.012908106463185139	0.09083885649851922	1.0397344822388088	0.9871748458403936	1.0950925239956808	1.04 [0.987:1.095]	overlaps null	Neutrophil-activating peptide 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2189	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	PAX-interacting protein 1	Inverse variance weighted	3	-0.021145908293539493	0.021249266607350315	0.31967016675981264	-0.06279447084394611	0.020502654256867123	0.9790760988242397	0.9391364737817566	1.0207142774774784	0.979 [0.939:1.021]	overlaps null	PAX-interacting protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2189	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	PAX-interacting protein 1	MR Egger	3	-0.020371282115506383	0.0784757910551514	0.8383106641902435	-0.17418383258360312	0.13344126835259038	0.979834810621747	0.8401424379065439	1.1427541483304433	0.98 [0.84:1.143]	overlaps null	PAX-interacting protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2189	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	PAX-interacting protein 1	Weighted median	3	-0.029625643816418443	0.024447029945467057	0.2255774695441792	-0.07754182250953387	0.018290534876696986	0.9708088938436643	0.9253883215254174	1.018458831220589	0.971 [0.925:1.018]	overlaps null	PAX-interacting protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2341	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Peptidyl-prolyl cis-trans isomerase E	Inverse variance weighted	2	-0.026384505559976252	0.016533971068131214	0.11053893038258968	-0.05879108885351343	0.0060220777335609245	0.973960524365339	0.9429037316821621	1.006040246897404	0.974 [0.943:1.006]	overlaps null	Peptidyl-prolyl cis-trans isomerase E (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2398	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	PH and SEC7 domain-containing protein 1	Inverse variance weighted	4	-0.029778927902200894	0.01358647003048231	0.028393404074494772	-0.05640840916194622	-0.003149446642455568	0.9706600956943875	0.9451530478906247	0.9968555076621505	0.971 [0.945:0.997]	negative	PH and SEC7 domain-containing protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2398	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	PH and SEC7 domain-containing protein 1	MR Egger	4	-0.060354949792648674	0.026140325481456197	0.14724933631159562	-0.11158998773630283	-0.009119911848994529	0.9414303137774637	0.8944109017694074	0.9909215484133632	0.941 [0.894:0.991]	negative	PH and SEC7 domain-containing protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2398	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	PH and SEC7 domain-containing protein 1	Weighted median	4	-0.03652440919798347	0.01196294869107327	0.0022646959448318713	-0.05997178863248708	-0.01307702976347986	0.9641345598577474	0.9417911024243861	0.9870081030912305	0.964 [0.942:0.987]	negative	PH and SEC7 domain-containing protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2166	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Platelet-activating factor acetylhydrolase IB subunit beta	Inverse variance weighted	3	-0.03282788474115436	0.023236436082215213	0.1577215272336209	-0.07837129946229618	0.012715529979987455	0.9677051020704989	0.9246210515007498	1.012796716074461	0.968 [0.925:1.013]	overlaps null	Platelet-activating factor acetylhydrolase IB subunit beta (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2166	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Platelet-activating factor acetylhydrolase IB subunit beta	MR Egger	3	-0.037977841185798694	0.2158523947293936	0.889125630364259	-0.4610485348554102	0.38509285248381275	0.96273427370474	0.6306220695043234	1.4697507851165346	0.963 [0.631:1.47]	overlaps null	Platelet-activating factor acetylhydrolase IB subunit beta (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2166	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Platelet-activating factor acetylhydrolase IB subunit beta	Weighted median	3	-0.03499140733603208	0.02538172658998809	0.168016183350154	-0.08473959145240872	0.014756776780344573	0.9656137134160813	0.918751503997445	1.0148661955711877	0.966 [0.919:1.015]	overlaps null	Platelet-activating factor acetylhydrolase IB subunit beta (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2308	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Plexin-B2	Inverse variance weighted	3	0.029582062060198488	0.01850785894330113	0.10996479650261351	-0.006693341468671728	0.0658574655890687	1.0300239578918406	0.9933290090469898	1.0680744689506836	1.03 [0.993:1.068]	overlaps null	Plexin-B2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2308	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Plexin-B2	MR Egger	3	0.07235433187571803	0.029178891754457478	0.24403470690939066	0.015163704036981376	0.12954495971445468	1.0750361961776633	1.015279256325145	1.1383102884178535	1.075 [1.015:1.138]	positive	Plexin-B2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2308	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Plexin-B2	Weighted median	3	0.03370187609623905	0.013033855834485158	0.009717638972838902	0.00815551866064814	0.05924823353182996	1.0342762182976546	1.0081888654948925	1.061038593409775	1.034 [1.008:1.061]	positive	Plexin-B2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1610	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Potassium voltage-gated channel subfamily E member 2	Inverse variance weighted	3	0.005241689800308019	0.011502181579596205	0.6485966147081713	-0.017302586095700543	0.02778596569631658	1.00525545149062	0.9828462440288286	1.0281755960212728	1.005 [0.983:1.028]	overlaps null	Potassium voltage-gated channel subfamily E member 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1610	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Potassium voltage-gated channel subfamily E member 2	MR Egger	3	0.003611727843516751	0.026093640906470397	0.9124391949849535	-0.047531808333165226	0.05475526402019873	1.003618257991864	0.9535801408553992	1.0562820728115005	1.004 [0.954:1.056]	overlaps null	Potassium voltage-gated channel subfamily E member 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1610	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Potassium voltage-gated channel subfamily E member 2	Weighted median	3	0.005038237958385209	0.011662187852462426	0.665730643732898	-0.017819650232441146	0.027896126149211563	1.005050951221095	0.9823381808460561	1.0282888665494379	1.005 [0.982:1.028]	overlaps null	Potassium voltage-gated channel subfamily E member 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2357	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	PR domain zinc finger protein 1	Inverse variance weighted	3	0.02940535656999395	0.017640488342596745	0.09552948210670671	-0.005170000581495672	0.06398071372148356	1.0298419630836535	0.99484334086983806	1.0660718380048493	1.03 [0.995:1.066]	overlaps null	PR domain zinc finger protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2357	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	PR domain zinc finger protein 1	MR Egger	3	0.3760140931964479	0.13155964313631116	0.21426553388631836	0.11815719264927804	0.6338709937436178	1.4564676599112973	1.125421005373147	1.8848928838538501	1.456 [1.125:1.885]	positive	PR domain zinc finger protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2357	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	PR domain zinc finger protein 1	Weighted median	3	0.03203681911643214	0.010320082854276625	0.0019071821519700514	0.011809456722049957	0.05226418151081433	1.0325555223872378	1.0118794636659911	1.0536540616702461	1.033 [1.012:1.054]	positive	PR domain zinc finger protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2073	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Pro-FMRFamide-related neuropeptide FF	Inverse variance weighted	3	-0.018285473626778157	0.010263406018410493	0.07481147197787101	-0.03840174942286272	0.0018308021693064086	0.981880691303206	0.9623262492045961	1.0018324791108246	0.982 [0.962:1.002]	overlaps null	Pro-FMRFamide-related neuropeptide FF (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2073	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Pro-FMRFamide-related neuropeptide FF	MR Egger	3	-0.04264552006767768	0.07555343960023994	0.6728644507290956	-0.19073026168414797	0.1054392215487926	0.9582510106225319	0.8263554578210857	1.111198565542618	0.958 [0.826:1.111]	overlaps null	Pro-FMRFamide-related neuropeptide FF (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2073	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Pro-FMRFamide-related neuropeptide FF	Weighted median	3	-0.020547979233111874	0.01103895126828643	0.06268674748480373	-0.042184323718953275	0.0010883652527295257	0.979661691930218	0.958693054416449	1.0010889577371183	0.98 [0.959:1.001]	overlaps null	Pro-FMRFamide-related neuropeptide FF (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-648	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Probable carboxypeptidase X1	Inverse variance weighted	3	0.03378050894597796	0.014091806261498755	0.01652208421329309	0.006160568673440402	0.06140044921851552	1.0343575495817299	1.006179584004994	1.0633246364611295	1.034 [1.006:1.063]	positive	Probable carboxypeptidase X1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-648	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Probable carboxypeptidase X1	MR Egger	3	0.04137956247807493	0.03395743582530561	0.43748259259217104	-0.02517701173952406	0.10793613669567392	1.0422476285705493	0.9751372860030967	1.1139766008880558	1.042 [0.975:1.114]	overlaps null	Probable carboxypeptidase X1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-648	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Probable carboxypeptidase X1	Weighted median	3	0.027984599526934367	0.015872650536051712	0.07788862533009715	-0.0031257955237269895	0.05909499457759572	1.0283798467633403	0.9968790846889279	1.0608760134224304	1.028 [0.997:1.061]	overlaps null	Probable carboxypeptidase X1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2427	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Prostaglandin F2 receptor negative regulator	Inverse variance weighted	3	0.014565405168128995	0.00832446796094431	0.08016836038263431	-0.0017505520353218538	0.030881362371579846	1.0146719975737428	0.9982509792872087	1.0313631381513257	1.015 [0.998:1.031]	overlaps null	Prostaglandin F2 receptor negative regulator (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2427	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Prostaglandin F2 receptor negative regulator	MR Egger	3	0.009946294051922829	0.01419079586212692	0.610816448624268	-0.017867665837845933	0.03776025394169159	1.0099959228389717	0.9822910144159619	1.0384822310095743	1.01 [0.982:1.038]	overlaps null	Prostaglandin F2 receptor negative regulator (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2427	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Prostaglandin F2 receptor negative regulator	Weighted median	3	0.01411313169477999	0.008357017489135215	0.09126233891784048	-0.002266622583925031	0.030492885973485012	1.0142131921056823	0.9977359442653182	1.030962555727735	1.014 [0.998:1.031]	overlaps null	Prostaglandin F2 receptor negative regulator (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-995	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Protein eva-1 homolog C	Inverse variance weighted	3	-0.016767200313503358	0.01082571834118025	0.12142252570846333	-0.03798560826221665	0.004451207635209932	0.9833725868196184	0.9627267961031055	1.0044611289751018	0.983 [0.963:1.004]	overlaps null	Protein eva-1 homolog C (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-995	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Protein eva-1 homolog C	MR Egger	3	-0.015517716909210742	0.05702559651564292	0.8308594925903552	-0.12728788607987088	0.09625245226144938	0.9846020624918543	0.8804801581261372	1.1010369881888147	0.985 [0.88:1.101]	overlaps null	Protein eva-1 homolog C (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-995	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Protein eva-1 homolog C	Weighted median	3	-0.018620357165184627	0.011128556825212738	0.09428694210404627	-0.04043232854260159	0.003191614212232338	0.9815519306743431	0.9603741522310105	1.0031967128357089	0.982 [0.96:1.003]	overlaps null	Protein eva-1 homolog C (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1049	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Protein FAM3B	Inverse variance weighted	3	0.040010412199723316	0.048765463648882054	0.41195041872098614	-0.05556989655208551	0.13559072095153213	1.0408216113784627	0.945945903002579	1.1452130859427234	1.041 [0.946:1.145]	overlaps null	Protein FAM3B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1049	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Protein FAM3B	MR Egger	3	-0.05654310255354461	0.024605297146938147	0.2612972108069335	-0.10476948496154337	-0.008316720145545846	0.9450257505942695	0.9005320848504056	0.9917177680955342	0.945 [0.901:0.992]	negative	Protein FAM3B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1049	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Protein FAM3B	Weighted median	3	0.01324411756212458	0.016006681579178117	0.40800368243973795	-0.018128978333064528	0.04461721345731369	1.0133322093568886	0.982034363034521	1.0456275311457888	1.013 [0.982:1.046]	overlaps null	Protein FAM3B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2030	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Protein kinase C-binding protein NELL1	Inverse variance weighted	2	-0.004030899343858273	0.016822281750962884	0.8106274307940613	-0.037002571575745526	0.02894077288802898	0.9959772138261173	0.9636736571860637	1.0293636264349064	0.996 [0.964:1.029]	overlaps null	Protein kinase C-binding protein NELL1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2329	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2	Inverse variance weighted	2	0.0041057664725833104	0.018026712990694107	0.8198327246441581	-0.03122659098917714	0.03943812393434376	1.004114206678966	0.969255923533183	1.0402261317931591	1.004 [0.969:1.04]	overlaps null	Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2616	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Protein S100-A13	Wald ratio	1	0.01399276236429433	0.006192199437072779	0.023837376053573108	0.0018560514676316843	0.026129473260956975	1.0140911192898379	1.0018577749973119	1.0264738407857095	1.014 [1.002:1.026]	positive	Protein S100-A13 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2616	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Protein S100-A13	NO SENSITIVITY	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Protein S100-A13 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2720	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Protein shisa-3 homolog	Inverse variance weighted	3	0.029099867682415025	0.03776228541756295	0.4409401274263945	-0.04491421173600835	0.1031139471008384	1.0295274058572839	0.9560794987154394	1.108617725654943	1.03 [0.956:1.109]	overlaps null	Protein shisa-3 homolog (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2720	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Protein shisa-3 homolog	MR Egger	3	-0.02883749097134677	0.047212165272319674	0.6509238790686462	-0.12137333490509333	0.06369835296239978	0.9715743412405162	0.8857032339282201	1.0657708636451064	0.972 [0.886:1.066]	overlaps null	Protein shisa-3 homolog (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2720	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Protein shisa-3 homolog	Weighted median	3	0.015505730861426077	0.013546756423112585	0.2523714212815693	-0.01104591172787459	0.04205737345072674	1.0156265684567574	0.9890148703513956	1.0429543149222404	1.016 [0.989:1.043]	overlaps null	Protein shisa-3 homolog (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3093	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Protein-tyrosine sulfotransferase 2	Inverse variance weighted	4	0.057002767098359795	0.03397485336579145	0.09338753966972449	-0.009587945498591453	0.12359347969531104	1.0586587398043097	0.9904578723010709	1.1315557770874787	1.059 [0.99:1.132]	overlaps null	Protein-tyrosine sulfotransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3093	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Protein-tyrosine sulfotransferase 2	MR Egger	4	0.2745778881422399	0.15279237635096599	0.21415640258359853	-0.02489516950565346	0.5740509457901333	1.3159750689308318	0.9754121596077902	1.7754447337870534	1.316 [0.975:1.775]	overlaps null	Protein-tyrosine sulfotransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3093	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Protein-tyrosine sulfotransferase 2	Weighted median	4	0.03642743772926413	0.02236198065667235	0.10331518457663927	-0.007402044357813671	0.08025691981634192	1.0370990470255435	0.9926252833040978	1.083565421345187	1.037 [0.993:1.084]	overlaps null	Protein-tyrosine sulfotransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2609	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Reticulon-4 receptor	Inverse variance weighted	3	-0.018160690188416134	0.015885298398265826	0.25293943835186755	-0.049295875049017154	0.012974494672184884	0.9820032213966322	0.9518994447339134	1.0130590286276766	0.982 [0.952:1.013]	overlaps null	Reticulon-4 receptor (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2609	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Reticulon-4 receptor	MR Egger	3	0.010455493397706527	0.049497095805215094	0.8674721620553841	-0.08655881438051505	0.10746980117592811	1.0105103430622309	0.9170816096117707	1.113457235139656	1.011 [0.917:1.113]	overlaps null	Reticulon-4 receptor (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2609	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Reticulon-4 receptor	Weighted median	3	-0.016386942268625772	0.016929857173045598	0.333078574758368	-0.04956946232779515	0.0167955777905436	0.9837465932618412	0.9516390527767461	1.0169374164821228	0.984 [0.952:1.017]	overlaps null	Reticulon-4 receptor (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2493	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Retinoic acid receptor responder protein 1	Inverse variance weighted	2	-0.007709884729309065	0.006617668917340355	0.24400061626597377	-0.02068051580729616	0.005260746348678031	0.992319760196716	0.9795318595296708	1.005274608372287	0.992 [0.98:1.005]	overlaps null	Retinoic acid receptor responder protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-149	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Rho GTPase-activating protein 30	Inverse variance weighted	5	-0.03200537947660647	0.01497298475157472	0.03255395674559342	-0.06135242958969292	-0.002658329363520017	0.9685013720347098	0.9404917242490138	0.9973452008651195	0.969 [0.94:0.997]	negative	Rho GTPase-activating protein 30 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-149	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Rho GTPase-activating protein 30	MR Egger	5	-0.11639425040110706	0.06020112508834428	0.14866649589263384	-0.23438845557426186	0.001599954772047732	0.8901242222792043	0.7910544666865629	1.0016012353825658	0.89 [0.791:1.002]	overlaps null	Rho GTPase-activating protein 30 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-149	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Rho GTPase-activating protein 30	Weighted median	5	-0.025782063852465318	0.017637346803307447	0.14379928328153288	-0.06035126358694791	0.008787135882017277	0.9745474555848573	0.9414337840896493	1.00882585609067	0.975 [0.941:1.009]	overlaps null	Rho GTPase-activating protein 30 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2561	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	RING finger protein 122	Inverse variance weighted	2	0.00550830349605398	0.028796240746163864	0.8483019155818036	-0.05093232836642719	0.06194893535853516	1.0055235020931037	0.9503429796183371	1.0639080152595373	1.006 [0.95:1.064]	overlaps null	RING finger protein 122 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2575	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	rRNA methyltransferase 3, mitochondrial	Inverse variance weighted	4	-0.012558087076715388	0.00895130215532106	0.1606364896823673	-0.030102639301144665	0.004986465147713887	0.9875204366524868	0.9703459328087084	1.0049989182554404	0.988 [0.97:1.005]	overlaps null	rRNA methyltransferase 3, mitochondrial (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2575	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	rRNA methyltransferase 3, mitochondrial	MR Egger	4	-0.00623195617835278	0.018204076493834546	0.7647252920758731	-0.04191194610626849	0.02944803374956293	0.9937874221846185	0.9589542165076473	1.0298859147719002	0.994 [0.959:1.03]	overlaps null	rRNA methyltransferase 3, mitochondrial (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2575	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	rRNA methyltransferase 3, mitochondrial	Weighted median	4	-0.011720971929415434	0.009412935309067082	0.21305883282339608	-0.030170325135186915	0.006728381276356048	0.9883474510731312	0.9702802563576445	1.0067510676860525	0.988 [0.97:1.007]	overlaps null	rRNA methyltransferase 3, mitochondrial (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2291	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Secretory phospholipase A2 receptor	Wald ratio	1	0.007981376787495843	0.006983704689058862	0.2530979089471156	-0.005706684403059527	0.021669437978051213	1.008013312883338	0.9943095677903027	1.0219059253428937	1.008 [0.994:1.022]	overlaps null	Secretory phospholipase A2 receptor (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2291	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Secretory phospholipase A2 receptor	NO SENSITIVITY	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Secretory phospholipase A2 receptor (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2820	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Serine protease inhibitor Kazal-type 6	Inverse variance weighted	2	-0.004669086550541393	0.012806796208503043	0.7154258331596786	-0.029770407119207358	0.020432234018124572	0.9953417966892155	0.9706683665136603	1.0206424010651773	0.995 [0.971:1.021]	overlaps null	Serine protease inhibitor Kazal-type 6 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2877	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Serine/threonine-protein kinase 16	Inverse variance weighted	4	-0.046496721726533775	0.021566856587783376	0.0310888106637027	-0.08876776063858918	-0.004225682814478361	0.9545676898987704	0.9150580613993118	0.9957832328205097	0.955 [0.915:0.996]	negative	Serine/threonine-protein kinase 16 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2877	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Serine/threonine-protein kinase 16	MR Egger	4	0.0546187733078084	0.06269395156667416	0.4755045676561518	-0.06826137176287296	0.17749891837848975	1.0561379099575665	0.9340163161795668	1.1942267662004025	1.056 [0.934:1.194]	overlaps null	Serine/threonine-protein kinase 16 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2877	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Serine/threonine-protein kinase 16	Weighted median	4	-0.059169270217570596	0.023905586418456984	0.013319024282861235	-0.10602421959774629	-0.012314320837394907	0.9425472104818261	0.8994028646365387	0.9877611901381754	0.943 [0.899:0.988]	negative	Serine/threonine-protein kinase 16 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2878	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Serine/threonine-protein kinase 17B	Inverse variance weighted	2	-0.009972222743112824	0.02177790867252445	0.6470203820313506	-0.05265692374126075	0.0327124782550351	0.9900773349996841	0.9487054349680163	1.0332534137038267	0.99 [0.949:1.033]	overlaps null	Serine/threonine-protein kinase 17B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2729	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Sialic acid-binding Ig-like lectin 7	Inverse variance weighted	3	0.0014510077398806464	0.01599304924747103	0.9277092001712988	-0.029895368785162565	0.03279738426492386	1.0014520609609603	0.9705470777558711	1.0333411468528715	1.001 [0.971:1.033]	overlaps null	Sialic acid-binding Ig-like lectin 7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2729	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Sialic acid-binding Ig-like lectin 7	MR Egger	3	-0.033024725877385905	0.033856087510842334	0.5079130915066769	-0.09938265739863687	0.03333320564386506	0.9675146366450006	0.9053961851790554	1.0338949814960652	0.968 [0.905:1.034]	overlaps null	Sialic acid-binding Ig-like lectin 7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2729	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Sialic acid-binding Ig-like lectin 7	Weighted median	3	0.0023572824465703593	0.018214407983196807	0.8970264626802106	-0.033342957200495384	0.0380575220936361	1.0023600630212741	0.9672067921675289	1.0387909845922434	1.002 [0.967:1.039]	overlaps null	Sialic acid-binding Ig-like lectin 7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2748	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Solute carrier family 22 member 16	Inverse variance weighted	4	-0.03970708037460707	0.03171048227139795	0.21050602037919383	-0.10185962562654705	0.022445464877332906	0.9610709144577291	0.9031563227739009	1.0226992596140492	0.961 [0.903:1.023]	overlaps null	Solute carrier family 22 member 16 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2748	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Solute carrier family 22 member 16	MR Egger	4	-0.06597107422551933	0.10589871266778673	0.5968765383400971	-0.27353255105438135	0.14159040260334266	0.9361579429935181	0.760687574770245	1.152104652813025	0.936 [0.761:1.152]	overlaps null	Solute carrier family 22 member 16 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2748	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Solute carrier family 22 member 16	Weighted median	4	-0.02220015690584436	0.023496966179105877	0.34475614010188604	-0.06825421061689188	0.023853896805203157	0.9780444531067974	0.9340230048307049	1.02414067673457	0.978 [0.934:1.024]	overlaps null	Solute carrier family 22 member 16 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2875	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Stromal interaction molecule 1	Inverse variance weighted	3	-0.04021636726039703	0.029807005805858273	0.17726460096584293	-0.09863809863987924	0.01820536411908518	0.960581578261512	0.9060705568623938	1.0183720920042123	0.961 [0.906:1.018]	overlaps null	Stromal interaction molecule 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2875	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Stromal interaction molecule 1	MR Egger	3	0.01266229338779995	0.13256326495491955	0.939374730417253	-0.24716170592384235	0.27248629269944225	1.0127427996638942	0.7810143886662758	1.3132254580130633	1.013 [0.781:1.313]	overlaps null	Stromal interaction molecule 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2875	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Stromal interaction molecule 1	Weighted median	3	-0.037724795947677386	0.029399874515680442	0.199435395551946	-0.09534854999841105	0.01989895810305628	0.9629779198537259	0.9090560277654912	1.0200982621557746	0.963 [0.909:1.02]	overlaps null	Stromal interaction molecule 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2889	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Syntaxin-7	Inverse variance weighted	3	-0.007663828695163449	0.012326703703824072	0.5341222385609701	-0.03182416795465863	0.01649651056433173	0.9923654635619247	0.9686768915449432	1.0166333293032654	0.992 [0.969:1.017]	overlaps null	Syntaxin-7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2889	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Syntaxin-7	MR Egger	3	0.0020350060533156343	0.03397683672045677	0.9619158402265716	-0.06455959391877962	0.06862960602541089	1.0020370780834271	0.9374802444757697	1.0710394291193233	1.002 [0.937:1.071]	overlaps null	Syntaxin-7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2889	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Syntaxin-7	Weighted median	3	-0.009040038383224298	0.013904961758879278	0.5156079924601376	-0.03629376343062768	0.018213686664179086	0.9910006999127516	0.9643569590598714	1.0183805674871391	0.991 [0.964:1.018]	overlaps null	Syntaxin-7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3071	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Tenascin-X	Inverse variance weighted	3	0.020023332607119474	0.008992836711537949	0.02597489385022732	0.0023973726525050934	0.037649292561733855	1.0202251442615118	1.0024002486481411	1.0383670059810421	1.02 [1.002:1.038]	positive	Tenascin-X (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3071	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Tenascin-X	MR Egger	3	0.031018654012452736	0.026101611639448206	0.44533308652269915	-0.02014050480086575	0.08217781282577122	1.0315047454094224	0.980060960362245	1.0856488349550075	1.032 [0.98:1.086]	overlaps null	Tenascin-X (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3071	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Tenascin-X	Weighted median	3	0.020113268704275215	0.009357917314648625	0.031608112194485616	0.0017717507675639108	0.03845478664098652	1.0203169034553767	1.0017733212453166	1.0392037414039248	1.02 [1.002:1.039]	positive	Tenascin-X (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3123	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Thioredoxin domain-containing protein 12	Inverse variance weighted	7	-0.0056390988965062455	0.011251536218041324	0.6162410727465375	-0.027692109883867243	0.01641391209085475	0.9943767709770677	0.9726878016625792	1.016549360410078	0.994 [0.973:1.017]	overlaps null	Thioredoxin domain-containing protein 12 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3123	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Thioredoxin domain-containing protein 12	MR Egger	7	0.020460552575767756	0.03520513093220111	0.5863310436906386	-0.04854150405134641	0.08946260920288193	1.0206713045950961	0.9526178009872147	1.0935864424790833	1.021 [0.953:1.094]	overlaps null	Thioredoxin domain-containing protein 12 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3123	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Thioredoxin domain-containing protein 12	Weighted median	7	-0.005980600263102199	0.009335968508705886	0.5217840727700557	-0.024279098540165737	0.01231789801396134	0.99403724792796	0.9760132678623674	1.0123940757816943	0.994 [0.976:1.012]	overlaps null	Thioredoxin domain-containing protein 12 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3109	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Thiosulfate sulfurtransferase	Inverse variance weighted	3	0.013513689679221548	0.007676469359175588	0.07833928056236064	-0.0015321902647626034	0.0285595696232057	1.0136054122881795	0.998468982939474	1.0289713044417823	1.014 [0.998:1.029]	overlaps null	Thiosulfate sulfurtransferase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3109	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Thiosulfate sulfurtransferase	MR Egger	3	0.011878674416165452	0.016847422229857578	0.6090371394131722	-0.021142273154355403	0.0448996219866863	1.011949506053247	0.9790796579085996	1.0459228669798475	1.012 [0.979:1.046]	overlaps null	Thiosulfate sulfurtransferase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3109	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Thiosulfate sulfurtransferase	Weighted median	3	0.014334733392620534	0.008142950380097984	0.07834243253928301	-0.0016254493523715132	0.03029491613761258	1.014437968375507	0.9983758709749551	1.0307584764412252	1.014 [0.998:1.031]	overlaps null	Thiosulfate sulfurtransferase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3076	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Torsin-1A-interacting protein 1	Inverse variance weighted	4	-0.03273048646032785	0.021209459657515504	0.12278170475963546	-0.07430102738905824	0.008840054468402539	0.9677993594739676	0.9283921802987245	1.0088792431414544	0.968 [0.928:1.009]	overlaps null	Torsin-1A-interacting protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3076	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Torsin-1A-interacting protein 1	MR Egger	4	1.0207052463795144e-4	0.07322661775095302	0.9990143648950416	-0.14342210026722996	0.14362624131650586	1.000102075734011	0.8663882889747175	1.1544525412169615	1 [0.866:1.154]	overlaps null	Torsin-1A-interacting protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3076	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Torsin-1A-interacting protein 1	Weighted median	4	-0.02586973341550974	0.014477177107465397	0.07394845325403793	-0.05424500054614192	0.0025055337151224377	0.9744620211803133	0.9472000135508838	1.002508675187862	0.974 [0.947:1.003]	overlaps null	Torsin-1A-interacting protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1258	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Transmembrane glycoprotein NMB	Inverse variance weighted	3	0.030050704243655784	0.016490380798953517	0.06840687282206677	-0.002270442122293107	0.06237185060960468	1.0305067836959132	0.9977321333818758	1.0643580533422023	1.031 [0.998:1.064]	overlaps null	Transmembrane glycoprotein NMB (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1258	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Transmembrane glycoprotein NMB	MR Egger	3	0.06340624380716188	0.034054689156366905	0.31377423669600235	-0.0033409469393172464	0.130153434553641	1.0654595876839423	0.9966646278138621	1.1390031323552179	1.065 [0.997:1.139]	overlaps null	Transmembrane glycoprotein NMB (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1258	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Transmembrane glycoprotein NMB	Weighted median	3	0.03304951502559439	0.018275416900747	0.07054213106799337	-0.002770302099869733	0.0688693321510585	1.0336017167897273	0.9972335316459641	1.0712962160301178	1.034 [0.997:1.071]	overlaps null	Transmembrane glycoprotein NMB (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3000	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Transmembrane protein 132C	Inverse variance weighted	2	-5.835651169366746e-4	0.06334270701120297	0.9926493351413885	-0.12473527085889449	0.12356814062502114	0.999416605124069	0.8827305561577352	1.1315271048793711	0.999 [0.883:1.132]	overlaps null	Transmembrane protein 132C (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2951	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Trefoil factor 1	Inverse variance weighted	4	-0.06058384817126007	0.03372808596178849	0.07245583226720251	-0.12669089665636551	0.005523200313845358	0.9412148465660528	0.8810059523993389	1.0055384813050703	0.941 [0.881:1.006]	overlaps null	Trefoil factor 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2951	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Trefoil factor 1	MR Egger	4	0.033090110732919106	0.07818804398804405	0.7133060930211136	-0.12015845548364722	0.18633867694948542	1.033643677434218	0.8867799104442742	1.2048302395173323	1.034 [0.887:1.205]	overlaps null	Trefoil factor 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2951	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Trefoil factor 1	Weighted median	4	-0.04294754029883812	0.02756590554611085	0.11923445671644278	-0.09697671516921538	0.011081634571539142	0.957961643130412	0.9075771386673358	1.0111432633226451	0.958 [0.908:1.011]	overlaps null	Trefoil factor 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2392	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Trypsin-2	Inverse variance weighted	3	-0.01235437757569563	0.021424663380132165	0.5641807897646067	-0.054346717800754674	0.029637962649363414	0.9877216244391201	0.9471036718658251	1.0300815384473194	0.988 [0.947:1.03]	overlaps null	Trypsin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2392	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Trypsin-2	MR Egger	3	-0.07769926378291303	0.12968897548261094	0.656370333817201	-0.33188965572883045	0.17649112816300438	0.9252426386782536	0.7175664978383297	1.1930238423995847	0.925 [0.718:1.193]	overlaps null	Trypsin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2392	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Trypsin-2	Weighted median	3	-0.01301146083388564	0.024330019117313386	0.5927947970476221	-0.06069829830381987	0.0346753766360486	0.9870728222778118	0.9411071305662689	1.0352835770070468	0.987 [0.941:1.035]	overlaps null	Trypsin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2393	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Trypsin-3	Inverse variance weighted	4	4.5350381273396423e-4	0.022762615207732997	0.9841046491978845	-0.04416122199442271	0.04506822961989064	1.000453606661135	0.9567996878836118	1.0460992324268257	1 [0.957:1.046]	overlaps null	Trypsin-3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2393	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Trypsin-3	MR Egger	4	0.1645505615996001	0.06427116970519896	0.12466237380719976	0.03857906897741015	0.29052205422179006	1.1788631732525146	1.039332904099081	1.3371253577847892	1.179 [1.039:1.337]	positive	Trypsin-3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2393	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Trypsin-3	Weighted median	4	-0.0013631755311047135	0.02049199400890124	0.9469619669769606	-0.041527483788551145	0.03880113272634171	0.9986377531706172	0.9593229691495162	1.0395637278880028	0.999 [0.959:1.04]	overlaps null	Trypsin-3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2930	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Tubulin-specific chaperone A	Inverse variance weighted	2	0.01902223844474115	0.008060793035122806	0.01828247247052686	0.003223084095900452	0.034821392793581846	1.0192043138842013	1.0032282838163231	1.0354347561739505	1.019 [1.003:1.035]	positive	Tubulin-specific chaperone A (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3048	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Tumor necrosis factor receptor superfamily member 1B	Inverse variance weighted	3	0.03734340702540325	0.024790297194053502	0.13197173068284432	-0.011245575474941615	0.08593238952574811	1.0380494331054604	0.9888174196490057	1.0897326484732215	1.038 [0.989:1.09]	overlaps null	Tumor necrosis factor receptor superfamily member 1B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3048	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Tumor necrosis factor receptor superfamily member 1B	MR Egger	3	0.06269754388882216	0.05237293057913339	0.4430323061663096	-0.039953400046279286	0.1653484878239236	1.064704764064468	0.9608342129389431	1.17980419447617	1.065 [0.961:1.18]	overlaps null	Tumor necrosis factor receptor superfamily member 1B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3048	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Tumor necrosis factor receptor superfamily member 1B	Weighted median	3	0.045396023796526665	0.028952310454801167	0.1168907974287751	-0.01135050469488362	0.10214255228793695	1.0464421938707098	0.9887136692518161	1.107541343027642	1.046 [0.989:1.108]	overlaps null	Tumor necrosis factor receptor superfamily member 1B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2978	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Tyrosine-protein kinase receptor Tie-1, soluble	Inverse variance weighted	4	-0.03136358722852277	0.008852171997067754	3.955447767810028e-4	-0.048713844342775564	-0.014013330114269973	0.9691231482117629	0.9524536407038938	0.9860843995575259	0.969 [0.952:0.986]	negative	Tyrosine-protein kinase receptor Tie-1, soluble (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2978	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Tyrosine-protein kinase receptor Tie-1, soluble	MR Egger	4	-0.03977175700678776	0.014305845956782902	0.10869269593312923	-0.06781121508208225	-0.011732298931493274	0.9610087576377637	0.934436864513482	0.9883362561229019	0.961 [0.934:0.988]	negative	Tyrosine-protein kinase receptor Tie-1, soluble (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2978	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Tyrosine-protein kinase receptor Tie-1, soluble	Weighted median	4	-0.03392828555408335	0.009530732209948536	3.7102095022887097e-4	-0.052608520685582486	-0.01524805042258422	0.9666408242629801	0.9487513563213652	0.9848676124741279	0.967 [0.949:0.985]	negative	Tyrosine-protein kinase receptor Tie-1, soluble (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3180	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ubiquitin carboxyl-terminal hydrolase 25	Inverse variance weighted	3	0.014101229745808666	0.01179860964381379	0.2320244093566503	-0.00902404515606636	0.03722650464768369	1.0142011210638584	0.9910165493388003	1.0379280897513414	1.014 [0.991:1.038]	overlaps null	Ubiquitin carboxyl-terminal hydrolase 25 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3180	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ubiquitin carboxyl-terminal hydrolase 25	MR Egger	3	0.015155936998545429	0.021112288137867658	0.6036273654179751	-0.026224147751675184	0.05653602174876604	1.015271370642762	0.974116719063583	1.0581647310578102	1.015 [0.974:1.058]	overlaps null	Ubiquitin carboxyl-terminal hydrolase 25 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3180	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ubiquitin carboxyl-terminal hydrolase 25	Weighted median	3	0.01202137327496976	0.012124066396325479	0.3214269426635863	-0.011741796861828177	0.0357845434117677	1.0120939203965644	0.9883268690185729	1.036432516218921	1.012 [0.988:1.036]	overlaps null	Ubiquitin carboxyl-terminal hydrolase 25 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1573	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ubiquitin-like protein ISG15	Inverse variance weighted	4	-0.033617995756847006	0.02044454782723888	0.10010389109535056	-0.07368930949823521	0.006453317984541192	0.9669408095871269	0.9289602681421474	1.0064741855051444	0.967 [0.929:1.006]	overlaps null	Ubiquitin-like protein ISG15 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1573	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ubiquitin-like protein ISG15	MR Egger	4	-0.052004343318517145	0.042578132881271616	0.34637402144499363	-0.13545748376580952	0.03144879712877522	0.9493247436141976	0.8733162922591781	1.031948535514901	0.949 [0.873:1.032]	overlaps null	Ubiquitin-like protein ISG15 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1573	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ubiquitin-like protein ISG15	Weighted median	4	-0.04354094696933361	0.024533193641116495	0.07593472112564706	-0.09162600650592194	0.004544112567254718	0.9573933509321663	0.9124463347334789	1.004554452703081	0.957 [0.912:1.005]	overlaps null	Ubiquitin-like protein ISG15 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2747	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Urea transporter 2	Inverse variance weighted	4	-0.013360346816224942	0.020084076074893688	0.5059092256367769	-0.05272513592301657	0.026004442290566684	0.9867285064735424	0.9486407239075199	1.0263455077882826	0.987 [0.949:1.026]	overlaps null	Urea transporter 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2747	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Urea transporter 2	MR Egger	4	0.00353970998736974	0.03760339368279068	0.9335850730646124	-0.07016294163089998	0.07724236160563946	1.00354598215914	0.9322419065131358	1.0803038688473314	1.004 [0.932:1.08]	overlaps null	Urea transporter 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2747	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Urea transporter 2	Weighted median	4	-0.01120670869028459	0.013866560971417741	0.4189856641332819	-0.03838516819426337	0.015971750813694185	0.9888558525495972	0.9623422058884117	1.01609998100299	0.989 [0.962:1.016]	overlaps null	Urea transporter 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3193	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Vascular cell adhesion protein 1	Inverse variance weighted	2	-0.02614542811802062	0.14598212511941647	0.8578590232866805	-0.3122703933520769	0.25997953711603566	0.9741934041931175	0.7317836320453485	1.2969035480074282	0.974 [0.732:1.297]	overlaps null	Vascular cell adhesion protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1622	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Vascular endothelial growth factor receptor 2	Inverse variance weighted	4	-0.036892504452255254	0.022930722733510673	0.10764522294628605	-0.08183672100993616	0.008051712105425664	0.9637797318110508	0.9214223953325755	1.008084214313585	0.964 [0.921:1.008]	overlaps null	Vascular endothelial growth factor receptor 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1622	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Vascular endothelial growth factor receptor 2	MR Egger	4	-0.034403399522097394	0.05489788069893983	0.5948655829307106	-0.14200324569201947	0.07319644664782468	0.9661816687895468	0.8676184404590959	1.0759418813309143	0.966 [0.868:1.076]	overlaps null	Vascular endothelial growth factor receptor 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1622	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Vascular endothelial growth factor receptor 2	Weighted median	4	-0.03154259704559631	0.017194093667731183	0.06657952995588262	-0.06524302063434942	0.002157826543156806	0.9689496811808938	0.936839764316931	1.0021601563263065	0.969 [0.937:1.002]	overlaps null	Vascular endothelial growth factor receptor 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1129	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Vascular endothelial growth factor receptor 3	Inverse variance weighted	4	-0.02854779431794759	0.01781071383535352	0.10896911828729254	-0.0634567934352405	0.006361204799345311	0.9718558438489151	0.9385146684194624	1.0063814802318547	0.972 [0.939:1.006]	overlaps null	Vascular endothelial growth factor receptor 3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1129	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Vascular endothelial growth factor receptor 3	MR Egger	4	-0.025515454018450824	0.05072088778650644	0.6648574674435479	-0.12492839408000345	0.07389748604310181	0.9748073141591165	0.8825600968497138	1.0766964234277216	0.975 [0.883:1.077]	overlaps null	Vascular endothelial growth factor receptor 3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1129	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Vascular endothelial growth factor receptor 3	Weighted median	4	-0.012312530014402164	0.011390103860536365	0.2797038410394957	-0.034637133581053435	0.010012073552249109	0.9877629590452099	0.9659558656163858	1.0100623620512528	0.988 [0.966:1.01]	overlaps null	Vascular endothelial growth factor receptor 3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3243	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Xyloside xylosyltransferase 1	Inverse variance weighted	3	0.050352651980235016	0.020140202914956346	0.01241559803602866	0.010877854266920575	0.08982744969354946	1.0516418945874437	1.0109372332335824	1.0939854998850682	1.052 [1.011:1.094]	positive	Xyloside xylosyltransferase 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3243	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Xyloside xylosyltransferase 1	MR Egger	3	0.021904684273987386	0.11873181543818266	0.8838567502836363	-0.21080967398485062	0.2546190425328254	1.0221463532053991	0.8099282026201523	1.2899701035118651	1.022 [0.81:1.29]	overlaps null	Xyloside xylosyltransferase 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3243	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Xyloside xylosyltransferase 1	Weighted median	3	0.048451342741143405	0.02237466571045265	0.03035282036059264	0.004596997948656215	0.0923056875336306	1.0496442977634697	1.0046075803532764	1.0967000183692914	1.05 [1.005:1.097]	positive	Xyloside xylosyltransferase 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3258	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Zinc fingers and homeoboxes protein 3	Inverse variance weighted	3	-0.018819205520229018	0.039967703260571655	0.6377404861860495	-0.09715590391094946	0.05951749287049142	0.9813567700918614	0.9074145256314792	1.061324326426146	0.981 [0.907:1.061]	overlaps null	Zinc fingers and homeoboxes protein 3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3258	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Zinc fingers and homeoboxes protein 3	MR Egger	3	0.173099506343684	0.09111051752096608	0.3084441094667366	-0.005477107997409497	0.3516761206847775	1.1889844106892604	0.9945378640116896	1.4214480715291014	1.189 [0.995:1.421]	overlaps null	Zinc fingers and homeoboxes protein 3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3258	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Zinc fingers and homeoboxes protein 3	Weighted median	3	-0.04936705968164197	0.03359582680779567	0.14171342060901407	-0.11521488022492149	0.01648076086163755	0.9518316865333442	0.8911746275266196	1.0166173177566686	0.952 [0.891:1.017]	overlaps null	Zinc fingers and homeoboxes protein 3 (M/F) Sun BB/2018 [  3K]	Proteins
ieu-a-1	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Adiponectin	Inverse variance weighted	11	-0.054050182812045426	0.041146397107631356	0.18897859374742673	-0.1346971211430029	0.02659675551891203	0.947384562887418	0.8739805818441806	1.026953605883893	0.947 [0.874:1.027]	overlaps null	Adiponectin (M/F) Dastani Z/2012 [ 39K]	Other biomarkers
ieu-a-1	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Adiponectin	MR Egger	11	0.02345632912613589	0.05290326474016745	0.6679566040109169	-0.0802340697645923	0.12714672801686408	1.0237335924298252	0.9229002980469242	1.1355836274916764	1.024 [0.923:1.136]	overlaps null	Adiponectin (M/F) Dastani Z/2012 [ 39K]	Other biomarkers
ieu-a-1	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Adiponectin	Weighted median	11	-0.02616145214463103	0.04318201701740961	0.5446200984613668	-0.11079820549875387	0.058475301209491806	0.9741777938171559	0.8951193608701523	1.0602187992491963	0.974 [0.895:1.06]	overlaps null	Adiponectin (M/F) Dastani Z/2012 [ 39K]	Other biomarkers
ukb-d-30630_irnt	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Apoliprotein A	Inverse variance weighted	222	0.06189797937719343	0.02412319638727012	0.01029051739878236	0.014616514458143999	0.10917944429624285	1.063853804163764	1.014723858064402	1.1153624778199316	1.064 [1.015:1.115]	positive	Apoliprotein A (M/F) Neale lab/2018 [  NA K]	Other biomarkers
ukb-d-30630_irnt	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Apoliprotein A	MR Egger	222	0.09135149019948446	0.036367043742811016	0.012725223378349776	0.020072084463574877	0.16263089593539404	1.0956540492452425	1.0202748833437234	1.1766023208306995	1.096 [1.02:1.177]	positive	Apoliprotein A (M/F) Neale lab/2018 [  NA K]	Other biomarkers
ukb-d-30630_irnt	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Apoliprotein A	Weighted median	222	0.06527522930943173	0.028379814622631977	0.02144491506833876	0.009650792649073058	0.1208996659697904	1.06745277824851	1.009697511719524	1.1285116785619882	1.067 [1.01:1.129]	positive	Apoliprotein A (M/F) Neale lab/2018 [  NA K]	Other biomarkers
ieu-a-780	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	HDL cholesterol	Inverse variance weighted	37	0.07909681735343335	0.026609197342689336	0.0029534983690218436	0.026942790561762256	0.13125084414510446	1.0823091033008905	1.027309029309844	1.140253771423513	1.082 [1.027:1.14]	positive	HDL cholesterol (M/F) Willer CJ/2013 [ 92K]	Other biomarkers
ieu-a-780	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	HDL cholesterol	MR Egger	37	0.07913839224307381	0.049066378395359996	0.1157514274252669	-0.017031709411831783	0.17530849389797942	1.0823541011178004	0.9831125102211875	1.1916137654915524	1.082 [0.983:1.192]	overlaps null	HDL cholesterol (M/F) Willer CJ/2013 [ 92K]	Other biomarkers
ieu-a-780	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	HDL cholesterol	Weighted median	37	0.07344482878828372	0.02774674098810491	0.008121623051720903	0.019061216451598098	0.12782844112496933	1.0762091592705683	1.0192440412111774	1.1363580336673167	1.076 [1.019:1.136]	positive	HDL cholesterol (M/F) Willer CJ/2013 [ 92K]	Other biomarkers
ukb-d-30760_irnt	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	HDL cholesterol	Inverse variance weighted	245	0.08180689134383543	0.022560831316794507	2.877803256843087e-4	0.03758766196291819	0.12602612072475267	1.085246219154325	1.0383030127726633	1.134311796942294	1.085 [1.038:1.134]	positive	HDL cholesterol (M/F) Neale lab/2018 [  NA K]	Other biomarkers
ukb-d-30760_irnt	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	HDL cholesterol	MR Egger	245	0.10401477887228205	0.03264664021925553	0.001630995373387309	0.040027364042541216	0.1680021937020229	1.1096168536801672	1.0408392553723689	1.182939205661093	1.11 [1.041:1.183]	positive	HDL cholesterol (M/F) Neale lab/2018 [  NA K]	Other biomarkers
ukb-d-30760_irnt	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	HDL cholesterol	Weighted median	245	0.054179537792868326	0.02699317138042421	0.04473292921277185	0.0012729218872368775	0.10708615369849978	1.0556741185431253	1.0012737323961707	1.1130301420120097	1.056 [1.001:1.113]	positive	HDL cholesterol (M/F) Neale lab/2018 [  NA K]	Other biomarkers
ieu-a-299	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	HDL cholesterol	Inverse variance weighted	78	0.0869594316987017	0.02925707380393905	0.0029562276104748075	0.029615567042981163	0.14430329635442224	1.0908524247907694	1.0300584694049661	1.1552344337883116	1.091 [1.03:1.155]	positive	HDL cholesterol (M/F) Willer CJ/2013 [187K]	Other biomarkers
ieu-a-299	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	HDL cholesterol	MR Egger	78	0.07122474680078589	0.054845781209367575	0.19799521802522693	-0.03627298436957456	0.17872247797114632	1.073822536930184	0.964376997700192	1.1956888681179985	1.074 [0.964:1.196]	overlaps null	HDL cholesterol (M/F) Willer CJ/2013 [187K]	Other biomarkers
ieu-a-299	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	HDL cholesterol	Weighted median	78	0.05621963400744733	0.03033186368515997	0.06381297025652148	-0.003230818815466212	0.11567008683036087	1.0578299936648037	0.9967743946635297	1.1226254421138184	1.058 [0.997:1.123]	overlaps null	HDL cholesterol (M/F) Willer CJ/2013 [187K]	Other biomarkers
ukb-d-30770_irnt	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	IGF-1	Inverse variance weighted	318	0.06625071609645594	0.02764873277865845	0.016567973182777616	0.012059199850285383	0.12044223234262649	1.0684945723750543	1.0121322051675572	1.1279955774215744	1.068 [1.012:1.128]	positive	IGF-1 (M/F) Neale lab/2018 [  NA K]	Other biomarkers
ukb-d-30770_irnt	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	IGF-1	MR Egger	318	0.0920890102546054	0.055142018404891364	0.09590295802013697	-0.015989345818981662	0.2001673663281925	1.0964624141360533	0.9841378051817532	1.2216071969626559	1.096 [0.984:1.222]	overlaps null	IGF-1 (M/F) Neale lab/2018 [  NA K]	Other biomarkers
ukb-d-30770_irnt	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	IGF-1	Weighted median	318	0.07337005682204106	0.03336307030291898	0.027867981016742746	0.007978439028319864	0.13876167461576228	1.0761286920040265	1.0080103515873282	1.148850267192886	1.076 [1.008:1.149]	positive	IGF-1 (M/F) Neale lab/2018 [  NA K]	Other biomarkers
ieu-a-1049	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Iron	Inverse variance weighted	3	-0.026231636617810285	0.03471861293741163	0.449919240271473	-0.09428011797513708	0.041816844739516516	0.9741094240611896	0.9100278113864315	1.0427034846321734	0.974 [0.91:1.043]	overlaps null	Iron (M/F) Benyamin/2014 [ 23K]	Other biomarkers
ieu-a-1049	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Iron	MR Egger	3	0.05173403014791004	0.04762923782687918	0.47371556941982784	-0.04161927599277316	0.14508733628859324	1.0530956135775105	0.9592349148210294	1.1561405388826036	1.053 [0.959:1.156]	overlaps null	Iron (M/F) Benyamin/2014 [ 23K]	Other biomarkers
ieu-a-1049	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Iron	Weighted median	3	-0.013074058512934885	0.026263508986630373	0.618622768413857	-0.06455053612673041	0.038402419100860646	0.9870110357439517	0.9374887360153317	1.039149322285208	0.987 [0.937:1.039]	overlaps null	Iron (M/F) Benyamin/2014 [ 23K]	Other biomarkers
ukb-d-30080_irnt	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Platelet count	Inverse variance weighted	394	0.024905429198548126	0.020250835699605542	0.21875441045984162	-0.014786208772678739	0.064597067169775	1.0252181602366184	0.9853225704083861	1.0667291175957934	1.025 [0.985:1.067]	overlaps null	Platelet count (M/F) Neale lab/2018 [350K]	Other biomarkers
ukb-d-30080_irnt	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Platelet count	MR Egger	394	0.029705331531213394	0.03681658379058408	0.4202441827227731	-0.04245517269833139	0.10186583576075818	1.030150936226378	0.9584334285424121	1.1072349104329295	1.03 [0.958:1.107]	overlaps null	Platelet count (M/F) Neale lab/2018 [350K]	Other biomarkers
ukb-d-30080_irnt	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Platelet count	Weighted median	394	0.05529434787705276	0.02433118655038359	0.023052047546067333	0.007605222238300922	0.10298347351580459	1.05685165093663	1.0076342153941402	1.1084730897616317	1.057 [1.008:1.108]	positive	Platelet count (M/F) Neale lab/2018 [350K]	Other biomarkers
ieu-a-1047	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Putamen volume	Inverse variance weighted	4	1.2326252727461268e-4	7.953131823085307e-5	0.12117476476914714	-3.261885645785932e-5	2.791439110070847e-4	1.000123270124412	0.9999673816755312	1.0002791828752942	1 [1:1]	overlaps null	Putamen volume (M/F) Hibar/2015 [ 30K]	Other biomarkers
ieu-a-1047	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Putamen volume	MR Egger	4	3.8526064581414506e-5	4.2897970843138844e-4	0.9366233977282795	-8.022741639441068e-4	8.793262931069359e-4	1.0000385268067198	0.9991980475719271	1.0008797130138147	1 [0.999:1.001]	overlaps null	Putamen volume (M/F) Hibar/2015 [ 30K]	Other biomarkers
ieu-a-1047	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Putamen volume	Weighted median	4	7.622438607111893e-5	8.726074965315654e-5	0.3823773620787031	-9.480668324906788e-5	2.4725545539130576e-4	1.0000762272912234	0.9999051978107625	1.000247286025541	1 [1:1]	overlaps null	Putamen volume (M/F) Hibar/2015 [ 30K]	Other biomarkers
ukb-d-30240_irnt	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Reticulocyte percentage	Inverse variance weighted	249	-0.04806827908390298	0.024649974457066445	0.05117211125066679	-0.09638222901975321	2.4567085194725224e-4	0.9530687101974062	0.9081168411127615	1.0002457010315025	0.953 [0.908:1]	overlaps null	Reticulocyte percentage (M/F) Neale lab/2018 [344K]	Other biomarkers
ukb-d-30240_irnt	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Reticulocyte percentage	MR Egger	249	-0.032500606412042804	0.043488260290956544	0.4555679624402741	-0.11773759658231762	0.05273638375823202	0.9680218628110128	0.8889292800946099	1.054151716973897	0.968 [0.889:1.054]	overlaps null	Reticulocyte percentage (M/F) Neale lab/2018 [344K]	Other biomarkers
ukb-d-30240_irnt	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Reticulocyte percentage	Weighted median	249	-0.04565726231437323	0.027018274114064707	0.09105359703543166	-0.09861307957794005	0.0072985549491935905	0.9553693471628913	0.9060932261813586	1.007325254317443	0.955 [0.906:1.007]	overlaps null	Reticulocyte percentage (M/F) Neale lab/2018 [344K]	Other biomarkers
ieu-a-302	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides	Inverse variance weighted	53	-0.06759103968787233	0.04013951598695194	0.09220047282566676	-0.14626449102229813	0.011082411646553464	0.9346426271695962	0.8639291714539284	1.0111440490571162	0.935 [0.864:1.011]	overlaps null	Triglycerides (M/F) Willer CJ/2013 [177K]	Other biomarkers
ieu-a-302	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides	MR Egger	53	-0.15076998904470826	0.06252688818794379	0.019536542996068967	-0.27332268989307806	-0.02821728819633844	0.8600454957966617	0.7608472303002367	0.9721771012404717	0.86 [0.761:0.972]	negative	Triglycerides (M/F) Willer CJ/2013 [177K]	Other biomarkers
ieu-a-302	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides	Weighted median	53	-0.08830731476212936	0.030451398263825594	0.003732306994677299	-0.14799205535922752	-0.028622574165031195	0.9154794931262091	0.8624379666746619	0.9717831713347784	0.915 [0.862:0.972]	negative	Triglycerides (M/F) Willer CJ/2013 [177K]	Other biomarkers
ieu-a-783	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides	Inverse variance weighted	27	-0.0933552859227908	0.03715204198279204	0.011978055439952518	-0.16617328820906319	-0.020537283636518397	0.9108698235748429	0.846899463781641	0.9796721700525077	0.911 [0.847:0.98]	negative	Triglycerides (M/F) Willer CJ/2013 [ 86K]	Other biomarkers
ieu-a-783	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides	MR Egger	27	-0.17516049868243622	0.06746287895313602	0.01555250945249531	-0.3073877414305828	-0.04293325593428962	0.8393222998349675	0.7353654139838143	0.9579753271014791	0.839 [0.735:0.958]	negative	Triglycerides (M/F) Willer CJ/2013 [ 86K]	Other biomarkers
ieu-a-783	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides	Weighted median	27	-0.10056663896850748	0.030283276970419507	8.9739310965072e-4	-0.1599218618305297	-0.04121141610648525	0.9043248471297761	0.8522103765234876	0.9596262280593736	0.904 [0.852:0.96]	negative	Triglycerides (M/F) Willer CJ/2013 [ 86K]	Other biomarkers
ukb-a-11	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Morning/evening person (chronotype)	Inverse variance weighted	77	0.2683885884289147	0.07484351324898442	3.357932571585207e-4	0.12169530246090526	0.4150818743969242	1.3078552587042482	1.1294099209239168	1.5144947339590298	1.308 [1.129:1.514]	positive	Morning/evening person (chronotype) (M/F) Neale Lab/2017 [301K]	Sleep
ukb-a-11	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Morning/evening person (chronotype)	MR Egger	77	0.2080838791032774	0.22339803002248487	0.35461004050048384	-0.2297762597407929	0.6459440179473477	1.2313164469368196	0.7947113915460484	1.907787164781396	1.231 [0.795:1.908]	overlaps null	Morning/evening person (chronotype) (M/F) Neale Lab/2017 [301K]	Sleep
ukb-a-11	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Morning/evening person (chronotype)	Weighted median	77	0.17681669332129935	0.0721132185300092	0.014209159218524628	0.03547478500248133	0.31815860164011733	1.1934123126284397	1.0361115222492217	1.3745942568435043	1.193 [1.036:1.375]	positive	Morning/evening person (chronotype) (M/F) Neale Lab/2017 [301K]	Sleep
ukb-b-4424	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Sleep duration	Inverse variance weighted	66	0.2835955116334008	0.1382455233212987	0.04022896272597622	0.012634285923655342	0.5545567373431463	1.32789570374486	1.012714435703448	1.741169018489635	1.328 [1.013:1.741]	positive	Sleep duration (M/F) MRC-IEU/2018 [460K]	Sleep
ukb-b-4424	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Sleep duration	MR Egger	66	0.286836418606372	0.5240575106820536	0.5860504438634289	-0.7403163023304532	1.3139891395431973	1.3322062714920444	0.4769630271420944	3.7209876841753684	1.332 [0.477:3.721]	overlaps null	Sleep duration (M/F) MRC-IEU/2018 [460K]	Sleep
ukb-b-4424	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Sleep duration	Weighted median	66	0.27788883805735676	0.12337486653686262	0.02429736976001505	0.03607409964510602	0.5197035764696075	1.3203394175564869	1.036732665167329	1.6815291310147293	1.32 [1.037:1.682]	positive	Sleep duration (M/F) MRC-IEU/2018 [460K]	Sleep
ukb-a-14	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Snoring	Inverse variance weighted	20	1.145291789536713	0.4729016791927548	0.015442185030263978	0.21840449831891362	2.072179080754512	3.1433584221353486	1.2440901982482233	7.942110776149537	3.143 [1.244:7.942]	positive	Snoring (M/F) Neale Lab/2017 [314K]	Sleep
ukb-a-14	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Snoring	MR Egger	20	-0.3468195765001512	2.28434255992699	0.8810139562233066	-4.824130993957052	4.130491840956749	0.7069328640536668	0.008033532025803043	62.208512105752604	0.707 [0.008:62.209]	overlaps null	Snoring (M/F) Neale Lab/2017 [314K]	Sleep
ukb-a-14	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Snoring	Weighted median	20	0.7746865197875095	0.33259164823841747	0.019846235715206873	0.12280688924021121	1.4265661503348077	2.1699117961429137	1.130666056082708	4.164374775124353	2.17 [1.131:4.164]	positive	Snoring (M/F) Neale Lab/2017 [314K]	Sleep
ukb-b-15895	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Treatment/medication code: allopurinol	Inverse variance weighted	12	-2.9052606026240806	1.7693817447158702	0.10059752640765696	-6.373248822267186	0.562727617019025	0.054734524781930034	0.0017066057505598388	1.75545418273725	0.055 [0.002:1.755]	overlaps null	Drug: allopurinol (M/F) MRC-IEU/2018 [462K]	Drugs
ukb-b-15895	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Treatment/medication code: allopurinol	MR Egger	12	-1.138349741270571	2.853873656814988	0.6983671849206128	-6.731942108627947	4.455242626086805	0.32034724167873574	0.0011922152966804397	86.07703284541998	0.32 [0.001:86.077]	overlaps null	Drug: allopurinol (M/F) MRC-IEU/2018 [462K]	Drugs
ukb-b-15895	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Treatment/medication code: allopurinol	Weighted median	12	-3.340430870192157	1.0050498495549856	8.884859755346491e-4	-5.310328575319929	-1.3705331650643853	0.03542169228176333	0.004940303189267784	0.25397151470978735	0.035 [0.005:0.254]	negative	Drug: allopurinol (M/F) MRC-IEU/2018 [462K]	Drugs
ukb-a-142	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Treatment/medication code: allopurinol	Inverse variance weighted	12	-2.310336803438658	1.5145427833903164	0.12715059621880542	-5.278840658883679	0.658167052006362	0.09922782565809012	0.00509833808071848	1.931249208849006	0.099 [0.005:1.931]	overlaps null	Drug: allopurinol (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-142	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Treatment/medication code: allopurinol	MR Egger	12	-1.4653586650162205	2.530801928479682	0.5753920291557062	-6.425730444836397	3.4950131148039563	0.23099512674699704	0.0016193499999764805	32.95072009240512	0.231 [0.002:32.951]	overlaps null	Drug: allopurinol (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-142	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Treatment/medication code: allopurinol	Weighted median	12	-3.2325106370949444	0.9959510523529705	0.001171819424387983	-5.184574699706767	-1.2804465744831222	0.03945830883165177	0.005602318776524109	0.2779131638096473	0.039 [0.006:0.278]	negative	Drug: allopurinol (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-132	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Treatment/medication code: aspirin	Inverse variance weighted	7	-1.222677583720258	0.8773515771336298	0.16343828188194706	-2.9422866749021725	0.4969315074616565	0.29444072081101763	0.052744980112300666	1.6436699357384605	0.294 [0.053:1.644]	overlaps null	Drug: aspirin (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-132	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Treatment/medication code: aspirin	MR Egger	7	1.1767291362058991	2.538908044153589	0.66249712620741	-3.799530630335135	6.152988902746933	3.243746977714668	0.02238127448246877	470.12043320744885	3.244 [0.022:470.12]	overlaps null	Drug: aspirin (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-132	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Treatment/medication code: aspirin	Weighted median	7	-0.07570697797467318	0.765199408210219	0.9211878304247516	-1.5754978180667023	1.4240838621173562	0.9270878239143242	0.2069045262278267	4.154050416005852	0.927 [0.207:4.154]	overlaps null	Drug: aspirin (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-153	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Treatment/medication code: insulin product	Inverse variance weighted	8	-0.5956887899415173	2.2630454287433714	0.7923776202272743	-5.031257830278525	3.83988025039549	0.5511827859296582	0.0065305910271069014	46.519903366198996	0.551 [0.007:46.52]	overlaps null	Drug: insulin product (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-153	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Treatment/medication code: insulin product	MR Egger	8	-4.535012887741838	4.899811614597605	0.3903888457937403	-14.138643652353146	5.068617876869468	0.010726768981793101	7.238775039222032e-7	158.95448078619205	0.011 [0:158.954]	overlaps null	Drug: insulin product (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-153	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Treatment/medication code: insulin product	Weighted median	8	-2.3653669245892144	0.8525528146821884	0.005529478066583288	-4.036370441366303	-0.6943634078121252	0.09391483438362988	0.017661459525799304	0.4993922560262167	0.094 [0.018:0.499]	negative	Drug: insulin product (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-117	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Treatment/medication code: ramipril	Inverse variance weighted	6	-2.87903078753713	1.712070645446455	0.09264498101860924	-6.234689252612181	0.47662767753792146	0.056189195720127504	0.001960238258610205	1.6106336573153335	0.056 [0.002:1.611]	overlaps null	Drug: ramipril (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-117	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Treatment/medication code: ramipril	MR Egger	6	-0.048527335687568486	4.387120071203718	0.9917042220232178	-8.647282675246855	8.550228003871718	0.9526312981183763	1.7560337181865232e-4	5167.932601498652	0.953 [0:5167.933]	overlaps null	Drug: ramipril (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-117	ieu-a-1126	Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Treatment/medication code: ramipril	Weighted median	6	-1.8622734551846731	1.3131751834313592	0.15614829447613768	-4.436096814710137	0.7115499043407909	0.1553191176193349	0.011842070225191553	2.037146194820727	0.155 [0.012:2.037]	overlaps null	Drug: ramipril (M/F) Neale Lab/2017 [337K]	Drugs
ieu-a-974	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Body mass index	Inverse variance weighted	36	-0.2678018801636752	0.06597122479754702	4.9204432526246554e-5	-0.39710548076686736	-0.13849827956048302	0.7650593395201284	0.6722631110641698	0.8706647491938683	0.765 [0.672:0.871]	negative	Body mass index (F) Locke AE/2015 [171K]	Antrophometric
ieu-a-974	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Body mass index	MR Egger	36	-0.5810371838430402	0.17025797903136566	0.0016775526430282057	-0.9147428227445169	-0.24733154494156345	0.5593179500771897	0.4006196431037407	0.780881753213335	0.559 [0.401:0.781]	negative	Body mass index (F) Locke AE/2015 [171K]	Antrophometric
ieu-a-974	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Body mass index	Weighted median	36	-0.2622243751193207	0.07082217803128449	2.1342284168224707e-4	-0.4010358440606383	-0.12341290617800307	0.7693383839485703	0.6696260584907172	0.8838986200009163	0.769 [0.67:0.884]	negative	Body mass index (F) Locke AE/2015 [171K]	Antrophometric
ieu-a-95	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Body mass index	Inverse variance weighted	11	-0.35911423141205284	0.12208982571661468	0.003267390753212692	-0.5984102898166176	-0.11981817300748807	0.6982945796195827	0.549684781380778	0.8870817174549146	0.698 [0.55:0.887]	negative	Body mass index (F) Randall JC/2013 [ 73K]	Antrophometric
ieu-a-95	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Body mass index	MR Egger	11	-0.8995040780868067	0.48051505054204824	0.09400462228287704	-1.8413135771492213	0.042305420975607855	0.4067713365479448	0.15860894412365084	1.0432130492464988	0.407 [0.159:1.043]	overlaps null	Body mass index (F) Randall JC/2013 [ 73K]	Antrophometric
ieu-a-95	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Body mass index	Weighted median	11	-0.3674065705142683	0.09211012460705023	6.641535366724694e-5	-0.5479424147440868	-0.18687072628444984	0.6925280263235294	0.5781381559456304	0.8295509685900497	0.693 [0.578:0.83]	negative	Body mass index (F) Randall JC/2013 [ 73K]	Antrophometric
ukb-b-19953	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Body mass index (BMI)	Inverse variance weighted	415	-0.12283988470028812	0.03617922216997993	6.854948241062375e-4	-0.1937511601534488	-0.05192860924712746	0.8844052580376747	0.8238628886781725	0.9493966425646683	0.884 [0.824:0.949]	negative	Body mass index (BMI) (M/F) MRC-IEU/2018 [461K]	Antrophometric
ukb-b-19953	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Body mass index (BMI)	MR Egger	415	-0.3246908213687171	0.09704920622618599	8.960476861190779e-4	-0.5149072655720416	-0.13447437716539254	0.722750778197605	0.5975560060633188	0.8741752774381653	0.723 [0.598:0.874]	negative	Body mass index (BMI) (M/F) MRC-IEU/2018 [461K]	Antrophometric
ukb-b-19953	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Body mass index (BMI)	Weighted median	415	-0.151490211029715	0.04241712015251211	3.55023520470462e-4	-0.23462776652863873	-0.06835265553079126	0.8594262951302155	0.7908651813371081	0.9339310595422615	0.859 [0.791:0.934]	negative	Body mass index (BMI) (M/F) MRC-IEU/2018 [461K]	Antrophometric
ukb-a-248	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Body mass index (BMI)	Inverse variance weighted	289	-0.11576031527172137	0.03640179821347281	0.0014723879861627425	-0.18710783977012807	-0.04441279077331467	0.8906886821898039	0.8293542941863378	0.9565590172283673	0.891 [0.829:0.957]	negative	Body mass index (BMI) (M/F) Neale Lab/2017 [336K]	Antrophometric
ukb-a-248	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Body mass index (BMI)	MR Egger	289	-0.3672664939954613	0.10448285573637046	5.10671207798772e-4	-0.5720528912387474	-0.1624800967521752	0.6926250400331457	0.5643656673306912	0.8500330084746605	0.693 [0.564:0.85]	negative	Body mass index (BMI) (M/F) Neale Lab/2017 [336K]	Antrophometric
ukb-a-248	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Body mass index (BMI)	Weighted median	289	-0.11043831068590713	0.04233269651910892	0.009085548753027065	-0.19341039586336062	-0.02746622550845365	0.8954415676618069	0.8241436795696001	0.9729075414560888	0.895 [0.824:0.973]	negative	Body mass index (BMI) (M/F) Neale Lab/2017 [336K]	Antrophometric
ukb-a-34	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Comparative body size at age 10	Inverse variance weighted	144	-0.40001707144716386	0.07018637834606274	1.2026171235882401e-8	-0.5375823730054469	-0.26245176988888086	0.6703086028000671	0.5841588247117816	0.7691634603131522	0.67 [0.584:0.769]	negative	body size at age 10 (M/F) Neale Lab/2017 [331K]	Antrophometric
ukb-a-34	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Comparative body size at age 10	MR Egger	144	-0.858895234959032	0.14901711658763656	4.92011448411111e-8	-1.1509687834707996	-0.5668216864472644	0.42362983532396664	0.3163301654510202	0.5673257152720029	0.424 [0.316:0.567]	negative	body size at age 10 (M/F) Neale Lab/2017 [331K]	Antrophometric
ukb-a-34	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Comparative body size at age 10	Weighted median	144	-0.5193314333645358	0.08332780711461098	4.593706305093973e-10	-0.6826539353091733	-0.3560089314198983	0.5949181574720782	0.5052742462101617	0.7004663640480921	0.595 [0.505:0.7]	negative	body size at age 10 (M/F) Neale Lab/2017 [331K]	Antrophometric
ukb-b-4650	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Comparative body size at age 10	Inverse variance weighted	204	-0.4495964458521186	0.07379834375987353	1.1134890426439638e-9	-0.5942411996214707	-0.3049516920827665	0.6378855210349205	0.551981250580563	0.7371589841466983	0.638 [0.552:0.737]	negative	body size at age 10 (M/F) MRC-IEU/2018 [454K]	Antrophometric
ukb-b-4650	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Comparative body size at age 10	MR Egger	204	-0.7052109265265397	0.15539248649827092	9.728339196690376e-6	-1.0097802000631506	-0.4006416529899287	0.4940043646415127	0.36429904367895305	0.6698900711359838	0.494 [0.364:0.67]	negative	body size at age 10 (M/F) MRC-IEU/2018 [454K]	Antrophometric
ukb-b-4650	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Comparative body size at age 10	Weighted median	204	-0.5221226628936848	0.07979064440639264	6.003212577855151e-11	-0.6785123259302144	-0.36573299985715524	0.5932599196812648	0.5073712342223653	0.6936879912785292	0.593 [0.507:0.694]	negative	body size at age 10 (M/F) MRC-IEU/2018 [454K]	Antrophometric
ukb-a-35	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Comparative height size at age 10	Inverse variance weighted	342	0.1434372590103403	0.05083140405237832	0.004775142478789196	0.043807707067678794	0.2430668109530018	1.1542343907273043	1.0447814314858925	1.275153815514207	1.154 [1.045:1.275]	positive	height size at age 10 (M/F) Neale Lab/2017 [332K]	Antrophometric
ukb-a-35	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Comparative height size at age 10	MR Egger	342	0.3198847023143934	0.1261242793851167	0.011651122493188008	0.0726811147195647	0.5670882899092221	1.3769689938450556	1.075387556969301	1.7631258588802796	1.377 [1.075:1.763]	positive	height size at age 10 (M/F) Neale Lab/2017 [332K]	Antrophometric
ukb-a-35	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Comparative height size at age 10	Weighted median	342	0.09872543087738088	0.05116089813117064	0.053643424447137246	-0.0015499294597135782	0.19900079121447534	1.1037631986566772	0.9984512710606307	1.2201829313258883	1.104 [0.998:1.22]	overlaps null	height size at age 10 (M/F) Neale Lab/2017 [332K]	Antrophometric
ieu-a-85	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Extreme body mass index	Inverse variance weighted	7	-0.11292919716131748	0.027480524567640854	3.96642850884375e-5	-0.16679102531389356	-0.05906736900874141	0.8932138999568766	0.8463764641135839	0.9426432620757564	0.893 [0.846:0.943]	negative	Extreme body mass index (M/F) Berndt SI/2013 [ 16K]	Antrophometric
ieu-a-85	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Extreme body mass index	MR Egger	7	-0.150950432606181	0.13831108552532329	0.3248810120527509	-0.4220401602358146	0.12013929502345264	0.8598903201250181	0.6557077054885795	1.127653917218736	0.86 [0.656:1.128]	overlaps null	Extreme body mass index (M/F) Berndt SI/2013 [ 16K]	Antrophometric
ieu-a-85	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Extreme body mass index	Weighted median	7	-0.12219060865032551	0.02374763347958876	2.6697920433255503e-7	-0.16873597027031947	-0.07564524703033154	0.8849796676452011	0.8447319082821738	0.9271450556876496	0.885 [0.845:0.927]	negative	Extreme body mass index (M/F) Berndt SI/2013 [ 16K]	Antrophometric
ieu-a-1034	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Height	Inverse variance weighted	4	0.2868457950384939	0.15704072390104215	0.06776452413343934	-0.02095402380754874	0.5946456138845365	1.3322187628922837	0.9792639863639839	1.8123885458017515	1.332 [0.979:1.812]	overlaps null	Height (M/F) Cousminer/2013 [ 13K]	Antrophometric
ieu-a-1034	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Height	MR Egger	4	-3.8720414542364714	3.2950705038561945	0.3609107617880455	-10.330379641794613	2.5862967333216695	0.02081583145302071	3.26266981926325e-5	13.280499194932638	0.021 [0:13.28]	overlaps null	Height (M/F) Cousminer/2013 [ 13K]	Antrophometric
ieu-a-1034	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Height	Weighted median	4	0.11790082662701545	0.07065528045588981	0.09518145123228286	-0.02058352306652858	0.25638517632055946	1.1251325226467934	0.9796268716170626	1.2922503763375612	1.125 [0.98:1.292]	overlaps null	Height (M/F) Cousminer/2013 [ 13K]	Antrophometric
ieu-a-51	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Hip circumference	Inverse variance weighted	16	-0.24148345683820283	0.10474283947976785	0.021139206071583615	-0.44677942221854783	-0.03618749145785782	0.7854617977031094	0.6396849930107363	0.9644594486221526	0.785 [0.64:0.964]	negative	Hip circumference (F) Shungin D/2015 [127K]	Antrophometric
ieu-a-51	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Hip circumference	MR Egger	16	-0.6351745257920131	0.35124114863771444	0.09207231350490135	-1.3236071771219333	0.05325812553790721	0.5298430089770039	0.2661734334741112	1.0547018554693977	0.53 [0.266:1.055]	overlaps null	Hip circumference (F) Shungin D/2015 [127K]	Antrophometric
ieu-a-51	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Hip circumference	Weighted median	16	-0.404711791304312	0.09724918569825122	3.160315300450903e-5	-0.5953201952728844	-0.2141033873357396	0.6671690670788125	0.551385986413001	0.8072649197388413	0.667 [0.551:0.807]	negative	Hip circumference (F) Shungin D/2015 [127K]	Antrophometric
ukb-a-388	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Hip circumference	Inverse variance weighted	261	-0.06885820872446179	0.04554930932356667	0.13060283534620576	-0.15813485499865246	0.020418437549728885	0.9334590270412647	0.8537346438209368	1.020628319901683	0.933 [0.854:1.021]	overlaps null	Hip circumference (M/F) Neale Lab/2017 [336K]	Antrophometric
ukb-a-388	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Hip circumference	MR Egger	261	-0.29106805308653944	0.13300641121460535	0.029535688939966807	-0.551760619067166	-0.030375487105912924	0.7474648089998818	0.5759349152275742	0.970081212166941	0.747 [0.576:0.97]	negative	Hip circumference (M/F) Neale Lab/2017 [336K]	Antrophometric
ukb-a-388	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Hip circumference	Weighted median	261	-0.12215526478301518	0.04761309966787627	0.010300316298315595	-0.21547694013205265	-0.028833589433977694	0.8850109468019066	0.8061568599145136	0.97157813188151	0.885 [0.806:0.972]	negative	Hip circumference (M/F) Neale Lab/2017 [336K]	Antrophometric
ieu-a-101	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Hip circumference	Inverse variance weighted	5	0.32416803613137196	0.2464689444702147	0.18842622745664953	-0.15891109503024886	0.8072471672929928	1.3828796613454257	0.8530721979558049	2.2417283816602738	1.383 [0.853:2.242]	overlaps null	Hip circumference (F) Randall JC/2013 [ 73K] AdjBMI	Antrophometric
ieu-a-101	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Hip circumference	MR Egger	5	3.1270217555965267	2.108377851246616	0.23466980539041155	-1.00539883284684	7.259442344039893	22.8059565856585	0.36589867328930403	1421.4636284720966	22.806 [0.366:1421.464]	overlaps null	Hip circumference (F) Randall JC/2013 [ 73K] AdjBMI	Antrophometric
ieu-a-101	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Hip circumference	Weighted median	5	0.009600553908605928	0.1333897288283698	0.9426228284720788	-0.25184331459499887	0.2710444224122107	1.0096467870624644	0.7773665305168158	1.3113333216801082	1.01 [0.777:1.311]	overlaps null	Hip circumference (F) Randall JC/2013 [ 73K] AdjBMI	Antrophometric
ukb-a-269	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Impedance of whole body	Inverse variance weighted	333	0.14151365274905656	0.052177771584146715	0.006684945770394435	0.039245220444128995	0.24378208505398413	1.1520162323419718	1.0400254878947999	1.2760662262862101	1.152 [1.04:1.276]	positive	Impedance of whole body (M/F) Neale Lab/2017 [331K]	Antrophometric
ukb-a-269	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Impedance of whole body	MR Egger	333	0.28339356173817315	0.14476922390896227	0.05112236552713292	-3.5411712339289414e-4	0.5671412405997391	1.3276275624230829	0.9996459455686754	1.763219220083724	1.328 [1:1.763]	overlaps null	Impedance of whole body (M/F) Neale Lab/2017 [331K]	Antrophometric
ukb-a-269	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Impedance of whole body	Weighted median	333	0.19736613951456713	0.0512682864933315	1.1827560920127046e-4	0.0968802979876374	0.29785198104149685	1.2181899865520553	1.1017284866106734	1.3469623971519449	1.218 [1.102:1.347]	positive	Impedance of whole body (M/F) Neale Lab/2017 [331K]	Antrophometric
ieu-a-90	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Obesity class 1	Inverse variance weighted	16	-0.1411278246932592	0.03583001666363809	8.188486904346602e-5	-0.21135465735398987	-0.07090099203252856	0.8683783044126885	0.809486925474802	0.9315541188418232	0.868 [0.809:0.932]	negative	Obesity class 1 (M/F) Berndt SI/2013 [ 98K]	Antrophometric
ieu-a-90	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Obesity class 1	MR Egger	16	-0.2477243512859826	0.09965931741239589	0.026179012951303003	-0.44305661341427854	-0.05239208915768667	0.7805750781423317	0.6420708562354518	0.9489567182496034	0.781 [0.642:0.949]	negative	Obesity class 1 (M/F) Berndt SI/2013 [ 98K]	Antrophometric
ieu-a-90	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Obesity class 1	Weighted median	16	-0.15045590613718018	0.03220889708755282	2.9936797918573497e-6	-0.2135853444287837	-0.08732646784557666	0.8603156638119449	0.8076832259454729	0.9163778788816331	0.86 [0.808:0.916]	negative	Obesity class 1 (M/F) Berndt SI/2013 [ 98K]	Antrophometric
ieu-a-91	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Obesity class 2	Inverse variance weighted	10	-0.10831034911702794	0.0338036798460778	0.0013548570827028679	-0.17456556161534043	-0.04205513661871546	0.8973490617221987	0.8398217923509527	0.958816913192473	0.897 [0.84:0.959]	negative	Obesity class 2 (M/F) Berndt SI/2013 [ 72K]	Antrophometric
ieu-a-91	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Obesity class 2	MR Egger	10	-0.23049354798829153	0.09683181008144102	0.04452138554859258	-0.4202838957479159	-0.04070320022866711	0.7941415587963381	0.6568603134921582	0.9601140492939929	0.794 [0.657:0.96]	negative	Obesity class 2 (M/F) Berndt SI/2013 [ 72K]	Antrophometric
ieu-a-91	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Obesity class 2	Weighted median	10	-0.1402366776008853	0.026315302267816712	9.870476765029174e-8	-0.19181467004580605	-0.08865868515596453	0.869152502124531	0.8254598367501782	0.9151578772426202	0.869 [0.825:0.915]	negative	Obesity class 2 (M/F) Berndt SI/2013 [ 72K]	Antrophometric
ieu-a-93	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Overweight	Inverse variance weighted	14	-0.2197932945740165	0.05676998000676515	1.0810265193064096e-4	-0.3310624553872762	-0.10852413376075681	0.8026847000983162	0.7181603146593075	0.897157242777441	0.803 [0.718:0.897]	negative	Overweight (M/F) Berndt SI/2013 [158K]	Antrophometric
ieu-a-93	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Overweight	MR Egger	14	-0.49901948041877797	0.18161810045189447	0.017679701646600102	-0.8549909573044912	-0.1430480035330648	0.6071256665613554	0.42528703680606394	0.8667124626365154	0.607 [0.425:0.867]	negative	Overweight (M/F) Berndt SI/2013 [158K]	Antrophometric
ieu-a-93	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Overweight	Weighted median	14	-0.22989440900857017	0.048806876847397394	2.4736791795577497e-6	-0.3255558876294691	-0.13423293038767126	0.7946175025236119	0.7221258212380175	0.8743863697248171	0.795 [0.722:0.874]	negative	Overweight (M/F) Berndt SI/2013 [158K]	Antrophometric
ukb-b-16881	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Sitting height	Inverse variance weighted	550	0.07187101192770497	0.03602951467730578	0.046066708077404074	0.0012531631601856441	0.1424888606952243	1.0745167352822331	1.0012539486972398	1.1531402357052916	1.075 [1.001:1.153]	positive	Sitting height (M/F) MRC-IEU/2018 [461K]	Antrophometric
ukb-b-16881	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Sitting height	MR Egger	550	0.16329453066205493	0.0829463183959121	0.049493701598411766	7.197466060672175e-4	0.32586931471804265	1.1773834141419288	1.0007200056858092	1.3852343273046672	1.177 [1.001:1.385]	positive	Sitting height (M/F) MRC-IEU/2018 [461K]	Antrophometric
ukb-b-16881	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Sitting height	Weighted median	550	0.08253432095498099	0.04048860022425276	0.041504126480153704	0.0031766645154455847	0.16189197739451638	1.0860359465902585	1.003181715461138	1.1757332286942885	1.086 [1.003:1.176]	positive	Sitting height (M/F) MRC-IEU/2018 [461K]	Antrophometric
ukb-a-195	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Sitting height	Inverse variance weighted	406	0.06306567454616302	0.037756228496765076	0.09485244940924137	-0.010936533307496527	0.13706788239982257	1.0650967866824819	0.9891230531519691	1.1469060006096672	1.065 [0.989:1.147]	overlaps null	Sitting height (M/F) Neale Lab/2017 [336K]	Antrophometric
ukb-a-195	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Sitting height	MR Egger	406	0.10202456073253631	0.09558216730481539	0.2864279296446814	-0.08531648718490185	0.28936560864997446	1.1074106702112037	0.9182216330304125	1.3355799388544887	1.107 [0.918:1.336]	overlaps null	Sitting height (M/F) Neale Lab/2017 [336K]	Antrophometric
ukb-a-195	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Sitting height	Weighted median	406	0.04862096428972661	0.03851061578153184	0.2067566765459081	-0.026859842642075783	0.12410177122152902	1.0498223551554764	0.9734976748250969	1.132131083499716	1.05 [0.973:1.132]	overlaps null	Sitting height (M/F) Neale Lab/2017 [336K]	Antrophometric
ukb-b-10787	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Standing height	Inverse variance weighted	710	0.09311384506269549	0.03120775241197863	0.0028480749243622507	0.031946650335217375	0.1542810397901736	1.0975866829803447	1.032462422311671	1.1668187632035019	1.098 [1.032:1.167]	positive	Standing height (M/F) MRC-IEU/2018 [461K]	Antrophometric
ukb-b-10787	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Standing height	MR Egger	710	0.1717137306293776	0.06299420420174127	0.006571853586179399	0.048245090393964685	0.2951823708647905	1.1873378860886359	1.0494278284877687	1.3433713281387998	1.187 [1.049:1.343]	positive	Standing height (M/F) MRC-IEU/2018 [461K]	Antrophometric
ukb-b-10787	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Standing height	Weighted median	710	0.06796500591895795	0.03650406873293906	0.06262460127469079	-0.003582968797602601	0.13951298063551848	1.0703278526837943	0.9964234423758026	1.1497137296360762	1.07 [0.996:1.15]	overlaps null	Standing height (M/F) MRC-IEU/2018 [461K]	Antrophometric
ieu-a-68	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist circumference	Inverse variance weighted	24	-0.21041249753926997	0.09047612690177666	0.02003918145770329	-0.3877457062667522	-0.03307928881178773	0.8102499509160371	0.6785848812082833	0.967461847647523	0.81 [0.679:0.967]	negative	Waist circumference (F) Shungin D/2015 [134K] AdjBMI	Antrophometric
ieu-a-68	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist circumference	MR Egger	24	-0.7919950755444145	0.32395718948093544	0.022967383111067947	-1.426951166927048	-0.15703898416178108	0.45294024325517657	0.24003964856580107	0.8546707395458474	0.453 [0.24:0.855]	negative	Waist circumference (F) Shungin D/2015 [134K] AdjBMI	Antrophometric
ieu-a-68	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist circumference	Weighted median	24	-0.2964721644171523	0.08502289381929178	4.8852863862501e-4	-0.4631170363029642	-0.12982729253134043	0.7434363209593966	0.6293189750317246	0.8782470976562892	0.743 [0.629:0.878]	negative	Waist circumference (F) Shungin D/2015 [134K] AdjBMI	Antrophometric
ukb-b-9405	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist circumference	Inverse variance weighted	344	-0.1707834533479832	0.04625257464473498	2.2213926207456403e-4	-0.26143849965166377	-0.08012840704430264	0.8430041034240146	0.769943225744878	0.9229978193550645	0.843 [0.77:0.923]	negative	Waist circumference (M/F) MRC-IEU/2018 [462K]	Antrophometric
ukb-b-9405	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist circumference	MR Egger	344	-0.4190075017224986	0.13024463861451163	0.0014187685921764025	-0.6742869934069414	-0.16372801003805582	0.6576992613719642	0.5095195819451692	0.8489729025876325	0.658 [0.51:0.849]	negative	Waist circumference (M/F) MRC-IEU/2018 [462K]	Antrophometric
ukb-b-9405	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist circumference	Weighted median	344	-0.18217231235645814	0.05477353082499436	8.812761832918452e-4	-0.2895284327734471	-0.0748161919394692	0.833457712979168	0.7486165073647364	0.9279140287324992	0.833 [0.749:0.928]	negative	Waist circumference (M/F) MRC-IEU/2018 [462K]	Antrophometric
ieu-a-62	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist circumference	Inverse variance weighted	17	-0.26207466389731526	0.10068065958042374	0.009240417119900023	-0.4594087566749458	-0.06474057111968473	0.769453571160361	0.6316569981087886	0.9373105972768213	0.769 [0.632:0.937]	negative	Waist circumference (F) Shungin D/2015 [134K]	Antrophometric
ieu-a-62	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist circumference	MR Egger	17	-0.5309359525640475	0.3472604078755025	0.1470941771944902	-1.2115663520000324	0.14969444687193745	0.5880543210784558	0.29773056314126667	1.1614792948716028	0.588 [0.298:1.161]	overlaps null	Waist circumference (F) Shungin D/2015 [134K]	Antrophometric
ieu-a-62	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist circumference	Weighted median	17	-0.4177033086100782	0.09198267083349326	5.59591635670146e-6	-0.597989343443725	-0.2374172737764314	0.6585575878087411	0.5499162179034994	0.7886621313222918	0.659 [0.55:0.789]	negative	Waist circumference (F) Shungin D/2015 [134K]	Antrophometric
ieu-a-105	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist circumference	Inverse variance weighted	5	-0.28987278871949174	0.14178152549112635	0.04090385731968221	-0.5677645786820994	-0.011980998756884076	0.7483587611998774	0.5667910403704697	0.988090487631134	0.748 [0.567:0.988]	negative	Waist circumference (F) Randall JC/2013 [ 73K] AdjBMI	Antrophometric
ieu-a-105	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist circumference	MR Egger	5	-0.5394809314223621	0.7503856751245895	0.524118457695943	-2.0102368546665574	0.9312749918218333	0.5830508171996238	0.13395694258403834	2.5377427170217888	0.583 [0.134:2.538]	overlaps null	Waist circumference (F) Randall JC/2013 [ 73K] AdjBMI	Antrophometric
ieu-a-105	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist circumference	Weighted median	5	-0.25646558508911	0.16413921245928806	0.11817302000643203	-0.5781784415093145	0.06524727133109459	0.7737816237268784	0.5609191836456878	1.0674229348440423	0.774 [0.561:1.067]	overlaps null	Waist circumference (F) Randall JC/2013 [ 73K] AdjBMI	Antrophometric
ieu-a-75	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist-to-hip ratio	Inverse variance weighted	20	-0.2613564197615982	0.11007673349575388	0.017581725782031175	-0.47710681741327576	-0.04560602210992057	0.7700064251938703	0.6205762374045164	0.9554183017377783	0.77 [0.621:0.955]	negative	Waist-to-hip ratio (F) Shungin D/2015 [118K]	Antrophometric
ieu-a-75	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist-to-hip ratio	MR Egger	20	-0.46365558998508927	0.5885456121744556	0.4410658424860201	-1.6172049898470222	0.6898938098768436	0.6289801442279682	0.19845260167790757	1.9935038315855798	0.629 [0.198:1.994]	overlaps null	Waist-to-hip ratio (F) Shungin D/2015 [118K]	Antrophometric
ieu-a-75	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist-to-hip ratio	Weighted median	20	-0.12847945259003107	0.09634907408310707	0.18237471140050182	-0.31732363779292094	0.06036473261285877	0.8794316322750589	0.728095077906681	1.0622239035999912	0.879 [0.728:1.062]	overlaps null	Waist-to-hip ratio (F) Shungin D/2015 [118K]	Antrophometric
ieu-a-109	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist-to-hip ratio	Inverse variance weighted	4	-0.35239575396399175	0.11732176678364845	0.0026674535521105667	-0.5823464168599427	-0.1224450910680408	0.703001851147296	0.5585861517018305	0.8847544845335364	0.703 [0.559:0.885]	negative	Waist-to-hip ratio (F) Randall JC/2013 [ 73K]	Antrophometric
ieu-a-109	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist-to-hip ratio	MR Egger	4	-3.6261552577853213	1.5864996104369935	0.14961800624531676	-6.735694494241828	-0.5166160213288142	0.026618328535556266	0.0011877500280967194	0.5965358006871058	0.027 [0.001:0.597]	negative	Waist-to-hip ratio (F) Randall JC/2013 [ 73K]	Antrophometric
ieu-a-109	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist-to-hip ratio	Weighted median	4	-0.45153593980906437	0.10425269464208753	1.4832042640079259e-5	-0.6558712213075559	-0.2472006583105728	0.63664954489322	0.5189897106720073	0.7809839668842707	0.637 [0.519:0.781]	negative	Waist-to-hip ratio (F) Randall JC/2013 [ 73K]	Antrophometric
ukb-a-266	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Whole body fat-free mass	Inverse variance weighted	374	0.00833340242063734	0.05117063379525885	0.870632466280461	-0.09196103981807001	0.10862784465934468	1.0083682218728864	0.9121406860199053	1.11474741393226	1.008 [0.912:1.115]	overlaps null	Whole body fat-free mass (M/F) Neale Lab/2017 [331K]	Antrophometric
ukb-a-266	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Whole body fat-free mass	MR Egger	374	0.019747512628933973	0.1300282723134103	0.8793710789145276	-0.23510790110535018	0.27460292636321815	1.0199437845885704	0.7904855507622067	1.3160080190179138	1.02 [0.79:1.316]	overlaps null	Whole body fat-free mass (M/F) Neale Lab/2017 [331K]	Antrophometric
ukb-a-266	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Whole body fat-free mass	Weighted median	374	0.052258214631266155	0.057569058655608706	0.36401122350574777	-0.0605771403337269	0.1650935695962592	1.0536477746621316	0.9412211601035024	1.1795034792124526	1.054 [0.941:1.18]	overlaps null	Whole body fat-free mass (M/F) Neale Lab/2017 [331K]	Antrophometric
ukb-b-2346	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Duration of moderate activity	Inverse variance weighted	6	0.30701933045266555	0.4695978894089254	0.5132458389301269	-0.6133925327888281	1.2274311936941593	1.3593672450021919	0.541510656690711	3.4124523385701044	1.359 [0.542:3.412]	overlaps null	Duration of moderate activity (M/F) MRC-IEU/2018 [343K]	Physical activity
ukb-b-2346	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Duration of moderate activity	MR Egger	6	0.14923790402003786	2.206377055148014	0.9493187839127333	-4.17526112407007	4.473736932110145	1.1609491508278449	0.015371177346537465	87.68377987073983	1.161 [0.015:87.684]	overlaps null	Duration of moderate activity (M/F) MRC-IEU/2018 [343K]	Physical activity
ukb-b-2346	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Duration of moderate activity	Weighted median	6	0.21868114576183018	0.36910207413012736	0.5535372826141773	-0.5047589195332194	0.9421212110568797	1.2444344202321966	0.6036510863720878	2.5654174426583953	1.244 [0.604:2.565]	overlaps null	Duration of moderate activity (M/F) MRC-IEU/2018 [343K]	Physical activity
ukb-a-508	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Number of days/week of moderate physical activity 10+ minutes	Inverse variance weighted	7	0.1055593248301339	0.16922808604081746	0.5327789485453638	-0.2261277238098683	0.4372463734701361	1.1113320321512898	0.7976162205769876	1.5484375239912829	1.111 [0.798:1.548]	overlaps null	Days/week of moderate physical activity 10+ minutes (M/F) Neale Lab/2017 [321K]	Physical activity
ukb-a-508	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Number of days/week of moderate physical activity 10+ minutes	MR Egger	7	0.9991588281401411	1.239451727627358	0.4567800668713649	-1.4301665580094804	3.428484214289763	2.715996247695658	0.2392690667452331	30.829875829086287	2.716 [0.239:30.83]	overlaps null	Days/week of moderate physical activity 10+ minutes (M/F) Neale Lab/2017 [321K]	Physical activity
ukb-a-508	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Number of days/week of moderate physical activity 10+ minutes	Weighted median	7	0.03726308763665438	0.12259258627655255	0.7611593280993688	-0.2030183814653886	0.2775445567386974	1.0379660609577472	0.8162632371732682	1.3198849276014222	1.038 [0.816:1.32]	overlaps null	Days/week of moderate physical activity 10+ minutes (M/F) Neale Lab/2017 [321K]	Physical activity
ukb-b-969	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Time spend outdoors in summer	Inverse variance weighted	44	0.1220085391312641	0.1271786640981479	0.33738369117716166	-0.12726164250110578	0.371278720763634	1.1297637489400791	0.8805032653797252	1.4495870470948193	1.13 [0.881:1.45]	overlaps null	Time spend outdoors in summer (M/F) MRC-IEU/2018 [419K]	Physical activity
ukb-b-969	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Time spend outdoors in summer	MR Egger	44	1.2424736891969428	0.6930689795216014	0.08022316781581305	-0.11594151066539604	2.6008888890592816	3.464172159870764	0.8905273081239532	13.475711125024048	3.464 [0.891:13.476]	overlaps null	Time spend outdoors in summer (M/F) MRC-IEU/2018 [419K]	Physical activity
ukb-b-969	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Time spend outdoors in summer	Weighted median	44	0.08660458001666223	0.15208840111985153	0.5690604290281568	-0.2114886861782468	0.3846978462115712	1.0904654026447664	0.8093784381643051	1.46917033898526	1.09 [0.809:1.469]	overlaps null	Time spend outdoors in summer (M/F) MRC-IEU/2018 [419K]	Physical activity
ukb-b-8865	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Time spent doing light physical activity	Inverse variance weighted	3	7.032635295965651e-4	0.0019020673753573827	0.7115789130611927	-0.003024788526103905	0.004431315585297035	1.0007035108773727	0.9969797815377232	1.0044411483829168	1.001 [0.997:1.004]	overlaps null	Time spent doing light physical activity (M/F) MRC-IEU/2018 [ 64K]	Physical activity
ukb-b-8865	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Time spent doing light physical activity	MR Egger	3	6.152929202487536e-4	0.00544613880106733	0.9283797719450668	-0.010059139129843212	0.01128972497034072	1.000615482251767	0.9899912847947829	1.0113536944211416	1.001 [0.99:1.011]	overlaps null	Time spent doing light physical activity (M/F) MRC-IEU/2018 [ 64K]	Physical activity
ukb-b-8865	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Time spent doing light physical activity	Weighted median	3	7.693579074422485e-4	0.0021716494643248727	0.7231339079100221	-0.0034870750426345015	0.005025790857518999	1.0007696539391504	0.9965189977427384	1.0050384413283855	1.001 [0.997:1.005]	overlaps null	Time spent doing light physical activity (M/F) MRC-IEU/2018 [ 64K]	Physical activity
ukb-a-487	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of physical activity in last 4 weeks: Heavy DIY (eg: weeding  lawn mowing  carpentry  digging)	Inverse variance weighted	3	-0.8933973030279375	0.5840356713444279	0.12609187856954002	-2.0381072188630163	0.2513126128071411	0.4092629978648375	0.13027505983842733	1.2857119515358495	0.409 [0.13:1.286]	overlaps null	Physical activity: Heavy DIY  (M/F) Neale Lab/2017 [335K]	Physical activity
ukb-a-487	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of physical activity in last 4 weeks: Heavy DIY (eg: weeding  lawn mowing  carpentry  digging)	MR Egger	3	-2.36969094804896	9.14602792879424	0.8386039882794311	-20.295905688485668	15.556523792387749	0.09350962114367664	1.53320474363075e-9	5703119.092709919	0.094 [0:5703119.093]	overlaps null	Physical activity: Heavy DIY  (M/F) Neale Lab/2017 [335K]	Physical activity
ukb-a-487	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of physical activity in last 4 weeks: Heavy DIY (eg: weeding  lawn mowing  carpentry  digging)	Weighted median	3	-1.0070567144630949	0.693995838355609	0.1467522759281813	-2.367288557640088	0.35317512871389867	0.36529255917699666	0.09373453782130887	1.423580431414308	0.365 [0.094:1.424]	overlaps null	Physical activity: Heavy DIY  (M/F) Neale Lab/2017 [335K]	Physical activity
ukb-b-7663	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of physical activity in last 4 weeks: Strenuous sports	Inverse variance weighted	6	-1.2984494825388933	1.079768705601186	0.22915996380719966	-3.4147961455172178	0.817897180439431	0.2729546861046404	0.032883109387560415	2.265730402449943	0.273 [0.033:2.266]	overlaps null	Physical activity: Strenuous sports (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-7663	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of physical activity in last 4 weeks: Strenuous sports	MR Egger	6	-7.226989222573976	4.761433663983886	0.20366760658816266	-16.55939920398239	2.1054207588344402	7.267055213187683e-4	6.431974324107413e-8	8.210556947278697	0.001 [0:8.211]	overlaps null	Physical activity: Strenuous sports (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-7663	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of physical activity in last 4 weeks: Strenuous sports	Weighted median	6	-1.6624871971230826	1.0001111072959707	0.09645213615992493	-3.6227049674231853	0.2977305731770201	0.1896666546040251	0.026710328119329843	1.3467988752503994	0.19 [0.027:1.347]	overlaps null	Physical activity: Strenuous sports (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-a-482	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of physical activity in last 4 weeks: Walking for pleasure (not as a means of transport)	Inverse variance weighted	6	-0.9789992735317049	0.6307545850162221	0.12063637042611833	-2.2152782601635	0.25727971310009023	0.3756868705928691	0.10912314539915909	1.2934068590085819	0.376 [0.109:1.293]	overlaps null	Physical activity: Walking for pleasure  (M/F) Neale Lab/2017 [335K]	Physical activity
ukb-a-482	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of physical activity in last 4 weeks: Walking for pleasure (not as a means of transport)	MR Egger	6	-16.07672263105567	19.690744676045032	0.460068968267021	-54.670582196103936	22.517136933992592	1.0422408096091344e-7	1.8066242267037664e-24	6012683153.245546	0 [0:6012683153.246]	overlaps null	Physical activity: Walking for pleasure  (M/F) Neale Lab/2017 [335K]	Physical activity
ukb-a-482	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of physical activity in last 4 weeks: Walking for pleasure (not as a means of transport)	Weighted median	6	-0.6302430794693541	0.6906872330550464	0.3615124416753055	-1.983990056257245	0.7235038973185368	0.5324623546080445	0.1375194308953266	2.061644359847171	0.532 [0.138:2.062]	overlaps null	Physical activity: Walking for pleasure  (M/F) Neale Lab/2017 [335K]	Physical activity
ukb-b-16886	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of transport used (excluding work): Car/motor vehicle	Inverse variance weighted	5	0.2845198088684372	1.018518606786919	0.7799787728086279	-1.711776660433924	2.280816278170798	1.3291236414745509	0.18054474080400634	9.784664158366718	1.329 [0.181:9.785]	overlaps null	Types of transport used : Car/motor vehicle (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-16886	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of transport used (excluding work): Car/motor vehicle	MR Egger	5	-7.637793319443435	8.009099558284296	0.41061982486450394	-23.335628453680656	8.060041814793784	4.8189065839859114e-4	7.336101489124491e-11	3165.4224930786886	0 [0:3165.422]	overlaps null	Types of transport used : Car/motor vehicle (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-16886	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of transport used (excluding work): Car/motor vehicle	Weighted median	5	-0.28736921617536304	0.9335625924097284	0.7582193193753113	-2.1171518972984305	1.5424134649477046	0.7502346789157851	0.12037397820902378	4.675861692221429	0.75 [0.12:4.676]	overlaps null	Types of transport used : Car/motor vehicle (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-17557	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of transport used (excluding work): Cycle	Inverse variance weighted	8	-0.9915327940282801	1.0462464372858922	0.34327974525542543	-3.0421758111086286	1.0591102230520686	0.3710075767678899	0.047730922957046236	2.8838039051340365	0.371 [0.048:2.884]	overlaps null	Types of transport used : Cycle (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-17557	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of transport used (excluding work): Cycle	MR Egger	8	-7.729175165875688	5.885126993413152	0.23705455355210403	-19.264024072965466	3.8056737412140897	4.3980673513466424e-4	4.302695832216568e-9	44.955528304255175	0 [0:44.956]	overlaps null	Types of transport used : Cycle (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-17557	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of transport used (excluding work): Cycle	Weighted median	8	-1.3609664011074933	1.1329463171643521	0.22964922916325872	-3.5815411827496235	0.8596083805346368	0.25641285950759984	0.027832769798757755	2.362235415168727	0.256 [0.028:2.362]	overlaps null	Types of transport used : Cycle (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-15957	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of transport used (excluding work): Public transport	Inverse variance weighted	9	0.9127710105170198	0.7092311063298689	0.1980989192420312	-0.47732195788952303	2.3028639789235625	2.491216164002906	0.6204427406980408	10.00278924821813	2.491 [0.62:10.003]	overlaps null	Types of transport used : Public transport (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-15957	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of transport used (excluding work): Public transport	MR Egger	9	2.6495846974640047	2.8178896056805747	0.3783831729037826	-2.873478929669922	8.172648324597931	14.14816165768022	0.05650201771655711	3542.7138070716296	14.148 [0.057:3542.714]	overlaps null	Types of transport used : Public transport (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-15957	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of transport used (excluding work): Public transport	Weighted median	9	1.1282083390328346	0.6873975153686521	0.10074034863100749	-0.2190907910897235	2.4755074691553927	3.0901150988442225	0.8032487870102358	11.887738243149512	3.09 [0.803:11.888]	overlaps null	Types of transport used : Public transport (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-14926	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of transport used (excluding work): Walk	Inverse variance weighted	7	-1.5742264051724033	0.5891001104755661	0.007534310718880183	-2.728862621704513	-0.41959018864029374	0.20716775461088294	0.06529351087343589	0.6573161402471929	0.207 [0.065:0.657]	negative	Types of transport used : Walk (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-14926	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of transport used (excluding work): Walk	MR Egger	7	-12.47317876619811	6.764612823713773	0.1245236830903143	-25.731819900677106	0.7854623682808857	3.8279591101940355e-6	6.680555984191613e-12	2.1934208745487584	0 [0:2.193]	overlaps null	Types of transport used : Walk (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-14926	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of transport used (excluding work): Walk	Weighted median	7	-1.712717805662736	0.6677378129199792	0.010318902490179577	-3.0214839189858953	-0.4039516923395765	0.1803749019166771	0.04872885501150437	0.6676763743734526	0.18 [0.049:0.668]	negative	Types of transport used : Walk (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-4711	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Usual walking pace	Inverse variance weighted	53	-0.33035405016218605	0.2499878185124379	0.18634116992949337	-0.8203301744465643	0.1596220741221922	0.7186692434212784	0.4402862592324462	1.1730674546603046	0.719 [0.44:1.173]	overlaps null	Usual walking pace (M/F) MRC-IEU/2018 [459K]	Physical activity
ukb-b-4711	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Usual walking pace	MR Egger	53	-0.1070643136577933	1.0209624888825384	0.9168934364829364	-2.1081507918675686	1.894022164551982	0.8984678873758764	0.12146236808560339	6.646046486404302	0.898 [0.121:6.646]	overlaps null	Usual walking pace (M/F) MRC-IEU/2018 [459K]	Physical activity
ukb-b-4711	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Usual walking pace	Weighted median	53	-0.7115382592381979	0.21221082394055232	7.994701309195742e-4	-1.1274714741616805	-0.29560504431471535	0.4908885026086213	0.32385108787600436	0.7440812491128554	0.491 [0.324:0.744]	negative	Usual walking pace (M/F) MRC-IEU/2018 [459K]	Physical activity
ukb-b-1004	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Added milk to espresso	Inverse variance weighted	3	-0.8781770350271915	1.6760657225853295	0.600312321039993	-4.163265851294438	2.4069117812400544	0.41553973602343935	0.015556669099637504	11.099630075595886	0.416 [0.016:11.1]	overlaps null	Added milk to espresso (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-1004	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Added milk to espresso	MR Egger	3	4.967503030625834	2.936559931522933	0.33988479890187	-0.7881544351591145	10.723160496410783	143.66770526407893	0.4546831686780131	45395.14756145041	143.668 [0.455:45395.148]	overlaps null	Added milk to espresso (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-1004	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Added milk to espresso	Weighted median	3	0.6039015777149974	1.3254132470057223	0.6486541455343109	-1.9939083864162181	3.2017115418462128	1.8292418249774487	0.13616220958712305	24.574554602140296	1.829 [0.136:24.575]	overlaps null	Added milk to espresso (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-d-1468_5	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cereal type: Other (e.g. Cornflakes, Frosties)	Inverse variance weighted	10	2.739022250377657	1.308808109996541	0.03637051661483201	0.1737583547844368	5.304286145970877	15.471850102833598	1.1897680293289357	201.19732561612736	15.472 [1.19:201.197]	positive	Cereal type: Other (e.g. Cornflakes, Frosties) (M/F) Neale lab/2018 [299K]	Diet and supplements
ukb-d-1468_5	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cereal type: Other (e.g. Cornflakes, Frosties)	MR Egger	10	-4.556594454700245	6.516102573764677	0.5041960146180473	-17.32815549927901	8.214966589878522	0.010497748696128765	2.981794333575132e-8	3695.852743637814	0.01 [0:3695.853]	overlaps null	Cereal type: Other (e.g. Cornflakes, Frosties) (M/F) Neale lab/2018 [299K]	Diet and supplements
ukb-d-1468_5	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cereal type: Other (e.g. Cornflakes, Frosties)	Weighted median	10	1.3966198903904186	0.7121705135752917	0.04987025811132191	7.656837828469154e-4	2.7924740969979904	4.041516086004883	1.0007659769935053	16.321350494454546	4.042 [1.001:16.321]	positive	Cereal type: Other (e.g. Cornflakes, Frosties) (M/F) Neale lab/2018 [299K]	Diet and supplements
ukb-b-2221	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cherry intake	Inverse variance weighted	3	-0.6454482525429085	0.7820979467670602	0.4092137621308538	-2.1783602282063463	0.8874637231205295	0.5244274134903618	0.1132270450129548	2.4289613138691757	0.524 [0.113:2.429]	overlaps null	Cherry intake (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-2221	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cherry intake	MR Egger	3	2.6600102802001957	4.132422133945162	0.6358989866738571	-5.439537102332322	10.759557662732712	14.296436068147027	0.004341492472415358	47077.83914154876	14.296 [0.004:47077.839]	overlaps null	Cherry intake (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-2221	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cherry intake	Weighted median	3	-1.225225181070262	0.679198258444864	0.07124249672325021	-2.5564537676221954	0.10600340548167164	0.2936915590973318	0.07757936767500412	1.1118256628020005	0.294 [0.078:1.112]	overlaps null	Cherry intake (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-4955	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Dairy smoothie intake	Inverse variance weighted	3	-0.26815817434104255	0.26540737929825414	0.31232072505787833	-0.7883566377656206	0.25204028908353554	0.7647868018867858	0.45459123985060945	1.2866478741042853	0.765 [0.455:1.287]	overlaps null	Dairy smoothie intake (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-4955	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Dairy smoothie intake	MR Egger	3	-0.5483833444995727	1.2176031438295734	0.7306020113701485	-2.9348855064055366	1.8381188174063912	0.5778832938221683	0.05313680278168143	6.284704457112826	0.578 [0.053:6.285]	overlaps null	Dairy smoothie intake (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-4955	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Dairy smoothie intake	Weighted median	3	-0.30655365063207185	0.2999961252382597	0.3068477818823999	-0.8945460560990608	0.2814387548349171	0.7359790313798985	0.40879312567437565	1.3250348418587576	0.736 [0.409:1.325]	overlaps null	Dairy smoothie intake (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-16576	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Dried fruit intake	Inverse variance weighted	40	-0.5521064982014108	0.1903963942398054	0.003734318997657733	-0.9252834309114293	-0.17892956549139222	0.5757357458039736	0.39641904573926484	0.83616479217922135	0.576 [0.396:0.836]	negative	Dried fruit intake (M/F) MRC-IEU/2018 [421K]	Diet and supplements
ukb-b-16576	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Dried fruit intake	MR Egger	40	-0.9243957130403856	0.8614548695199199	0.29001003441288387	-2.6128472572994283	0.7640558312186573	0.39677111025445044	0.0733254697815223	2.146966318819553	0.397 [0.073:2.147]	overlaps null	Dried fruit intake (M/F) MRC-IEU/2018 [421K]	Diet and supplements
ukb-b-16576	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Dried fruit intake	Weighted median	40	-0.2991070942308109	0.18158411984109168	0.09951498392678532	-0.6550119691193506	0.05679778065772878	0.7414799969528417	0.5194358453602128	1.0584417513579987	0.741 [0.519:1.058]	overlaps null	Dried fruit intake (M/F) MRC-IEU/2018 [421K]	Diet and supplements
ukb-b-3881	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Fresh fruit intake	Inverse variance weighted	53	-0.4295694388610893	0.1952555326440804	0.027804254539696392	-0.8122702828434869	-0.04686859487869166	0.6507892389652965	0.4438492581605252	0.9542127777982106	0.651 [0.444:0.954]	negative	Fresh fruit intake (M/F) MRC-IEU/2018 [446K]	Diet and supplements
ukb-b-3881	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Fresh fruit intake	MR Egger	53	-1.359484621518227	0.6584886707175521	0.04406846909893646	-2.650122416124629	-0.06884682691182498	0.2567930884874429	0.070642564742084	0.9334696515574776	0.257 [0.071:0.933]	negative	Fresh fruit intake (M/F) MRC-IEU/2018 [446K]	Diet and supplements
ukb-b-3881	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Fresh fruit intake	Weighted median	53	-0.4342557712807086	0.20714584934039498	0.03604877085205529	-0.8402616359878827	-0.028249906573534433	0.6477465593290407	0.43159758719453883	0.9721453909182546	0.648 [0.432:0.972]	negative	Fresh fruit intake (M/F) MRC-IEU/2018 [446K]	Diet and supplements
ukb-d-1418_1	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Milk type used: Full cream	Inverse variance weighted	3	5.718321107852575	4.141361319229447	0.16734570678967794	-2.3987470778371405	13.835389293542292	304.39344995019223	0.09083168705855968	1020077.6334017098	304.393 [0.091:1020077.633]	overlaps null	Milk type used: Full cream (M/F) Neale lab/2018 [360K]	Diet and supplements
ukb-d-1418_1	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Milk type used: Full cream	MR Egger	3	-1.9940395197784946	36.37743837413728	0.9651383965178666	-73.29381873308756	69.30573969353057	0.13614435534943362	1.475363267797966e-32	12563201143795163e14	0.136 [0:1.25632011437952e+30]	overlaps null	Milk type used: Full cream (M/F) Neale lab/2018 [360K]	Diet and supplements
ukb-d-1418_1	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Milk type used: Full cream	Weighted median	3	0.8823544401303158	1.897295815876342	0.641889226586164	-2.836345358987314	4.601054239247946	2.416582712960239	0.05863958145359297	99.58925121591996	2.417 [0.059:99.589]	overlaps null	Milk type used: Full cream (M/F) Neale lab/2018 [360K]	Diet and supplements
ukb-d-1418_3	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Milk type used: Skimmed	Inverse variance weighted	3	-5.0090698425676905	1.5715445400956447	0.001435805886777403	-8.089297141155154	-1.928842543980227	0.006677111183249682	3.068053222027176e-4	0.14531629840508378	0.007 [0:0.145]	negative	Milk type used: Skimmed (M/F) Neale lab/2018 [360K]	Diet and supplements
ukb-d-1418_3	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Milk type used: Skimmed	MR Egger	3	-14.479689584766895	3.7868677247144316	0.16284752223896626	-21.90195032520718	-7.057428844326609	5.14695905845843e-7	3.0768323338946405e-10	8.609889872001845e-4	0 [0:0.001]	negative	Milk type used: Skimmed (M/F) Neale lab/2018 [360K]	Diet and supplements
ukb-d-1418_3	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Milk type used: Skimmed	Weighted median	3	-4.1516465560029205	1.1233627252439615	2.1925494112103513e-4	-6.353437497481085	-1.9498556145247559	0.015738480848357404	0.0017407530056869173	0.14229461537903143	0.016 [0.002:0.142]	negative	Milk type used: Skimmed (M/F) Neale lab/2018 [360K]	Diet and supplements
ukb-b-14238	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Mineral and other dietary supplements: None of the above	Inverse variance weighted	7	0.24855043646002545	0.48244297561662697	0.6064193295490257	-0.6970377957485634	1.1941386686686142	1.282165488626941	0.4980584717244471	3.300713537778117	1.282 [0.498:3.301]	overlaps null	Supplements None of the above (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-14238	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Mineral and other dietary supplements: None of the above	MR Egger	7	-5.127637743252123	3.57154705042352	0.21057169094200515	-12.127869962082222	1.8725944755779755	0.005930553429555227	5.406709032731371e-6	6.505151982081281	0.006 [0:6.505]	overlaps null	Supplements None of the above (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-14238	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Mineral and other dietary supplements: None of the above	Weighted median	7	0.3909262981606616	0.6219599131406616	0.5296506576778764	-0.828115131595035	1.6099677279163582	1.478349552316689	0.43687195691367353	5.002649779296354	1.478 [0.437:5.003]	overlaps null	Supplements None of the above (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-5495	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Never eat eggs, dairy, wheat, sugar: Sugar or foods/drinks containing sugar	Inverse variance weighted	20	0.34408578479225066	0.5112802428371924	0.500954531141039	-0.6580234911686464	1.3461950607531479	1.4106996468932727	0.5178739059466777	3.8427761485818333	1.411 [0.518:3.843]	overlaps null	Never eat: Sugar or foods/drinks containing sugar (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-5495	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Never eat eggs, dairy, wheat, sugar: Sugar or foods/drinks containing sugar	MR Egger	20	7.169584680149851	2.596669344273527	0.012864737017298303	2.0801127653737383	12.259056594925962	1299.3048636283281	8.005371592119495	210882.54420445487	1299.305 [8.005:210882.544]	positive	Never eat: Sugar or foods/drinks containing sugar (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-5495	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Never eat eggs, dairy, wheat, sugar: Sugar or foods/drinks containing sugar	Weighted median	20	-0.39220920061467845	0.5066891800120595	0.4388937069941133	-1.3853199934383151	0.6009015922089582	0.6755627710296742	0.25024371063299466	1.8237623492988504	0.676 [0.25:1.824]	overlaps null	Never eat: Sugar or foods/drinks containing sugar (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-3599	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Never eat eggs, dairy, wheat, sugar: Wheat products	Inverse variance weighted	5	-0.1820670879174755	1.2887311124599958	0.8876517178603445	-2.7079800683390673	2.3438458925041163	0.8335454177136918	0.06667134234816682	10.421238554987589	0.834 [0.067:10.421]	overlaps null	Never eat: Wheat products (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-3599	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Never eat eggs, dairy, wheat, sugar: Wheat products	MR Egger	5	-1.6015294708382208	5.083807589503615	0.7733827467190248	-11.565792346265306	8.362733404588864	0.2015879591840461	9.485062680046332e-6	4284.38974615085	0.202 [0:4284.39]	overlaps null	Never eat: Wheat products (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-3599	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Never eat eggs, dairy, wheat, sugar: Wheat products	Weighted median	5	-0.8670933530106533	0.8761374207467638	0.3223318536495975	-2.5843226976743106	0.8501359916530038	0.42017106499923607	0.07544716283863444	2.3399650460042083	0.42 [0.075:2.34]	overlaps null	Never eat: Wheat products (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-6500	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Pancake intake	Inverse variance weighted	4	-0.4076466436835456	0.5777379185308351	0.4804425572240319	-1.5400129640039824	0.7247196766368913	0.6652138948292925	0.21437832220754025	2.0641523887175603	0.665 [0.214:2.064]	overlaps null	Pancake intake (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-6500	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Pancake intake	MR Egger	4	3.820024879429674	3.06891293499808	0.33930013563814587	-2.195044473166562	9.83509423202591	45.6053429416568	0.11135360914718301	18677.861640542425	45.605 [0.111:18677.862]	overlaps null	Pancake intake (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-6500	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Pancake intake	Weighted median	4	-0.36130214848018455	0.70422539266727	0.6079170302592708	-1.741583918108034	1.0189796211476647	0.6967684391334587	0.17524261073242098	2.77036649787059	0.697 [0.175:2.77]	overlaps null	Pancake intake (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-8006	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Poultry intake	Inverse variance weighted	7	0.9570271216092471	0.59703321906191	0.10894098824651602	-0.2131579877520965	2.1272122309705908	2.6039437470802653	0.8080284685303365	8.39144077471801	2.604 [0.808:8.391]	overlaps null	Poultry intake (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-8006	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Poultry intake	MR Egger	7	-6.557694821188095	18.92189983472642	0.7430255465833834	-43.64461849725188	30.52922885487569	0.0014191533448803429	1.1101534728938312e-19	18141601728589.824	0.001 [0:18141601728589.8]	overlaps null	Poultry intake (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-8006	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Poultry intake	Weighted median	7	0.7831307183363382	0.43416847242804674	0.07127074714677857	-0.06783948762263337	1.6341009242953097	2.1883125426234984	0.9344104459827988	5.124848298508293	2.188 [0.934:5.125]	overlaps null	Poultry intake (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-4643	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Age at hysterectomy	Inverse variance weighted	4	0.21991677530134623	0.11589427226218055	0.05775356730077323	-0.007235998332527638	0.4470695489352201	1.2459730305422405	0.9927901184717224	1.5637230507777597	1.246 [0.993:1.564]	overlaps null	Age at hysterectomy (M/F) MRC-IEU/2018 [ 46K]	Reproductive
ukb-b-4643	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Age at hysterectomy	MR Egger	4	0.26542231734166755	1.065674285296641	0.8265536768811309	-1.8232992818397484	2.3541439165230837	1.3039815535341908	0.16149206319349874	10.529111204183899	1.304 [0.161:10.529]	overlaps null	Age at hysterectomy (M/F) MRC-IEU/2018 [ 46K]	Reproductive
ukb-b-4643	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Age at hysterectomy	Weighted median	4	0.11796359593296117	0.1286090197531344	0.35902398402736435	-0.13411008278318226	0.37003727464910463	1.1252031486508862	0.8744937925939216	1.447788579468836	1.125 [0.874:1.448]	overlaps null	Age at hysterectomy (M/F) MRC-IEU/2018 [ 46K]	Reproductive
ukb-a-320	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Age at last live birth	Inverse variance weighted	4	-0.3905874133222913	0.18679630303436445	0.036529818654027955	-0.7567081672696456	-0.024466659374936972	0.6766592790579975	0.46920844329861194	0.9758302231656439	0.677 [0.469:0.976]	negative	Age at last live birth (M/F) Neale Lab/2017 [123K]	Reproductive
ukb-a-320	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Age at last live birth	MR Egger	4	-2.3532848517842866	1.2507421872164965	0.20062865004311478	-4.80473953872862	0.0981698351600464	0.09505640261856955	0.008190834131636395	1.1031501228774616	0.095 [0.008:1.103]	overlaps null	Age at last live birth (M/F) Neale Lab/2017 [123K]	Reproductive
ukb-a-320	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Age at last live birth	Weighted median	4	-0.5009711578890218	0.2019690052384916	0.013122187948242846	-0.8968304081564653	-0.1051119076215783	0.6059419086089327	0.4078603640402839	0.9002237750476082	0.606 [0.408:0.9]	negative	Age at last live birth (M/F) Neale Lab/2017 [123K]	Reproductive
ukb-b-17422	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Age at menopause (last menstrual period)	Inverse variance weighted	102	0.1481564683455542	0.04069322181358916	2.7177699724421255e-4	0.06839775359091946	0.22791518310018896	1.1596943376220532	1.0707911348051786	1.2559787926870953	1.16 [1.071:1.256]	positive	Age at menopause (last menstrual period) (M/F) MRC-IEU/2018 [143K]	Reproductive
ukb-b-17422	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Age at menopause (last menstrual period)	MR Egger	102	0.19946801975341433	0.08730404902573403	0.024440004414042676	0.02835208366297562	0.37058395584385306	1.2207531688193718	1.0287578294899244	1.4485802746419176	1.221 [1.029:1.449]	positive	Age at menopause (last menstrual period) (M/F) MRC-IEU/2018 [143K]	Reproductive
ukb-b-17422	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Age at menopause (last menstrual period)	Weighted median	102	0.2386632229921352	0.04120212198446696	6.934701372870206e-9	0.15790706390257994	0.3194193820816904	1.2695509090238402	1.1710573561496969	1.3763284113619683	1.27 [1.171:1.376]	positive	Age at menopause (last menstrual period) (M/F) MRC-IEU/2018 [143K]	Reproductive
ukb-b-4564	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Age last used hormone-replacement therapy (HRT)	Inverse variance weighted	4	0.3720851783851971	0.2803160900758032	0.18438394782265133	-0.17733435816337723	0.9215047149337714	1.4507565491305987	0.8374997128376626	2.513068998810855	1.451 [0.837:2.513]	overlaps null	Age last used hormone-replacement therapy (HRT) (M/F) MRC-IEU/2018 [ 72K]	Reproductive
ukb-b-4564	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Age last used hormone-replacement therapy (HRT)	MR Egger	4	1.2474354151558718	0.5227921851286046	0.13974440339595703	0.22276273230380683	2.2721080980079367	3.4814031451657197	1.2495240668649408	9.699827462770923	3.481 [1.25:9.7]	positive	Age last used hormone-replacement therapy (HRT) (M/F) MRC-IEU/2018 [ 72K]	Reproductive
ukb-b-4564	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Age last used hormone-replacement therapy (HRT)	Weighted median	4	0.21103402265826077	0.15830610122025915	0.1825069505385121	-0.09924593573344714	0.5213139810499687	1.2349543707771717	0.9055199809157363	1.6842392548415346	1.235 [0.906:1.684]	overlaps null	Age last used hormone-replacement therapy (HRT) (M/F) MRC-IEU/2018 [ 72K]	Reproductive
ukb-b-9487	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Age started hormone-replacement therapy (HRT)	Inverse variance weighted	22	0.16245207972717127	0.10389176843702898	0.11789590482447236	-0.04117578640940553	0.36607994586374804	1.1763919440750499	0.9596604198603073	1.4420705256200128	1.176 [0.96:1.442]	overlaps null	Age started hormone-replacement therapy (HRT) (M/F) MRC-IEU/2018 [ 87K]	Reproductive
ukb-b-9487	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Age started hormone-replacement therapy (HRT)	MR Egger	22	1.0760209692383684	0.2906716330357696	0.0014111465358668729	0.50630456848826	1.6457373699884768	2.9329858607539596	1.65914858218065	5.184831637005254	2.933 [1.659:5.185]	positive	Age started hormone-replacement therapy (HRT) (M/F) MRC-IEU/2018 [ 87K]	Reproductive
ukb-b-9487	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Age started hormone-replacement therapy (HRT)	Weighted median	22	0.29618546919302235	0.08819838322298856	7.845936282033199e-4	0.12331663807596477	0.46905430031007994	1.344719537752607	1.1312425587117108	1.5984817944551986	1.345 [1.131:1.598]	positive	Age started hormone-replacement therapy (HRT) (M/F) MRC-IEU/2018 [ 87K]	Reproductive
ukb-b-18541	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ever used hormone-replacement therapy (HRT)	Inverse variance weighted	6	-1.2508902894244684	0.7363649822725342	0.08936878742089727	-2.6941656546786357	0.19238507582969855	0.28624983817983474	0.06759875896020182	1.212137191841383	0.286 [0.068:1.212]	overlaps null	Ever used hormone-replacement therapy (HRT) (M/F) MRC-IEU/2018 [250K]	Reproductive
ukb-b-18541	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ever used hormone-replacement therapy (HRT)	MR Egger	6	-0.20195981369007104	1.6746289049593648	0.9098232198111709	-3.484232467410426	3.080312840030284	0.8171277646320406	0.03067729521926423	21.765210360307965	0.817 [0.031:21.765]	overlaps null	Ever used hormone-replacement therapy (HRT) (M/F) MRC-IEU/2018 [250K]	Reproductive
ukb-b-18541	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ever used hormone-replacement therapy (HRT)	Weighted median	6	-0.9730812623924319	0.5905278928573957	0.09939045137271539	-2.1305159323929272	0.18435340760806374	0.37791678148852614	0.11877599765672951	1.2024406997060877	0.378 [0.119:1.202]	overlaps null	Ever used hormone-replacement therapy (HRT) (M/F) MRC-IEU/2018 [250K]	Reproductive
ukb-b-18105	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Had menopause	Inverse variance weighted	9	-1.1145202402133716	0.5964253712371024	0.06166919735826669	-2.2835139678380925	0.05447348741134905	0.3280726372079016	0.10192541406490836	1.055984479160469	0.328 [0.102:1.056]	overlaps null	Had menopause (M/F) MRC-IEU/2018 [211K]	Reproductive
ukb-b-18105	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Had menopause	MR Egger	9	-2.684961552068158	1.4721638692403987	0.11094581743532193	-5.570402735779339	0.20047963164302374	0.0682238170105595	0.003808946124766428	1.2219887220840464	0.068 [0.004:1.222]	overlaps null	Had menopause (M/F) MRC-IEU/2018 [211K]	Reproductive
ukb-b-18105	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Had menopause	Weighted median	9	-1.7696289566527106	0.33188807924037045	9.713416896019351e-8	-2.420129591963837	-1.1191283213415844	0.1703962014743282	0.08891009467899823	0.3265643297502672	0.17 [0.089:0.327]	negative	Had menopause (M/F) MRC-IEU/2018 [211K]	Reproductive
ukb-a-316	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Had menopause	Inverse variance weighted	7	-1.0889986956630628	0.6564400798268512	0.09712665850522087	-2.375621252123691	0.19762386079756533	0.33655331734337385	0.09295672170765726	1.2185039804980484	0.337 [0.093:1.219]	overlaps null	Had menopause (M/F) Neale Lab/2017 [152K]	Reproductive
ukb-a-316	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Had menopause	MR Egger	7	-2.875479803667382	1.6273692083918998	0.1374867716285299	-6.065123452115506	0.31416384478074155	0.05638907732592917	0.0023224712828384415	1.3691140403611224	0.056 [0.002:1.369]	overlaps null	Had menopause (M/F) Neale Lab/2017 [152K]	Reproductive
ukb-a-316	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Had menopause	Weighted median	7	-1.5988057128692388	0.4035568992702445	7.439148153928521e-5	-2.389777235438918	-0.8078341902995595	0.20213778444987623	0.0916500979975027	0.44582258824663745	0.202 [0.092:0.446]	negative	Had menopause (M/F) Neale Lab/2017 [152K]	Reproductive
ukb-b-1209	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Number of live births	Inverse variance weighted	10	-0.3319695347261247	0.2095964239410531	0.11322759871417032	-0.7427785256505888	0.07883945619833932	0.7175091816352013	0.47579008227251396	1.0820305948200657	0.718 [0.476:1.082]	overlaps null	Number of live births (M/F) MRC-IEU/2018 [250K]	Reproductive
ukb-b-1209	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Number of live births	MR Egger	10	-1.324451283599915	1.9810906568174311	0.5226033034552999	-5.20738897096208	2.55848640376225	0.2659488495543548	0.005475952909854419	12.916252521456613	0.266 [0.005:12.916]	overlaps null	Number of live births (M/F) MRC-IEU/2018 [250K]	Reproductive
ukb-b-1209	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Number of live births	Weighted median	10	-0.29527368825979894	0.1659557070217737	0.0752017501502286	-0.6205468740224753	0.029999497502877503	0.7443278457934941	0.5376503301834004	1.0304540161532088	0.744 [0.538:1.03]	overlaps null	Number of live births (M/F) MRC-IEU/2018 [250K]	Reproductive
ukb-a-317	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Number of live births	Inverse variance weighted	3	-0.025446678567732483	0.18474448506385394	0.8904460199271707	-0.3875458692928862	0.33665251215742126	0.9748743592770139	0.678720501107939	1.400252408501547	0.975 [0.679:1.4]	overlaps null	Number of live births (M/F) Neale Lab/2017 [180K]	Reproductive
ukb-a-317	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Number of live births	MR Egger	3	-0.9900278658117799	1.3428079643805337	0.595548045315287	-3.621931475997626	1.6418757443740661	0.3715663368801758	0.026730996321412098	5.164848367135573	0.372 [0.027:5.165]	overlaps null	Number of live births (M/F) Neale Lab/2017 [180K]	Reproductive
ukb-a-317	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Number of live births	Weighted median	3	0.031214439732368815	0.21507004733493063	0.8846033729091791	-0.3903228530440952	0.4527517325088328	1.0317067190797342	0.6768383199076132	1.5726337042198795	1.032 [0.677:1.573]	overlaps null	Number of live births (M/F) Neale Lab/2017 [180K]	Reproductive
ukb-a-26	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Average weekly red wine intake	Inverse variance weighted	13	-0.5303463043700172	0.34751713291230174	0.12698466986381562	-1.2114798848781285	0.15078727613809417	0.5884011684957986	0.29775630815919707	1.1627492872531013	0.588 [0.298:1.163]	overlaps null	Average weekly red wine intake (M/F) Neale Lab/2017 [241K]	Alcohol
ukb-a-26	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Average weekly red wine intake	MR Egger	13	0.2913145142620895	0.9970269116145616	0.7755836935097699	-1.6628582325024512	2.2454872610266303	1.3381853961632582	0.1895962946187096	9.445016623905602	1.338 [0.19:9.445]	overlaps null	Average weekly red wine intake (M/F) Neale Lab/2017 [241K]	Alcohol
ukb-a-26	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Average weekly red wine intake	Weighted median	13	-0.26249587779113925	0.2124030015153762	0.2165184766582305	-0.6788057607612765	0.15381400517899807	0.7691295348746194	0.5072223756711755	1.1662739456903375	0.769 [0.507:1.166]	overlaps null	Average weekly red wine intake (M/F) Neale Lab/2017 [241K]	Alcohol
ukb-b-1707	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Average weekly spirits intake	Inverse variance weighted	3	-0.9478934641494006	1.4002966689551541	0.4984546099590692	-3.6924749353015027	1.7966880070027014	0.38755656596849697	0.024910274370378054	6.02964421796589	0.388 [0.025:6.03]	overlaps null	Average weekly spirits intake (M/F) MRC-IEU/2018 [326K]	Alcohol
ukb-b-1707	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Average weekly spirits intake	MR Egger	3	4.062366588388121	8.047363950679687	0.7023892311209836	-11.710466754944065	19.835199931720307	58.11167488805428	8.207462513368416e-6	411450768.46765655	58.112 [0:411450768.468]	overlaps null	Average weekly spirits intake (M/F) MRC-IEU/2018 [326K]	Alcohol
ukb-b-1707	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Average weekly spirits intake	Weighted median	3	0.564475374246697	0.4269547104709081	0.18613598335292947	-0.27235585827628284	1.4013066067696769	1.7585249731893962	0.761583197178736	4.060501981643653	1.759 [0.762:4.061]	overlaps null	Average weekly spirits intake (M/F) MRC-IEU/2018 [326K]	Alcohol
ukb-d-20406	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ever addicted to alcohol	Inverse variance weighted	2	-0.06778861048491153	0.08348839013683523	0.41681886450329914	-0.23142585515310857	0.09584863418328551	0.9344579873211212	0.7934015199565528	1.1005924593086969	0.934 [0.793:1.101]	overlaps null	Ever addicted to alcohol (M/F) Neale lab/2018 [  6K]	Alcohol
ukb-b-223	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Current tobacco smoking	Inverse variance weighted	34	0.4743491871401689	0.21117668677506757	0.024689953213793366	0.06044288106103646	0.8882554932193013	1.6069680216365425	1.0623069179933555	2.4308852543673405	1.607 [1.062:2.431]	positive	Current tobacco smoking (M/F) MRC-IEU/2018 [462K]	Smoking
ukb-b-223	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Current tobacco smoking	MR Egger	34	0.9812638461934465	0.7950286004231533	0.2260975373541186	-0.5769922106359339	2.539519903022827	2.667825833682717	0.5615849581018372	12.673584960183788	2.668 [0.562:12.674]	overlaps null	Current tobacco smoking (M/F) MRC-IEU/2018 [462K]	Smoking
ukb-b-223	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Current tobacco smoking	Weighted median	34	0.4938946379612753	0.2507707462469284	0.04889494627834788	0.002383975317295617	0.985405300605255	1.6386858964109072	1.0023868192459553	2.6788974231684604	1.639 [1.002:2.679]	positive	Current tobacco smoking (M/F) MRC-IEU/2018 [462K]	Smoking
ukb-b-17685	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Maternal smoking around birth	Inverse variance weighted	16	0.20426364838763333	0.2869376188477664	0.4765423333745987	-0.3581340845539889	0.7666613813292555	1.2266215076111548	0.6989793463889782	2.152567641243237	1.227 [0.699:2.153]	overlaps null	Maternal smoking around birth (M/F) MRC-IEU/2018 [397K]	Smoking
ukb-b-17685	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Maternal smoking around birth	MR Egger	16	-1.212089665810963	1.548215201557802	0.44673054056190453	-4.246591460864255	1.8224121292423288	0.2975747973863789	0.01431293706467225	6.186763739645644	0.298 [0.014:6.187]	overlaps null	Maternal smoking around birth (M/F) MRC-IEU/2018 [397K]	Smoking
ukb-b-17685	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Maternal smoking around birth	Weighted median	16	0.18188481483802627	0.40820291456457064	0.655904624472343	-0.6181928977085323	0.9819625273845847	1.1994760240823483	0.5389174371105745	2.669690444722423	1.199 [0.539:2.67]	overlaps null	Maternal smoking around birth (M/F) MRC-IEU/2018 [397K]	Smoking
ukb-b-4801	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Number of unsuccessful stop-smoking attempts	Inverse variance weighted	3	0.7223006274343468	0.7042166057877679	0.30504261921417924	-0.6579639199096784	2.102565174778372	2.0591651371631827	0.5179047572661585	8.18714445584672	2.059 [0.518:8.187]	overlaps null	Number of unsuccessful stop-smoking attempts (M/F) MRC-IEU/2018 [104K]	Smoking
ukb-b-4801	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Number of unsuccessful stop-smoking attempts	MR Egger	3	5.212186853669648	2.317834276425286	0.2663831490479292	0.6692316718760871	9.755142035463209	183.49489623409465	1.952736401814602	17242.663634821674	183.495 [1.953:17242.664]	positive	Number of unsuccessful stop-smoking attempts (M/F) MRC-IEU/2018 [104K]	Smoking
ukb-b-4801	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Number of unsuccessful stop-smoking attempts	Weighted median	3	0.18835624710189924	0.2958000276633437	0.5242754110431318	-0.3914118071182544	0.7681243013220529	1.2072635228818442	0.6761016752205135	2.1557189799976704	1.207 [0.676:2.156]	overlaps null	Number of unsuccessful stop-smoking attempts (M/F) MRC-IEU/2018 [104K]	Smoking
ukb-a-225	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Smoking status: Current	Inverse variance weighted	15	0.8450179454255803	0.7199526132956272	0.2405098879546088	-0.5660891766338491	2.2561250674850095	2.3280195914977098	0.5677414391681705	9.546027195650593	2.328 [0.568:9.546]	overlaps null	Smoking status: Current (M/F) Neale Lab/2017 [336K]	Smoking
ukb-a-225	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Smoking status: Current	MR Egger	15	4.192181390940833	3.150203007895168	0.2061369400973402	-1.982216504533696	10.366579286415362	66.16696967639949	0.13776354512963485	31779.581978946808	66.167 [0.138:31779.582]	overlaps null	Smoking status: Current (M/F) Neale Lab/2017 [336K]	Smoking
ukb-a-225	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Smoking status: Current	Weighted median	15	0.9071658583767328	0.6724142348526049	0.17729920570898208	-0.4107660419343728	2.2250977586878387	2.4772915795530444	0.663142060886947	9.254387456461844	2.477 [0.663:9.254]	overlaps null	Smoking status: Current (M/F) Neale Lab/2017 [336K]	Smoking
ukb-d-22506_114	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Tobacco smoking: Never smoked	Inverse variance weighted	3	-1.338261031347098	0.5895218283678851	0.023202799626142103	-2.4937238149481527	-0.18279824774604303	0.26230140613169695	0.08260179933728036	0.8329361855391602	0.262 [0.083:0.833]	negative	Tobacco smoking: Never smoked (M/F) Neale lab/2018 [ 91K]	Smoking
ukb-d-22506_114	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Tobacco smoking: Never smoked	MR Egger	3	-15.968017461717702	5.884694092745667	0.22478174878189722	-27.502017883499207	-4.434017039936196	1.1619250892170085e-7	1.1376938016746142e-12	0.011866724693100525	0 [0:0.012]	negative	Tobacco smoking: Never smoked (M/F) Neale lab/2018 [ 91K]	Smoking
ukb-d-22506_114	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Tobacco smoking: Never smoked	Weighted median	3	-0.9244898059148896	0.43813294530374763	0.034852597747644806	-1.7832303787102348	-0.06574923311954428	0.3967337786765118	0.16809426113998086	0.936365644344456	0.397 [0.168:0.936]	negative	Tobacco smoking: Never smoked (M/F) Neale lab/2018 [ 91K]	Smoking
met-a-558	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	1-arachidonoylglycerophosphocholine*	Inverse variance weighted	3	-0.009288049372224076	0.12937252747463981	0.9427665974568896	-0.26285820322251807	0.24428210447806994	0.9907549513245016	0.7688509101635673	1.276704443733036	0.991 [0.769:1.277]	overlaps null	1-arachidonoylglycerophosphocholine* (M/F) Shin/2014 [  7K]	Metabolites
met-a-558	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	1-arachidonoylglycerophosphocholine*	MR Egger	3	-0.053282915315448424	0.2525757319140031	0.8676405608352603	-0.5483313498668945	0.44176551923599766	0.9481117392030008	0.577913341432912	1.5554509743376315	0.948 [0.578:1.555]	overlaps null	1-arachidonoylglycerophosphocholine* (M/F) Shin/2014 [  7K]	Metabolites
met-a-558	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	1-arachidonoylglycerophosphocholine*	Weighted median	3	-0.009724662981736038	0.13815806032284414	0.9438848800105043	-0.2805144612145105	0.26106513525103847	0.9903224686498432	0.7553950200338099	1.298312228572574	0.99 [0.755:1.298]	overlaps null	1-arachidonoylglycerophosphocholine* (M/F) Shin/2014 [  7K]	Metabolites
met-a-682	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	1-arachidonoylglycerophosphoethanolamine*	Inverse variance weighted	2	0.08014786388857732	0.32738410739295953	0.8066012786967456	-0.5615249866016233	0.7218207143787779	1.0834472585561619	0.570338641539586	2.0581771540222524	1.083 [0.57:2.058]	overlaps null	1-arachidonoylglycerophosphoethanolamine* (M/F) Shin/2014 [  7K]	Metabolites
met-a-634	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	1-arachidonoylglycerophosphoinositol*	Inverse variance weighted	3	0.3074831840617717	0.3736483439461856	0.41055274441813666	-0.42486757007275205	1.0398339381962955	1.3599979386683452	0.6538563695479864	2.8287472284789095	1.36 [0.654:2.829]	overlaps null	1-arachidonoylglycerophosphoinositol* (M/F) Shin/2014 [  7K]	Metabolites
met-a-634	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	1-arachidonoylglycerophosphoinositol*	MR Egger	3	-0.8973166340499376	4.170379824454778	0.8650791696527165	-9.071261089981302	7.276627821881426	0.4076620999748337	1.1492152084662013e-4	1446.1032757971795	0.408 [0:1446.103]	overlaps null	1-arachidonoylglycerophosphoinositol* (M/F) Shin/2014 [  7K]	Metabolites
met-a-634	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	1-arachidonoylglycerophosphoinositol*	Weighted median	3	0.1929494760987972	0.265966037023017	0.4681658291456202	-0.3283439564663162	0.7142429086639106	1.2128215154967046	0.7201152887933455	2.0426396319351636	1.213 [0.72:2.043]	overlaps null	1-arachidonoylglycerophosphoinositol* (M/F) Shin/2014 [  7K]	Metabolites
met-a-427	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	2-hydroxyisobutyrate	Inverse variance weighted	2	0.009214953810763035	0.39836699022549227	0.9815451231840845	-0.7715843470312018	0.7900142546527278	1.0092575422138352	0.46228007574166935	2.2034278351306753	1.009 [0.462:2.203]	overlaps null	2-hydroxyisobutyrate (M/F) Shin/2014 [  6K]	Metabolites
met-a-500	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	3-dehydrocarnitine*	Inverse variance weighted	3	-0.8593704434058593	0.2793086295823728	0.002092515900333413	-1.40681535738731	-0.31192552942440865	0.4234285706730112	0.2449220316161703	0.7320360413438284	0.423 [0.245:0.732]	negative	3-dehydrocarnitine* (M/F) Shin/2014 [  7K]	Metabolites
met-a-500	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	3-dehydrocarnitine*	MR Egger	3	0.2837883053956304	1.7860935148157666	0.8996874744867135	-3.216954983643272	3.784531594434533	1.328151738433586	0.04007690748888804	44.01504883562311	1.328 [0.04:44.015]	overlaps null	3-dehydrocarnitine* (M/F) Shin/2014 [  7K]	Metabolites
met-a-500	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	3-dehydrocarnitine*	Weighted median	3	-0.8622949839580569	0.27434253239853934	0.0016715004596645814	-1.4000063474591942	-0.3245836204569198	0.4221920456622145	0.24659539868240818	0.7228282618931172	0.422 [0.247:0.723]	negative	3-dehydrocarnitine* (M/F) Shin/2014 [  7K]	Metabolites
met-c-841	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Albumin	Inverse variance weighted	3	0.19098308082189594	0.07609812529651747	0.012083549585600647	0.04183075524072172	0.34013540640307016	1.2104389722754934	1.0427179892611362	1.405137842343698	1.21 [1.043:1.405]	positive	Albumin (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-841	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Albumin	MR Egger	3	-0.021013171184412253	0.24044684254854842	0.944505408422763	-0.49228898257956716	0.45026264021074264	0.9792060671808344	0.6112257067265084	1.5687241414288053	0.979 [0.611:1.569]	overlaps null	Albumin (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-841	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Albumin	Weighted median	3	0.1649746347339689	0.08865791062415675	0.06277243404521222	-0.00879487008937832	0.3387441395573161	1.1793632034705848	0.991243691649267	1.403184279928354	1.179 [0.991:1.403]	overlaps null	Albumin (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-851	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Average number of double bonds in a fatty acid chain	Inverse variance weighted	5	0.007368956987390021	0.02410686175358005	0.7598492032109759	-0.039880492049626876	0.054618406024406915	1.0073961745649092	0.9609042679902793	1.0561375220557137	1.007 [0.961:1.056]	overlaps null	Average number of double bonds in a fatty acid chain (M/F) Kettunen/2016 [ 15K]	Metabolites
met-c-851	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Average number of double bonds in a fatty acid chain	MR Egger	5	-0.007976339090383311	0.050836721692846684	0.8852875197664853	-0.10761631360836281	0.09166363542759619	0.9920553874922255	0.8979720700046286	1.0959961058112608	0.992 [0.898:1.096]	overlaps null	Average number of double bonds in a fatty acid chain (M/F) Kettunen/2016 [ 15K]	Metabolites
met-c-851	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Average number of double bonds in a fatty acid chain	Weighted median	5	0.004865669501963708	0.025123925996834964	0.8464368158529504	-0.04437722545183282	0.05410856445576024	1.0048775260941014	0.9565930381623106	1.0555991964867995	1.005 [0.957:1.056]	overlaps null	Average number of double bonds in a fatty acid chain (M/F) Kettunen/2016 [ 15K]	Metabolites
met-a-362	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Betaine	Inverse variance weighted	3	-0.1734225172477235	0.249412140230867	0.486851598074517	-0.6622703121002228	0.3154252776047758	0.8407822947643595	0.5156792516533522	1.3708421754855127	0.841 [0.516:1.371]	overlaps null	Betaine (M/F) Shin/2014 [  7K]	Metabolites
met-a-362	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Betaine	MR Egger	3	0.4483443509777271	0.7261792461045271	0.6478749399749868	-0.9749669713871458	1.8716556733426002	1.5657177592759035	0.3772048119091141	6.499047796618852	1.566 [0.377:6.499]	overlaps null	Betaine (M/F) Shin/2014 [  7K]	Metabolites
met-a-362	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Betaine	Weighted median	3	-0.07346110864207356	0.28271541721889937	0.7949862817865967	-0.6275833263911164	0.48066110910696924	0.9291722818606135	0.5338804580612656	1.617143156940545	0.929 [0.534:1.617]	overlaps null	Betaine (M/F) Shin/2014 [  7K]	Metabolites
met-c-875	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cholesterol esters in large HDL	Inverse variance weighted	13	0.06846478915589038	0.02661314074471286	0.010093972773187356	0.016303033296253176	0.12062654501552758	1.0708629182998628	1.0164366528908952	1.1282035004623068	1.071 [1.016:1.128]	positive	Cholesterol esters in large HDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-875	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cholesterol esters in large HDL	MR Egger	13	0.04106966310523201	0.07075233873847045	0.5732964036373247	-0.09760492082217008	0.17974424703263409	1.0419246867264302	0.9070071726250218	1.1969112103800146	1.042 [0.907:1.197]	overlaps null	Cholesterol esters in large HDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-875	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cholesterol esters in large HDL	Weighted median	13	0.05987485394973017	0.028438565027239987	0.03525558894780415	0.004135266496339794	0.11561444140312055	1.061703670210175	1.0041438285088373	1.1225629748794852	1.062 [1.004:1.123]	positive	Cholesterol esters in large HDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-887	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cholesterol esters in large VLDL	Inverse variance weighted	12	-0.12180690324873716	0.025032526101641757	1.1391101034892839e-6	-0.170870654407955	-0.07274315208951931	0.885319304280011	0.8429305957776543	0.9298396267224694	0.885 [0.843:0.93]	negative	Cholesterol esters in large VLDL (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-887	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cholesterol esters in large VLDL	MR Egger	12	-0.11346174110286883	0.062116833394283165	0.09771968676570765	-0.23521073455566383	0.008287252349926166	0.8927383509425573	0.7904042665850366	1.0083216866819535	0.893 [0.79:1.008]	overlaps null	Cholesterol esters in large VLDL (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-887	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cholesterol esters in large VLDL	Weighted median	12	-0.12181783705758127	0.032814281101805405	2.053501749246917e-4	-0.18613382801711986	-0.05750184609804268	0.885309624420891	0.830162488547792	0.9441201474464571	0.885 [0.83:0.944]	negative	Cholesterol esters in large VLDL (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-910	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cholesterol esters in medium VLDL	Inverse variance weighted	14	-0.09025613778546021	0.023578736898204875	1.2926148534344383e-4	-0.13647046210594177	-0.04404181346497866	0.9136971229387532	0.8724320896856711	0.9569139447488009	0.914 [0.872:0.957]	negative	Cholesterol esters in medium VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-910	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cholesterol esters in medium VLDL	MR Egger	14	-0.1384213307646015	0.06493094906284139	0.05437790516777437	-0.2656859909277706	-0.011156670601432384	0.8707317483756554	0.7666798341304208	0.9889053342445834	0.871 [0.767:0.989]	negative	Cholesterol esters in medium VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-910	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cholesterol esters in medium VLDL	Weighted median	14	-0.11452464895177962	0.030756803125777242	1.9643702010945549e-4	-0.174807983078303	-0.05424131482525623	0.8917899564595759	0.8396182261988223	0.9472035046721903	0.892 [0.84:0.947]	negative	Cholesterol esters in medium VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-958	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of chylomicrons and largest VLDL particles	Inverse variance weighted	7	-0.13647228924331092	0.034392046551524155	7.243724808176846e-5	-0.20388070048429827	-0.06906387800232358	0.8724304956338542	0.815559661256462	0.9332670629384954	0.872 [0.816:0.933]	negative	Concentration of chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-958	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of chylomicrons and largest VLDL particles	MR Egger	7	-0.20278226566051225	0.1183409980428357	0.1472830512130664	-0.4347306218244702	0.029166090503445707	0.8164559925799079	0.6474390495394972	1.0295955863239545	0.816 [0.647:1.03]	overlaps null	Concentration of chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-958	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of chylomicrons and largest VLDL particles	Weighted median	7	-0.12329892310255597	0.04499938231891932	0.0061436627358605785	-0.21149771244763782	-0.0351001337574741	0.8839993752260936	0.8093711325294543	0.9655087313997891	0.884 [0.809:0.966]	negative	Concentration of chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-878	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of large HDL particles	Inverse variance weighted	11	0.04769466315705248	0.022571632772541067	0.03459772263209845	0.0034542629228719868	0.09193506339123297	1.0488503537712817	1.003460235764317	1.0962936301788049	1.049 [1.003:1.096]	positive	Concentration of large HDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-878	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of large HDL particles	MR Egger	11	-0.03724546047527307	0.061912860208784296	0.5622995459510625	-0.15859466648449028	0.08410374553394415	0.9634396199756369	0.85334217706312665	1.0877417363024986	0.963 [0.853:1.088]	overlaps null	Concentration of large HDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-878	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of large HDL particles	Weighted median	11	0.039862327948886625	0.02582751937066679	0.12273249045979709	-0.010759610017620283	0.09048426591539353	1.0406674935013838	0.9892980675382291	1.0947042833363294	1.041 [0.989:1.095]	overlaps null	Concentration of large HDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-890	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of large VLDL particles	Inverse variance weighted	10	-0.12646981816478128	0.02655322153662789	1.908489744448696e-6	-0.17851413237657193	-0.07442550395299062	0.8812007453978499	0.8365122348879458	0.9282766244222876	0.881 [0.837:0.928]	negative	Concentration of large VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-890	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of large VLDL particles	MR Egger	10	-0.14112289705271303	0.06866390849724356	0.07390087652083754	-0.2757041577073104	-0.006541636398115641	0.8683825834793736	0.7590374529283391	0.9934797135254205	0.868 [0.759:0.993]	negative	Concentration of large VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-890	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of large VLDL particles	Weighted median	10	-0.1236804286963851	0.03458213455401212	3.4832449267251965e-4	-0.19146141242224884	-0.055899444970521336	0.8836621888428389	0.8257514882414739	0.9456342193865607	0.884 [0.826:0.946]	negative	Concentration of large VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-913	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of medium VLDL particles	Inverse variance weighted	14	-0.11035454073457089	0.02355048317663528	2.7877097407829377e-6	-0.15651348776077603	-0.06419559370836575	0.89551658190028	0.8551199839713493	0.9378215495958171	0.896 [0.855:0.938]	negative	Concentration of medium VLDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-913	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of medium VLDL particles	MR Egger	14	-0.11406153282325966	0.058088043447828246	0.07317150853560525	-0.22791409798100304	-2.089676655162992e-4	0.8922030544204453	0.796192651454193	0.9997910541667056	0.892 [0.796:1]	negative	Concentration of medium VLDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-913	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of medium VLDL particles	Weighted median	14	-0.11440293136978946	0.03189294459211793	3.3438616905639095e-4	-0.1769131027703406	-0.051892759969238325	0.8918985095829971	0.8378525884285166	0.9494306783588102	0.892 [0.838:0.949]	negative	Concentration of medium VLDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-922	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of small HDL particles	Inverse variance weighted	5	-0.10790029524882243	0.033157303116209146	0.0011371461411958529	-0.17288860935659234	-0.042911981141052505	0.8977170986284101	0.8412313149232943	0.9579957080452889	0.898 [0.841:0.958]	negative	Concentration of small HDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-922	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of small HDL particles	MR Egger	5	-0.0918478143584173	0.1017545022680234	0.43324872738211334	-0.29128663880374317	0.10759101008690858	0.9122439694153924	0.747301441724049	1.1135922042581154	0.912 [0.747:1.114]	overlaps null	Concentration of small HDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-922	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of small HDL particles	Weighted median	5	-0.12129533405155979	0.03789157182352351	0.0013689619229939763	-0.19556281482566587	-0.04702785327745371	0.8857723222308823	0.8223716848077177	0.9540608234994604	0.886 [0.822:0.954]	negative	Concentration of small HDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-930	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of small VLDL particles	Inverse variance weighted	15	-0.09300584129086811	0.02485398122391065	1.8249593276333087e-4	-0.14171964448973298	-0.04429203809200324	0.9111881777654134	0.8678645329863549	0.956674531268705	0.911 [0.868:0.957]	negative	Concentration of small VLDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-930	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of small VLDL particles	MR Egger	15	-0.14921413070397127	0.06936477795954253	0.050849304070001274	-0.2851690955046746	-0.013259165903267922	0.8613846462487709	0.7518871028402008	0.986828349615693	0.861 [0.752:0.987]	negative	Concentration of small VLDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-930	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of small VLDL particles	Weighted median	15	-0.11042423180961508	0.03038293737400863	2.7861107803300395e-4	-0.169974789062672	-0.05087367455655817	0.89545417456161	0.8436860864453161	0.950398722489524	0.895 [0.844:0.95]	negative	Concentration of small VLDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-950	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of very large VLDL particles	Inverse variance weighted	8	-0.1391135720800407	0.03054059008982566	5.237591602806355e-6	-0.19897312865609898	-0.0792540155039824	0.8701292004631066	0.8195719160358419	0.9238052337867739	0.87 [0.82:0.924]	negative	Concentration of very large VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-950	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of very large VLDL particles	MR Egger	8	-0.1474471708351918	0.09406101746894645	0.16802695798173464	-0.3318067650743268	0.03691242340394324	0.8629080238274478	0.7176259798602032	1.0376021471949004	0.863 [0.718:1.038]	overlaps null	Concentration of very large VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-950	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of very large VLDL particles	Weighted median	8	-0.1257316760997071	0.038953422141044504	0.0012477056358277843	-0.20208038349615431	-0.049382968703259866	0.8818514368576273	0.817029249635	0.9518165439429187	0.882 [0.817:0.952]	negative	Concentration of very large VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-876	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in large HDL	Inverse variance weighted	15	0.07445180427094335	0.028229346242206483	0.008354664028228386	0.019122285636218643	0.12978132290566805	1.0772934213292022	1.0193062875143497	1.1385793748700286	1.077 [1.019:1.139]	positive	Free cholesterol in large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-876	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in large HDL	MR Egger	15	0.02131627183290428	0.06835952569043706	0.7601175625469423	-0.11266839852035236	0.15530094218616092	1.0215450864883218	0.893446879307105	1.1680094115251047	1.022 [0.893:1.168]	overlaps null	Free cholesterol in large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-876	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in large HDL	Weighted median	15	0.06246314860057412	0.0274318915474934	0.022784633177449512	0.008696641167487057	0.11622965603366119	1.0644552315301636	1.0087345668134733	1.1232538045277984	1.064 [1.009:1.123]	positive	Free cholesterol in large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-888	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in large VLDL	Inverse variance weighted	11	-0.12507005035914637	0.02637282075439679	2.1121749142335026e-6	-0.17676077903776408	-0.07337932168052866	0.8824350855248027	0.837980222982774	0.9292482791460498	0.882 [0.838:0.929]	negative	Free cholesterol in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-888	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in large VLDL	MR Egger	11	-0.1535991016708226	0.07400215525877674	0.06774622456470622	-0.298643325978025	-0.008554877363620206	0.857615768831691	0.7418239515869592	0.991481611473088	0.858 [0.742:0.991]	negative	Free cholesterol in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-888	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in large VLDL	Weighted median	11	-0.12323526509205208	0.03460548986308423	3.692371131536707e-4	-0.1910620252236972	-0.05540850496040699	0.8840556506587792	0.8260813486816965	0.9460985830378118	0.884 [0.826:0.946]	negative	Free cholesterol in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-900	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in medium HDL	Inverse variance weighted	5	0.11669574610345133	0.03952141376631666	0.0031498553598640964	0.03923377512147068	0.194157717085432	1.1237774639987026	1.040013584535637	1.2142877817843363	1.124 [1.04:1.214]	positive	Free cholesterol in medium HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-900	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in medium HDL	MR Egger	5	0.03682892044723237	0.10411507636804955	0.7469385187522444	-0.16723662923414473	0.24089447012860948	1.0375155079650864	0.8459993994601498	1.2723867534125315	1.038 [0.846:1.272]	overlaps null	Free cholesterol in medium HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-900	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in medium HDL	Weighted median	5	0.09410323523355575	0.044327712584716294	0.033762356904511404	0.007220918567511822	0.1809855518995997	1.0986731618432775	1.0072470522652224	1.1983978645954505	1.099 [1.007:1.198]	positive	Free cholesterol in medium HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-911	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in medium VLDL	Inverse variance weighted	12	-0.09803225220913797	0.02568532701648649	1.352684059889097e-4	-0.1483754931614515	-0.047689011256824454	0.9066196627954076	0.8621073387478393	0.9534302470514942	0.907 [0.862:0.953]	negative	Free cholesterol in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-911	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in medium VLDL	MR Egger	12	-0.1581984893165408	0.06429818617493616	0.03365410043291088	-0.2842229342194157	-0.03217404441366592	0.8536803187277081	0.752598845966592	0.9683380335868752	0.854 [0.753:0.968]	negative	Free cholesterol in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-911	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in medium VLDL	Weighted median	12	-0.107295916676635	0.031354324015921156	6.21519609321743e-4	-0.16875039174784046	-0.045841441605429536	0.8982598235958577	0.8447197260877901	0.955193404116864	0.898 [0.845:0.955]	negative	Free cholesterol in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-928	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in small VLDL	Inverse variance weighted	14	-0.08928076033160041	0.023129484166710342	1.1336793894604074e-4	-0.13461454929835268	-0.043946971364848146	0.9145887572814528	0.8740527510125415	0.957004704780833	0.915 [0.874:0.957]	negative	Free cholesterol in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-928	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in small VLDL	MR Egger	14	-0.11987207309103168	0.06945203071418214	0.10998368997536542	-0.2559980532908287	0.016253907108765314	0.887033904964794	0.7741434758229858	1.0163867204598207	0.887 [0.774:1.016]	overlaps null	Free cholesterol in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-928	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in small VLDL	Weighted median	14	-0.11749955820744458	0.03195936252925698	2.3642797289115378e-4	-0.18013990876478825	-0.05485920765010091	0.8891409045621936	0.8351533579623305	0.9466184152028932	0.889 [0.835:0.947]	negative	Free cholesterol in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-944	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in very large HDL	Inverse variance weighted	13	0.03288667900735022	0.023260297628003326	0.1574045957103306	-0.012703504343536301	0.07847686235823674	1.0334334229042401	0.9873768445702961	1.0816383283125888	1.033 [0.987:1.082]	overlaps null	Free cholesterol in very large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-944	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in very large HDL	MR Egger	13	0.09423142219776633	0.06720487548849277	0.18845397810704995	-0.03749013375967951	0.22595297815521215	1.0988140064475822	0.9632039208753025	1.2535167212236644	1.099 [0.963:1.254]	overlaps null	Free cholesterol in very large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-944	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in very large HDL	Weighted median	13	0.02741290738962521	0.02970827552010288	0.3561445885307011	-0.030815312629776433	0.08564112740902685	1.0277920981124278	0.9696546395052583	1.0894152968538626	1.028 [0.97:1.089]	overlaps null	Free cholesterol in very large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-a-573	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Isobutyrylcarnitine	Inverse variance weighted	3	0.008620633555971006	0.10764768613117211	0.9361721010746648	-0.20236883126112631	0.21961009837306833	1.0086578982221313	0.8167936133600383	1.2455909779468692	1.009 [0.817:1.246]	overlaps null	Isobutyrylcarnitine (M/F) Shin/2014 [  7K]	Metabolites
met-a-573	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Isobutyrylcarnitine	MR Egger	3	-0.05726221810678428	0.22755683809781754	0.8430599634917567	-0.5032736207785067	0.3887491845649381	0.9443464121694941	0.6045483547698178	1.475134518423999	0.944 [0.605:1.475]	overlaps null	Isobutyrylcarnitine (M/F) Shin/2014 [  7K]	Metabolites
met-a-573	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Isobutyrylcarnitine	Weighted median	3	-0.019724653146590415	0.12009142735022871	0.8695367259043918	-0.25510385075303865	0.21565454445985785	0.9804686050878945	0.77483602647781	1.2406737073557228	0.98 [0.775:1.241]	overlaps null	Isobutyrylcarnitine (M/F) Shin/2014 [  7K]	Metabolites
met-a-652	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Isovalerylcarnitine	Inverse variance weighted	3	-0.5378056523021991	0.2690561898813127	0.04562350508258359	-1.0651557844695718	-0.010455520134826313	0.5840284087003479	0.3446741557040673	0.989598948816793	0.584 [0.345:0.99]	negative	Isovalerylcarnitine (M/F) Shin/2014 [  7K]	Metabolites
met-a-652	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Isovalerylcarnitine	MR Egger	3	-5.282615422119265	2.295121990293282	0.26092616659620504	-9.781054523094097	-0.7841763211444324	0.005079129338604079	5.6512171225328604e-5	0.4564955527085873	0.005 [0:0.456]	negative	Isovalerylcarnitine (M/F) Shin/2014 [  7K]	Metabolites
met-a-652	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Isovalerylcarnitine	Weighted median	3	-0.5218900279102952	0.1733011459419774	0.002599918929754271	-0.8615602739565709	-0.18221978186401944	0.5933979487473978	0.422502348357999	0.8334181500909825	0.593 [0.423:0.833]	negative	Isovalerylcarnitine (M/F) Shin/2014 [  7K]	Metabolites
met-c-896	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Mean diameter for LDL particles	Inverse variance weighted	8	0.06580256885905464	0.04784888582219956	0.1690643889870824	-0.027981247352456495	0.15958638507056577	1.0680158367642991	0.9724066018285419	1.173025589742418	1.068 [0.972:1.173]	overlaps null	Mean diameter for LDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-896	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Mean diameter for LDL particles	MR Egger	8	0.11494204678257361	0.13092219397888225	0.41374548454726107	-0.14166545341603556	0.3715495469811828	1.1218084232805978	0.8679115647715613	1.449979686437906	1.122 [0.868:1.45]	overlaps null	Mean diameter for LDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-896	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Mean diameter for LDL particles	Weighted median	8	0.07688040889273073	0.03752757535707855	0.04049754689319522	0.003326361192856786	0.15043445659260468	1.079912920687878	1.0033318996715404	1.1623391189400083	1.08 [1.003:1.162]	positive	Mean diameter for LDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-941	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Mean diameter for VLDL particles	Inverse variance weighted	14	-0.08740642742509121	0.025746985869436943	6.867329728094295e-4	-0.13787051972918762	-0.0369423351209948	0.91630460862113	0.8712114891426711	0.9637317072190558	0.916 [0.871:0.964]	negative	Mean diameter for VLDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-941	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Mean diameter for VLDL particles	MR Egger	14	-0.21713305390679283	0.08749367981233498	0.028868012819410524	-0.3886206663389694	-0.04564544147461627	0.8048228773525501	0.6779914062029441	0.9553806404976011	0.805 [0.678:0.955]	negative	Mean diameter for VLDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-941	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Mean diameter for VLDL particles	Weighted median	14	-0.09720512861197068	0.03112472113975596	0.0017896646678850245	-0.15820958204589236	-0.036200675178049	0.9073698595220996	0.8536708491355016	0.9644467335424624	0.907 [0.854:0.964]	negative	Mean diameter for VLDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-959	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Phospholipids in chylomicrons and largest VLDL particles	Inverse variance weighted	8	-0.16139536229168447	0.033812756987187255	1.813132908055248e-6	-0.22766836598657147	-0.09512235859679745	0.850955568847561	0.7963883255030891	0.9092616716791225	0.851 [0.796:0.909]	negative	Phospholipids in chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-959	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Phospholipids in chylomicrons and largest VLDL particles	MR Egger	8	-0.13214049418743964	0.10936833490429751	0.2724189613587813	-0.34650243059986274	0.08222144222498348	0.876217882911824	0.7071571004692311	1.0856962021947267	0.876 [0.707:1.086]	overlaps null	Phospholipids in chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-959	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Phospholipids in chylomicrons and largest VLDL particles	Weighted median	8	-0.14534783670843335	0.042109456481676945	5.571341062879541e-4	-0.22788237141252016	-0.06281330200434654	0.8647214589272034	0.7962179123155931	0.9391187889186946	0.865 [0.796:0.939]	negative	Phospholipids in chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-891	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Phospholipids in large VLDL	Inverse variance weighted	9	-0.1437606428089494	0.02838859143939504	4.1048773317549194e-7	-0.1994022820301637	-0.08811900358773513	0.8660950293244867	0.8192202694433443	0.9156519043776667	0.866 [0.819:0.916]	negative	Phospholipids in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-891	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Phospholipids in large VLDL	MR Egger	9	-0.10411786366875334	0.07904076140105579	0.22922740262151137	-0.2590377560148227	0.05080202867731601	0.9011190819608723	0.7717938826323213	1.0521145841484278	0.901 [0.772:1.052]	overlaps null	Phospholipids in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-891	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Phospholipids in large VLDL	Weighted median	9	-0.1283436032572234	0.03661558086376739	4.563266843329563e-4	-0.2001101417502075	-0.05657706476423932	0.8795511105908944	0.8186405816058022	0.944993655975621	0.88 [0.819:0.945]	negative	Phospholipids in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-914	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Phospholipids in medium VLDL	Inverse variance weighted	15	-0.10670024010894345	0.023124976924004968	3.948611623378793e-6	-0.1520251948799932	-0.061375285337893715	0.8987950553211446	0.8589666389071074	0.9404702288526271	0.899 [0.859:0.94]	negative	Phospholipids in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-914	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Phospholipids in medium VLDL	MR Egger	15	-0.1442039428575533	0.058814814026673996	0.029112676871059118	-0.25948097834983436	-0.028926907365272272	0.8657111744436213	0.7714518821422399	0.9714874704503862	0.866 [0.771:0.971]	negative	Phospholipids in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-914	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Phospholipids in medium VLDL	Weighted median	15	-0.11003332657056042	0.029995057232977233	2.4409034969977207e-4	-0.1688236387471958	-0.05124301439392504	0.895804280714486	0.8446578551685152	0.9500477671948013	0.896 [0.845:0.95]	negative	Phospholipids in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-931	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Phospholipids in small VLDL	Inverse variance weighted	14	-0.0869378799931443	0.024375253610818774	3.61580575317713e-4	-0.13471337707034908	-0.0391623829159395	0.9167340413893346	0.8739663745948164	0.9615945499409454	0.917 [0.874:0.962]	negative	Phospholipids in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-931	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Phospholipids in small VLDL	MR Egger	14	-0.1553254723160559	0.0706893905569387	0.048370944343098146	-0.2938766778076557	-0.01677426682445607	0.8561364834083558	0.7453684062415669	0.9833656378310156	0.856 [0.745:0.983]	negative	Phospholipids in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-931	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Phospholipids in small VLDL	Weighted median	14	-0.10545031060507827	0.030402271884566956	5.233705680217289e-4	-0.1650387634988295	-0.04586185771132704	0.8999191881757743	0.847860837398328	0.9551739029862423	0.9 [0.848:0.955]	negative	Phospholipids in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-951	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Phospholipids in very large VLDL	Inverse variance weighted	9	-0.13071630542882093	0.030511608099948028	1.8343913920705106e-5	-0.19051905730471907	-0.0709135535529228	0.8774666716151064	0.8265300061447788	0.9315424171792565	0.877 [0.827:0.932]	negative	Phospholipids in very large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-951	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Phospholipids in very large VLDL	MR Egger	9	-0.20277548693944575	0.09738920408335945	0.07584796434791861	-0.39365832694283026	-0.011892646936061235	0.8164615271261031	0.6745845042191455	0.9881777910815066	0.816 [0.675:0.988]	negative	Phospholipids in very large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-951	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Phospholipids in very large VLDL	Weighted median	9	-0.11880898128920075	0.039413529011820894	0.0025747000143003873	-0.1960594981523697	-0.04155846442603181	0.8879774048617517	0.8219633279239431	0.9592932491727564	0.888 [0.822:0.959]	negative	Phospholipids in very large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-a-355	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Proline	Inverse variance weighted	3	-0.41343546335839454	0.21269887823640674	0.05192446081334407	-0.8303252647017517	0.003454337984962641	0.6613742158738989	0.43590747794435114	1.0034603110861429	0.661 [0.436:1.003]	overlaps null	Proline (M/F) Shin/2014 [  7K]	Metabolites
met-a-355	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Proline	MR Egger	3	-0.72129811964253	0.2757889222149565	0.23249328160908175	-1.2618444071838448	-0.18075183210121526	0.4861208032347297	0.2831313351515824	0.8346424644628674	0.486 [0.283:0.835]	negative	Proline (M/F) Shin/2014 [  7K]	Metabolites
met-a-355	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Proline	Weighted median	3	-0.46749464811248914	0.19721346103452062	0.017764010131000874	-0.8540330317401496	-0.08095626448482873	0.6265700820377472	0.4256946253193642	0.9222340249427878	0.627 [0.426:0.922]	negative	Proline (M/F) Shin/2014 [  7K]	Metabolites
met-a-501	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Pyroglutamine*	Inverse variance weighted	3	-0.15165467574489636	0.14492660221073558	0.2953653138052186	-0.43571081607793805	0.13240146458814536	0.8592849614518877	0.6468047444255673	1.141566525819357	0.859 [0.647:1.142]	overlaps null	Pyroglutamine* (M/F) Shin/2014 [  7K]	Metabolites
met-a-501	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Pyroglutamine*	MR Egger	3	-0.20476639857291729	0.39897276935550763	0.698128472357967	-0.9867530265097122	0.5772202293638777	0.8148376414163282	0.37278515154532804	1.781080547646737	0.815 [0.373:1.781]	overlaps null	Pyroglutamine* (M/F) Shin/2014 [  7K]	Metabolites
met-a-501	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Pyroglutamine*	Weighted median	3	-0.20540877769083699	0.16429866440021984	0.2112207454279033	-0.5274341599152679	0.1166166045335939	0.8143143748167496	0.5901171751126503	1.1236885300052657	0.814 [0.59:1.124]	overlaps null	Pyroglutamine* (M/F) Shin/2014 [  7K]	Metabolites
met-c-844	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ratio of bisallylic groups to double bonds	Inverse variance weighted	4	9.857213553321703e-4	0.019376413055844484	0.9594273335305832	-0.03699204823412302	0.038963490944787356	1.0009862073382956	0.96368379830653	1.0397325233051142	1.001 [0.964:1.04]	overlaps null	Ratio of bisallylic groups to double bonds (M/F) Kettunen/2016 [ 13K]	Metabolites
met-c-844	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ratio of bisallylic groups to double bonds	MR Egger	4	0.0037748770588465594	0.043355485324233764	0.938549950308044	-0.08120187417665162	0.08875162829434474	1.0037820108808604	0.9220075431423341	1.092809199731764	1.004 [0.922:1.093]	overlaps null	Ratio of bisallylic groups to double bonds (M/F) Kettunen/2016 [ 13K]	Metabolites
met-c-844	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ratio of bisallylic groups to double bonds	Weighted median	4	6.232038171379695e-4	0.020537220297922102	0.9757918357628799	-0.03962974796678935	0.04087615560106529	1.0006233980489834	0.9611452392594486	1.0417230859870292	1.001 [0.961:1.042]	overlaps null	Ratio of bisallylic groups to double bonds (M/F) Kettunen/2016 [ 13K]	Metabolites
met-c-845	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ratio of bisallylic groups to total fatty acids	Inverse variance weighted	6	0.010146816280090102	0.021632118797011688	0.639024944138288	-0.03225213656205281	0.05254576912223301	1.0101984697787623	0.9682624169420393	1.0539507993776038	1.01 [0.968:1.054]	overlaps null	Ratio of bisallylic groups to total fatty acids (M/F) Kettunen/2016 [ 13K]	Metabolites
met-c-845	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ratio of bisallylic groups to total fatty acids	MR Egger	6	-0.021671919188979802	0.03763889397270726	0.5956035722432083	-0.09544415137548604	0.05210031299752643	0.9785612295540874	0.908969124911481	1.0534814150916958	0.979 [0.909:1.053]	overlaps null	Ratio of bisallylic groups to total fatty acids (M/F) Kettunen/2016 [ 13K]	Metabolites
met-c-845	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ratio of bisallylic groups to total fatty acids	Weighted median	6	0.005996552862870561	0.02138135560582238	0.7791268389330565	-0.0359109041245413	0.047904009850282425	1.0060145681779171	0.9647262427833808	1.0490699501096183	1.006 [0.965:1.049]	overlaps null	Ratio of bisallylic groups to total fatty acids (M/F) Kettunen/2016 [ 13K]	Metabolites
met-a-464	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Serine	Inverse variance weighted	3	0.42679103282379804	0.3468814952273124	0.21856025734468176	-0.25309669782173416	1.1066787634693303	1.5323324210862561	0.7763928027009712	3.0242972893920803	1.532 [0.776:3.024]	overlaps null	Serine (M/F) Shin/2014 [  7K]	Metabolites
met-a-464	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Serine	MR Egger	3	-2.2074602446421197	4.905816403147815	0.7308197874942098	-11.822860394811837	7.4079399055275985	0.10997961542924553	7.3349468328668945e-6	1649.025696514445	0.11 [0:1649.026]	overlaps null	Serine (M/F) Shin/2014 [  7K]	Metabolites
met-a-464	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Serine	Weighted median	3	0.17863707979149568	0.30055988150765056	0.5522795688305244	-0.4104602879634994	0.7677344475464908	1.1955867628250978	0.6633448502055563	2.154878728612497	1.196 [0.663:2.155]	overlaps null	Serine (M/F) Shin/2014 [  7K]	Metabolites
met-c-864	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in HDL	Inverse variance weighted	12	0.05999628415924076	0.023417591021135848	0.010406599591494405	0.014097805757814504	0.10589476256066702	1.061832600937171	1.0141976484573414	1.1117048773757054	1.062 [1.014:1.112]	positive	Total cholesterol in HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-864	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in HDL	MR Egger	12	0.03278721628590523	0.06023448848562157	0.5981439174199733	-0.08527238114591304	0.15084681371772352	1.0333306399151885	0.9182621330427003	1.1628185165922333	1.033 [0.918:1.163]	overlaps null	Total cholesterol in HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-864	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in HDL	Weighted median	12	0.05753865421210337	0.029672861360504656	0.05248912682089741	-6.20154054485754e-4	0.1156974624786925	1.059226213418141	0.9993800382012951	1.122656175133796	1.059 [0.999:1.123]	overlaps null	Total cholesterol in HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-874	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in large HDL	Inverse variance weighted	14	0.06827598102190094	0.025763352843493254	0.008046314548516375	0.017779809448654163	0.11877215259514771	1.0706607497566334	1.0179388112030963	1.1261133070607785	1.071 [1.018:1.126]	positive	Total cholesterol in large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-874	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in large HDL	MR Egger	14	0.049435012294841714	0.0645893272999413	0.4588380969479482	-0.07716006921304322	0.17603009380272663	1.0506773088888934	0.9257416590072768	1.1924739441863337	1.051 [0.926:1.192]	overlaps null	Total cholesterol in large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-874	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in large HDL	Weighted median	14	0.05945930517242475	0.02793464391591515	0.03329441777359646	0.0047074030972310554	0.11421120724761845	1.0612625722033746	1.0047185003254	1.1209888608550087	1.061 [1.005:1.121]	positive	Total cholesterol in large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-886	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in large VLDL	Inverse variance weighted	10	-0.12704895722217777	0.027009031955249025	2.5518403647291545e-6	-0.17998665985446585	-0.07411125458988968	0.8806905553785264	0.8352813541117751	0.9285683805999895	0.881 [0.835:0.929]	negative	Total cholesterol in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-886	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in large VLDL	MR Egger	10	-0.14964163628946006	0.08016091253887898	0.09889735416004168	-0.30675702486566286	0.007473752286742741	0.8610164782038002	0.7358293674278641	1.0075017504804227	0.861 [0.736:1.008]	overlaps null	Total cholesterol in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-886	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in large VLDL	Weighted median	10	-0.12157493890969891	0.03486880662533823	4.89131237459446e-4	-0.18991779989536184	-0.053232077924035975	0.8855246906074971	0.8270271128646028	0.9481599399557794	0.886 [0.827:0.948]	negative	Total cholesterol in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-898	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in medium HDL	Inverse variance weighted	6	0.1282270726508281	0.04128856867219345	0.0018987328030868414	0.047301478053328946	0.20915266724832726	1.136811112103874	1.0484380424987805	1.2326331668801018	1.137 [1.048:1.233]	positive	Total cholesterol in medium HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-898	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in medium HDL	MR Egger	6	0.009686890072176317	0.09027558118654538	0.9197148046904773	-0.16725324905345262	0.18662702919780527	1.0097339598556487	0.8459853392198358	1.2051777051195771	1.01 [0.846:1.205]	overlaps null	Total cholesterol in medium HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-898	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in medium HDL	Weighted median	6	0.09393472313726355	0.04316959632632063	0.02955927663247467	0.009322314337675122	0.17854713193685195	1.0984880377239001	1.0093659024520594	1.195479227197113	1.098 [1.009:1.195]	positive	Total cholesterol in medium HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-909	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in medium VLDL	Inverse variance weighted	15	-0.08677884385983368	0.02565408625204566	7.178956176853554e-4	-0.13706085291384318	-0.03649683480582419	0.91687984682041	0.8719171658175185	0.964161145648737	0.917 [0.872:0.964]	negative	Total cholesterol in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-909	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in medium VLDL	MR Egger	15	-0.1443103293228145	0.06946000037438936	0.05812475189655003	-0.2804519300566176	-0.008168728589011381	0.8656190793907556	0.7554422572359621	0.991864544812267	0.866 [0.755:0.992]	negative	Total cholesterol in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-909	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in medium VLDL	Weighted median	15	-0.10964135850933875	0.030358063184938174	3.043068331471029e-4	-0.16914316235181756	-0.050139554666859924	0.8961554762058432	0.8443880101591805	0.9510966852576763	0.896 [0.844:0.951]	negative	Total cholesterol in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-927	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in small VLDL	Inverse variance weighted	16	-0.07309572499407573	0.025738730921479377	0.004512601248719013	-0.12354363760017531	-0.022647812387976148	0.9295118482508036	0.8837830742301636	0.9776067241287939	0.93 [0.884:0.978]	negative	Total cholesterol in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-927	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in small VLDL	MR Egger	16	-0.11115923678940622	0.06920516952624252	0.1305367655712348	-0.24680136906084155	0.02448289548202913	0.8947962531015264	0.781295867651628	1.0247850625027721	0.895 [0.781:1.025]	overlaps null	Total cholesterol in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-927	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in small VLDL	Weighted median	16	-0.11880429567237741	0.03473252172255456	6.249485496234096e-4	-0.18688003824858435	-0.05072855309617047	0.8879815655933664	0.8295432438771486	0.9505366557483782	0.888 [0.83:0.951]	negative	Total cholesterol in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-942	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in very large HDL	Inverse variance weighted	13	0.076499152284363	0.023164231956281034	9.583776413372994e-4	0.031097257650052182	0.12190104691867383	1.0795012752266664	1.0315858286212884	1.1296423146617378	1.08 [1.032:1.13]	positive	Total cholesterol in very large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-942	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in very large HDL	MR Egger	13	0.15715980456272013	0.060018968399500924	0.02389238480554394	0.03952262649969833	0.2747969826257419	1.1701825994785537	1.040314037283912	1.3162634233961437	1.17 [1.04:1.316]	positive	Total cholesterol in very large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-942	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in very large HDL	Weighted median	13	0.06403487352242243	0.03095963636168123	0.03860861152771259	0.0033539862535272233	0.12471576079131763	1.0661295778069562	1.0033596171589882	1.1328264136174944	1.066 [1.003:1.133]	positive	Total cholesterol in very large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-957	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in chylomicrons and largest VLDL particles	Inverse variance weighted	9	-0.1580819956803169	0.03255767449229373	1.2011673108995228e-6	-0.2218950376852126	-0.09426895367542118	0.8537797728449829	0.8009994346772803	0.9100379712663815	0.854 [0.801:0.91]	negative	Total lipids in chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-957	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in chylomicrons and largest VLDL particles	MR Egger	9	-0.14349196880799683	0.10312194614188781	0.20669840497559125	-0.34561098324609696	0.058627045630103264	0.8663277578038663	0.7077877748598841	1.060379693743722	0.866 [0.708:1.06]	overlaps null	Total lipids in chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-957	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in chylomicrons and largest VLDL particles	Weighted median	9	-0.14797936743054527	0.041037613821936554	3.110193307640811e-4	-0.2284130905215409	-0.06754564433954963	0.8624489092954954	0.7957954563672207	0.934685056560255	0.862 [0.796:0.935]	negative	Total lipids in chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-877	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in large HDL	Inverse variance weighted	11	0.048765567456615304	0.022433951357405946	0.029724700209653933	0.004795022796099654	0.09273611211713095	1.049974173769164	1.0048065373146773	1.097172166622741	1.05 [1.005:1.097]	positive	Total lipids in large HDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-877	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in large HDL	MR Egger	11	-0.03119514834165917	0.06337815690130184	0.6343562531117103	-0.15541633586821077	0.09302603918489244	0.9692863999846689	0.8560586953404475	1.0974903126491833	0.969 [0.856:1.097]	overlaps null	Total lipids in large HDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-877	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in large HDL	Weighted median	11	0.0423095208213381	0.026080753711836324	0.10474968113453813	-0.008808756453861095	0.09342779809653728	1.043217326267832	0.9912299269736443	1.097931327747675	1.043 [0.991:1.098]	overlaps null	Total lipids in large HDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-889	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in large VLDL	Inverse variance weighted	9	-0.13801087319195948	0.028963381386987706	1.8884197963830093e-6	-0.1947791007104554	-0.08124264567346358	0.8710892201740006	0.8230164417245981	0.9219699522810514	0.871 [0.823:0.922]	negative	Total lipids in large VLDL (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-889	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in large VLDL	MR Egger	9	-0.1399677688897556	0.08735175932157849	0.15311321331900124	-0.3111772171600494	0.031241679380538234	0.8693862562315017	0.7325840379022198	1.0317348227905419	0.869 [0.733:1.032]	overlaps null	Total lipids in large VLDL (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-889	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in large VLDL	Weighted median	9	-0.1289171776891787	0.03763654916576735	6.140785029765181e-4	-0.20268481405408273	-0.0551495413242747	0.879046767215321	0.8165355614049556	0.946343619893463	0.879 [0.817:0.946]	negative	Total lipids in large VLDL (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-912	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in medium VLDL	Inverse variance weighted	12	-0.11445934418932477	0.024417679938437607	2.7648141153228274e-6	-0.16231799686866247	-0.06660069150998707	0.8918481964924971	0.8501708098948115	0.9355687072875755	0.892 [0.85:0.936]	negative	Total lipids in medium VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-912	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in medium VLDL	MR Egger	12	-0.09426061943347849	0.05814542321906888	0.13605908284793825	-0.2082256489428535	0.019704410075896517	0.9100455557746165	0.8120237837289253	1.0198998233549275	0.91 [0.812:1.02]	overlaps null	Total lipids in medium VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-912	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in medium VLDL	Weighted median	12	-0.1105312698016938	0.03260744616874808	6.995498730686275e-4	-0.17444186429244002	-0.04662067531094756	0.8953583320742518	0.8399256824837131	0.9544493751449623	0.895 [0.84:0.954]	negative	Total lipids in medium VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-929	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in small VLDL	Inverse variance weighted	14	-0.08653354122459518	0.02516489010622232	5.845975082123421e-4	-0.13585672583279093	-0.03721035661639943	0.917104787451169	0.8729676972490544	0.9634734410177108	0.917 [0.873:0.963]	negative	Total lipids in small VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-929	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in small VLDL	MR Egger	14	-0.16125724404660235	0.07022748412663785	0.04047405171388618	-0.29890311293481253	-0.023611375158392178	0.8510731094544373	0.7416312604305126	0.976665192370637	0.851 [0.742:0.977]	negative	Total lipids in small VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-929	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in small VLDL	Weighted median	14	-0.11245877879880363	0.030221671316441642	1.9833301300939613e-4	-0.17169325457902923	-0.053224303018578015	0.8936341830237545	0.8422374860405419	0.9481673118383294	0.894 [0.842:0.948]	negative	Total lipids in small VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-945	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in very large HDL	Inverse variance weighted	13	0.03113368171531053	0.022282571760654027	0.1623470626541994	-0.012540158935571359	0.07480752236619242	1.031623403855147	0.9875381412169622	1.0776767022590013	1.032 [0.988:1.078]	overlaps null	Total lipids in very large HDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-945	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in very large HDL	MR Egger	13	0.08360077193370295	0.06559164300454602	0.2287296957664085	-0.044958848355207234	0.21216039222261313	1.0871947684919734	0.9560368235113769	1.2363461694864832	1.087 [0.956:1.236]	overlaps null	Total lipids in very large HDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-945	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in very large HDL	Weighted median	13	0.025597766347294947	0.028032400871374877	0.36116404127107143	-0.029345739360599813	0.08054127205518971	1.0259282026205179	0.9710806656120896	1.083873579409326	1.026 [0.971:1.084]	overlaps null	Total lipids in very large HDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-949	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in very large VLDL	Inverse variance weighted	8	-0.13888720379556607	0.03193228050540157	1.3649213549752374e-5	-0.20147447358615314	-0.076299934004979	0.8703261924130103	0.8175244457610849	0.9265382645468836	0.87 [0.818:0.927]	negative	Total lipids in very large VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-949	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in very large VLDL	MR Egger	8	-0.15665991487470268	0.09928921316465975	0.165684021041172	-0.3512667726774358	0.037946942928030414	0.8549947803868588	0.7037959752729448	1.0386761223027337	0.855 [0.704:1.039]	overlaps null	Total lipids in very large VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-949	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in very large VLDL	Weighted median	8	-0.1321570084196415	0.03982136984824031	9.042266582133542e-4	-0.2102068933221925	-0.0541071235170905	0.8762034129657266	0.8104165588498923	0.9473306196782552	0.876 [0.81:0.947]	negative	Total lipids in very large VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-960	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in chylomicrons and largest VLDL particles	Inverse variance weighted	9	-0.1434123807589228	0.031290879986435836	4.5791230400172605e-6	-0.20474250553233703	-0.08208225598550856	0.866396709883813	0.814857110597749	0.921196181680064	0.866 [0.815:0.921]	negative	Triglycerides in chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-960	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in chylomicrons and largest VLDL particles	MR Egger	9	-0.13613945657791493	0.1012844855387672	0.2208353923785597	-0.33465704823389864	0.062378135078068775	0.8727209173293212	0.715583454885015	1.0643647422878413	0.873 [0.716:1.064]	overlaps null	Triglycerides in chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-960	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in chylomicrons and largest VLDL particles	Weighted median	9	-0.1208612007442065	0.03982472137155677	0.002406724727376278	-0.19891765463245778	-0.04280474685595523	0.8861569489822952	0.819617382248773	0.9580984435384525	0.886 [0.82:0.958]	negative	Triglycerides in chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-892	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in large VLDL	Inverse variance weighted	9	-0.13898693491108374	0.028578113504227242	1.1538352315127515e-6	-0.19500003737936913	-0.08297383244279835	0.8702393981390936	0.8228346272989785	0.9203752308765191	0.87 [0.823:0.92]	negative	Triglycerides in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-892	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in large VLDL	MR Egger	9	-0.11327873719501394	0.08293484741362912	0.21423988726737914	-0.275831038125727	0.04927356373569913	0.8929017404994795	0.7589411520481949	1.0505076922437995	0.893 [0.759:1.051]	overlaps null	Triglycerides in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-892	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in large VLDL	Weighted median	9	-0.1265279612649587	0.037147170525694856	6.589164501355365e-4	-0.1993364154953206	-0.05371950703459677	0.8811495111441073	0.8192742304208575	0.9476978918165821	0.881 [0.819:0.948]	negative	Triglycerides in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-915	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in medium VLDL	Inverse variance weighted	13	-0.12579674830294924	0.025042050322852935	5.075924831135174e-7	-0.174879166935741	-0.07671432967015748	0.8817940547087104	0.8395584610618879	0.9261543906497661	0.882 [0.84:0.926]	negative	Triglycerides in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-915	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in medium VLDL	MR Egger	13	-0.10763554913961602	0.061850134410503334	0.10967490920985735	-0.22886181258420257	0.013590714304970511	0.8979547972009378	0.795438445493901	1.0136834878725507	0.898 [0.795:1.014]	overlaps null	Triglycerides in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-915	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in medium VLDL	Weighted median	13	-0.1157791414210209	0.0356632822919518	0.001168530671679128	-0.1856791747132464	-0.04587910812879538	0.8906719141095333	0.8305400104802558	0.9551574259797789	0.891 [0.831:0.955]	negative	Triglycerides in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-923	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in small HDL	Inverse variance weighted	11	-0.12681078099445475	0.026375200898970833	1.5248202051290666e-6	-0.1785061747564376	-0.07511538723247192	0.8809003399146508	0.8365188915610344	0.9276364427510715	0.881 [0.837:0.928]	negative	Triglycerides in small HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-923	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in small HDL	MR Egger	11	-0.08727435267118043	0.07532308609844134	0.2764111790390633	-0.23490760142412542	0.060358896081764576	0.9164256373190628	0.7906439006242212	1.0622177039152412	0.916 [0.791:1.062]	overlaps null	Triglycerides in small HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-923	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in small HDL	Weighted median	11	-0.11574537914351934	0.03378036213397634	6.116158428018876e-4	-0.18195488892611297	-0.049535869360925716	0.8907019857295007	0.833638945915601	0.95167102169288	0.891 [0.834:0.952]	negative	Triglycerides in small HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-932	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in small VLDL	Inverse variance weighted	14	-0.11045884081425132	0.022008326801599195	5.195283806463968e-7	-0.15359516134538576	-0.0673225202831169	0.895423184320205	0.8576191481235776	0.9348936305496338	0.895 [0.858:0.935]	negative	Triglycerides in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-932	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in small VLDL	MR Egger	14	-0.08295394941334716	0.05925179190217503	0.1868258992077923	-0.19908746154161022	0.033179562714915886	0.9203935309062701	0.819478217370319	1.0337361430453973	0.92 [0.819:1.034]	overlaps null	Triglycerides in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-932	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in small VLDL	Weighted median	14	-0.11024371026439743	0.02840605026319151	1.040304133496538e-4	-0.16591956878025277	-0.054567851748542076	0.8956158379242946	0.847114365891119	0.946894258246985	0.896 [0.847:0.947]	negative	Triglycerides in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-952	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in very large VLDL	Inverse variance weighted	9	-0.12919312947451506	0.030344978388132226	2.0674442697885334e-5	-0.18866928711525421	-0.0697169718337759	0.878804226156872	0.828060311631231	0.9326577509671952	0.879 [0.828:0.933]	negative	Triglycerides in very large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-952	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in very large VLDL	MR Egger	9	-0.1768021798402719	0.08801568970510383	0.08452052483509577	-0.3493129316622754	-0.004291428018268401	0.837945530647207	0.7051724249597823	0.9957177670009927	0.838 [0.705:0.996]	negative	Triglycerides in very large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-952	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in very large VLDL	Weighted median	9	-0.11233003023569328	0.038999300802102246	0.003972858102874547	-0.18876865980781368	-0.03589140066357288	0.8937492445476091	0.8279780291368467	0.964745058467487	0.894 [0.828:0.965]	negative	Triglycerides in very large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-956	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in very small VLDL	Inverse variance weighted	19	-0.05829070810011696	0.02705990034299835	0.031229500496405174	-0.11132811277239373	-0.005253303427840195	0.9433756606240346	0.894645156263383	0.994760471039571	0.943 [0.895:0.995]	negative	Triglycerides in very small VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-956	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in very small VLDL	MR Egger	19	-0.186950211258257	0.07600684634344747	0.024918703837987975	-0.335923630091414	-0.037976792425099964	0.8294850343734641	0.7146776836013456	0.9627352833831391	0.829 [0.715:0.963]	negative	Triglycerides in very small VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-956	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in very small VLDL	Weighted median	19	-0.09861071084699942	0.029804020761964225	9.375102310622293e-4	-0.1570265915404493	-0.04019483015354954	0.9060953724749605	0.854681331222315	0.9606022666323819	0.906 [0.855:0.961]	negative	Triglycerides in very small VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-a-316	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Uridine	Inverse variance weighted	3	-0.613019112500326	0.436892928354729	0.16057702715689812	-1.4693292520755947	0.24329102707494277	0.5417129055159164	0.23007975896230407	1.2754397576128162	0.542 [0.23:1.275]	overlaps null	Uridine (M/F) Shin/2014 [  7K]	Metabolites
met-a-316	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Uridine	MR Egger	3	-1.0382132110770557	2.0921612166460224	0.7067508082818752	-5.13884919570326	3.0624227735491485	0.35408679542776456	0.00586443464813228	21.37929164855372	0.354 [0.006:21.379]	overlaps null	Uridine (M/F) Shin/2014 [  7K]	Metabolites
met-a-316	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Uridine	Weighted median	3	-0.7187557784891332	0.522432349340956	0.16888750209444434	-1.7427231831974068	0.30521162621914044	0.48735826051107006	0.17504307662654514	1.3569121308072156	0.487 [0.175:1.357]	overlaps null	Uridine (M/F) Shin/2014 [  7K]	Metabolites
met-a-485	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-02269	Inverse variance weighted	2	0.2629313037834396	0.11727214843884891	0.02495743377908358	0.033077892843295736	0.49278471472358343	1.3007373601470726	1.0336310485670062	1.6368680898546895	1.301 [1.034:1.637]	positive	X-02269 (M/F) Shin/2014 [  7K]	Metabolites
met-a-373	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-03094	Inverse variance weighted	5	-0.4925463041581029	0.2804932296708164	0.07908829116130744	-1.042313034312903	0.057220425996697244	0.6110684453970464	0.3526380739366207	1.0588891913783387	0.611 [0.353:1.059]	overlaps null	X-03094 (M/F) Shin/2014 [  7K]	Metabolites
met-a-373	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-03094	MR Egger	5	-0.4204339367655353	1.262069721619165	0.7609590147954134	-2.894090591139099	2.053222717608028	0.6567617648956389	0.05534933739186867	7.792975239703621	0.657 [0.055:7.793]	overlaps null	X-03094 (M/F) Shin/2014 [  7K]	Metabolites
met-a-373	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-03094	Weighted median	5	-0.7300674267438123	0.31050774432062933	0.018712710493214112	-1.338662605612246	-0.1214722478753788	0.48187649763162943	0.2621960937840619	0.885615630723179	0.482 [0.262:0.886]	negative	X-03094 (M/F) Shin/2014 [  7K]	Metabolites
met-a-444	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-10510	Inverse variance weighted	3	0.2930065898297068	0.19759159568501758	0.13810365419897816	-0.09427293771292766	0.6802861173723412	1.340451623750507	0.910034345648194	1.9744425737421476	1.34 [0.91:1.974]	overlaps null	X-10510 (M/F) Shin/2014 [  7K]	Metabolites
met-a-444	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-10510	MR Egger	3	0.27942540860245724	0.44257271557621264	0.6414786043753313	-0.5880171139269195	1.146867931131834	1.3223697717067504	0.5554275430702981	3.1483167065455433	1.322 [0.555:3.148]	overlaps null	X-10510 (M/F) Shin/2014 [  7K]	Metabolites
met-a-444	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-10510	Weighted median	3	0.2774729078713748	0.21404135322776052	0.19485428685323194	-0.14204814445503583	0.6969939601977855	1.319790362729137	0.8675794863388515	2.0077083759820384	1.32 [0.868:2.008]	overlaps null	X-10510 (M/F) Shin/2014 [  7K]	Metabolites
met-a-495	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-11315	Inverse variance weighted	3	-0.632528413097631	0.4826439237613749	0.1900102482469245	-1.5785105036699258	0.3134536774746638	0.5312468898834773	0.20628212595933876	1.3681420854974988	0.531 [0.206:1.368]	overlaps null	X-11315 (M/F) Shin/2014 [  7K]	Metabolites
met-a-495	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-11315	MR Egger	3	-1.1455852732741036	2.164103472327524	0.6900571059207614	-5.387228079036051	3.096057532487844	0.3180377243284993	0.004574636307531847	22.110608865128103	0.318 [0.005:22.111]	overlaps null	X-11315 (M/F) Shin/2014 [  7K]	Metabolites
met-a-495	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-11315	Weighted median	3	-0.8356462293756782	0.3024774007947073	0.005733012378808503	-1.4285019349333046	-0.24279052381805188	0.4335941895739027	0.239667691242873	0.7844358171820968	0.434 [0.24:0.784]	negative	X-11315 (M/F) Shin/2014 [  7K]	Metabolites
met-a-513	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-11440	Inverse variance weighted	3	-0.11663942959489236	0.05799922191888383	0.04432000387103707	-0.23031790455590467	-0.0029609546338800613	0.8899060090917769	0.7942810567961213	0.9970434246689199	0.89 [0.794:0.997]	negative	X-11440 (M/F) Shin/2014 [  7K]	Metabolites
met-a-513	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-11440	MR Egger	3	-0.17062356012574406	0.09140069978190919	0.3130815910306134	-0.34976893169828605	0.00852181144679795	0.8431389048431013	0.7048509396128424	1.0085582254462129	0.843 [0.705:1.009]	overlaps null	X-11440 (M/F) Shin/2014 [  7K]	Metabolites
met-a-513	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-11440	Weighted median	3	-0.11682654305408942	0.05876703259874094	0.04681605204823573	-0.23200992694762168	-0.00164315916055717	0.8897395112775323	0.7929382518111209	0.998358190086346	0.89 [0.793:0.998]	negative	X-11440 (M/F) Shin/2014 [  7K]	Metabolites
met-a-517	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-11445--5-alpha-pregnan-3beta,20alpha-disulfate	Inverse variance weighted	2	-0.22231737484341588	0.09958286964060731	0.02558285119444048	-0.41749979933900616	-0.027134950347825565	0.8006612142788645	0.6586916240217384	0.9732298949490655	0.801 [0.659:0.973]	negative	X-11445--5-alpha-pregnan-3beta,20alpha-disulfate (M/F) Shin/2014 [  2K]	Metabolites
met-a-519	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-11469	Inverse variance weighted	2	0.24366217154225853	0.11755630458130313	0.038197657874711764	0.01325181456290439	0.47407252852161264	1.275913217877893	1.0133400090057112	1.6065235015766006	1.276 [1.013:1.607]	positive	X-11469 (M/F) Shin/2014 [  7K]	Metabolites
met-a-629	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-12510--2-aminooctanoic acid	Inverse variance weighted	3	0.08417405426007751	0.1516857573222502	0.5789467035392954	-0.21313003009153286	0.3814781386116879	1.0878182167269292	0.8080510594317784	1.4644476470027616	1.088 [0.808:1.464]	overlaps null	X-12510--2-aminooctanoic acid (M/F) Shin/2014 [  7K]	Metabolites
met-a-629	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-12510--2-aminooctanoic acid	MR Egger	3	-0.09284722323425679	0.27637214792902176	0.7936691741973231	-0.6345366331751394	0.4488421867066259	0.911332720126589	0.5301810997418694	1.5664974235741118	0.911 [0.53:1.566]	overlaps null	X-12510--2-aminooctanoic acid (M/F) Shin/2014 [  7K]	Metabolites
met-a-629	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-12510--2-aminooctanoic acid	Weighted median	3	0.05584876607809561	0.08150396281232529	0.4932003003511156	-0.10389900103406197	0.21559653319025318	1.057437751185021	0.9013163248410818	1.2406017363863777	1.057 [0.901:1.241]	overlaps null	X-12510--2-aminooctanoic acid (M/F) Shin/2014 [  7K]	Metabolites
prot-a-54	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Advanced glycosylation end product-specific receptor, soluble	Inverse variance weighted	5	0.003107477845390231	0.026237564181465813	0.9057220306812249	-0.04831814795028276	0.054533103641063216	1.0031123110597422	0.9528305977488899	1.0560474348503248	1.003 [0.953:1.056]	overlaps null	Advanced glycosylation end product-specific receptor, soluble (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-54	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Advanced glycosylation end product-specific receptor, soluble	MR Egger	5	0.010335836678264213	0.08347642327584152	0.9092898267800376	-0.15327795294238516	0.17394962629891358	1.0103894359434364	0.8578912352758207	1.1899956198268773	1.01 [0.858:1.19]	overlaps null	Advanced glycosylation end product-specific receptor, soluble (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-54	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Advanced glycosylation end product-specific receptor, soluble	Weighted median	5	0.015104933897403342	0.023011051587004835	0.5115533828215845	-0.029996727213126136	0.060206595007932816	1.015219589974857	0.9704487096151094	1.0620559393370639	1.015 [0.97:1.062]	overlaps null	Advanced glycosylation end product-specific receptor, soluble (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-67	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Alcohol dehydrogenase [NADP(+)]	Inverse variance weighted	3	-0.03097325087266536	0.009933694616649766	0.0018208335970268717	-0.050443292321298905	-0.01150320942403182	0.9695015060484187	0.9508078452493653	0.9885626995259369	0.97 [0.951:0.989]	negative	Alcohol dehydrogenase [NADP(+)] (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-67	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Alcohol dehydrogenase [NADP(+)]	MR Egger	3	-0.022761561698953395	0.021176955674501934	0.47705078425561254	-0.06426839482097718	0.0187452714230704	0.9774955283618584	0.9377532776287433	1.018922066989256	0.977 [0.938:1.019]	overlaps null	Alcohol dehydrogenase [NADP(+)] (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-67	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Alcohol dehydrogenase [NADP(+)]	Weighted median	3	-0.029509688730157566	0.009813815848342643	0.0026388005222273392	-0.04874476779290915	-0.010274609667405985	0.9709214705994904	0.9524241880066228	0.9897779938202513	0.971 [0.952:0.99]	negative	Alcohol dehydrogenase [NADP(+)] (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1411	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Alpha-L-iduronidase	Inverse variance weighted	2	0.01900193425190641	0.01289633815060682	0.14063339726818402	-0.006274888523282958	0.04427875702709578	1.0191836199733615	0.9937447574760765	1.0452736916672607	1.019 [0.994:1.045]	overlaps null	Alpha-L-iduronidase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-99	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Angiopoietin-related protein 4	Inverse variance weighted	3	0.06414666115837656	0.03470786162037629	0.06457511825342246	-0.0038807476175609784	0.13217406993431408	1.0662487645737593	0.9961267727521105	1.1413069692064046	1.066 [0.996:1.141]	overlaps null	Angiopoietin-related protein 4 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-99	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Angiopoietin-related protein 4	MR Egger	3	-0.24169358210412273	0.18391900486608284	0.41410735469105436	-0.6021748316416451	0.11878766743339964	0.7852967696728836	0.5476193601522128	1.126130778662125	0.785 [0.548:1.126]	overlaps null	Angiopoietin-related protein 4 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-99	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Angiopoietin-related protein 4	Weighted median	3	0.03956425245201452	0.03706592889486521	0.28579027487842196	-0.03308496818192129	0.11221347308595032	1.0403573422477208	0.9674563530892029	1.1187516585246355	1.04 [0.967:1.119]	overlaps null	Angiopoietin-related protein 4 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-216	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Beta-1,4-galactosyltransferase 1	Inverse variance weighted	5	0.025865222839561622	0.04131379237930605	0.5312706661842211	-0.05510981022387823	0.10684025590300147	1.026202630476028	0.9463812199137748	1.1127564840010953	1.026 [0.946:1.113]	overlaps null	Beta-1,4-galactosyltransferase 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-216	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Beta-1,4-galactosyltransferase 1	MR Egger	5	-0.11631874098906626	0.12285942733335647	0.41360655292770815	-0.35712321856244494	0.12448573658431243	0.8901914375735336	0.6996862780854414	1.1325658660872957	0.89 [0.7:1.133]	overlaps null	Beta-1,4-galactosyltransferase 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-216	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Beta-1,4-galactosyltransferase 1	Weighted median	5	-0.014309807109040267	0.02608215992643965	0.5832501376742667	-0.06543084056486198	0.03681122634678145	0.985792091551596	0.9366638236605936	1.0374971502238814	0.986 [0.937:1.037]	overlaps null	Beta-1,4-galactosyltransferase 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-212	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Beta-1,4-glucuronyltransferase 1	Inverse variance weighted	3	0.032347109271670844	0.017637694998032864	0.06665755722844426	-0.002222772924473565	0.06691699146781525	1.0328759639129264	0.9977796956059304	1.0692067212103287	1.033 [0.998:1.069]	overlaps null	Beta-1,4-glucuronyltransferase 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-212	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Beta-1,4-glucuronyltransferase 1	MR Egger	3	0.05074352198518305	0.051859252133605434	0.5069225016942163	-0.05090061219668359	0.1523876561670497	1.0520530302050408	0.9503731213355807	1.1646116178119343	1.052 [0.95:1.165]	overlaps null	Beta-1,4-glucuronyltransferase 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-212	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Beta-1,4-glucuronyltransferase 1	Weighted median	3	0.03620327044852635	0.01720213045542111	0.03532782971673022	0.002487094755900976	0.06991944614115173	1.0368665894079854	1.002490190141704	1.0724217900611888	1.037 [1.002:1.072]	positive	Beta-1,4-glucuronyltransferase 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-674	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Beta-crystallin B2	Inverse variance weighted	3	0.03968012683900044	0.08876550653847379	0.6548592358211168	-0.13430026597640818	0.21366051965440905	1.040477900001643	0.8743274943860532	1.238202238112184	1.04 [0.874:1.238]	overlaps null	Beta-crystallin B2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-674	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Beta-crystallin B2	MR Egger	3	0.9928752390977786	0.3195094087464359	0.1982032009466088	0.3666367979547642	1.619113680240793	2.698983549812229	1.4428737692307831	5.048613646944667	2.699 [1.443:5.049]	positive	Beta-crystallin B2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-674	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Beta-crystallin B2	Weighted median	3	0.0034418049070433637	0.04137668775725827	0.9337066469879366	-0.07765650309718285	0.08454011291126957	1.0034477347186856	0.9252822035338545	1.0882164948882223	1.003 [0.925:1.088]	overlaps null	Beta-crystallin B2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-390	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	C-C motif chemokine 14	Inverse variance weighted	3	-0.025570755715501003	0.014169584709116645	0.07113372684037388	-0.053343141745369624	0.0022016303143676218	0.9747534071509348	0.9480546395372541	1.0022040556819825	0.975 [0.948:1.002]	overlaps null	C-C motif chemokine 14 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-390	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	C-C motif chemokine 14	MR Egger	3	-0.010297412090475853	0.023778448271472172	0.7398295704574123	-0.05690317070256131	0.0363083465216096	0.9897554247410069	0.9446855381749836	1.0369755450017244	0.99 [0.945:1.037]	overlaps null	C-C motif chemokine 14 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-390	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	C-C motif chemokine 14	Weighted median	3	-0.023288308745290136	0.014561598164637727	0.1097548014409856	-0.05182904114798008	0.005252423657399811	0.9769807710648314	0.9494911768899288	1.0052662418168878	0.977 [0.949:1.005]	overlaps null	C-C motif chemokine 14 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-394	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	C-C motif chemokine 17	Inverse variance weighted	6	0.01075223098590553	0.015764246851116243	0.4951982535166865	-0.020145692842282306	0.041650154814093364	1.010810243958015	0.9800558757785813	1.042529690951312	1.011 [0.98:1.043]	overlaps null	C-C motif chemokine 17 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-394	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	C-C motif chemokine 17	MR Egger	6	-0.02250801594002713	0.034056402150417914	0.5447980194673077	-0.08925856415484625	0.04424253227479198	0.9777433996294703	0.9146090578804639	1.045235827572503	0.978 [0.915:1.045]	overlaps null	C-C motif chemokine 17 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-394	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	C-C motif chemokine 17	Weighted median	6	0.00712846059806292	0.019116210966129477	0.7092218780473363	-0.03033931289555085	0.04459623409167669	1.0071539285531177	0.9701163047234972	1.0456055947735992	1.007 [0.97:1.046]	overlaps null	C-C motif chemokine 17 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-399	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	C-C motif chemokine 23	Inverse variance weighted	3	0.013813699344682911	0.014708889775516359	0.34765912783934205	-0.015015724615329152	0.042643123304694976	1.0139095493285746	0.9850964492185468	1.0435654042151614	1.014 [0.985:1.044]	overlaps null	C-C motif chemokine 23 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-399	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	C-C motif chemokine 23	MR Egger	3	0.04608236701488214	0.04174145260112418	0.4685590451772826	-0.03573088008332124	0.12789561411308553	1.0471606589024713	0.9648999323339561	1.1364343687958087	1.047 [0.965:1.136]	overlaps null	C-C motif chemokine 23 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-399	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	C-C motif chemokine 23	Weighted median	3	0.016280937318321333	0.015735723463411712	0.30083325431568014	-0.014561080669965622	0.04712295530660829	1.0164141939771705	0.9855444191804822	1.0482508891657278	1.016 [0.986:1.048]	overlaps null	C-C motif chemokine 23 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-408	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	C-C motif chemokine 3-like 1	Inverse variance weighted	3	0.011665608248264464	0.02018578446639201	0.5633234938476674	-0.027898529305863874	0.051229745802392805	1.0117339168180848	0.9724870407299675	1.0525646878252746	1.012 [0.972:1.053]	overlaps null	C-C motif chemokine 3-like 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-408	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	C-C motif chemokine 3-like 1	MR Egger	3	-0.010861626688063907	0.04934718086966736	0.8620752311567765	-0.10758210119261194	0.08585884781648412	0.9891971477911384	0.8980027923239596	1.0896525106183854	0.989 [0.898:1.09]	overlaps null	C-C motif chemokine 3-like 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-408	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	C-C motif chemokine 3-like 1	Weighted median	3	0.013219085331199512	0.021450648159941185	0.5377257368623973	-0.028824185062285207	0.05526235572468423	1.0133068437085009	0.971587269006355	1.0568178405184192	1.013 [0.972:1.057]	overlaps null	C-C motif chemokine 3-like 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-670	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	C-reactive protein	Inverse variance weighted	3	0.06808708328432635	0.025609651997690424	0.007845458172661189	0.017892165368853116	0.11828200119979958	1.0704585234639403	1.0180531890803308	1.1255614763033586	1.07 [1.018:1.126]	positive	C-reactive protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-670	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	C-reactive protein	MR Egger	3	0.5025071383004491	0.3768784669729627	0.409663999602167	-0.2361746569665577	1.241188933567456	1.6528600289964557	0.7896427452814982	3.459724402939025	1.653 [0.79:3.46]	overlaps null	C-reactive protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-670	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	C-reactive protein	Weighted median	3	0.06409950053342559	0.031492570454148605	0.041812165338154655	0.002374062443294321	0.12582493862355684	1.0661984808013851	1.0023768827609651	1.1340836166652373	1.066 [1.002:1.134]	positive	C-reactive protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-486	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cadherin-7	Inverse variance weighted	4	-0.04964580694248379	0.028379283100757793	0.0802274454839737	-0.10526920181996907	0.0059775879350014785	0.9515664030331827	0.9000821862063834	1.005995489365111	0.952 [0.9:1.006]	overlaps null	Cadherin-7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-486	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cadherin-7	MR Egger	4	0.0018403688668681133	0.08506182845781153	0.9847030675641989	-0.16488081491044249	0.1685615526441787	1.0018420633850045	0.8479947663974133	1.1836010783787605	1.002 [0.848:1.184]	overlaps null	Cadherin-7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-486	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cadherin-7	Weighted median	4	-0.04312539867511186	0.02218119211210761	0.051867398089997636	-0.08660053521484277	3.4973786461905965e-4	0.9577912767790226	0.9170433490000088	1.0003497990300365	0.958 [0.917:1]	overlaps null	Cadherin-7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-488	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cadherin-related family member 3	Inverse variance weighted	2	-0.09947081491636542	0.04125437226497285	0.015901952388373164	-0.18032938455571218	-0.018612245277018644	0.9053163712169612	0.8349951316097929	0.9815598929461283	0.905 [0.835:0.982]	negative	Cadherin-related family member 3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-346	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Calcium/calmodulin-dependent protein kinase type 1	Inverse variance weighted	3	-0.017707581441697214	0.007729771343069135	0.02197332748856303	-0.03285793327411272	-0.0025572296092817096	0.9824482764671114	0.9676760243887184	0.997446037317002	0.982 [0.968:0.997]	negative	Calcium/calmodulin-dependent protein kinase type 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-346	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Calcium/calmodulin-dependent protein kinase type 1	MR Egger	3	0.009130334985583443	0.04761090514431428	0.8793799370447872	-0.08418703909727254	0.10244770906843942	1.0091721436395238	0.9192593025844965	1.10787936835089	1.009 [0.919:1.108]	overlaps null	Calcium/calmodulin-dependent protein kinase type 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-346	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Calcium/calmodulin-dependent protein kinase type 1	Weighted median	3	-0.01765383536920533	0.00785887852385069	0.02468124322558771	-0.03305723727595268	-0.0022504334624579778	0.9825010806223932	0.967483181902351	0.9977520968644598	0.983 [0.967:0.998]	negative	Calcium/calmodulin-dependent protein kinase type 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-366	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Calpastatin	Inverse variance weighted	4	0.07193657549437726	0.024309294293937248	0.003084177789684635	0.02429035867826026	0.11958279231049426	1.0745871867413466	1.0245877726556754	1.1270265493366811	1.075 [1.025:1.127]	positive	Calpastatin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-366	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Calpastatin	MR Egger	4	0.015336099359500118	0.03583675150484489	0.7103684078381556	-0.05490393358999586	0.08557613230899609	1.015454300807977	0.9465760777513497	1.0893444924986615	1.015 [0.947:1.089]	overlaps null	Calpastatin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-366	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Calpastatin	Weighted median	4	0.06768097097665764	0.02597938832989167	0.009182612764743942	0.016761369850069964	0.11860057210324532	1.070023885344631	1.016902629742509	1.1259201045609792	1.07 [1.017:1.126]	positive	Calpastatin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-550	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Carbohydrate sulfotransferase 11	Inverse variance weighted	2	0.078374249172355	0.03265273742299078	0.016384541211747976	0.014374883823293064	0.14237361452141695	1.081527343652091	1.0144786993145045	1.1530073483627892	1.082 [1.014:1.153]	positive	Carbohydrate sulfotransferase 11 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-643	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Carboxypeptidase A4	Inverse variance weighted	2	0.009650067186179646	0.006980398035849426	0.16683287286001683	-0.004031512964085229	0.023331647336444522	1.0096967792217113	0.9959766026745408	1.0236059594502736	1.01 [0.996:1.024]	overlaps null	Carboxypeptidase A4 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-710	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cardiotrophin-1	Inverse variance weighted	3	-0.02971990168449531	0.011948530795832609	0.012870708291619353	-0.053139022044327223	-0.006300781324663399	0.970717391779483	0.9482481759184704	0.9937190269735672	0.971 [0.948:0.994]	negative	Cardiotrophin-1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-710	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cardiotrophin-1	MR Egger	3	-0.2205114571950144	0.1386162515556744	0.3572664512258445	-0.4921993102441362	0.05117639585410741	0.8021084488960627	0.6112805192206515	1.052508535051499	0.802 [0.611:1.053]	overlaps null	Cardiotrophin-1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-710	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cardiotrophin-1	Weighted median	3	-0.031051431330471033	0.012416330746434515	0.012389421668213425	-0.05538743959348268	-0.0067154230674593834	0.9694257129396411	0.9461185131615271	0.9933070749965183	0.969 [0.946:0.993]	negative	Cardiotrophin-1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-722	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cathepsin F	Inverse variance weighted	2	0.07131580260029848	0.10017837895921326	0.47653402999086214	-0.1250338201597595	0.2676654253603565	1.0739203191515703	0.8824670569030584	1.3069098079808599	1.074 [0.882:1.307]	overlaps null	Cathepsin F (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-532	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cell growth regulator with EF hand domain protein 1	Inverse variance weighted	4	0.03785240311852926	0.021036365285628734	0.07195868010302912	-0.003378872841303053	0.07908367907836159	1.0385779307015786	0.9966268291256541	1.0822948837195894	1.039 [0.997:1.082]	overlaps null	Cell growth regulator with EF hand domain protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-532	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cell growth regulator with EF hand domain protein 1	MR Egger	4	0.055476186680869954	0.04978537796336952	0.38110105705174113	-0.0421031541273343	0.1530555274890742	1.0570438450502928	0.9587708742984252	1.1653896883093318	1.057 [0.959:1.165]	overlaps null	Cell growth regulator with EF hand domain protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-532	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cell growth regulator with EF hand domain protein 1	Weighted median	4	0.03828493807876235	0.023815135917451085	0.10792533756959607	-0.00839272831944178	0.08496260447696648	1.039027249131493	0.9916423923035855	1.0886763543154891	1.039 [0.992:1.089]	overlaps null	Cell growth regulator with EF hand domain protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-412	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cerebral cavernous malformations 2 protein	Inverse variance weighted	4	-0.05429856911058014	0.05132463396845744	0.29008114654185774	-0.15489485168875672	0.046297713467596445	0.947149274764936	0.8565052328277497	1.0473861855180948	0.947 [0.857:1.047]	overlaps null	Cerebral cavernous malformations 2 protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-412	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cerebral cavernous malformations 2 protein	MR Egger	4	0.12133082374537411	0.1435810408656176	0.48706472740052775	-0.16008801635123637	0.40274966384198463	1.1289983500555973	0.8520687896798079	1.4959323588266233	1.129 [0.852:1.496]	overlaps null	Cerebral cavernous malformations 2 protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-412	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cerebral cavernous malformations 2 protein	Weighted median	4	-0.015646980348141964	0.03363955265748135	0.641833782109912	-0.0815805035568054	0.05028654286052148	0.9844747976687994	0.9216585100790331	1.0515723737655442	0.984 [0.922:1.052]	overlaps null	Cerebral cavernous malformations 2 protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-381	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Coiled-coil domain-containing protein 134	Inverse variance weighted	3	0.04642377181974514	0.05469861746631166	0.39603750939622484	-0.06078551841422571	0.153633062053716	1.0475182256169082	0.9410250506779977	1.166062935528664	1.048 [0.941:1.166]	overlaps null	Coiled-coil domain-containing protein 134 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-381	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Coiled-coil domain-containing protein 134	MR Egger	3	-0.40801844929193776	0.19946842398117515	0.289474135794612	-0.798976560295041	-0.017060338288834465	0.664966610546105	0.4497890606200419	0.9830843652169344	0.665 [0.45:0.983]	negative	Coiled-coil domain-containing protein 134 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-381	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Coiled-coil domain-containing protein 134	Weighted median	3	0.060020878753916714	0.044429861661682266	0.17672329581861224	-0.027061650102980526	0.14710340761081395	1.0618587166007554	0.9733012355532658	1.1584737518390795	1.062 [0.973:1.158]	overlaps null	Coiled-coil domain-containing protein 134 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-303	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Complement C1q tumor necrosis factor-related protein 1	Inverse variance weighted	6	0.018873767415339682	0.014954942952352638	0.20693364244044046	-0.010437920771271487	0.04818545560195085	1.0190530028034823	0.9896163652817256	1.0493652479434907	1.019 [0.99:1.049]	overlaps null	Complement C1q tumor necrosis factor-related protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-303	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Complement C1q tumor necrosis factor-related protein 1	MR Egger	6	0.0023654260600521238	0.03145242467697185	0.9436615074447243	-0.0592813263068127	0.06401217842691695	1.0023682258874345	0.9424415982448511	1.0661053821689288	1.002 [0.942:1.066]	overlaps null	Complement C1q tumor necrosis factor-related protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-303	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Complement C1q tumor necrosis factor-related protein 1	Weighted median	6	0.006066487778680418	0.01350943401524657	0.6533915068006002	-0.02041200289120286	0.032544978448563695	1.006084926182258	0.9797949118005651	1.0330803584507608	1.006 [0.98:1.033]	overlaps null	Complement C1q tumor necrosis factor-related protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-305	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Complement C1q tumor necrosis factor-related protein 5	Inverse variance weighted	4	-0.08843736531564968	0.027684638309849914	0.0014009452736029374	-0.1426992564029555	-0.03417547422834385	0.9153604422528754	0.8670147788333787	0.9664019111286715	0.915 [0.867:0.966]	negative	Complement C1q tumor necrosis factor-related protein 5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-305	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Complement C1q tumor necrosis factor-related protein 5	MR Egger	4	0.04138275647701942	0.145744344163663	0.8031519684743512	-0.24427615808376005	0.3270416710377989	1.0422509575136911	0.7832712976920561	1.3868592678411673	1.042 [0.783:1.387]	overlaps null	Complement C1q tumor necrosis factor-related protein 5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-305	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Complement C1q tumor necrosis factor-related protein 5	Weighted median	4	-0.0705478678516277	0.025173965043684656	0.005072176398504048	-0.11988883933724961	-0.021206896366005777	0.9318831312146975	0.8870190328606147	0.9790163886809964	0.932 [0.887:0.979]	negative	Complement C1q tumor necrosis factor-related protein 5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-322	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Complement component C8	Inverse variance weighted	3	2.44526901577286e-4	0.03746509126824469	0.9947924094759867	-0.07318705198418231	0.07367610578733687	1.000244556800717	0.9294269626076685	1.0764580904801997	1 [0.929:1.076]	overlaps null	Complement component C8 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-322	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Complement component C8	MR Egger	3	0.07992277284756545	0.05332148830480521	0.3745526282375937	-0.02458734422985276	0.18443288992498366	1.0832034117297495	0.9757124623428557	1.2025362762771326	1.083 [0.976:1.203]	overlaps null	Complement component C8 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-322	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Complement component C8	Weighted median	3	0.011385293131923227	0.036965741483310395	0.75808552798649	-0.061067560175365146	0.0838381464392116	1.0114503522530593	0.9407596797400306	1.0874528714448544	1.011 [0.941:1.087]	overlaps null	Complement component C8 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-518	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Complement factor B	Inverse variance weighted	4	0.017860965449424906	0.014855559612205995	0.22924402866694643	-0.011255931390498842	0.04697786228934865	1.018021426398357	0.988807179592329	1.0480988063147203	1.018 [0.989:1.048]	overlaps null	Complement factor B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-518	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Complement factor B	MR Egger	4	0.047268733986417066	0.025221611973235022	0.20176399594741148	-0.002165625481123576	0.09670309345395771	1.0484037129354118	0.9978367177938814	1.1015332726248743	1.048 [0.998:1.102]	overlaps null	Complement factor B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-518	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Complement factor B	Weighted median	4	0.019710244730427547	0.016439919458354133	0.23055677167571761	-0.012511997407946555	0.05193248686880165	1.0199057741354134	0.9875659521912046	1.0533046282192606	1.02 [0.988:1.053]	overlaps null	Complement factor B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-521	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Complement factor H-related protein 5	Inverse variance weighted	3	0.016623975345745817	0.01576362557218354	0.2916182939216038	-0.014272730775733922	0.04752068146722556	1.0167629225074726	0.9858286417853233	1.0486678888875915	1.017 [0.986:1.049]	overlaps null	Complement factor H-related protein 5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-521	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Complement factor H-related protein 5	MR Egger	3	0.03612496431510834	0.022115422264860397	0.3497182684962821	-0.00722126332401804	0.07947119195423472	1.0367853995733711	0.9928047473503443	1.0827143681950906	1.037 [0.993:1.083]	overlaps null	Complement factor H-related protein 5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-521	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Complement factor H-related protein 5	Weighted median	3	0.02174851556155384	0.017418070304646226	0.2118048370260129	-0.01239090223555276	0.05588793335866044	1.021986738389245	0.9876855489015813	1.0574791689572072	1.022 [0.988:1.057]	overlaps null	Complement factor H-related protein 5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-608	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Contactin-4	Inverse variance weighted	3	-0.00599889393099458	0.023631260633949578	0.7996082262188287	-0.05231616477353575	0.04031837691154659	0.9940190635070042	0.9490287699392278	1.0411421970680763	0.994 [0.949:1.041]	overlaps null	Contactin-4 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-608	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Contactin-4	MR Egger	3	0.11820764351974737	0.09784205942690544	0.440166842132814	-0.07356279295698727	0.309978079996482	1.1254777852747984	0.9290778044172142	1.3633952281764308	1.125 [0.929:1.363]	overlaps null	Contactin-4 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-608	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Contactin-4	Weighted median	3	-0.009005760597479616	0.027812297478449814	0.7460856810766017	-0.06351786365524126	0.04550634246028202	0.9910346698046191	0.9384573548722814	1.0465576423431784	0.991 [0.938:1.047]	overlaps null	Contactin-4 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-609	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Contactin-5	Inverse variance weighted	3	-0.026088640488691726	0.01719550248004015	0.12922171360026796	-0.05979182534957042	0.007614544372186973	0.9742487278978856	0.9419606054947072	1.0076436087389873	0.974 [0.942:1.008]	overlaps null	Contactin-5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-609	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Contactin-5	MR Egger	3	0.019184285052114683	0.08921373229473349	0.8651563789597263	-0.15567463024556294	0.19404320034979233	1.019369485867905	0.8558376087466989	1.2141487334732706	1.019 [0.856:1.214]	overlaps null	Contactin-5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-609	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Contactin-5	Weighted median	3	-0.024841201671059833	0.018068792768765364	0.16918959015987525	-0.06025603549783995	0.010573632155720283	0.9754648019103633	0.9415234392987092	1.0106297305511263	0.975 [0.942:1.011]	overlaps null	Contactin-5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-500	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Corneodesmosin	Inverse variance weighted	4	0.02429747851525707	0.017880897967302852	0.17419376551989738	-0.010749081500656517	0.05934403853117066	1.024595067579575	0.9893084834345474	1.0611402510810959	1.025 [0.989:1.061]	overlaps null	Corneodesmosin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-500	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Corneodesmosin	MR Egger	4	-0.004392108569151041	0.06352548974372924	0.9511694452650157	-0.12890206846686034	0.12011785132855826	0.9956175226341011	0.8790600490286938	1.1276297364114527	0.996 [0.879:1.128]	overlaps null	Corneodesmosin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-500	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Corneodesmosin	Weighted median	4	0.018516191522004722	0.02155411036506613	0.3903095265601421	-0.02372986479352489	0.06076224783753434	1.018688679156208	0.9765494745241643	1.0626462377102446	1.019 [0.977:1.063]	overlaps null	Corneodesmosin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-655	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	CREB-binding protein	Inverse variance weighted	4	-0.03081610856255553	0.04603556178853	0.5032416884204431	-0.12104580966807432	0.059413592542963266	0.9696538677256534	0.8859933716009524	1.061214060209464	0.97 [0.886:1.061]	overlaps null	CREB-binding protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-655	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	CREB-binding protein	MR Egger	4	0.10845868917424509	0.05340342861942451	0.17935853835414212	0.003787969080173051	0.21312940926831714	1.1145588642402495	1.0037951525023792	1.237544790647483	1.115 [1.004:1.238]	positive	CREB-binding protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-655	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	CREB-binding protein	Weighted median	4	-0.03347579732500858	0.033395916749309945	0.31615433991238645	-0.09893179415365606	0.03198019950363891	0.9670783168303562	0.9058044870783415	1.0324970611484148	0.967 [0.906:1.032]	overlaps null	CREB-binding protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-735	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	CUB and zona pellucida-like domain-containing protein 1	Inverse variance weighted	2	0.02198297382399415	0.010786988489525367	0.041558358401045416	8.404763845244294e-4	0.043125471263463874	1.0222263797160116	1.0008408296837739	1.044068887274978	1.022 [1.001:1.044]	positive	CUB and zona pellucida-like domain-containing protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-706	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cystatin-8	Inverse variance weighted	2	0.023131762462648624	0.01181390723469713	0.050228700663651316	-2.349571735775144e-5	0.046287020642655	1.0234013765494467	0.9999765045586645	1.047374986060844	1.023 [1:1.047]	overlaps null	Cystatin-8 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-831	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Delta-like protein 1	Inverse variance weighted	3	0.060338310723331165	0.03423509943120937	0.07799004388575993	-0.006762484161839208	0.12743910560850152	1.0621958380081313	0.9932603299784583	1.1359156952400042	1.062 [0.993:1.136]	overlaps null	Delta-like protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-831	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Delta-like protein 1	MR Egger	3	0.05678440639205633	0.07655152866550202	0.5936967631065493	-0.09325658979232763	0.20682540257644028	1.058427595571479	0.9109597273382892	1.2297678387391597	1.058 [0.911:1.23]	overlaps null	Delta-like protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-831	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Delta-like protein 1	Weighted median	3	0.06270458143625512	0.03965471245946779	0.1138176169969532	-0.015018654984301744	0.140427817856812	1.0647122570011132	0.9850935625267064	1.1507660118098393	1.065 [0.985:1.151]	overlaps null	Delta-like protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-867	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Desmocollin-3	Inverse variance weighted	3	0.029525824832318342	0.04138206420629037	0.4755405683547564	-0.051583021012010774	0.11063467067664746	1.0299660338285583	0.9497247995751329	1.116986764286983	1.03 [0.95:1.117]	overlaps null	Desmocollin-3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-867	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Desmocollin-3	MR Egger	3	0.501291099384132	2.732701520666	0.8845015733681669	-4.854803881121228	5.857386079889492	1.650851308466672	0.007790861138443959	349.80857625841867	1.651 [0.008:349.809]	overlaps null	Desmocollin-3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-867	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Desmocollin-3	Weighted median	3	0.01958025496873618	0.046061139587325675	0.6707690869904835	-0.07069957862242214	0.1098600885598945	1.0197732054433588	0.9317417652302129	1.116121901311655	1.02 [0.932:1.116]	overlaps null	Desmocollin-3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2629	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Diamine acetyltransferase 2	Inverse variance weighted	3	-0.0664706457904404	0.027991692297752748	0.017565302209223043	-0.12133436269403579	-0.011606928886845017	0.9356903819047601	0.8857377524142137	0.9884601716509449	0.936 [0.886:0.988]	negative	Diamine acetyltransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2629	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Diamine acetyltransferase 2	MR Egger	3	-0.12196500059715215	0.09424240438927983	0.41881418108096297	-0.30668011320014066	0.06275011200583633	0.8851793487090976	0.7358859634664731	1.064760735060223	0.885 [0.736:1.065]	overlaps null	Diamine acetyltransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2629	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Diamine acetyltransferase 2	Weighted median	3	-0.05761030357612762	0.03421520736949541	0.09222746143231635	-0.12467211002033862	0.009451502868083383	0.9440177561089094	0.8827863119206528	1.0094963093729992	0.944 [0.883:1.009]	overlaps null	Diamine acetyltransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2464	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Dihydropteridine reductase	Inverse variance weighted	4	-0.019115236800183254	0.014172755899029261	0.17742334906877008	-0.0468938383622806	0.008663364761914098	0.9810663007872406	0.9541886904476394	1.0087010003114019	0.981 [0.954:1.009]	overlaps null	Dihydropteridine reductase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2464	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Dihydropteridine reductase	MR Egger	4	0.013839700697864369	0.028355172456639537	0.6737560584911326	-0.04173643731714912	0.06941583871287786	1.0139359126916008	0.9591225361713656	1.071881846452689	1.014 [0.959:1.072]	overlaps null	Dihydropteridine reductase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2464	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Dihydropteridine reductase	Weighted median	4	-0.017336094478434358	0.015237879363213195	0.25524689386806865	-0.04720233803033222	0.012530149073463503	0.9828133109924847	0.9538943689547534	1.012608980302962	0.983 [0.954:1.013]	overlaps null	Dihydropteridine reductase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-766	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Discoidin, CUB and LCCL domain-containing protein 2	Inverse variance weighted	3	-0.06560484632844342	0.029146104122918428	0.024392131366396272	-0.12273121040936354	-0.008478482247523303	0.9365008529360724	0.884501375374629	0.9915573587192275	0.937 [0.885:0.992]	negative	Discoidin, CUB and LCCL domain-containing protein 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-766	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Discoidin, CUB and LCCL domain-containing protein 2	MR Egger	3	-0.04983526776588225	0.2014946336576351	0.8456437204598464	-0.44476474973484703	0.3450942142030825	0.9513861355562974	0.6409750478470312	1.4121229554395323	0.951 [0.641:1.412]	overlaps null	Discoidin, CUB and LCCL domain-containing protein 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-766	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Discoidin, CUB and LCCL domain-containing protein 2	Weighted median	3	-0.05565433700329304	0.023258508504349858	0.016717653289604527	-0.10124101367181876	-0.010067660334767317	0.9458660302760035	0.9037151989180666	0.9899828489121141	0.946 [0.904:0.99]	negative	Discoidin, CUB and LCCL domain-containing protein 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-836	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	DnaJ homolog subfamily B member 11	Inverse variance weighted	3	0.03925402167779464	0.024804364735782406	0.1135252236600317	-0.009362533204338878	0.08787057655992817	1.0400346414424184	0.9906811588472476	1.091846802314166	1.04 [0.991:1.092]	overlaps null	DnaJ homolog subfamily B member 11 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-836	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	DnaJ homolog subfamily B member 11	MR Egger	3	0.015846636495662834	0.05249140955295007	0.8133494991373011	-0.0870365262281193	0.11872979921944496	1.015972860299291	0.9166436134879374	1.1260656133708022	1.016 [0.917:1.126]	overlaps null	DnaJ homolog subfamily B member 11 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-836	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	DnaJ homolog subfamily B member 11	Weighted median	3	0.040333169416166915	0.027773522853144543	0.14644140354897944	-0.01410293537599639	0.09476927420833023	1.041157598282748	0.9859960451653876	1.099405164733771	1.041 [0.986:1.099]	overlaps null	DnaJ homolog subfamily B member 11 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-842	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	DnaJ homolog subfamily B member 9	Inverse variance weighted	4	-0.04968040579468293	0.0255140512884962	0.0515133680468089	-0.09968794632013547	3.271347307696182e-4	0.9515334804973908	0.9051198199419221	1.000327188245171	0.952 [0.905:1]	overlaps null	DnaJ homolog subfamily B member 9 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-842	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	DnaJ homolog subfamily B member 9	MR Egger	4	-0.020091645779382796	0.09851790933402492	0.8572697779578128	-0.21318674807407165	0.17300345651530605	0.9801088463515837	0.8080052297055961	1.1888702144250232	0.98 [0.808:1.189]	overlaps null	DnaJ homolog subfamily B member 9 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-842	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	DnaJ homolog subfamily B member 9	Weighted median	4	-0.05335642788793667	0.021180754909093054	0.01176554228280234	-0.09487070750975905	-0.01184214826611428	0.9480420436318275	0.9094905171606023	0.9882276940056324	0.948 [0.909:0.988]	negative	DnaJ homolog subfamily B member 9 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-586	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Dual specificity protein kinase CLK2	Inverse variance weighted	3	-0.044569352154824854	0.017840029611096545	0.01247983086448864	-0.07953581019257408	-0.009602894117075628	0.9564092687498543	0.9235449470540313	0.9904430664348771	0.956 [0.924:0.99]	negative	Dual specificity protein kinase CLK2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-586	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Dual specificity protein kinase CLK2	MR Egger	3	-0.024509103323543852	0.06818493070663181	0.7803222602779208	-0.1581515675085422	0.10913336086145449	0.9757888059567641	0.8537203758914855	1.1153110792702396	0.976 [0.854:1.115]	overlaps null	Dual specificity protein kinase CLK2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-586	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Dual specificity protein kinase CLK2	Weighted median	3	-0.050904211796846587	0.0168213147654485	0.0024767039476027504	-0.08387398873712565	-0.017934434856567524	0.9503697003784953	0.9195471220888881	0.9822254299983583	0.95 [0.92:0.982]	negative	Dual specificity protein kinase CLK2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2573	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	E3 ubiquitin-protein ligase RNF8	Inverse variance weighted	3	-0.04751443724928449	0.02326237267245227	0.04109752488911486	-0.09310868768729094	-0.0019201868112780351	0.9535967057198874	0.9110944701636944	0.9980816555679909	0.954 [0.911:0.998]	negative	E3 ubiquitin-protein ligase RNF8 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2573	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	E3 ubiquitin-protein ligase RNF8	MR Egger	3	-0.01710839326004985	0.12977776415947706	0.9165566024950592	-0.2714728110126249	0.23725602449252517	0.9830371242611521	0.7622560081552785	1.2677656552872707	0.983 [0.762:1.268]	overlaps null	E3 ubiquitin-protein ligase RNF8 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2573	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	E3 ubiquitin-protein ligase RNF8	Weighted median	3	-0.05664058334425748	0.02162727360824398	0.008820284535266081	-0.09903003961641568	-0.01425112707209928	0.9449336332267674	0.9057155002686855	0.9858499395651895	0.945 [0.906:0.986]	negative	E3 ubiquitin-protein ligase RNF8 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-892	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Endothelin-2	Inverse variance weighted	3	0.03661790474814459	0.02505057719589367	0.1438072840690412	-0.012481226555807003	0.08571703605209618	1.0372965990022849	0.9875963409046384	1.0894979960295372	1.037 [0.988:1.089]	overlaps null	Endothelin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-892	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Endothelin-2	MR Egger	3	0.1456307519406732	0.0597425122171377	0.24783386139592573	0.02853542799508331	0.2627260758862631	1.1567689744828427	1.028946463699051	1.3004704399445435	1.157 [1.029:1.3]	positive	Endothelin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-892	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Endothelin-2	Weighted median	3	0.03534357943805964	0.02046585218962506	0.08417597660153932	-0.004769490853605479	0.07545664972972475	1.0359755875700292	0.9952418651066728	1.0783764787929553	1.036 [0.995:1.078]	overlaps null	Endothelin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-387	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Eotaxin	Inverse variance weighted	3	0.009926838806119172	0.01991190068221517	0.6181049043493319	-0.02910048653102256	0.048954164143260905	1.009976273311176	0.9713188551002078	1.0501722140936878	1.01 [0.971:1.05]	overlaps null	Eotaxin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-387	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Eotaxin	MR Egger	3	9.719122420646122e-4	0.05200844079660345	0.9881044974736966	-0.10096463171927815	0.10290845620340737	1.0009723847018186	0.9039650040085034	1.1083899382085152	1.001 [0.904:1.108]	overlaps null	Eotaxin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-387	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Eotaxin	Weighted median	3	0.009562605838164739	0.021138787460975594	0.6510006645784117	-0.03186941758534742	0.0509946292616769	1.009608473642033	0.9686330602650262	1.0523172415474897	1.01 [0.969:1.052]	overlaps null	Eotaxin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2071	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Epididymal secretory protein E1	Inverse variance weighted	3	-0.0010456304739072545	0.016598022809474873	0.9497686614611558	-0.033577755180478	0.031486494232663496	0.9989549160071477	0.9669797206255154	1.0319874377192972	0.999 [0.967:1.032]	overlaps null	Epididymal secretory protein E1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2071	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Epididymal secretory protein E1	MR Egger	3	0.020760467969861796	0.012488462121871612	0.344766861288542	-0.003716917789006565	0.045237853728730154	1.0209774655405497	0.9962899813993662	1.0462766911270953	1.021 [0.996:1.046]	overlaps null	Epididymal secretory protein E1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2071	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Epididymal secretory protein E1	Weighted median	3	-2.2084219767362634e-5	0.00881480458222308	0.998001017561781	-0.017299101200924597	0.017254932761389872	0.9999779160240873	0.9828496691505381	1.0174046590463046	1 [0.983:1.017]	overlaps null	Epididymal secretory protein E1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1707	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Epididymal-specific lipocalin-10	Inverse variance weighted	3	-0.03591618803627658	0.03352341371901352	0.2840003039699997	-0.10162207892554308	0.029789702852989916	0.9647211452685327	0.9033708900627335	1.0302378550891749	0.965 [0.903:1.03]	overlaps null	Epididymal-specific lipocalin-10 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1707	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Epididymal-specific lipocalin-10	MR Egger	3	0.02790952682591237	0.06717646519104828	0.7493198252392255	-0.10375634494854226	0.159575398600367	1.028302646408423	0.9014449122714703	1.1730127024025272	1.028 [0.901:1.173]	overlaps null	Epididymal-specific lipocalin-10 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1707	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Epididymal-specific lipocalin-10	Weighted median	3	-0.048873582054679954	0.02927292348728742	0.09500185127022893	-0.1062485120897633	0.00850134798040339	0.9523015100894544	0.8992011579481957	1.0085375870600266	0.952 [0.899:1.009]	overlaps null	Epididymal-specific lipocalin-10 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1835	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Epididymis-specific alpha-mannosidase	Inverse variance weighted	3	-0.03555388761207215	0.036938893818162157	0.3357957533370939	-0.10795411949566998	0.03684634427152568	0.9650707274717688	0.8976687809820364	1.0375335856104893	0.965 [0.898:1.038]	overlaps null	Epididymis-specific alpha-mannosidase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1835	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Epididymis-specific alpha-mannosidase	MR Egger	3	0.1889065228453409	0.11206081420331118	0.3408527407345806	-0.030732672993149024	0.4085457186838308	1.2079280335297056	0.9697347747234482	1.5046280407991444	1.208 [0.97:1.505]	overlaps null	Epididymis-specific alpha-mannosidase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1835	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Epididymis-specific alpha-mannosidase	Weighted median	3	-0.04362646854326475	0.023340209600614725	0.061601258457990485	-0.0893732793604696	0.002120342273940111	0.9573114766469821	0.9145041443320288	1.0021225917892527	0.957 [0.915:1.002]	overlaps null	Epididymis-specific alpha-mannosidase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2892	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Estrogen sulfotransferase	Inverse variance weighted	3	0.002656920949928319	0.04273179073926036	0.9504221318858688	-0.08109738889902197	0.08641123079887862	1.0026604536924417	0.9221038843894893	1.090254582393767	1.003 [0.922:1.09]	overlaps null	Estrogen sulfotransferase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2892	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Estrogen sulfotransferase	MR Egger	3	0.11401738317975758	0.0722507006595912	0.3595741868423769	-0.02759399011304116	0.25562875647255634	1.1207716072891363	0.9727832462491875	1.2912732621051992	1.121 [0.973:1.291]	overlaps null	Estrogen sulfotransferase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2892	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Estrogen sulfotransferase	Weighted median	3	0.013137514563712559	0.019086689123140287	0.49125905120157665	-0.024272396117642404	0.05054742524506752	1.0132241908626338	0.9760198095375995	1.0518467462618544	1.013 [0.976:1.052]	overlaps null	Estrogen sulfotransferase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2891	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Extracellular sulfatase Sulf-2	Inverse variance weighted	3	-0.026062104718964287	0.03414887288917063	0.44534963040523756	-0.0929938955817387	0.04086968614381014	0.9742745806807965	0.9111990626193607	1.0417163466258528	0.974 [0.911:1.042]	overlaps null	Extracellular sulfatase Sulf-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2891	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Extracellular sulfatase Sulf-2	MR Egger	3	0.2183483014234988	0.20815643164109618	0.4847900604039323	-0.18963830459304973	0.6263349074400473	1.244020286205904	0.8272582953632395	1.870741558188053	1.244 [0.827:1.871]	overlaps null	Extracellular sulfatase Sulf-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2891	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Extracellular sulfatase Sulf-2	Weighted median	3	-0.03906489900312991	0.026365506070777124	0.13842893483131677	-0.09074129090185307	0.012611492895593247	0.9616882945094294	0.9132539474447989	1.012691353137958	0.962 [0.913:1.013]	overlaps null	Extracellular sulfatase Sulf-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-b-71	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	fatty acid binding protein 4	Inverse variance weighted	3	0.027408375920684742	0.013129234267893822	0.0368354003864261	0.001675076755612851	0.05314167508575664	1.0277874407150103	1.0016764804803542	1.0545790421124186	1.028 [1.002:1.055]	positive	fatty acid binding protein 4 (M/F) Folkersen L/2018 [  3K]	Proteins
prot-b-71	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	fatty acid binding protein 4	MR Egger	3	0.04875736141258811	0.036847124368520376	0.41199143074231703	-0.023463002349711833	0.12097772517488806	1.0499655576702187	0.9768101136792943	1.1285997727247956	1.05 [0.977:1.129]	overlaps null	fatty acid binding protein 4 (M/F) Folkersen L/2018 [  3K]	Proteins
prot-b-71	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	fatty acid binding protein 4	Weighted median	3	0.027650022110836527	0.014968395894470384	0.06471427617184336	-0.0016880338423254232	0.05698807806399848	1.028035831644497	0.9983133900854755	1.0586431892439154	1.028 [0.998:1.059]	overlaps null	fatty acid binding protein 4 (M/F) Folkersen L/2018 [  3K]	Proteins
prot-a-1148	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ferritin	Inverse variance weighted	3	0.008641714070527698	0.029314789702366645	0.7681541180020014	-0.04881527374611093	0.06609870188716632	1.0086791614737567	0.9523570387986322	1.0683321583624361	1.009 [0.952:1.068]	overlaps null	Ferritin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1148	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ferritin	MR Egger	3	0.057117182932586164	0.061126366363891786	0.5215770590332545	-0.06269049514064173	0.17692486100581406	1.0587798740568914	0.93923412623377	1.1935414082568299	1.059 [0.939:1.194]	overlaps null	Ferritin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1148	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ferritin	Weighted median	3	0.022149356660448625	0.016765653754352232	0.18646302226449601	-0.01071132469808175	0.055010038018978996	1.0223964747906253	0.9893458372648181	1.0565512203034662	1.022 [0.989:1.057]	overlaps null	Ferritin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1097	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Fibroblast growth factor 7	Inverse variance weighted	3	0.021681243508645753	0.02996245831803644	0.46930296542935734	-0.03704517479470566	0.08040766181199717	1.0219179895557722	0.9636326024607783	1.0837287724708515	1.022 [0.964:1.084]	overlaps null	Fibroblast growth factor 7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1097	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Fibroblast growth factor 7	MR Egger	3	-0.02161803470780041	0.10127845620226103	0.8661216808262081	-0.22012380886423202	0.1768877394486312	0.9786139602389142	0.8024194451720829	1.193497102963539	0.979 [0.802:1.193]	overlaps null	Fibroblast growth factor 7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1097	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Fibroblast growth factor 7	Weighted median	3	0.025994783282313326	0.033833129399120726	0.44229510637074027	-0.0403181503399633	0.09230771690458994	1.0263355943564292	0.9604838122858474	1.096702243982718	1.026 [0.96:1.097]	overlaps null	Fibroblast growth factor 7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1117	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Filamin-A	Inverse variance weighted	2	-0.10258937590876376	0.03486069677889497	0.003252187720496988	-0.1709163415953979	-0.03426241022212961	0.9024974846153748	0.8428920855292428	0.9663178996699937	0.902 [0.843:0.966]	negative	Filamin-A (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1166	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Galanin peptides	Inverse variance weighted	3	-0.050058145155983974	0.043859891461311966	0.25373703045855006	-0.1360235324201554	0.03590724210818748	0.9511741167254051	0.8728220926308393	1.0365596929396375	0.951 [0.873:1.037]	overlaps null	Galanin peptides (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1166	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Galanin peptides	MR Egger	3	-0.08199875864174594	0.27352565552743735	0.8145786986848248	-0.6181090434755232	0.45411152619203127	0.9212731023256087	0.5389626295136792	1.5747736161865182	0.921 [0.539:1.575]	overlaps null	Galanin peptides (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1166	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Galanin peptides	Weighted median	3	-0.06642293667785856	0.038851556169250887	0.08732883422349871	-0.14257198676959032	0.00972611341387318	0.9357350239274392	0.8671251305084627	1.0097735657725122	0.936 [0.867:1.01]	overlaps null	Galanin peptides (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1414	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Gamma-interferon-inducible protein 16	Inverse variance weighted	3	-8.835282335083737e-4	0.014168391923401493	0.9502768613725276	-0.0286535764033753	0.02688651993635855	0.9991168619626364	0.9717530443482864	1.0272512236146782	0.999 [0.972:1.027]	overlaps null	Gamma-interferon-inducible protein 16 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1414	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Gamma-interferon-inducible protein 16	MR Egger	3	-0.008764473854544267	0.05678160539350562	0.9025045487892309	-0.12005642042581528	0.10252747271672676	0.9912738221832212	0.8868703977000783	1.1079677403755628	0.991 [0.887:1.108]	overlaps null	Gamma-interferon-inducible protein 16 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1414	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Gamma-interferon-inducible protein 16	Weighted median	3	-0.0010670940390528419	0.012675421706238305	0.9329084871257873	-0.025910920583279918	0.023776732505174234	0.9989334751033304	0.9744218866760802	1.0240616526850754	0.999 [0.974:1.024]	overlaps null	Gamma-interferon-inducible protein 16 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1305	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	GDH/6PGL endoplasmic bifunctional protein	Inverse variance weighted	4	0.025342468726968746	0.02403575972455732	0.29171574621737795	-0.0217676203331636	0.0724525577871011	1.0256663190223154	0.978467584605801	1.0751417977741244	1.026 [0.978:1.075]	overlaps null	GDH/6PGL endoplasmic bifunctional protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1305	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	GDH/6PGL endoplasmic bifunctional protein	MR Egger	4	-0.008764292736203938	0.04962025169872454	0.876068454421004	-0.10601998606570404	0.08849140059329616	0.9912740017211069	0.8994066722954449	1.0925248575044995	0.991 [0.899:1.093]	overlaps null	GDH/6PGL endoplasmic bifunctional protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1305	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	GDH/6PGL endoplasmic bifunctional protein	Weighted median	4	0.024142174525569347	0.01516014284272348	0.11127763022351275	-0.005571705446168671	0.05385605449730736	1.0244359562333987	0.9944437877168186	1.0553326808278967	1.024 [0.994:1.055]	overlaps null	GDH/6PGL endoplasmic bifunctional protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1223	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Glycolipid transfer protein domain-containing protein 2	Inverse variance weighted	3	-0.03968163982316853	0.025032539356605286	0.11292037031838033	-0.08874541696211488	0.009382137315777826	0.96109536494278	0.9150785073890093	1.009426287532529	0.961 [0.915:1.009]	overlaps null	Glycolipid transfer protein domain-containing protein 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1223	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Glycolipid transfer protein domain-containing protein 2	MR Egger	3	0.04914669899026685	0.10514311653286805	0.7216373136850844	-0.15693380941415452	0.25522720739468824	1.0503744283062748	0.8547606340524161	1.2907548566071156	1.05 [0.855:1.291]	overlaps null	Glycolipid transfer protein domain-containing protein 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1223	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Glycolipid transfer protein domain-containing protein 2	Weighted median	3	-0.042332346015328266	0.028060951191087233	0.13140472434763853	-0.09733181034985924	0.012667118319202711	0.9585511569712675	0.9072549196119352	1.0127476860902196	0.959 [0.907:1.013]	overlaps null	Glycolipid transfer protein domain-containing protein 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1046	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Glycosaminoglycan xylosylkinase	Inverse variance weighted	3	0.07437655884766763	0.07555904555254558	0.3249433727990553	-0.07371917043532171	0.22247228813065695	1.0772123629793953	0.9289325289321859	1.2491612025789691	1.077 [0.929:1.249]	overlaps null	Glycosaminoglycan xylosylkinase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1046	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Glycosaminoglycan xylosylkinase	MR Egger	3	0.4601245117048967	0.1373319297826281	0.18465135760317328	0.19095392933094563	0.7292950940788478	1.5842712330266255	1.2104036866890633	2.073618386491637	1.584 [1.21:2.074]	positive	Glycosaminoglycan xylosylkinase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1046	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Glycosaminoglycan xylosylkinase	Weighted median	3	0.09177691122249025	0.04056009232094494	0.0236517702777975	0.01227913027343816	0.17127469217154234	1.0961202626731983	1.01235482831163	1.1868167135099723	1.096 [1.012:1.187]	positive	Glycosaminoglycan xylosylkinase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1277	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Granulins	Inverse variance weighted	4	0.009634154308264139	0.009991322184183722	0.33491950377475715	-0.009948837172735956	0.029217145789264234	1.0096807121679687	0.9901004887936116	1.0296481539628084	1.01 [0.99:1.03]	overlaps null	Granulins (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1277	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Granulins	MR Egger	4	-0.012194160437026426	0.018473630992529685	0.5770522743913296	-0.04840247718238461	0.024014156308331758	0.9878798870494422	0.9527502496641523	1.0243048181628178	0.988 [0.953:1.024]	overlaps null	Granulins (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1277	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Granulins	Weighted median	4	0.00524833652524692	0.010262826417490727	0.6090759681546752	-0.014866803253034905	0.025363476303528747	1.005262133169305	0.9852431620478217	1.0256878660123614	1.005 [0.985:1.026]	overlaps null	Granulins (M/F) Sun BB/2018 [  3K]	Proteins
prot-b-55	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	growth differentiation factor 15	Inverse variance weighted	3	-0.020750956281174366	0.014401371836237601	0.14961255149778915	-0.04897764508020007	0.0074757325178513336	0.9794628632713999	0.9522024158692187	1.0075037455687064	0.979 [0.952:1.008]	overlaps null	growth differentiation factor 15 (M/F) Folkersen L/2018 [  3K]	Proteins
prot-b-55	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	growth differentiation factor 15	MR Egger	3	-0.019586868083615594	0.020905375776132516	0.5207222794494362	-0.06056140460483533	0.02138766843760414	0.9806037083237815	0.9412359710210348	1.0216180239427572	0.981 [0.941:1.022]	overlaps null	growth differentiation factor 15 (M/F) Folkersen L/2018 [  3K]	Proteins
prot-b-55	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	growth differentiation factor 15	Weighted median	3	-0.020769614393147895	0.015539044577845915	0.18135056119766976	-0.05122614176572589	0.009686912979430098	0.9794445885141098	0.9500637971327818	1.009733982985881	0.979 [0.95:1.01]	overlaps null	growth differentiation factor 15 (M/F) Folkersen L/2018 [  3K]	Proteins
prot-a-1317	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Hemoglobin subunit zeta	Inverse variance weighted	3	0.007760042256209415	0.00919455015764994	0.3986790128564476	-0.010261276052784466	0.025781360565203297	1.0077902294181482	0.9897911912265662	1.0261165743979634	1.008 [0.99:1.026]	overlaps null	Hemoglobin subunit zeta (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1317	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Hemoglobin subunit zeta	MR Egger	3	0.011335864234612235	0.02131089593714875	0.6887803757100583	-0.030433491802199314	0.05310522027142378	1.011400358613038	0.9700249445327654	1.0545405983299738	1.011 [0.97:1.055]	overlaps null	Hemoglobin subunit zeta (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1317	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Hemoglobin subunit zeta	Weighted median	3	0.008059529777190086	0.009121459994191092	0.3769235621893542	-0.009818531811424454	0.025937591365804626	1.0080920952158887	0.9902295126016029	1.0262768979353032	1.008 [0.99:1.026]	overlaps null	Hemoglobin subunit zeta (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1313	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Heparin-binding EGF-like growth factor	Inverse variance weighted	2	-0.019938454411869967	0.11048777207521274	0.8567926544659603	-0.23649448767928694	0.19661757885554698	0.9802590020670537	0.7893902336621116	1.217278438669917	0.98 [0.789:1.217]	overlaps null	Heparin-binding EGF-like growth factor (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1360	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Hepatocyte nuclear factor 4-alpha	Inverse variance weighted	5	-0.02889959032166004	0.02840132580111748	0.30889485151588797	-0.0845661888918503	0.02676700824853022	0.9715140089784606	0.9189108316742695	1.027128462422965	0.972 [0.919:1.027]	overlaps null	Hepatocyte nuclear factor 4-alpha (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1360	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Hepatocyte nuclear factor 4-alpha	MR Egger	5	-0.06375968882118024	0.05683873617300598	0.34365094599996715	-0.17516361172027195	0.047644234077911476	0.9382304397047176	0.8393196869969587	1.0487974625474232	0.938 [0.839:1.049]	overlaps null	Hepatocyte nuclear factor 4-alpha (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1360	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Hepatocyte nuclear factor 4-alpha	Weighted median	5	-0.02840640613423134	0.02935730959012317	0.33323952488222464	-0.08594673293087275	0.029133920662410075	0.9719932624959685	0.9176431100773014	1.0295624649303694	0.972 [0.918:1.03]	overlaps null	Hepatocyte nuclear factor 4-alpha (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-10	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Histo-blood group ABO system transferase	Inverse variance weighted	3	0.017020175979552257	0.010486329701059168	0.10457181585510282	-0.0035330302345237125	0.03757338219362823	1.0171658444354919	0.996473203573224	1.0382881861510485	1.017 [0.996:1.038]	overlaps null	Histo-blood group ABO system transferase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-10	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Histo-blood group ABO system transferase	MR Egger	3	-0.007829590538565858	0.011316102567665225	0.6146745723834052	-0.030009151571189698	0.014349970494057984	0.9922009808662099	0.9704366524877601	1.0144534255874942	0.992 [0.97:1.014]	overlaps null	Histo-blood group ABO system transferase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-10	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Histo-blood group ABO system transferase	Weighted median	3	0.015149723853842775	0.005954644945519998	0.01095327655811613	0.0034786197606235802	0.02682082794706197	1.01526506263442	1.0034846771801262	1.0271837436547624	1.015 [1.003:1.027]	positive	Histo-blood group ABO system transferase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2904	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Histone-lysine N-methyltransferase SUV420H2	Inverse variance weighted	3	-0.09668093978187896	0.03240939694009792	0.002853312907746669	-0.16020335778447087	-0.033158521779287034	0.9078456173497987	0.8519705165119849	0.9673851958111078	0.908 [0.852:0.967]	negative	Histone-lysine N-methyltransferase SUV420H2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2904	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Histone-lysine N-methyltransferase SUV420H2	MR Egger	3	-0.038124942269519894	0.08880062448410539	0.7418289797671832	-0.21217416625836646	0.13592428171932666	0.9625926648654047	0.8088238154807831	1.1455951478158424	0.963 [0.809:1.146]	overlaps null	Histone-lysine N-methyltransferase SUV420H2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2904	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Histone-lysine N-methyltransferase SUV420H2	Weighted median	3	-0.07518354253139661	0.0439777685119705	0.08734344442431266	-0.16137996881485878	0.011012883752065564	0.9275732215664761	0.850968668113211	1.0110737487843047	0.928 [0.851:1.011]	overlaps null	Histone-lysine N-methyltransferase SUV420H2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1347	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	HLA class II histocompatibility antigen, DQ alpha 2 chain	Inverse variance weighted	4	-0.009332757709109586	0.01769544972038982	0.5979088782003523	-0.044015839161073635	0.02535032374285446	0.9907106573085301	0.9569388002452134	1.0256743756791873	0.991 [0.957:1.026]	overlaps null	HLA class II histocompatibility antigen, DQ alpha 2 chain (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1347	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	HLA class II histocompatibility antigen, DQ alpha 2 chain	MR Egger	4	-0.05356864801073527	0.031055126980515654	0.22667764209991334	-0.11443669689254596	0.007299400871075411	0.9478408713800648	0.891868394672001	1.007326106436278	0.948 [0.892:1.007]	overlaps null	HLA class II histocompatibility antigen, DQ alpha 2 chain (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1347	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	HLA class II histocompatibility antigen, DQ alpha 2 chain	Weighted median	4	-0.016233014971289962	0.015065949589042579	0.28127312432387686	-0.045762276165813416	0.013296246223233492	0.9838980303710588	0.9552690254158767	1.0133850343850581	0.984 [0.955:1.013]	overlaps null	HLA class II histocompatibility antigen, DQ alpha 2 chain (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1576	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Immunoglobulin superfamily containing leucine-rich repeat protein 2	Inverse variance weighted	4	-0.07815150887038681	0.03313768509461695	0.018354512412899027	-0.14310137165583603	-0.013201646084937582	0.92482429684384	0.8666662090536464	0.9868851134355928	0.925 [0.867:0.987]	negative	Immunoglobulin superfamily containing leucine-rich repeat protein 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1576	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Immunoglobulin superfamily containing leucine-rich repeat protein 2	MR Egger	4	-0.08367219717526168	0.1120634496540284	0.5331143677549202	-0.30331655849715733	0.135972164146634	0.9197326976620246	0.7383653235538716	1.1456500030055206	0.92 [0.738:1.146]	overlaps null	Immunoglobulin superfamily containing leucine-rich repeat protein 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1576	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Immunoglobulin superfamily containing leucine-rich repeat protein 2	Weighted median	4	-0.09051030398436137	0.018952670204234537	1.791754137407949e-6	-0.12765753758466106	-0.05336307038406168	0.9134649215241945	0.8801547474587248	0.9480357462871414	0.913 [0.88:0.948]	negative	Immunoglobulin superfamily containing leucine-rich repeat protein 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1115	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inactive peptidyl-prolyl cis-trans isomerase FKBP6	Inverse variance weighted	3	-0.01948723600724249	0.012327546363895017	0.11392654434864995	-0.04364922688047672	0.004674754865991743	0.9807014127745087	0.9572896900774938	1.0046856985789334	0.981 [0.957:1.005]	overlaps null	Inactive peptidyl-prolyl cis-trans isomerase FKBP6 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1115	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inactive peptidyl-prolyl cis-trans isomerase FKBP6	MR Egger	3	-0.03309641795859857	0.0282218024002042	0.4494968384753768	-0.0884111506629988	0.02221831474580166	0.9674452759934302	0.9153844384234436	1.0224669797249133	0.967 [0.915:1.022]	overlaps null	Inactive peptidyl-prolyl cis-trans isomerase FKBP6 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1115	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inactive peptidyl-prolyl cis-trans isomerase FKBP6	Weighted median	3	-0.018975105037729385	0.00699364423984258	0.0066638327420334275	-0.03268264774782084	-0.005267562327637927	0.9812037889700597	0.9678456588567325	0.9947462869508167	0.981 [0.968:0.995]	negative	Inactive peptidyl-prolyl cis-trans isomerase FKBP6 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1403	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inducible T-cell costimulator	Inverse variance weighted	3	0.01848637716107646	0.016719756595875716	0.26887342235008366	-0.01428434576683994	0.051257100088992855	1.0186583080570037	0.9858171914609146	1.0525934803752084	1.019 [0.986:1.053]	overlaps null	Inducible T-cell costimulator (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1403	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inducible T-cell costimulator	MR Egger	3	-0.002748548372642852	0.049744265706018344	0.9648602145165619	-0.1002473091564388	0.0947502124111531	0.9972552254281524	0.904613671125861	1.0993842082952396	0.997 [0.905:1.099]	overlaps null	Inducible T-cell costimulator (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1403	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inducible T-cell costimulator	Weighted median	3	0.01911889978993516	0.018164092908424512	0.2925401190988276	-0.016482722310576882	0.0547205218904472	1.019302836305787	0.9836523744840806	1.0562453759601398	1.019 [0.984:1.056]	overlaps null	Inducible T-cell costimulator (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1397	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Intercellular adhesion molecule 1	Inverse variance weighted	3	1.5284633198588035e-4	0.021024827109821433	0.994199588247321	-0.041055814803264125	0.04136150746723589	1.0001528580135817	0.9597755587687901	1.0422288109481952	1 [0.96:1.042]	overlaps null	Intercellular adhesion molecule 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1397	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Intercellular adhesion molecule 1	MR Egger	3	0.0408202065497706	0.03241967268910826	0.427298117227755	-0.02272235192088158	0.10436276502042278	1.041664804199077	0.9775338564960055	1.1100030521669562	1.042 [0.978:1.11]	overlaps null	Intercellular adhesion molecule 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1397	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Intercellular adhesion molecule 1	Weighted median	3	0.003513724318748551	0.006499265199859381	0.5887598168999243	-0.009224835472975836	0.01625228411047294	1.0035199046846233	0.990817582787743	1.0163850708672477	1.004 [0.991:1.016]	overlaps null	Intercellular adhesion molecule 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-b-38	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	interleukin 1 receptor like 1	Inverse variance weighted	3	9.828418825348895e-5	0.020193345858790016	0.9961165857648301	-0.039480673694974946	0.03967724207148192	1.0000982890183026	0.9612885319664617	1.0404748984691228	1 [0.961:1.04]	overlaps null	interleukin 1 receptor like 1 (M/F) Folkersen L/2018 [  3K]	Proteins
prot-b-38	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	interleukin 1 receptor like 1	MR Egger	3	0.0514380075053894	0.06938509263610242	0.5938771909119316	-0.08455677406137133	0.18743278907215014	1.0527839195676707	0.9189194831047007	1.2061491802911128	1.053 [0.919:1.206]	overlaps null	interleukin 1 receptor like 1 (M/F) Folkersen L/2018 [  3K]	Proteins
prot-b-38	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	interleukin 1 receptor like 1	Weighted median	3	-0.0011100402086841182	0.012955600837197987	0.9317205357152439	-0.026503017849592175	0.024282937432223938	0.9988905756580483	0.9738451049130478	1.0245801689659433	0.999 [0.974:1.025]	overlaps null	interleukin 1 receptor like 1 (M/F) Folkersen L/2018 [  3K]	Proteins
prot-a-1486	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Interleukin-17 receptor A	Inverse variance weighted	3	-0.007117001699629817	0.007853787633767723	0.36483678528325564	-0.022510425461814552	0.00827642206255492	0.9929082641823261	0.9777410437382847	1.0083107663274595	0.993 [0.978:1.008]	overlaps null	Interleukin-17 receptor A (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1486	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Interleukin-17 receptor A	MR Egger	3	-8.92258188001529e-4	0.013845296115962599	0.9590297827338972	-0.028029038575288222	0.026244522199285168	0.9991081397559705	0.972360130438422	1.0265919423049106	0.999 [0.972:1.027]	overlaps null	Interleukin-17 receptor A (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1486	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Interleukin-17 receptor A	Weighted median	3	-0.0068727989238466704	0.008275368611533107	0.4062489571124583	-0.023092521402451563	0.00934692355475822	0.9931507647449876	0.9771720702603721	1.0093907424623143	0.993 [0.977:1.009]	overlaps null	Interleukin-17 receptor A (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1506	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Interleukin-21	Inverse variance weighted	3	0.04718316434839465	0.02157200593866112	0.028724974152655482	0.004902032708618859	0.08946429598817045	1.0483140052473765	1.00491406732762	1.093588287126162	1.048 [1.005:1.094]	positive	Interleukin-21 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1506	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Interleukin-21	MR Egger	3	0.10172688082739263	0.0796939032279932	0.42306134025083075	-0.05447316949947405	0.2579269311542593	1.107081065368743	0.9469839165694443	1.2942442462359531	1.107 [0.947:1.294]	overlaps null	Interleukin-21 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1506	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Interleukin-21	Weighted median	3	0.044337577019336306	0.024321503810996112	0.06830665671331702	-0.0033325704502160727	0.09200772448888869	1.0453351764659438	0.9966729763992204	1.096373290971412	1.045 [0.997:1.096]	overlaps null	Interleukin-21 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1530	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Interleukin-3 receptor subunit alpha	Inverse variance weighted	3	-0.05287452915552542	0.016406705807564894	0.0012697123149298796	-0.08503167253835262	-0.02071738577269823	0.9484990139888008	0.9184831932466001	0.9794957448896766	0.948 [0.918:0.979]	negative	Interleukin-3 receptor subunit alpha (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1530	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Interleukin-3 receptor subunit alpha	MR Egger	3	-0.06946153758462065	0.034552907282331354	0.2938618096887137	-0.13718523585799008	-0.0017378393112511964	0.9328960141285226	0.8718087209378684	0.9982636698571273	0.933 [0.872:0.998]	negative	Interleukin-3 receptor subunit alpha (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1530	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Interleukin-3 receptor subunit alpha	Weighted median	3	-0.05252438060962261	0.010349269895493817	3.8713465940979423e-7	-0.0728089496047905	-0.03223981161445473	0.9488311876910148	0.9297784475981696	0.9682743507991312	0.949 [0.93:0.968]	negative	Interleukin-3 receptor subunit alpha (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1540	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Interleukin-6 receptor subunit alpha	Inverse variance weighted	2	-0.010883613023628618	0.00675342640218578	0.10705574846697163	-0.024120328771912745	0.0023531027246555102	0.9891753992097941	0.9761682415649616	1.002355873443708	0.989 [0.976:1.002]	overlaps null	Interleukin-6 receptor subunit alpha (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1541	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Interleukin-6 receptor subunit alpha	Inverse variance weighted	2	-0.010940856216400912	0.006789952735790594	0.10710776162014873	-0.024249163578550476	0.0023674511457486523	0.9891187772723572	0.9760424852193849	1.0023702557710468	0.989 [0.976:1.002]	overlaps null	Interleukin-6 receptor subunit alpha (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1542	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Interleukin-6 receptor subunit beta	Inverse variance weighted	4	-0.044013032710943964	0.047380462550792236	0.3529264623603809	-0.13687873931049674	0.04885267388860881	0.9569414858500019	0.8720759682540082	1.0500656372565975	0.957 [0.872:1.05]	overlaps null	Interleukin-6 receptor subunit beta (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1542	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Interleukin-6 receptor subunit beta	MR Egger	4	0.013894360085964199	0.17583694540640465	0.9442125445391694	-0.33074605291058895	0.3585347730825173	1.0139913353228307	0.7183875783130197	1.4312307995695517	1.014 [0.718:1.431]	overlaps null	Interleukin-6 receptor subunit beta (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1542	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Interleukin-6 receptor subunit beta	Weighted median	4	-0.011887037041037204	0.025661850835756797	0.6432079527504	-0.06218426467912053	0.03841019059704612	0.988183334670729	0.9397097155277071	1.0391573980615827	0.988 [0.94:1.039]	overlaps null	Interleukin-6 receptor subunit beta (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1657	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Kallikrein-12	Inverse variance weighted	3	-0.017712535198996994	0.022056418310695252	0.4219424690094906	-0.06094311508795969	0.0255180446899657	0.9824434096688447	0.9408767599454805	1.0258464171839827	0.982 [0.941:1.026]	overlaps null	Kallikrein-12 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1657	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Kallikrein-12	MR Egger	3	0.05278387877963168	0.05023601205696253	0.48425845988047445	-0.04567870485201488	0.15124646241127823	1.0542017851212375	0.9553488618393325	1.1632833283677535	1.054 [0.955:1.163]	overlaps null	Kallikrein-12 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1657	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Kallikrein-12	Weighted median	3	-0.015158179308666747	0.023239995755303722	0.5142429047556996	-0.06070857098906204	0.030392212371728546	0.9849561276009392	0.9410974629185939	1.0308587702382912	0.985 [0.941:1.031]	overlaps null	Kallikrein-12 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1659	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Kallikrein-14	Inverse variance weighted	2	0.008783682018553984	0.012914789245248694	0.4964247776095945	-0.016529304902133453	0.034096668939241424	1.008822371749922	0.9836065544745021	1.034684623758798	1.009 [0.984:1.035]	overlaps null	Kallikrein-14 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1666	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Kallikrein-7	Inverse variance weighted	3	0.02467202277182803	0.016698032679769666	0.139530758719717	-0.008056121280520512	0.05740016682417658	1.024978895653261	0.9919762422979045	1.059079534103473	1.025 [0.992:1.059]	overlaps null	Kallikrein-7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1666	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Kallikrein-7	MR Egger	3	0.011729037180274283	0.02641716228890357	0.7339901140886076	-0.040048600905976714	0.06350667526652527	1.0117980920551686	0.9607427450498246	1.0655665987187735	1.012 [0.961:1.066]	overlaps null	Kallikrein-7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1666	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Kallikrein-7	Weighted median	3	0.021618677642177717	0.016959756550746184	0.20241386082562468	-0.011622445197284802	0.054859800481640235	1.0218540543713974	0.9884448345150524	1.056392498573335	1.022 [0.988:1.056]	overlaps null	Kallikrein-7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1655	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Kelch-like protein 13	Inverse variance weighted	3	-0.04351667294719405	0.021099578415568122	0.03916560092363683	-0.08487184664170758	-0.0021614992526805335	0.9574165910016269	0.9186300023781522	0.9978408351046224	0.957 [0.919:0.998]	negative	Kelch-like protein 13 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1655	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Kelch-like protein 13	MR Egger	3	0.06948682656212903	0.15585812407317168	0.7330118844020278	-0.23599509662128748	0.3749687497455455	1.0719579397404375	0.7897845465360412	1.4549459464767147	1.072 [0.79:1.455]	overlaps null	Kelch-like protein 13 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1655	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Kelch-like protein 13	Weighted median	3	-0.048702411684645175	0.0198232765099988	0.014016917112534942	-0.08755603364424283	-0.009848789725047526	0.9524645298429988	0.9161675340069061	0.990199550775837	0.952 [0.916:0.99]	negative	Kelch-like protein 13 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1644	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Killer cell immunoglobulin-like receptor 2DL5A	Inverse variance weighted	2	0.00824465743746205	0.009027350123333815	0.3610860305531884	-0.009448948804272229	0.025938263679196327	1.0082787382226732	0.9905955522394896	1.0262775879152373	1.008 [0.991:1.026]	overlaps null	Killer cell immunoglobulin-like receptor 2DL5A (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2824	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Kunitz-type protease inhibitor 2	Inverse variance weighted	3	-0.004921493587206257	0.008205522382655124	0.5486540521955356	-0.0210043174572103	0.011161330282797787	0.9950905971194477	0.9792147368426071	1.0112238503153763	0.995 [0.979:1.011]	overlaps null	Kunitz-type protease inhibitor 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2824	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Kunitz-type protease inhibitor 2	MR Egger	3	-1.422396257960411e-4	0.01783298483304334	0.9949222949045566	-0.03509488989856099	0.0348104106469689	0.9998577704897799	0.9655137944046308	1.0354233849400905	1 [0.966:1.035]	overlaps null	Kunitz-type protease inhibitor 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2824	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Kunitz-type protease inhibitor 2	Weighted median	3	-0.004435233201474152	0.008329060174280692	0.5943790220003866	-0.020760191143064308	0.011889724740116002	0.9955745879202815	0.9794538181088966	1.0119606884848953	0.996 [0.979:1.012]	overlaps null	Kunitz-type protease inhibitor 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2666	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	L-Selectin	Inverse variance weighted	2	-0.023510396855020106	0.04040475672266438	0.5606528977193541	-0.10270372003144229	0.05568292632140207	0.9767638193442336	0.902394295231939	1.0572624005061049	0.977 [0.902:1.057]	overlaps null	L-Selectin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1792	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Leucine-rich repeat neuronal protein 1	Inverse variance weighted	2	-0.015673938014685668	0.016499193819165547	0.3421213719671647	-0.04801235790025014	0.0166644818708788	0.9844482588831966	0.9531220084180189	1.0168041088745001	0.984 [0.953:1.017]	overlaps null	Leucine-rich repeat neuronal protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1744	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Leukocyte immunoglobulin-like receptor subfamily B member 2	Inverse variance weighted	3	-0.024232956011963895	0.013110374469120934	0.06454736730409999	-0.04992928997144093	0.0014633779475131357	0.9760583046211521	0.9512966883385726	1.0014644492075109	0.976 [0.951:1.001]	overlaps null	Leukocyte immunoglobulin-like receptor subfamily B member 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1744	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Leukocyte immunoglobulin-like receptor subfamily B member 2	MR Egger	3	0.008338984710112867	0.10459857587475263	0.9493534406339565	-0.19667422400440226	0.21335219342462802	1.0083738508919102	0.821458201090014	1.2378205267332396	1.008 [0.821:1.238]	overlaps null	Leukocyte immunoglobulin-like receptor subfamily B member 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1744	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Leukocyte immunoglobulin-like receptor subfamily B member 2	Weighted median	3	-0.0229203591486474	0.013163143954486744	0.08163930397649775	-0.04872012129944142	0.0028794030021466153	0.9773403168887864	0.9524476622124283	1.0028835524646735	0.977 [0.952:1.003]	overlaps null	Leukocyte immunoglobulin-like receptor subfamily B member 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1746	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Leukocyte immunoglobulin-like receptor subfamily B member 4	Inverse variance weighted	2	0.09361193579801166	0.03876002593402113	0.015727996394379818	0.017642284967330252	0.16958158662869308	1.0981335169134958	1.0177988293217546	1.1848090076625404	1.098 [1.018:1.185]	positive	Leukocyte immunoglobulin-like receptor subfamily B member 4 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1074	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Low affinity immunoglobulin gamma Fc region receptor II-a	Inverse variance weighted	4	0.010223388859620685	0.00604467337097801	0.09077848461554974	-0.0016241709474962146	0.022070948666737585	1.0102758262430853	0.9983771473043518	1.0223163138769291	1.01 [0.998:1.022]	overlaps null	Low affinity immunoglobulin gamma Fc region receptor II-a (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1074	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Low affinity immunoglobulin gamma Fc region receptor II-a	MR Egger	4	0.009934627359747782	0.01140597488702668	0.47558959744835283	-0.012421083418824513	0.03229033813832008	1.0099841395961777	0.9876557398328538	1.0328173280382724	1.01 [0.988:1.033]	overlaps null	Low affinity immunoglobulin gamma Fc region receptor II-a (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1074	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Low affinity immunoglobulin gamma Fc region receptor II-a	Weighted median	4	0.010786906557746594	0.005986236591401679	0.07155307457263715	-9.461171614006964e-4	0.022519930276893883	1.0108452949889508	0.9990543302663234	1.0227754181586002	1.011 [0.999:1.023]	overlaps null	Low affinity immunoglobulin gamma Fc region receptor II-a (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1779	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Low-density lipoprotein receptor-related protein 1B	Inverse variance weighted	3	-0.02160210529741903	0.04545538902848054	0.6346177034925995	-0.1106946677932409	0.06749045719840284	0.9786295491064523	0.8952120442729677	1.069820050468704	0.979 [0.895:1.07]	overlaps null	Low-density lipoprotein receptor-related protein 1B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1779	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Low-density lipoprotein receptor-related protein 1B	MR Egger	3	-0.008966628331302042	0.17229553623594995	0.9668988070318052	-0.3466658793537639	0.3287326226911599	0.9910734519959217	0.7070415259678584	1.389206363666628	0.991 [0.707:1.389]	overlaps null	Low-density lipoprotein receptor-related protein 1B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1779	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Low-density lipoprotein receptor-related protein 1B	Weighted median	3	0.01237925349565255	0.03243894196171936	0.7027454319938644	-0.0512010727493174	0.07595957974062251	1.0124561936134906	0.9500876145962401	1.078918963091569	1.012 [0.95:1.079]	overlaps null	Low-density lipoprotein receptor-related protein 1B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2356	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Lysosomal Pro-X carboxypeptidase	Inverse variance weighted	2	-0.013287077327172206	0.027797796934247627	0.6326571081968304	-0.06777075931829755	0.04119660466395314	0.9868008062156957	0.9344746686352365	1.0420569586654587	0.987 [0.934:1.042]	overlaps null	Lysosomal Pro-X carboxypeptidase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1931	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MAGUK p55 subfamily member 6	Inverse variance weighted	3	-0.05423910279937437	0.029749288637944075	0.06827208848991884	-0.11254770852974476	0.004069502930996019	0.9472055999131754	0.8935547159098453	1.004077794601893	0.947 [0.894:1.004]	overlaps null	MAGUK p55 subfamily member 6 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1931	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MAGUK p55 subfamily member 6	MR Egger	3	0.006594100579460816	0.09958539433517097	0.9579073251741644	-0.1885932723174743	0.2017814734763959	1.0066158895271955	0.8281232588607993	1.2235805940803193	1.007 [0.828:1.224]	overlaps null	MAGUK p55 subfamily member 6 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1931	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MAGUK p55 subfamily member 6	Weighted median	3	-0.06565925003980093	0.023318988777399033	0.0048671265233050445	-0.11136446804350303	-0.019954032036098822	0.9364499051998687	0.8946126317874021	0.9802437320796079	0.936 [0.895:0.98]	negative	MAGUK p55 subfamily member 6 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1833	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB	Inverse variance weighted	3	0.08424245200574947	0.05207821846397882	0.1057458236255464	-0.017830856183649033	0.18631576019514795	1.087892623585256	0.9823271728740094	1.2048026290350875	1.088 [0.982:1.205]	overlaps null	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1833	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB	MR Egger	3	-0.04695767799359563	0.20922879622816382	0.8594509498589759	-0.4570461186007967	0.36313076261360544	0.9541277773377922	0.6331511393447774	1.4378238605550806	0.954 [0.633:1.438]	overlaps null	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1833	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB	Weighted median	3	0.04335155317688894	0.032099843022588795	0.1768485120170518	-0.01956413914738509	0.10626724550116298	1.0443049590515345	0.9806259966562294	1.1121190456079058	1.044 [0.981:1.112]	overlaps null	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1854	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MAP kinase-activated protein kinase 5	Inverse variance weighted	4	-0.009171720428491738	0.015624653346947081	0.5572016042022966	-0.039796040988508016	0.021452600131524537	0.9908702115054043	0.960985420802017	1.0216843614852726	0.991 [0.961:1.022]	overlaps null	MAP kinase-activated protein kinase 5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1854	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MAP kinase-activated protein kinase 5	MR Egger	4	0.0016654665909088798	0.04430445616468988	0.9734282507954499	-0.08517126749188328	0.08850220067370104	1.0016668542506517	0.9183549865766304	1.092536656924522	1.002 [0.918:1.093]	overlaps null	MAP kinase-activated protein kinase 5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1854	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MAP kinase-activated protein kinase 5	Weighted median	4	0.004627486635407562	0.010862463845566725	0.6701026782236064	-0.01666294250190322	0.02591791577271834	1.004638209986028	0.9834751164381718	1.026256705527315	1.005 [0.983:1.026]	overlaps null	MAP kinase-activated protein kinase 5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2815	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Maspardin	Inverse variance weighted	3	-0.01490879489496234	0.016957356530447405	0.3792964558854813	-0.048145213694639255	0.018327623904714572	0.985201790938376	0.9529953890476855	1.0184966055692175	0.985 [0.953:1.018]	overlaps null	Maspardin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2815	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Maspardin	MR Egger	3	-0.035831600042349206	0.032092668660878176	0.4649922191613178	-0.09873323061767042	0.027070030532972016	0.9648027525463596	0.9059843646781826	1.0274397523975813	0.965 [0.906:1.027]	overlaps null	Maspardin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2815	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Maspardin	Weighted median	3	-0.013293390241208812	0.016044821757917452	0.4073783834620028	-0.04474124088672702	0.018154460404309396	0.9867945766466981	0.9562448869015678	1.0183202544010796	0.987 [0.956:1.018]	overlaps null	Maspardin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1898	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MHC class I polypeptide-related sequence B	Inverse variance weighted	4	0.03275285565876797	0.0157380241933978	0.03742211689576416	0.0019063282397082798	0.06359938307782766	1.0332951346363561	1.0019081464385649	1.065665389645212	1.033 [1.002:1.066]	positive	MHC class I polypeptide-related sequence B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1898	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MHC class I polypeptide-related sequence B	MR Egger	4	0.004684725908285047	0.021467770271256344	0.8474990649659361	-0.03739210382337739	0.04676155563994748	1.0046957163924695	0.9632983483225945	1.0478721200914376	1.005 [0.963:1.048]	overlaps null	MHC class I polypeptide-related sequence B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1898	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MHC class I polypeptide-related sequence B	Weighted median	4	0.031083293731707734	0.013877457243039971	0.025101265686301142	0.0038834775353493896	0.05828310992806608	1.031571423741587	1.0038910280050959	1.0600150540192326	1.032 [1.004:1.06]	positive	MHC class I polypeptide-related sequence B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1922	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Multimerin-2	Inverse variance weighted	4	0.026871202972513296	0.013489880972980976	0.04637626296955878	4.3103626547058224e-4	0.053311369679556006	1.027235489365327	1.0004311291749504	1.0547580136594217	1.027 [1:1.055]	positive	Multimerin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1922	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Multimerin-2	MR Egger	4	0.023691597124090774	0.0224134839816404	0.40131876654007714	-0.020238831479924405	0.06762202572810595	1.0239744725171323	0.9799645989602634	1.0699608143796384	1.024 [0.98:1.07]	overlaps null	Multimerin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1922	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Multimerin-2	Weighted median	4	0.029517016385233172	0.015386863716106893	0.05506972338736475	-6.412364983363374e-4	0.05967526926880268	1.0299569614672066	0.9993589690498497	1.0614917915664857	1.03 [0.999:1.061]	overlaps null	Multimerin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2395	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Myeloblastin	Inverse variance weighted	3	0.04214902201102923	0.018542408406279264	0.023019265915597994	0.005805901534721873	0.07849214248733657	1.0430499045639239	1.005822788446468	1.081654856012157	1.043 [1.006:1.082]	positive	Myeloblastin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2395	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Myeloblastin	MR Egger	3	0.0818802539751502	0.03350684143786211	0.24728046485103705	0.016206844756940467	0.14755366319335994	1.0853258385930966	1.0163388880359543	1.1589954785594483	1.085 [1.016:1.159]	positive	Myeloblastin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2395	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Myeloblastin	Weighted median	3	0.04312574352722926	0.017661022466774583	0.014611813630156826	0.008510139492351076	0.07774134756210745	1.0440691715371433	1.0085464536692483	1.0808430598197782	1.044 [1.009:1.081]	positive	Myeloblastin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2396	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Myeloblastin	Inverse variance weighted	3	0.05586636543327829	0.02615106889270003	0.03265547674904577	0.004610270403586227	0.10712246046297036	1.0574563615713528	1.0046209140505942	1.1130705532688208	1.057 [1.005:1.113]	positive	Myeloblastin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2396	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Myeloblastin	MR Egger	3	0.019197107223636687	0.06598162732994059	0.8197538137568648	-0.11012688234304688	0.14852109679032025	1.0193825564820937	0.8957204769732301	1.1601172722670994	1.019 [0.896:1.16]	overlaps null	Myeloblastin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2396	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Myeloblastin	Weighted median	3	0.05089660069673325	0.016486020027147108	0.0020201203805746515	0.018584001443524914	0.08320919994994158	1.0522140894544438	1.0187577586977077	1.086769136817898	1.052 [1.019:1.087]	positive	Myeloblastin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1930	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Myeloperoxidase	Inverse variance weighted	4	-0.028716698340880593	0.02196806533752254	0.1911441258139258	-0.07177410640242476	0.014340709720663584	0.9716917073492258	0.93074112052623	1.0144440310077014	0.972 [0.931:1.014]	overlaps null	Myeloperoxidase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1930	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Myeloperoxidase	MR Egger	4	-0.028154452956572176	0.044911481930662814	0.5947533466194743	-0.11618095754067129	0.05987205162752693	0.9722381901409712	0.8903140996697434	1.0617006949785754	0.972 [0.89:1.062]	overlaps null	Myeloperoxidase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1930	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Myeloperoxidase	Weighted median	4	-0.028895410704225282	0.024800974209804018	0.24398185172162892	-0.07750532015544116	0.019714498746990595	0.9715180695438365	0.9254221009941143	1.0199101128406978	0.972 [0.925:1.02]	overlaps null	Myeloperoxidase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-213	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2	Inverse variance weighted	3	0.04800603476446667	0.03451585211158773	0.16427388886416788	-0.019645035374245286	0.11565710490317863	1.0491769868413654	0.9805466709217585	1.1226108683666738	1.049 [0.981:1.123]	overlaps null	N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-213	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2	MR Egger	3	0.03464929140029914	0.1340276350766242	0.8389450397764219	-0.22804487334988433	0.29734345615048263	1.035256571743094	0.7960885358745237	1.3462776073768128	1.035 [0.796:1.346]	overlaps null	N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-213	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2	Weighted median	3	0.0365015151853286	0.016942468154156603	0.03120575608467822	0.0032942776031816556	0.06970875276747554	1.037175875530229	1.003299709698951	1.0721958616978773	1.037 [1.003:1.072]	positive	N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2736	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	NAD-dependent protein deacetylase sirtuin-2	Inverse variance weighted	3	-0.01144568607825465	0.029260460119783668	0.6956748176745416	-0.06879618791303063	0.04590481575652134	0.9886195665955005	0.9335169227229095	1.046974750714382	0.989 [0.934:1.047]	overlaps null	NAD-dependent protein deacetylase sirtuin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2736	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	NAD-dependent protein deacetylase sirtuin-2	MR Egger	3	-0.09335698398606268	0.03794096113156708	0.24574649469170182	-0.16772126780393415	-0.018992700168191212	0.9108682768615632	0.845589494856966	0.9811865247132671	0.911 [0.846:0.981]	negative	NAD-dependent protein deacetylase sirtuin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2736	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	NAD-dependent protein deacetylase sirtuin-2	Weighted median	3	-0.018053774333021994	0.02125871835863539	0.3957472270842527	-0.05972086231594736	0.02361331364990337	0.9821082187238872	0.9420274522486227	1.0238943153754752	0.982 [0.942:1.024]	overlaps null	NAD-dependent protein deacetylase sirtuin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2025	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial	Inverse variance weighted	2	0.012273775732551978	0.008770888572620875	0.16170009713634204	-0.004917165869784936	0.029464717334888892	1.012349407630823	0.9950949035996792	1.0299030971047662	1.012 [0.995:1.03]	overlaps null	NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2007	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Neural cell adhesion molecule 1	Inverse variance weighted	3	0.022065626550057293	0.03265587148312953	0.49923008220295095	-0.041939881556876585	0.08607113465699118	1.022310873004701	0.958927428063672	1.0898838540618307	1.022 [0.959:1.09]	overlaps null	Neural cell adhesion molecule 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2007	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Neural cell adhesion molecule 1	MR Egger	3	0.29256349803156756	0.24121899932022287	0.43895141318648856	-0.18022574063606928	0.7653527366992043	1.3398578121964508	0.8350816782630553	2.1497525375456212	1.34 [0.835:2.15]	overlaps null	Neural cell adhesion molecule 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2007	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Neural cell adhesion molecule 1	Weighted median	3	0.041387902644176036	0.03974171527629409	0.29767966599672097	-0.036505859297360374	0.11928166458571245	1.0422563211251386	0.9641524446238998	1.126687221489186	1.042 [0.964:1.127]	overlaps null	Neural cell adhesion molecule 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2101	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Neurensin-1	Inverse variance weighted	3	-0.04842149452784024	0.030968742581146045	0.11792087878107042	-0.10912022998688649	0.01227724093120601	0.952732131055806	0.8966226100928703	1.0123529156287059	0.953 [0.897:1.012]	overlaps null	Neurensin-1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2101	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Neurensin-1	MR Egger	3	-0.43292116778745504	0.22431728635086226	0.3043427462755737	-0.872583049035145	0.0067407134602349705	0.6486116212788126	0.4178707733021381	1.0067634832018946	0.649 [0.418:1.007]	overlaps null	Neurensin-1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2101	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Neurensin-1	Weighted median	3	-0.03695614765350094	0.029108262101081694	0.20422349975631593	-0.09400834137162106	0.020096046064619177	0.9637183957354555	0.9102751692656348	1.0202993310563357	0.964 [0.91:1.02]	overlaps null	Neurensin-1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2082	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Neuropeptide W	Inverse variance weighted	3	-0.008420014117843022	0.01676768293128289	0.6155568878557067	-0.04128467266315749	0.02444464442747144	0.9916153349183259	0.9595559317210789	1.0247458641431304	0.992 [0.96:1.025]	overlaps null	Neuropeptide W (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2082	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Neuropeptide W	MR Egger	3	-0.019416397904957042	0.047369569855188615	0.7523519850711737	-0.11226075482112673	0.07342795901121264	0.9807708862621544	0.8938111615416816	1.0761910040151075	0.981 [0.894:1.076]	overlaps null	Neuropeptide W (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2082	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Neuropeptide W	Weighted median	3	-0.010530987709777798	0.01834802808627449	0.5659965842009695	-0.0464931227588758	0.025431147339320205	0.9895242690019389	0.9545711253631958	1.0257572777212078	0.99 [0.955:1.026]	overlaps null	Neuropeptide W (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2337	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Neutrophil-activating peptide 2	Inverse variance weighted	3	0.07282686331759258	0.026988455552917016	0.006966424541045234	0.019929490433875235	0.12572423620130993	1.0755443046206636	1.020129408608867	1.1339694174481738	1.076 [1.02:1.134]	positive	Neutrophil-activating peptide 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2337	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Neutrophil-activating peptide 2	MR Egger	3	-0.03726854999592477	0.2527073947787548	0.9067850883898494	-0.5325750437622843	0.45803794377043466	0.9634173748734501	0.5870912359245108	1.5809689898477652	0.963 [0.587:1.581]	overlaps null	Neutrophil-activating peptide 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2337	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Neutrophil-activating peptide 2	Weighted median	3	0.0643467601845503	0.03266685315618746	0.048862725651286514	3.197279984228779e-4	0.1283737923706777	1.0664621412607311	1.0003197791168672	1.1369779169482446	1.066 [1:1.137]	positive	Neutrophil-activating peptide 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2189	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	PAX-interacting protein 1	Inverse variance weighted	3	-0.06784044376513247	0.02516712596780082	0.007026249535071587	-0.11716801066202208	-0.018512876868242864	0.9344095525536869	0.8894357459208996	0.9816574338369698	0.934 [0.889:0.982]	negative	PAX-interacting protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2189	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	PAX-interacting protein 1	MR Egger	3	-0.02617377250106167	0.08645724702470056	0.8128557270986811	-0.19562997666947476	0.1432824316673514	0.9741657916734447	0.8223164546637697	1.154055697517056	0.974 [0.822:1.154]	overlaps null	PAX-interacting protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2189	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	PAX-interacting protein 1	Weighted median	3	-0.05546252095579157	0.031020655443664877	0.07378854803898993	-0.11626300562537473	0.0053379637137915825	0.9460474799613213	0.8902410540997465	1.0053522360258238	0.946 [0.89:1.005]	overlaps null	PAX-interacting protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2341	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Peptidyl-prolyl cis-trans isomerase E	Inverse variance weighted	2	-0.03374488586145366	0.019648624824451014	0.08590297463261712	-0.07225619051737764	0.004766418794470324	0.9668181221507254	0.930292533154002	1.0047777962379036	0.967 [0.93:1.005]	overlaps null	Peptidyl-prolyl cis-trans isomerase E (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2398	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	PH and SEC7 domain-containing protein 1	Inverse variance weighted	4	-0.03613362094928282	0.02142646975303272	0.09171858060401415	-0.07812950166522695	0.0058622597666613124	0.9645114059426209	0.9248446498658333	1.0058794764378718	0.965 [0.925:1.006]	overlaps null	PH and SEC7 domain-containing protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2398	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	PH and SEC7 domain-containing protein 1	MR Egger	4	-0.0663278231607034	0.05088165347547636	0.3222414859191506	-0.16605586397263705	0.03340021765123026	0.9358240292094259	0.8469989161434499	1.033964267195641	0.936 [0.847:1.034]	overlaps null	PH and SEC7 domain-containing protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2398	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	PH and SEC7 domain-containing protein 1	Weighted median	4	-0.041962835337136184	0.014270895650552895	0.0032773735721781444	-0.06993379081221986	-0.013991879862052511	0.9589054173068193	0.9324555549871477	0.986105551543461	0.959 [0.932:0.986]	negative	PH and SEC7 domain-containing protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2166	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Platelet-activating factor acetylhydrolase IB subunit beta	Inverse variance weighted	3	-0.041755723958283454	0.027663158827894236	0.13118780385839826	-0.09597551526095616	0.012464067344389249	0.95910403809759	0.9084862598453858	1.0125420675615466	0.959 [0.908:1.013]	overlaps null	Platelet-activating factor acetylhydrolase IB subunit beta (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2166	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Platelet-activating factor acetylhydrolase IB subunit beta	MR Egger	3	-0.12823603622898694	0.2152482325202553	0.6579472770768864	-0.5501225719686873	0.2936504995107134	0.8796457263787211	0.5768790968402321	1.3413150314764257	0.88 [0.577:1.341]	overlaps null	Platelet-activating factor acetylhydrolase IB subunit beta (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2166	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Platelet-activating factor acetylhydrolase IB subunit beta	Weighted median	3	-0.035670018459776874	0.029201637282791723	0.22189393407390418	-0.09290522753404865	0.021565190614494904	0.9649586594974929	0.9112798604433399	1.0217993998969692	0.965 [0.911:1.022]	overlaps null	Platelet-activating factor acetylhydrolase IB subunit beta (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2308	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Plexin-B2	Inverse variance weighted	3	0.03996691828023756	0.018983516783229758	0.035260984603015764	0.002759225385107235	0.07717461117536789	1.0407763429515562	1.002763035551033	1.0802306802746995	1.041 [1.003:1.08]	positive	Plexin-B2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2308	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Plexin-B2	MR Egger	3	0.08584218629722648	0.030729503182200885	0.21884649346708548	0.02561236006011275	0.1460720125343402	1.089634355503342	1.0259431748313284	1.1572795236815956	1.09 [1.026:1.157]	positive	Plexin-B2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2308	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Plexin-B2	Weighted median	3	0.04495891004551018	0.01514443944119962	0.00299087302950478	0.015275808740758925	0.07464201135026143	1.0459848795545947	1.015393080285408	1.0774983496532329	1.046 [1.015:1.077]	positive	Plexin-B2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1610	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Potassium voltage-gated channel subfamily E member 2	Inverse variance weighted	3	0.014575429676952035	0.013687505246784389	0.28693423467853096	-0.012252080606745366	0.041402939960649435	1.0146821692131178	0.9878226705357335	1.0422719939811242	1.015 [0.988:1.042]	overlaps null	Potassium voltage-gated channel subfamily E member 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1610	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Potassium voltage-gated channel subfamily E member 2	MR Egger	3	-0.015235087492339757	0.031012079409049677	0.7092980090602976	-0.07601876313407713	0.045548588149397606	0.9848803793270362	0.9267988167457779	1.0466018558258863	0.985 [0.927:1.047]	overlaps null	Potassium voltage-gated channel subfamily E member 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1610	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Potassium voltage-gated channel subfamily E member 2	Weighted median	3	0.013674350052225382	0.013546059223928075	0.31274894077202936	-0.012875926026673645	0.04022462613112441	1.0137682715939644	0.9872066140690009	1.0410445937498358	1.014 [0.987:1.041]	overlaps null	Potassium voltage-gated channel subfamily E member 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2357	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	PR domain zinc finger protein 1	Inverse variance weighted	3	0.025904927436022674	0.02456122886177537	0.2915588384672017	-0.022235081133057052	0.0740449360051024	1.0262433762462502	0.9780102962565473	1.0768551939795104	1.026 [0.978:1.077]	overlaps null	PR domain zinc finger protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2357	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	PR domain zinc finger protein 1	MR Egger	3	0.5091857822067963	0.15728314506937496	0.19072747270870705	0.20091081787082143	0.8174607465427712	1.6639358370772204	1.2225157404048888	2.2647417766522184	1.664 [1.223:2.265]	positive	PR domain zinc finger protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2357	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	PR domain zinc finger protein 1	Weighted median	3	0.024541358451315755	0.012441915342588428	0.04855548552853399	1.5520437984243782e-4	0.04892751252278907	1.0248449762317566	1.0001552164246654	1.0501442256753777	1.025 [1:1.05]	positive	PR domain zinc finger protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2073	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Pro-FMRFamide-related neuropeptide FF	Inverse variance weighted	3	-0.0323825005235515	0.012200053694707861	0.007947510502562951	-0.05629460576517891	-0.008470395281924094	0.9681361986449337	0.9452606156386111	0.9915653774419005	0.968 [0.945:0.992]	negative	Pro-FMRFamide-related neuropeptide FF (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2073	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Pro-FMRFamide-related neuropeptide FF	MR Egger	3	0.05814629649440905	0.08980305636378895	0.6341941628865022	-0.1178676939786173	0.2341602869674354	1.059870039640148	0.8888136402321607	1.2638470541849391	1.06 [0.889:1.264]	overlaps null	Pro-FMRFamide-related neuropeptide FF (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2073	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Pro-FMRFamide-related neuropeptide FF	Weighted median	3	-0.031657575838631186	0.013325840367117989	0.017517916778894065	-0.057776222958182445	-0.005538928719079926	0.9688382789206116	0.9438611382594947	0.9944763828636319	0.969 [0.944:0.994]	negative	Pro-FMRFamide-related neuropeptide FF (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-648	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Probable carboxypeptidase X1	Inverse variance weighted	3	0.040926300990575704	0.016720873330176012	0.014380425623559944	0.008153389263430719	0.07369921271772069	1.0417753249066974	1.0081867186626134	1.0764829644097365	1.042 [1.008:1.076]	positive	Probable carboxypeptidase X1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-648	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Probable carboxypeptidase X1	MR Egger	3	0.03903204975768886	0.032892918838932556	0.4457929242354466	-0.02543807116661894	0.10350217068199666	1.039803808576236	0.9748827504477726	1.1090482007534177	1.04 [0.975:1.109]	overlaps null	Probable carboxypeptidase X1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-648	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Probable carboxypeptidase X1	Weighted median	3	0.04160104606758441	0.01755447914322072	0.01779649951555673	0.007194266946871801	0.07600782518829702	1.0424784948820887	1.0072202078566197	1.0789710172756266	1.042 [1.007:1.079]	positive	Probable carboxypeptidase X1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2427	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Prostaglandin F2 receptor negative regulator	Inverse variance weighted	3	0.021502860565368147	0.009867004598668941	0.029311665733719076	0.002163531551977023	0.04084218957875927	1.0217357130749978	1.0021658736751464	1.04168770339836	1.022 [1.002:1.042]	positive	Prostaglandin F2 receptor negative regulator (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2427	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Prostaglandin F2 receptor negative regulator	MR Egger	3	0.016480706522333115	0.016760471730487107	0.5053578082205934	-0.016369818069421612	0.04933123111408784	1.0166172625143923	0.9837634392787076	1.0505682740151676	1.017 [0.984:1.051]	overlaps null	Prostaglandin F2 receptor negative regulator (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2427	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Prostaglandin F2 receptor negative regulator	Weighted median	3	0.02092918873698213	0.009930684283513475	0.035071893473500204	0.0014650475412957172	0.040393329932668545	1.0211497401744938	1.0014661212477245	1.0412202367457823	1.021 [1.001:1.041]	positive	Prostaglandin F2 receptor negative regulator (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-995	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Protein eva-1 homolog C	Inverse variance weighted	3	-0.015753753430214065	0.013132490389994807	0.2302941952285809	-0.04149343459460389	0.009985927734175757	0.9843696878719784	0.9593556338794516	1.01003595348973	0.984 [0.959:1.01]	overlaps null	Protein eva-1 homolog C (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-995	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Protein eva-1 homolog C	MR Egger	3	-0.01658154866357187	0.06886087315041901	0.8495672445937206	-0.15154886003839313	0.1183857627112494	0.9835551685106305	0.8593758921080322	1.1256782723227303	0.984 [0.859:1.126]	overlaps null	Protein eva-1 homolog C (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-995	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Protein eva-1 homolog C	Weighted median	3	-0.016369953772406416	0.01422373612949334	0.24977754730042626	-0.044248476586213364	0.011508569041400532	0.9837633057790816	0.9567162063595461	1.0115750474009204	0.984 [0.957:1.012]	overlaps null	Protein eva-1 homolog C (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1049	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Protein FAM3B	Inverse variance weighted	3	0.04442782898101903	0.04609641853359853	0.33514511017078463	-0.04592115134483407	0.13477680930687214	1.045429524273709	0.9551172689339391	1.1442813628980106	1.045 [0.955:1.144]	overlaps null	Protein FAM3B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1049	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Protein FAM3B	MR Egger	3	-0.04643614564760839	0.02914347672271062	0.35680573492164375	-0.10355736002412119	0.010685068728904422	0.9546255156179033	0.9016243040667479	1.0107423579403456	0.955 [0.902:1.011]	overlaps null	Protein FAM3B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1049	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Protein FAM3B	Weighted median	3	0.018475556832588426	0.01911464791617047	0.3337613507844469	-0.018989153083105698	0.05594026674828255	1.0186472858991251	0.9811900050715275	1.057534511874702	1.019 [0.981:1.058]	overlaps null	Protein FAM3B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2030	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Protein kinase C-binding protein NELL1	Inverse variance weighted	2	-0.007152680055895335	0.01662526164356075	0.6670286151287323	-0.0397381928772744	0.02543283276548373	0.992872839479489	0.9610410136014872	1.0257590065608182	0.993 [0.961:1.026]	overlaps null	Protein kinase C-binding protein NELL1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2329	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2	Inverse variance weighted	2	-0.006709017470727217	0.04700008991171213	0.8864917498955962	-0.09882919369768299	0.08541115875622855	0.9933134377414505	0.9058974277995369	1.0891647942906797	0.993 [0.906:1.089]	overlaps null	Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2616	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Protein S100-A13	Wald ratio	1	0.01407318053880177	0.00731805388017692	0.054470390027477396	-2.702050663449928e-4	0.02841656614394853	1.0141726739256287	0.9997298314357562	1.028824168485919	1.014 [1:1.029]	overlaps null	Protein S100-A13 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2616	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Protein S100-A13	NO SENSITIVITY	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Protein S100-A13 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2720	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Protein shisa-3 homolog	Inverse variance weighted	3	0.033836929420630234	0.040548461977216385	0.4040098740786826	-0.045638056054713876	0.11331191489597434	1.034415910171988	0.9553876964108532	1.119981217297145	1.034 [0.955:1.12]	overlaps null	Protein shisa-3 homolog (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2720	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Protein shisa-3 homolog	MR Egger	3	-0.023123921178862118	0.059838756330981624	0.7652401527173446	-0.1404078835875861	0.09416004122986185	0.9771413877575656	0.8690037107501618	1.0987355748395502	0.977 [0.869:1.099]	overlaps null	Protein shisa-3 homolog (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2720	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Protein shisa-3 homolog	Weighted median	3	0.01701023576781276	0.0157262447231991	0.27940968478661704	-0.01381320388965748	0.047833675425282995	1.0171557336418757	0.9862817606534655	1.0489961669726708	1.017 [0.986:1.049]	overlaps null	Protein shisa-3 homolog (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3093	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Protein-tyrosine sulfotransferase 2	Inverse variance weighted	4	0.05933724787576086	0.028970466658012076	0.04054061584562638	0.002555133226057195	0.11611936252546454	1.0611330452677754	1.002558400361021	1.1231299237568497	1.061 [1.003:1.123]	positive	Protein-tyrosine sulfotransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3093	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Protein-tyrosine sulfotransferase 2	MR Egger	4	0.23843174592298103	0.13639785386046072	0.2225630497237892	-0.028908047643521978	0.5057715394894841	1.269257071109959	0.9715057926065376	1.658264443529773	1.269 [0.972:1.658]	overlaps null	Protein-tyrosine sulfotransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3093	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Protein-tyrosine sulfotransferase 2	Weighted median	4	0.04351891758756668	0.0257778825113235	0.09136765970503521	-0.007005732134627379	0.09404356730976074	1.0444797531623227	0.993018750799754	1.0986076082525238	1.044 [0.993:1.099]	overlaps null	Protein-tyrosine sulfotransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2609	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Reticulon-4 receptor	Inverse variance weighted	3	-0.008436708964991902	0.019034938009524497	0.6576049520836913	-0.045745187463659916	0.028871769533676116	0.9915987801900686	0.9552853498632098	1.0292925993424156	0.992 [0.955:1.029]	overlaps null	Reticulon-4 receptor (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2609	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Reticulon-4 receptor	MR Egger	3	0.037425867138451606	0.05943557215380494	0.6422430087425686	-0.07906785428300608	0.15391958855990928	1.0381350343083582	0.9239772265057306	1.1663970913375448	1.038 [0.924:1.166]	overlaps null	Reticulon-4 receptor (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2609	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Reticulon-4 receptor	Weighted median	3	-0.00706022867692228	0.020743104923857277	0.7335816086271542	-0.04771671432768254	0.03359625697383799	0.9929646361859444	0.9534038344716583	1.0341669847198365	0.993 [0.953:1.034]	overlaps null	Reticulon-4 receptor (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2493	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Retinoic acid receptor responder protein 1	Inverse variance weighted	2	0.005655394052375548	0.013177821897330714	0.6678067899526017	-0.020173136866392653	0.031483924971143745	1.0056714159825224	0.9800289794705701	1.0319847862770908	1.006 [0.98:1.032]	overlaps null	Retinoic acid receptor responder protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-149	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Rho GTPase-activating protein 30	Inverse variance weighted	5	-0.052299485098033914	0.020176549798430362	0.009539409562800796	-0.09184552270295743	-0.012753447493110408	0.9490445995631684	0.9122460599666611	0.9873275330922572	0.949 [0.912:0.987]	negative	Rho GTPase-activating protein 30 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-149	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Rho GTPase-activating protein 30	MR Egger	5	-0.20546953172745136	0.07190237046927922	0.06470319378258534	-0.34639817784723864	-0.06454088560766408	0.8142649034342148	0.707230827386543	0.9374977833119086	0.814 [0.707:0.937]	negative	Rho GTPase-activating protein 30 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-149	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Rho GTPase-activating protein 30	Weighted median	5	-0.05560988368997472	0.022314083518005557	0.01269749581979459	-0.09934548738526561	-0.01187427999468383	0.9459080780895799	0.9054298393928246	0.988195941051745	0.946 [0.905:0.988]	negative	Rho GTPase-activating protein 30 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2561	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	RING finger protein 122	Inverse variance weighted	2	0.018830515375172472	0.034208510620651	0.5820019283217059	-0.04821816544130349	0.08587919619164842	1.0190089276352499	0.9529258689053303	1.0896746835020605	1.019 [0.953:1.09]	overlaps null	RING finger protein 122 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2575	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	rRNA methyltransferase 3, mitochondrial	Inverse variance weighted	4	-0.02799166726612272	0.011713988056513178	0.01686703954333183	-0.05095108385688855	-0.0050322506753568905	0.9723964694884916	0.9503251556367972	0.9949803898856935	0.972 [0.95:0.995]	negative	rRNA methyltransferase 3, mitochondrial (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2575	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	rRNA methyltransferase 3, mitochondrial	MR Egger	4	-0.03130219990598013	0.02702626982292696	0.36639198301580145	-0.08427368875891697	0.021669288946956716	0.9691826419131067	0.9191796525278391	1.0219057730471466	0.969 [0.919:1.022]	overlaps null	rRNA methyltransferase 3, mitochondrial (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2575	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	rRNA methyltransferase 3, mitochondrial	Weighted median	4	-0.02952289354132961	0.011095328531242798	0.007794599573453426	-0.051269737462565496	-0.0077760496200937265	0.9709086498494562	0.950022379342329	0.9922541056401963	0.971 [0.95:0.992]	negative	rRNA methyltransferase 3, mitochondrial (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2291	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Secretory phospholipase A2 receptor	Wald ratio	1	0.01474337656579093	0.008313934153641503	0.07617348872494967	-0.001551934375346415	0.031038687506928276	1.0148525962375412	0.9984492692520756	1.0315254102610347	1.015 [0.998:1.032]	overlaps null	Secretory phospholipase A2 receptor (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2291	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Secretory phospholipase A2 receptor	NO SENSITIVITY	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Secretory phospholipase A2 receptor (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2820	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Serine protease inhibitor Kazal-type 6	Inverse variance weighted	2	0.005328892227924331	0.012531176557240191	0.6706538918921188	-0.019232213824266445	0.029889998280115106	1.0053431160285893	0.9809515452829558	1.030341188416735	1.005 [0.981:1.03]	overlaps null	Serine protease inhibitor Kazal-type 6 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2877	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Serine/threonine-protein kinase 16	Inverse variance weighted	4	-0.07196589114827383	0.037605541533069824	0.05565793364263344	-0.1456727525530907	0.0017409702565430313	0.9305626356928599	0.8644405428634941	1.0017424866251166	0.931 [0.864:1.002]	overlaps null	Serine/threonine-protein kinase 16 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2877	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Serine/threonine-protein kinase 16	MR Egger	4	0.09983511642745335	0.07822495698135033	0.3300311171318705	-0.05348579925599331	0.2531560321109	1.1049887085684906	0.9479194020689921	1.2880842436591389	1.105 [0.948:1.288]	overlaps null	Serine/threonine-protein kinase 16 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2877	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Serine/threonine-protein kinase 16	Weighted median	4	-0.0816622917673854	0.03197524932237853	0.010651712404617882	-0.14433378043924733	-0.01899080309552348	0.9215831323612742	0.8655987798949621	0.9811883860971706	0.922 [0.866:0.981]	negative	Serine/threonine-protein kinase 16 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2878	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Serine/threonine-protein kinase 17B	Inverse variance weighted	2	-0.005048543573081025	0.028834049045890986	0.8610091902732994	-0.06156327970302736	0.05146619255686531	0.9949641789040259	0.9402934423669791	1.052813592754805	0.995 [0.94:1.053]	overlaps null	Serine/threonine-protein kinase 17B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2729	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Sialic acid-binding Ig-like lectin 7	Inverse variance weighted	3	0.00869184434960645	0.0190606644522891	0.6483831361324928	-0.028667057976880184	0.04605074667609309	1.0087297281090715	0.9717399436764994	1.0471275478511644	1.009 [0.972:1.047]	overlaps null	Sialic acid-binding Ig-like lectin 7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2729	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Sialic acid-binding Ig-like lectin 7	MR Egger	3	0.002088053730029504	0.040315438537105334	0.9670570472949154	-0.07693020580269695	0.08110631326275596	1.0020902352323198	0.9259544776007825	1.0844861857030854	1.002 [0.926:1.084]	overlaps null	Sialic acid-binding Ig-like lectin 7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2729	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Sialic acid-binding Ig-like lectin 7	Weighted median	3	0.011972355418289332	0.021028421387014377	0.5691243297794203	-0.02924335050025885	0.05318806133683751	1.012044310937712	0.9711800985450663	1.0546279612152287	1.012 [0.971:1.055]	overlaps null	Sialic acid-binding Ig-like lectin 7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2748	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Solute carrier family 22 member 16	Inverse variance weighted	4	-0.043088792448612454	0.028559984243963006	0.13137238414371252	-0.09906636156677995	0.012888776669555034	0.9578263385451752	0.9056826035126814	1.0129721949528543	0.958 [0.906:1.013]	overlaps null	Solute carrier family 22 member 16 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2748	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Solute carrier family 22 member 16	MR Egger	4	-0.05642913199566809	0.0963820486910705	0.6174911050664396	-0.2453379474301663	0.1324796834388301	0.9451334618441114	0.7824400699452975	1.1416558213332375	0.945 [0.782:1.142]	overlaps null	Solute carrier family 22 member 16 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2748	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Solute carrier family 22 member 16	Weighted median	4	-0.045061669162959186	0.02708290768232084	0.09614408292813277	-0.09814416822030803	0.008020829894389653	0.955938528086437	0.9065182032166808	1.0080530829248422	0.956 [0.907:1.008]	overlaps null	Solute carrier family 22 member 16 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2875	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Stromal interaction molecule 1	Inverse variance weighted	3	-0.037423852883877104	0.03365256078230117	0.2661099755615629	-0.1033828720171874	0.028535166249433197	0.963267764990553	0.9017816404208218	1.0289461943768252	0.963 [0.902:1.029]	overlaps null	Stromal interaction molecule 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2875	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Stromal interaction molecule 1	MR Egger	3	0.04070135592521602	0.139646289117478	0.8194521148935519	-0.23300537074504085	0.31440808259547287	1.0415410090432329	0.7921493190808622	1.3694484706210537	1.042 [0.792:1.369]	overlaps null	Stromal interaction molecule 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2875	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Stromal interaction molecule 1	Weighted median	3	-0.042308715720013775	0.03435123706356742	0.2180796960844079	-0.10963714036460592	0.025019708924578367	0.958573808085806	0.8961592563273175	1.025335328581947	0.959 [0.896:1.025]	overlaps null	Stromal interaction molecule 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2889	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Syntaxin-7	Inverse variance weighted	3	-0.01582331869849169	0.014605012347771298	0.2786233722364174	-0.04444914290012343	0.012802505503140053	0.9843012123123451	0.9565242449057008	1.0128848084295727	0.984 [0.957:1.013]	overlaps null	Syntaxin-7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2889	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Syntaxin-7	MR Egger	3	0.00235332599705772	0.02985730252439098	0.9499257199097234	-0.05616698695074861	0.06087363894486404	1.0023560972421366	0.9453812563755567	1.0627646136442535	1.002 [0.945:1.063]	overlaps null	Syntaxin-7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2889	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Syntaxin-7	Weighted median	3	-0.0135009157183315	0.01566390709907322	0.38873572639241305	-0.04420217363251501	0.01720034219585201	0.9865898128789417	0.9567605061713499	1.0173491198665578	0.987 [0.957:1.017]	overlaps null	Syntaxin-7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3071	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Tenascin-X	Inverse variance weighted	3	0.017275624183990524	0.010243776062632073	0.09170900674562374	-0.0028021768987683375	0.03735342526674938	1.0174257108138556	0.9972017455342785	1.0380598325873027	1.017 [0.997:1.038]	overlaps null	Tenascin-X (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3071	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Tenascin-X	MR Egger	3	0.036117559555729255	0.023136377148893914	0.3627002966238085	-0.009229739656102819	0.08146485876756132	1.0367777224553831	0.9908127236487867	1.08487509306632	1.037 [0.991:1.085]	overlaps null	Tenascin-X (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3071	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Tenascin-X	Weighted median	3	0.0189095828672674	0.010904370960065928	0.08289524651115704	-0.0024629842144618178	0.04028214994899662	1.0190895013009171	0.9975400464424945	1.0411044803318794	1.019 [0.998:1.041]	overlaps null	Tenascin-X (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3123	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Thioredoxin domain-containing protein 12	Inverse variance weighted	7	0.00334159819460776	0.013417548648749705	0.8033245435741189	-0.022956797156941662	0.02963999354615718	1.003347187557923	0.9773047052030267	1.0300836304387375	1.003 [0.977:1.03]	overlaps null	Thioredoxin domain-containing protein 12 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3123	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Thioredoxin domain-containing protein 12	MR Egger	7	0.041373213249230135	0.04103790858960936	0.3596422847875744	-0.039061087586404204	0.12180751408486448	1.0422410111228504	0.9616919599112652	1.1295366609559787	1.042 [0.962:1.13]	overlaps null	Thioredoxin domain-containing protein 12 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3123	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Thioredoxin domain-containing protein 12	Weighted median	7	-0.0015092744946058664	0.011837574195963025	0.898545757295073	-0.024710919918693397	0.02169237092948166	0.9984918638873619	0.9755918954529329	1.0219293609305689	0.998 [0.976:1.022]	overlaps null	Thioredoxin domain-containing protein 12 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3109	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Thiosulfate sulfurtransferase	Inverse variance weighted	3	0.017807196585591767	0.009116059034860414	0.05077368565098614	-6.027912273464525e-5	0.03567467229391818	1.0179666900144715	0.9999397226940152	1.036318648475291	1.018 [1:1.036]	overlaps null	Thiosulfate sulfurtransferase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3109	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Thiosulfate sulfurtransferase	MR Egger	3	0.019140704632617776	0.020040371861230203	0.5146153544143885	-0.020138424215393424	0.05841983348062897	1.0193250622860948	0.9800629994649623	1.0601599929512453	1.019 [0.98:1.06]	overlaps null	Thiosulfate sulfurtransferase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3109	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Thiosulfate sulfurtransferase	Weighted median	3	0.017869847846791968	0.00902481398331832	0.04769461261048689	1.8121243948806057e-4	0.03555848325409587	1.018030468909354	1.000181228859454	1.0361982466013993	1.018 [1:1.036]	positive	Thiosulfate sulfurtransferase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3076	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Torsin-1A-interacting protein 1	Inverse variance weighted	4	-0.04725672429686411	0.020596968847523194	0.021770210936280836	-0.08762678323800957	-0.006886665355718649	0.9538424916120805	0.9161027178189393	0.9931369933830497	0.954 [0.916:0.993]	negative	Torsin-1A-interacting protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3076	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Torsin-1A-interacting protein 1	MR Egger	4	-0.05144637463935527	0.0749642127534264	0.5634175633496308	-0.19837623163607104	0.09548348235736048	0.9498545848911601	0.8200612621002972	1.1001906493278697	0.95 [0.82:1.1]	overlaps null	Torsin-1A-interacting protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3076	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Torsin-1A-interacting protein 1	Weighted median	4	-0.051033888043790165	0.01793824016370791	0.004441457278235997	-0.08619283876465766	-0.015874937322922666	0.9502464679928707	0.9174173005422405	0.984250405349044	0.95 [0.917:0.984]	negative	Torsin-1A-interacting protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1258	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Transmembrane glycoprotein NMB	Inverse variance weighted	3	0.028806758438103784	0.023179271598060592	0.21394854422205128	-0.016624613894094975	0.07423813077030254	1.0292256860779436	0.983512812392611	1.0770632568635488	1.029 [0.984:1.077]	overlaps null	Transmembrane glycoprotein NMB (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1258	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Transmembrane glycoprotein NMB	MR Egger	3	0.08653001064436878	0.04031492105208822	0.2775681348030733	0.007512765382275882	0.1655472559064617	1.0903840903559243	1.0075410570091938	1.1800387252015154	1.09 [1.008:1.18]	positive	Transmembrane glycoprotein NMB (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1258	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Transmembrane glycoprotein NMB	Weighted median	3	0.022113548112665346	0.021991838808086583	0.31463964467997574	-0.02099045595118436	0.06521755217651505	1.0223598649130816	0.9792283103276568	1.0673912124082243	1.022 [0.979:1.067]	overlaps null	Transmembrane glycoprotein NMB (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3000	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Transmembrane protein 132C	Inverse variance weighted	2	-0.017995541328542797	0.07865310353837483	0.819027220404793	-0.17215562426375747	0.13616454160667185	0.9821654115014247	0.841848150974957	1.145870421444281	0.982 [0.842:1.146]	overlaps null	Transmembrane protein 132C (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2951	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Trefoil factor 1	Inverse variance weighted	4	-0.08409501941610624	0.06243525940804256	0.17800744490009013	-0.20646812785586965	0.038278089023657175	0.9193438964245189	0.8134521875091628	1.039020132800978	0.919 [0.813:1.039]	overlaps null	Trefoil factor 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2951	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Trefoil factor 1	MR Egger	4	0.050348947428771176	0.1696945591679406	0.7946693365999785	-0.2822523885403924	0.38295028339793474	1.05163799873314	0.7540833385203798	1.4666051136330134	1.052 [0.754:1.467]	overlaps null	Trefoil factor 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2951	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Trefoil factor 1	Weighted median	4	-0.055277684991229564	0.03683518736563111	0.13343935993409092	-0.12747465222786653	0.01691928224540741	0.9462223597213381	0.8803157295939371	1.017063223952171	0.946 [0.88:1.017]	overlaps null	Trefoil factor 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2392	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Trypsin-2	Inverse variance weighted	3	-0.019645020259439486	0.02516653048402284	0.43503717079009496	-0.06897142000812424	0.029681379489245274	0.9805466857425311	0.9333533549283177	1.0301262623034166	0.981 [0.933:1.03]	overlaps null	Trypsin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2392	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Trypsin-2	MR Egger	3	-0.1312167256585215	0.124227629960475	0.482586083264795	-0.3747028803810525	0.1122694290640095	0.877027679391198	0.6874935162595702	1.1188142611193719	0.877 [0.687:1.119]	overlaps null	Trypsin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2392	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Trypsin-2	Weighted median	3	-0.02642864908561537	0.028070620125678555	0.3464457653384453	-0.08144706453194533	0.028589766360714596	0.9739175312629007	0.9217815034977505	1.0290023764873015	0.974 [0.922:1.029]	overlaps null	Trypsin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2393	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Trypsin-3	Inverse variance weighted	4	-0.010585807405033194	0.027407643971922798	0.6993222015153089	-0.06430478959000188	0.04313317477993549	0.9894700250698959	0.9377191489358585	1.0440769303078283	0.989 [0.938:1.044]	overlaps null	Trypsin-3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2393	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Trypsin-3	MR Egger	4	0.1644344765896365	0.07609555422095407	0.16326473445275036	0.015287190316566529	0.31358176286270645	1.178726332852015	1.0154046371244934	1.3683173357306748	1.179 [1.015:1.368]	positive	Trypsin-3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2393	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Trypsin-3	Weighted median	4	-0.025536977898510928	0.023500450066826137	0.27718749614240146	-0.07159786002949016	0.020523904232468304	0.9747863327492063	0.9309051747294184	1.0207359678614298	0.975 [0.931:1.021]	overlaps null	Trypsin-3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2930	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Tubulin-specific chaperone A	Inverse variance weighted	2	0.01951509904373788	0.011284162899554227	0.08373328674272314	-0.002601860239388406	0.04163205832686416	1.0197067633414416	0.9974015216652473	1.0425108249967778	1.02 [0.997:1.043]	overlaps null	Tubulin-specific chaperone A (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3048	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Tumor necrosis factor receptor superfamily member 1B	Inverse variance weighted	3	0.05449084124487149	0.040660880909756274	0.18020328486140028	-0.025204485338250808	0.13418616782799378	1.0560028046983312	0.9751104958406104	1.1436057024177708	1.056 [0.975:1.144]	overlaps null	Tumor necrosis factor receptor superfamily member 1B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3048	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Tumor necrosis factor receptor superfamily member 1B	MR Egger	3	0.1332160371477531	0.0834273812494018	0.35619016648867896	-0.030301630101074423	0.29673370439658064	1.1424967934200483	0.9701528621056141	1.3454569624647392	1.142 [0.97:1.345]	overlaps null	Tumor necrosis factor receptor superfamily member 1B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3048	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Tumor necrosis factor receptor superfamily member 1B	Weighted median	3	0.07274188483958836	0.03713221528228024	0.05011318070257293	-3.72571136808969e-5	0.1455210267928576	1.0754529103859574	0.9999627435803567	1.1566420547993967	1.075 [1:1.157]	overlaps null	Tumor necrosis factor receptor superfamily member 1B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2978	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Tyrosine-protein kinase receptor Tie-1, soluble	Inverse variance weighted	4	-0.03753002713076892	0.010531569714426378	3.6583961572579464e-4	-0.058171903771044614	-0.016888150490493217	0.9631654961903025	0.9434877443943448	0.9832536549237575	0.963 [0.943:0.983]	negative	Tyrosine-protein kinase receptor Tie-1, soluble (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2978	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Tyrosine-protein kinase receptor Tie-1, soluble	MR Egger	4	-0.032359193826149546	0.017036937810393275	0.19791647939659135	-0.06575159193452036	0.00103320428222127	0.9681587629653083	0.936363435633756	1.0010337382216394	0.968 [0.936:1.001]	overlaps null	Tyrosine-protein kinase receptor Tie-1, soluble (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2978	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Tyrosine-protein kinase receptor Tie-1, soluble	Weighted median	4	-0.03566898382094781	0.011436251212676975	0.0018150278491067713	-0.05808403619779468	-0.01325393144410094	0.964959657881707	0.9435706500151404	0.9868335151419133	0.965 [0.944:0.987]	negative	Tyrosine-protein kinase receptor Tie-1, soluble (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3180	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ubiquitin carboxyl-terminal hydrolase 25	Inverse variance weighted	3	0.022156348193548666	0.014058016780962376	0.11501082449929924	-0.005397364697137589	0.049710061084234924	1.0224036229344085	0.9946171749054254	1.0509663361572243	1.022 [0.995:1.051]	overlaps null	Ubiquitin carboxyl-terminal hydrolase 25 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3180	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ubiquitin carboxyl-terminal hydrolase 25	MR Egger	3	0.016187628572333523	0.02516363930438681	0.6360783300765263	-0.03313310446426462	0.06550836160893167	1.016319358067905	0.9674097844578651	1.0677016649799513	1.016 [0.967:1.068]	overlaps null	Ubiquitin carboxyl-terminal hydrolase 25 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3180	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ubiquitin carboxyl-terminal hydrolase 25	Weighted median	3	0.01785580070856491	0.014155893252459344	0.2071760388776478	-0.009889750066255403	0.04560135148338522	1.0180161685950773	0.9901589926950155	1.0466570794860366	1.018 [0.99:1.047]	overlaps null	Ubiquitin carboxyl-terminal hydrolase 25 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1573	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ubiquitin-like protein ISG15	Inverse variance weighted	4	-0.030415502431391205	0.024078705660819464	0.2065280349990207	-0.07760976552659735	0.016778760663814944	0.9700423948281451	0.9253254499867628	1.0169203146605168	0.97 [0.925:1.017]	overlaps null	Ubiquitin-like protein ISG15 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1573	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ubiquitin-like protein ISG15	MR Egger	4	-0.06378612575062352	0.049847923927817825	0.32906132384009357	-0.16148805664914645	0.03391580514789941	0.9382056361006486	0.8508766937235739	1.0344975036970336	0.938 [0.851:1.034]	overlaps null	Ubiquitin-like protein ISG15 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1573	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ubiquitin-like protein ISG15	Weighted median	4	-0.045395839359956495	0.029861255053346154	0.1284543277136146	-0.10392389926451495	0.013132220544601968	0.9556191352889383	0.9012938839388854	1.0132188268486026	0.956 [0.901:1.013]	overlaps null	Ubiquitin-like protein ISG15 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2747	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Urea transporter 2	Inverse variance weighted	4	-0.012135338139188179	0.025618121850857017	0.6357129118456136	-0.06234685696686793	0.03807618068849158	0.9879379981234834	0.9395569383957693	1.0388103671531896	0.988 [0.94:1.039]	overlaps null	Urea transporter 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2747	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Urea transporter 2	MR Egger	4	0.005164234660785139	0.049282402211774955	0.9261058337935499	-0.09142927367429377	0.10175774299586404	1.0051775923047046	0.9126258605433512	1.107115232818332	1.005 [0.913:1.107]	overlaps null	Urea transporter 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2747	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Urea transporter 2	Weighted median	4	-0.007007342209866034	0.016638034773618693	0.6736352892858868	-0.03961789036615867	0.0256032059464266	0.9930171519661389	0.96115663620341385	1.0259337832738562	0.993 [0.961:1.026]	overlaps null	Urea transporter 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3193	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Vascular cell adhesion protein 1	Inverse variance weighted	2	-0.03626700957555947	0.18037262353850445	0.8406460669514982	-0.38979735171102814	0.31726333255990924	0.9643827596713195	0.6771940928183777	1.3733641758164354	0.964 [0.677:1.373]	overlaps null	Vascular cell adhesion protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1622	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Vascular endothelial growth factor receptor 2	Inverse variance weighted	4	-0.044174639306549794	0.0170147548184378	0.009424613942395877	-0.07752355875068788	-0.010825719862411709	0.9567868502896796	0.9254052227489001	0.9892326673583535	0.957 [0.925:0.989]	negative	Vascular endothelial growth factor receptor 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1622	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Vascular endothelial growth factor receptor 2	MR Egger	4	-0.0403418896363114	0.04059112711531075	0.4250203590074675	-0.11990049878232047	0.03921671950969767	0.9604610113466302	0.8870086907712158	1.0399958466189665	0.96 [0.887:1.04]	overlaps null	Vascular endothelial growth factor receptor 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1622	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Vascular endothelial growth factor receptor 2	Weighted median	4	-0.03614989257504851	0.016732060007105445	0.03073270375136027	-0.06894473018897518	-0.003355054961121838	0.9644957119016607	0.9333782662930014	0.9966505669467468	0.964 [0.933:0.997]	negative	Vascular endothelial growth factor receptor 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1129	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Vascular endothelial growth factor receptor 3	Inverse variance weighted	4	-0.034294468341675176	0.015513680142337479	0.027063874820583762	-0.06470128142065663	-0.0038876552626937178	0.9662869218317954	0.9373474246515476	0.9961198918856224	0.966 [0.937:0.996]	negative	Vascular endothelial growth factor receptor 3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1129	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Vascular endothelial growth factor receptor 3	MR Egger	4	-0.03600614664832066	0.044687831128040416	0.504971209435269	-0.12359429565927987	0.05158200236263855	0.9646343641967057	0.8837383046289338	1.052935525952891	0.965 [0.884:1.053]	overlaps null	Vascular endothelial growth factor receptor 3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1129	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Vascular endothelial growth factor receptor 3	Weighted median	4	-0.032291150814241436	0.011981214638951503	0.00703572994517994	-0.05577433150658638	-0.008807970121896491	0.9682246416448123	0.9457525383608576	0.9912307064097267	0.968 [0.946:0.991]	negative	Vascular endothelial growth factor receptor 3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3243	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Xyloside xylosyltransferase 1	Inverse variance weighted	3	0.05626488339793473	0.024183023505706763	0.019985108668795593	0.008866157326749474	0.10366360946911998	1.05787786091023	1.0089055781171348	1.1092272586028609	1.058 [1.009:1.109]	positive	Xyloside xylosyltransferase 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3243	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Xyloside xylosyltransferase 1	MR Egger	3	0.045505155387665926	0.14215315233937054	0.8027713897373588	-0.23311502319750033	0.32412533397283216	1.0465564000039973	0.792062462727404	1.3828206106596903	1.047 [0.792:1.383]	overlaps null	Xyloside xylosyltransferase 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3243	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Xyloside xylosyltransferase 1	Weighted median	3	0.05532630583102214	0.025528528116969495	0.030216981102520118	0.005290390721761927	0.10536222094028236	1.0568854262927359	1.0053044095495458	1.1111130058710113	1.057 [1.005:1.111]	positive	Xyloside xylosyltransferase 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3258	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Zinc fingers and homeoboxes protein 3	Inverse variance weighted	3	-0.06331852405150103	0.0490510985995163	0.1967492376182215	-0.15945867730655297	0.03282162920355092	0.9386444452361687	0.8526051986117474	1.0333662004492679	0.939 [0.853:1.033]	overlaps null	Zinc fingers and homeoboxes protein 3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3258	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Zinc fingers and homeoboxes protein 3	MR Egger	3	0.15395112097592206	0.10790065317191717	0.38917437183237735	-0.05753415924103558	0.3654364011928797	1.1664338712357414	0.9440896404500213	1.4411427873707554	1.166 [0.944:1.441]	overlaps null	Zinc fingers and homeoboxes protein 3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3258	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Zinc fingers and homeoboxes protein 3	Weighted median	3	-0.056803044172870944	0.04242699898554034	0.1806221453188476	-0.13995996218453	0.026353873838788115	0.9447801309951162	0.8693930433002236	1.0267042079550066	0.945 [0.869:1.027]	overlaps null	Zinc fingers and homeoboxes protein 3 (M/F) Sun BB/2018 [  3K]	Proteins
ieu-a-1	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Adiponectin	Inverse variance weighted	11	-0.04495183536282018	0.048373966190003274	0.3527560353160904	-0.1397648090952266	0.04986113836958624	0.956043528213852	0.8695627245948184	1.0511251252927003	0.956 [0.87:1.051]	overlaps null	Adiponectin (M/F) Dastani Z/2012 [ 39K]	Other biomarkers
ieu-a-1	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Adiponectin	MR Egger	11	0.04755946062796921	0.0616210771669164	0.4600143667170906	-0.07321785061918692	0.16833677187512536	1.0487085561367373	0.929398337966686	1.183335057517417	1.049 [0.929:1.183]	overlaps null	Adiponectin (M/F) Dastani Z/2012 [ 39K]	Other biomarkers
ieu-a-1	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Adiponectin	Weighted median	11	-0.0069439068466224186	0.04911001260235494	0.8875579584642683	-0.1031995315472381	0.08931171785399325	0.9930801463678963	0.9019469886476158	1.093421442194522	0.993 [0.902:1.093]	overlaps null	Adiponectin (M/F) Dastani Z/2012 [ 39K]	Other biomarkers
ukb-d-30630_irnt	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Apoliprotein A	Inverse variance weighted	222	0.06319645921853051	0.02739742218786507	0.02107394197562036	0.009497511730314975	0.11689540670674604	1.0652360941262085	1.0095427562180954	1.1240018604859572	1.065 [1.01:1.124]	positive	Apoliprotein A (M/F) Neale lab/2018 [  NA K]	Other biomarkers
ukb-d-30630_irnt	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Apoliprotein A	MR Egger	222	0.10174964393238489	0.04129177334064131	0.014499842292389821	0.020817768184727928	0.18268151968004187	1.1071062662580933	1.0210359694448257	1.2004320332166014	1.107 [1.021:1.2]	positive	Apoliprotein A (M/F) Neale lab/2018 [  NA K]	Other biomarkers
ukb-d-30630_irnt	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Apoliprotein A	Weighted median	222	0.07165983808613263	0.032104225946182265	0.02560836400994722	0.0087355552316154	0.13458412094064987	1.0742898494124333	1.0087738215388702	1.1440608944332316	1.074 [1.009:1.144]	positive	Apoliprotein A (M/F) Neale lab/2018 [  NA K]	Other biomarkers
ieu-a-780	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	HDL cholesterol	Inverse variance weighted	37	0.08079042916166827	0.028181300330281295	0.004146320640396867	0.025555080514316937	0.13602577780901962	1.0841436678599912	1.0258844109552618	1.1457114271445656	1.084 [1.026:1.146]	positive	HDL cholesterol (M/F) Willer CJ/2013 [ 92K]	Other biomarkers
ieu-a-780	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	HDL cholesterol	MR Egger	37	0.07463336772481656	0.05200340076799572	0.16011725253732398	-0.027293297780455056	0.17656003323008818	1.077489036201332	0.9730757986945372	1.1931060506197269	1.077 [0.973:1.193]	overlaps null	HDL cholesterol (M/F) Willer CJ/2013 [ 92K]	Other biomarkers
ieu-a-780	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	HDL cholesterol	Weighted median	37	0.06979147088999998	0.033325294114481076	0.0362377861215954	0.004473894425617075	0.1351090473543829	1.0722845553947729	1.0044839172327023	1.144661599864919	1.072 [1.004:1.145]	positive	HDL cholesterol (M/F) Willer CJ/2013 [ 92K]	Other biomarkers
ukb-d-30760_irnt	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	HDL cholesterol	Inverse variance weighted	245	0.08548940948389505	0.025028540057485293	6.362365757855745e-4	0.03643347097122388	0.13454534799656623	1.0892500255630428	1.0371053041139056	1.1440165366840893	1.089 [1.037:1.144]	positive	HDL cholesterol (M/F) Neale lab/2018 [  NA K]	Other biomarkers
ukb-d-30760_irnt	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	HDL cholesterol	MR Egger	245	0.10932805675377591	0.03623790638765961	0.0028247122805370047	0.038301760233963075	0.18035435327358873	1.1155282468961705	1.039044727956151	1.1976416761875517	1.116 [1.039:1.198]	positive	HDL cholesterol (M/F) Neale lab/2018 [  NA K]	Other biomarkers
ukb-d-30760_irnt	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	HDL cholesterol	Weighted median	245	0.0560632802647889	0.030739813824568956	0.06818227546633948	-0.0041867548313662545	0.11631331536094405	1.0576646109156407	0.995821997407889	1.1233477791163238	1.058 [0.996:1.123]	overlaps null	HDL cholesterol (M/F) Neale lab/2018 [  NA K]	Other biomarkers
ieu-a-299	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	HDL cholesterol	Inverse variance weighted	78	0.10040668305146848	0.03336870027792103	0.0026210229264781244	0.035004030506743264	0.1658093355961937	1.1056204637621148	1.0356238828802549	1.1803480299139593	1.106 [1.036:1.18]	positive	HDL cholesterol (M/F) Willer CJ/2013 [187K]	Other biomarkers
ieu-a-299	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	HDL cholesterol	MR Egger	78	0.07671044159100467	0.06253699194365825	0.22374422637958338	-0.0458620626185655	0.19928294580057482	1.079729386400505	0.9551737072642156	1.2205272601105308	1.08 [0.955:1.221]	overlaps null	HDL cholesterol (M/F) Willer CJ/2013 [187K]	Other biomarkers
ieu-a-299	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	HDL cholesterol	Weighted median	78	0.1066878831308249	0.03650064393551216	0.003467832657473202	0.035146621017221075	0.17822914524442873	1.1125869431279052	1.0357715635470583	1.195099141146152	1.113 [1.036:1.195]	positive	HDL cholesterol (M/F) Willer CJ/2013 [187K]	Other biomarkers
ukb-d-30770_irnt	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	IGF-1	Inverse variance weighted	318	0.0643324419795887	0.029595265793603536	0.029724593413392654	0.006325721024125777	0.12233916293505163	1.0664468715465265	1.0063457706511842	1.1301373374833643	1.066 [1.006:1.13]	positive	IGF-1 (M/F) Neale lab/2018 [  NA K]	Other biomarkers
ukb-d-30770_irnt	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	IGF-1	MR Egger	318	0.09542017552910087	0.05904004104782696	0.10705018426745276	-0.020298304924639965	0.2111386559828417	1.1001210019519803	0.9799063188229414	1.2350835949191499	1.1 [0.98:1.235]	overlaps null	IGF-1 (M/F) Neale lab/2018 [  NA K]	Other biomarkers
ukb-d-30770_irnt	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	IGF-1	Weighted median	318	0.07324052062209913	0.035420151279584935	0.03866220202714757	0.003817024114112652	0.14266401713008559	1.075989303410745	1.003824318228307	1.153342233327948	1.076 [1.004:1.153]	positive	IGF-1 (M/F) Neale lab/2018 [  NA K]	Other biomarkers
ieu-a-1049	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Iron	Inverse variance weighted	3	2.7681703553632497e-4	0.041538070371377356	0.9946827957577167	-0.08113780089236329	0.08169143496343594	1.0002768553529076	0.9220666210864007	1.0851209277870022	1 [0.922:1.085]	overlaps null	Iron (M/F) Benyamin/2014 [ 23K]	Other biomarkers
ieu-a-1049	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Iron	MR Egger	3	0.09597659590328003	0.0571629992614833	0.341974850681272	-0.016062882649227228	0.2080160744557873	1.1007333020238488	0.9840654374679141	1.2312329607895927	1.101 [0.984:1.231]	overlaps null	Iron (M/F) Benyamin/2014 [ 23K]	Other biomarkers
ieu-a-1049	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Iron	Weighted median	3	0.01521161325817938	0.029720503723027612	0.6087754598477702	-0.04304057403895474	0.0734638005553135	1.0153278987288143	0.9578725245214463	1.0762295770536932	1.015 [0.958:1.076]	overlaps null	Iron (M/F) Benyamin/2014 [ 23K]	Other biomarkers
ukb-d-30080_irnt	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Platelet count	Inverse variance weighted	394	0.023626501543339347	0.021758741658109794	0.2775499995476721	-0.01902063210655585	0.06627363519323454	1.0239078184736345	0.9811591186544885	1.0685190615862001	1.024 [0.981:1.069]	overlaps null	Platelet count (M/F) Neale lab/2018 [350K]	Other biomarkers
ukb-d-30080_irnt	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Platelet count	MR Egger	394	0.02485842069017789	0.039537009832960365	0.5298867763435242	-0.05263411858242442	0.10235095996278021	1.0251699673928973	0.9487270705928506	1.107772187197748	1.025 [0.949:1.108]	overlaps null	Platelet count (M/F) Neale lab/2018 [350K]	Other biomarkers
ukb-d-30080_irnt	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Platelet count	Weighted median	394	0.04694695548272219	0.028287800607484714	0.09699123654680844	-0.00849713370794785	0.10239104467339222	1.048066413428171	0.9915388648988616	1.107816592815283	1.048 [0.992:1.108]	overlaps null	Platelet count (M/F) Neale lab/2018 [350K]	Other biomarkers
ieu-a-1047	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Putamen volume	Inverse variance weighted	4	1.6062397781003602e-4	8.597327473959328e-5	0.06172009064575966	-7.883640679566805e-6	3.291315962996389e-4	1.0001606368785319	0.9999921163903962	1.0003291857660463	1 [1:1]	overlaps null	Putamen volume (M/F) Hibar/2015 [ 30K]	Other biomarkers
ieu-a-1047	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Putamen volume	MR Egger	4	3.7158733558731124e-4	3.818322441115709e-4	0.43311631580863985	-3.7680386287136766e-4	0.0011199785340459901	1.0003716563827134	0.9996232671187885	1.001120605944211	1 [1:1.001]	overlaps null	Putamen volume (M/F) Hibar/2015 [ 30K]	Other biomarkers
ieu-a-1047	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Putamen volume	Weighted median	4	1.7032885265633567e-4	1.0012315834797635e-4	0.0889066833702952	-2.591253770569798e-5	3.665702430183693e-4	1.0001703433594389	0.9999740877980212	1.0003666374381002	1 [1:1]	overlaps null	Putamen volume (M/F) Hibar/2015 [ 30K]	Other biomarkers
ukb-d-30240_irnt	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Reticulocyte percentage	Inverse variance weighted	249	-0.04059484847249359	0.026930776696412678	0.1317139072514977	-0.09337917079746244	0.012189473852475256	0.9602180849734833	0.9108480678230824	1.0122640682696502	0.96 [0.911:1.012]	overlaps null	Reticulocyte percentage (M/F) Neale lab/2018 [344K]	Other biomarkers
ukb-d-30240_irnt	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Reticulocyte percentage	MR Egger	249	-0.02365580939824761	0.0475373950352039	0.6191909015846676	-0.11682910366724725	0.06951748487075204	0.9766217959593712	0.8897372330017495	1.0719908046615738	0.977 [0.89:1.072]	overlaps null	Reticulocyte percentage (M/F) Neale lab/2018 [344K]	Other biomarkers
ukb-d-30240_irnt	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Reticulocyte percentage	Weighted median	249	-0.010227932930083904	0.03426047107316929	0.7652952413590963	-0.07737845623349572	0.056922590373327905	0.9898241945059163	0.9255395111186984	1.0585738634162265	0.99 [0.926:1.059]	overlaps null	Reticulocyte percentage (M/F) Neale lab/2018 [344K]	Other biomarkers
ieu-a-302	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides	Inverse variance weighted	53	-0.08393856480211863	0.04428563835693229	0.05804072648284779	-0.17073841598170592	0.002861286377468658	0.9194877432714138	0.8430420709635662	1.002865383764336	0.919 [0.843:1.003]	overlaps null	Triglycerides (M/F) Willer CJ/2013 [177K]	Other biomarkers
ieu-a-302	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides	MR Egger	53	-0.17291890648119282	0.06905528374389991	0.015517970634425162	-0.30826726261923665	-0.03757055034314899	0.841205828419414	0.7347189288611685	0.9631264664211543	0.841 [0.735:0.963]	negative	Triglycerides (M/F) Willer CJ/2013 [177K]	Other biomarkers
ieu-a-302	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides	Weighted median	53	-0.08734682823184599	0.036232614495785576	0.015920897582036783	-0.15836275264358574	-0.016330903820106255	0.9163592212639893	0.8535401018748797	0.9838017224393264	0.916 [0.854:0.984]	negative	Triglycerides (M/F) Willer CJ/2013 [177K]	Other biomarkers
ieu-a-783	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides	Inverse variance weighted	27	-0.1062502442158207	0.04360847414592538	0.014831864945427122	-0.19172285354183444	-0.020777634889806967	0.899199600419788	0.825535631066089	0.9794367329135628	0.899 [0.826:0.979]	negative	Triglycerides (M/F) Willer CJ/2013 [ 86K]	Other biomarkers
ieu-a-783	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides	MR Egger	27	-0.22684640134695816	0.0772065164264596	0.007001566976924952	-0.378171173542819	-0.07552162915109734	0.7970431976500569	0.6851132173716086	0.9272596744774961	0.797 [0.685:0.927]	negative	Triglycerides (M/F) Willer CJ/2013 [ 86K]	Other biomarkers
ieu-a-783	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides	Weighted median	27	-0.1278977176497427	0.036016806011471114	3.8368785582410496e-4	-0.19849065743222608	-0.05730477786725932	0.8799433772186733	0.8199674313059195	0.9443062218676376	0.88 [0.82:0.944]	negative	Triglycerides (M/F) Willer CJ/2013 [ 86K]	Other biomarkers
ukb-a-11	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Morning/evening person (chronotype)	Inverse variance weighted	77	0.3361771106095176	0.08046424465580088	2.941238778990858e-5	0.17846719108414788	0.49388703013488733	1.399586884547183	1.195383663388078	1.6386734296205256	1.4 [1.195:1.639]	positive	Morning/evening person (chronotype) (M/F) Neale Lab/2017 [301K]	Sleep
ukb-a-11	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Morning/evening person (chronotype)	MR Egger	77	0.2866019000726387	0.23822227790204772	0.23272708116289326	-0.18031376461537485	0.7535175647606522	1.3318938810627283	0.8350081742857932	2.1244598137373214	1.332 [0.835:2.124]	overlaps null	Morning/evening person (chronotype) (M/F) Neale Lab/2017 [301K]	Sleep
ukb-a-11	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Morning/evening person (chronotype)	Weighted median	77	0.26708085000474674	0.08724519008607638	0.0022040221557342423	0.09608027743603703	0.43808142257345645	1.3061460439756671	1.1008474336563283	1.549731085375709	1.306 [1.101:1.55]	positive	Morning/evening person (chronotype) (M/F) Neale Lab/2017 [301K]	Sleep
ukb-b-4424	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Sleep duration	Inverse variance weighted	66	0.402095380643477	0.14929329740836647	0.007074325766013607	0.10948051772307871	0.6947102435638752	1.4949539155425446	1.1156983343794986	2.0031285704472523	1.495 [1.116:2.003]	positive	Sleep duration (M/F) MRC-IEU/2018 [460K]	Sleep
ukb-b-4424	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Sleep duration	MR Egger	66	0.4598501911985258	0.5676325296560498	0.42087356126132425	-0.652709566927332	1.5724099493243835	1.5838366945438862	0.5206331734256392	4.8182459417215595	1.584 [0.521:4.818]	overlaps null	Sleep duration (M/F) MRC-IEU/2018 [460K]	Sleep
ukb-b-4424	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Sleep duration	Weighted median	66	0.42143353822232626	0.15159618066231256	0.00543631432017736	0.12430502412419364	0.7185620523204589	1.524144910268791	1.1323612158153724	2.051481166127312	1.524 [1.132:2.051]	positive	Sleep duration (M/F) MRC-IEU/2018 [460K]	Sleep
ukb-a-14	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Snoring	Inverse variance weighted	20	1.0290833563048423	0.4758410664725733	0.030567191687104724	0.09643486601859863	1.961731846591086	2.7984994317802063	1.1012378508020857	7.111632663161733	2.798 [1.101:7.112]	positive	Snoring (M/F) Neale Lab/2017 [314K]	Sleep
ukb-a-14	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Snoring	MR Egger	20	-0.019829905487491306	2.3217098598036174	0.9932792396419923	-4.570381230702582	4.530721419727598	0.9803654139026813	0.01035401169795421	92.82550308171625	0.98 [0.01:92.826]	overlaps null	Snoring (M/F) Neale Lab/2017 [314K]	Sleep
ukb-a-14	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Snoring	Weighted median	20	1.000552666137717	0.35699629136325745	0.005067715392073755	0.3008399350657325	1.7002653972097017	2.7197845459907044	1.350993077612178	5.4754003548886745	2.72 [1.351:5.475]	positive	Snoring (M/F) Neale Lab/2017 [314K]	Sleep
ukb-b-15895	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Treatment/medication code: allopurinol	Inverse variance weighted	12	-2.7154354811154207	2.1006243017795962	0.1961216822372759	-6.832659112603429	1.401788150372588	0.06617612827705967	0.0010779878120843699	4.062457761256309	0.066 [0.001:4.062]	overlaps null	Drug: allopurinol (M/F) MRC-IEU/2018 [462K]	Drugs
ukb-b-15895	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Treatment/medication code: allopurinol	MR Egger	12	-0.051341014177523625	3.329448037975549	0.9880002042469487	-6.5770591686096	6.4743771402545525	0.9499546672811681	0.0013919367328945546	648.315292328474	0.95 [0.001:648.315]	overlaps null	Drug: allopurinol (M/F) MRC-IEU/2018 [462K]	Drugs
ukb-b-15895	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Treatment/medication code: allopurinol	Weighted median	12	-1.9432815259082517	1.1337306778519791	0.0865178495595852	-4.16539365449813	0.2788306026816272	0.14323315442943216	0.015523602761094832	1.3215834522139405	0.143 [0.016:1.322]	overlaps null	Drug: allopurinol (M/F) MRC-IEU/2018 [462K]	Drugs
ukb-a-142	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Treatment/medication code: allopurinol	Inverse variance weighted	12	-2.1533999790545	1.837029505044612	0.24110934096713146	-5.753977808941939	1.4471778508329391	0.11608878658463592	0.003170145449755446	4.251100330974646	0.116 [0.003:4.251]	overlaps null	Drug: allopurinol (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-142	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Treatment/medication code: allopurinol	MR Egger	12	-0.3873716828963316	3.021091703609844	0.9005149725106214	-6.308711421971625	5.533968056178963	0.6788387352833882	0.0018203774269071897	253.14641991802995	0.679 [0.002:253.146]	overlaps null	Drug: allopurinol (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-142	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Treatment/medication code: allopurinol	Weighted median	12	-1.7718155393430206	1.0781156713405473	0.10029248203013519	-3.884922255170493	0.34129117648445195	0.17002402313733106	0.02054942631097409	1.4067627974784753	0.17 [0.021:1.407]	overlaps null	Drug: allopurinol (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-132	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Treatment/medication code: aspirin	Inverse variance weighted	7	-1.5449661570587827	1.0333166448676334	0.13487459839387134	-3.5702667809993445	0.48033446688177883	0.21331909044619315	0.02814834323538442	1.6166150159625785	0.213 [0.028:1.617]	overlaps null	Drug: aspirin (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-132	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Treatment/medication code: aspirin	MR Egger	7	1.8473329021790343	2.8491719877469284	0.5453374442467039	-3.7370441938049455	7.431709998163014	6.342879861719242	0.023824419526121222	1688.692767355477	6.343 [0.024:1688.693]	overlaps null	Drug: aspirin (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-132	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Treatment/medication code: aspirin	Weighted median	7	-0.024984795281961746	0.8902165684723642	0.9776095319969396	-1.7698092694877956	1.7198396789238721	0.9753247414532833	0.17036547962200804	5.583633218428301	0.975 [0.17:5.584]	overlaps null	Drug: aspirin (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-153	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Treatment/medication code: insulin product	Inverse variance weighted	8	-1.2109956263763466	2.0380495419493996	0.552382753592499	-5.205572728597169	2.7835814758444766	0.2979005341013832	0.0054859076048504535	16.17685433480949	0.298 [0.005:16.177]	overlaps null	Drug: insulin product (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-153	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Treatment/medication code: insulin product	MR Egger	8	-5.4274889178034424	4.279086489721902	0.25165299817910425	-13.81449843765837	2.9595206020514855	0.00439411594695807	1.0010126326725049e-6	19.288722564631385	0.004 [0:19.289]	overlaps null	Drug: insulin product (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-153	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Treatment/medication code: insulin product	Weighted median	8	-3.175765813217809	1.0202348985178584	0.0018533471544522533	-5.175426214312811	-1.1761054121228063	0.04176210985994903	0.005653806667025373	0.30847779605312514	0.042 [0.006:0.308]	negative	Drug: insulin product (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-117	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Treatment/medication code: ramipril	Inverse variance weighted	6	-3.9374624826164255	2.122859007964618	0.063625896033927	-8.098266138227077	0.22334117299422518	0.019497627594849454	3.040658895120913e-4	1.2502470515105826	0.019 [0:1.25]	overlaps null	Drug: ramipril (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-117	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Treatment/medication code: ramipril	MR Egger	6	-0.10886161205061395	5.243026354405738	0.9844290546387005	-10.38519326668586	10.167470042584632	0.896854522769004	3.08864411935264e-5	26042.107925979	0.897 [0:26042.108]	overlaps null	Drug: ramipril (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-117	ieu-a-1127	ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Treatment/medication code: ramipril	Weighted median	6	-3.358994073913781	1.6060837383306914	0.036490518891959416	-6.506918201041936	-0.21106994678562563	0.03477021762780041	0.001493073993992573	0.8097174277690999	0.035 [0.001:0.81]	negative	Drug: ramipril (M/F) Neale Lab/2017 [337K]	Drugs
ieu-a-974	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Body mass index	Inverse variance weighted	36	-0.4525084058239372	0.09635869298860689	2.651980074098559e-6	-0.6413714440816067	-0.26364536756626766	0.63603072578647	0.5265697676235214	0.7682459362796005	0.636 [0.527:0.768]	negative	Body mass index (F) Locke AE/2015 [171K]	Antrophometric
ieu-a-974	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Body mass index	MR Egger	36	-0.9314200291240544	0.2477098797820919	6.402919264187686e-4	-1.4169313934969545	-0.44590866475115426	0.39399383022900636	0.24245688129750675	0.640242246076104	0.394 [0.242:0.64]	negative	Body mass index (F) Locke AE/2015 [171K]	Antrophometric
ieu-a-974	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Body mass index	Weighted median	36	-0.41272314346219613	0.10877351304750618	1.4803971131044724e-4	-0.6259192290353083	-0.199527057889084	0.6618454937170635	0.5347696267462798	0.8191180569075406	0.662 [0.535:0.819]	negative	Body mass index (F) Locke AE/2015 [171K]	Antrophometric
ieu-a-95	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Body mass index	Inverse variance weighted	11	-0.5196417894160118	0.19870065356364885	0.0089175431267525	-0.9090950704007635	-0.13018850843126006	0.5947335496703298	0.40288864498115606	0.8779299181291503	0.595 [0.403:0.878]	negative	Body mass index (F) Randall JC/2013 [ 73K]	Antrophometric
ieu-a-95	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Body mass index	MR Egger	11	-1.5782131584366355	0.752813010902248	0.06549753080073	-3.0537266598050414	-0.10269965706822948	0.20634347208624298	0.04718276224327844	0.9023979616342123	0.206 [0.047:0.902]	negative	Body mass index (F) Randall JC/2013 [ 73K]	Antrophometric
ieu-a-95	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Body mass index	Weighted median	11	-0.507457738758286	0.14623927387810245	5.203595470637979e-4	-0.7940867155593668	-0.22082876195720524	0.6020241376227428	0.45199384542482535	0.8018539764402306	0.602 [0.452:0.802]	negative	Body mass index (F) Randall JC/2013 [ 73K]	Antrophometric
ukb-b-19953	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Body mass index (BMI)	Inverse variance weighted	415	-0.11014841836823032	0.04801655748915647	0.02179237037369464	-0.204260871046977	-0.01603596568948365	0.8957011869221969	0.815249668409955	0.9840919258741715	0.896 [0.815:0.984]	negative	Body mass index (BMI) (M/F) MRC-IEU/2018 [461K]	Antrophometric
ukb-b-19953	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Body mass index (BMI)	MR Egger	415	-0.5789737637764744	0.12751361414042564	7.3738222477546025e-6	-0.8289004474917085	-0.3290470800612401	0.5604732494830478	0.43652900909990855	0.7196091367073194	0.56 [0.437:0.72]	negative	Body mass index (BMI) (M/F) MRC-IEU/2018 [461K]	Antrophometric
ukb-b-19953	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Body mass index (BMI)	Weighted median	415	-0.1334050495869585	0.06502610509479317	0.04021230318878179	-0.2608562155727531	-0.00595388360116389	0.8751105571417841	0.7703916819786859	0.9940638056398321	0.875 [0.77:0.994]	negative	Body mass index (BMI) (M/F) MRC-IEU/2018 [461K]	Antrophometric
ukb-a-248	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Body mass index (BMI)	Inverse variance weighted	289	-0.17037234288922318	0.05057452055973442	7.551298914374449e-4	-0.26949840318630264	-0.0712462825921437	0.8433507424762975	0.7637624991078105	0.9312325175249611	0.843 [0.764:0.931]	negative	Body mass index (BMI) (M/F) Neale Lab/2017 [336K]	Antrophometric
ukb-a-248	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Body mass index (BMI)	MR Egger	289	-0.6838816151829293	0.14354373918647098	3.0140092787601543e-6	-0.9652273439884125	-0.4025358863774462	0.5046543118057215	0.3808965953440577	0.6686223440618096	0.505 [0.381:0.669]	negative	Body mass index (BMI) (M/F) Neale Lab/2017 [336K]	Antrophometric
ukb-a-248	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Body mass index (BMI)	Weighted median	289	-0.13537768795362876	0.06272597623602923	0.03090920543113691	-0.258320601376246	-0.01243477453101148	0.8733859820224482	0.7723475767136847	0.9876422178198836	0.873 [0.772:0.988]	negative	Body mass index (BMI) (M/F) Neale Lab/2017 [336K]	Antrophometric
ukb-a-34	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Comparative body size at age 10	Inverse variance weighted	144	-0.598269805341958	0.09155489569530623	6.380218778427303e-11	-0.7777174009047582	-0.41882220977915774	0.5497620089830313	0.459453563567971	0.6578211390373637	0.55 [0.459:0.658]	negative	body size at age 10 (M/F) Neale Lab/2017 [331K]	Antrophometric
ukb-a-34	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Comparative body size at age 10	MR Egger	144	-1.2170666635333054	0.1940517863665547	4.042480204453683e-9	-1.5974081648117526	-0.8367251622548582	0.29609744773005464	0.2024204792116244	0.43312662282847525	0.296 [0.202:0.433]	negative	body size at age 10 (M/F) Neale Lab/2017 [331K]	Antrophometric
ukb-a-34	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Comparative body size at age 10	Weighted median	144	-0.5867760421256226	0.1259159186837238	3.1611348907173753e-6	-0.8335712427457213	-0.339980841505524	0.5561172964598737	0.4344948258010145	0.7117839593410343	0.556 [0.434:0.712]	negative	body size at age 10 (M/F) Neale Lab/2017 [331K]	Antrophometric
ukb-b-4650	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Comparative body size at age 10	Inverse variance weighted	204	-0.6359259841288092	0.08903642838190541	9.177374229260882e-13	-0.8104373837573438	-0.4614145845002746	0.5294450035916766	0.4446635350759351	0.6303912727638472	0.529 [0.445:0.63]	negative	body size at age 10 (M/F) MRC-IEU/2018 [454K]	Antrophometric
ukb-b-4650	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Comparative body size at age 10	MR Egger	204	-1.1516870916452095	0.18458948512724205	2.535739068328327e-9	-1.513482482494604	-0.7898917007958152	0.3161030244957332	0.22014200083784083	0.4538939489741131	0.316 [0.22:0.454]	negative	body size at age 10 (M/F) MRC-IEU/2018 [454K]	Antrophometric
ukb-b-4650	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Comparative body size at age 10	Weighted median	204	-0.5956304812623059	0.11722513729449793	3.7529196812568197e-7	-0.8253917503595218	-0.36586921216508994	0.5512149256069118	0.43806334737230457	0.6935935088712301	0.551 [0.438:0.694]	negative	body size at age 10 (M/F) MRC-IEU/2018 [454K]	Antrophometric
ukb-a-35	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Comparative height size at age 10	Inverse variance weighted	342	0.04072118239586655	0.05424267802633539	0.45281986172570077	-0.0655944665357508	0.1470368313274839	1.0415616593301904	0.9365105736712318	1.1583966275297002	1.042 [0.937:1.158]	overlaps null	height size at age 10 (M/F) Neale Lab/2017 [332K]	Antrophometric
ukb-a-35	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Comparative height size at age 10	MR Egger	342	0.10659173089463896	0.1354840775629411	0.43197784200465406	-0.15895706112872554	0.3721405229180035	1.1124799705482808	0.8530329864563527	1.4508368427959133	1.112 [0.853:1.451]	overlaps null	height size at age 10 (M/F) Neale Lab/2017 [332K]	Antrophometric
ukb-a-35	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Comparative height size at age 10	Weighted median	342	0.062038348554888365	0.06885052328864234	0.3675572218346952	-0.07290867709085062	0.19698537420062734	1.0640031469287574	0.9296857277544331	1.2177262303561274	1.064 [0.93:1.218]	overlaps null	height size at age 10 (M/F) Neale Lab/2017 [332K]	Antrophometric
ieu-a-85	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Extreme body mass index	Inverse variance weighted	7	-0.16595123022033706	0.03742573255699715	9.243719168116714e-6	-0.23930566603205147	-0.09259679440862265	0.8470875454549679	0.7871742331710317	0.9115609726887699	0.847 [0.787:0.912]	negative	Extreme body mass index (M/F) Berndt SI/2013 [ 16K]	Antrophometric
ieu-a-85	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Extreme body mass index	MR Egger	7	-0.3615730449647796	0.16789595478030048	0.08386734627905258	-0.6906491163341686	-0.032496973595390666	0.6965797125765552	0.5012505934939802	0.9680253794633433	0.697 [0.501:0.968]	negative	Extreme body mass index (M/F) Berndt SI/2013 [ 16K]	Antrophometric
ieu-a-85	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Extreme body mass index	Weighted median	7	-0.15485257124073623	0.03604097117877822	1.7346086868474653e-5	-0.22549287475114155	-0.08421226773033093	0.8565414470182963	0.7981227472508248	0.9192361112214105	0.857 [0.798:0.919]	negative	Extreme body mass index (M/F) Berndt SI/2013 [ 16K]	Antrophometric
ieu-a-1034	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Height	Inverse variance weighted	4	0.04537942673831435	0.07636411676328056	0.5523444742701646	-0.10429424211771554	0.19505309559434425	1.0464248261528293	0.9009601579906594	1.215375515861969	1.046 [0.901:1.215]	overlaps null	Height (M/F) Cousminer/2013 [ 13K]	Antrophometric
ieu-a-1034	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Height	MR Egger	4	-1.3770761574295545	1.805323783987083	0.5252795374739352	-4.915510774044237	2.161358459185128	0.2523152055461588	0.007331971954863594	8.682925049593264	0.252 [0.007:8.683]	overlaps null	Height (M/F) Cousminer/2013 [ 13K]	Antrophometric
ieu-a-1034	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Height	Weighted median	4	0.0672659607955655	0.09433288236117959	0.4758023611922513	-0.1176264886323465	0.2521584102234775	1.0695799066724083	0.8890280526916994	1.2867998633942757	1.07 [0.889:1.287]	overlaps null	Height (M/F) Cousminer/2013 [ 13K]	Antrophometric
ieu-a-51	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Hip circumference	Inverse variance weighted	16	-0.5385308159352242	0.15295428366145658	4.3014757130061015e-4	-0.8383212119116792	-0.23874041995876932	0.5836050460598526	0.4324358826052291	0.7876193060913307	0.584 [0.432:0.788]	negative	Hip circumference (F) Shungin D/2015 [127K]	Antrophometric
ieu-a-51	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Hip circumference	MR Egger	16	-1.3833226081831054	0.48446445153973844	0.012714663818785043	-2.3328729332009925	-0.4337722831652181	0.2507440432429692	0.09701662405031132	0.6480598128133923	0.251 [0.097:0.648]	negative	Hip circumference (F) Shungin D/2015 [127K]	Antrophometric
ieu-a-51	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Hip circumference	Weighted median	16	-0.4252651758989213	0.15635982385737407	0.006532428326448912	-0.7317304306593745	-0.11879992113846816	0.6535964441233322	0.48107580109452147	0.8879854501073323	0.654 [0.481:0.888]	negative	Hip circumference (F) Shungin D/2015 [127K]	Antrophometric
ukb-a-388	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Hip circumference	Inverse variance weighted	261	-0.20854781164025893	0.057045832994960174	2.5638722416639656e-4	-0.3203576443103809	-0.09673797897013699	0.8117622220913654	0.7258893804372201	0.9077938360495171	0.812 [0.726:0.908]	negative	Hip circumference (M/F) Neale Lab/2017 [336K]	Antrophometric
ukb-a-388	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Hip circumference	MR Egger	261	-0.7143246982376169	0.16477251127442977	2.0864317965052795e-5	-1.0372788203354992	-0.3913705761397346	0.4895225756604279	0.3544178054733973	0.6761295521288538	0.49 [0.354:0.676]	negative	Hip circumference (M/F) Neale Lab/2017 [336K]	Antrophometric
ukb-a-388	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Hip circumference	Weighted median	261	-0.16970341463394067	0.06831382707303842	0.012985244031447253	-0.30359851569709595	-0.03580831357078537	0.8439150723441071	0.7381571654819232	0.9648252196598104	0.844 [0.738:0.965]	negative	Hip circumference (M/F) Neale Lab/2017 [336K]	Antrophometric
ieu-a-101	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Hip circumference	Inverse variance weighted	5	0.39044454968626985	0.12523309951772016	0.0018224198710492523	0.14498767463153833	0.6359014247410013	1.4776375311965575	1.1560253217421712	1.8887239167998302	1.478 [1.156:1.889]	positive	Hip circumference (F) Randall JC/2013 [ 73K] AdjBMI	Antrophometric
ieu-a-101	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Hip circumference	MR Egger	5	0.11498171829518801	1.337907722258431	0.9369274626451402	-2.5073174173313366	2.7372808539217126	1.1218529280003917	0.08148654068591595	15.444930923182255	1.122 [0.081:15.445]	overlaps null	Hip circumference (F) Randall JC/2013 [ 73K] AdjBMI	Antrophometric
ieu-a-101	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Hip circumference	Weighted median	5	0.38882391314455794	0.14867026617591295	0.008913758655326008	0.09743019143976855	0.6802176348493474	1.4752447572502532	1.1023344864939004	1.974307363563011	1.475 [1.102:1.974]	positive	Hip circumference (F) Randall JC/2013 [ 73K] AdjBMI	Antrophometric
ukb-a-269	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Impedance of whole body	Inverse variance weighted	333	0.2337842078964865	0.06523738426372802	3.389005326945953e-4	0.10591893473957958	0.3616494810533934	1.263371837124176	1.1117317500296833	1.435695615238028	1.263 [1.112:1.436]	positive	Impedance of whole body (M/F) Neale Lab/2017 [331K]	Antrophometric
ukb-a-269	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Impedance of whole body	MR Egger	333	0.536994271475036	0.18137030079513622	0.003290402418049257	0.181508481916569	0.892480061033503	1.710856755199237	1.1990247066941095	2.4411764165236627	1.711 [1.199:2.441]	positive	Impedance of whole body (M/F) Neale Lab/2017 [331K]	Antrophometric
ukb-a-269	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Impedance of whole body	Weighted median	333	0.19952683700212015	0.07663586416662396	0.009225842510636401	0.049320543235537195	0.3497331307687031	1.2208249722737308	1.050557045729049	1.4186888936553292	1.221 [1.051:1.419]	positive	Impedance of whole body (M/F) Neale Lab/2017 [331K]	Antrophometric
ieu-a-90	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Obesity class 1	Inverse variance weighted	16	-0.19431576195406758	0.05849698414751327	8.943614722295995e-4	-0.30896985088319356	-0.07966167302494158	0.8233978654965778	0.7342029052617332	0.9234287143860164	0.823 [0.734:0.923]	negative	Obesity class 1 (M/F) Berndt SI/2013 [ 98K]	Antrophometric
ieu-a-90	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Obesity class 1	MR Egger	16	-0.4585828623924683	0.15223743462581393	0.009321669689738356	-0.7569682342590636	-0.160197490525873	0.6321788954983831	0.4690864335373971	0.8519755152579874	0.632 [0.469:0.852]	negative	Obesity class 1 (M/F) Berndt SI/2013 [ 98K]	Antrophometric
ieu-a-90	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Obesity class 1	Weighted median	16	-0.22168513788807506	0.050237716921943905	1.0207848026481442e-5	-0.3201510630550851	-0.12321921272106501	0.8011675819425473	0.7260393510666637	0.8840698419619586	0.801 [0.726:0.884]	negative	Obesity class 1 (M/F) Berndt SI/2013 [ 98K]	Antrophometric
ieu-a-91	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Obesity class 2	Inverse variance weighted	10	-0.18968047896125106	0.03318470721631943	1.0912468830430614e-8	-0.25472250510523714	-0.12463845281726499	0.8272234070029957	0.7751315631715016	0.8828160245388428	0.827 [0.775:0.883]	negative	Obesity class 2 (M/F) Berndt SI/2013 [ 72K]	Antrophometric
ieu-a-91	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Obesity class 2	MR Egger	10	-0.3729854333889962	0.07958773082825717	0.0015686804619928117	-0.5289773858123803	-0.21699348096561216	0.6886752644355775	0.5892071933400013	0.8049352166882551	0.689 [0.589:0.805]	negative	Obesity class 2 (M/F) Berndt SI/2013 [ 72K]	Antrophometric
ieu-a-91	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Obesity class 2	Weighted median	10	-0.21306594723984348	0.034867504058042204	9.917564525176617e-10	-0.2814062551936062	-0.14472563928608076	0.8081028433071888	0.7547216635953402	0.865259653804371	0.808 [0.755:0.865]	negative	Obesity class 2 (M/F) Berndt SI/2013 [ 72K]	Antrophometric
ieu-a-93	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Overweight	Inverse variance weighted	14	-0.3539794210634374	0.08549968623817064	3.471160450397351e-5	-0.5215588060902518	-0.18640003603662292	0.7018894113444426	0.5935945276498057	0.829941522048682	0.702 [0.594:0.83]	negative	Overweight (M/F) Berndt SI/2013 [158K]	Antrophometric
ieu-a-93	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Overweight	MR Egger	14	-0.723425284585146	0.27978519607080515	0.02384847310767068	-1.271804268883924	-0.17504630028636792	0.4850878431319688	0.2803253828544858	0.8394181545685172	0.485 [0.28:0.839]	negative	Overweight (M/F) Berndt SI/2013 [158K]	Antrophometric
ieu-a-93	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Overweight	Weighted median	14	-0.32012118388789723	0.0736936556671421	1.3994659410492488e-5	-0.4645607489954957	-0.17568161878029873	0.7260610448419136	0.6284110747710805	0.8388850260619107	0.726 [0.628:0.839]	negative	Overweight (M/F) Berndt SI/2013 [158K]	Antrophometric
ukb-b-16881	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Sitting height	Inverse variance weighted	549	-0.05435724589133881	0.04113546753290486	0.1863612282668273	-0.13498276225583233	0.02626827047315472	0.9470937007250638	0.873730972709204	1.0266163223809999	0.947 [0.874:1.027]	overlaps null	Sitting height (M/F) MRC-IEU/2018 [461K]	Antrophometric
ukb-b-16881	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Sitting height	MR Egger	549	-0.18015280017939586	0.09467947646132244	0.05759600654942702	-0.3657245740435878	0.005418973684796102	0.8351425917235282	0.6936938361888417	1.0054336828802728	0.835 [0.694:1.005]	overlaps null	Sitting height (M/F) MRC-IEU/2018 [461K]	Antrophometric
ukb-b-16881	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Sitting height	Weighted median	549	-0.1317779037112012	0.05345525133945122	0.013693666325870144	-0.2365501963365256	-0.02700561108587682	0.8765356487772344	0.7893462590170525	0.9733557799261442	0.877 [0.789:0.973]	negative	Sitting height (M/F) MRC-IEU/2018 [461K]	Antrophometric
ukb-a-195	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Sitting height	Inverse variance weighted	406	-0.05892514132572831	0.04012124701852059	0.1419204957050129	-0.13756278548202866	0.01971250283057204	0.9427773415775118	0.8714796320106544	1.0199080771873896	0.943 [0.871:1.02]	overlaps null	Sitting height (M/F) Neale Lab/2017 [336K]	Antrophometric
ukb-a-195	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Sitting height	MR Egger	406	-0.2230491969207618	0.10140211875748342	0.028397467546446745	-0.4217973496854293	-0.024301044156094298	0.800075487075971	0.6558669375682732	0.9759918488850768	0.8 [0.656:0.976]	negative	Sitting height (M/F) Neale Lab/2017 [336K]	Antrophometric
ukb-a-195	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Sitting height	Weighted median	406	-0.16848938817369016	0.054466867066160406	0.001978578651824971	-0.27524444762336453	-0.06173432872401577	0.8449402297303219	0.7593864703168027	0.9401326198488796	0.845 [0.759:0.94]	negative	Sitting height (M/F) Neale Lab/2017 [336K]	Antrophometric
ukb-b-10787	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Standing height	Inverse variance weighted	710	0.0032729636285828367	0.034471681820668114	0.9243573656597581	-0.06429153273992666	0.07083745999709234	1.0032783256223141	0.9377315802204282	1.0734067401536216	1.003 [0.938:1.073]	overlaps null	Standing height (M/F) MRC-IEU/2018 [461K]	Antrophometric
ukb-b-10787	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Standing height	MR Egger	710	0.00915655220357269	0.06980771878134757	0.895679520608706	-0.12766657660786854	0.14597968101501393	1.0091986016724288	0.8801467917554923	1.1571726752377043	1.009 [0.88:1.157]	overlaps null	Standing height (M/F) MRC-IEU/2018 [461K]	Antrophometric
ukb-b-10787	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Standing height	Weighted median	710	0.009056918352409595	0.04749039476489614	0.8487523884163432	-0.08402425538678683	0.10213809209160603	1.0090980563380985	0.9194089552048437	1.1075364031868238	1.009 [0.919:1.108]	overlaps null	Standing height (M/F) MRC-IEU/2018 [461K]	Antrophometric
ieu-a-68	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist circumference	Inverse variance weighted	24	-0.1568290786524297	0.11334918059133056	0.16648325933754968	-0.37899347261143757	0.06533531530657818	0.8548501584726113	0.684550080976064	1.0675169191400633	0.855 [0.685:1.068]	overlaps null	Waist circumference (F) Shungin D/2015 [134K] AdjBMI	Antrophometric
ieu-a-68	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist circumference	MR Egger	24	-0.2732067557683191	0.4363950157368147	0.5377215038290326	-1.1285409866124758	0.5821274750758377	0.7609354435713223	0.3235049102589513	1.7898422278029813	0.761 [0.324:1.79]	overlaps null	Waist circumference (F) Shungin D/2015 [134K] AdjBMI	Antrophometric
ieu-a-68	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist circumference	Weighted median	24	-0.1989850520885247	0.11655215308775327	0.0877733815123915	-0.4274272721405211	0.029457167963471698	0.8195621439837414	0.6521848322782031	1.029895322013111	0.82 [0.652:1.03]	overlaps null	Waist circumference (F) Shungin D/2015 [134K] AdjBMI	Antrophometric
ukb-b-9405	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist circumference	Inverse variance weighted	344	-0.12951549417188052	0.0605526347601306	0.03244448553368474	-0.24819865830173649	-0.010832330042024552	0.8785209763557846	0.7802049336944396	0.9892261283743552	0.879 [0.78:0.989]	negative	Waist circumference (M/F) MRC-IEU/2018 [462K]	Antrophometric
ukb-b-9405	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist circumference	MR Egger	344	-0.8238841673975906	0.16732358726659083	1.3226835576285743e-6	-1.1518383984401086	-0.4959299363550726	0.43872426227789746	0.3160551995784476	0.6090043086397966	0.439 [0.316:0.609]	negative	Waist circumference (M/F) MRC-IEU/2018 [462K]	Antrophometric
ukb-b-9405	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist circumference	Weighted median	344	-0.19950692295797215	0.07899245161230438	0.011548597779311425	-0.35433212811808873	-0.04468171779785557	0.8191345499592316	0.7016418936506607	0.9563018072449743	0.819 [0.702:0.956]	negative	Waist circumference (M/F) MRC-IEU/2018 [462K]	Antrophometric
ieu-a-62	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist circumference	Inverse variance weighted	17	-0.5785611915122437	0.130441406734411	9.189698470216692e-6	-0.8342263487116892	-0.3228960343127982	0.5607045329079102	0.43421027886282493	0.7240491267200039	0.561 [0.434:0.724]	negative	Waist circumference (F) Shungin D/2015 [134K]	Antrophometric
ieu-a-62	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist circumference	MR Egger	17	-1.2004189729765058	0.42947479970225627	0.013593818607504526	-2.042189580392928	-0.3586483655600835	0.30106804610860766	0.12974431403107195	0.698619967006394	0.301 [0.13:0.699]	negative	Waist circumference (F) Shungin D/2015 [134K]	Antrophometric
ieu-a-62	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist circumference	Weighted median	17	-0.45045068054860105	0.14832095736198447	0.002389458136354161	-0.7411597569780906	-0.15974160411911148	0.6373408497621397	0.4765609000719133	0.8523640078618074	0.637 [0.477:0.852]	negative	Waist circumference (F) Shungin D/2015 [134K]	Antrophometric
ieu-a-105	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist circumference	Inverse variance weighted	5	0.05912467586396604	0.2042659132015061	0.7722373844534076	-0.3412365140109859	0.459485865738918	1.0609075020544976	0.7108907526983332	1.5832597676131688	1.061 [0.711:1.583]	overlaps null	Waist circumference (F) Randall JC/2013 [ 73K] AdjBMI	Antrophometric
ieu-a-105	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist circumference	MR Egger	5	-0.8272476610468248	0.9734577070448203	0.45787403415563604	-2.7352247668546723	1.080729444761023	0.43725109489137454	0.06487942272110976	2.9468283157442308	0.437 [0.065:2.947]	overlaps null	Waist circumference (F) Randall JC/2013 [ 73K] AdjBMI	Antrophometric
ieu-a-105	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist circumference	Weighted median	5	-0.16163933715313483	0.239278143926863	0.4993397015844983	-0.6306244992497863	0.30734582494351664	0.8507479824045174	0.5322593016603285	1.3598111433799729	0.851 [0.532:1.36]	overlaps null	Waist circumference (F) Randall JC/2013 [ 73K] AdjBMI	Antrophometric
ieu-a-75	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist-to-hip ratio	Inverse variance weighted	20	-0.2724311286521684	0.1500621941751265	0.0694540482471797	-0.5665530292354164	0.021690771931079544	0.7615258746825861	0.5674781518925595	1.02192772686846	0.762 [0.567:1.022]	overlaps null	Waist-to-hip ratio (F) Shungin D/2015 [118K]	Antrophometric
ieu-a-75	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist-to-hip ratio	MR Egger	20	-0.9531969826776607	0.787865322468597	0.24198723520227905	-2.497413014716111	0.5910190493607894	0.38550659337895515	0.08229762622101518	1.805827705644045	0.386 [0.082:1.806]	overlaps null	Waist-to-hip ratio (F) Shungin D/2015 [118K]	Antrophometric
ieu-a-75	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist-to-hip ratio	Weighted median	20	-0.3057069484974754	0.12974941697326878	0.01846627965321768	-0.5600158057650821	-0.05139809122986855	0.7366024502846005	0.5712000355238889	0.9499004482162453	0.737 [0.571:0.95]	negative	Waist-to-hip ratio (F) Shungin D/2015 [118K]	Antrophometric
ieu-a-109	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist-to-hip ratio	Inverse variance weighted	4	-0.17608545964057848	0.21299556645361342	0.40840173177848965	-0.5935567698896608	0.24138585060850382	0.8385463184079085	0.5523591722755312	1.2730121330631274	0.839 [0.552:1.273]	overlaps null	Waist-to-hip ratio (F) Randall JC/2013 [ 73K]	Antrophometric
ieu-a-109	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist-to-hip ratio	MR Egger	4	-6.331856710573042	2.548974998690382	0.13096520691884975	-11.32784770800619	-1.3358657131398939	0.001778728117929275	1.2033120023781849e-5	0.26293045455037833	0.002 [0:0.263]	negative	Waist-to-hip ratio (F) Randall JC/2013 [ 73K]	Antrophometric
ieu-a-109	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Waist-to-hip ratio	Weighted median	4	-0.2042026008187275	0.17137403359557934	0.23343345690449932	-0.540095706666063	0.13169050502860802	0.8152971745782979	0.5826924821504346	1.1407552066267201	0.815 [0.583:1.141]	overlaps null	Waist-to-hip ratio (F) Randall JC/2013 [ 73K]	Antrophometric
ukb-a-266	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Whole body fat-free mass	Inverse variance weighted	374	-0.18443519766298463	0.06526993915130269	0.004717307009351999	-0.3123642783995379	-0.05650611692643137	0.8315738260807408	0.7317149317293394	0.945060703610669	0.832 [0.732:0.945]	negative	Whole body fat-free mass (M/F) Neale Lab/2017 [331K]	Antrophometric
ukb-a-266	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Whole body fat-free mass	MR Egger	374	-0.6411552828418511	0.16479039574028453	1.1839748349228633e-4	-0.9641444584928087	-0.3181661071908934	0.5266836039003608	0.3813092861505967	0.7274819383966321	0.527 [0.381:0.727]	negative	Whole body fat-free mass (M/F) Neale Lab/2017 [331K]	Antrophometric
ukb-a-266	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Whole body fat-free mass	Weighted median	374	-0.211816109879902	0.08030919509774999	0.008351776185772113	-0.3692221322714919	-0.054410087488312026	0.8091134718605325	0.6912718396104691	0.9470436561036647	0.809 [0.691:0.947]	negative	Whole body fat-free mass (M/F) Neale Lab/2017 [331K]	Antrophometric
ukb-b-2346	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Duration of moderate activity	Inverse variance weighted	6	0.47807958554091606	0.5326514797704421	0.369427258031478	-0.5659173148091505	1.5220764858909828	1.612973847671735	0.5678390206328872	4.581729220322416	1.613 [0.568:4.582]	overlaps null	Duration of moderate activity (M/F) MRC-IEU/2018 [343K]	Physical activity
ukb-b-2346	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Duration of moderate activity	MR Egger	6	-3.148432603960223	1.657280251187932	0.13027510574831733	-6.39670189628857	0.0998366883681241	0.04291934578656017	0.0016670463081110173	1.1049904455465476	0.043 [0.002:1.105]	overlaps null	Duration of moderate activity (M/F) MRC-IEU/2018 [343K]	Physical activity
ukb-b-2346	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Duration of moderate activity	Weighted median	6	0.5118163105071472	0.5141547618418455	0.3195165499175318	-0.49592702270287004	1.5195596437171643	1.6683186293889325	0.6090060830691268	4.570212230294326	1.668 [0.609:4.57]	overlaps null	Duration of moderate activity (M/F) MRC-IEU/2018 [343K]	Physical activity
ukb-a-508	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Number of days/week of moderate physical activity 10+ minutes	Inverse variance weighted	7	0.100112436874949	0.1362699474312179	0.4625449896309024	-0.16697666009023807	0.3672015338401361	1.105295187026036	0.8462193617902435	1.4436888419550755	1.105 [0.846:1.444]	overlaps null	Days/week of moderate physical activity 10+ minutes (M/F) Neale Lab/2017 [321K]	Physical activity
ukb-a-508	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Number of days/week of moderate physical activity 10+ minutes	MR Egger	7	-0.7897533924756965	0.9575097543212894	0.44703435407506553	-2.6664725109454235	1.0869657259940306	0.45395673062522	0.06949694314211244	2.965262988021471	0.454 [0.069:2.965]	overlaps null	Days/week of moderate physical activity 10+ minutes (M/F) Neale Lab/2017 [321K]	Physical activity
ukb-a-508	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Number of days/week of moderate physical activity 10+ minutes	Weighted median	7	0.06346438572756295	0.1753456560057787	0.7173978097174352	-0.28021310004376326	0.4071418714988892	1.0655215373513989	0.7556227010668121	1.5025172549167527	1.066 [0.756:1.503]	overlaps null	Days/week of moderate physical activity 10+ minutes (M/F) Neale Lab/2017 [321K]	Physical activity
ukb-b-969	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Time spend outdoors in summer	Inverse variance weighted	44	0.35253008243189565	0.21520512745258633	0.10139835089340793	-0.06927196737517355	0.7743321322389649	1.4226624522512448	0.9330728801850514	2.169142942665017	1.423 [0.933:2.169]	overlaps null	Time spend outdoors in summer (M/F) MRC-IEU/2018 [419K]	Physical activity
ukb-b-969	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Time spend outdoors in summer	MR Egger	44	1.528283638825958	1.1999632739342028	0.2098056622158733	-0.8236443780850795	3.8802116557369954	4.6102571613506145	0.43882947628122365	48.43446541900871	4.61 [0.439:48.434]	overlaps null	Time spend outdoors in summer (M/F) MRC-IEU/2018 [419K]	Physical activity
ukb-b-969	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Time spend outdoors in summer	Weighted median	44	0.5357549832343889	0.2230258476430904	0.016296337808338404	0.09862432185393166	0.9728856446148461	1.7087378237956667	1.1036516038792565	2.645567623158536	1.709 [1.104:2.646]	positive	Time spend outdoors in summer (M/F) MRC-IEU/2018 [419K]	Physical activity
ukb-b-8865	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Time spent doing light physical activity	Inverse variance weighted	3	-1.7608000644938666e-4	0.002933654218757452	0.9521391409503478	-0.0059260422752139925	0.0055738822623152195	0.9998239354947251	0.9940914820795326	1.0055894452460294	1 [0.994:1.006]	overlaps null	Time spent doing light physical activity (M/F) MRC-IEU/2018 [ 64K]	Physical activity
ukb-b-8865	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Time spent doing light physical activity	MR Egger	3	0.0016423366735495353	0.00859755652002165	0.8798381773021698	-0.015208874105692898	0.01849354745279197	1.0016436860470317	0.9849061967155995	1.0186656121604172	1.002 [0.985:1.019]	overlaps null	Time spent doing light physical activity (M/F) MRC-IEU/2018 [ 64K]	Physical activity
ukb-b-8865	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Time spent doing light physical activity	Weighted median	3	-5.256381907245114e-4	0.00327428937029381	0.8724596178455786	-0.0069432453565003785	0.0058919689750513565	0.9994744999328272	0.9930808032808208	1.0059093607647702	0.999 [0.993:1.006]	overlaps null	Time spent doing light physical activity (M/F) MRC-IEU/2018 [ 64K]	Physical activity
ukb-a-487	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of physical activity in last 4 weeks: Heavy DIY (eg: weeding  lawn mowing  carpentry  digging)	Inverse variance weighted	3	-0.8985421581350536	0.88347342865689	0.3091266788353997	-2.630150078302558	0.833065762032451	0.4071628062634512	0.0720676456371912	2.300360298141549	0.407 [0.072:2.3]	overlaps null	Physical activity: Heavy DIY  (M/F) Neale Lab/2017 [335K]	Physical activity
ukb-a-487	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of physical activity in last 4 weeks: Heavy DIY (eg: weeding  lawn mowing  carpentry  digging)	MR Egger	3	-3.7380289882079416	13.864847369375706	0.8323503702839827	-30.913129832184325	23.437071855768444	0.023800968920025322	3.7548993092084364e-14	15086586213.983797	0.024 [0:15086586213.984]	overlaps null	Physical activity: Heavy DIY  (M/F) Neale Lab/2017 [335K]	Physical activity
ukb-a-487	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of physical activity in last 4 weeks: Heavy DIY (eg: weeding  lawn mowing  carpentry  digging)	Weighted median	3	-0.9796543464495793	1.0533578430069641	0.3523555756060658	-3.044235718743229	1.0849270258440704	0.37544084888821844	0.04763270286133379	2.959223863996348	0.375 [0.048:2.959]	overlaps null	Physical activity: Heavy DIY  (M/F) Neale Lab/2017 [335K]	Physical activity
ukb-b-7663	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of physical activity in last 4 weeks: Strenuous sports	Inverse variance weighted	6	-2.0427206492955534	1.921660233738884	0.28778293758095475	-5.809174707423766	1.723733408832659	0.12967542915352473	0.00299990485017973	5.605416760182692	0.13 [0.003:5.605]	overlaps null	Physical activity: Strenuous sports (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-7663	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of physical activity in last 4 weeks: Strenuous sports	MR Egger	6	-4.5332522351512035	9.909556147500222	0.6710833404396743	-23.955982284251636	14.889477813949231	0.010745671731094253	3.94501887444409e-11	2926968.5298707136	0.011 [0:2926968.53]	overlaps null	Physical activity: Strenuous sports (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-7663	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of physical activity in last 4 weeks: Strenuous sports	Weighted median	6	-0.5245585426055934	1.6695568091760444	0.7533765149450752	-3.7968898885906404	2.747772803379454	0.5918165685076233	0.02244045575512642	15.60783143542556	0.592 [0.022:15.608]	overlaps null	Physical activity: Strenuous sports (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-a-482	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of physical activity in last 4 weeks: Walking for pleasure (not as a means of transport)	Inverse variance weighted	6	-1.008032434945731	0.9541353811949481	0.2907453901196896	-2.8781377820878293	0.8620729121963673	0.36493630957313417	0.05623939538905033	2.3680643990491395	0.365 [0.056:2.368]	overlaps null	Physical activity: Walking for pleasure  (M/F) Neale Lab/2017 [335K]	Physical activity
ukb-a-482	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of physical activity in last 4 weeks: Walking for pleasure (not as a means of transport)	MR Egger	6	-33.784818012509824	27.323486652630947	0.2839215272756297	-87.33885185166648	19.769215826646835	2.1253965195421854e-15	1.1727854925033107e-38	385177885.8246164	0 [0:385177885.825]	overlaps null	Physical activity: Walking for pleasure  (M/F) Neale Lab/2017 [335K]	Physical activity
ukb-a-482	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of physical activity in last 4 weeks: Walking for pleasure (not as a means of transport)	Weighted median	6	-0.6466741647195753	1.0889098564297157	0.5525970579945624	-2.780937483321818	1.4875891538826673	0.5237849054480691	0.06198037456491024	4.426411248740088	0.524 [0.062:4.426]	overlaps null	Physical activity: Walking for pleasure  (M/F) Neale Lab/2017 [335K]	Physical activity
ukb-b-16886	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of transport used (excluding work): Car/motor vehicle	Inverse variance weighted	5	-0.8991458437597827	1.595495656915114	0.573058602723248	-4.026317331313406	2.2280256437938406	0.4069170821079183	0.01783990759826022	9.281522945072325	0.407 [0.018:9.282]	overlaps null	Types of transport used : Car/motor vehicle (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-16886	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of transport used (excluding work): Car/motor vehicle	MR Egger	5	-8.387791342585396	13.766385568281162	0.5853721934671925	-35.36990705641647	18.594324371245683	2.276294790965611e-4	4.3555654079555853e-16	118963153.80577175	0 [0:118963153.806]	overlaps null	Types of transport used : Car/motor vehicle (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-16886	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of transport used (excluding work): Car/motor vehicle	Weighted median	5	-1.9314666855219746	1.3395157787123468	0.14932660862170355	-4.556917611798174	0.6939842407542249	0.14493546776503455	0.010494356822208919	2.0016748212538698	0.145 [0.01:2.002]	overlaps null	Types of transport used : Car/motor vehicle (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-17557	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of transport used (excluding work): Cycle	Inverse variance weighted	8	-3.587032145611873	1.2480777108869494	0.004052505589174581	-6.033264458950294	-1.1407998322734523	0.027680359914883525	0.0023976541456398204	0.3195633225129004	0.028 [0.002:0.32]	negative	Types of transport used : Cycle (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-17557	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of transport used (excluding work): Cycle	MR Egger	8	0.9481590804376594	7.183749733350555	0.8993096533828215	-13.13199039692943	15.028308557804747	2.5809539545994853	1.980838343760015e-6	3362880.841208996	2.581 [0:3362880.841]	overlaps null	Types of transport used : Cycle (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-17557	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of transport used (excluding work): Cycle	Weighted median	8	-4.309991355553424	1.6344007524045328	0.008363128031904851	-7.5134168302663085	-1.1065658808405399	0.013433665720349023	5.457132898699307e-4	0.33069265131712916	0.013 [0.001:0.331]	negative	Types of transport used : Cycle (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-15957	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of transport used (excluding work): Public transport	Inverse variance weighted	9	2.3673362200014565	0.8635767693544405	0.0061193752258750286	0.6747257520667531	4.05994668793616	10.668934703702073	1.9634944178379616	57.97122043117109	10.669 [1.963:57.971]	positive	Types of transport used : Public transport (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-15957	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of transport used (excluding work): Public transport	MR Egger	9	-0.22777554665789007	3.3670372243228273	0.9479570507660497	-6.827168506330631	6.371617413014851	0.7963029726419016	0.0010839228974255115	585.003255992113	0.796 [0.001:585.003]	overlaps null	Types of transport used : Public transport (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-15957	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of transport used (excluding work): Public transport	Weighted median	9	1.7935063241163403	0.9846633609536712	0.06853983101379278	-0.13643386335285523	3.7234465115855357	6.010490289168573	0.8724640201966111	41.40685768113243	6.01 [0.872:41.407]	overlaps null	Types of transport used : Public transport (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-14926	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of transport used (excluding work): Walk	Inverse variance weighted	7	-0.27348283027389414	1.535910225809401	0.8586765428295816	-3.28386687286032	2.736901212312532	0.7607253976904542	0.037483034082010716	15.439068497633642	0.761 [0.037:15.439]	overlaps null	Types of transport used : Walk (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-14926	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of transport used (excluding work): Walk	MR Egger	7	-26.72058289321828	18.27355976957792	0.20352675742730317	-62.536760041590995	9.095594255154438	2.485411458517016e-12	6.928356045873032e-28	8915.924755061129	0 [0:8915.925]	overlaps null	Types of transport used : Walk (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-14926	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Types of transport used (excluding work): Walk	Weighted median	7	-0.03897971155979929	1.15817858140212	0.9731514293448265	-2.3090097311079543	2.2310503079883555	0.9617702217660569	0.09935959557472351	9.309638934472927	0.962 [0.099:9.31]	overlaps null	Types of transport used : Walk (M/F) MRC-IEU/2018 [460K]	Physical activity
ukb-b-4711	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Usual walking pace	Inverse variance weighted	53	-0.19319496699804134	0.35651340770840517	0.5878867178015017	-0.8919612461065154	0.5055713121104328	0.8243212430328108	0.4098511450309316	1.6579324468249954	0.824 [0.41:1.658]	overlaps null	Usual walking pace (M/F) MRC-IEU/2018 [459K]	Physical activity
ukb-b-4711	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Usual walking pace	MR Egger	53	-0.24100114680354565	1.466538011633856	0.870118286222246	-3.1154156496059033	2.633413355998812	0.7858407251828988	0.04436006507146856	13.921206931528523	0.786 [0.044:13.921]	overlaps null	Usual walking pace (M/F) MRC-IEU/2018 [459K]	Physical activity
ukb-b-4711	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Usual walking pace	Weighted median	53	-0.0761539097915475	0.3283197109864969	0.8165764873934851	-0.7196605433250814	0.5673527237419865	0.9266735714469796	0.48691751530989674	1.7635921506577332	0.927 [0.487:1.764]	overlaps null	Usual walking pace (M/F) MRC-IEU/2018 [459K]	Physical activity
ukb-b-1004	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Added milk to espresso	Inverse variance weighted	3	1.3932699691506791	1.6495390087967243	0.3983107375504506	-1.8398264880909003	4.626366426392258	4.0279999770176955	0.15884498521257018	102.14224763307544	4.028 [0.159:102.142]	overlaps null	Added milk to espresso (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-1004	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Added milk to espresso	MR Egger	3	2.3114374663637562	4.411150536498006	0.6927279633901915	-6.334417585172336	10.957292517899848	10.08891671501834	0.0017741788458169269	57370.90188092545	10.089 [0.002:57370.902]	overlaps null	Added milk to espresso (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-1004	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Added milk to espresso	Weighted median	3	1.1876282610923083	1.9094439964553767	0.5339576762235106	-2.55488197196023	4.930138494144847	3.279294346841069	0.07770140247033033	138.3986784193508	3.279 [0.078:138.399]	overlaps null	Added milk to espresso (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-d-1468_5	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cereal type: Other (e.g. Cornflakes, Frosties)	Inverse variance weighted	10	2.2992952192352702	1.649410787583561	0.16331456893989393	-0.9335499244285095	5.5321403628990495	9.96715531946245	0.39315555765332744	252.6841684631284	9.967 [0.393:252.684]	overlaps null	Cereal type: Other (e.g. Cornflakes, Frosties) (M/F) Neale lab/2018 [299K]	Diet and supplements
ukb-d-1468_5	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cereal type: Other (e.g. Cornflakes, Frosties)	MR Egger	10	-0.8275444149733933	8.905237083407965	0.9282459565621701	-18.281809098453003	16.62672026850622	0.43712135816296305	1.1489766142190131e-8	16630023.570332816	0.437 [0:16630023.57]	overlaps null	Cereal type: Other (e.g. Cornflakes, Frosties) (M/F) Neale lab/2018 [299K]	Diet and supplements
ukb-d-1468_5	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cereal type: Other (e.g. Cornflakes, Frosties)	Weighted median	10	2.5192048723558123	1.0864756455486086	0.02041161851729889	0.38971260708053945	4.6486971376310855	12.41871827060399	1.476556381049844	104.4488144604261	12.419 [1.477:104.449]	positive	Cereal type: Other (e.g. Cornflakes, Frosties) (M/F) Neale lab/2018 [299K]	Diet and supplements
ukb-b-2221	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cherry intake	Inverse variance weighted	3	-0.5283733228290413	1.1970760338887967	0.6589331400956691	-2.874642349251083	1.8178957035930001	0.58956321911518506	0.05643632038696076	6.158884685433297	0.59 [0.056:6.159]	overlaps null	Cherry intake (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-2221	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cherry intake	MR Egger	3	1.6320599900711839	7.871497906189794	0.8698486952370069	-13.796075906060812	17.06019588620318	5.114399486518377	1.019624734147962e-6	25653636.315087315	5.114 [0:25653636.315]	overlaps null	Cherry intake (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-2221	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cherry intake	Weighted median	3	-0.8566217242578953	0.9885411866015379	0.38618786581349945	-2.7941624499969095	1.080919001481119	0.4245940579578077	0.06116608253749707	2.947386959800144	0.425 [0.061:2.947]	overlaps null	Cherry intake (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-4955	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Dairy smoothie intake	Inverse variance weighted	3	-0.19656187733602498	0.4372601938230098	0.6530488729664704	-1.053591857229124	0.6604681025570742	0.8215504943664417	0.3486830773271481	1.935698227650104	0.822 [0.349:1.936]	overlaps null	Dairy smoothie intake (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-4955	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Dairy smoothie intake	MR Egger	3	2.058455576401088	1.8626350831045893	0.46823340101637867	-1.5923091864839067	5.709220339286083	7.833861661848902	0.2034552527501882	301.6358029956504	7.834 [0.203:301.636]	overlaps null	Dairy smoothie intake (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-4955	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Dairy smoothie intake	Weighted median	3	-0.33428969289555777	0.46818211696396	0.4752170606525933	-1.2519266421449193	0.5833472563538038	0.7158463765770822	0.2859533360482414	1.7920267759075483	0.716 [0.286:1.792]	overlaps null	Dairy smoothie intake (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-16576	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Dried fruit intake	Inverse variance weighted	40	-0.5809798748644844	0.19924290762813118	0.003546214805076596	-0.9714959738156215	-0.19046377591334734	0.5593500049361033	0.3785163637751103	0.8265756991365034	0.559 [0.379:0.827]	negative	Dried fruit intake (M/F) MRC-IEU/2018 [421K]	Diet and supplements
ukb-b-16576	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Dried fruit intake	MR Egger	40	0.34482119855913584	0.8918406954974877	0.7011795128552645	-1.40318656461594	2.0928289617342117	1.411737476404819	0.2458124174498267	8.107819462345278	1.412 [0.246:8.108]	overlaps null	Dried fruit intake (M/F) MRC-IEU/2018 [421K]	Diet and supplements
ukb-b-16576	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Dried fruit intake	Weighted median	40	-0.6681950803254955	0.24963820825109165	0.007436140845860173	-1.157485968497635	-0.17890419215335585	0.5126330046733785	0.31427528651949627	0.8361860087403138	0.513 [0.314:0.836]	negative	Dried fruit intake (M/F) MRC-IEU/2018 [421K]	Diet and supplements
ukb-b-3881	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Fresh fruit intake	Inverse variance weighted	53	-0.596508118100449	0.29809607762580265	0.04538593117714245	-1.1807764302470223	-0.01223980595387586	0.5507313713060367	0.3070402506908089	0.9878347957905275	0.551 [0.307:0.988]	negative	Fresh fruit intake (M/F) MRC-IEU/2018 [446K]	Diet and supplements
ukb-b-3881	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Fresh fruit intake	MR Egger	53	-1.0391602466825998	1.0243986849376674	0.31517567183009104	-3.046981669160428	0.9686611757952284	0.35375162136097993	0.04750208523787225	2.6344150785985043	0.354 [0.048:2.634]	overlaps null	Fresh fruit intake (M/F) MRC-IEU/2018 [446K]	Diet and supplements
ukb-b-3881	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Fresh fruit intake	Weighted median	53	-0.7169157630901104	0.3204172736619545	0.025257323965529137	-1.3449336194675412	-0.08889790671267961	0.4882558327353694	0.2605570031985405	0.9149389779343466	0.488 [0.261:0.915]	negative	Fresh fruit intake (M/F) MRC-IEU/2018 [446K]	Diet and supplements
ukb-d-1418_1	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Milk type used: Full cream	Inverse variance weighted	3	6.901627371614947	5.538504061227939	0.21272122540399802	-3.953840588391812	17.757095331621706	993.8908299640804	0.019180894214214407	51500152.74859519	993.891 [0.019:51500152.749]	overlaps null	Milk type used: Full cream (M/F) Neale lab/2018 [360K]	Diet and supplements
ukb-d-1418_1	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Milk type used: Full cream	MR Egger	3	-9.338758104764418	46.776433964095034	0.8745503990787236	-101.02056867439069	82.34305246486184	8.794859122961548e-5	1.3406779479749691e-44	5769435315138284e20	0 [0:5.76943531513828e+35]	overlaps null	Milk type used: Full cream (M/F) Neale lab/2018 [360K]	Diet and supplements
ukb-d-1418_1	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Milk type used: Full cream	Weighted median	3	1.127095980381032	2.912022690595983	0.6987198030730581	-4.5804684931870945	6.834660453949159	3.086679693634542	0.010250093072581469	929.5126847756829	3.087 [0.01:929.513]	overlaps null	Milk type used: Full cream (M/F) Neale lab/2018 [360K]	Diet and supplements
ukb-d-1418_3	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Milk type used: Skimmed	Inverse variance weighted	3	-6.078720096822807	2.449121505050309	0.013064719731038132	-10.878998246721412	-1.2784419469242012	0.0022911071724808166	1.8849988640029094e-5	0.27847083497154546	0.002 [0:0.278]	negative	Milk type used: Skimmed (M/F) Neale lab/2018 [360K]	Diet and supplements
ukb-d-1418_3	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Milk type used: Skimmed	MR Egger	3	-21.677538660586954	4.689507219351817	0.1356301120231898	-30.868972810516514	-12.486104510657395	3.8509207261352825e-10	3.9244196930536866e-14	3.778798293471773e-6	0 [0:0]	negative	Milk type used: Skimmed (M/F) Neale lab/2018 [360K]	Diet and supplements
ukb-d-1418_3	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Milk type used: Skimmed	Weighted median	3	-4.030538562473412	1.559229524909732	0.009739163403629873	-7.086628431296487	-0.9744486936503369	0.01776475994381177	8.362119642222292e-4	0.37740035943493117	0.018 [0.001:0.377]	negative	Milk type used: Skimmed (M/F) Neale lab/2018 [360K]	Diet and supplements
ukb-b-14238	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Mineral and other dietary supplements: None of the above	Inverse variance weighted	7	1.630042457430765	0.8472306348139175	0.05435891610281844	-0.03052958680451323	3.2906145016660435	5.104091420544494	0.9699317344620587	26.85936370947248	5.104 [0.97:26.859]	overlaps null	Supplements None of the above (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-14238	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Mineral and other dietary supplements: None of the above	MR Egger	7	-1.3661551448657245	7.086800391051926	0.8547211096430838	-15.256283911327499	12.52397362159605	0.2550858446306535	2.3674460063517801e-7	274848.03436427494	0.255 [0:274848.034]	overlaps null	Supplements None of the above (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-14238	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Mineral and other dietary supplements: None of the above	Weighted median	7	1.9691567030396917	0.9713427971980862	0.04263663978896457	0.06532482053144273	3.8729885855479407	7.164632027656509	1.0675057158488317	48.085880318593524	7.165 [1.068:48.086]	positive	Supplements None of the above (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-5495	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Never eat eggs, dairy, wheat, sugar: Sugar or foods/drinks containing sugar	Inverse variance weighted	20	1.5327160797978094	0.5557435962285037	0.005816412427506175	0.4434586311899422	2.6219735284056767	4.630737208854037	1.5580867576845527	13.762858192397738	4.631 [1.558:13.763]	positive	Never eat: Sugar or foods/drinks containing sugar (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-5495	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Never eat eggs, dairy, wheat, sugar: Sugar or foods/drinks containing sugar	MR Egger	20	3.467774223710053	3.287901066588026	0.30551118034321995	-2.9765118668024777	9.912060314222584	32.06529279035411	0.05097031539455413	20172.19226077205	32.065 [0.051:20172.192]	overlaps null	Never eat: Sugar or foods/drinks containing sugar (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-5495	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Never eat eggs, dairy, wheat, sugar: Sugar or foods/drinks containing sugar	Weighted median	20	1.033624974904359	0.755449171793823	0.17124143822278784	-0.447055401811534	2.514305351620252	2.811238053936095	0.6395084773652042	12.358021317339318	2.811 [0.64:12.358]	overlaps null	Never eat: Sugar or foods/drinks containing sugar (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-3599	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Never eat eggs, dairy, wheat, sugar: Wheat products	Inverse variance weighted	5	1.5367026951483203	1.470156558010287	0.29590066612220806	-1.3448041585518422	4.418209548848482	4.649235024233442	0.2605907373303451	82.94763863059943	4.649 [0.261:82.948]	overlaps null	Never eat: Wheat products (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-3599	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Never eat eggs, dairy, wheat, sugar: Wheat products	MR Egger	5	-3.324861483630562	5.094917631386574	0.5605701331041508	-13.310900041148246	6.6611770738871225	0.03597750188124134	1.6563402781282225e-6	781.4702441924939	0.036 [0:781.47]	overlaps null	Never eat: Wheat products (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-3599	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Never eat eggs, dairy, wheat, sugar: Wheat products	Weighted median	5	1.0258495767850502	1.4764556269772486	0.48717716414647855	-1.8680034520903572	3.919702605660458	2.789464318287647	0.1544316844786373	50.38545819965033	2.789 [0.154:50.385]	overlaps null	Never eat: Wheat products (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-6500	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Pancake intake	Inverse variance weighted	4	2.0560099461248527	0.9027723535227411	0.02275995864403844	0.2865761332202801	3.825443759029425	7.814726341086278	1.3318595627918766	45.85314359875256	7.815 [1.332:45.853]	positive	Pancake intake (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-6500	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Pancake intake	MR Egger	4	-1.0245603998661617	5.011003543234456	0.8569111641154203	-10.846127344605694	8.797006544873373	0.3589542270536449	1.947990094726067e-5	6614.414388888304	0.359 [0:6614.414]	overlaps null	Pancake intake (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-6500	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Pancake intake	Weighted median	4	1.2544386843421713	1.1567790483058369	0.2781769539151421	-1.012848250337269	3.5217256190216117	3.5058699222511063	0.3631830687071747	33.842777846163855	3.506 [0.363:33.843]	overlaps null	Pancake intake (M/F) MRC-IEU/2018 [ 64K]	Diet and supplements
ukb-b-8006	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Poultry intake	Inverse variance weighted	7	1.827602281189922	0.6065669029019217	0.0025865614916783363	0.6387311515021554	3.0164734108776887	6.218957456390466	1.8940760583893996	20.41915459154354	6.219 [1.894:20.419]	positive	Poultry intake (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-8006	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Poultry intake	MR Egger	7	-14.814192637138767	18.089159898415385	0.45006868159172847	-50.26894603803292	20.64056076375539	3.683645967763529e-7	1.473920721669663e-22	920622623.4779584	0 [0:920622623.478]	overlaps null	Poultry intake (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-8006	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Poultry intake	Weighted median	7	1.510990024034758	0.5932860905000037	0.010871099059224556	0.34814928665475087	2.673830761414765	4.531214585763922	1.4164436900971566	14.495391356384516	4.531 [1.416:14.495]	positive	Poultry intake (M/F) MRC-IEU/2018 [461K]	Diet and supplements
ukb-b-4643	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Age at hysterectomy	Inverse variance weighted	4	0.19090024713221032	0.1487661435273761	0.19941370093846086	-0.10068139418144684	0.4824818884458675	1.210338711301831	0.9042210770935676	1.6200903000231532	1.21 [0.904:1.62]	overlaps null	Age at hysterectomy (M/F) MRC-IEU/2018 [ 46K]	Reproductive
ukb-b-4643	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Age at hysterectomy	MR Egger	4	-0.9450091563853469	1.0917201538328638	0.4779471286900737	-3.0847806578977597	1.1947623451270661	0.38867601201811863	0.04574006552212774	3.302772757184308	0.389 [0.046:3.303]	overlaps null	Age at hysterectomy (M/F) MRC-IEU/2018 [ 46K]	Reproductive
ukb-b-4643	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Age at hysterectomy	Weighted median	4	0.11020391393536239	0.18088771843197138	0.5423658088931894	-0.24433601419130152	0.4647438420620263	1.1165057183226743	0.7832244155241334	1.5916064340423006	1.117 [0.783:1.592]	overlaps null	Age at hysterectomy (M/F) MRC-IEU/2018 [ 46K]	Reproductive
ukb-a-320	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Age at last live birth	Inverse variance weighted	4	-0.5227887473508717	0.31151065530559213	0.09330081643029853	-1.1333496317498324	0.08777213704808895	0.5928648900458485	0.3219530241704331	1.0917393267379514	0.593 [0.322:1.092]	overlaps null	Age at last live birth (M/F) Neale Lab/2017 [123K]	Reproductive
ukb-a-320	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Age at last live birth	MR Egger	4	-4.554904496483164	1.9086242529689157	0.13970843649885764	-8.29580803230224	-0.8140009606640897	0.010515504451815438	2.495607882164023e-4	0.4430817624292254	0.011 [0:0.443]	negative	Age at last live birth (M/F) Neale Lab/2017 [123K]	Reproductive
ukb-a-320	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Age at last live birth	Weighted median	4	-0.4151635170329142	0.33843682921318735	0.21993196969716713	-1.0784997022907614	0.248172668224933	0.6602323126491169	0.34010540242197235	1.281681218709861	0.66 [0.34:1.282]	overlaps null	Age at last live birth (M/F) Neale Lab/2017 [123K]	Reproductive
ukb-b-17422	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Age at menopause (last menstrual period)	Inverse variance weighted	102	0.12403842703571807	0.04900348397527937	0.011366766499000253	0.027991598444170512	0.22008525562726564	1.1320593718492824	1.0283870443339627	1.246182970169365	1.132 [1.028:1.246]	positive	Age at menopause (last menstrual period) (M/F) MRC-IEU/2018 [143K]	Reproductive
ukb-b-17422	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Age at menopause (last menstrual period)	MR Egger	102	0.13977795268854248	0.10509456935213041	0.18653701670147846	-0.0662074032416331	0.34576330861871807	1.1500184120077819	0.9359367278487317	1.4130681151885014	1.15 [0.936:1.413]	overlaps null	Age at menopause (last menstrual period) (M/F) MRC-IEU/2018 [143K]	Reproductive
ukb-b-17422	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Age at menopause (last menstrual period)	Weighted median	102	0.19826445640520454	0.05817327805990299	6.539999103433094e-4	0.08424483140779469	0.3122840814026144	1.2192847988635525	1.0878952121222691	1.3665428473019585	1.219 [1.088:1.367]	positive	Age at menopause (last menstrual period) (M/F) MRC-IEU/2018 [143K]	Reproductive
ukb-b-4564	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Age last used hormone-replacement therapy (HRT)	Inverse variance weighted	4	0.41492266644036013	0.38050265162266517	0.2755108592738571	-0.33086253074006355	1.1607078636207837	1.514253633540271	0.7183039069601997	3.1921921132150586	1.514 [0.718:3.192]	overlaps null	Age last used hormone-replacement therapy (HRT) (M/F) MRC-IEU/2018 [ 72K]	Reproductive
ukb-b-4564	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Age last used hormone-replacement therapy (HRT)	MR Egger	4	0.8631565065301927	1.1042916016104645	0.5162668919600988	-1.3012550326263177	3.027568045686703	2.370631810979377	0.2721899712856365	20.6469590216086	2.371 [0.272:20.647]	overlaps null	Age last used hormone-replacement therapy (HRT) (M/F) MRC-IEU/2018 [ 72K]	Reproductive
ukb-b-4564	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Age last used hormone-replacement therapy (HRT)	Weighted median	4	0.0889404544483258	0.23723029268223425	0.7077260052789496	-0.37603091920885334	0.5539118281055049	1.0930155701734394	0.6865811041695582	1.7400464845104882	1.093 [0.687:1.74]	overlaps null	Age last used hormone-replacement therapy (HRT) (M/F) MRC-IEU/2018 [ 72K]	Reproductive
ukb-b-9487	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Age started hormone-replacement therapy (HRT)	Inverse variance weighted	22	0.06887436522383673	0.13002961654441328	0.5963323347185421	-0.1859836832032133	0.32373241365088673	1.071301607955509	0.8302871424979851	1.3822773790705114	1.071 [0.83:1.382]	overlaps null	Age started hormone-replacement therapy (HRT) (M/F) MRC-IEU/2018 [ 87K]	Reproductive
ukb-b-9487	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Age started hormone-replacement therapy (HRT)	MR Egger	22	1.3056452788247506	0.3424245093640587	0.001089126265622427	0.6344932404711955	1.9767973171783058	3.690069449303384	1.8860661172651327	7.219583882046927	3.69 [1.886:7.22]	positive	Age started hormone-replacement therapy (HRT) (M/F) MRC-IEU/2018 [ 87K]	Reproductive
ukb-b-9487	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Age started hormone-replacement therapy (HRT)	Weighted median	22	2.8760202597815504e-4	0.13186562740525326	0.9982597964399796	-0.25816902768831823	0.25874423174027456	1.000287643387406	0.7724646531568793	1.2953024651994325	1 [0.772:1.295]	overlaps null	Age started hormone-replacement therapy (HRT) (M/F) MRC-IEU/2018 [ 87K]	Reproductive
ukb-b-18541	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ever used hormone-replacement therapy (HRT)	Inverse variance weighted	6	-1.5913662053980535	0.6885112326378756	0.020815472849243812	-2.94084822136829	-0.24188418942781742	0.2036471976913503	0.052820905910112056	0.785147100621772	0.204 [0.053:0.785]	negative	Ever used hormone-replacement therapy (HRT) (M/F) MRC-IEU/2018 [250K]	Reproductive
ukb-b-18541	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ever used hormone-replacement therapy (HRT)	MR Egger	6	-1.9657582099463204	1.6338271202846422	0.29525396323125996	-5.168059365704218	1.236542945811578	0.14004965930493876	0.005695611199572389	3.443687847390634	0.14 [0.006:3.444]	overlaps null	Ever used hormone-replacement therapy (HRT) (M/F) MRC-IEU/2018 [250K]	Reproductive
ukb-b-18541	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ever used hormone-replacement therapy (HRT)	Weighted median	6	-1.0714985764990406	0.6510715207810148	0.09981599279355037	-2.3475987572298296	0.20460160423174845	0.342494877875731	0.09559844189473467	1.227036121574829	0.342 [0.096:1.227]	overlaps null	Ever used hormone-replacement therapy (HRT) (M/F) MRC-IEU/2018 [250K]	Reproductive
ukb-b-18105	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Had menopause	Inverse variance weighted	9	-0.9918538270291992	0.7167933605520934	0.16643885762483435	-2.3967688137113026	0.4130611596529039	0.3708884902085369	0.09101155398003652	1.511437462097851	0.371 [0.091:1.511]	overlaps null	Had menopause (M/F) MRC-IEU/2018 [211K]	Reproductive
ukb-b-18105	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Had menopause	MR Egger	9	-4.286222994055296	1.3521820998567617	0.015710992935586036	-6.9364999097745494	-1.635946078336043	0.01375678676055856	9.716645659967705e-4	0.1947680183040742	0.014 [0.001:0.195]	negative	Had menopause (M/F) MRC-IEU/2018 [211K]	Reproductive
ukb-b-18105	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Had menopause	Weighted median	9	-1.7430843520733093	0.4905930401947676	3.8084298025912533e-4	-2.704646710855054	-0.7815219932915647	0.17497986793051937	0.06689395257976956	0.45770885110235887	0.175 [0.067:0.458]	negative	Had menopause (M/F) MRC-IEU/2018 [211K]	Reproductive
ukb-a-316	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Had menopause	Inverse variance weighted	7	-1.4124465293561104	0.7647598254974382	0.06475943458687321	-2.911375787331089	0.0864827286188683	0.24354670950913818	0.0544008343821286	1.0903325360063654	0.244 [0.054:1.09]	overlaps null	Had menopause (M/F) Neale Lab/2017 [152K]	Reproductive
ukb-a-316	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Had menopause	MR Egger	7	-3.5835899848922623	1.8514975791884152	0.11070600647979323	-7.212525240101556	0.04534527031703117	0.027775804335766277	7.372929609325242e-4	1.0463890846360306	0.028 [0.001:1.046]	overlaps null	Had menopause (M/F) Neale Lab/2017 [152K]	Reproductive
ukb-a-316	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Had menopause	Weighted median	7	-2.1899719924083945	0.5271278033269442	3.259467927436185e-5	-3.223142486929205	-1.1568014978875838	0.11191988317981354	0.03982969708840091	0.31449047235237226	0.112 [0.04:0.314]	negative	Had menopause (M/F) Neale Lab/2017 [152K]	Reproductive
ukb-b-1209	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Number of live births	Inverse variance weighted	10	-0.26368753500820763	0.3263405660516832	0.4190828952597959	-0.9033150444695067	0.37593997445309146	0.7682135419966837	0.40522409477471527	1.4563597123591234	0.768 [0.405:1.456]	overlaps null	Number of live births (M/F) MRC-IEU/2018 [250K]	Reproductive
ukb-b-1209	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Number of live births	MR Egger	10	-0.5524880734004236	3.127827010473039	0.864183829997325	-6.683029013927579	5.578052867126732	0.5755161012303155	0.0012519799586159746	264.55597830934516	0.576 [0.001:264.556]	overlaps null	Number of live births (M/F) MRC-IEU/2018 [250K]	Reproductive
ukb-b-1209	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Number of live births	Weighted median	10	-0.01951305759927105	0.30062617331241687	0.9482472140245614	-0.608740357291608	0.569714242093066	0.980676089829667	0.5440357282832267	1.767761827331546	0.981 [0.544:1.768]	overlaps null	Number of live births (M/F) MRC-IEU/2018 [250K]	Reproductive
ukb-a-317	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Number of live births	Inverse variance weighted	3	0.29882966593237753	0.2817665112039053	0.2888909177841096	-0.25343269602727686	0.851092027892032	1.348279945905029	0.7761319799329123	2.3422032070973304	1.348 [0.776:2.342]	overlaps null	Number of live births (M/F) Neale Lab/2017 [180K]	Reproductive
ukb-a-317	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Number of live births	MR Egger	3	0.8591803140221271	2.4097395067515266	0.7819618541145248	-3.863909119210865	5.582269747255119	2.3612244376910683	0.02098580296411709	265.6739346444191	2.361 [0.021:265.674]	overlaps null	Number of live births (M/F) Neale Lab/2017 [180K]	Reproductive
ukb-a-317	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Number of live births	Weighted median	3	0.17869426384718423	0.33145988170989366	0.5898090262255242	-0.4709671043042073	0.8283556319985758	1.195655133279955	0.624398118084122	2.2895507791170266	1.196 [0.624:2.29]	overlaps null	Number of live births (M/F) Neale Lab/2017 [180K]	Reproductive
ukb-a-26	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Average weekly red wine intake	Inverse variance weighted	13	-0.7431729761599398	0.39111991983001676	0.0574179794283926	-1.5097680190267728	0.023422066706893063	0.47560244364172705	0.2209612308156747	1.0236985174411688	0.476 [0.221:1.024]	overlaps null	Average weekly red wine intake (M/F) Neale Lab/2017 [241K]	Alcohol
ukb-a-26	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Average weekly red wine intake	MR Egger	13	-0.6374407640538899	1.1469978081525967	0.5895082674900994	-2.8855564680329797	1.6106749399251996	0.5286436180434074	0.055823716777919016	5.006188964625973	0.529 [0.056:5.006]	overlaps null	Average weekly red wine intake (M/F) Neale Lab/2017 [241K]	Alcohol
ukb-a-26	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Average weekly red wine intake	Weighted median	13	-0.6328440552234891	0.28115284452886513	0.02439252126476406	-1.1839036305000648	-0.0817844799469134	0.5310792324470658	0.3060815741092505	0.9214705326753627	0.531 [0.306:0.921]	negative	Average weekly red wine intake (M/F) Neale Lab/2017 [241K]	Alcohol
ukb-b-1707	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Average weekly spirits intake	Inverse variance weighted	3	-1.6885439297277685	2.291800808084468	0.46125855458042714	-6.180473513573326	2.803385654117789	0.18478839308516454	0.002069447711022462	16.500417013255298	0.185 [0.002:16.5]	overlaps null	Average weekly spirits intake (M/F) MRC-IEU/2018 [326K]	Alcohol
ukb-b-1707	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Average weekly spirits intake	MR Egger	3	12.775915881976355	5.616611477401406	0.2636832114536213	1.7673573862695982	23.78447437768311	353597.97466658615	5.855359444915526	21353347965.150497	353597.975 [5.855:21353347965.15]	positive	Average weekly spirits intake (M/F) MRC-IEU/2018 [326K]	Alcohol
ukb-b-1707	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Average weekly spirits intake	Weighted median	3	-1.8173678839926104	0.8720160357011763	0.03715114882485347	-3.526519313966916	-0.10821645401830504	0.16245278325929163	0.029407094801635503	0.8974333223567065	0.162 [0.029:0.897]	negative	Average weekly spirits intake (M/F) MRC-IEU/2018 [326K]	Alcohol
ukb-d-20406	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ever addicted to alcohol	Inverse variance weighted	2	-0.2231949905119729	0.12545647736263882	0.07522941620356507	-0.46908968614274493	0.02269970511879918	0.7999588497001677	0.6255714755476577	1.0229593039762308	0.8 [0.626:1.023]	overlaps null	Ever addicted to alcohol (M/F) Neale lab/2018 [  6K]	Alcohol
ukb-b-223	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Current tobacco smoking	Inverse variance weighted	34	-0.04458889210760695	0.2711651290861451	0.8693891360546231	-0.5760725451164513	0.4868947609012374	0.9563905807404846	0.5621016659868575	1.627255349480689	0.956 [0.562:1.627]	overlaps null	Current tobacco smoking (M/F) MRC-IEU/2018 [462K]	Smoking
ukb-b-223	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Current tobacco smoking	MR Egger	34	-1.250893584547651	1.0211750205384245	0.22953284207441377	-3.252396624802963	0.750609455707661	0.286248894952911	0.03868139187046112	2.118290627601086	0.286 [0.039:2.118]	overlaps null	Current tobacco smoking (M/F) MRC-IEU/2018 [462K]	Smoking
ukb-b-223	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Current tobacco smoking	Weighted median	34	0.158268906887524	0.379198257566851	0.6764021435536992	-0.5849596779435039	0.901497491718552	1.1714811717117066	0.5571283259191047	2.4632891056311172	1.171 [0.557:2.463]	overlaps null	Current tobacco smoking (M/F) MRC-IEU/2018 [462K]	Smoking
ukb-b-17685	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Maternal smoking around birth	Inverse variance weighted	16	0.6676884223087648	0.6107666652219634	0.2743072160702067	-0.5294142415262836	1.8647910861438133	1.9497251663489565	0.5889498510257406	6.4545872924048355	1.95 [0.589:6.455]	overlaps null	Maternal smoking around birth (M/F) MRC-IEU/2018 [397K]	Smoking
ukb-b-17685	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Maternal smoking around birth	MR Egger	16	-1.9588741330402657	3.3383636590087544	0.5666959972661887	-8.502066904697426	4.584318638616893	0.14101709807107932	2.0304825360177898e-4	97.93643429895599	0.141 [0:97.936]	overlaps null	Maternal smoking around birth (M/F) MRC-IEU/2018 [397K]	Smoking
ukb-b-17685	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Maternal smoking around birth	Weighted median	16	0.6375046190180568	0.6634242600723105	0.3365871040763315	-0.6628069307236718	1.9378161687597855	1.8917543367010292	0.5154026027972914	6.943570814357476	1.892 [0.515:6.944]	overlaps null	Maternal smoking around birth (M/F) MRC-IEU/2018 [397K]	Smoking
ukb-b-4801	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Number of unsuccessful stop-smoking attempts	Inverse variance weighted	3	-0.07110788793983762	0.7804401397302122	0.9274031640378466	-1.6007705618110535	1.458554785931378	0.9313614040438368	0.20174100417230525	4.299740989698054	0.931 [0.202:4.3]	overlaps null	Number of unsuccessful stop-smoking attempts (M/F) MRC-IEU/2018 [104K]	Smoking
ukb-b-4801	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Number of unsuccessful stop-smoking attempts	MR Egger	3	3.659032612871153	4.204558675536536	0.544093993377007	-4.581902391180456	11.899967616922762	38.82376708652471	0.010235406017079087	147261.85637126866	38.824 [0.01:147261.856]	overlaps null	Number of unsuccessful stop-smoking attempts (M/F) MRC-IEU/2018 [104K]	Smoking
ukb-b-4801	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Number of unsuccessful stop-smoking attempts	Weighted median	3	-0.08364782652052893	0.5121425352896563	0.8702592505446505	-1.0874471956882552	0.9201515426471973	0.9197551124231759	0.3370758850838466	2.509670683259176	0.92 [0.337:2.51]	overlaps null	Number of unsuccessful stop-smoking attempts (M/F) MRC-IEU/2018 [104K]	Smoking
ukb-a-225	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Smoking status: Current	Inverse variance weighted	15	-0.08252036045055929	0.6569610736580569	0.9000412733982384	-1.3701640648203508	1.2051233439192321	0.9207926899119085	0.2540652729598766	3.337170672392944	0.921 [0.254:3.337]	overlaps null	Smoking status: Current (M/F) Neale Lab/2017 [336K]	Smoking
ukb-a-225	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Smoking status: Current	MR Egger	15	2.31778707753375	2.9214682819487874	0.4418063815546741	-3.408290755085873	8.043864910153374	10.153181224693842	0.0330977241723306	3114.627714121067	10.153 [0.033:3114.628]	overlaps null	Smoking status: Current (M/F) Neale Lab/2017 [336K]	Smoking
ukb-a-225	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Smoking status: Current	Weighted median	15	0.0048432276427930465	0.8418694590840533	0.9954098403224713	-1.6452209121619514	1.6549073674475374	1.0048549750272218	0.1929699286806016	5.232595191078922	1.005 [0.193:5.233]	overlaps null	Smoking status: Current (M/F) Neale Lab/2017 [336K]	Smoking
ukb-d-22506_114	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Tobacco smoking: Never smoked	Inverse variance weighted	3	-0.4379989086207555	0.5888053909373164	0.4569507669318842	-1.5920574748578957	0.7160596576163846	0.6453264871528442	0.20350647124855376	2.046353968333523	0.645 [0.204:2.046]	overlaps null	Tobacco smoking: Never smoked (M/F) Neale lab/2018 [ 91K]	Smoking
ukb-d-22506_114	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Tobacco smoking: Never smoked	MR Egger	3	14.057832883681245	8.878013592994037	0.35859827314720716	-3.343073758587069	31.45873952594956	1274204.8356194803	0.03532820030115801	45957562210233.8	1274204.836 [0.035:45957562210233.8]	overlaps null	Tobacco smoking: Never smoked (M/F) Neale lab/2018 [ 91K]	Smoking
ukb-d-22506_114	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Tobacco smoking: Never smoked	Weighted median	3	-0.2704154021194729	0.6377448566670125	0.6715525677209221	-1.5203953211868175	0.9795645169478717	0.7630624507317953	0.218625442597262	2.6632961690073014	0.763 [0.219:2.663]	overlaps null	Tobacco smoking: Never smoked (M/F) Neale lab/2018 [ 91K]	Smoking
met-a-558	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	1-arachidonoylglycerophosphocholine*	Inverse variance weighted	3	0.4883052158132898	0.19851700077476558	0.013902792798341815	0.09921189429474925	0.8773985373318303	1.6295521391599037	1.1043002696963766	2.404635991776695	1.63 [1.104:2.405]	positive	1-arachidonoylglycerophosphocholine* (M/F) Shin/2014 [  7K]	Metabolites
met-a-558	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	1-arachidonoylglycerophosphocholine*	MR Egger	3	0.6722359242956955	0.3863134537180478	0.33205185404399484	-0.08493844499167824	1.4294102935830693	1.9586117359490045	0.9185688251729333	4.1762357126315095	1.959 [0.919:4.176]	overlaps null	1-arachidonoylglycerophosphocholine* (M/F) Shin/2014 [  7K]	Metabolites
met-a-558	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	1-arachidonoylglycerophosphocholine*	Weighted median	3	0.5056790726597448	0.21227610270806885	0.01721066183461529	0.08961791135192981	0.9217402339675598	1.6581111161627675	1.0937562919924257	2.513660944097753	1.658 [1.094:2.514]	positive	1-arachidonoylglycerophosphocholine* (M/F) Shin/2014 [  7K]	Metabolites
met-a-682	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	1-arachidonoylglycerophosphoethanolamine*	Inverse variance weighted	2	0.7551431897489269	0.3210677586624943	0.01867405372665144	0.12585038277043803	1.3844359967274158	2.1279161973277154	1.1341124728224639	3.9925734451899215	2.128 [1.134:3.993]	positive	1-arachidonoylglycerophosphoethanolamine* (M/F) Shin/2014 [  7K]	Metabolites
met-a-634	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	1-arachidonoylglycerophosphoinositol*	Inverse variance weighted	3	0.5767166898817486	0.5969247220900079	0.3339709136970212	-0.5932557654146668	1.746689145178164	1.7801839290305266	0.5525254598835916	5.735581527494195	1.78 [0.553:5.736]	overlaps null	1-arachidonoylglycerophosphoinositol* (M/F) Shin/2014 [  7K]	Metabolites
met-a-634	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	1-arachidonoylglycerophosphoinositol*	MR Egger	3	7.332350657970355	2.6086692657939197	0.2176033612928038	2.2193588970142724	12.445342418926437	1528.9716404341427	9.201429910335776	254064.23784480742	1528.972 [9.201:254064.238]	positive	1-arachidonoylglycerophosphoinositol* (M/F) Shin/2014 [  7K]	Metabolites
met-a-634	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	1-arachidonoylglycerophosphoinositol*	Weighted median	3	0.7490869143518519	0.37648146015360995	0.04662347945470543	0.011183252450776449	1.4869905762529274	2.115067896510183	1.0112460187774763	4.423762490809271	2.115 [1.011:4.424]	positive	1-arachidonoylglycerophosphoinositol* (M/F) Shin/2014 [  7K]	Metabolites
met-a-427	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	2-hydroxyisobutyrate	Inverse variance weighted	2	0.16553564966773382	0.5978996775208743	0.7818861373094783	-1.0063477182731797	1.3374190176086473	1.180025029469841	0.36555164204318713	3.809199330612746	1.18 [0.366:3.809]	overlaps null	2-hydroxyisobutyrate (M/F) Shin/2014 [  6K]	Metabolites
met-a-500	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	3-dehydrocarnitine*	Inverse variance weighted	3	0.11821663276771421	0.3572940890193545	0.7407453524640324	-0.5820797817102206	0.818513047245649	1.1254879025191644	0.5587351102619337	2.267126220371495	1.125 [0.559:2.267]	overlaps null	3-dehydrocarnitine* (M/F) Shin/2014 [  7K]	Metabolites
met-a-500	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	3-dehydrocarnitine*	MR Egger	3	-1.7183476853022865	1.990805950615576	0.5466794785436551	-5.620327348508815	2.183631977904242	0.1793622661124077	0.0036234547822854746	8.87849426526763	0.179 [0.004:8.878]	overlaps null	3-dehydrocarnitine* (M/F) Shin/2014 [  7K]	Metabolites
met-a-500	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	3-dehydrocarnitine*	Weighted median	3	0.08311423983656153	0.3927645187804252	0.8324086452157498	-0.6867042169730718	0.8529326966461949	1.0866659419972213	0.5032318820625695	2.3465183975563133	1.087 [0.503:2.347]	overlaps null	3-dehydrocarnitine* (M/F) Shin/2014 [  7K]	Metabolites
met-c-841	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Albumin	Inverse variance weighted	3	0.21183403737138526	0.1903160902291964	0.26568083370152423	-0.1611854994778397	0.5848535742206102	1.2359427477491753	0.8511341715180701	1.794728171927651	1.236 [0.851:1.795]	overlaps null	Albumin (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-841	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Albumin	MR Egger	3	-0.4072420442752758	0.3966434284436048	0.49160714091641355	-1.1846631640247411	0.37017907547418955	0.665483094432841	0.30584918315796	1.4479938916403268	0.665 [0.306:1.448]	overlaps null	Albumin (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-841	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Albumin	Weighted median	3	0.2752801801625999	0.14137223319226289	0.05151061955222321	-0.0018093968942353156	0.5523697572194352	1.3168995923254372	0.998192239077469	1.73736527732341	1.317 [0.998:1.737]	overlaps null	Albumin (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-851	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Average number of double bonds in a fatty acid chain	Inverse variance weighted	5	0.09011797151562545	0.039875031567954994	0.023820627992645886	0.01196290964243367	0.16827303338881722	1.094303372718081	1.0120347514391432	1.1832596359357097	1.094 [1.012:1.183]	positive	Average number of double bonds in a fatty acid chain (M/F) Kettunen/2016 [ 15K]	Metabolites
met-c-851	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Average number of double bonds in a fatty acid chain	MR Egger	5	0.13476857119223065	0.08417768339256662	0.2076906182794349	-0.030219688257199923	0.29975683064166125	1.14427193621579	0.9702323614770932	1.3495306031821601	1.144 [0.97:1.35]	overlaps null	Average number of double bonds in a fatty acid chain (M/F) Kettunen/2016 [ 15K]	Metabolites
met-c-851	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Average number of double bonds in a fatty acid chain	Weighted median	5	0.08940108413729356	0.039846490912033385	0.024855729757904555	0.01130196194970813	0.167500206324879	1.0935191615712356	1.0113660704111558	1.182345534132196	1.094 [1.011:1.182]	positive	Average number of double bonds in a fatty acid chain (M/F) Kettunen/2016 [ 15K]	Metabolites
met-a-362	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Betaine	Inverse variance weighted	3	-1.1514562888766642	0.5704586090836311	0.04354184301648274	-2.2695551626805814	-0.03335741507274714	0.31617599036897126	0.10335814741958703	0.9671928085163739	0.316 [0.103:0.967]	negative	Betaine (M/F) Shin/2014 [  7K]	Metabolites
met-a-362	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Betaine	MR Egger	3	0.28798451107661266	1.785872708734729	0.8982168075846964	-3.212325998043456	3.788295020196682	1.3337366458186715	0.04026285295395045	44.18100829650985	1.334 [0.04:44.181]	overlaps null	Betaine (M/F) Shin/2014 [  7K]	Metabolites
met-a-362	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Betaine	Weighted median	3	-1.2922559685537545	0.5186191941450459	0.01271247268343766	-2.3087495890780443	-0.27576234802946464	0.2746504808136291	0.09938544654392337	0.7589932855794946	0.275 [0.099:0.759]	negative	Betaine (M/F) Shin/2014 [  7K]	Metabolites
met-c-875	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cholesterol esters in large HDL	Inverse variance weighted	13	0.03885047528667834	0.030999707382555287	0.21011365880941327	-0.02190895118313002	0.09960990175648671	1.0396150238894974	0.9783293067220996	1.1047398769213892	1.04 [0.978:1.105]	overlaps null	Cholesterol esters in large HDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-875	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cholesterol esters in large HDL	MR Egger	13	0.003718424913918729	0.08067772280577094	0.9640647328094496	-0.15440991178539232	0.16184676161322975	1.003725346832725	0.8569206871196287	1.1756800681996242	1.004 [0.857:1.176]	overlaps null	Cholesterol esters in large HDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-875	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cholesterol esters in large HDL	Weighted median	13	0.04450737011280459	0.04082688526379897	0.27564770917540615	-0.03551332500424138	0.12452806522985056	1.0455126822284668	0.9651098740511546	1.1326138070810214	1.046 [0.965:1.133]	overlaps null	Cholesterol esters in large HDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-887	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cholesterol esters in large VLDL	Inverse variance weighted	12	-0.11437321456557302	0.04619803131284238	0.01329692273970576	-0.20492135593874408	-0.023825073192401958	0.8919250143502039	0.8147113861041858	0.9764565032381645	0.892 [0.815:0.976]	negative	Cholesterol esters in large VLDL (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-887	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cholesterol esters in large VLDL	MR Egger	12	-0.1992159837472161	0.11668111593655102	0.11856030494980621	-0.42791097098285613	0.02947900348842389	0.8193729029901398	0.651869447511614	1.0299178105636368	0.819 [0.652:1.03]	overlaps null	Cholesterol esters in large VLDL (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-887	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cholesterol esters in large VLDL	Weighted median	12	-0.07964444120692199	0.05093632068784941	0.11790964257635898	-0.17947962975510684	0.020190747341262846	0.9234446268786769	0.8357049742847569	1.0203959592808813	0.923 [0.836:1.02]	overlaps null	Cholesterol esters in large VLDL (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-910	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cholesterol esters in medium VLDL	Inverse variance weighted	14	-0.06654568789152437	0.03441862955358402	0.053184403835345305	-0.13400620181654904	9.148260335002933e-4	0.9356201683670565	0.8745846405730172	1.0009152446144693	0.936 [0.875:1.001]	overlaps null	Cholesterol esters in medium VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-910	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cholesterol esters in medium VLDL	MR Egger	14	-0.10865159345415978	0.09448885940139698	0.27259124868701756	-0.29384975788089784	0.0765465709725783	0.8970428986776291	0.7453884717745506	1.0795524649747301	0.897 [0.745:1.08]	overlaps null	Cholesterol esters in medium VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-910	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cholesterol esters in medium VLDL	Weighted median	14	-0.08130487328011426	0.04778584735034252	0.08885991976324145	-0.1749651340867856	0.012355387526557071	0.9219125820825407	0.839486289715082	1.0124320306536005	0.922 [0.839:1.012]	overlaps null	Cholesterol esters in medium VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-958	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of chylomicrons and largest VLDL particles	Inverse variance weighted	7	-0.06901865910284687	0.0546676132203131	0.20676368092204958	-0.17616718101466056	0.03812986280896681	0.9333092652021622	0.8384777940505272	1.0388661341933032	0.933 [0.838:1.039]	overlaps null	Concentration of chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-958	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of chylomicrons and largest VLDL particles	MR Egger	7	-0.20365684458882075	0.1974708222788998	0.3496687729863746	-0.5906996562554644	0.18338596707782287	0.8157422495307163	0.5539395818273657	1.2012779723634464	0.816 [0.554:1.201]	overlaps null	Concentration of chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-958	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of chylomicrons and largest VLDL particles	Weighted median	7	-0.08852849026474215	0.06784264860939007	0.19192379855188052	-0.2215000815391467	0.04444310100966238	0.9152770338795234	0.801315856809321	1.0454454902252643	0.915 [0.801:1.045]	overlaps null	Concentration of chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-878	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of large HDL particles	Inverse variance weighted	11	0.041258545801917214	0.029837055570923834	0.166727583044381	-0.0172220831170935	0.09973917472092793	1.0421215068583756	0.9829253692638514	1.1048826991515428	1.042 [0.983:1.105]	overlaps null	Concentration of large HDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-878	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of large HDL particles	MR Egger	11	-0.07502279041950419	0.08648143568633739	0.4082015018545202	-0.24452640436472545	0.09448082352571707	0.9277223429062418	0.7830753114862541	1.0990880862964796	0.928 [0.783:1.099]	overlaps null	Concentration of large HDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-878	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of large HDL particles	Weighted median	11	0.03774002881601309	0.0376742417805975	0.31646618360599277	-0.036101485073958	0.1115815427059842	1.0384612277883343	0.9645424018589493	1.1180449086958395	1.038 [0.965:1.118]	overlaps null	Concentration of large HDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-890	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of large VLDL particles	Inverse variance weighted	10	-0.07435561662260373	0.040591004658744934	0.0669774991152312	-0.15391398575374382	0.005202752508536343	0.9283415014644444	0.8573457617895145	1.0052163103278307	0.928 [0.857:1.005]	overlaps null	Concentration of large VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-890	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of large VLDL particles	MR Egger	10	-0.09373412173253451	0.10506637177740624	0.3983560054688082	-0.29966421041625074	0.11219596695118172	0.9105248188218615	0.7410670214936972	1.1187320736787567	0.911 [0.741:1.119]	overlaps null	Concentration of large VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-890	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of large VLDL particles	Weighted median	10	-0.06187981324112176	0.054381744955211496	0.2551712595177065	-0.1684680333533363	0.044708406871092767	0.9399958550574864	0.8449582734697973	1.0457228898378714	0.94 [0.845:1.046]	overlaps null	Concentration of large VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-913	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of medium VLDL particles	Inverse variance weighted	14	-0.07761878984033123	0.04169971156489698	0.06269127495216284	-0.15935022450752928	0.0041126448268668375	0.9253170995972745	0.8526976710463556	1.0041211133559738	0.925 [0.853:1.004]	overlaps null	Concentration of medium VLDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-913	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of medium VLDL particles	MR Egger	14	-0.11785018862145798	0.10521140585248795	0.28457760664086	-0.3240645440923344	0.0883641668494184	0.8888291993685647	0.7232035623558934	1.0923858603193535	0.889 [0.723:1.092]	overlaps null	Concentration of medium VLDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-913	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of medium VLDL particles	Weighted median	14	-0.05931516031578193	0.04816414947195597	0.21812807674049886	-0.15371689328081561	0.03508657264925177	0.9424097122067824	0.8575147548389421	1.0357093690224368	0.942 [0.858:1.036]	overlaps null	Concentration of medium VLDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-922	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of small HDL particles	Inverse variance weighted	5	-0.011717546829153701	0.05053438050745234	0.8166368339539763	-0.11076493262376029	0.08732983896545289	0.9883508362680418	0.8951491445602426	1.0912565592984236	0.988 [0.895:1.091]	overlaps null	Concentration of small HDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-922	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of small HDL particles	MR Egger	5	0.045923307669061254	0.13749627304432424	0.7603669745980852	-0.22356938749781427	0.3154160028359368	1.0469941114589119	0.7996594035774036	1.370829461300181	1.047 [0.8:1.371]	overlaps null	Concentration of small HDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-922	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of small HDL particles	Weighted median	5	-0.0015755386927295756	0.06078894788671255	0.9793226020064013	-0.12072187655068616	0.11757079916522702	0.9984257018167808	0.8862804206856427	1.1247612592830911	0.998 [0.886:1.125]	overlaps null	Concentration of small HDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-930	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of small VLDL particles	Inverse variance weighted	15	-0.05673183594978958	0.03413221167901332	0.0964886911141987	-0.12363097084065569	0.01016729894107652	0.94484740950481	0.8837058939606599	1.0102191615434584	0.945 [0.884:1.01]	overlaps null	Concentration of small VLDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-930	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of small VLDL particles	MR Egger	15	-0.12364011290933836	0.09581110180564498	0.21937242310992378	-0.31142987244840253	0.06414964662972579	0.8836978150976109	0.7323989700510509	1.066251947833649	0.884 [0.732:1.066]	overlaps null	Concentration of small VLDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-930	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of small VLDL particles	Weighted median	15	-0.07473793231408032	0.04698738824857863	0.11170061865014586	-0.1668332132812944	0.017357348653133778	0.9279866497783916	0.8463407579640974	1.0175088627876936	0.928 [0.846:1.018]	overlaps null	Concentration of small VLDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-950	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of very large VLDL particles	Inverse variance weighted	8	-0.07027953483526247	0.046821480071892935	0.13335283683988536	-0.16204963577617262	0.021490566105647674	0.9321332197782048	0.8503989932785595	1.0217231514636478	0.932 [0.85:1.022]	overlaps null	Concentration of very large VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-950	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of very large VLDL particles	MR Egger	8	-0.15136054936730367	0.14482397482496692	0.33622727844263767	-0.4352155400242388	0.13249444128963148	0.8595377369970748	0.6471251706700734	1.1416726698438389	0.86 [0.647:1.142]	overlaps null	Concentration of very large VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-950	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Concentration of very large VLDL particles	Weighted median	8	-0.07201695366849312	0.06063211110025577	0.23492435477744097	-0.19085589142499443	0.046821984088008195	0.9305151200326046	0.826251649519914	1.047935443290663	0.931 [0.826:1.048]	overlaps null	Concentration of very large VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-876	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in large HDL	Inverse variance weighted	15	0.05868725257171595	0.038725824307341325	0.12965716251785853	-0.017215363070673048	0.13458986821410496	1.0604435378839414	0.9829319745901548	1.144067469682936	1.06 [0.983:1.144]	overlaps null	Free cholesterol in large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-876	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in large HDL	MR Egger	15	-0.06611968150106302	0.08877913525281556	0.46966373520880744	-0.2401267865965815	0.10788742359445545	0.9360188334487325	0.7865281335194644	1.1139223369548346	0.936 [0.787:1.114]	overlaps null	Free cholesterol in large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-876	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in large HDL	Weighted median	15	0.04846045618998875	0.04078777126452825	0.23478913563163856	-0.031483575488486605	0.12840448786846412	1.0496538636866724	0.9690068717875607	1.1370128175870209	1.05 [0.969:1.137]	overlaps null	Free cholesterol in large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-888	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in large VLDL	Inverse variance weighted	11	-0.05126771461026159	0.040493358877458	0.20548547827647776	-0.13063469801007926	0.02809926878955609	0.9500243010992315	0.8775382823271517	1.0284977770834258	0.95 [0.878:1.028]	overlaps null	Free cholesterol in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-888	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in large VLDL	MR Egger	11	-0.12143017306976386	0.11339602440232788	0.31211226201685605	-0.3436863808983265	0.10082603475879878	0.8856528936126	0.7091512965707614	1.1060842048197588	0.886 [0.709:1.106]	overlaps null	Free cholesterol in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-888	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in large VLDL	Weighted median	11	-0.08151519567900163	0.05436425141465487	0.13376304003286266	-0.1880691284517252	0.02503873709372191	0.9217187036059205	0.8285574283607156	1.0253548390216316	0.922 [0.829:1.025]	overlaps null	Free cholesterol in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-900	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in medium HDL	Inverse variance weighted	5	-0.030569656093761548	0.11891261436871468	0.7971196054522319	-0.2636383802564423	0.2024990680689192	0.9698928707654649	0.7682513042707333	1.224458944010036	0.97 [0.768:1.224]	overlaps null	Free cholesterol in medium HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-900	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in medium HDL	MR Egger	5	0.40670285510506976	0.23509883730508013	0.18208165935123308	-0.05409086601288732	0.8674965762230269	1.5018577699827886	0.9473460210349799	2.3809428774434993	1.502 [0.947:2.381]	overlaps null	Free cholesterol in medium HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-900	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in medium HDL	Weighted median	5	0.01836009394974769	0.06787907680039691	0.7867891739829848	-0.11468289657903025	0.15140308447852563	1.0185296767367746	0.8916488439806122	1.1634655384761263	1.019 [0.892:1.163]	overlaps null	Free cholesterol in medium HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-911	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in medium VLDL	Inverse variance weighted	12	-0.0490221127159611	0.03630984840538763	0.17698226205954568	-0.12018941559052086	0.022145190158598657	0.9521600746204336	0.8867524560684709	1.022392214982696	0.952 [0.887:1.022]	overlaps null	Free cholesterol in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-911	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in medium VLDL	MR Egger	12	-0.07564182044965642	0.09347886459911979	0.4372373961942515	-0.2588603950639312	0.10757675416461837	0.9271482326304236	0.7719307808690791	1.1135763290873464	0.927 [0.772:1.114]	overlaps null	Free cholesterol in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-911	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in medium VLDL	Weighted median	12	-0.05133427409390153	0.05058873001654765	0.3102310425265809	-0.15048818492633492	0.047819636738531866	0.9499610700766404	0.8602878943122115	1.0489814405474496	0.95 [0.86:1.049]	overlaps null	Free cholesterol in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-928	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in small VLDL	Inverse variance weighted	14	-0.06433785769721129	0.037614384303287646	0.08718105079517384	-0.13806205093165508	0.009386335537232504	0.9376881408512013	0.8710446409373809	1.0094305253365219	0.938 [0.871:1.009]	overlaps null	Free cholesterol in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-928	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in small VLDL	MR Egger	14	-0.1288692148944437	0.11227864463387177	0.27343416836829504	-0.34893535837683237	0.09119692858794498	0.8790889297660883	0.7054387295006546	1.095484716276227	0.879 [0.705:1.095]	overlaps null	Free cholesterol in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-928	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in small VLDL	Weighted median	14	-0.07222348575790678	0.049292070745967205	0.14286224449037563	-0.1688359444200025	0.02438897290418894	0.9303229586450628	0.8446474611492687	1.0246888165678736	0.93 [0.845:1.025]	overlaps null	Free cholesterol in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-944	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in very large HDL	Inverse variance weighted	13	0.06829703424641911	0.040524354417749694	0.09192433066971074	-0.011130700412370284	0.14772476890520853	1.0706832908550614	0.9889310166365651	1.1591938062728548	1.071 [0.989:1.159]	overlaps null	Free cholesterol in very large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-944	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in very large HDL	MR Egger	13	-0.015971671545411178	0.1189179455770875	0.89558465003324506	-0.24905084487650267	0.2171075017856803	0.9841551992562664	0.7795403367448983	1.2424776635260886	0.984 [0.78:1.242]	overlaps null	Free cholesterol in very large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-944	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Free cholesterol in very large HDL	Weighted median	13	0.029332336339074498	0.041973243347177745	0.48465567647829405	-0.05293522062139388	0.11159989329954287	1.0297667665311667	0.9484414499401079	1.1180654256717881	1.03 [0.948:1.118]	overlaps null	Free cholesterol in very large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-a-573	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Isobutyrylcarnitine	Inverse variance weighted	3	0.11058236647481616	0.16529701328337865	0.5035006314926379	-0.21339977956060596	0.4345645125102383	1.116928342713681	0.8078331174836966	1.5442903933463799	1.117 [0.808:1.544]	overlaps null	Isobutyrylcarnitine (M/F) Shin/2014 [  7K]	Metabolites
met-a-573	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Isobutyrylcarnitine	MR Egger	3	0.15438387673198753	0.3494115283141167	0.7351361816328238	-0.5304627187636812	0.8392304722276562	1.1669387614467812	0.58833267411748	2.3145851537306092	1.167 [0.588:2.315]	overlaps null	Isobutyrylcarnitine (M/F) Shin/2014 [  7K]	Metabolites
met-a-573	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Isobutyrylcarnitine	Weighted median	3	0.11811224783745973	0.18035039867186747	0.5125293849728159	-0.23537453355940052	0.47159902923431996	1.1253704246745229	0.79027480975636	1.602554677305939	1.125 [0.79:1.603]	overlaps null	Isobutyrylcarnitine (M/F) Shin/2014 [  7K]	Metabolites
met-a-652	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Isovalerylcarnitine	Inverse variance weighted	3	-0.0459094831852468	0.2851777819894303	0.8721048338107364	-0.6048579358845301	0.5130389695140365	0.9551284134596755	0.5461520097308669	1.6703596616765102	0.955 [0.546:1.67]	overlaps null	Isovalerylcarnitine (M/F) Shin/2014 [  7K]	Metabolites
met-a-652	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Isovalerylcarnitine	MR Egger	3	2.1013663294319076	5.203943727090062	0.7556779177586759	-8.098363375664613	12.30109603452843	8.177335216870091	3.040363243615959e-4	219936.91506918622	8.177 [0:219936.915]	overlaps null	Isovalerylcarnitine (M/F) Shin/2014 [  7K]	Metabolites
met-a-652	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Isovalerylcarnitine	Weighted median	3	-0.0013232481518440364	0.2465032024568039	0.9957169148746524	-0.48446952496717965	0.4818230286634916	0.9986776269549545	0.6160238954000196	1.6190232392409687	0.999 [0.616:1.619]	overlaps null	Isovalerylcarnitine (M/F) Shin/2014 [  7K]	Metabolites
met-c-896	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Mean diameter for LDL particles	Inverse variance weighted	8	0.01477009147734744	0.04473518746076862	0.741273630883274	-0.07291087594575905	0.10245105890045393	1.014879708297039	0.9296836835126548	1.1078830795668824	1.015 [0.93:1.108]	overlaps null	Mean diameter for LDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-896	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Mean diameter for LDL particles	MR Egger	8	-0.1401114815581133	0.11497382511186066	0.26871787429783134	-0.36546017877736015	0.0852372156611336	0.8692613233902162	0.6938772698037625	1.0889753580713313	0.869 [0.694:1.089]	overlaps null	Mean diameter for LDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-896	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Mean diameter for LDL particles	Weighted median	8	-4.398426457672532e-4	0.05445292511018905	0.9935551700977721	-0.1071675758617378	0.10628789057020328	0.9995602540708287	0.8983751143917065	1.1121420056193883	1 [0.898:1.112]	overlaps null	Mean diameter for LDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-941	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Mean diameter for VLDL particles	Inverse variance weighted	14	-0.10777407590169516	0.038437478125157847	0.005049169466589585	-0.18311153302700456	-0.032436618776385776	0.8978304150457157	0.8326752797633541	0.9680838062230634	0.898 [0.833:0.968]	negative	Mean diameter for VLDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-941	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Mean diameter for VLDL particles	MR Egger	14	-0.02526169096965396	0.14083238998504619	0.8606370283781991	-0.3012931753403445	0.25076979340103656	0.9750547156244944	0.7398608319961942	1.2850142315230089	0.975 [0.74:1.285]	overlaps null	Mean diameter for VLDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-941	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Mean diameter for VLDL particles	Weighted median	14	-0.07524740134507686	0.04779806794888991	0.11542341340311874	-0.16893161452490107	0.018436811834747366	0.9275139897322028	0.8445666575033666	1.0186078191768062	0.928 [0.845:1.019]	overlaps null	Mean diameter for VLDL particles (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-959	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Phospholipids in chylomicrons and largest VLDL particles	Inverse variance weighted	8	-0.07524468029743633	0.05189311419061021	0.147060320936284	-0.17695518411103234	0.026465823516159684	0.9275165135453898	0.8378173312101342	1.0268191535937867	0.928 [0.838:1.027]	overlaps null	Phospholipids in chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-959	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Phospholipids in chylomicrons and largest VLDL particles	MR Egger	8	-0.1204822596992561	0.1690600182834344	0.5028161969077554	-0.45183989553478754	0.2108753761362753	0.8864928138550064	0.636456061025525	1.2347584651017252	0.886 [0.636:1.235]	overlaps null	Phospholipids in chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-959	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Phospholipids in chylomicrons and largest VLDL particles	Weighted median	8	-0.08725538792869088	0.0665692578916046	0.18994359484325565	-0.2177311333962359	0.04322035753885413	0.9164430172600879	0.8043416732104787	1.0441679597831786	0.916 [0.804:1.044]	overlaps null	Phospholipids in chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-891	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Phospholipids in large VLDL	Inverse variance weighted	9	-0.0812179179440347	0.043448473134917	0.06158208947829422	-0.16637692528847203	0.0039410894004026226	0.9219927507864495	0.8467270212067307	1.0039488657055822	0.922 [0.847:1.004]	overlaps null	Phospholipids in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-891	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Phospholipids in large VLDL	MR Egger	9	-0.11569796665658501	0.12082782473120665	0.3701872444719572	-0.35252050312975003	0.12112456981658003	0.8907442171269013	0.7029141577227933	1.1287655137228259	0.891 [0.703:1.129]	overlaps null	Phospholipids in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-891	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Phospholipids in large VLDL	Weighted median	9	-0.08098457588170378	0.057015283986368695	0.15549092341451265	-0.19273453249498643	0.030765380731578862	0.922207915578894	0.82470087636614	1.031243525899673	0.922 [0.825:1.031]	overlaps null	Phospholipids in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-914	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Phospholipids in medium VLDL	Inverse variance weighted	15	-0.056826488643385	0.034618051858531305	0.10068793631755546	-0.12467787028610636	0.011024892999336351	0.9447579813848367	0.8827812268515257	1.0110858910918727	0.945 [0.883:1.011]	overlaps null	Phospholipids in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-914	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Phospholipids in medium VLDL	MR Egger	15	-0.08215398314242853	0.08634984730389475	0.35875169955701036	-0.2513996838580622	0.08709171757320519	0.9211301092666081	0.7777114707109979	1.0909967387028725	0.921 [0.778:1.091]	overlaps null	Phospholipids in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-914	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Phospholipids in medium VLDL	Weighted median	15	-0.06348136280717874	0.04905636545299906	0.19564834007490414	-0.1596318390950569	0.03266911348069941	0.9384916099867713	0.8524575727526159	1.0332086078742144	0.938 [0.852:1.033]	overlaps null	Phospholipids in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-931	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Phospholipids in small VLDL	Inverse variance weighted	14	-0.060790367376525024	0.03820280294305558	0.1115523987653263	-0.13566786114491397	0.014087126391863915	0.9410204876940671	0.8731325855910246	1.014186817527341	0.941 [0.873:1.014]	overlaps null	Phospholipids in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-931	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Phospholipids in small VLDL	MR Egger	14	-0.1340215460572614	0.11345551750812549	0.2603781693490933	-0.3563943603731874	0.08835126825866454	0.874571220838727	0.7001964360529568	1.0923717701720677	0.875 [0.7:1.092]	overlaps null	Phospholipids in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-931	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Phospholipids in small VLDL	Weighted median	14	-0.06211550794557617	0.04700169745270682	0.1863151028163971	-0.15423883495288154	0.030007819061729182	0.939774329119511	0.8570672989370791	1.0304625911726268	0.94 [0.857:1.03]	overlaps null	Phospholipids in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-951	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Phospholipids in very large VLDL	Inverse variance weighted	9	-0.06458851058263253	0.046859205483459995	0.16809443151815484	-0.1564325533302141	0.027255532164949067	0.9374531360666157	0.855189195421071	1.0276303618270428	0.937 [0.855:1.028]	overlaps null	Phospholipids in very large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-951	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Phospholipids in very large VLDL	MR Egger	9	-0.24797935713822034	0.1495858572309501	0.14132942279347613	-0.5411676373108825	0.04520892303444185	0.7803760523067494	0.5820682108698456	1.046246422053858	0.78 [0.582:1.046]	overlaps null	Phospholipids in very large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-951	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Phospholipids in very large VLDL	Weighted median	9	-0.08732760245115834	0.059103259138291474	0.13953016050255004	-0.20316999036220962	0.028514785459892944	0.9163768391547666	0.8161394937849011	1.028925223854688	0.916 [0.816:1.029]	overlaps null	Phospholipids in very large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-a-355	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Proline	Inverse variance weighted	3	-0.0011255878568429633	0.3171671817442873	0.9971684104178224	-0.622773264075646	0.6205220883619602	0.9988750453795587	0.5364546423638301	1.859898819936632	0.999 [0.536:1.86]	overlaps null	Proline (M/F) Shin/2014 [  7K]	Metabolites
met-a-355	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Proline	MR Egger	3	0.47158153962956967	0.4170543801040173	0.46098559706865616	-0.3458450453743042	1.2890081246334435	1.6025266495031403	0.7076221279335736	3.6291850706636386	1.603 [0.708:3.629]	overlaps null	Proline (M/F) Shin/2014 [  7K]	Metabolites
met-a-355	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Proline	Weighted median	3	0.1032229691899062	0.2975001669617401	0.7286155329978443	-0.4798773580551044	0.6863232964349169	1.1087385960640241	0.6188592852585463	1.986398691405991	1.109 [0.619:1.986]	overlaps null	Proline (M/F) Shin/2014 [  7K]	Metabolites
met-a-501	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Pyroglutamine*	Inverse variance weighted	3	-0.4275914059867886	0.38774232971488276	0.27012616631051123	-1.1875663722279588	0.33238356025438165	0.6520777954576268	0.30496252699696214	1.394287539246139	0.652 [0.305:1.394]	overlaps null	Pyroglutamine* (M/F) Shin/2014 [  7K]	Metabolites
met-a-501	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Pyroglutamine*	MR Egger	3	-0.19568353162765073	1.4906317490426622	0.9169025498777104	-3.1173217597512686	2.7259546964959673	0.8222724167196684	0.04427559043594317	15.270986126683399	0.822 [0.044:15.271]	overlaps null	Pyroglutamine* (M/F) Shin/2014 [  7K]	Metabolites
met-a-501	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Pyroglutamine*	Weighted median	3	-0.2588559884203385	0.2893887638186281	0.3710586078706612	-0.8260579655048496	0.3083459886641725	0.7719341825004035	0.43777160012967886	1.3611718575075473	0.772 [0.438:1.361]	overlaps null	Pyroglutamine* (M/F) Shin/2014 [  7K]	Metabolites
met-c-844	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ratio of bisallylic groups to double bonds	Inverse variance weighted	4	0.07736332678455286	0.031342359659421976	0.01357446267476942	0.015932301852085794	0.13879435171701993	1.0804345559022395	1.0160598977044766	1.1488878089027708	1.08 [1.016:1.149]	positive	Ratio of bisallylic groups to double bonds (M/F) Kettunen/2016 [ 13K]	Metabolites
met-c-844	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ratio of bisallylic groups to double bonds	MR Egger	4	0.09946321018198517	0.07226654510907005	0.3025548026556787	-0.042179218231792104	0.24110563859576245	1.104577832774975	0.9586979490240245	1.2726554697440848	1.105 [0.959:1.273]	overlaps null	Ratio of bisallylic groups to double bonds (M/F) Kettunen/2016 [ 13K]	Metabolites
met-c-844	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ratio of bisallylic groups to double bonds	Weighted median	4	0.07644653815366087	0.030749345689024057	0.01291447068333933	0.016177820603173722	0.13671525570414803	1.0794444796996152	1.0163093900878675	1.1465016422343919	1.079 [1.016:1.147]	positive	Ratio of bisallylic groups to double bonds (M/F) Kettunen/2016 [ 13K]	Metabolites
met-c-845	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ratio of bisallylic groups to total fatty acids	Inverse variance weighted	6	0.08861659865434723	0.03271843230241736	0.006759605129502942	0.02448847134160921	0.15274472596708527	1.0926616480610867	1.0247907765763107	1.1650275397015795	1.093 [1.025:1.165]	positive	Ratio of bisallylic groups to total fatty acids (M/F) Kettunen/2016 [ 13K]	Metabolites
met-c-845	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ratio of bisallylic groups to total fatty acids	MR Egger	6	0.0905856203802512	0.06395227845117828	0.2295899975372613	-0.034760845384058214	0.2159320861445606	1.094815242126134	0.9658363728661116	1.241018093815217	1.095 [0.966:1.241]	overlaps null	Ratio of bisallylic groups to total fatty acids (M/F) Kettunen/2016 [ 13K]	Metabolites
met-c-845	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ratio of bisallylic groups to total fatty acids	Weighted median	6	0.08820129423045178	0.03224778095200282	0.0062359045048733155	0.024995643564526257	0.1514069448963773	1.0922079550617019	1.0253106538149954	1.1634700299479304	1.092 [1.025:1.163]	positive	Ratio of bisallylic groups to total fatty acids (M/F) Kettunen/2016 [ 13K]	Metabolites
met-a-464	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Serine	Inverse variance weighted	3	0.7096689936974295	0.6297061056042415	0.2597490524872775	-0.5245549732868836	1.9438929606817426	2.0333181061357735	0.591818680893344	6.985893913485058	2.033 [0.592:6.986]	overlaps null	Serine (M/F) Shin/2014 [  7K]	Metabolites
met-a-464	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Serine	MR Egger	3	10.582738052594248	4.09245234315159	0.23491103027112437	2.5615314600171324	18.603944645171364	39447.97730518893	12.955643179935155	120113134.62852639	39447.977 [12.956:120113134.629]	positive	Serine (M/F) Shin/2014 [  7K]	Metabolites
met-a-464	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Serine	Weighted median	3	0.13196621818427873	0.501135509420798	0.7922928484753371	-0.8502593802804852	1.1141918166490428	1.141069771207391	0.4273040833203899	3.0471045646128925	1.141 [0.427:3.047]	overlaps null	Serine (M/F) Shin/2014 [  7K]	Metabolites
met-c-864	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in HDL	Inverse variance weighted	12	0.07148175239934915	0.05628676631647918	0.20410007718527184	-0.03884030958095004	0.18180381437964832	1.074098550801074	0.9619043037836015	1.1993788699094037	1.074 [0.962:1.199]	overlaps null	Total cholesterol in HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-864	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in HDL	MR Egger	12	-0.14298727101233333	0.12710865968269996	0.2868978405278157	-0.3921202439904252	0.1061457019657586	0.8667651018675611	0.6756228694862945	1.1119838829415527	0.867 [0.676:1.112]	overlaps null	Total cholesterol in HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-864	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in HDL	Weighted median	12	0.04095252975374356	0.04700798331965719	0.38365454463579995	-0.051183117552784534	0.13308817706027165	1.0418026497433153	0.9501046737592336	1.1423507230185805	1.042 [0.95:1.142]	overlaps null	Total cholesterol in HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-874	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in large HDL	Inverse variance weighted	14	0.05366055822208414	0.04016857466507965	0.18158717492157897	-0.025069848121471977	0.13239096456564026	1.0551263873851304	0.9752417908422206	1.1415545394080737	1.055 [0.975:1.142]	overlaps null	Total cholesterol in large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-874	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in large HDL	MR Egger	14	-0.06515558242708173	0.09409638427117893	0.5018445753586598	-0.24958449559859242	0.11927333074442896	0.9369216834878005	0.779124445461508	1.126677831895832	0.937 [0.779:1.127]	overlaps null	Total cholesterol in large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-874	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in large HDL	Weighted median	14	0.045940907209190335	0.04084215453888864	0.2606566530982818	-0.0341097156870314	0.1259915301054121	1.0470125382359423	0.9664654623981653	1.1342725610733126	1.047 [0.966:1.134]	overlaps null	Total cholesterol in large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-886	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in large VLDL	Inverse variance weighted	10	-0.060308747474564134	0.04133474218783619	0.14455606128556533	-0.14132484216272306	0.020707347213594796	0.9414738110451049	0.8682072355689444	1.0209232318859276	0.941 [0.868:1.021]	overlaps null	Total cholesterol in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-886	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in large VLDL	MR Egger	10	-0.16449016577326578	0.12244046115995463	0.215992749564778	-0.4044734696467769	0.0754931381002453	0.8483260995345253	0.6673280868649117	1.0784158277113587	0.848 [0.667:1.078]	overlaps null	Total cholesterol in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-886	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in large VLDL	Weighted median	10	-0.07996730081435609	0.055431558462298997	0.14912436350683683	-0.1886131554004621	0.028678553771749937	0.9231465320329375	0.8281067933810121	1.029093743000297	0.923 [0.828:1.029]	overlaps null	Total cholesterol in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-898	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in medium HDL	Inverse variance weighted	6	0.007253492396111058	0.1094387204030143	0.9471556769557845	-0.20724639959379698	0.2217533843860191	1.0072798626924377	0.8128193469543715	1.2482634986328058	1.007 [0.813:1.248]	overlaps null	Total cholesterol in medium HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-898	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in medium HDL	MR Egger	6	0.26970016933233126	0.2550234662068859	0.3498983363703425	-0.23014582443316506	0.7695461630978275	1.3095717420933506	0.794417748538493	2.158786294546533	1.31 [0.794:2.159]	overlaps null	Total cholesterol in medium HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-898	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in medium HDL	Weighted median	6	0.04504761759667432	0.066670155630921	0.49924453360060533	-0.08562588743993084	0.1757211226332795	1.0460776704273793	0.9179375789684454	1.192105561030081	1.046 [0.918:1.192]	overlaps null	Total cholesterol in medium HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-909	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in medium VLDL	Inverse variance weighted	15	-0.05507730305091026	0.03686833163566495	0.13520386843416982	-0.12733923305681355	0.01718462695499303	0.9464119845918177	0.8804349492924378	1.0173331321057275	0.946 [0.88:1.017]	overlaps null	Total cholesterol in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-909	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in medium VLDL	MR Egger	15	-0.076984888413358	0.10254846197854621	0.4661949288437188	-0.27797987389130857	0.12401009706459255	0.9259038453769578	0.7573120631058534	1.1320273010942494	0.926 [0.757:1.132]	overlaps null	Total cholesterol in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-909	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in medium VLDL	Weighted median	15	-0.05629332641289989	0.04848218576764407	0.24559569498424047	-0.15131841051748227	0.03873175769168249	0.9452618249607075	0.8595739576918338	1.0394916106199479	0.945 [0.86:1.039]	overlaps null	Total cholesterol in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-927	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in small VLDL	Inverse variance weighted	16	-0.04145211282721852	0.044815017783253454	0.354986552289391	-0.12928954768239528	0.046385322027958246	0.9593952769688502	0.878719497513066	1.0474779495335487	0.959 [0.879:1.047]	overlaps null	Total cholesterol in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-927	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in small VLDL	MR Egger	16	-0.1414806160870059	0.11965155733379958	0.2567253186187911	-0.37599766846125304	0.09303643628724126	0.8680720020539703	0.6866039338841105	1.09750172342761	0.868 [0.687:1.098]	overlaps null	Total cholesterol in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-927	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in small VLDL	Weighted median	16	-0.0690817816646082	0.05169746375485197	0.18146096402738962	-0.17040881062411806	0.03224524729490166	0.9332503541897536	0.8433199879457749	1.0327707584837922	0.933 [0.843:1.033]	overlaps null	Total cholesterol in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-942	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in very large HDL	Inverse variance weighted	13	0.060767390821787705	0.04914847453738035	0.21630827649835083	-0.03556361927147778	0.1570984009150532	1.0626517028971656	0.9650613357778453	1.1701107482044972	1.063 [0.965:1.17]	overlaps null	Total cholesterol in very large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-942	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in very large HDL	MR Egger	13	-0.09669210678151587	0.12331597144686308	0.44953647860798696	-0.3383914108173675	0.14500719725433575	0.9078354794947242	0.7129161901722011	1.1560478906087728	0.908 [0.713:1.156]	overlaps null	Total cholesterol in very large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-942	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total cholesterol in very large HDL	Weighted median	13	0.017297750190328174	0.052290975323146194	0.7407970697332613	-0.08519256144303837	0.11978806182369471	1.0174482226306285	0.9183354313786076	1.127257917273407	1.017 [0.918:1.127]	overlaps null	Total cholesterol in very large HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-957	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in chylomicrons and largest VLDL particles	Inverse variance weighted	9	-0.08619446436928543	0.04990931011772964	0.08416375641451052	-0.18401671220003551	0.011627783461464647	0.9174158091856432	0.8319219004652797	1.0116956489221252	0.917 [0.832:1.012]	overlaps null	Total lipids in chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-957	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in chylomicrons and largest VLDL particles	MR Egger	9	-0.15167347052624044	0.15911672981346675	0.37222576369382054	-0.4635422609606352	0.16019531990815436	0.8592688115306925	0.6290514299734102	1.1737401034134496	0.859 [0.629:1.174]	overlaps null	Total lipids in chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-957	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in chylomicrons and largest VLDL particles	Weighted median	9	-0.08600260801865274	0.061298727147294195	0.16061443662988947	-0.20614811322734936	0.034142897190043875	0.9175918381204009	0.8137125457657711	1.0347324565246907	0.918 [0.814:1.035]	overlaps null	Total lipids in chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-877	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in large HDL	Inverse variance weighted	11	0.04155689189730572	0.029921575444500043	0.16487519759043842	-0.01708939597391436	0.1002031797685258	1.0424324661253022	0.9830557994760721	1.1053954892603517	1.042 [0.983:1.105]	overlaps null	Total lipids in large HDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-877	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in large HDL	MR Egger	11	-0.07667269764668111	0.08797358665912083	0.4061065108829457	-0.24910092749855794	0.09575553220519573	0.9261929491337287	0.7795012962984683	1.1004899967434723	0.926 [0.78:1.1]	overlaps null	Total lipids in large HDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-877	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in large HDL	Weighted median	11	0.03966320098293319	0.03768472945081859	0.2925699277847795	-0.034198868740671254	0.11352527070653763	1.040460289171506	0.9663793028917037	1.1202201972905557	1.04 [0.966:1.12]	overlaps null	Total lipids in large HDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-889	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in large VLDL	Inverse variance weighted	9	-0.07356371942615478	0.04436230933523409	0.09726738046296854	-0.1605138457232136	0.013386406870904047	0.929076943655673	0.8517060310043483	1.0134764059550958	0.929 [0.852:1.013]	overlaps null	Total lipids in large VLDL (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-889	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in large VLDL	MR Egger	9	-0.08340849133498247	0.13371206474736663	0.552540974103771	-0.34548413823982105	0.17866715556985613	0.9199752685281652	0.7078775598988998	1.195622721568328	0.92 [0.708:1.196]	overlaps null	Total lipids in large VLDL (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-889	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in large VLDL	Weighted median	9	-0.07329433765316695	0.057351619685763	0.20125577291549057	-0.18570351223726245	0.03911483693092853	0.9293272537629735	0.8305197974387732	1.03988989455763	0.929 [0.831:1.04]	overlaps null	Total lipids in large VLDL (M/F) Kettunen/2016 [ 18K]	Metabolites
met-c-912	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in medium VLDL	Inverse variance weighted	12	-0.07593238402160944	0.044518587980121684	0.08807638415453145	-0.16318881646264793	0.01132404841942905	0.9268788762626897	0.8494307867554105	1.0113884081639268	0.927 [0.849:1.011]	overlaps null	Total lipids in medium VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-912	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in medium VLDL	MR Egger	12	-0.1070945613899641	0.11059243124236479	0.35569597789439955	-0.32385572662499906	0.10966660384507088	0.8984407111708663	0.7233545956607998	1.1159059696742808	0.898 [0.723:1.116]	overlaps null	Total lipids in medium VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-912	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in medium VLDL	Weighted median	12	-0.05044507185248903	0.05160961781931787	0.32835360234296596	-0.15159992277835205	0.050709779073373984	0.9508061532586544	0.8593320111406774	1.052017531471343	0.951 [0.859:1.052]	overlaps null	Total lipids in medium VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-929	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in small VLDL	Inverse variance weighted	14	-0.060286956491468036	0.03732994772971996	0.10631596875140721	-0.13345365404171916	0.01287974105878309	0.9414943269085363	0.8750680239039598	1.0129630421717284	0.941 [0.875:1.013]	overlaps null	Total lipids in small VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-929	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in small VLDL	MR Egger	14	-0.14353177218407231	0.10651318314597655	0.20269555061127414	-0.3522976111501863	0.06523406678204172	0.866293275720574	0.7030708491128498	1.0674088400985966	0.866 [0.703:1.067]	overlaps null	Total lipids in small VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-929	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in small VLDL	Weighted median	14	-0.0752797948615985	0.04708527250857682	0.10986570439448366	-0.16756692897840905	0.017007339255212056	0.9274839447790858	0.8457200122181676	1.0171527874417432	0.927 [0.846:1.017]	overlaps null	Total lipids in small VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-945	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in very large HDL	Inverse variance weighted	13	0.0674043906086985	0.03512814184089142	0.055007804448470414	-0.001446767399448684	0.1362555486168457	1.0697279786675726	0.9985542786639744	1.1459747084307348	1.07 [0.999:1.146]	overlaps null	Total lipids in very large HDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-945	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in very large HDL	MR Egger	13	-0.08864574315588201	0.09417155158051328	0.36675313342923577	-0.27322198425368804	0.09593049794192403	0.9151697212925857	0.7609238557652857	1.100682561632152	0.915 [0.761:1.101]	overlaps null	Total lipids in very large HDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-945	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in very large HDL	Weighted median	13	0.02642473994897226	0.0387186719093167	0.4949351463569526	-0.049463856993288466	0.102313336891233	1.0267769690666522	0.9517395562440019	1.1077305101895043	1.027 [0.952:1.108]	overlaps null	Total lipids in very large HDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-949	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in very large VLDL	Inverse variance weighted	8	-0.06859435164879522	0.04895971686658211	0.1612031507049318	-0.16455539670729616	0.02736669340970571	0.9337053593072209	0.8482707642354965	1.0277446008465714	0.934 [0.848:1.028]	overlaps null	Total lipids in very large VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-949	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in very large VLDL	MR Egger	8	-0.18004629794271645	0.15274966581389596	0.2831386948008864	-0.4794356429379525	0.11934304705251961	0.8352315410140582	0.6191327051426372	1.1267563824527749	0.835 [0.619:1.127]	overlaps null	Total lipids in very large VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-949	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Total lipids in very large VLDL	Weighted median	8	-0.07684857020662654	0.060454209439143126	0.203662335762613	-0.19533882070734707	0.041641680294093986	0.9260300715320314	0.8225559118603044	1.0425208560500319	0.926 [0.823:1.043]	overlaps null	Total lipids in very large VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-960	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in chylomicrons and largest VLDL particles	Inverse variance weighted	9	-0.09292058434203303	0.047995534801555925	0.052864564941475775	-0.18699183255308266	0.001150663869016591	0.9112658662009567	0.8294505108507567	1.0011513261366778	0.911 [0.829:1.001]	overlaps null	Triglycerides in chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-960	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in chylomicrons and largest VLDL particles	MR Egger	9	-0.1652582838285983	0.15658305643008674	0.3262995595429387	-0.4721610744315683	0.14164450677437168	0.8476747351350666	0.6236530502664196	1.1521669881664902	0.848 [0.624:1.152]	overlaps null	Triglycerides in chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-960	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in chylomicrons and largest VLDL particles	Weighted median	9	-0.0871910020330681	0.061711633577896434	0.15769163399888586	-0.2081458038457451	0.033763799779608916	0.9165020251641594	0.8120886224352835	1.0343402664737424	0.917 [0.812:1.034]	overlaps null	Triglycerides in chylomicrons and largest VLDL particles (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-892	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in large VLDL	Inverse variance weighted	9	-0.07608590554789321	0.04382519756480689	0.08254220101786443	-0.16198329277491472	0.009811481679128292	0.9267365913251056	0.8504554131715522	1.0098597720697113	0.927 [0.85:1.01]	overlaps null	Triglycerides in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-892	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in large VLDL	MR Egger	9	-0.14792774443862006	0.12718144095941622	0.28289112652116066	-0.39720336871907586	0.10134787984183574	0.86249343263778	0.672197307825607	1.1066615600553622	0.862 [0.672:1.107]	overlaps null	Triglycerides in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-892	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in large VLDL	Weighted median	9	-0.0942128307041213	0.05422229609857066	0.08229377869473739	-0.20048853105731979	0.012062869649077199	0.9100890467345648	0.8183308753618151	1.0121359194959163	0.91 [0.818:1.012]	overlaps null	Triglycerides in large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-915	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in medium VLDL	Inverse variance weighted	13	-0.08696738505962992	0.04285910096467003	0.04244339381589421	-0.1709712229503832	-0.0029635471688766596	0.9167069934895208	0.8428458277388393	0.9970408398022991	0.917 [0.843:0.997]	negative	Triglycerides in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-915	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in medium VLDL	MR Egger	13	-0.21330419533682898	0.1024359172438036	0.061451425589609435	-0.41407859313468404	-0.01252979753897393	0.8079103372756107	0.660949003170532	0.9875483735443089	0.808 [0.661:0.988]	negative	Triglycerides in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-915	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in medium VLDL	Weighted median	13	-0.08584838690203092	0.05199685447027897	0.09873236969091052	-0.1877622216637777	0.016065447859715865	0.9177333610709122	0.8288117572853242	1.0161951910300522	0.918 [0.829:1.016]	overlaps null	Triglycerides in medium VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-923	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in small HDL	Inverse variance weighted	11	-0.0847483123060204	0.04027531297535128	0.03535884237609536	-0.1636879257377089	-0.005808698874331886	0.9187434917350101	0.8490069337544993	0.9942081389991537	0.919 [0.849:0.994]	negative	Triglycerides in small HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-923	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in small HDL	MR Egger	11	-0.08098355117724929	0.11532535175059264	0.5002995347319676	-0.30702124060841085	0.14505413825391228	0.9222088605699372	0.7356349754068604	1.1561021579259874	0.922 [0.736:1.156]	overlaps null	Triglycerides in small HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-923	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in small HDL	Weighted median	11	-0.0655559783067149	0.04833713955008431	0.175027976790439	-0.16029677182488017	0.029184815211450346	0.9365466189983418	0.8518909342208375	1.0296148653811683	0.937 [0.852:1.03]	overlaps null	Triglycerides in small HDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-932	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in small VLDL	Inverse variance weighted	14	-0.06799801341629015	0.03845062288250749	0.07698566327208684	-0.14336123426600483	0.007365207433424517	0.9342623295656947	0.8664410241702497	1.0073923972856695	0.934 [0.866:1.007]	overlaps null	Triglycerides in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-932	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in small VLDL	MR Egger	14	-0.09870943784661107	0.10716241722676362	0.37513504608018045	-0.30874777561106775	0.11132889991784561	0.9060059208131938	0.7343659716775539	1.1177624783913345	0.906 [0.734:1.118]	overlaps null	Triglycerides in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-932	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in small VLDL	Weighted median	14	-0.06257800105225444	0.045518946439351476	0.16920331309742903	-0.15179513607338335	0.02663913396887445	0.9393397904637721	0.8591642744800024	1.0269971275080767	0.939 [0.859:1.027]	overlaps null	Triglycerides in small VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-952	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in very large VLDL	Inverse variance weighted	9	-0.06858706801485671	0.04655448988990168	0.14067978264486944	-0.159833868199064	0.022659732169350577	0.9337121601000318	0.8522853689086685	1.022918414092935	0.934 [0.852:1.023]	overlaps null	Triglycerides in very large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-952	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in very large VLDL	MR Egger	9	-0.23432728005623546	0.13527597665409544	0.12683973670297133	-0.4994681942982625	0.03081363418579161	0.7911028613336182	0.6068533019596364	1.031293288162523	0.791 [0.607:1.031]	overlaps null	Triglycerides in very large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-952	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in very large VLDL	Weighted median	9	-0.0860803373361739	0.05994255791081268	0.1509889351335976	-0.20356775084136675	0.03140707616901896	0.9175205171049637	0.8158149303023365	1.0319054825296925	0.918 [0.816:1.032]	overlaps null	Triglycerides in very large VLDL (M/F) Kettunen/2016 [ 21K]	Metabolites
met-c-956	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in very small VLDL	Inverse variance weighted	19	-0.03916086465617714	0.03401169827167673	0.24957018913084525	-0.10582379326866354	0.027502063956309254	0.9615960098923665	0.8995831467170986	1.0278837366121867	0.962 [0.9:1.028]	overlaps null	Triglycerides in very small VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-956	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in very small VLDL	MR Egger	19	-0.20245994054955466	0.09557208875070373	0.04917408010530623	-0.38978123450093394	-0.015138646598175348	0.8167191992650913	0.6772050073858021	0.9849753666517211	0.817 [0.677:0.985]	negative	Triglycerides in very small VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-c-956	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides in very small VLDL	Weighted median	19	-0.04457332039605225	0.044005160183583206	0.31110256964942967	-0.13082343435587535	0.04167679356377083	0.9564054734946941	0.8773726745870405	1.0425574630086853	0.956 [0.877:1.043]	overlaps null	Triglycerides in very small VLDL (M/F) Kettunen/2016 [ 19K]	Metabolites
met-a-316	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Uridine	Inverse variance weighted	3	-0.36216294829776646	0.6648429860886615	0.5859360952356463	-1.6652552010315431	0.9409293044360103	0.6961689190585604	0.18914238249114623	2.5623615261685257	0.696 [0.189:2.562]	overlaps null	Uridine (M/F) Shin/2014 [  7K]	Metabolites
met-a-316	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Uridine	MR Egger	3	1.8645491831483263	3.199367901448212	0.6640770544038653	-4.40621190369017	8.135310269986823	6.453026097240677	0.01220131063773905	3412.874817142235	6.453 [0.012:3412.875]	overlaps null	Uridine (M/F) Shin/2014 [  7K]	Metabolites
met-a-316	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Uridine	Weighted median	3	-0.49459949527109776	0.763319138357613	0.5170114774921045	-1.990705006452019	1.0015060159098237	0.6098150922226275	0.13659908825178507	2.72237868833383	0.61 [0.137:2.722]	overlaps null	Uridine (M/F) Shin/2014 [  7K]	Metabolites
met-a-485	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-02269	Inverse variance weighted	2	0.13690186284286826	0.17854444474232814	0.4432204778020549	-0.21304524885209492	0.48684897453783144	1.1467156075884977	0.8081195699062865	1.627180845081559	1.147 [0.808:1.627]	overlaps null	X-02269 (M/F) Shin/2014 [  7K]	Metabolites
met-a-373	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-03094	Inverse variance weighted	5	-0.261522031764434	0.3457253808117377	0.44938278994890346	-0.9391437781554399	0.4160997146265719	0.7698789134466268	0.3909624426728521	1.5160370324003911	0.77 [0.391:1.516]	overlaps null	X-03094 (M/F) Shin/2014 [  7K]	Metabolites
met-a-373	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-03094	MR Egger	5	-1.3094104349712914	1.3479650151107916	0.4029990016077211	-3.9514218645884425	1.33260099464586	0.2699791797561539	0.019227343651154666	3.790890661978076	0.27 [0.019:3.791]	overlaps null	X-03094 (M/F) Shin/2014 [  7K]	Metabolites
met-a-373	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-03094	Weighted median	5	-0.5141999733084127	0.4253193854213945	0.22667292951198137	-1.347825968734346	0.3194260221175206	0.5979788023061224	0.25980447016019037	1.376337550262275	0.598 [0.26:1.376]	overlaps null	X-03094 (M/F) Shin/2014 [  7K]	Metabolites
met-a-444	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-10510	Inverse variance weighted	3	0.1865530069451244	0.5702600360014038	0.7435644676214838	-0.9311566636176272	1.304262677507876	1.2050884984526433	0.3940976082788133	3.684971079741818	1.205 [0.394:3.685]	overlaps null	X-10510 (M/F) Shin/2014 [  7K]	Metabolites
met-a-444	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-10510	MR Egger	3	1.3807312200183057	1.218459005287126	0.4603061780400818	-1.007448430344461	3.7689108703810725	3.9778092180502247	0.3651494963020515	43.33284404181839	3.978 [0.365:43.333]	overlaps null	X-10510 (M/F) Shin/2014 [  7K]	Metabolites
met-a-444	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-10510	Weighted median	3	0.3444381103260278	0.32561734285820565	0.2901465137133594	-0.2937718816760553	0.9826481023281108	1.4111967599670359	0.7454465220602045	2.671521345136308	1.411 [0.745:2.672]	overlaps null	X-10510 (M/F) Shin/2014 [  7K]	Metabolites
met-a-495	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-11315	Inverse variance weighted	3	-0.6630818030981676	0.32602030566688683	0.04196504965277294	-1.3020816022052657	-0.02408200399106941	0.5152609523288315	0.27196508029250793	0.9762056537157875	0.515 [0.272:0.976]	negative	X-11315 (M/F) Shin/2014 [  7K]	Metabolites
met-a-495	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-11315	MR Egger	3	-1.8714957036554485	1.07027533614746	0.3307164065337876	-3.96923536250447	0.22624395519357288	0.15389331080213325	0.01888786998857233	1.2538815188780383	0.154 [0.019:1.254]	overlaps null	X-11315 (M/F) Shin/2014 [  7K]	Metabolites
met-a-495	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-11315	Weighted median	3	-0.5202397783812066	0.39838219685088017	0.19159299742458422	-1.3010688842089317	0.2605893274465185	0.5943780118848268	0.2722406437341714	1.2976946284226527	0.594 [0.272:1.298]	overlaps null	X-11315 (M/F) Shin/2014 [  7K]	Metabolites
met-a-513	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-11440	Inverse variance weighted	3	-0.0620296630097654	0.13484514899587108	0.6455114592362571	-0.3263261550416727	0.2022668290221419	0.9398550074493344	0.7215698054183313	1.2241746098500863	0.94 [0.722:1.224]	overlaps null	X-11440 (M/F) Shin/2014 [  7K]	Metabolites
met-a-513	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-11440	MR Egger	3	-0.1667010076193548	0.2676412077411021	0.6453686715885932	-0.691277774791915	0.3578757595532054	0.8464526564008709	0.5009355770981654	1.430287909831739	0.846 [0.501:1.43]	overlaps null	X-11440 (M/F) Shin/2014 [  7K]	Metabolites
met-a-513	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-11440	Weighted median	3	-0.07082538229452706	0.0897827047129997	0.43019775698434454	-0.24679948353200648	0.10514871894295236	0.9316245560675196	0.7812973408089039	1.1108758063471855	0.932 [0.781:1.111]	overlaps null	X-11440 (M/F) Shin/2014 [  7K]	Metabolites
met-a-517	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-11445--5-alpha-pregnan-3beta,20alpha-disulfate	Inverse variance weighted	2	-0.11652895878541975	0.151881944998004	0.44294253201655764	-0.4142175709815076	0.1811596534106681	0.8900043231592731	0.6608571522839781	1.198606525638112	0.89 [0.661:1.199]	overlaps null	X-11445--5-alpha-pregnan-3beta,20alpha-disulfate (M/F) Shin/2014 [  2K]	Metabolites
met-a-519	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-11469	Inverse variance weighted	2	0.14738787471095868	0.17999428633842782	0.4128734158315613	-0.20540092651235983	0.5001766759342772	1.158803346385039	0.8143207681693405	1.649012585804418	1.159 [0.814:1.649]	overlaps null	X-11469 (M/F) Shin/2014 [  7K]	Metabolites
met-a-629	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-12510--2-aminooctanoic acid	Inverse variance weighted	3	0.07289357011602172	0.11638170830016598	0.5310973027931234	-0.1552145781523036	0.30100171838434703	1.0756160531308236	0.8562314292121117	1.3512116634369926	1.076 [0.856:1.351]	overlaps null	X-12510--2-aminooctanoic acid (M/F) Shin/2014 [  7K]	Metabolites
met-a-629	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-12510--2-aminooctanoic acid	MR Egger	3	0.031967605750555	0.19339186609572526	0.8957100293561704	-0.3470804517970665	0.4110156632981765	1.0324840582172448	0.7067484667862494	1.5083489820928915	1.032 [0.707:1.508]	overlaps null	X-12510--2-aminooctanoic acid (M/F) Shin/2014 [  7K]	Metabolites
met-a-629	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	X-12510--2-aminooctanoic acid	Weighted median	3	0.06687606631506715	0.1213914538694767	0.5816936751824414	-0.17105118326910718	0.3048033158992415	1.0691629646573217	0.842778436212178	1.3563582026759928	1.069 [0.843:1.356]	overlaps null	X-12510--2-aminooctanoic acid (M/F) Shin/2014 [  7K]	Metabolites
prot-a-54	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Advanced glycosylation end product-specific receptor, soluble	Inverse variance weighted	5	-0.061573690962234764	0.027580756215987608	0.025582766528636638	-0.11563197314557047	-0.0075154087788990576	0.9402836527791807	0.8908030024049075	0.9925127612916183	0.94 [0.891:0.993]	negative	Advanced glycosylation end product-specific receptor, soluble (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-54	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Advanced glycosylation end product-specific receptor, soluble	MR Egger	5	-0.09019058629044477	0.07598750242791048	0.3206851870189935	-0.2391260910491493	0.05874491846825977	0.9137570191142736	0.7873156026633267	1.0605046910744975	0.914 [0.787:1.061]	overlaps null	Advanced glycosylation end product-specific receptor, soluble (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-54	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Advanced glycosylation end product-specific receptor, soluble	Weighted median	5	-0.07566050444205197	0.03448563030189156	0.028237428478175286	-0.1432523398337594	-0.00806866905034452	0.9271309099617243	0.866535379910965	0.9919637952864365	0.927 [0.867:0.992]	negative	Advanced glycosylation end product-specific receptor, soluble (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-67	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Alcohol dehydrogenase [NADP(+)]	Inverse variance weighted	3	-0.015701671518288284	0.015619081370457278	0.31475830121158815	-0.04631507100438455	0.01491172796780798	0.9844209570624517	0.9547411035588623	1.0150234624773402	0.984 [0.955:1.015]	overlaps null	Alcohol dehydrogenase [NADP(+)] (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-67	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Alcohol dehydrogenase [NADP(+)]	MR Egger	3	0.011511070535979431	0.028524573418493335	0.7558166332274069	-0.044397093364267504	0.06741923443622637	1.0115775778535827	0.9565740328443914	1.0697438576430418	1.012 [0.957:1.07]	overlaps null	Alcohol dehydrogenase [NADP(+)] (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-67	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Alcohol dehydrogenase [NADP(+)]	Weighted median	3	-0.01293127302902338	0.016250210519805727	0.42617134826902814	-0.04478168564784261	0.018919139589795846	0.9871519766542349	0.956206212587641	1.0190992405030501	0.987 [0.956:1.019]	overlaps null	Alcohol dehydrogenase [NADP(+)] (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1411	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Alpha-L-iduronidase	Inverse variance weighted	2	0.005307718389473159	0.03127005261837609	0.865216132714667	-0.055981584742543986	0.0665970215214903	1.0053218292812243	0.9455565483973458	1.0688646619203974	1.005 [0.946:1.069]	overlaps null	Alpha-L-iduronidase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-99	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Angiopoietin-related protein 4	Inverse variance weighted	3	0.03225875675268115	0.04451889729482285	0.46869244460168463	-0.05499828194517163	0.11951579545053394	1.0327847107509935	0.9464867740682592	1.126951044626101	1.033 [0.946:1.127]	overlaps null	Angiopoietin-related protein 4 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-99	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Angiopoietin-related protein 4	MR Egger	3	0.12522893137251298	0.2833837284959975	0.7351009287450085	-0.4302031764796421	0.6806610392246681	1.1334078959936273	0.6503769400012956	1.97518297419669	1.133 [0.65:1.975]	overlaps null	Angiopoietin-related protein 4 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-99	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Angiopoietin-related protein 4	Weighted median	3	0.03331903488372316	0.053027874072776406	0.5297874028288586	-0.07061559829891859	0.1372536680663649	1.0338803305220785	0.9318200164908158	1.1471190991001616	1.034 [0.932:1.147]	overlaps null	Angiopoietin-related protein 4 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-216	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Beta-1,4-galactosyltransferase 1	Inverse variance weighted	5	0.057383754643110206	0.025318828869043984	0.023424098975839715	0.007758850059783995	0.10700865922643642	1.0590621524410315	1.0077890279349553	1.1129438916707692	1.059 [1.008:1.113]	positive	Beta-1,4-galactosyltransferase 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-216	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Beta-1,4-galactosyltransferase 1	MR Egger	5	-0.04666535179422115	0.0796616262362024	0.5991679783380806	-0.20280213921717785	0.10947143562873554	0.9544067346559388	0.8164397668567063	1.115688201547981	0.954 [0.816:1.116]	overlaps null	Beta-1,4-galactosyltransferase 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-216	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Beta-1,4-galactosyltransferase 1	Weighted median	5	0.0577406792127535	0.03269675829395876	0.07740506434062824	-0.006344967043405675	0.12182632546891267	1.0594402252117339	0.9936751197541756	1.1295579093037593	1.059 [0.994:1.13]	overlaps null	Beta-1,4-galactosyltransferase 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-212	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Beta-1,4-glucuronyltransferase 1	Inverse variance weighted	3	0.03503114625879395	0.02452298033112974	0.1531471870257683	-0.013033895190220343	0.08309618770780824	1.0356519649814127	0.9870506781827837	1.0866463255407846	1.036 [0.987:1.087]	overlaps null	Beta-1,4-glucuronyltransferase 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-212	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Beta-1,4-glucuronyltransferase 1	MR Egger	3	0.03308305732654584	0.05917771560249615	0.6754756373808979	-0.0829052652543466	0.1490713799074383	1.0336363867510279	0.9204383405820237	1.1607558408965593	1.034 [0.92:1.161]	overlaps null	Beta-1,4-glucuronyltransferase 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-212	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Beta-1,4-glucuronyltransferase 1	Weighted median	3	0.04466659971439437	0.026674405370342196	0.0940301076140538	-0.007615234811476329	0.09694843424026507	1.0456791720510175	0.992413687625524	1.1018035568186364	1.046 [0.992:1.102]	overlaps null	Beta-1,4-glucuronyltransferase 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-674	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Beta-crystallin B2	Inverse variance weighted	3	0.15612198477701666	0.13973973474022305	0.2638942807034256	-0.11776789531382054	0.43001186486785387	1.1689687907902118	0.8889023470730475	1.5372757630138598	1.169 [0.889:1.537]	overlaps null	Beta-crystallin B2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-674	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Beta-crystallin B2	MR Egger	3	1.3983129951128845	0.9727657019680859	0.38694681493467004	-0.5083077807445637	3.304933770970333	4.048364591958911	0.6015126092701006	27.246737004090434	4.048 [0.602:27.247]	overlaps null	Beta-crystallin B2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-674	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Beta-crystallin B2	Weighted median	3	0.1348728919690371	0.07105175842555135	0.05766521125236134	-0.004388554545043555	0.27413433848311775	1.1443913137797257	0.9956210610890662	1.3153914980684904	1.144 [0.996:1.315]	overlaps null	Beta-crystallin B2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-390	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	C-C motif chemokine 14	Inverse variance weighted	3	0.0038474806563321725	0.022295007929377896	0.8629883367115694	-0.039850734885248505	0.047545696197912844	1.003854891711615	0.960932862201973	1.0486941213605103	1.004 [0.961:1.049]	overlaps null	C-C motif chemokine 14 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-390	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	C-C motif chemokine 14	MR Egger	3	0.04349614396049528	0.036571967362326915	0.4450826545225134	-0.028184912069665474	0.11517719999065604	1.044455966840792	0.9722085770789801	1.1220722511489551	1.044 [0.972:1.122]	overlaps null	C-C motif chemokine 14 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-390	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	C-C motif chemokine 14	Weighted median	3	0.004167405799551917	0.022742224227048337	0.8546055484279473	-0.040407353685462825	0.04874216528456666	1.0041761015104234	0.9603981377377784	1.0499496023804158	1.004 [0.96:1.05]	overlaps null	C-C motif chemokine 14 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-394	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	C-C motif chemokine 17	Inverse variance weighted	6	-0.022297027880767185	0.02426601177407579	0.3581696601773196	-0.06985841095795572	0.02526435519642136	0.9779497135759366	0.9325258460002203	1.0255862037340577	0.978 [0.933:1.026]	overlaps null	C-C motif chemokine 17 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-394	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	C-C motif chemokine 17	MR Egger	6	-0.08577619624510262	0.05261789372971135	0.17839893263829434	-0.18890726795533686	0.017354875465131633	0.9177996152365699	0.8278632725893181	1.017506346300094	0.918 [0.828:1.018]	overlaps null	C-C motif chemokine 17 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-394	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	C-C motif chemokine 17	Weighted median	6	-0.031580541026212675	0.03023445019478734	0.2962440586441497	-0.09084006340799586	0.02767898135557051	0.9689129160704846	0.9131637475183747	1.02806560321682	0.969 [0.913:1.028]	overlaps null	C-C motif chemokine 17 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-399	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	C-C motif chemokine 23	Inverse variance weighted	3	-0.02947538936307073	0.022612506897958837	0.19240431823281365	-0.07379590288307006	0.01484512415692859	0.9709547731625481	0.9288612524000943	1.0149558602979136	0.971 [0.929:1.015]	overlaps null	C-C motif chemokine 23 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-399	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	C-C motif chemokine 23	MR Egger	3	-0.01674900399147075	0.06285971793144149	0.8342238444473556	-0.13995405113709608	0.10645604315415456	0.9833904807466876	0.8693981823389297	1.1123290308953049	0.983 [0.869:1.112]	overlaps null	C-C motif chemokine 23 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-399	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	C-C motif chemokine 23	Weighted median	3	-0.029190476001127168	0.02294505765283709	0.20330557170955185	-0.07416278900068787	0.01578183699843353	0.9712314505639377	0.9285205286086321	1.0159070279017213	0.971 [0.929:1.016]	overlaps null	C-C motif chemokine 23 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-408	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	C-C motif chemokine 3-like 1	Inverse variance weighted	3	-8.699367496352177e-4	0.030643129793797203	0.977351664763786	-0.060930471145477734	0.0591905976462073	0.9991304415356362	0.9408886564123248	1.0609774412730597	0.999 [0.941:1.061]	overlaps null	C-C motif chemokine 3-like 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-408	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	C-C motif chemokine 3-like 1	MR Egger	3	-0.06488176970005798	0.07483562907260088	0.5452780780781605	-0.21155960268235569	0.08179606328223975	0.9371782596942763	0.8093210419101642	1.085234468105038	0.937 [0.809:1.085]	overlaps null	C-C motif chemokine 3-like 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-408	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	C-C motif chemokine 3-like 1	Weighted median	3	-0.00875872239933545	0.032865984500682545	0.7898556230750914	-0.07317605202067323	0.05565860722200233	0.9912795234666045	0.9294371863265718	1.0572366891493352	0.991 [0.929:1.057]	overlaps null	C-C motif chemokine 3-like 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-670	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	C-reactive protein	Inverse variance weighted	3	0.04686887437690345	0.04391856637029589	0.28589201440696776	-0.039211515708876495	0.1329492644626834	1.0479845824384078	0.9615473052756744	1.142192047133584	1.048 [0.962:1.142]	overlaps null	C-reactive protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-670	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	C-reactive protein	MR Egger	3	0.742621155211526	0.6087423978728227	0.437135600543484	-0.45051394461920635	1.9357562550422585	2.1014364931010574	0.637300530261022	6.929282379112685	2.101 [0.637:6.929]	overlaps null	C-reactive protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-670	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	C-reactive protein	Weighted median	3	0.04799765871030683	0.04906278023755741	0.32793059759503074	-0.048165390555305686	0.14416070797591934	1.0491681989149044	0.9529761607864886	1.1550697225268418	1.049 [0.953:1.155]	overlaps null	C-reactive protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-486	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cadherin-7	Inverse variance weighted	4	-0.02114555776529936	0.024652139435108595	0.3910263759237461	-0.0694637510581122	0.027172635527513485	0.9790764420181218	0.9328939491902104	1.0275451782562852	0.979 [0.933:1.028]	overlaps null	Cadherin-7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-486	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cadherin-7	MR Egger	4	-0.042635195108908425	0.06607245368472985	0.5848885568679736	-0.17213720433097893	0.08686681411316208	0.9582609045757844	0.8418636579041257	1.0907513973515361	0.958 [0.842:1.091]	overlaps null	Cadherin-7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-486	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cadherin-7	Weighted median	4	-0.025905004881117355	0.028835220100143603	0.36898262848219493	-0.08242203627739882	0.030612026515164106	0.9744276510827927	0.9208832305428898	1.0310853924823489	0.974 [0.921:1.031]	overlaps null	Cadherin-7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-488	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cadherin-related family member 3	Inverse variance weighted	2	-0.11215813101325314	0.06280329772477801	0.07412132619074137	-0.23525259455381803	0.010936332527311757	0.8939028925534113	0.7903711809563833	1.0109963528129349	0.894 [0.79:1.011]	overlaps null	Cadherin-related family member 3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-346	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Calcium/calmodulin-dependent protein kinase type 1	Inverse variance weighted	3	-0.020211062036503788	0.011736161261018356	0.0850480296400668	-0.043213938108099766	0.0027918140350921897	0.9799918124095979	0.9577064782365188	1.0027957147770996	0.98 [0.958:1.003]	overlaps null	Calcium/calmodulin-dependent protein kinase type 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-346	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Calcium/calmodulin-dependent protein kinase type 1	MR Egger	3	-0.04814880564108636	0.07253857561484318	0.6269450509080141	-0.190324413846179	0.09402680256400628	0.9529919659454316	0.8266909004617671	1.0985891905296723	0.953 [0.827:1.099]	overlaps null	Calcium/calmodulin-dependent protein kinase type 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-346	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Calcium/calmodulin-dependent protein kinase type 1	Weighted median	3	-0.02046823427318745	0.01124814415630488	0.06880488820926446	-0.04251459681954502	0.0015781282731701166	0.9797398181276242	0.9583764761703684	1.0015793741729038	0.98 [0.958:1.002]	overlaps null	Calcium/calmodulin-dependent protein kinase type 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-366	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Calpastatin	Inverse variance weighted	4	0.0038108918166746644	0.031192111588119097	0.9027605373562958	-0.057325646896038765	0.06494743052938809	1.0038181624978866	0.9442865153195458	1.0671029258737694	1.004 [0.944:1.067]	overlaps null	Calpastatin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-366	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Calpastatin	MR Egger	4	0.013699214693611433	0.0544365003259274	0.8248052425400467	-0.09299632594520628	0.12039475533242915	1.01379347889187	0.9111968480771383	1.127942024835311	1.014 [0.911:1.128]	overlaps null	Calpastatin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-366	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Calpastatin	Weighted median	4	0.003203006157304421	0.03436540235294458	0.9257411916223085	-0.06415318245446697	0.0705591947690758	1.003208141262654	0.9378613246271172	1.0731080899362306	1.003 [0.938:1.073]	overlaps null	Calpastatin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-550	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Carbohydrate sulfotransferase 11	Inverse variance weighted	2	-0.0015478613331091364	0.04990696024273941	0.9752576257172579	-0.09936550340887838	0.09626978074266011	0.998453335986403	0.9054117164691547	1.1010560676528856	0.998 [0.905:1.101]	overlaps null	Carbohydrate sulfotransferase 11 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-643	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Carboxypeptidase A4	Inverse variance weighted	2	-0.014022583950168558	0.010557335154884577	0.18410167741812833	-0.03471496085374233	0.0066697929534052115	0.9860752745365311	0.9658806908311892	1.0066920855572166	0.986 [0.966:1.007]	overlaps null	Carboxypeptidase A4 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-710	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cardiotrophin-1	Inverse variance weighted	3	-0.03679952292229856	0.03684422642867209	0.31789803557238044	-0.10901420672249586	0.03541516087789874	0.963869349691395	0.896717677988534	1.036049746848408	0.964 [0.897:1.036]	overlaps null	Cardiotrophin-1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-710	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cardiotrophin-1	MR Egger	3	-0.4750592868023382	0.4098700616757289	0.4531873106591542	-1.2784046076867668	0.32828603408209045	0.6218481879815184	0.27848123305429806	1.3885860984409688	0.622 [0.278:1.389]	overlaps null	Cardiotrophin-1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-710	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cardiotrophin-1	Weighted median	3	-0.028064896304709985	0.020279160118069208	0.16638052028928238	-0.06781205013612562	0.01168225752670566	0.9723252644370758	0.9344360842085258	1.0117507615980006	0.972 [0.934:1.012]	overlaps null	Cardiotrophin-1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-722	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cathepsin F	Inverse variance weighted	2	0.03699456588212285	0.07465808872192757	0.6202332047016044	-0.10933528801285519	0.1833244197771009	1.037687381907283	0.8964298049371959	1.2012040392220467	1.038 [0.896:1.201]	overlaps null	Cathepsin F (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-532	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cell growth regulator with EF hand domain protein 1	Inverse variance weighted	4	-0.04260464014691104	0.037386764354004655	0.2544676627433931	-0.11588269828076016	0.03067341798693808	0.9582901846486308	0.8905796836986785	1.0311486942751933	0.958 [0.891:1.031]	overlaps null	Cell growth regulator with EF hand domain protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-532	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cell growth regulator with EF hand domain protein 1	MR Egger	4	-0.02131554885425825	0.10614491530758419	0.8594122601504911	-0.22935958285712327	0.18672848514860674	0.9789100218929391	0.7950425984104247	1.2052999837723783	0.979 [0.795:1.205]	overlaps null	Cell growth regulator with EF hand domain protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-532	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cell growth regulator with EF hand domain protein 1	Weighted median	4	-0.048067414088777224	0.042856674189764056	0.26203882148237817	-0.13206649550071475	0.03593166732316032	0.9530695345975516	0.876282724283503	1.0365850114421733	0.953 [0.876:1.037]	overlaps null	Cell growth regulator with EF hand domain protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-412	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cerebral cavernous malformations 2 protein	Inverse variance weighted	4	-0.0792493389385595	0.10538088812045716	0.45203444651704483	-0.2857958796546555	0.12729720177753656	0.9238095540324897	0.7514159795832842	1.1357545158874507	0.924 [0.751:1.136]	overlaps null	Cerebral cavernous malformations 2 protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-412	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cerebral cavernous malformations 2 protein	MR Egger	4	0.12077272798103679	0.36739710345154997	0.7735920720637335	-0.5993255947840012	0.8408710507460747	1.128368436650839	0.5491818823579819	2.318385528967466	1.128 [0.549:2.318]	overlaps null	Cerebral cavernous malformations 2 protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-412	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cerebral cavernous malformations 2 protein	Weighted median	4	0.013387906365340409	0.04980480229412887	0.7880777910615894	-0.08422950613115218	0.11100531886183299	1.0134779256584674	0.9192202651974564	1.1174008501393864	1.013 [0.919:1.117]	overlaps null	Cerebral cavernous malformations 2 protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-381	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Coiled-coil domain-containing protein 134	Inverse variance weighted	3	0.06882647455747228	0.05181668430713704	0.18408939006749697	-0.032734226684516324	0.1703871757994609	1.0712503038361307	0.9677957396941631	1.1857638615268682	1.071 [0.968:1.186]	overlaps null	Coiled-coil domain-containing protein 134 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-381	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Coiled-coil domain-containing protein 134	MR Egger	3	0.14182630741156052	0.31493750030855083	0.730627299744312	-0.47545119319319906	0.7591038080163202	1.152376471900648	0.6216045294512894	2.136360772921698	1.152 [0.622:2.136]	overlaps null	Coiled-coil domain-containing protein 134 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-381	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Coiled-coil domain-containing protein 134	Weighted median	3	0.07906376962403389	0.05945011566897178	0.18354534166890563	-0.0374584570871508	0.19558599633521856	1.0822733360335348	0.9632344324537325	1.216023362978585	1.082 [0.963:1.216]	overlaps null	Coiled-coil domain-containing protein 134 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-303	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Complement C1q tumor necrosis factor-related protein 1	Inverse variance weighted	6	0.024048923617233327	0.01761476280783637	0.17216791186807617	-0.01047601148612596	0.05857385872059261	1.0243404311039197	0.9895786708048496	1.0603232969247034	1.024 [0.99:1.06]	overlaps null	Complement C1q tumor necrosis factor-related protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-303	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Complement C1q tumor necrosis factor-related protein 1	MR Egger	6	-0.02093357859383028	0.034746050390884624	0.5793467909806111	-0.08903583735996415	0.04716868017230358	0.9792840078301428	0.9148127885117887	1.048298821392689	0.979 [0.915:1.048]	overlaps null	Complement C1q tumor necrosis factor-related protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-303	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Complement C1q tumor necrosis factor-related protein 1	Weighted median	6	0.01584609305259966	0.0197453586541004	0.42225082352124316	-0.022854809909437127	0.054546996014636445	1.015972308176038	0.9774043829027242	1.0560621059577089	1.016 [0.977:1.056]	overlaps null	Complement C1q tumor necrosis factor-related protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-305	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Complement C1q tumor necrosis factor-related protein 5	Inverse variance weighted	4	-0.034154592368930384	0.02938036411970632	0.24503354280127781	-0.09174010604355477	0.023430921305694005	0.9664220916082188	0.9123422309677798	1.0237075819209651	0.966 [0.912:1.024]	overlaps null	Complement C1q tumor necrosis factor-related protein 5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-305	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Complement C1q tumor necrosis factor-related protein 5	MR Egger	4	-0.10180887229525774	0.15016219975758324	0.5676990166743705	-0.3961267838201209	0.19250903922960538	0.9032021621291968	0.6729213749862809	1.2122874618026325	0.903 [0.673:1.212]	overlaps null	Complement C1q tumor necrosis factor-related protein 5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-305	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Complement C1q tumor necrosis factor-related protein 5	Weighted median	4	-0.026614354590963608	0.03350930007543238	0.4270569750827005	-0.09229258273881107	0.03906387355688386	0.9737366862080709	0.9118383223587708	1.0398368996103806	0.974 [0.912:1.04]	overlaps null	Complement C1q tumor necrosis factor-related protein 5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-322	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Complement component C8	Inverse variance weighted	3	0.01452211178900955	0.04422144880048951	0.7426128672444867	-0.0721519278599499	0.10119615143796898	1.0146280699451646	0.9303895329823358	1.1064936608010993	1.015 [0.93:1.106]	overlaps null	Complement component C8 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-322	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Complement component C8	MR Egger	3	0.002567439835781469	0.08212563201569444	0.9801042529957924	-0.15839879891497963	0.16353367858654258	1.0025707385319005	0.8535093354912321	1.1776650166127283	1.003 [0.854:1.178]	overlaps null	Complement component C8 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-322	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Complement component C8	Weighted median	3	0.018469609325593606	0.05005654241342612	0.712146409957554	-0.0796412138047216	0.11658043245590881	1.0186412275052832	0.923447607210707	1.1236478845915834	1.019 [0.923:1.124]	overlaps null	Complement component C8 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-518	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Complement factor B	Inverse variance weighted	4	0.06003899275036762	0.028265683672626878	0.033662214164733306	0.004638252752018943	0.1154397327487163	1.0618779512799872	1.0046490260963727	1.122366870543721	1.062 [1.005:1.122]	positive	Complement factor B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-518	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Complement factor B	MR Egger	4	0.06336725421021472	0.058736005249391966	0.3934757991322093	-0.05175531607859353	0.17848982449902295	1.0654180466538943	0.9495611807733157	1.1954107193086492	1.065 [0.95:1.195]	overlaps null	Complement factor B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-518	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Complement factor B	Weighted median	4	0.0689537584078108	0.028022211956094445	0.013867313688576448	0.014030222973865691	0.12387729384175591	1.0713866653776063	1.0141291084728719	1.131876974202494	1.071 [1.014:1.132]	positive	Complement factor B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-521	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Complement factor H-related protein 5	Inverse variance weighted	3	-0.002531361625702104	0.024133213059741074	0.9164621435405196	-0.049832459222794605	0.0447697359713904	0.9974718395684415	0.9513888075690042	1.0457870250485233	0.997 [0.951:1.046]	overlaps null	Complement factor H-related protein 5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-521	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Complement factor H-related protein 5	MR Egger	3	-0.0018716028567248271	0.033891240313297245	0.9648791144999652	-0.06829843387078743	0.06455522815733777	0.9981301474997408	0.9339817002075371	1.0666844876366184	0.998 [0.934:1.067]	overlaps null	Complement factor H-related protein 5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-521	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Complement factor H-related protein 5	Weighted median	3	-0.006882018260643084	0.026036644951941704	0.7915329873527805	-0.05791384236644882	0.04414980584516265	0.9931416085958047	0.9437312535856928	1.0451389110795213	0.993 [0.944:1.045]	overlaps null	Complement factor H-related protein 5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-608	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Contactin-4	Inverse variance weighted	3	0.06839093543706946	0.035773101816377925	0.055902140948677355	-0.0017243441230312684	0.1385062149971702	1.0707838340113691	0.9982771417041476	1.1485568198253815	1.071 [0.998:1.149]	overlaps null	Contactin-4 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-608	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Contactin-4	MR Egger	3	0.21096042168895168	0.14938015941486535	0.3922460503935894	-0.08182469076418442	0.5037455341420878	1.2348634802832854	0.92143348033711	1.6549081919396522	1.235 [0.921:1.655]	overlaps null	Contactin-4 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-608	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Contactin-4	Weighted median	3	0.07163602681973624	0.041205821239712816	0.08212400366674712	-0.009127382810100879	0.15239943644957338	1.0742642695151883	0.9909141453046698	1.1646253373466324	1.074 [0.991:1.165]	overlaps null	Contactin-4 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-609	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Contactin-5	Inverse variance weighted	3	-0.019722038348431285	0.026633471438495725	0.45899773729712207	-0.0719236423678829	0.03247956567102034	0.98047116881875	0.9306019516598153	1.0330127840052292	0.98 [0.931:1.033]	overlaps null	Contactin-5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-609	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Contactin-5	MR Egger	3	-0.05931096518000022	0.13711647060315446	0.7400963249845948	-0.32805924756218297	0.2094373172021825	0.9424136657517799	0.7203203412168078	1.232984085796332	0.942 [0.72:1.233]	overlaps null	Contactin-5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-609	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Contactin-5	Weighted median	3	-0.029069420329742867	0.02899391604948485	0.3160518964506144	-0.08589749578673317	0.02775865512724743	0.9713490307559862	0.9176882933157186	1.02814751634408	0.971 [0.918:1.028]	overlaps null	Contactin-5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-500	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Corneodesmosin	Inverse variance weighted	4	-0.010122515881646343	0.044102287383342646	0.8184619780255372	-0.09656299915299792	0.07631796738970524	0.989928544351003	0.9079526955471466	1.0793057036196771	0.99 [0.908:1.079]	overlaps null	Corneodesmosin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-500	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Corneodesmosin	MR Egger	4	-0.22946314873306844	0.10334345221459214	0.15655119913942545	-0.432016315073669	-0.026909982392467863	0.7949602633909293	0.6491987848727435	0.9734488651183373	0.795 [0.649:0.973]	negative	Corneodesmosin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-500	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Corneodesmosin	Weighted median	4	-0.027299242140111403	0.0327935881727881	0.40515121002358523	-0.09157467495877608	0.03697619067855328	0.9730700143992088	0.912493173217664	1.0376683143655843	0.973 [0.912:1.038]	overlaps null	Corneodesmosin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-655	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	CREB-binding protein	Inverse variance weighted	4	0.049593396900630776	0.037819364396089725	0.18974870991926507	-0.024532557315705084	0.12371935111696664	1.0508437331794482	0.9757659200821418	1.1316982165861662	1.051 [0.976:1.132]	overlaps null	CREB-binding protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-655	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	CREB-binding protein	MR Egger	4	0.06817349979454453	0.08048570611791704	0.4861743465413043	-0.08957848419657287	0.2259254837856619	1.0705510327509786	0.9143165029120972	1.2534822570454813	1.071 [0.914:1.253]	overlaps null	CREB-binding protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-655	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	CREB-binding protein	Weighted median	4	0.044610505447851924	0.043663703797003704	0.3069305090322797	-0.04097035399427534	0.13019136488997918	1.0456205170899415	0.9598575854694742	1.1390463359464766	1.046 [0.96:1.139]	overlaps null	CREB-binding protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-735	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	CUB and zona pellucida-like domain-containing protein 1	Inverse variance weighted	2	0.0075681080900175295	0.016598758412992874	0.6484300842052814	-0.0249654583994485	0.04010167457948356	1.007596818602434	0.9753436013755665	1.0409166035701638	1.008 [0.975:1.041]	overlaps null	CUB and zona pellucida-like domain-containing protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-706	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Cystatin-8	Inverse variance weighted	2	-0.022936244311974337	0.02188760296865283	0.29467994221393734	-0.06583594613053388	0.019963457506585208	0.9773247918015362	0.936284452780281	1.0201640600071626	0.977 [0.936:1.02]	overlaps null	Cystatin-8 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-831	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Delta-like protein 1	Inverse variance weighted	3	0.014486776943789378	0.053355269697123814	0.7859946634168554	-0.0900895516625733	0.11906310555015205	1.0145922188527572	0.9138493448786359	1.1264410007245458	1.015 [0.914:1.126]	overlaps null	Delta-like protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-831	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Delta-like protein 1	MR Egger	3	-0.046851651306408885	0.12054699043558739	0.7640105063953588	-0.28312375256016015	0.1894204499473424	0.954228945708355	0.7534265436265636	1.2085489800303544	0.954 [0.753:1.209]	overlaps null	Delta-like protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-831	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Delta-like protein 1	Weighted median	3	0.03215869072061036	0.06471634328953972	0.6192471517359088	-0.09468534212688748	0.1590027235681082	1.0326813692535783	0.9096591208446942	1.1723411396273093	1.033 [0.91:1.172]	overlaps null	Delta-like protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-867	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Desmocollin-3	Inverse variance weighted	3	0.05700970458508962	0.04991602751052014	0.2534073800398325	-0.04082570933552986	0.1548451185057091	1.0586660842607445	0.9599964337839602	1.1674771264996169	1.059 [0.96:1.167]	overlaps null	Desmocollin-3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-867	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Desmocollin-3	MR Egger	3	-1.8109694005494263	2.35898595043076	0.5831879908259057	-6.434581863393716	2.812643062294863	0.16349556726368855	0.0016050797046843503	16.65387733510224	0.163 [0.002:16.654]	overlaps null	Desmocollin-3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-867	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Desmocollin-3	Weighted median	3	0.0352578918969757	0.05875914754452908	0.5484789766883311	-0.07991003729030129	0.15042582108425268	1.0358868211724488	0.9231993961701597	1.1623290815941776	1.036 [0.923:1.162]	overlaps null	Desmocollin-3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2629	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Diamine acetyltransferase 2	Inverse variance weighted	3	-0.11118249516993185	0.048243578182493536	0.021188585232427844	-0.2057399084076192	-0.016625081932244518	0.894775441831798	0.814044774952992	0.9835123520712019	0.895 [0.814:0.984]	negative	Diamine acetyltransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2629	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Diamine acetyltransferase 2	MR Egger	3	-0.3022555242187876	0.14332568766868362	0.28188563527120275	-0.5831738720494075	-0.021337176388167733	0.7391491702426873	0.5581241378660756	0.9788888507121872	0.739 [0.558:0.979]	negative	Diamine acetyltransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2629	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Diamine acetyltransferase 2	Weighted median	3	-0.06802755492211433	0.05692736955272746	0.23209150285489943	-0.17960519924546015	0.04355008940123148	0.9342347304573061	0.8356000418253459	1.0445123119980213	0.934 [0.836:1.045]	overlaps null	Diamine acetyltransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2464	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Dihydropteridine reductase	Inverse variance weighted	4	-0.0442548233817913	0.02843729865762899	0.11965469653695597	-0.09999192875074411	0.011482281987161516	0.9567101342966274	0.9048447212337695	1.0115484564222834	0.957 [0.905:1.012]	overlaps null	Dihydropteridine reductase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2464	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Dihydropteridine reductase	MR Egger	4	-0.10464139809994237	0.048771113001181754	0.1650585700043117	-0.2002327795822586	-0.009050016617626139	0.900647438566415	0.818540191455586	0.99099081152481	0.901 [0.819:0.991]	negative	Dihydropteridine reductase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2464	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Dihydropteridine reductase	Weighted median	4	-0.05893595993965484	0.022517239980318505	0.008861010076389895	-0.10306975030107912	-0.014802169578230572	0.9427671420886068	0.9020640520479245	0.9853068439919375	0.943 [0.902:0.985]	negative	Dihydropteridine reductase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-766	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Discoidin, CUB and LCCL domain-containing protein 2	Inverse variance weighted	3	-0.0783119506973722	0.03265897688079516	0.01649075835924131	-0.1423235453837307	-0.014300356011013704	0.9246759282465966	0.8673405870406514	0.9858014084133142	0.925 [0.867:0.986]	negative	Discoidin, CUB and LCCL domain-containing protein 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-766	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Discoidin, CUB and LCCL domain-containing protein 2	MR Egger	3	-0.010786172811267496	0.16338275722798512	0.9580326517719612	-0.3310163769781183	0.30944403135558335	0.9892717893668179	0.7181934071065452	1.3626673031987888	0.989 [0.718:1.363]	overlaps null	Discoidin, CUB and LCCL domain-containing protein 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-766	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Discoidin, CUB and LCCL domain-containing protein 2	Weighted median	3	-0.07434479098744741	0.034384834085191336	0.03060746324697632	-0.14173906579442241	-0.006950516180472391	0.9283515514052381	0.8678476780885033	0.9930735827913596	0.928 [0.868:0.993]	negative	Discoidin, CUB and LCCL domain-containing protein 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-836	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	DnaJ homolog subfamily B member 11	Inverse variance weighted	3	-0.019120318735281135	0.05081583022691883	0.7067184282975588	-0.11871934598004204	0.08047870850947976	0.9810613150846418	0.8880570025582911	1.0838057705563	0.981 [0.888:1.084]	overlaps null	DnaJ homolog subfamily B member 11 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-836	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	DnaJ homolog subfamily B member 11	MR Egger	3	-0.0871355188179826	0.13297071603314703	0.6307025806007002	-0.3477581222429508	0.1734870846069856	0.916552877053848	0.7062696864835878	1.1894453245165686	0.917 [0.706:1.189]	overlaps null	DnaJ homolog subfamily B member 11 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-836	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	DnaJ homolog subfamily B member 11	Weighted median	3	-0.03723108131395758	0.047210671792244495	0.430336598314069	-0.12976399802675678	0.05530183539884162	0.9634534735289513	0.8783026876304887	1.056859564166019	0.963 [0.878:1.057]	overlaps null	DnaJ homolog subfamily B member 11 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-842	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	DnaJ homolog subfamily B member 9	Inverse variance weighted	4	0.019195543792406226	0.02549330317971718	0.45147144703507414	-0.03077133043983945	0.0691624180246519	1.0193809627488148	0.9696972879776661	1.071610243833779	1.019 [0.97:1.072]	overlaps null	DnaJ homolog subfamily B member 9 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-842	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	DnaJ homolog subfamily B member 9	MR Egger	4	-0.023178785636698722	0.08336732542943584	0.8070943218274095	-0.18657874347839298	0.14022117220499553	0.9770877788957206	0.8297932185743199	1.150528235585798	0.977 [0.83:1.151]	overlaps null	DnaJ homolog subfamily B member 9 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-842	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	DnaJ homolog subfamily B member 9	Weighted median	4	0.023817008389120674	0.028330870908814844	0.40053094966566183	-0.03171149859215642	0.07934551537039777	1.0241028985039533	0.968786037901394	1.0825783049021886	1.024 [0.969:1.083]	overlaps null	DnaJ homolog subfamily B member 9 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-586	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Dual specificity protein kinase CLK2	Inverse variance weighted	3	0.02034795429651793	0.0245508023197509	0.4072118405479302	-0.02777161825019383	0.06846752684322968	1.0205563852325017	0.9726104679189037	1.0708658499917294	1.021 [0.973:1.071]	overlaps null	Dual specificity protein kinase CLK2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-586	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Dual specificity protein kinase CLK2	MR Egger	3	0.019478879049347305	0.06976807312059849	0.8266727358262068	-0.11726654426702574	0.15622430236572035	1.0196698302370557	0.8893481109280016	1.1690884029772663	1.02 [0.889:1.169]	overlaps null	Dual specificity protein kinase CLK2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-586	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Dual specificity protein kinase CLK2	Weighted median	3	0.021647904013951405	0.025323932248556436	0.3926398668060702	-0.027987003193219208	0.07128281122112201	1.0218839198943173	0.9724010048270929	1.0738848896235536	1.022 [0.972:1.074]	overlaps null	Dual specificity protein kinase CLK2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2573	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	E3 ubiquitin-protein ligase RNF8	Inverse variance weighted	3	0.006238756998037684	0.02931732092715072	0.8314821361650997	-0.05122319201917773	0.0637007060152531	1.006258258576588	0.9500665995843212	1.0657733714632287	1.006 [0.95:1.066]	overlaps null	E3 ubiquitin-protein ligase RNF8 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2573	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	E3 ubiquitin-protein ligase RNF8	MR Egger	3	0.13233919450275555	0.11959042062129016	0.46781162793094005	-0.10205802991497315	0.36673641892048425	1.1414954425875186	0.9029771504612087	1.4430175168691064	1.141 [0.903:1.443]	overlaps null	E3 ubiquitin-protein ligase RNF8 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2573	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	E3 ubiquitin-protein ligase RNF8	Weighted median	3	0.018698965049288162	0.03177197056633403	0.5561722272574179	-0.04357409726072654	0.08097202735930287	1.0188748854955774	0.9573616135896592	1.0843405642735273	1.019 [0.957:1.084]	overlaps null	E3 ubiquitin-protein ligase RNF8 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-892	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Endothelin-2	Inverse variance weighted	3	-0.012144194729178232	0.027915298308606847	0.6635353864050193	-0.06685817941404765	0.04256978995569119	0.9879292484004448	0.9353278406734818	1.04348887887513	0.988 [0.935:1.043]	overlaps null	Endothelin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-892	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Endothelin-2	MR Egger	3	-0.07500874952603588	0.09111547762218308	0.561531731140013	-0.2535950856655147	0.10357758661344295	0.9277353690482759	0.7760059543743655	1.1091318438104663	0.928 [0.776:1.109]	overlaps null	Endothelin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-892	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Endothelin-2	Weighted median	3	-0.0148000359448475	0.02877799540557517	0.6070540936581562	-0.07120490693977484	0.041604835050079836	0.9853089462777551	0.931271048675001	1.0424824448223409	0.985 [0.931:1.042]	overlaps null	Endothelin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-387	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Eotaxin	Inverse variance weighted	3	-0.04169921197438649	0.03043149837155754	0.17060424714400338	-0.10134494878263926	0.017946524833866287	0.9591582405010748	0.9036212760597429	1.0181085314112202	0.959 [0.904:1.018]	overlaps null	Eotaxin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-387	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Eotaxin	MR Egger	3	-0.0750912624069639	0.08009968612426721	0.5205382809691748	-0.23208664721052763	0.08190412239659983	0.9276588220883354	0.7928774197135308	1.0853517439167808	0.928 [0.793:1.085]	overlaps null	Eotaxin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-387	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Eotaxin	Weighted median	3	-0.03960679452568526	0.03388565422354434	0.24246945152001795	-0.10602267680383216	0.026809087752461644	0.9611673011032871	0.899404252230875	1.0271716843885108	0.961 [0.899:1.027]	overlaps null	Eotaxin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2071	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Epididymal secretory protein E1	Inverse variance weighted	3	-0.02070288678020266	0.015397451679595777	0.17876549720344834	-0.05088189207221038	0.009476118511805062	0.9795099466940869	0.950390912605235	1.0095211590803335	0.98 [0.95:1.01]	overlaps null	Epididymal secretory protein E1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2071	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Epididymal secretory protein E1	MR Egger	3	-0.028693658841752952	0.028505600685758435	0.4979069465220659	-0.08456463618583948	0.02717731850233358	0.9717140948973676	0.9189122584737489	1.0275499902357486	0.972 [0.919:1.028]	overlaps null	Epididymal secretory protein E1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2071	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Epididymal secretory protein E1	Weighted median	3	-0.020374115648370765	0.014014233659936728	0.14599735549085507	-0.04784201362184675	0.00709378232510522	0.979832034231543	0.9532843811280117	1.0071190027998587	0.98 [0.953:1.007]	overlaps null	Epididymal secretory protein E1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1707	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Epididymal-specific lipocalin-10	Inverse variance weighted	3	-0.011495919765194179	0.03440386751325587	0.7382692791788464	-0.07892750009117569	0.05593566056078733	0.9885699058370218	0.9241069196839041	1.0575296406836765	0.989 [0.924:1.058]	overlaps null	Epididymal-specific lipocalin-10 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1707	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Epididymal-specific lipocalin-10	MR Egger	3	-0.02603283275060148	0.0715182602724804	0.7777595830864353	-0.16620862288466307	0.11414295738346011	0.9743031000329057	0.8468695393925101	1.1209123561282806	0.974 [0.847:1.121]	overlaps null	Epididymal-specific lipocalin-10 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1707	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Epididymal-specific lipocalin-10	Weighted median	3	-0.008157019430534915	0.038901951022544505	0.8339162656771792	-0.08440484343472214	0.06809080457365231	0.9918761587794042	0.9190591057238164	1.0704625069572293	0.992 [0.919:1.07]	overlaps null	Epididymal-specific lipocalin-10 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1835	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Epididymis-specific alpha-mannosidase	Inverse variance weighted	3	-0.061032935460991866	0.03188839003731694	0.05562593827551905	-0.12353417993413306	0.0014683090121493242	0.9407922538391668	0.8837914327948597	1.0014693875056162	0.941 [0.884:1.001]	overlaps null	Epididymis-specific alpha-mannosidase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1835	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Epididymis-specific alpha-mannosidase	MR Egger	3	-0.004863661755617213	0.15853014049327865	0.9804748023462038	-0.31558273712244334	0.30585541361120894	0.9951481466953588	0.7293637230881931	1.3577859749839245	0.995 [0.729:1.358]	overlaps null	Epididymis-specific alpha-mannosidase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1835	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Epididymis-specific alpha-mannosidase	Weighted median	3	-0.06856316291037821	0.03327763706481308	0.039366289173249164	-0.13378733155741185	-0.00333899426334458	0.9337344808535607	0.8747760820895998	0.9966665739788338	0.934 [0.875:0.997]	negative	Epididymis-specific alpha-mannosidase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2892	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Estrogen sulfotransferase	Inverse variance weighted	3	0.03556319102719655	0.026536670188749004	0.18019569559189297	-0.016448682542751496	0.08757506459714459	1.0362031247991144	0.9836858583524173	1.0915241961918871	1.036 [0.984:1.092]	overlaps null	Estrogen sulfotransferase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2892	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Estrogen sulfotransferase	MR Egger	3	0.01534720600847134	0.06250919512320831	0.8467293398045218	-0.10717081643301694	0.13786522844995963	1.0154655791650748	0.8983722031478298	1.1478208462549442	1.015 [0.898:1.148]	overlaps null	Estrogen sulfotransferase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2892	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Estrogen sulfotransferase	Weighted median	3	0.03276351438141281	0.029007384273582012	0.25869171010687014	-0.02409095879480793	0.08961798755763356	1.0333061483013022	0.9761969120248901	1.093756375342897	1.033 [0.976:1.094]	overlaps null	Estrogen sulfotransferase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2891	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Extracellular sulfatase Sulf-2	Inverse variance weighted	3	-0.061665732117619866	0.035020141821960935	0.07826130298678396	-0.1303052100886633	0.006973745853423564	0.9401971119681083	0.8778274682307735	1.006998119043574	0.94 [0.878:1.007]	overlaps null	Extracellular sulfatase Sulf-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2891	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Extracellular sulfatase Sulf-2	MR Egger	3	-0.1311502201585349	0.23440018905529103	0.6752485555094563	-0.5905745907069053	0.32827415038983554	0.8770860084950995	0.5540088649174091	1.3885695970091547	0.877 [0.554:1.389]	overlaps null	Extracellular sulfatase Sulf-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2891	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Extracellular sulfatase Sulf-2	Weighted median	3	-0.05047622484594591	0.03833003425359551	0.1878773703256439	-0.12560309198299313	0.024650642291101296	0.9507765332621614	0.8819648362362319	1.0249569813460073	0.951 [0.882:1.025]	overlaps null	Extracellular sulfatase Sulf-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-b-71	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	fatty acid binding protein 4	Inverse variance weighted	3	0.027139616159809397	0.02013306789026828	0.17765453826344246	-0.01232119690511643	0.06660042922473522	1.0275112499243608	0.9877543982486902	1.0688683043001803	1.028 [0.988:1.069]	overlaps null	fatty acid binding protein 4 (M/F) Folkersen L/2018 [  3K]	Proteins
prot-b-71	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	fatty acid binding protein 4	MR Egger	3	-0.0064436788496439225	0.05606153256186442	0.9271470054934646	-0.11632428267089819	0.10343692497161035	0.9935770371293269	0.890186504429486	1.1089758424762663	0.994 [0.89:1.109]	overlaps null	fatty acid binding protein 4 (M/F) Folkersen L/2018 [  3K]	Proteins
prot-b-71	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	fatty acid binding protein 4	Weighted median	3	0.023420954065602767	0.022188672867131602	0.2911800259684844	-0.02006884475397517	0.0669107528851807	1.0236973784325631	0.9801311940930663	1.0692000508966517	1.024 [0.98:1.069]	overlaps null	fatty acid binding protein 4 (M/F) Folkersen L/2018 [  3K]	Proteins
prot-a-1148	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ferritin	Inverse variance weighted	3	0.047929557582158326	0.023527519156113823	0.041633003172322144	0.0018156200361752334	0.09404349512814142	1.0490967518097827	1.0018172692722107	1.0986075289532504	1.049 [1.002:1.099]	positive	Ferritin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1148	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ferritin	MR Egger	3	0.050991227295174225	0.04706691729790416	0.47453591584627836	-0.04125993060871793	0.14324238519906637	1.0523136616055733	0.959579673399887	1.1540094825875447	1.052 [0.96:1.154]	overlaps null	Ferritin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1148	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ferritin	Weighted median	3	0.04835909713049849	0.02510014094484287	0.05402370725081354	-8.371791213935345e-4	0.09755537338239051	1.0495474771499695	0.9991631712152754	1.102472487503776	1.05 [0.999:1.102]	overlaps null	Ferritin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1097	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Fibroblast growth factor 7	Inverse variance weighted	3	0.11810859708984697	0.04617872663092138	0.010538487405141893	0.02759829289324106	0.20861890128645288	1.125366316238631	1.027982653530709	1.2319754048132616	1.125 [1.028:1.232]	positive	Fibroblast growth factor 7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1097	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Fibroblast growth factor 7	MR Egger	3	0.02912808564192404	0.16128832263434734	0.8862548063188117	-0.2869970267213967	0.3452531980052448	1.029556457429822	0.7505139603208503	1.412347477963358	1.03 [0.751:1.412]	overlaps null	Fibroblast growth factor 7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1097	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Fibroblast growth factor 7	Weighted median	3	0.11627750185504707	0.05415973220780895	0.03179834325185154	0.010124426727741526	0.2224305769823526	1.1233075488144104	1.0101758521404411	1.2491090997174348	1.123 [1.01:1.249]	positive	Fibroblast growth factor 7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1117	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Filamin-A	Inverse variance weighted	2	0.04149108301380236	0.05317271256423323	0.4352097155204407	-0.06272743361209476	0.14570959963969948	1.0423638670658173	0.9391994330015718	1.156860186650673	1.042 [0.939:1.157]	overlaps null	Filamin-A (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1166	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Galanin peptides	Inverse variance weighted	3	-0.024373550441888447	0.039839401460482586	0.540673334708965	-0.10245877730443431	0.05371167642065741	0.9759210859065602	0.9026153572241079	1.0551803249239038	0.976 [0.903:1.055]	overlaps null	Galanin peptides (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1166	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Galanin peptides	MR Egger	3	-0.13321328940703234	0.17475146107668812	0.5853519380487635	-0.475726153117341	0.20929957430327636	0.8752783845904735	0.6214336366124429	1.2328142626902812	0.875 [0.621:1.233]	overlaps null	Galanin peptides (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1166	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Galanin peptides	Weighted median	3	-0.02854797156608868	0.04809640278715269	0.5528082395009895	-0.12281692102890794	0.06572097789673058	0.97185567158928865	0.8844255674625758	1.0679286998792397	0.972 [0.884:1.068]	overlaps null	Galanin peptides (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1414	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Gamma-interferon-inducible protein 16	Inverse variance weighted	3	-0.02337578714750404	0.019085698311030307	0.2206580124526872	-0.06078375583712344	0.014032181542115364	0.9768953100860344	0.9410267093086664	1.01413109471589	0.977 [0.941:1.014]	overlaps null	Gamma-interferon-inducible protein 16 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1414	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Gamma-interferon-inducible protein 16	MR Egger	3	0.004783675956655559	0.05385014845979593	0.9435951468148545	-0.10076261502454446	0.11032996693785559	1.0047951360009104	0.9041476384777529	1.1166464660914228	1.005 [0.904:1.117]	overlaps null	Gamma-interferon-inducible protein 16 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1414	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Gamma-interferon-inducible protein 16	Weighted median	3	-0.02090920569180228	0.020004552983501338	0.29592022039664095	-0.060118129539464896	0.01829971815586034	0.9793078761141918	0.9416532899443214	1.0184681840552972	0.979 [0.942:1.018]	overlaps null	Gamma-interferon-inducible protein 16 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1305	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	GDH/6PGL endoplasmic bifunctional protein	Inverse variance weighted	4	-0.02569375056966011	0.022655279283709074	0.25674522930983407	-0.0700980979657299	0.018710596826409676	0.9746335248703841	0.9323023584551208	1.0188867368900865	0.975 [0.932:1.019]	overlaps null	GDH/6PGL endoplasmic bifunctional protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1305	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	GDH/6PGL endoplasmic bifunctional protein	MR Egger	4	-0.06616986443019897	0.043229080883335574	0.2655024456837952	-0.1508988629615367	0.018559134101138755	0.9359718624605243	0.859934665506688	1.018732425214703	0.936 [0.86:1.019]	overlaps null	GDH/6PGL endoplasmic bifunctional protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1305	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	GDH/6PGL endoplasmic bifunctional protein	Weighted median	4	-0.03194465580944768	0.02005529539071765	0.11119856078842236	-0.07125303477525427	0.0073637231563589145	0.9685601847753126	0.9312262296937126	1.007390902037348	0.969 [0.931:1.007]	overlaps null	GDH/6PGL endoplasmic bifunctional protein (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1223	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Glycolipid transfer protein domain-containing protein 2	Inverse variance weighted	3	-0.00310640121355161	0.03790401682653734	0.9346829695543286	-0.07739827419356479	0.07118547176646156	0.9968984186585876	0.925521168995377	1.0737803633413778	0.997 [0.926:1.074]	overlaps null	Glycolipid transfer protein domain-containing protein 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1223	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Glycolipid transfer protein domain-containing protein 2	MR Egger	3	0.07578109664675185	0.15945209352489906	0.71755732724853	-0.23674500666205028	0.388307199955554	1.0787264114811155	0.7891925011926739	1.4744826757329144	1.079 [0.789:1.474]	overlaps null	Glycolipid transfer protein domain-containing protein 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1223	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Glycolipid transfer protein domain-containing protein 2	Weighted median	3	-0.0017083320433583654	0.03986710510983022	0.9658205746672994	-0.0798478580586256	0.07643119397190887	0.9982931263252494	0.9232568017839969	1.0794279166344012	0.998 [0.923:1.079]	overlaps null	Glycolipid transfer protein domain-containing protein 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1046	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Glycosaminoglycan xylosylkinase	Inverse variance weighted	3	0.0773192701702095	0.04882904574798525	0.11331465391731099	-0.018385659495841603	0.1730241998362606	1.0803869566622253	0.9817823256603371	1.1888948757972329	1.08 [0.982:1.189]	overlaps null	Glycosaminoglycan xylosylkinase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1046	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Glycosaminoglycan xylosylkinase	MR Egger	3	0.3200558108971768	0.15617090941716227	0.2890001701421966	0.01396082843953872	0.6261507933548148	1.377204625216829	1.0140587358974062	1.8703971600226104	1.377 [1.014:1.87]	positive	Glycosaminoglycan xylosylkinase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1046	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Glycosaminoglycan xylosylkinase	Weighted median	3	0.09802411791070453	0.04710270678496131	0.037427328529275695	0.0057028126121803635	0.1903454232092287	1.1029893865872542	1.0057191046033591	1.209667372684474	1.103 [1.006:1.21]	positive	Glycosaminoglycan xylosylkinase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1277	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Granulins	Inverse variance weighted	4	0.020499560928052638	0.02457457006343	0.40418079598113066	-0.02766659639627016	0.06866571825237544	1.0207111200774759	0.9727126186373252	1.0710781074366515	1.021 [0.973:1.071]	overlaps null	Granulins (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1277	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Granulins	MR Egger	4	-0.026223411814697114	0.04304394054278353	0.6043626573479097	-0.11058953527855284	0.0581427116491586	0.9741174359523612	0.8953061651138549	1.0598662401768804	0.974 [0.895:1.06]	overlaps null	Granulins (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1277	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Granulins	Weighted median	4	0.010630738899954025	0.015986713570440604	0.5060675218450574	-0.02070321969810956	0.04196469749801761	1.010687445972618	0.9795096205977399	1.0428576626162143	1.011 [0.98:1.043]	overlaps null	Granulins (M/F) Sun BB/2018 [  3K]	Proteins
prot-b-55	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	growth differentiation factor 15	Inverse variance weighted	3	0.02336413246085841	0.022076545137008095	0.28990786004906094	-0.019905896007677455	0.06663416092939428	1.0236392119573199	0.9802909182554236	1.0689043596582415	1.024 [0.98:1.069]	overlaps null	growth differentiation factor 15 (M/F) Folkersen L/2018 [  3K]	Proteins
prot-b-55	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	growth differentiation factor 15	MR Egger	3	0.026283988354658838	0.03494704321351985	0.5894760256038692	-0.042212216343840064	0.09478019305315774	1.0266324587415196	0.958666314323628	1.0994171690337038	1.027 [0.959:1.099]	overlaps null	growth differentiation factor 15 (M/F) Folkersen L/2018 [  3K]	Proteins
prot-b-55	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	growth differentiation factor 15	Weighted median	3	0.015338041710661207	0.023358641902392972	0.5114172935466439	-0.03044489641802902	0.061120979839351434	1.0154562731787329	0.9700138818340108	1.063027511305753	1.015 [0.97:1.063]	overlaps null	growth differentiation factor 15 (M/F) Folkersen L/2018 [  3K]	Proteins
prot-a-1317	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Hemoglobin subunit zeta	Inverse variance weighted	3	-0.012042965900232563	0.01414779115697711	0.39464389219554435	-0.0397726365679077	0.01568670476744257	0.9880292603833041	0.9610079123721963	1.0158103869965829	0.988 [0.961:1.016]	overlaps null	Hemoglobin subunit zeta (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1317	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Hemoglobin subunit zeta	MR Egger	3	-0.017957383177012204	0.026038617109199524	0.615645938919329	-0.06899307271104327	0.03307830635701886	0.9822028898330722	0.9333331455241999	1.0336314759877179	0.982 [0.933:1.034]	overlaps null	Hemoglobin subunit zeta (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1317	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Hemoglobin subunit zeta	Weighted median	3	-0.012302771088770459	0.014346519287810498	0.3911443259634096	-0.040421948892879034	0.01581640671533812	0.9877725985975048	0.9603841206300475	1.0159421481271218	0.988 [0.96:1.016]	overlaps null	Hemoglobin subunit zeta (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1313	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Heparin-binding EGF-like growth factor	Inverse variance weighted	2	0.05432480319105399	0.047387738547356346	0.25163404894918917	-0.03855516436176445	0.14720477074387242	1.0558274826032858	0.96217862530601606	1.1585911843196937	1.056 [0.962:1.159]	overlaps null	Heparin-binding EGF-like growth factor (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1360	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Hepatocyte nuclear factor 4-alpha	Inverse variance weighted	5	0.051418144203836315	0.03651203613792068	0.15905649353074583	-0.020145446626488213	0.12298173503416085	1.0527630080108932	0.9800561170838468	1.130863765570808	1.053 [0.98:1.131]	overlaps null	Hepatocyte nuclear factor 4-alpha (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1360	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Hepatocyte nuclear factor 4-alpha	MR Egger	5	0.01652554867011982	0.06894533543615149	0.8260136398422251	-0.11860730878473708	0.15165840612497672	1.016662850838052	0.8881565035479305	1.1637626343388876	1.017 [0.888:1.164]	overlaps null	Hepatocyte nuclear factor 4-alpha (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1360	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Hepatocyte nuclear factor 4-alpha	Weighted median	5	0.03761465893555539	0.04452470679678332	0.39822017387858344	-0.049653766386139914	0.1248830842572507	1.038331044189068	0.9515588291241549	1.1330159779181568	1.038 [0.952:1.133]	overlaps null	Hepatocyte nuclear factor 4-alpha (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-10	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Histo-blood group ABO system transferase	Inverse variance weighted	3	0.005828663026117493	0.008884173969572296	0.5117774195647178	-0.011584317954244206	0.02324164400647919	1.0058456827337658	0.9884825219099438	1.023513835651137	1.006 [0.988:1.024]	overlaps null	Histo-blood group ABO system transferase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-10	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Histo-blood group ABO system transferase	MR Egger	3	-0.010867718619767288	0.01728703914899848	0.6427105779944706	-0.04475031535180431	0.023014878112269734	0.9891911216880283	0.9562362095301077	1.0232817639349294	0.989 [0.956:1.023]	overlaps null	Histo-blood group ABO system transferase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-10	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Histo-blood group ABO system transferase	Weighted median	3	0.004640053198324913	0.00864743688253916	0.5915568421000238	-0.012308923091451839	0.021589029488101666	1.0046508349146288	0.9877665218365218	1.0218237587340573	1.005 [0.988:1.022]	overlaps null	Histo-blood group ABO system transferase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2904	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Histone-lysine N-methyltransferase SUV420H2	Inverse variance weighted	3	0.03644184074389314	0.04970605110846511	0.46346879523951046	-0.060982019428698485	0.13386570091648475	1.0371139844858615	0.9408401564674401	1.143239273347665	1.037 [0.941:1.143]	overlaps null	Histone-lysine N-methyltransferase SUV420H2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2904	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Histone-lysine N-methyltransferase SUV420H2	MR Egger	3	0.002299151800332008	0.13778354222923303	0.989377906515966	-0.2677565909689647	0.27235489456962875	1.002301796876588	0.7650939892261437	1.3130529139800868	1.002 [0.765:1.313]	overlaps null	Histone-lysine N-methyltransferase SUV420H2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2904	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Histone-lysine N-methyltransferase SUV420H2	Weighted median	3	0.028716358129136425	0.05592187346285127	0.6075956568693426	-0.08089051385805206	0.1383232301163249	1.0291326479633256	0.922294664401482	1.148346670520221	1.029 [0.922:1.148]	overlaps null	Histone-lysine N-methyltransferase SUV420H2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1347	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	HLA class II histocompatibility antigen, DQ alpha 2 chain	Inverse variance weighted	4	-0.0069109534598528885	0.022298440735451775	0.7566142662880286	-0.05061589730133837	0.03679399038163259	0.9931128722612642	0.9506437452428613	1.0374792681132663	0.993 [0.951:1.037]	overlaps null	HLA class II histocompatibility antigen, DQ alpha 2 chain (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1347	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	HLA class II histocompatibility antigen, DQ alpha 2 chain	MR Egger	4	0.03214299464161639	0.05000681509940935	0.586224832827686	-0.06587036295322593	0.13015635223645872	1.0326651603324395	0.9362522293987967	1.1390064556099346	1.033 [0.936:1.139]	overlaps null	HLA class II histocompatibility antigen, DQ alpha 2 chain (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1347	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	HLA class II histocompatibility antigen, DQ alpha 2 chain	Weighted median	4	0.008849238295974074	0.02387684237653584	0.7109204906985025	-0.03794937276203617	0.05564784935398432	1.0088885085570098	0.9627616816221428	1.0572253155977471	1.009 [0.963:1.057]	overlaps null	HLA class II histocompatibility antigen, DQ alpha 2 chain (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1576	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Immunoglobulin superfamily containing leucine-rich repeat protein 2	Inverse variance weighted	4	-0.07186147244590588	0.03929930588273733	0.06746427658068486	-0.14888811197607105	0.005165167084259278	0.9306598089090133	0.8616655195578654	1.0051785295563243	0.931 [0.862:1.005]	overlaps null	Immunoglobulin superfamily containing leucine-rich repeat protein 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1576	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Immunoglobulin superfamily containing leucine-rich repeat protein 2	MR Egger	4	-0.03943189740324021	0.13096003918065213	0.7917585738024566	-0.2961135741973184	0.21724977939083795	0.9613354211998703	0.7437029577569787	1.2426544528487993	0.961 [0.744:1.243]	overlaps null	Immunoglobulin superfamily containing leucine-rich repeat protein 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1576	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Immunoglobulin superfamily containing leucine-rich repeat protein 2	Weighted median	4	-0.07734006107086536	0.028757150933579896	0.007157626952759004	-0.13370407690068195	-0.020976045241048763	0.9255750480409671	0.8748489143037981	0.9792424218046715	0.926 [0.875:0.979]	negative	Immunoglobulin superfamily containing leucine-rich repeat protein 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1115	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inactive peptidyl-prolyl cis-trans isomerase FKBP6	Inverse variance weighted	3	0.010636100339794407	0.017057608200830063	0.532929751211834	-0.022796811733832512	0.04406901241342133	1.0106928647270834	0.9774610722176831	1.0450544741312702	1.011 [0.977:1.045]	overlaps null	Inactive peptidyl-prolyl cis-trans isomerase FKBP6 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1115	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inactive peptidyl-prolyl cis-trans isomerase FKBP6	MR Egger	3	-0.01696781014889521	0.030367624801866798	0.6756207612909293	-0.07648835476055413	0.04255273446276371	0.9831753323930982	0.9263637019531328	1.0434710818097057	0.983 [0.926:1.043]	overlaps null	Inactive peptidyl-prolyl cis-trans isomerase FKBP6 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1115	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inactive peptidyl-prolyl cis-trans isomerase FKBP6	Weighted median	3	0.009597522491775843	0.011330464316486797	0.3969646606781384	-0.012610187568538277	0.03180523255208996	1.0096437264068407	0.9874689876923217	1.032316424088361	1.01 [0.987:1.032]	overlaps null	Inactive peptidyl-prolyl cis-trans isomerase FKBP6 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1403	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inducible T-cell costimulator	Inverse variance weighted	3	0.011928890580333373	0.03483307508874471	0.7320056987406225	-0.05634393659360626	0.08020171775427301	1.0120003235516921	0.9452139862995033	1.0835056079504688	1.012 [0.945:1.084]	overlaps null	Inducible T-cell costimulator (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1403	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inducible T-cell costimulator	MR Egger	3	-0.12052512444577658	0.07751138566088261	0.3638403922996678	-0.2724474403411065	0.031397191449553344	0.8864548153796518	0.7615134530107095	1.031895282483895	0.886 [0.762:1.032]	overlaps null	Inducible T-cell costimulator (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1403	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Inducible T-cell costimulator	Weighted median	3	-0.006243232110686581	0.02869526092480831	0.8277640472498933	-0.06248594352331087	0.04999947930193771	0.9937762163680699	0.9394262677441019	1.0512705489813436	0.994 [0.939:1.051]	overlaps null	Inducible T-cell costimulator (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1397	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Intercellular adhesion molecule 1	Inverse variance weighted	3	0.007516763603067384	0.015501273985575404	0.6277383198458151	-0.022865733408660407	0.03789926061479518	1.0075450853888492	0.9773937062850199	1.0386265970032698	1.008 [0.977:1.039]	overlaps null	Intercellular adhesion molecule 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1397	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Intercellular adhesion molecule 1	MR Egger	3	0.04271723290326522	0.019032517456984234	0.2668355497554373	0.005413498687576124	0.08002096711895432	1.0436427452941726	1.0054281781487233	1.0833097813218873	1.044 [1.005:1.083]	positive	Intercellular adhesion molecule 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1397	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Intercellular adhesion molecule 1	Weighted median	3	0.01094696450762962	0.009943892867727233	0.2709518761926035	-0.008543065513115755	0.030436994528375	1.0110071017634006	0.9914933227748266	1.0309049353508992	1.011 [0.991:1.031]	overlaps null	Intercellular adhesion molecule 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-b-38	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	interleukin 1 receptor like 1	Inverse variance weighted	3	-0.050976247265621735	0.019144728738853572	0.007752156585856008	-0.08849991559377474	-0.013452578937468734	0.9503012425173455	0.9153031879932814	0.9866375026071029	0.95 [0.915:0.987]	negative	interleukin 1 receptor like 1 (M/F) Folkersen L/2018 [  3K]	Proteins
prot-b-38	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	interleukin 1 receptor like 1	MR Egger	3	-0.043446386872024574	0.0591843435712605	0.5968681764473911	-0.15944770027169514	0.072554926527646	0.9574838864210483	0.8526145577401003	1.0752518643194604	0.957 [0.853:1.075]	overlaps null	interleukin 1 receptor like 1 (M/F) Folkersen L/2018 [  3K]	Proteins
prot-b-38	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	interleukin 1 receptor like 1	Weighted median	3	-0.051536342060052275	0.019295989876561215	0.007566356597888469	-0.08935648221811227	-0.01371620190199229	0.9497691327681315	0.9145195055173392	0.9863774365849495	0.95 [0.915:0.986]	negative	interleukin 1 receptor like 1 (M/F) Folkersen L/2018 [  3K]	Proteins
prot-a-1486	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Interleukin-17 receptor A	Inverse variance weighted	3	0.0068478505961384484	0.01197371995457228	0.5673851886611124	-0.016620640514823218	0.030316341707100118	1.0068713507362232	0.983516720269797	1.0307805612651761	1.007 [0.984:1.031]	overlaps null	Interleukin-17 receptor A (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1486	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Interleukin-17 receptor A	MR Egger	3	-0.002476786126338827	0.021033128966346043	0.925377582827242	-0.04370171890037707	0.03874814664769941	0.9975262785776914	0.9572394413268726	1.0395086469418378	0.998 [0.957:1.04]	overlaps null	Interleukin-17 receptor A (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1486	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Interleukin-17 receptor A	Weighted median	3	0.006179405989223508	0.012169451582899235	0.6116075297863293	-0.017672719113258992	0.030031531091706008	1.0061985379060723	0.9824825274986311	1.0304870258221752	1.006 [0.982:1.03]	overlaps null	Interleukin-17 receptor A (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1506	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Interleukin-21	Inverse variance weighted	3	0.005261510497088838	0.03359795410111281	0.8755584396856919	-0.06059047954109227	0.07111350053526995	1.005275376551575	0.9412086050430086	1.0737030848275468	1.005 [0.941:1.074]	overlaps null	Interleukin-21 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1506	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Interleukin-21	MR Egger	3	-0.005315262479969749	0.1099378850095459	0.9692447392655268	-0.22079351709867973	0.21016299213874023	0.994698838533055	0.8018822381682258	1.2338791561703584	0.995 [0.802:1.234]	overlaps null	Interleukin-21 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1506	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Interleukin-21	Weighted median	3	0.004105743675008338	0.03546173817712939	0.9078272674780549	-0.06539926315216527	0.07361075050218194	1.0041141837875973	0.9366934015477056	1.076387740553634	1.004 [0.937:1.076]	overlaps null	Interleukin-21 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1530	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Interleukin-3 receptor subunit alpha	Inverse variance weighted	3	-0.045910167720665467	0.017124615893205755	0.007341439705348845	-0.07947441487134874	-0.01234592056998219	0.9551277596406709	0.9236016501333559	0.9877299776418628	0.955 [0.924:0.988]	negative	Interleukin-3 receptor subunit alpha (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1530	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Interleukin-3 receptor subunit alpha	MR Egger	3	-0.055824388981099086	0.03988049775832228	0.39490789512617597	-0.13399016458741075	0.022341386625212588	0.9457051975621635	0.8745986665997679	1.0225928244015554	0.946 [0.875:1.023]	overlaps null	Interleukin-3 receptor subunit alpha (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1530	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Interleukin-3 receptor subunit alpha	Weighted median	3	-0.04469069429204292	0.016496348930426875	0.006746063474301575	-0.07702353819567959	-0.012357850388406248	0.9562932230458883	0.9258680600864345	0.9877181942728644	0.956 [0.926:0.988]	negative	Interleukin-3 receptor subunit alpha (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1540	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Interleukin-6 receptor subunit alpha	Inverse variance weighted	2	7.731325158648934e-4	0.010305256027127709	0.9401963122810424	-0.019425169297305415	0.0209714343290352	1.0007734314598447	0.9807622835736359	1.021192880161073	1.001 [0.981:1.021]	overlaps null	Interleukin-6 receptor subunit alpha (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1541	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Interleukin-6 receptor subunit alpha	Inverse variance weighted	2	6.112142050826943e-4	0.01036062116983149	0.9529569086383819	-0.019695603287787026	0.02091803169795241	1.0006114010345473	0.9804970879761433	1.0211383472305433	1.001 [0.98:1.021]	overlaps null	Interleukin-6 receptor subunit alpha (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1542	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Interleukin-6 receptor subunit beta	Inverse variance weighted	4	-0.027776236876003217	0.03889354690550653	0.47512790751055434	-0.10400758881079603	0.048455115058789584	0.9726059758054678	0.9012184582188888	1.0496482573626449	0.973 [0.901:1.05]	overlaps null	Interleukin-6 receptor subunit beta (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1542	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Interleukin-6 receptor subunit beta	MR Egger	4	-0.04742283930086762	0.14804749719813595	0.7790939918484674	-0.33759593380921404	0.24275025520747884	0.9536840572222965	0.7134835242309067	1.274750222130753	0.954 [0.713:1.275]	overlaps null	Interleukin-6 receptor subunit beta (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1542	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Interleukin-6 receptor subunit beta	Weighted median	4	7.401638448304403e-5	0.03683092533747136	0.998396551535606	-0.07211459727696082	0.0722626300459269	1.0000740191237631	0.9304242656142997	1.074937617911355	1 [0.93:1.075]	overlaps null	Interleukin-6 receptor subunit beta (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1657	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Kallikrein-12	Inverse variance weighted	3	0.05229915304819828	0.03009133382223553	0.08220838450497765	-0.006679861243383357	0.11127816733977991	1.053690910216975	0.9933423994360698	1.1177057728575617	1.054 [0.993:1.118]	overlaps null	Kallikrein-12 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1657	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Kallikrein-12	MR Egger	3	0.047376533958502054	0.07862030422778844	0.6547429540206879	-0.1067192623279633	0.2014723302449674	1.0485167369182817	0.8987779584073594	1.2232023908840433	1.049 [0.899:1.223]	overlaps null	Kallikrein-12 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1657	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Kallikrein-12	Weighted median	3	0.051298521913892586	0.03237661779845994	0.1130956369450459	-0.012159648971088899	0.11475669279887407	1.0526370816210586	0.9879139808208242	1.1216005108896852	1.053 [0.988:1.122]	overlaps null	Kallikrein-12 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1659	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Kallikrein-14	Inverse variance weighted	2	0.04502521867556995	0.023364759610723835	0.05397255282623732	-7.697101614487639e-4	0.09082014751258867	1.0460542396785832	0.9992305859894293	1.0950720361167112	1.046 [0.999:1.095]	overlaps null	Kallikrein-14 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1666	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Kallikrein-7	Inverse variance weighted	3	0.02718422255789165	0.03794689587575523	0.47375958307257665	-0.04719169335858859	0.1015601384743719	1.0275570845224595	0.9539045229012316	1.1068964834561577	1.028 [0.954:1.107]	overlaps null	Kallikrein-7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1666	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Kallikrein-7	MR Egger	3	0.08607044963939733	0.04122771440687779	0.28438226778968684	0.005264129401916867	0.1668767698768778	1.0898831074724713	1.0052780092755595	1.18160864655724	1.09 [1.005:1.182]	positive	Kallikrein-7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1666	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Kallikrein-7	Weighted median	3	0.03882516930985755	0.02835738036148838	0.17095611686346981	-0.016755296198659675	0.09440563481837477	1.0395887157486783	0.9833842930695021	1.0990054503906979	1.04 [0.983:1.099]	overlaps null	Kallikrein-7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1655	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Kelch-like protein 13	Inverse variance weighted	3	0.02658062180891849	0.02673395213881119	0.3200940728488004	-0.025817924383151444	0.07897916800098842	1.0269370374458944	0.9745125084225369	1.0821817778257687	1.027 [0.975:1.082]	overlaps null	Kelch-like protein 13 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1655	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Kelch-like protein 13	MR Egger	3	-0.10113837934483184	0.17238347569238574	0.6622178405733856	-0.43900999170190785	0.2367332330122442	0.9038079558792382	0.6446743382038059	1.2671030514206132	0.904 [0.645:1.267]	overlaps null	Kelch-like protein 13 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1655	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Kelch-like protein 13	Weighted median	3	0.022446058263066376	0.02742165155103656	0.41304184300027497	-0.031300378776965274	0.07619249530309803	1.0226998664693796	0.9691844069213437	1.0791702893764883	1.023 [0.969:1.079]	overlaps null	Kelch-like protein 13 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1644	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Killer cell immunoglobulin-like receptor 2DL5A	Inverse variance weighted	2	0.026264161224779727	0.015757131561401152	0.09555197951841879	-0.004619816635566529	0.05714813908512598	1.026612103768213	0.9953908383030375	1.0588126503154898	1.027 [0.995:1.059]	overlaps null	Killer cell immunoglobulin-like receptor 2DL5A (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2824	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Kunitz-type protease inhibitor 2	Inverse variance weighted	3	0.013873393776542732	0.01581986672402932	0.380508246154857	-0.017133545002554734	0.0448803325556402	1.0139700758896102	0.983012399475467	1.0459026919174088	1.014 [0.983:1.046]	overlaps null	Kunitz-type protease inhibitor 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2824	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Kunitz-type protease inhibitor 2	MR Egger	3	-0.02422332819357214	0.027483075513827983	0.5400816279376711	-0.07809015620067498	0.029643499813530705	0.9760677019784867	0.92488103902409	1.0300872421936946	0.976 [0.925:1.03]	overlaps null	Kunitz-type protease inhibitor 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2824	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Kunitz-type protease inhibitor 2	Weighted median	3	0.011524250038294702	0.012785082586540174	0.3673849688611687	-0.013534511831324038	0.036583011907913444	1.0115909100304676	0.986556667852886	1.037260405409236	1.012 [0.987:1.037]	overlaps null	Kunitz-type protease inhibitor 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2666	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	L-Selectin	Inverse variance weighted	2	-0.04082844167809906	0.02336096600478996	0.08051241878604982	-0.08661593504748738	0.004959051691289261	0.9599938107484214	0.9170292267946465	1.0049713681390116	0.96 [0.917:1.005]	overlaps null	L-Selectin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1792	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Leucine-rich repeat neuronal protein 1	Inverse variance weighted	2	-0.010255132884954837	0.01398517993451434	0.4633841763367237	-0.03766608555660294	0.01715581978669327	0.9897972716986468	0.9630344583236782	1.0173038260410885	0.99 [0.963:1.017]	overlaps null	Leucine-rich repeat neuronal protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1744	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Leukocyte immunoglobulin-like receptor subfamily B member 2	Inverse variance weighted	3	-5.415818318591554e-4	0.019801987474119705	0.9781806792570876	-0.03935347728113378	0.038270313617415466	0.9994585647971094	0.9614108121970331	1.0390120540287602	0.999 [0.961:1.039]	overlaps null	Leukocyte immunoglobulin-like receptor subfamily B member 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1744	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Leukocyte immunoglobulin-like receptor subfamily B member 2	MR Egger	3	-0.06934430906382834	0.18211560974953941	0.7683847455542081	-0.4262909041729256	0.28760228604526894	0.9330053825587364	0.6529263754837301	1.3332269557017848	0.933 [0.653:1.333]	overlaps null	Leukocyte immunoglobulin-like receptor subfamily B member 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1744	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Leukocyte immunoglobulin-like receptor subfamily B member 2	Weighted median	3	5.856934421991433e-4	0.020553082650305154	0.9772660616088739	-0.039698348552398954	0.04086973543679724	1.000585864994094	0.9610793063947219	1.0417163979751645	1.001 [0.961:1.042]	overlaps null	Leukocyte immunoglobulin-like receptor subfamily B member 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1746	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Leukocyte immunoglobulin-like receptor subfamily B member 4	Inverse variance weighted	2	-0.06008696845988286	0.058351090760212505	0.3031279187298172	-0.17445510634989936	0.054281169430133655	0.9416826333346116	0.8399145602132051	1.05578141388442	0.942 [0.84:1.056]	overlaps null	Leukocyte immunoglobulin-like receptor subfamily B member 4 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1074	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Low affinity immunoglobulin gamma Fc region receptor II-a	Inverse variance weighted	4	0.011364225557518134	0.010986947013966766	0.30097780548756814	-0.010170190589856725	0.032898641704893	1.011429043671967	0.9898813509214773	1.0334457856296544	1.011 [0.99:1.033]	overlaps null	Low affinity immunoglobulin gamma Fc region receptor II-a (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1074	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Low affinity immunoglobulin gamma Fc region receptor II-a	MR Egger	4	-0.003908454576080602	0.022223612467379347	0.8765921093068904	-0.047466735012144115	0.03964982585998292	0.9960991734912851	0.9536421955010534	1.040446372980279	0.996 [0.954:1.04]	overlaps null	Low affinity immunoglobulin gamma Fc region receptor II-a (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1074	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Low affinity immunoglobulin gamma Fc region receptor II-a	Weighted median	4	0.011272978806363543	0.009615903727906456	0.2410659942839718	-0.0075741925003331104	0.0301201501130602	1.0113367582681443	0.9924544194127318	1.0305783506204191	1.011 [0.992:1.031]	overlaps null	Low affinity immunoglobulin gamma Fc region receptor II-a (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1779	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Low-density lipoprotein receptor-related protein 1B	Inverse variance weighted	3	-0.08421506550900715	0.03981023218432612	0.034394799530346264	-0.16224312059028634	-0.006187010427727957	0.9192335394058178	0.850234469904323	0.9938320897100703	0.919 [0.85:0.994]	negative	Low-density lipoprotein receptor-related protein 1B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1779	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Low-density lipoprotein receptor-related protein 1B	MR Egger	3	0.04161109530894823	0.10725747395643304	0.764399751556174	-0.1686135536456605	0.251835744263557	1.042488971052739	0.8448353238408902	1.2863847238604278	1.042 [0.845:1.286]	overlaps null	Low-density lipoprotein receptor-related protein 1B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1779	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Low-density lipoprotein receptor-related protein 1B	Weighted median	3	-0.05372513333404415	0.04847844083466784	0.2677636479985162	-0.14874287736999312	0.04129261070190482	0.947692559799457	0.8617906722982037	1.0421570072279365	0.948 [0.862:1.042]	overlaps null	Low-density lipoprotein receptor-related protein 1B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2356	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Lysosomal Pro-X carboxypeptidase	Inverse variance weighted	2	-0.010909205903944978	0.042548691634428606	0.7976470438717802	-0.09430464150742504	0.07248622969953508	0.9891500836861402	0.9100054945636608	1.0751780004640965	0.989 [0.91:1.075]	overlaps null	Lysosomal Pro-X carboxypeptidase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1931	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MAGUK p55 subfamily member 6	Inverse variance weighted	3	0.032071412793812384	0.031122218509512235	0.30277585547804453	-0.028928135484831592	0.09307096107245635	1.0325912428977049	0.9714862773483547	1.0975396150929817	1.033 [0.971:1.098]	overlaps null	MAGUK p55 subfamily member 6 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1931	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MAGUK p55 subfamily member 6	MR Egger	3	0.06094601619231721	0.08934977836367032	0.6189096523724014	-0.11417954940047662	0.23607158178511103	1.062841536405375	0.8920977658827987	1.2662649484282489	1.063 [0.892:1.266]	overlaps null	MAGUK p55 subfamily member 6 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1931	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MAGUK p55 subfamily member 6	Weighted median	3	0.028203201802404855	0.03416370667620445	0.40907014284039467	-0.03875766328295586	0.09516406688776557	1.028604677511252	0.9619838048985251	1.0998392875331544	1.029 [0.962:1.1]	overlaps null	MAGUK p55 subfamily member 6 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1833	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB	Inverse variance weighted	3	0.07830078926119156	0.037391562851373975	0.03625317516189268	0.005013326072498575	0.15158825244988455	1.0814478976675888	1.0050259138183535	1.1636809949768379	1.081 [1.005:1.164]	positive	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1833	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB	MR Egger	3	0.012951627316090153	0.12738712556425316	0.935495629641556	-0.23672713878984605	0.2626303934220264	1.0130358629109943	0.7892066025094097	1.3003460136809832	1.013 [0.789:1.3]	overlaps null	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1833	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB	Weighted median	3	0.058085557413868505	0.042814394788941106	0.17488198718845624	-0.02583065637245606	0.14200177120019308	1.0598056660634634	0.974500101018688	1.1525786899827952	1.06 [0.975:1.153]	overlaps null	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1854	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MAP kinase-activated protein kinase 5	Inverse variance weighted	4	0.022740902918954614	0.011663852961672081	0.051213023326438026	-1.2024888592266497e-4	0.04560205472383189	1.0230014485173284	0.9998797583436848	1.0466578155378876	1.023 [1:1.047]	overlaps null	MAP kinase-activated protein kinase 5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1854	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MAP kinase-activated protein kinase 5	MR Egger	4	0.03775244228866816	0.029063261636678776	0.32353647690574916	-0.019211550519222236	0.09471643509655855	1.0384741187783997	0.9809718151933905	1.0993470746761163	1.038 [0.981:1.099]	overlaps null	MAP kinase-activated protein kinase 5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1854	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MAP kinase-activated protein kinase 5	Weighted median	4	0.024344338298328508	0.012843989217000504	0.05804106612191959	-8.298805669924789e-4	0.049518557163649495	1.0246430810071183	0.9991704636886484	1.050765091253656	1.025 [0.999:1.051]	overlaps null	MAP kinase-activated protein kinase 5 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2815	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Maspardin	Inverse variance weighted	3	-0.023743465900452686	0.02368215115671478	0.3160591716404285	-0.07016048216761366	0.02267355036670828	0.9765361924606666	0.9322441993306984	1.0229325490791217	0.977 [0.932:1.023]	overlaps null	Maspardin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2815	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Maspardin	MR Egger	3	0.016157956477630495	0.040512021586204046	0.7583970688118508	-0.06324560583132943	0.09556151878659042	1.0162892021910601	0.9387128920139676	1.1002765076276093	1.016 [0.939:1.1]	overlaps null	Maspardin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2815	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Maspardin	Weighted median	3	-0.018444670088644505	0.024645276420364036	0.4542153695494622	-0.066749411872558	0.029860071695269004	0.9817243918126687	0.9354295795160403	1.030310354285122	0.982 [0.935:1.03]	overlaps null	Maspardin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1898	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MHC class I polypeptide-related sequence B	Inverse variance weighted	4	-0.01146838920925316	0.019682882662700126	0.5601235467013309	-0.05004683922814541	0.02711006080963909	0.9885971220907537	0.9511848706921223	1.027480881918336	0.989 [0.951:1.027]	overlaps null	MHC class I polypeptide-related sequence B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1898	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MHC class I polypeptide-related sequence B	MR Egger	4	-0.008373840582251546	0.03310928869224592	0.823955054166457	-0.07326804641905355	0.05652036525455045	0.9916611223613617	0.929351687244562	1.05814816403751	0.992 [0.929:1.058]	overlaps null	MHC class I polypeptide-related sequence B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1898	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	MHC class I polypeptide-related sequence B	Weighted median	4	-0.01653927856832464	0.021193529175662064	0.4351596769897327	-0.05807859575262228	0.025000038615973007	0.9835967443599858	0.9435757834734921	1.0253151601179706	0.984 [0.944:1.025]	overlaps null	MHC class I polypeptide-related sequence B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1922	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Multimerin-2	Inverse variance weighted	4	0.036430437058484845	0.029755537563561394	0.22082979495528057	-0.021890416566095486	0.09475129068306518	1.0371021576316848	0.9783474398491782	1.0993853937309912	1.037 [0.978:1.099]	overlaps null	Multimerin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1922	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Multimerin-2	MR Egger	4	-0.005307153920378034	0.029487001090811694	0.8737512331459616	-0.06310167605836896	0.052487368217612886	0.9947069041405633	0.9388480104709414	1.053889249494797	0.995 [0.939:1.054]	overlaps null	Multimerin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1922	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Multimerin-2	Weighted median	4	0.02977150477249188	0.0242270939364871	0.21912742577543412	-0.017713599343022836	0.07725660888800659	1.0302191069083468	0.9824423642081158	1.0803192603512364	1.03 [0.982:1.08]	overlaps null	Multimerin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2395	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Myeloblastin	Inverse variance weighted	3	-0.00656433303313182	0.04319855528453663	0.8792206650964869	-0.09123350139082362	0.07810483532455997	0.9934571651348539	0.9128045448821736	1.0812360044561113	0.993 [0.913:1.081]	overlaps null	Myeloblastin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2395	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Myeloblastin	MR Egger	3	-0.10513776561913275	0.05701538332337062	0.31634031819304725	-0.21688791693293916	0.00661238569467365	0.900200497364393	0.8050201933809314	1.0066342957829901	0.9 [0.805:1.007]	overlaps null	Myeloblastin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2395	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Myeloblastin	Weighted median	3	-0.014399531439406851	0.027728217355566076	0.6035448102231943	-0.06874683745631635	0.039947774577502655	0.9857036459842198	0.9335629933461902	1.0407564188293446	0.986 [0.934:1.041]	overlaps null	Myeloblastin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2396	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Myeloblastin	Inverse variance weighted	3	-7.058753777797277e-4	0.02455996803140209	0.9770712430821595	-0.04884341271932782	0.04743166196376837	0.9992943736936368	0.95233024082646	1.0485745411477776	0.999 [0.952:1.049]	overlaps null	Myeloblastin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2396	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Myeloblastin	MR Egger	3	-0.05117133639973503	0.05141400360751204	0.5015059311049146	-0.15194278347045861	0.049600110670988566	0.9501158671537436	0.8590374304755394	1.050850788326638	0.95 [0.859:1.051]	overlaps null	Myeloblastin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2396	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Myeloblastin	Weighted median	3	-0.004065118882904681	0.025867379266511333	0.8751247977442433	-0.05476518224526689	0.046634944479457534	0.9959431325280859	0.9467074255671583	1.0477394561848106	0.996 [0.947:1.048]	overlaps null	Myeloblastin (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1930	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Myeloperoxidase	Inverse variance weighted	4	-0.006092613068908909	0.03397652234133	0.8576877589419211	-0.0726865968579157	0.06050137072009789	0.9939259092625378	0.9298922155049844	1.0623690537799404	0.994 [0.93:1.062]	overlaps null	Myeloperoxidase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1930	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Myeloperoxidase	MR Egger	4	9.367301915789214e-4	0.07040081602226597	0.9905918852450111	-0.13704886921206239	0.13892232959522022	1.000937169060328	0.8719276146754191	1.1490348505356816	1.001 [0.872:1.149]	overlaps null	Myeloperoxidase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1930	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Myeloperoxidase	Weighted median	4	0.008491160466196948	0.0402524424973709	0.8329280764346719	-0.07040362682865	0.08738594776104391	1.0085273126213663	0.9320175566854402	1.091317790107424	1.009 [0.932:1.091]	overlaps null	Myeloperoxidase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-213	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2	Inverse variance weighted	3	0.032477959727857816	0.035460197589403365	0.35971986815898244	-0.03702402754737277	0.1019799470030884	1.033011125046744	0.9636529808532334	1.1073612655932454	1.033 [0.964:1.107]	overlaps null	N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-213	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2	MR Egger	3	-0.05299419677745142	0.10285734008591761	0.6971283779865229	-0.25459458334584995	0.14860618979094709	0.9483855161585407	0.7752307257072067	1.1602159943270942	0.948 [0.775:1.16]	overlaps null	N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-213	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2	Weighted median	3	0.03456625140505875	0.024177239202069576	0.1528025165657778	-0.012821137430997616	0.08195364024111512	1.0351706076115836	0.9872607032147485	1.0854054895263527	1.035 [0.987:1.085]	overlaps null	N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2736	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	NAD-dependent protein deacetylase sirtuin-2	Inverse variance weighted	3	-0.03016984365961866	0.026076016143529182	0.24727403712234283	-0.08127883530093585	0.020939147981698533	0.9702807235239947	0.9219365871356775	1.0211599101052906	0.97 [0.922:1.021]	overlaps null	NAD-dependent protein deacetylase sirtuin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2736	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	NAD-dependent protein deacetylase sirtuin-2	MR Egger	3	-0.05002142420533204	0.05758495127521985	0.5446737899875762	-0.16288792870476293	0.06284508029409887	0.9512090453845096	0.8496864085351193	1.0648618583663185	0.951 [0.85:1.065]	overlaps null	NAD-dependent protein deacetylase sirtuin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2736	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	NAD-dependent protein deacetylase sirtuin-2	Weighted median	3	-0.03285239009781091	0.028820245748534087	0.2543251897137194	-0.08934007176493772	0.023635291569315903	0.9676813884023914	0.9145345133200038	1.0239168186895125	0.968 [0.915:1.024]	overlaps null	NAD-dependent protein deacetylase sirtuin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2025	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial	Inverse variance weighted	2	-0.006407206560654	0.01344522537594139	0.6336887182839767	-0.032759848297499124	0.019945435176191125	0.9936132758190087	0.9677709435239346	1.0201456744390929	0.994 [0.968:1.02]	overlaps null	NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2007	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Neural cell adhesion molecule 1	Inverse variance weighted	3	0.0011372135112045184	0.050424044736810704	0.9820068343685371	-0.09769391417294446	0.0999683411953535	1.001137860383677	0.9069264586091121	1.1051359302392907	1.001 [0.907:1.105]	overlaps null	Neural cell adhesion molecule 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2007	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Neural cell adhesion molecule 1	MR Egger	3	0.06331039398018531	0.3726356036214299	0.8928620273530659	-0.6670553891178173	0.7936761770781879	1.0653574684609455	0.5132175810565772	2.21151140860935	1.065 [0.513:2.212]	overlaps null	Neural cell adhesion molecule 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2007	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Neural cell adhesion molecule 1	Weighted median	3	-0.013560818940627932	0.06191480421669397	0.8266314673024098	-0.1349138352053481	0.10779219732409226	0.9865307147401675	0.8737911984836382	1.1138162673355996	0.987 [0.874:1.114]	overlaps null	Neural cell adhesion molecule 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2101	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Neurensin-1	Inverse variance weighted	3	0.028243047558920365	0.03619282399588023	0.4351852579727019	-0.042694887473004886	0.09918098259084561	1.0286456638593435	0.9582037054241623	1.1042661344210114	1.029 [0.958:1.104]	overlaps null	Neurensin-1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2101	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Neurensin-1	MR Egger	3	0.08072869443135	0.3437228704893915	0.8531416001062291	-0.5929681317278573	0.7544255205905573	1.084076740608919	0.5526844076769482	2.126389605360807	1.084 [0.553:2.126]	overlaps null	Neurensin-1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2101	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Neurensin-1	Weighted median	3	0.03874698836181634	0.040612477101147446	0.3400501754771881	-0.04085346675643266	0.11834744348006533	1.039507442894344	0.9599697871287054	1.1256351380232161	1.04 [0.96:1.126]	overlaps null	Neurensin-1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2082	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Neuropeptide W	Inverse variance weighted	3	0.03588420994824914	0.025551249878309236	0.160199367662167	-0.014196239813236963	0.08596465970973524	1.0365358190059393	0.9859040516510403	1.0897678149136951	1.037 [0.986:1.09]	overlaps null	Neuropeptide W (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2082	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Neuropeptide W	MR Egger	3	0.054271930813503254	0.07232938932237302	0.5901942932334989	-0.08749367225834787	0.1960375338853544	1.0557716599697478	0.9162246692655371	1.2165725671726393	1.056 [0.916:1.217]	overlaps null	Neuropeptide W (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2082	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Neuropeptide W	Weighted median	3	0.03831390469019222	0.027700177071867928	0.1666143975879327	-0.01597844237066892	0.09260625175105336	1.0390573466659934	0.9841485357359445	1.097029696694332	1.039 [0.984:1.097]	overlaps null	Neuropeptide W (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2337	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Neutrophil-activating peptide 2	Inverse variance weighted	3	-0.0025643833254579565	0.10142563066757657	0.9798289261011417	-0.20135861943390804	0.1962298527829921	0.9974389018966724	0.817619164849382	1.2168065595675128	0.997 [0.818:1.217]	overlaps null	Neutrophil-activating peptide 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2337	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Neutrophil-activating peptide 2	MR Egger	3	-0.7870982569719914	1.0768693706043833	0.5981825563638805	-2.8977622233565827	1.3235657094125997	0.45516364881447746	0.05514648760427482	3.756793155871804	0.455 [0.055:3.757]	overlaps null	Neutrophil-activating peptide 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2337	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Neutrophil-activating peptide 2	Weighted median	3	-0.04000006267746348	0.053890698569739895	0.4579393455546624	-0.14562583187415368	0.06562570651922671	0.9607893789324801	0.8644811039522355	1.067826961687372	0.961 [0.864:1.068]	overlaps null	Neutrophil-activating peptide 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2189	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	PAX-interacting protein 1	Inverse variance weighted	3	0.0696612848801715	0.03939783874096638	0.07703584611687743	-0.007558479052122619	0.1468810488124656	1.0721449680334632	0.9924700144163779	1.1582161836450409	1.072 [0.992:1.158]	overlaps null	PAX-interacting protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2189	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	PAX-interacting protein 1	MR Egger	3	0.05292821210575182	0.12317527788835299	0.741632040788939	-0.18849533255542003	0.29435175676692366	1.0543539525524375	0.8282043690276142	1.3422559682559247	1.054 [0.828:1.342]	overlaps null	PAX-interacting protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2189	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	PAX-interacting protein 1	Weighted median	3	0.05622612094401948	0.04824478570602206	0.24384329965596174	-0.03833365903978375	0.1507859009278227	1.0578368557631337	0.9623917765984187	1.1627476882294379	1.058 [0.962:1.163]	overlaps null	PAX-interacting protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2341	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Peptidyl-prolyl cis-trans isomerase E	Inverse variance weighted	2	-0.012141436242061945	0.030246074474093602	0.6881095390078008	-0.0714237422112854	0.047140869727161513	0.9879319735943071	0.9310672760193497	1.0482696681412083	0.988 [0.931:1.048]	overlaps null	Peptidyl-prolyl cis-trans isomerase E (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2398	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	PH and SEC7 domain-containing protein 1	Inverse variance weighted	4	-0.015014416839035897	0.019880288205100464	0.4501041479629925	-0.05397978172103281	0.02395094804296101	0.985097737505172	0.9474512621420764	1.0242400756782024	0.985 [0.947:1.024]	overlaps null	PH and SEC7 domain-containing protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2398	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	PH and SEC7 domain-containing protein 1	MR Egger	4	-0.03558603304940021	0.04310558088378308	0.4958568923902782	-0.12007297158161505	0.04890090548281463	0.9650397053497943	0.886855719091426	1.0501162848176997	0.965 [0.887:1.05]	overlaps null	PH and SEC7 domain-containing protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2398	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	PH and SEC7 domain-containing protein 1	Weighted median	4	-0.017872111686399475	0.02168648820327283	0.40987548953990366	-0.06037762856481422	0.02463340519201527	0.9822866473085841	0.9414089635359674	1.0249393142132264	0.982 [0.941:1.025]	overlaps null	PH and SEC7 domain-containing protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2166	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Platelet-activating factor acetylhydrolase IB subunit beta	Inverse variance weighted	3	-0.05376307554449384	0.04282619222279291	0.2093414362483546	-0.13770241230116795	0.030176261212180262	0.9476566029310572	0.871357958576327	1.030636179126797	0.948 [0.871:1.031]	overlaps null	Platelet-activating factor acetylhydrolase IB subunit beta (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2166	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Platelet-activating factor acetylhydrolase IB subunit beta	MR Egger	3	-0.33336132196341106	0.3687280738074846	0.5320417293365304	-1.056068346626081	0.38934570269925883	0.716511256124648	0.3478206357377544	1.4760147254184177	0.717 [0.348:1.476]	overlaps null	Platelet-activating factor acetylhydrolase IB subunit beta (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2166	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Platelet-activating factor acetylhydrolase IB subunit beta	Weighted median	3	-0.03516112170547799	0.049237252987286886	0.4751553079592098	-0.13166613756056028	0.061343894149604304	0.9654498487990639	0.8766336212674999	1.0632645017635163	0.965 [0.877:1.063]	overlaps null	Platelet-activating factor acetylhydrolase IB subunit beta (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2308	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Plexin-B2	Inverse variance weighted	3	0.01613055847182421	0.022001570854375995	0.4634639868750015	-0.026992520402752736	0.059253637346401156	1.0162613582750333	0.9733685219016266	1.0610443270810785	1.016 [0.973:1.061]	overlaps null	Plexin-B2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2308	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Plexin-B2	MR Egger	3	0.04147342100000071	0.04735963040994284	0.5421217935523441	-0.05135145460348726	0.1342982966034887	1.0423454569833908	0.949944749401569	1.143733940714299	1.042 [0.95:1.144]	overlaps null	Plexin-B2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2308	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Plexin-B2	Weighted median	3	0.01687920024976301	0.02253386562237883	0.45382150090831413	-0.027287176370099493	0.061045576869625515	1.0170224588454373	0.9730817553090395	1.062947358896403	1.017 [0.973:1.063]	overlaps null	Plexin-B2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1610	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Potassium voltage-gated channel subfamily E member 2	Inverse variance weighted	3	-0.013335936488373515	0.021624509813910286	0.5374295312342189	-0.055719975723637676	0.029048102746890646	0.9867525931338662	0.9458039468777184	1.0294741138168404	0.987 [0.946:1.029]	overlaps null	Potassium voltage-gated channel subfamily E member 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1610	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Potassium voltage-gated channel subfamily E member 2	MR Egger	3	5.472743214624896e-4	0.0488689719589917	0.9928709142800334	-0.09523591071816125	0.09633045936108624	1.0005474241033767	0.909158428949255	1.1011228802409077	1.001 [0.909:1.101]	overlaps null	Potassium voltage-gated channel subfamily E member 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1610	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Potassium voltage-gated channel subfamily E member 2	Weighted median	3	-0.011316189798870871	0.022552773061640233	0.6158329098426314	-0.05551962499968573	0.03288724540194399	0.9887475974406807	0.94599345836694	1.0334340082355096	0.989 [0.946:1.033]	overlaps null	Potassium voltage-gated channel subfamily E member 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2357	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	PR domain zinc finger protein 1	Inverse variance weighted	3	0.07888713590110333	0.02214203756432524	3.6695277743180636e-4	0.03548874227502586	0.1222855295271808	1.082082186947147	1.0361259836410448	1.130076725992008	1.082 [1.036:1.13]	positive	PR domain zinc finger protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2357	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	PR domain zinc finger protein 1	MR Egger	3	0.51601558692006	0.24515963645977853	0.28236055466887755	0.03550269945889406	0.9965284743812259	1.675339090570553	1.0361404451428298	2.7088616041880904	1.675 [1.036:2.709]	positive	PR domain zinc finger protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2357	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	PR domain zinc finger protein 1	Weighted median	3	0.07908308144594753	0.018017318208304302	1.1372578072275219e-5	0.0437691377576711	0.11439702513422395	1.0822942369052786	1.0447411357640655	1.1211971799901523	1.082 [1.045:1.121]	positive	PR domain zinc finger protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2073	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Pro-FMRFamide-related neuropeptide FF	Inverse variance weighted	3	0.006026110115751796	0.023443102857346795	0.79713818200001	-0.03992237148464792	0.051974591716151514	1.006044303644358	0.9608640267050736	1.0533489783835166	1.006 [0.961:1.053]	overlaps null	Pro-FMRFamide-related neuropeptide FF (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2073	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Pro-FMRFamide-related neuropeptide FF	MR Egger	3	-0.1906017790783183	0.14381335574406173	0.4115042182072509	-0.47247595633667927	0.09127239818004271	0.8264616369445872	0.62345670412037	1.0955673951807459	0.826 [0.623:1.096]	overlaps null	Pro-FMRFamide-related neuropeptide FF (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2073	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Pro-FMRFamide-related neuropeptide FF	Weighted median	3	0.0024288190822163436	0.020346021289472195	0.9049777687190814	-0.03744938264514916	0.04230702080958185	1.0024317710527337	0.9632431733083829	1.043214718215512	1.002 [0.963:1.043]	overlaps null	Pro-FMRFamide-related neuropeptide FF (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-648	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Probable carboxypeptidase X1	Inverse variance weighted	3	0.02161501511396851	0.026212105206748423	0.40958760318481024	-0.0297607110912584	0.07299074131919542	1.0218503118089513	0.970677778186899	1.075720577115138	1.022 [0.971:1.076]	overlaps null	Probable carboxypeptidase X1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-648	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Probable carboxypeptidase X1	MR Egger	3	0.05423127037712161	0.05121691443416032	0.48180645651066945	-0.046153881913832615	0.15461642266807585	1.0557287327060607	0.9548950098127288	1.1672101598684967	1.056 [0.955:1.167]	overlaps null	Probable carboxypeptidase X1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-648	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Probable carboxypeptidase X1	Weighted median	3	0.01618788684076682	0.028388181437458773	0.568519462252789	-0.03945294877665237	0.07182872245818601	1.0163196205511473	0.9613151839819557	1.0744712955003277	1.016 [0.961:1.074]	overlaps null	Probable carboxypeptidase X1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2427	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Prostaglandin F2 receptor negative regulator	Inverse variance weighted	3	0.020420496374293426	0.015013318559237689	0.17377969780539695	-0.009005608001812444	0.049846600750399296	1.0206304211985024	0.9910348210322272	1.051109844546984	1.021 [0.991:1.051]	overlaps null	Prostaglandin F2 receptor negative regulator (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2427	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Prostaglandin F2 receptor negative regulator	MR Egger	3	0.017719592828398762	0.02586337697017267	0.617600695834392	-0.03297262603313966	0.0684118116899372	1.0178775162137659	0.9675650453200064	1.0708061881987898	1.018 [0.968:1.071]	overlaps null	Prostaglandin F2 receptor negative regulator (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2427	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Prostaglandin F2 receptor negative regulator	Weighted median	3	0.020570973201614245	0.015337205394799876	0.1798404304481512	-0.009489949372193513	0.050631895775422	1.020784013981939	0.9905549380918748	1.0519356000670739	1.021 [0.991:1.052]	overlaps null	Prostaglandin F2 receptor negative regulator (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-995	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Protein eva-1 homolog C	Inverse variance weighted	3	-0.011740457457267732	0.028637279490146147	0.6818271352602632	-0.06786952525795417	0.04438861034341871	0.988328192788975	0.9343823789241186	1.0453885247560377	0.988 [0.934:1.045]	overlaps null	Protein eva-1 homolog C (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-995	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Protein eva-1 homolog C	MR Egger	3	0.023871115507452727	0.21029740034833005	0.9280444991253124	-0.38831178917527415	0.43605402019017964	1.0241583112597656	0.6782008546107516	1.5465923397051211	1.024 [0.678:1.547]	overlaps null	Protein eva-1 homolog C (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-995	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Protein eva-1 homolog C	Weighted median	3	-0.020276728003680997	0.020934264413125406	0.3327495840461117	-0.06130788625340679	0.020754430246044796	0.9799274624122358	0.9405336178211943	1.0209713011791988	0.98 [0.941:1.021]	overlaps null	Protein eva-1 homolog C (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1049	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Protein FAM3B	Inverse variance weighted	3	0.0032779385459116117	0.04755003465021201	0.9450400713678065	-0.08992012936850392	0.09647600646032715	1.0032833168614574	0.9140041844473461	1.101283157145671	1.003 [0.914:1.101]	overlaps null	Protein FAM3B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1049	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Protein FAM3B	MR Egger	3	-0.09133981789535031	0.0441201860569272	0.2864677326751821	-0.17781538256692764	-0.004864253223772999	0.9127075038522685	0.8370969519145036	0.9951475580970939	0.913 [0.837:0.995]	negative	Protein FAM3B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1049	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Protein FAM3B	Weighted median	3	-0.017772175835515554	0.028384333834999383	0.5312321511883551	-0.07340547015211435	0.037861118481083235	0.9823848178657921	0.929223981041507	1.038586982324229	0.982 [0.929:1.039]	overlaps null	Protein FAM3B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2030	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Protein kinase C-binding protein NELL1	Inverse variance weighted	2	-0.02855968766694288	0.025376073791422957	0.2603952988502625	-0.07829679229813187	0.021177416964246115	0.9718442852969262	0.92468994495972	1.0214032498270924	0.972 [0.925:1.021]	overlaps null	Protein kinase C-binding protein NELL1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2329	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2	Inverse variance weighted	2	0.035763879519164925	0.03294107777284275	0.2776150809331951	-0.028800632915606854	0.1003283919539367	1.0364110997099907	0.971610152241699	1.105533906910913	1.036 [0.972:1.106]	overlaps null	Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2616	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Protein S100-A13	Wald ratio	1	0.003699236027342179	0.011258544431041415	0.742479646732962	-0.018367511057498995	0.025765983112183352	1.003706086645682	0.9818001436380239	1.026100795459868	1.004 [0.982:1.026]	overlaps null	Protein S100-A13 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2616	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Protein S100-A13	NO SENSITIVITY	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Protein S100-A13 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2720	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Protein shisa-3 homolog	Inverse variance weighted	3	0.007909269997893759	0.028969715640766475	0.784838949882934	-0.04887137265800853	0.06468991265379605	1.0079406308999335	0.9523036141035652	1.0668281631749321	1.008 [0.952:1.067]	overlaps null	Protein shisa-3 homolog (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2720	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Protein shisa-3 homolog	MR Egger	3	-0.04258562246757904	0.037141034700737256	0.4565921971786633	-0.11538205048102407	0.030210805545865978	0.9583084092773639	0.8910256620875461	1.0306717823818192	0.958 [0.891:1.031]	overlaps null	Protein shisa-3 homolog (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2720	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Protein shisa-3 homolog	Weighted median	3	0.004848511198896935	0.023756620023269233	0.8382824247238051	-0.04171446404671076	0.05141148644450463	1.0048602842488845	0.9591436114617821	1.0527559989914848	1.005 [0.959:1.053]	overlaps null	Protein shisa-3 homolog (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3093	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Protein-tyrosine sulfotransferase 2	Inverse variance weighted	4	0.0680224965086214	0.027109180689438003	0.012100317784351071	0.014888502357322912	0.12115649065991987	1.0703893882320188	1.014999888211532	1.1288015454450353	1.07 [1.015:1.129]	positive	Protein-tyrosine sulfotransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3093	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Protein-tyrosine sulfotransferase 2	MR Egger	4	0.14502833873644086	0.1424038530815956	0.4156211653679771	-0.13408321330348646	0.42413989077636816	1.1560723314329215	0.8745172901028072	1.528275370459094	1.156 [0.875:1.528]	overlaps null	Protein-tyrosine sulfotransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3093	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Protein-tyrosine sulfotransferase 2	Weighted median	4	0.0696511620792349	0.031758016677249555	0.028294151985699963	0.007405449391825775	0.13189687476664402	1.0721341149783084	1.0074329375443192	1.140990648273055	1.072 [1.007:1.141]	positive	Protein-tyrosine sulfotransferase 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2609	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Reticulon-4 receptor	Inverse variance weighted	3	-0.02025882700246321	0.029041295705689144	0.48543558591758024	-0.07717976658561393	0.03666211258068751	0.9799450042519415	0.9257234245085015	1.0373424566502571	0.98 [0.926:1.037]	overlaps null	Reticulon-4 receptor (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2609	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Reticulon-4 receptor	MR Egger	3	-0.014798482239559268	0.09077173571586551	0.8971172391573705	-0.19271108424265565	0.16311411976353712	0.9853104771586648	0.824720214387107	1.1771710205019232	0.985 [0.825:1.177]	overlaps null	Reticulon-4 receptor (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2609	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Reticulon-4 receptor	Weighted median	3	-0.02087543674034719	0.032606120930367445	0.5220226842885843	-0.08478343376386738	0.043032560283173	0.9793409468726991	0.9187112246908291	1.0439718863174667	0.979 [0.919:1.044]	overlaps null	Reticulon-4 receptor (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2493	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Retinoic acid receptor responder protein 1	Inverse variance weighted	2	-0.024586791758071203	0.011849656715566127	0.03799628061831771	-0.047812118920580814	-0.0013614645955615928	0.9757130013966069	0.9533128797057832	0.9986394617769054	0.976 [0.953:0.999]	negative	Retinoic acid receptor responder protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-149	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Rho GTPase-activating protein 30	Inverse variance weighted	5	-0.013548095226969144	0.02731727981623203	0.6199273557909204	-0.06708996366678392	0.039993773212845626	0.9865432671543539	0.9351110715316752	1.040804293305407	0.987 [0.935:1.041]	overlaps null	Rho GTPase-activating protein 30 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-149	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Rho GTPase-activating protein 30	MR Egger	5	-0.039595580359842106	0.12472513571577164	0.7717049315371748	-0.2840568463627545	0.20486568564307028	0.9611780798532419	0.7527238538767048	1.227360201795455	0.961 [0.753:1.227]	overlaps null	Rho GTPase-activating protein 30 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-149	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Rho GTPase-activating protein 30	Weighted median	5	0.006245772093393699	0.03422280166713986	0.8551878140334698	-0.06083091917420042	0.07332246336098783	1.0062653175989844	0.940982328395361	1.0760774765338057	1.006 [0.941:1.076]	overlaps null	Rho GTPase-activating protein 30 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2561	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	RING finger protein 122	Inverse variance weighted	2	-0.048271473753978014	0.05251081782920534	0.3579558167804728	-0.15119267669922049	0.05464972919126444	0.952875071389132	0.859682042002397	1.0561706041456567	0.953 [0.86:1.056]	overlaps null	RING finger protein 122 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2575	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	rRNA methyltransferase 3, mitochondrial	Inverse variance weighted	4	0.014524707521255394	0.01621303149621887	0.3703242082454127	-0.017252834211333595	0.04630224925384438	1.0146307036513815	0.9828951436979273	1.0473909362487255	1.015 [0.983:1.047]	overlaps null	rRNA methyltransferase 3, mitochondrial (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2575	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	rRNA methyltransferase 3, mitochondrial	MR Egger	4	0.008636090953763529	0.030735019481141577	0.805122633442325	-0.05160454722927396	0.06887672913680101	1.008673489569001	0.9497043558127962	1.071304140422262	1.009 [0.95:1.071]	overlaps null	rRNA methyltransferase 3, mitochondrial (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2575	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	rRNA methyltransferase 3, mitochondrial	Weighted median	4	0.01408854008832064	0.01700627685843962	0.40742601888636754	-0.019243762554221014	0.04742084273086229	1.0141882512806648	0.9809402166038769	1.0485631964369682	1.014 [0.981:1.049]	overlaps null	rRNA methyltransferase 3, mitochondrial (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2291	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Secretory phospholipase A2 receptor	Wald ratio	1	-0.007870524332113956	0.012748032368916971	0.536976656191027	-0.032856667775191216	0.017115619110963307	0.9921603671473433	0.9676772489824584	1.0172629305618774	0.992 [0.968:1.017]	overlaps null	Secretory phospholipase A2 receptor (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2291	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Secretory phospholipase A2 receptor	NO SENSITIVITY	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Secretory phospholipase A2 receptor (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2820	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Serine protease inhibitor Kazal-type 6	Inverse variance weighted	2	-0.030592622306571574	0.019042860150298685	0.10816101130569955	-0.06791662820115699	0.0067313835880138465	0.9698705962551736	0.9343383678005293	1.0067540902710568	0.97 [0.934:1.007]	overlaps null	Serine protease inhibitor Kazal-type 6 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2877	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Serine/threonine-protein kinase 16	Inverse variance weighted	4	0.0064096713713385515	0.035301741493787404	0.8559216575826452	-0.06278174195648477	0.07560108469916187	1.0064302572743375	0.93914842802032406	1.0785322453155073	1.006 [0.939:1.079]	overlaps null	Serine/threonine-protein kinase 16 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2877	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Serine/threonine-protein kinase 16	MR Egger	4	0.009776592706052798	0.11343214212990871	0.9391681053238727	-0.21255040586856827	0.23210359128067387	1.0098245397139274	0.8085195611635766	1.26125037660299	1.01 [0.809:1.261]	overlaps null	Serine/threonine-protein kinase 16 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2877	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Serine/threonine-protein kinase 16	Weighted median	4	0.006486570750599615	0.041385451455905664	0.8754532826748225	-0.07462891410297548	0.08760205560417472	1.0065076541122377	0.928087822737627	1.0915536579267393	1.007 [0.928:1.092]	overlaps null	Serine/threonine-protein kinase 16 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2878	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Serine/threonine-protein kinase 17B	Inverse variance weighted	2	-0.018712708871209134	0.02408041758261511	0.43710427276287556	-0.06591032733313475	0.02848490959071648	0.9814612868646134	0.936214813406669	1.0288944842784957	0.981 [0.936:1.029]	overlaps null	Serine/threonine-protein kinase 17B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2729	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Sialic acid-binding Ig-like lectin 7	Inverse variance weighted	3	-0.03827037370114945	0.02948473233168621	0.19429676203189097	-0.09606044907125441	0.019519701668955523	0.9624526838151461	0.9084091019224381	1.0197114566803058	0.962 [0.908:1.02]	overlaps null	Sialic acid-binding Ig-like lectin 7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2729	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Sialic acid-binding Ig-like lectin 7	MR Egger	3	-0.09281086834297135	0.06250922425094442	0.37734150558412055	-0.21532894787482243	0.029707211188879715	0.9113658521308056	0.8062761737164356	1.0301528725593025	0.911 [0.806:1.03]	overlaps null	Sialic acid-binding Ig-like lectin 7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2729	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Sialic acid-binding Ig-like lectin 7	Weighted median	3	-0.03579254329646611	0.033263006705578274	0.28190644249568547	-0.10098803643939953	0.02940294984646731	0.964840435338172	0.9039438472081706	1.029839484541755	0.965 [0.904:1.03]	overlaps null	Sialic acid-binding Ig-like lectin 7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2748	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Solute carrier family 22 member 16	Inverse variance weighted	4	-0.001620605827205547	0.03257229132080351	0.9603183249738075	-0.06546229681598044	0.062221085161569344	0.9983807066453221	0.9366343601915506	1.0641975970193587	0.998 [0.937:1.064]	overlaps null	Solute carrier family 22 member 16 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2748	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Solute carrier family 22 member 16	MR Egger	4	-0.11677990150395277	0.0874353160160065	0.31338498519399904	-0.2881531208953255	0.05459331788741996	0.8897810110753559	0.7496467968617667	1.0561110258652546	0.89 [0.75:1.056]	overlaps null	Solute carrier family 22 member 16 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2748	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Solute carrier family 22 member 16	Weighted median	4	-0.02690305450357497	0.039349560333376686	0.4941684740091065	-0.10402819275699328	0.05022208374984334	0.9734556090872785	0.9011998897535561	1.0515045925301	0.973 [0.901:1.052]	overlaps null	Solute carrier family 22 member 16 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2875	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Stromal interaction molecule 1	Inverse variance weighted	3	-0.042116324651205586	0.03939373030742879	0.2850190351625426	-0.11932803605376602	0.035095386751354846	0.9587582468668934	0.8875166155567193	1.035718497910796	0.959 [0.888:1.036]	overlaps null	Stromal interaction molecule 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2875	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Stromal interaction molecule 1	MR Egger	3	0.04683919991557676	0.13309945581782706	0.7845828274886293	-0.2140357334873643	0.3077141333185178	1.0479534845218546	0.8073195361648049	1.3603120654537344	1.048 [0.807:1.36]	overlaps null	Stromal interaction molecule 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2875	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Stromal interaction molecule 1	Weighted median	3	-0.05545001261592108	0.04446644433748982	0.21239455767390442	-0.1426042435174011	0.031704218285558965	0.9460593135187432	0.8670971603229236	1.032212150668594	0.946 [0.867:1.032]	overlaps null	Stromal interaction molecule 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2889	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Syntaxin-7	Inverse variance weighted	3	-0.0014007503965122144	0.02237397209415676	0.9500800557453577	-0.045253735701059464	0.04245223490803504	0.9986002301964158	0.9557549419136554	1.0433662187000476	0.999 [0.956:1.043]	overlaps null	Syntaxin-7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2889	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Syntaxin-7	MR Egger	3	-0.03526467067714217	0.04574704637378389	0.5819191936368087	-0.12492888156975859	0.05439954021547427	0.96534988263581345	0.8825596666108132	1.0559063949564373	0.965 [0.883:1.056]	overlaps null	Syntaxin-7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2889	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Syntaxin-7	Weighted median	3	-0.0034913215853931596	0.023419884801717215	0.8814943764524439	-0.0493942957967589	0.04241165262597259	0.9965147659911899	0.9518057626889918	1.0433238773770257	0.997 [0.952:1.043]	overlaps null	Syntaxin-7 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3071	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Tenascin-X	Inverse variance weighted	3	0.025917969313937157	0.020121750400831046	0.19772598623885237	-0.013520661471691692	0.06535660009956601	1.0262567604743513	0.9865703321121607	1.067539641258515	1.026 [0.987:1.068]	overlaps null	Tenascin-X (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3071	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Tenascin-X	MR Egger	3	0.00990129078844552	0.061764083925229696	0.8988056068154776	-0.11115631370500467	0.13095889528189572	1.009950470749099	0.8947988686703192	1.1399209242207218	1.01 [0.895:1.14]	overlaps null	Tenascin-X (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3071	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Tenascin-X	Weighted median	3	0.04677515050140746	0.01845989488437842	0.011280749377650353	0.010593756528025758	0.08295654447478916	1.0478863658645725	1.010650069044736	1.0864945933291725	1.048 [1.011:1.086]	positive	Tenascin-X (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3123	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Thioredoxin domain-containing protein 12	Inverse variance weighted	7	-0.04043161234472554	0.01844042965941856	0.02833962803710833	-0.07657485447718591	-0.0042883702122651635	0.9603748400491849	0.9262835752209356	0.9957208117174132	0.96 [0.926:0.996]	negative	Thioredoxin domain-containing protein 12 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3123	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Thioredoxin domain-containing protein 12	MR Egger	7	-0.04431361704040841	0.06057440209588531	0.49726948853679376	-0.16303944514834362	0.0744122110675268	0.9566538874610908	0.849557676825071	1.0772507686760153	0.957 [0.85:1.077]	overlaps null	Thioredoxin domain-containing protein 12 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3123	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Thioredoxin domain-containing protein 12	Weighted median	7	-0.0506685718787549	0.016347295230724118	0.0019384236159494	-0.08270927053097417	-0.018627873226535627	0.9505936718041172	0.9206187593199502	0.9815445532975374	0.951 [0.921:0.982]	negative	Thioredoxin domain-containing protein 12 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3109	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Thiosulfate sulfurtransferase	Inverse variance weighted	3	0.0013772181451324386	0.014302280979540031	0.9232873927395298	-0.026655252574766024	0.029409688865030897	1.0013781669455604	0.9736968631551973	1.0298464246725434	1.001 [0.974:1.03]	overlaps null	Thiosulfate sulfurtransferase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3109	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Thiosulfate sulfurtransferase	MR Egger	3	-0.03210355528727649	0.03096755894464605	0.48853485382118933	-0.09279997081878275	0.028592860244229766	0.9684062932946678	0.9113757838163391	1.0290055601057162	0.968 [0.911:1.029]	overlaps null	Thiosulfate sulfurtransferase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3109	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Thiosulfate sulfurtransferase	Weighted median	3	-0.0026742762106457124	0.015105919368245152	0.8594809094261192	-0.032281878172406214	0.026933325751114786	0.9973292964804824	0.9682336196867553	1.0272993060704194	0.997 [0.968:1.027]	overlaps null	Thiosulfate sulfurtransferase (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3076	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Torsin-1A-interacting protein 1	Inverse variance weighted	4	0.0017905288362849276	0.021955756108960965	0.9350032255647471	-0.041242753137278564	0.04482381080984842	1.0017921327902075	0.959596156693891	1.0458435773419785	1.002 [0.96:1.046]	overlaps null	Torsin-1A-interacting protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3076	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Torsin-1A-interacting protein 1	MR Egger	4	-0.004801409197584932	0.0652606707656724	0.9480464439691361	-0.13271232389830281	0.12310950550313296	0.9952100991414408	0.8757169787227834	1.1310082657957128	0.995 [0.876:1.131]	overlaps null	Torsin-1A-interacting protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3076	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Torsin-1A-interacting protein 1	Weighted median	4	0.02133612858497198	0.0245219575481688	0.3842552657519313	-0.026726908209438866	0.06939916537938283	1.0215653712572244	0.9736270947881671	1.0718639747581866	1.022 [0.974:1.072]	overlaps null	Torsin-1A-interacting protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1258	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Transmembrane glycoprotein NMB	Inverse variance weighted	3	0.03621051784136442	0.03007160360996636	0.22853422437331986	-0.022729825234169644	0.09515086091689848	1.03687410401471	0.977526551106544	1.099824763183469	1.037 [0.978:1.1]	overlaps null	Transmembrane glycoprotein NMB (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1258	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Transmembrane glycoprotein NMB	MR Egger	3	0.06112256050472054	0.06211424054886703	0.5051227351921951	-0.06062135097105883	0.1828664719804999	1.0630291915978545	0.9411795490359767	1.2006540764157556	1.063 [0.941:1.201]	overlaps null	Transmembrane glycoprotein NMB (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1258	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Transmembrane glycoprotein NMB	Weighted median	3	0.046689513805733496	0.033230721491927004	0.16001814536881354	-0.01844270031844343	0.11182172792991042	1.047796632181061	0.9817263255860258	1.11831347881459	1.048 [0.982:1.118]	overlaps null	Transmembrane glycoprotein NMB (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3000	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Transmembrane protein 132C	Inverse variance weighted	2	0.0894512381582881	0.04951625595875716	0.07083989036587593	-0.00760062352087594	0.1865030998374521	1.0935740073295792	0.9924281881762452	1.20502835747194	1.094 [0.992:1.205]	overlaps null	Transmembrane protein 132C (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2951	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Trefoil factor 1	Inverse variance weighted	4	-0.01678887327796887	0.052397737210393334	0.7486558925312892	-0.1194884382103398	0.08591069165440207	0.9833512744514399	0.8873742673943703	1.0897090038509332	0.983 [0.887:1.09]	overlaps null	Trefoil factor 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2951	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Trefoil factor 1	MR Egger	4	0.0032152620774586263	0.16458965517884178	0.9861879731015157	-0.31938046207307125	0.32581098622798854	1.0032204365768764	0.7265990533294359	1.3851535310343697	1.003 [0.727:1.385]	overlaps null	Trefoil factor 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2951	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Trefoil factor 1	Weighted median	4	-0.02077476575301195	0.050547248621369174	0.681074760436728	-0.11984737305089553	0.07829784154487164	0.9794395430555629	0.887055815008437	1.0814447098706699	0.979 [0.887:1.081]	overlaps null	Trefoil factor 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2392	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Trypsin-2	Inverse variance weighted	3	-0.04303111792509227	0.03832712978595705	0.26155107980724035	-0.11815229230556809	0.03209005645538355	0.9578815823159296	0.8885607213490322	1.032610494358837	0.958 [0.889:1.033]	overlaps null	Trypsin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2392	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Trypsin-2	MR Egger	3	-0.06686135017542545	0.18284110621155222	0.7768171181856081	-0.4252299183500678	0.2915072179992169	0.9353248749767908	0.6536194887381374	1.3384432943382412	0.935 [0.654:1.338]	overlaps null	Trypsin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2392	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Trypsin-2	Weighted median	3	-0.04347158815134858	0.043613465492073684	0.31888736040278864	-0.128953980515813	0.04201080421311584	0.957459756906227	0.8790144164048481	1.0429057464658382	0.957 [0.879:1.043]	overlaps null	Trypsin-2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2393	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Trypsin-3	Inverse variance weighted	4	0.0441025994898427	0.027425107908228743	0.1078110159111598	-0.009650612010285636	0.09785581098997104	1.0450895750452225	0.9903958057060025	1.1028037614614308	1.045 [0.99:1.103]	overlaps null	Trypsin-3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2393	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Trypsin-3	MR Egger	4	0.03831029416282925	0.11850123257126151	0.7771480482092106	-0.1939521216768433	0.2705727100025018	1.039053595127784	0.8236973405719524	1.3107148953501613	1.039 [0.824:1.311]	overlaps null	Trypsin-3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2393	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Trypsin-3	Weighted median	4	0.037013659519481386	0.031527609052622876	0.24039189406764488	-0.024780454223659452	0.09880777326262222	1.037707195322999	0.9755240607070004	1.1038540888932042	1.038 [0.976:1.104]	overlaps null	Trypsin-3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2930	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Tubulin-specific chaperone A	Inverse variance weighted	2	0.013337861176601906	0.013945143040058144	0.3388438795570261	-0.013994619181912055	0.04067034153511587	1.0134272072335127	0.9861028502886399	1.041508706784993	1.013 [0.986:1.042]	overlaps null	Tubulin-specific chaperone A (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3048	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Tumor necrosis factor receptor superfamily member 1B	Inverse variance weighted	3	-0.012742425970664733	0.04514194647494159	0.7777329417981762	-0.10122064106155024	0.07573578912022078	0.9873384150047919	0.9037336101431497	1.0786775381627804	0.987 [0.904:1.079]	overlaps null	Tumor necrosis factor receptor superfamily member 1B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3048	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Tumor necrosis factor receptor superfamily member 1B	MR Egger	3	-0.055378758119275485	0.09601969006689286	0.6669563243718184	-0.24357735065038547	0.1328198344118345	0.9461267269006496	0.7838188447899412	1.142044222725511	0.946 [0.784:1.142]	overlaps null	Tumor necrosis factor receptor superfamily member 1B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3048	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Tumor necrosis factor receptor superfamily member 1B	Weighted median	3	-0.01314921291750705	0.05139673060214367	0.798076288618168	-0.11388680489770864	0.08758837906269454	0.9869368603045945	0.8923589608295195	1.0915387293499446	0.987 [0.892:1.092]	overlaps null	Tumor necrosis factor receptor superfamily member 1B (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2978	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Tyrosine-protein kinase receptor Tie-1, soluble	Inverse variance weighted	4	-0.026728515496966025	0.016031640245747318	0.09546763897469189	-0.05815053037863077	0.004693499384698721	0.9736255298907392	0.9435079101436479	1.0047045311053078	0.974 [0.944:1.005]	overlaps null	Tyrosine-protein kinase receptor Tie-1, soluble (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2978	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Tyrosine-protein kinase receptor Tie-1, soluble	MR Egger	4	-0.052724386057455726	0.02596221822372707	0.1793742582186912	-0.10361033377596078	-0.0018384383389506709	0.948641435260795	0.9015765429096667	0.9981632505536788	0.949 [0.902:0.998]	negative	Tyrosine-protein kinase receptor Tie-1, soluble (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2978	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Tyrosine-protein kinase receptor Tie-1, soluble	Weighted median	4	-0.02903354412520185	0.017436427701653982	0.09589110951287483	-0.06320894242044366	0.005141854170039956	0.9713838796976144	0.9387473090613506	1.0051550961886409	0.971 [0.939:1.005]	overlaps null	Tyrosine-protein kinase receptor Tie-1, soluble (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3180	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ubiquitin carboxyl-terminal hydrolase 25	Inverse variance weighted	3	-0.006324309118014755	0.021794859781726874	0.7716828634963915	-0.04904223429019943	0.036393616054169915	0.9936956472326891	0.9521409158535583	1.0370639711916996	0.994 [0.952:1.037]	overlaps null	Ubiquitin carboxyl-terminal hydrolase 25 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3180	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ubiquitin carboxyl-terminal hydrolase 25	MR Egger	3	-0.022695097677729602	0.03898719155403524	0.6643955315159487	-0.09910999312363868	0.053719797768179464	0.977560498804476	0.9056430880327374	1.055188894444819	0.978 [0.906:1.055]	overlaps null	Ubiquitin carboxyl-terminal hydrolase 25 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3180	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ubiquitin carboxyl-terminal hydrolase 25	Weighted median	3	-0.0060624863365143595	0.021667644229044252	0.7796352192974096	-0.04853106902544109	0.036406096352412376	0.9939558534534843	0.9526277416305112	1.0370769141401222	0.994 [0.953:1.037]	overlaps null	Ubiquitin carboxyl-terminal hydrolase 25 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1573	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ubiquitin-like protein ISG15	Inverse variance weighted	4	-0.06507951174690575	0.03741107735202502	0.08193302936739758	-0.13840522335687477	0.008246199863063283	0.9369929584684688	0.8707457737199027	1.0082802934188115	0.937 [0.871:1.008]	overlaps null	Ubiquitin-like protein ISG15 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1573	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ubiquitin-like protein ISG15	MR Egger	4	-0.0408593587286628	0.080269654131063	0.6613339306448649	-0.19818788082554628	0.11646916336822066	0.9599641310300406	0.8202157358508652	1.1235228642721595	0.96 [0.82:1.124]	overlaps null	Ubiquitin-like protein ISG15 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1573	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Ubiquitin-like protein ISG15	Weighted median	4	-0.06817247499196005	0.04638298239961749	0.14162312837935567	-0.15908312049521034	0.02273817051129022	0.9340993509047599	0.8529254604359628	1.0229986532641486	0.934 [0.853:1.023]	overlaps null	Ubiquitin-like protein ISG15 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2747	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Urea transporter 2	Inverse variance weighted	4	-0.04134739883888779	0.023098005636119648	0.0734402101031139	-0.0866194898856823	0.003924692207906713	0.9594957443347647	0.9170259669099194	1.0039324038977393	0.959 [0.917:1.004]	overlaps null	Urea transporter 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2747	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Urea transporter 2	MR Egger	4	-0.04513480950671636	0.037943538335593836	0.3563048019109085	-0.11950414464448028	0.02923452563104756	0.955868612970721	0.8873603300183351	1.029666049240325	0.956 [0.887:1.03]	overlaps null	Urea transporter 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-2747	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Urea transporter 2	Weighted median	4	-0.04606986272134007	0.024444190772485185	0.05947092505737986	-0.09398047663541104	0.0018407511927308953	0.9549752426908721	0.9103005341964968	1.001842446415209	0.955 [0.91:1.002]	overlaps null	Urea transporter 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3193	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Vascular cell adhesion protein 1	Inverse variance weighted	2	0.11465139784286466	0.05442013026822751	0.035136405632410245	0.007987942517138746	0.22131485316859056	1.1214824182306207	1.0080199312479539	1.2477162161300803	1.121 [1.008:1.248]	positive	Vascular cell adhesion protein 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1622	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Vascular endothelial growth factor receptor 2	Inverse variance weighted	4	-0.01652667308510319	0.03091543278433681	0.5929425307459576	-0.07712092134240334	0.04406757517219696	0.9836091431503897	0.9257779005313741	1.0450529721369777	0.984 [0.926:1.045]	overlaps null	Vascular endothelial growth factor receptor 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1622	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Vascular endothelial growth factor receptor 2	MR Egger	4	-0.01802555709714437	0.07428182560849668	0.8308819454762196	-0.16361793528979787	0.12756682109550913	0.9821359314941392	0.8490663582096203	1.1360607785307157	0.982 [0.849:1.136]	overlaps null	Vascular endothelial growth factor receptor 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1622	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Vascular endothelial growth factor receptor 2	Weighted median	4	-0.04984206634017477	0.023763366271332687	0.03595527083786591	-0.09641826423198682	-0.0032658684483627062	0.9513796675089606	0.9080841175192634	0.996739458699166	0.951 [0.908:0.997]	negative	Vascular endothelial growth factor receptor 2 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1129	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Vascular endothelial growth factor receptor 3	Inverse variance weighted	4	-0.018637851452093394	0.0180235035102577	0.30109599165272355	-0.053963918332198484	0.016688215428011695	0.9815347592734532	0.9474662920490616	1.0168282415392869	0.982 [0.947:1.017]	overlaps null	Vascular endothelial growth factor receptor 3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1129	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Vascular endothelial growth factor receptor 3	MR Egger	4	0.012043672826632988	0.04608499160967979	0.8182840575518966	-0.0782829107283394	0.10237025638160538	1.0121164898888741	0.9247027811968208	1.1077935634400768	1.012 [0.925:1.108]	overlaps null	Vascular endothelial growth factor receptor 3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-1129	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Vascular endothelial growth factor receptor 3	Weighted median	4	-0.012174468226905072	0.016270150726984418	0.45429722176147114	-0.04406396365179453	0.01971502719798439	0.9878993407792955	0.956892749160902	1.019910651813353	0.988 [0.957:1.02]	overlaps null	Vascular endothelial growth factor receptor 3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3243	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Xyloside xylosyltransferase 1	Inverse variance weighted	3	0.013144105860173151	0.03673767178663535	0.7205058880933122	-0.05886173084163213	0.08514994256197844	1.0132308693456666	0.942837125440578	1.0888803239639495	1.013 [0.943:1.089]	overlaps null	Xyloside xylosyltransferase 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3243	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Xyloside xylosyltransferase 1	MR Egger	3	-0.17309028421086722	0.2174695944131888	0.5720301384005118	-0.5993306892607173	0.2531501208389828	0.8410616768268898	0.5491790845707959	1.2880766294654271	0.841 [0.549:1.288]	overlaps null	Xyloside xylosyltransferase 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3243	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Xyloside xylosyltransferase 1	Weighted median	3	0.007823064673498546	0.04071705969045154	0.8476385293468147	-0.07198237231978646	0.08762850166678357	1.0078537447959517	0.9305472990568411	1.0915825256048342	1.008 [0.931:1.092]	overlaps null	Xyloside xylosyltransferase 1 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3258	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Zinc fingers and homeoboxes protein 3	Inverse variance weighted	3	0.060059139171944255	0.047012990695206244	0.20142545352543625	-0.03208632259065999	0.1522046009345485	1.0618993445363547	0.9684229816903143	1.164398449072884	1.062 [0.968:1.164]	overlaps null	Zinc fingers and homeoboxes protein 3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3258	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Zinc fingers and homeoboxes protein 3	MR Egger	3	0.12690661134261536	0.16769336923582168	0.5875819372451119	-0.20177239235959513	0.45558561504482586	1.1353109876617065	0.8172809261572768	1.577096684203491	1.135 [0.817:1.577]	overlaps null	Zinc fingers and homeoboxes protein 3 (M/F) Sun BB/2018 [  3K]	Proteins
prot-a-3258	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Zinc fingers and homeoboxes protein 3	Weighted median	3	0.06680397478956779	0.057036244724390554	0.2414963783131171	-0.044987064870237695	0.17859501444937326	1.069085889846446	0.9560098478645578	1.1955364711166587	1.069 [0.956:1.196]	overlaps null	Zinc fingers and homeoboxes protein 3 (M/F) Sun BB/2018 [  3K]	Proteins
ieu-a-1	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Adiponectin	Inverse variance weighted	11	-0.10826523129921764	0.06004926790498302	0.07139762709693302	-0.22596179639298436	0.00943133379454908	0.8973895490670213	0.797748577956688	1.0094759489730287	0.897 [0.798:1.009]	overlaps null	Adiponectin (M/F) Dastani Z/2012 [ 39K]	Other biomarkers
ieu-a-1	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Adiponectin	MR Egger	11	-0.09415111335468448	0.08768370304476948	0.3108751179611679	-0.2660111713224327	0.07770894461306369	0.9101452167515952	0.7664305654102258	1.0808080378845966	0.91 [0.766:1.081]	overlaps null	Adiponectin (M/F) Dastani Z/2012 [ 39K]	Other biomarkers
ieu-a-1	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Adiponectin	Weighted median	11	-0.06638600617439025	0.07864029998021876	0.3985728235463211	-0.22052099413561901	0.08774898178683851	0.9357695817311005	0.8021007992719043	1.091714047521298	0.936 [0.802:1.092]	overlaps null	Adiponectin (M/F) Dastani Z/2012 [ 39K]	Other biomarkers
ukb-d-30630_irnt	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Apoliprotein A	Inverse variance weighted	222	0.0705508873536756	0.03405319734560946	0.03828554030946372	0.0038066205562810596	0.13729515415107013	1.0730991752185874	1.0038138749382832	1.147166689567438	1.073 [1.004:1.147]	positive	Apoliprotein A (M/F) Neale lab/2018 [  NA K]	Other biomarkers
ukb-d-30630_irnt	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Apoliprotein A	MR Egger	222	0.06187220669105546	0.051568511790362655	0.2315052014303763	-0.03920207641805534	0.16294648980016627	1.063826386146892	0.9615563816431644	1.176973707905089	1.064 [0.962:1.177]	overlaps null	Apoliprotein A (M/F) Neale lab/2018 [  NA K]	Other biomarkers
ukb-d-30630_irnt	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Apoliprotein A	Weighted median	222	0.04173310438426648	0.05067838048273384	0.41022979592870223	-0.05759652136189184	0.1410627301304248	1.0426161719277995	0.9440307668535247	1.1514968792686018	1.043 [0.944:1.151]	overlaps null	Apoliprotein A (M/F) Neale lab/2018 [  NA K]	Other biomarkers
ieu-a-780	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	HDL cholesterol	Inverse variance weighted	37	0.09570475473278271	0.04972860572726796	0.05428677110144636	-0.0017633124926624971	0.19317282195822794	1.100434118061723	0.9982382412294442	1.2130924244124854	1.1 [0.998:1.213]	overlaps null	HDL cholesterol (M/F) Willer CJ/2013 [ 92K]	Other biomarkers
ieu-a-780	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	HDL cholesterol	MR Egger	37	0.11102173998468697	0.09163494346291727	0.2337953633644448	-0.06858274920263087	0.2906262291720048	1.11741919926668	0.9337161926362321	1.3372646600081426	1.117 [0.934:1.337]	overlaps null	HDL cholesterol (M/F) Willer CJ/2013 [ 92K]	Other biomarkers
ieu-a-780	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	HDL cholesterol	Weighted median	37	0.08144539299258127	0.0520711024205366	0.11778965925349139	-0.02061396775167046	0.183504753736833	1.084853975337414	0.9795970476393928	1.20142067663584	1.085 [0.98:1.201]	overlaps null	HDL cholesterol (M/F) Willer CJ/2013 [ 92K]	Other biomarkers
ukb-d-30760_irnt	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	HDL cholesterol	Inverse variance weighted	245	0.0849939982967306	0.03358350645269414	0.011379440917514335	0.019170325649450093	0.1508176709440111	1.088710532561228	1.019355256178107	1.1627846293291224	1.089 [1.019:1.163]	positive	HDL cholesterol (M/F) Neale lab/2018 [  NA K]	Other biomarkers
ukb-d-30760_irnt	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	HDL cholesterol	MR Egger	245	0.1087607139250709	0.04870025362343095	0.026442301285444638	0.013308216823146243	0.20421321102699558	1.1148955394430653	1.013397165284469	1.226559641620001	1.115 [1.013:1.227]	positive	HDL cholesterol (M/F) Neale lab/2018 [  NA K]	Other biomarkers
ukb-d-30760_irnt	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	HDL cholesterol	Weighted median	245	0.04143905587776891	0.04574330878127407	0.36498655727213225	-0.04821782933352827	0.13109594108906608	1.0423096372698317	0.9529261891911779	1.1400771563091239	1.042 [0.953:1.14]	overlaps null	HDL cholesterol (M/F) Neale lab/2018 [  NA K]	Other biomarkers
ieu-a-299	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	HDL cholesterol	Inverse variance weighted	78	0.07104737688829015	0.04545972982268221	0.11808457801369374	-0.018053693564166987	0.1601484473407473	1.0736320900110485	0.9821082980476467	1.1736850884906893	1.074 [0.982:1.174]	overlaps null	HDL cholesterol (M/F) Willer CJ/2013 [187K]	Other biomarkers
ieu-a-299	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	HDL cholesterol	MR Egger	78	0.16280592123907067	0.08441386418910221	0.05750706790674944	-0.0026452525715696673	0.328257095049711	1.1768082740321946	0.9973582430260884	1.3885459146843466	1.177 [0.997:1.389]	overlaps null	HDL cholesterol (M/F) Willer CJ/2013 [187K]	Other biomarkers
ieu-a-299	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	HDL cholesterol	Weighted median	78	0.09994714506440934	0.0545886790802494	0.0671134670710824	-0.007046665932879476	0.20694095606169816	1.105112505881656	0.992978103602476	1.2299099509096043	1.105 [0.993:1.23]	overlaps null	HDL cholesterol (M/F) Willer CJ/2013 [187K]	Other biomarkers
ukb-d-30770_irnt	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	IGF-1	Inverse variance weighted	318	0.019669221758654147	0.03896129535358053	0.6136711932539329	-0.05669491713436369	0.09603336065167198	1.0198639354278094	0.9448822927958481	1.10079578664623	1.02 [0.945:1.101]	overlaps null	IGF-1 (M/F) Neale lab/2018 [  NA K]	Other biomarkers
ukb-d-30770_irnt	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	IGF-1	MR Egger	318	0.10948801021053717	0.07764436523274111	0.15948724718330087	-0.04269494564563542	0.26167096606670975	1.1157066937665927	0.9582036496829338	1.2990990244375313	1.116 [0.958:1.299]	overlaps null	IGF-1 (M/F) Neale lab/2018 [  NA K]	Other biomarkers
ukb-d-30770_irnt	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	IGF-1	Weighted median	318	0.04471521975910158	0.05567373201455308	0.4218790942144835	-0.06440529498942246	0.1538357345076256	1.0457300142550772	0.9376249078341995	1.1662992883155114	1.046 [0.938:1.166]	overlaps null	IGF-1 (M/F) Neale lab/2018 [  NA K]	Other biomarkers
ieu-a-1049	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Iron	Inverse variance weighted	3	-0.07868616632555371	0.04421393057213542	0.075130129170465	-0.16534547024693913	0.007973137595831709	0.924329964799745	0.8476008326326863	1.008005007702667	0.924 [0.848:1.008]	overlaps null	Iron (M/F) Benyamin/2014 [ 23K]	Other biomarkers
ieu-a-1049	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Iron	MR Egger	3	-0.03969495249348531	0.08818112543691635	0.7307221082977915	-0.21252995834984137	0.13314005336287074	0.9610825702822093	0.8085360935514672	1.1424099854875076	0.961 [0.809:1.142]	overlaps null	Iron (M/F) Benyamin/2014 [ 23K]	Other biomarkers
ieu-a-1049	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Iron	Weighted median	3	-0.07146850550589	0.04718501111768783	0.1298625212155817	-0.16395112729655814	0.021014116284778145	0.9310255993133769	0.8487835032109848	1.021236467600581	0.931 [0.849:1.021]	overlaps null	Iron (M/F) Benyamin/2014 [ 23K]	Other biomarkers
ukb-d-30080_irnt	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Platelet count	Inverse variance weighted	394	0.021629764099883774	0.029445826509402383	0.46260672470512015	-0.03608405585854489	0.07934358405831245	1.021865383175951	0.9645592132227505	1.082576214107644	1.022 [0.965:1.083]	overlaps null	Platelet count (M/F) Neale lab/2018 [350K]	Other biomarkers
ukb-d-30080_irnt	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Platelet count	MR Egger	394	0.07834374787071596	0.05343791644787776	0.14343079248513685	-0.026394568367124435	0.18308206410855637	1.0814943561634347	0.9739507236377238	1.2009129558883354	1.081 [0.974:1.201]	overlaps null	Platelet count (M/F) Neale lab/2018 [350K]	Other biomarkers
ukb-d-30080_irnt	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Platelet count	Weighted median	394	0.0572540133204132	0.042150051734988134	0.1743564851873951	-0.02536008808016353	0.13986811472098992	1.0589247572296665	0.974958777777969	1.1501221046796613	1.059 [0.975:1.15]	overlaps null	Platelet count (M/F) Neale lab/2018 [350K]	Other biomarkers
ieu-a-1047	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Putamen volume	Inverse variance weighted	4	3.3327123835962756e-4	1.57610026753917e-4	0.03446996652287928	2.435558592195022e-5	0.00064218689079730495	1.0003333267793888	1.0000243558825217	1.000642393136946	1 [1:1.001]	positive	Putamen volume (M/F) Hibar/2015 [ 30K]	Other biomarkers
ieu-a-1047	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Putamen volume	MR Egger	4	-2.7901253464335734e-4	7.345684856763751e-4	0.740611057799941	-0.0017187667665690524	0.0011607416972823378	0.999721026385734	0.9982827094671416	1.0011614156186506	1 [0.998:1.001]	overlaps null	Putamen volume (M/F) Hibar/2015 [ 30K]	Other biomarkers
ieu-a-1047	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Putamen volume	Weighted median	4	2.665156099316517e-4	1.596760849732377e-4	0.09509724500849971	-4.644951661589416e-5	5.794807364791976e-4	1.0002665511283722	0.9999535515621462	1.0005796486678773	1 [1:1.001]	overlaps null	Putamen volume (M/F) Hibar/2015 [ 30K]	Other biomarkers
ukb-d-30240_irnt	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Reticulocyte percentage	Inverse variance weighted	249	-0.1022223821707156	0.03651927900263141	0.005123975271644956	-0.17380016901587314	-0.030644595325558036	0.9028287563244362	0.8404648317931122	0.969820190462142	0.903 [0.84:0.97]	negative	Reticulocyte percentage (M/F) Neale lab/2018 [344K]	Other biomarkers
ukb-d-30240_irnt	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Reticulocyte percentage	MR Egger	249	-0.07651552887140071	0.06456512032611933	0.23712050690836048	-0.2030631647105946	0.05003210696779316	0.926338529185237	0.816226683075077	1.0513048500451183	0.926 [0.816:1.051]	overlaps null	Reticulocyte percentage (M/F) Neale lab/2018 [344K]	Other biomarkers
ukb-d-30240_irnt	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Reticulocyte percentage	Weighted median	249	-0.1269255917583738	0.05407802320046325	0.01892105549284714	-0.2329185172312818	-0.020932666285465834	0.8807992088792654	0.792218123020535	0.9792849012395419	0.881 [0.792:0.979]	negative	Reticulocyte percentage (M/F) Neale lab/2018 [344K]	Other biomarkers
ieu-a-302	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides	Inverse variance weighted	53	-0.056273557792683865	0.04579704504416636	0.2191619607117367	-0.14603576607924992	0.033488650493882194	0.9452805116674344	0.8641267962044603	1.0340557076380992	0.945 [0.864:1.034]	overlaps null	Triglycerides (M/F) Willer CJ/2013 [177K]	Other biomarkers
ieu-a-302	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides	MR Egger	53	-0.10142825131864472	0.0728151439086029	0.16967579353279036	-0.2441459333795064	0.04128943074221697	0.9035460052510267	0.7833733056069795	1.042153693215934	0.904 [0.783:1.042]	overlaps null	Triglycerides (M/F) Willer CJ/2013 [177K]	Other biomarkers
ieu-a-302	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides	Weighted median	53	-0.08859529544673338	0.05505910912414314	0.10759573617804108	-0.19651114933005392	0.019320558436587185	0.915215890673067	0.8215921710419037	1.0195084082632697	0.915 [0.822:1.02]	overlaps null	Triglycerides (M/F) Willer CJ/2013 [177K]	Other biomarkers
ieu-a-783	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides	Inverse variance weighted	27	-0.09076122599167191	0.04854849897615818	0.06155383576148389	-0.18591628398494192	0.004393832001598111	0.9132357418267951	0.8303431050882265	1.0044034990346813	0.913 [0.83:1.004]	overlaps null	Triglycerides (M/F) Willer CJ/2013 [ 86K]	Other biomarkers
ieu-a-783	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides	MR Egger	27	-0.13143805820116083	0.0910872246493307	0.16143671139756258	-0.309969018513849	0.047092902111527335	0.8768335861053258	0.7334696798530101	1.0482193863506444	0.877 [0.733:1.048]	overlaps null	Triglycerides (M/F) Willer CJ/2013 [ 86K]	Other biomarkers
ieu-a-783	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Triglycerides	Weighted median	27	-0.08616963950836404	0.054509050658880294	0.11391650630355207	-0.19300737879976942	0.020668099783041335	0.9174385841882053	0.8244758904741526	1.0208831640585685	0.917 [0.824:1.021]	overlaps null	Triglycerides (M/F) Willer CJ/2013 [ 86K]	Other biomarkers
ukb-a-11	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Morning/evening person (chronotype)	Inverse variance weighted	77	0.25614040972335345	0.10371964158502539	0.013528468324031831	0.05284991221670368	0.45943090723000324	1.2919341153168529	1.0542713999869056	1.5831727564081408	1.292 [1.054:1.583]	positive	Morning/evening person (chronotype) (M/F) Neale Lab/2017 [301K]	Sleep
ukb-a-11	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Morning/evening person (chronotype)	MR Egger	77	0.19926130011747817	0.31248427492966313	0.5256316948616724	-0.4132078787446615	0.8117304789796178	1.2205008412501759	0.6615247515985092	2.2518013118826796	1.221 [0.662:2.252]	overlaps null	Morning/evening person (chronotype) (M/F) Neale Lab/2017 [301K]	Sleep
ukb-a-11	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Morning/evening person (chronotype)	Weighted median	77	0.21464855807048464	0.12260316725548717	0.07998748853890286	-0.025653649750270208	0.4549507658912395	1.2394262340682483	0.9746726092569891	1.5760957834525142	1.239 [0.975:1.576]	overlaps null	Morning/evening person (chronotype) (M/F) Neale Lab/2017 [301K]	Sleep
ukb-b-4424	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Sleep duration	Inverse variance weighted	66	0.2529026724379151	0.1870307948624787	0.17631197361692114	-0.11367768549254315	0.6194830303683734	1.2877579363946847	0.8925455899178041	1.8579672808648513	1.288 [0.893:1.858]	overlaps null	Sleep duration (M/F) MRC-IEU/2018 [460K]	Sleep
ukb-b-4424	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Sleep duration	MR Egger	66	-0.4049479833711208	0.7050034936605372	0.5677164326139676	-1.7867548309457737	0.976858864203532	0.6670115056460609	0.1675028637336633	2.656099954038052	0.667 [0.168:2.656]	overlaps null	Sleep duration (M/F) MRC-IEU/2018 [460K]	Sleep
ukb-b-4424	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Sleep duration	Weighted median	66	0.21553255347464728	0.21537753771346418	0.316962321343676	-0.20660742044374253	0.637672527393037	1.2405223655791915	0.81333888753996	1.8920720047663846	1.241 [0.813:1.892]	overlaps null	Sleep duration (M/F) MRC-IEU/2018 [460K]	Sleep
ukb-a-14	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Snoring	Inverse variance weighted	20	1.7622048864466424	0.5719243196836523	0.0020617819844558167	0.6412332198666839	2.883176553026601	5.825267297877867	1.898821099908777	17.870951135604905	5.825 [1.899:17.871]	positive	Snoring (M/F) Neale Lab/2017 [314K]	Sleep
ukb-a-14	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Snoring	MR Egger	20	-0.3177297856937	2.7761346057272407	0.9101477346072585	-5.7589536129190915	5.123494041531691	0.727799423662961	0.0031544106066303127	167.9210689853657	0.728 [0.003:167.921]	overlaps null	Snoring (M/F) Neale Lab/2017 [314K]	Sleep
ukb-a-14	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Snoring	Weighted median	20	1.450260947930266	0.5203470216025774	0.005318150853511381	0.43038078558921433	2.4701411102713173	4.264227111236544	1.537843000523683	11.824115238039692	4.264 [1.538:11.824]	positive	Snoring (M/F) Neale Lab/2017 [314K]	Sleep
ukb-b-15895	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Treatment/medication code: allopurinol	Inverse variance weighted	12	-3.506537338332713	1.5120352847201668	0.020390464136316677	-6.47012649638424	-0.5429481802811864	0.030000616775958177	0.0015490297738678866	0.5810327355364736	0.03 [0.002:0.581]	negative	Drug: allopurinol (M/F) MRC-IEU/2018 [462K]	Drugs
ukb-b-15895	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Treatment/medication code: allopurinol	MR Egger	12	-4.781021145287362	2.473537119638161	0.0820440631173078	-9.6291538997781565	0.06711160920343406	0.008387429808635832	6.578268502502763e-5	1.0694148280513034	0.008 [0:1.069]	overlaps null	Drug: allopurinol (M/F) MRC-IEU/2018 [462K]	Drugs
ukb-b-15895	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Treatment/medication code: allopurinol	Weighted median	12	-3.7719390402567283	1.5115528182381262	0.012581283423017387	-6.734582564003455	-0.8092955165100011	0.023007407716976812	0.001189071457801262	0.44517157180277456	0.023 [0.001:0.445]	negative	Drug: allopurinol (M/F) MRC-IEU/2018 [462K]	Drugs
ukb-a-142	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Treatment/medication code: allopurinol	Inverse variance weighted	12	-2.282711290064753	1.520160384014533	0.13319390605692424	-5.262225642733238	0.6968030626037316	0.10200726017294816	0.005183754684403786	2.0073251458635193	0.102 [0.005:2.007]	overlaps null	Drug: allopurinol (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-142	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Treatment/medication code: allopurinol	MR Egger	12	-3.854785553327531	2.4954491523153237	0.15344574190306812	-8.745865891865567	1.0362947852105036	0.021178144405784586	1.5911777735623539e-4	2.818753554281523	0.021 [0:2.819]	overlaps null	Drug: allopurinol (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-142	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Treatment/medication code: allopurinol	Weighted median	12	-3.543785195471142	1.5195787340401448	0.019696274562281672	-6.522159514189825	-0.5654108767524586	0.02890371355311551	0.0014704901267732226	0.5681266687548402	0.029 [0.001:0.568]	negative	Drug: allopurinol (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-132	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Treatment/medication code: aspirin	Inverse variance weighted	7	-1.2811133761068858	0.8616014154278043	0.13704176646542743	-2.9698521503453823	0.4076253981316107	0.2777279126305112	0.05131089606939295	1.5032439376967093	0.278 [0.051:1.503]	overlaps null	Drug: aspirin (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-132	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Treatment/medication code: aspirin	MR Egger	7	-1.071386436474646	2.744961887847903	0.7123814419148409	-6.451511736656537	4.308738863707244	0.342533287413274	0.001578134640548904	74.34666851070156	0.343 [0.002:74.347]	overlaps null	Drug: aspirin (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-132	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Treatment/medication code: aspirin	Weighted median	7	-0.8354209538753297	1.0355338686173445	0.4198083021704414	-2.8650673363653247	1.1942254286146656	0.4336918787249803	0.056979294224281954	3.3009999199296565	0.434 [0.057:3.301]	overlaps null	Drug: aspirin (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-153	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Treatment/medication code: insulin product	Inverse variance weighted	8	1.1076585278525937	2.4702736536130017	0.6538680991392525	-3.7340778332288895	5.949394888934076	3.027261840204127	0.023895196267720138	383.5211959123384	3.027 [0.024:383.521]	overlaps null	Drug: insulin product (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-153	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Treatment/medication code: insulin product	MR Egger	8	-0.8046486971388419	5.662076954223495	0.8916434615583226	-11.902319527416891	10.293022133139209	0.4472450174187646	6.7746725300348594e-6	29525.870766314674	0.447 [0:29525.871]	overlaps null	Drug: insulin product (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-153	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Treatment/medication code: insulin product	Weighted median	8	0.2912826661645451	1.5510839818648106	0.8510389476157237	-2.7488419382904836	3.331407270619574	1.3381427781828832	0.06400193649854331	27.977686188350873	1.338 [0.064:27.978]	overlaps null	Drug: insulin product (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-117	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Treatment/medication code: ramipril	Inverse variance weighted	6	1.0633428794301698	1.9883772642097972	0.592802521007656	-2.833876558421033	4.960562317281372	2.8960359248326246	0.05878452973607167	142.67400140099548	2.896 [0.059:142.674]	overlaps null	Drug: ramipril (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-117	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Treatment/medication code: ramipril	MR Egger	6	4.717108913231453	5.083056535700104	0.4059320779673531	-5.24568189674075	14.679899723203656	111.84443283783396	0.005270226718633017	2373555.7926929872	111.844 [0.005:2373555.793]	overlaps null	Drug: ramipril (M/F) Neale Lab/2017 [337K]	Drugs
ukb-a-117	ieu-a-1128	ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)	Treatment/medication code: ramipril	Weighted median	6	3.0960528757442622	2.156793541167216	0.15114787037399116	-1.1312624649434806	7.323368216432005	22.11050590193192	0.32262569558021065	1515.2992397588587	22.111 [0.323:1515.299]	overlaps null	Drug: ramipril (M/F) Neale Lab/2017 [337K]	Drugs
